sign in sign up
<<
Home , Abetimus, Acefylline, Acetoxolone, Acetrizoic acid, Acetyldigitoxin, Acetyldihydrocodeine

MTC

eHealth DSI

[eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue

Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC

Table of Contents

epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC

epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient

epSOSActiveIngredient

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND 2.16.840.1.113883.6.73 2017-01 A01 STOMATOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A01A STOMATOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A01AA Caries prophylactic agents 2.16.840.1.113883.6.73 2017-01 A01AA01 fluoride 2.16.840.1.113883.6.73 2017-01 A01AA02 sodium monofluorophosphate 2.16.840.1.113883.6.73 2017-01 A01AA03 2.16.840.1.113883.6.73 2017-01 A01AA04 stannous fluoride 2.16.840.1.113883.6.73 2017-01 A01AA30 combinations 2.16.840.1.113883.6.73 2017-01 A01AA51 , combinations 2.16.840.1.113883.6.73 2017-01 A01AB Antiinfectives and for local oral treatment 2.16.840.1.113883.6.73 2017-01 A01AB02 2.16.840.1.113883.6.73 2017-01 A01AB03 2.16.840.1.113883.6.73 2017-01 A01AB04 2.16.840.1.113883.6.73 2017-01 A01AB05 2.16.840.1.113883.6.73 2017-01 A01AB06 domiphen 2.16.840.1.113883.6.73 2017-01 A01AB07 oxyquinoline 2.16.840.1.113883.6.73 2017-01 A01AB08 2.16.840.1.113883.6.73 2017-01 A01AB09 2.16.840.1.113883.6.73 2017-01 A01AB10 2.16.840.1.113883.6.73 2017-01 A01AB11 various 2.16.840.1.113883.6.73 2017-01 A01AB12 2.16.840.1.113883.6.73 2017-01 A01AB13 2.16.840.1.113883.6.73 2017-01 A01AB14 2.16.840.1.113883.6.73 2017-01 A01AB15 2.16.840.1.113883.6.73 2017-01 A01AB16 2.16.840.1.113883.6.73 2017-01 A01AB17 2.16.840.1.113883.6.73 2017-01 A01AB18 2.16.840.1.113883.6.73 2017-01 A01AB19 2.16.840.1.113883.6.73 2017-01 A01AB21 2.16.840.1.113883.6.73 2017-01 A01AB22 2.16.840.1.113883.6.73 2017-01 A01AB23

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 4 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A01AC for local oral treatment 2.16.840.1.113883.6.73 2017-01 A01AC01 2.16.840.1.113883.6.73 2017-01 A01AC02 2.16.840.1.113883.6.73 2017-01 A01AC03 2.16.840.1.113883.6.73 2017-01 A01AC54 , combinations 2.16.840.1.113883.6.73 2017-01 A01AD Other agents for local oral treatment 2.16.840.1.113883.6.73 2017-01 A01AD01 epinephrine 2.16.840.1.113883.6.73 2017-01 A01AD02 2.16.840.1.113883.6.73 2017-01 A01AD05 acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 A01AD06 2.16.840.1.113883.6.73 2017-01 A01AD07 2.16.840.1.113883.6.73 2017-01 A01AD08 2.16.840.1.113883.6.73 2017-01 A01AD11 various 2.16.840.1.113883.6.73 2017-01 A02 FOR ACID RELATED DISORDERS 2.16.840.1.113883.6.73 2017-01 A02A 2.16.840.1.113883.6.73 2017-01 A02AA compounds 2.16.840.1.113883.6.73 2017-01 A02AA01 2.16.840.1.113883.6.73 2017-01 A02AA02 2.16.840.1.113883.6.73 2017-01 A02AA03 2.16.840.1.113883.6.73 2017-01 A02AA04 2.16.840.1.113883.6.73 2017-01 A02AA05 magnesium silicate 2.16.840.1.113883.6.73 2017-01 A02AA10 combinations 2.16.840.1.113883.6.73 2017-01 A02AB compounds 2.16.840.1.113883.6.73 2017-01 A02AB01 2.16.840.1.113883.6.73 2017-01 A02AB02 algeldrate 2.16.840.1.113883.6.73 2017-01 A02AB03 aluminium 2.16.840.1.113883.6.73 2017-01 A02AB04 dihydroxialumini sodium carbonate 2.16.840.1.113883.6.73 2017-01 A02AB05 aluminium acetoacetate 2.16.840.1.113883.6.73 2017-01 A02AB06 2.16.840.1.113883.6.73 2017-01 A02AB07 2.16.840.1.113883.6.73 2017-01 A02AB10 combinations 2.16.840.1.113883.6.73 2017-01 A02AC compounds 2.16.840.1.113883.6.73 2017-01 A02AC01 2.16.840.1.113883.6.73 2017-01 A02AC02 2.16.840.1.113883.6.73 2017-01 A02AC10 combinations 2.16.840.1.113883.6.73 2017-01 A02AD Combinations and complexes of aluminium, calcium and magnesium compounds 2.16.840.1.113883.6.73 2017-01 A02AD01 ordinary combinations 2.16.840.1.113883.6.73 2017-01 A02AD02 2.16.840.1.113883.6.73 2017-01 A02AD03 2.16.840.1.113883.6.73 2017-01 A02AD04 2.16.840.1.113883.6.73 2017-01 A02AD05 2.16.840.1.113883.6.73 2017-01 A02AF Antacids with antiflatulents

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 5 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A02AF01 magaldrate and antiflatulents 2.16.840.1.113883.6.73 2017-01 A02AF02 ordinary salt combinations and antiflatulents 2.16.840.1.113883.6.73 2017-01 A02AG Antacids with 2.16.840.1.113883.6.73 2017-01 A02AH Antacids with 2.16.840.1.113883.6.73 2017-01 A02AX Antacids, other combinations 2.16.840.1.113883.6.73 2017-01 A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) 2.16.840.1.113883.6.73 2017-01 A02BA H2- antagonists 2.16.840.1.113883.6.73 2017-01 A02BA01 2.16.840.1.113883.6.73 2017-01 A02BA02 2.16.840.1.113883.6.73 2017-01 A02BA03 2.16.840.1.113883.6.73 2017-01 A02BA04 2.16.840.1.113883.6.73 2017-01 A02BA05 2.16.840.1.113883.6.73 2017-01 A02BA06 roxatidine 2.16.840.1.113883.6.73 2017-01 A02BA07 ranitidine bismuth citrate 2.16.840.1.113883.6.73 2017-01 A02BA08 2.16.840.1.113883.6.73 2017-01 A02BA51 cimetidine, combinations 2.16.840.1.113883.6.73 2017-01 A02BA53 famotidine, combinations 2.16.840.1.113883.6.73 2017-01 A02BB 2.16.840.1.113883.6.73 2017-01 A02BB01 2.16.840.1.113883.6.73 2017-01 A02BB02 2.16.840.1.113883.6.73 2017-01 A02BC Proton pump inhibitors 2.16.840.1.113883.6.73 2017-01 A02BC01 2.16.840.1.113883.6.73 2017-01 A02BC02 2.16.840.1.113883.6.73 2017-01 A02BC03 2.16.840.1.113883.6.73 2017-01 A02BC04 2.16.840.1.113883.6.73 2017-01 A02BC05 2.16.840.1.113883.6.73 2017-01 A02BC06 2.16.840.1.113883.6.73 2017-01 A02BC07 dexrabeprazole 2.16.840.1.113883.6.73 2017-01 A02BC53 lansoprazole, combinations 2.16.840.1.113883.6.73 2017-01 A02BC54 rabeprazole, combinations 2.16.840.1.113883.6.73 2017-01 A02BD Combinations for eradication of Helicobacter pylori 2.16.840.1.113883.6.73 2017-01 A02BD01 omeprazole, amoxicillin and metronidazole 2.16.840.1.113883.6.73 2017-01 A02BD02 lansoprazole, tetracycline and metronidazole 2.16.840.1.113883.6.73 2017-01 A02BD03 lansoprazole, amoxicillin and metronidazole 2.16.840.1.113883.6.73 2017-01 A02BD04 pantoprazole, amoxicillin and 2.16.840.1.113883.6.73 2017-01 A02BD05 omeprazole, amoxicillin and clarithromycin 2.16.840.1.113883.6.73 2017-01 A02BD06 esomeprazole, amoxicillin and clarithromycin 2.16.840.1.113883.6.73 2017-01 A02BD07 lansoprazole, amoxicillin and clarithromycin 2.16.840.1.113883.6.73 2017-01 A02BD08 , tetracycline and metronidazole 2.16.840.1.113883.6.73 2017-01 A02BD09 lansoprazole, clarithromycin and 2.16.840.1.113883.6.73 2017-01 A02BD10 lansoprazole, amoxicillin and 2.16.840.1.113883.6.73 2017-01 A02BD11 pantoprazole, amoxicillin, clarithromycin and metronidazole

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 6 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) 2.16.840.1.113883.6.73 2017-01 A02BX01 2.16.840.1.113883.6.73 2017-01 A02BX02 2.16.840.1.113883.6.73 2017-01 A02BX03 2.16.840.1.113883.6.73 2017-01 A02BX04 methiosulfonium chloride 2.16.840.1.113883.6.73 2017-01 A02BX05 bismuth subcitrate 2.16.840.1.113883.6.73 2017-01 A02BX06 2.16.840.1.113883.6.73 2017-01 A02BX07 2.16.840.1.113883.6.73 2017-01 A02BX08 2.16.840.1.113883.6.73 2017-01 A02BX09 acetoxolone 2.16.840.1.113883.6.73 2017-01 A02BX10 2.16.840.1.113883.6.73 2017-01 A02BX11 2.16.840.1.113883.6.73 2017-01 A02BX12 bismuth subnitrate 2.16.840.1.113883.6.73 2017-01 A02BX13 2.16.840.1.113883.6.73 2017-01 A02BX51 carbenoxolone, combinations excl. 2.16.840.1.113883.6.73 2017-01 A02BX71 carbenoxolone, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 A02BX77 gefarnate, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 A02X OTHER DRUGS FOR ACID RELATED DISORDERS 2.16.840.1.113883.6.73 2017-01 A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS 2.16.840.1.113883.6.73 2017-01 A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS 2.16.840.1.113883.6.73 2017-01 A03AA Synthetic , esters with tertiary amino group 2.16.840.1.113883.6.73 2017-01 A03AA01 2.16.840.1.113883.6.73 2017-01 A03AA03 2.16.840.1.113883.6.73 2017-01 A03AA04 2.16.840.1.113883.6.73 2017-01 A03AA05 2.16.840.1.113883.6.73 2017-01 A03AA06 2.16.840.1.113883.6.73 2017-01 A03AA07 2.16.840.1.113883.6.73 2017-01 A03AA08 2.16.840.1.113883.6.73 2017-01 A03AA09 2.16.840.1.113883.6.73 2017-01 A03AA30 2.16.840.1.113883.6.73 2017-01 A03AB Synthetic anticholinergics, quaternary ammonium compounds 2.16.840.1.113883.6.73 2017-01 A03AB01 2.16.840.1.113883.6.73 2017-01 A03AB02 glycopyrronium 2.16.840.1.113883.6.73 2017-01 A03AB03 oxyphenonium 2.16.840.1.113883.6.73 2017-01 A03AB04 2.16.840.1.113883.6.73 2017-01 A03AB05 propantheline 2.16.840.1.113883.6.73 2017-01 A03AB06 2.16.840.1.113883.6.73 2017-01 A03AB07 2.16.840.1.113883.6.73 2017-01 A03AB08 2.16.840.1.113883.6.73 2017-01 A03AB09 2.16.840.1.113883.6.73 2017-01 A03AB10

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 7 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03AB11 2.16.840.1.113883.6.73 2017-01 A03AB12 2.16.840.1.113883.6.73 2017-01 A03AB13 2.16.840.1.113883.6.73 2017-01 A03AB14 pipenzolate 2.16.840.1.113883.6.73 2017-01 A03AB15 diphemanil 2.16.840.1.113883.6.73 2017-01 A03AB16 (2-benzhydryloxyethyl)diethyl-methylammonium iodide 2.16.840.1.113883.6.73 2017-01 A03AB17 2.16.840.1.113883.6.73 2017-01 A03AB18 2.16.840.1.113883.6.73 2017-01 A03AB19 2.16.840.1.113883.6.73 2017-01 A03AB21 2.16.840.1.113883.6.73 2017-01 A03AB53 oxyphenonium, combinations 2.16.840.1.113883.6.73 2017-01 A03AC Synthetic antispasmodics, amides with tertiary amines 2.16.840.1.113883.6.73 2017-01 A03AC02 dimethylaminopropionylphenothiazine 2.16.840.1.113883.6.73 2017-01 A03AC04 nicofetamide 2.16.840.1.113883.6.73 2017-01 A03AC05 2.16.840.1.113883.6.73 2017-01 A03AD and derivatives 2.16.840.1.113883.6.73 2017-01 A03AD01 papaverine 2.16.840.1.113883.6.73 2017-01 A03AD02 2.16.840.1.113883.6.73 2017-01 A03AD30 2.16.840.1.113883.6.73 2017-01 A03AE Serotonin receptor antagonists 2.16.840.1.113883.6.73 2017-01 A03AE01 2.16.840.1.113883.6.73 2017-01 A03AE03 2.16.840.1.113883.6.73 2017-01 A03AX Other drugs for functional gastrointestinal disorders 2.16.840.1.113883.6.73 2017-01 A03AX01 2.16.840.1.113883.6.73 2017-01 A03AX02 2.16.840.1.113883.6.73 2017-01 A03AX03 2.16.840.1.113883.6.73 2017-01 A03AX04 pinaverium 2.16.840.1.113883.6.73 2017-01 A03AX05 2.16.840.1.113883.6.73 2017-01 A03AX06 2.16.840.1.113883.6.73 2017-01 A03AX07 2.16.840.1.113883.6.73 2017-01 A03AX08 2.16.840.1.113883.6.73 2017-01 A03AX09 2.16.840.1.113883.6.73 2017-01 A03AX10 2.16.840.1.113883.6.73 2017-01 A03AX11 2.16.840.1.113883.6.73 2017-01 A03AX12 2.16.840.1.113883.6.73 2017-01 A03AX13 silicones 2.16.840.1.113883.6.73 2017-01 A03AX14 valethamate 2.16.840.1.113883.6.73 2017-01 A03AX30 trimethyldiphenylpropylamine 2.16.840.1.113883.6.73 2017-01 A03AX58 alverine, combinations 2.16.840.1.113883.6.73 2017-01 A03B BELLADONNA AND DERIVATIVES, PLAIN 2.16.840.1.113883.6.73 2017-01 A03BA Belladonna alkaloids, tertiary amines 2.16.840.1.113883.6.73 2017-01 A03BA01 2.16.840.1.113883.6.73 2017-01 A03BA03 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 8 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03BA04 belladonna total alkaloids 2.16.840.1.113883.6.73 2017-01 A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds 2.16.840.1.113883.6.73 2017-01 A03BB01 butylscopolamine 2.16.840.1.113883.6.73 2017-01 A03BB02 2.16.840.1.113883.6.73 2017-01 A03BB03 methylscopolamine 2.16.840.1.113883.6.73 2017-01 A03BB04 fentonium 2.16.840.1.113883.6.73 2017-01 A03BB05 2.16.840.1.113883.6.73 2017-01 A03C ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS 2.16.840.1.113883.6.73 2017-01 A03CA Synthetic agents in combination with psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA01 isopropamide and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA02 clidinium and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA03 oxyphencyclimine and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA04 otilonium bromide and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA05 and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA06 bevonium and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA07 ambutonium and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA08 diphemanil and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA09 pipenzolate and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA30 emepronium and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CA34 propantheline and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CB Belladonna and derivatives in combination with psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CB01 methylscopolamine and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CB02 belladonna total alkaloids and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CB03 atropine and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CB04 methylhomatropine and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CB31 hyoscyamine and psycholeptics 2.16.840.1.113883.6.73 2017-01 A03CC Other antispasmodics in combination with psycholeptics 2.16.840.1.113883.6.73 2017-01 A03D ANTISPASMODICS IN COMBINATION WITH 2.16.840.1.113883.6.73 2017-01 A03DA Synthetic anticholinergic agents in combination with analgesics 2.16.840.1.113883.6.73 2017-01 A03DA01 tropenzilone and analgesics 2.16.840.1.113883.6.73 2017-01 A03DA02 pitofenone and analgesics 2.16.840.1.113883.6.73 2017-01 A03DA03 bevonium and analgesics 2.16.840.1.113883.6.73 2017-01 A03DA04 ciclonium and analgesics 2.16.840.1.113883.6.73 2017-01 A03DA05 camylofin and analgesics 2.16.840.1.113883.6.73 2017-01 A03DA06 trospium and analgesics 2.16.840.1.113883.6.73 2017-01 A03DA07 tiemonium iodide and analgesics 2.16.840.1.113883.6.73 2017-01 A03DB Belladonna and derivatives in combination with analgesics 2.16.840.1.113883.6.73 2017-01 A03DB04 butylscopolamine and analgesics 2.16.840.1.113883.6.73 2017-01 A03DC Other antispasmodics in combination with analgesics 2.16.840.1.113883.6.73 2017-01 A03E ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 9 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A03EA Antispasmodics, psycholeptics and analgesics in combination 2.16.840.1.113883.6.73 2017-01 A03ED Antispasmodics in combination with other drugs 2.16.840.1.113883.6.73 2017-01 A03F PROPULSIVES 2.16.840.1.113883.6.73 2017-01 A03FA Propulsives 2.16.840.1.113883.6.73 2017-01 A03FA01 2.16.840.1.113883.6.73 2017-01 A03FA02 2.16.840.1.113883.6.73 2017-01 A03FA03 2.16.840.1.113883.6.73 2017-01 A03FA04 2.16.840.1.113883.6.73 2017-01 A03FA05 2.16.840.1.113883.6.73 2017-01 A03FA06 2.16.840.1.113883.6.73 2017-01 A03FA07 2.16.840.1.113883.6.73 2017-01 A03FA08 2.16.840.1.113883.6.73 2017-01 A04 AND ANTINAUSEANTS 2.16.840.1.113883.6.73 2017-01 A04A ANTIEMETICS AND ANTINAUSEANTS 2.16.840.1.113883.6.73 2017-01 A04AA Serotonin (5HT3) antagonists 2.16.840.1.113883.6.73 2017-01 A04AA01 ondansetron 2.16.840.1.113883.6.73 2017-01 A04AA02 granisetron 2.16.840.1.113883.6.73 2017-01 A04AA03 2.16.840.1.113883.6.73 2017-01 A04AA04 dolasetron 2.16.840.1.113883.6.73 2017-01 A04AA05 palonosetron 2.16.840.1.113883.6.73 2017-01 A04AA55 palonosetron, combinations 2.16.840.1.113883.6.73 2017-01 A04AD Other antiemetics 2.16.840.1.113883.6.73 2017-01 A04AD01 2.16.840.1.113883.6.73 2017-01 A04AD02 cerium 2.16.840.1.113883.6.73 2017-01 A04AD04 2.16.840.1.113883.6.73 2017-01 A04AD05 2.16.840.1.113883.6.73 2017-01 A04AD10 dronabinol 2.16.840.1.113883.6.73 2017-01 A04AD11 2.16.840.1.113883.6.73 2017-01 A04AD12 aprepitant 2.16.840.1.113883.6.73 2017-01 A04AD13 casopitant 2.16.840.1.113883.6.73 2017-01 A04AD14 rolapitant 2.16.840.1.113883.6.73 2017-01 A04AD51 scopolamine, combinations 2.16.840.1.113883.6.73 2017-01 A04AD54 chlorobutanol, combinations 2.16.840.1.113883.6.73 2017-01 A05 AND THERAPY 2.16.840.1.113883.6.73 2017-01 A05A BILE THERAPY 2.16.840.1.113883.6.73 2017-01 A05AA preparations 2.16.840.1.113883.6.73 2017-01 A05AA01 2.16.840.1.113883.6.73 2017-01 A05AA02 2.16.840.1.113883.6.73 2017-01 A05AA03 2.16.840.1.113883.6.73 2017-01 A05AA04 2.16.840.1.113883.6.73 2017-01 A05AB Preparations for biliary tract therapy 2.16.840.1.113883.6.73 2017-01 A05AB01 nicotinyl methylamide 2.16.840.1.113883.6.73 2017-01 A05AX Other drugs for bile therapy © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 10 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A05AX01 2.16.840.1.113883.6.73 2017-01 A05AX02 2.16.840.1.113883.6.73 2017-01 A05AX03 2.16.840.1.113883.6.73 2017-01 A05B LIVER THERAPY, LIPOTROPICS 2.16.840.1.113883.6.73 2017-01 A05BA Liver therapy 2.16.840.1.113883.6.73 2017-01 A05BA01 glutamate 2.16.840.1.113883.6.73 2017-01 A05BA03 silymarin 2.16.840.1.113883.6.73 2017-01 A05BA04 2.16.840.1.113883.6.73 2017-01 A05BA05 2.16.840.1.113883.6.73 2017-01 A05BA06 ornithine oxoglurate 2.16.840.1.113883.6.73 2017-01 A05BA07 arginine 2.16.840.1.113883.6.73 2017-01 A05BA08 glycyrrhizic acid 2.16.840.1.113883.6.73 2017-01 A05C DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION 2.16.840.1.113883.6.73 2017-01 A06 DRUGS FOR CONSTIPATION 2.16.840.1.113883.6.73 2017-01 A06A DRUGS FOR CONSTIPATION 2.16.840.1.113883.6.73 2017-01 A06AA Softeners, emollients 2.16.840.1.113883.6.73 2017-01 A06AA01 2.16.840.1.113883.6.73 2017-01 A06AA02 sodium 2.16.840.1.113883.6.73 2017-01 A06AA51 liquid paraffin, combinations 2.16.840.1.113883.6.73 2017-01 A06AB Contact 2.16.840.1.113883.6.73 2017-01 A06AB01 2.16.840.1.113883.6.73 2017-01 A06AB02 2.16.840.1.113883.6.73 2017-01 A06AB03 2.16.840.1.113883.6.73 2017-01 A06AB04 2.16.840.1.113883.6.73 2017-01 A06AB05 2.16.840.1.113883.6.73 2017-01 A06AB06 senna glycosides 2.16.840.1.113883.6.73 2017-01 A06AB07 cascara 2.16.840.1.113883.6.73 2017-01 A06AB08 2.16.840.1.113883.6.73 2017-01 A06AB09 bisoxatin 2.16.840.1.113883.6.73 2017-01 A06AB20 contact laxatives in combination 2.16.840.1.113883.6.73 2017-01 A06AB30 contact laxatives in combination with belladonna alkaloids 2.16.840.1.113883.6.73 2017-01 A06AB52 bisacodyl, combinations 2.16.840.1.113883.6.73 2017-01 A06AB53 dantron, combinations 2.16.840.1.113883.6.73 2017-01 A06AB56 senna glycosides, combinations 2.16.840.1.113883.6.73 2017-01 A06AB57 cascara, combinations 2.16.840.1.113883.6.73 2017-01 A06AB58 sodium picosulfate, combinations 2.16.840.1.113883.6.73 2017-01 A06AC Bulk-forming laxatives 2.16.840.1.113883.6.73 2017-01 A06AC01 ispaghula (psylla seeds) 2.16.840.1.113883.6.73 2017-01 A06AC02 2.16.840.1.113883.6.73 2017-01 A06AC03 sterculia 2.16.840.1.113883.6.73 2017-01 A06AC05 linseed 2.16.840.1.113883.6.73 2017-01 A06AC06 methylcellulose

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 11 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A06AC07 triticum (wheat fibre) 2.16.840.1.113883.6.73 2017-01 A06AC08 2.16.840.1.113883.6.73 2017-01 A06AC51 ispaghula, combinations 2.16.840.1.113883.6.73 2017-01 A06AC53 sterculia, combinations 2.16.840.1.113883.6.73 2017-01 A06AC55 linseed, combinations 2.16.840.1.113883.6.73 2017-01 A06AD Osmotically acting laxatives 2.16.840.1.113883.6.73 2017-01 A06AD01 magnesium carbonate 2.16.840.1.113883.6.73 2017-01 A06AD02 magnesium oxide 2.16.840.1.113883.6.73 2017-01 A06AD03 magnesium peroxide 2.16.840.1.113883.6.73 2017-01 A06AD04 2.16.840.1.113883.6.73 2017-01 A06AD10 in combination 2.16.840.1.113883.6.73 2017-01 A06AD11 2.16.840.1.113883.6.73 2017-01 A06AD12 2.16.840.1.113883.6.73 2017-01 A06AD13 2.16.840.1.113883.6.73 2017-01 A06AD14 pentaerithrityl 2.16.840.1.113883.6.73 2017-01 A06AD15 2.16.840.1.113883.6.73 2017-01 A06AD16 2.16.840.1.113883.6.73 2017-01 A06AD17 sodium phosphate 2.16.840.1.113883.6.73 2017-01 A06AD18 2.16.840.1.113883.6.73 2017-01 A06AD19 2.16.840.1.113883.6.73 2017-01 A06AD21 2.16.840.1.113883.6.73 2017-01 A06AD61 lactulose, combinations 2.16.840.1.113883.6.73 2017-01 A06AD65 macrogol, combinations 2.16.840.1.113883.6.73 2017-01 A06AG 2.16.840.1.113883.6.73 2017-01 A06AG01 sodium phosphate 2.16.840.1.113883.6.73 2017-01 A06AG02 bisacodyl 2.16.840.1.113883.6.73 2017-01 A06AG03 dantron, incl. combinations 2.16.840.1.113883.6.73 2017-01 A06AG04 2.16.840.1.113883.6.73 2017-01 A06AG06 oil 2.16.840.1.113883.6.73 2017-01 A06AG07 sorbitol 2.16.840.1.113883.6.73 2017-01 A06AG10 docusate sodium, incl. combinations 2.16.840.1.113883.6.73 2017-01 A06AG11 sodium lauryl sulfoacetate, incl. combinations 2.16.840.1.113883.6.73 2017-01 A06AG20 combinations 2.16.840.1.113883.6.73 2017-01 A06AH Peripheral receptor antagonists 2.16.840.1.113883.6.73 2017-01 A06AH01 bromide 2.16.840.1.113883.6.73 2017-01 A06AH02 2.16.840.1.113883.6.73 2017-01 A06AH03 2.16.840.1.113883.6.73 2017-01 A06AH04 2.16.840.1.113883.6.73 2017-01 A06AX Other drugs for constipation 2.16.840.1.113883.6.73 2017-01 A06AX01 glycerol 2.16.840.1.113883.6.73 2017-01 A06AX02 carbon dioxide producing drugs 2.16.840.1.113883.6.73 2017-01 A06AX03 2.16.840.1.113883.6.73 2017-01 A06AX04 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 12 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A06AX05 2.16.840.1.113883.6.73 2017-01 A06AX06 2.16.840.1.113883.6.73 2017-01 A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS 2.16.840.1.113883.6.73 2017-01 A07A INTESTINAL ANTIINFECTIVES 2.16.840.1.113883.6.73 2017-01 A07AA 2.16.840.1.113883.6.73 2017-01 A07AA01 neomycin 2.16.840.1.113883.6.73 2017-01 A07AA02 2.16.840.1.113883.6.73 2017-01 A07AA03 natamycin 2.16.840.1.113883.6.73 2017-01 A07AA04 2.16.840.1.113883.6.73 2017-01 A07AA05 2.16.840.1.113883.6.73 2017-01 A07AA06 2.16.840.1.113883.6.73 2017-01 A07AA07 amphotericin B 2.16.840.1.113883.6.73 2017-01 A07AA08 kanamycin 2.16.840.1.113883.6.73 2017-01 A07AA09 2.16.840.1.113883.6.73 2017-01 A07AA10 2.16.840.1.113883.6.73 2017-01 A07AA11 2.16.840.1.113883.6.73 2017-01 A07AA12 2.16.840.1.113883.6.73 2017-01 A07AA51 neomycin, combinations 2.16.840.1.113883.6.73 2017-01 A07AA54 streptomycin, combinations 2.16.840.1.113883.6.73 2017-01 A07AB Sulfonamides 2.16.840.1.113883.6.73 2017-01 A07AB02 2.16.840.1.113883.6.73 2017-01 A07AB03 2.16.840.1.113883.6.73 2017-01 A07AB04 2.16.840.1.113883.6.73 2017-01 A07AC derivatives 2.16.840.1.113883.6.73 2017-01 A07AC01 miconazole 2.16.840.1.113883.6.73 2017-01 A07AX Other intestinal antiinfectives 2.16.840.1.113883.6.73 2017-01 A07AX01 2.16.840.1.113883.6.73 2017-01 A07AX02 2.16.840.1.113883.6.73 2017-01 A07AX03 2.16.840.1.113883.6.73 2017-01 A07AX04 2.16.840.1.113883.6.73 2017-01 A07B INTESTINAL ADSORBENTS 2.16.840.1.113883.6.73 2017-01 A07BA Charcoal preparations 2.16.840.1.113883.6.73 2017-01 A07BA01 medicinal charcoal 2.16.840.1.113883.6.73 2017-01 A07BA51 medicinal charcoal, combinations 2.16.840.1.113883.6.73 2017-01 A07BB Bismuth preparations 2.16.840.1.113883.6.73 2017-01 A07BC Other intestinal adsorbents 2.16.840.1.113883.6.73 2017-01 A07BC01 pectin 2.16.840.1.113883.6.73 2017-01 A07BC02 kaolin 2.16.840.1.113883.6.73 2017-01 A07BC03 crospovidone 2.16.840.1.113883.6.73 2017-01 A07BC04 attapulgite 2.16.840.1.113883.6.73 2017-01 A07BC05 2.16.840.1.113883.6.73 2017-01 A07BC30 combinations

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 13 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A07BC54 attapulgite, combinations 2.16.840.1.113883.6.73 2017-01 A07C ELECTROLYTES WITH 2.16.840.1.113883.6.73 2017-01 A07CA Oral rehydration salt formulations 2.16.840.1.113883.6.73 2017-01 A07D 2.16.840.1.113883.6.73 2017-01 A07DA Antipropulsives 2.16.840.1.113883.6.73 2017-01 A07DA01 2.16.840.1.113883.6.73 2017-01 A07DA02 2.16.840.1.113883.6.73 2017-01 A07DA03 2.16.840.1.113883.6.73 2017-01 A07DA04 2.16.840.1.113883.6.73 2017-01 A07DA05 loperamide oxide 2.16.840.1.113883.6.73 2017-01 A07DA06 2.16.840.1.113883.6.73 2017-01 A07DA52 , combinations 2.16.840.1.113883.6.73 2017-01 A07DA53 loperamide, combinations 2.16.840.1.113883.6.73 2017-01 A07E INTESTINAL ANTIINFLAMMATORY AGENTS 2.16.840.1.113883.6.73 2017-01 A07EA Corticosteroids acting locally 2.16.840.1.113883.6.73 2017-01 A07EA01 prednisolone 2.16.840.1.113883.6.73 2017-01 A07EA02 hydrocortisone 2.16.840.1.113883.6.73 2017-01 A07EA03 2.16.840.1.113883.6.73 2017-01 A07EA04 2.16.840.1.113883.6.73 2017-01 A07EA05 2.16.840.1.113883.6.73 2017-01 A07EA06 2.16.840.1.113883.6.73 2017-01 A07EA07 2.16.840.1.113883.6.73 2017-01 A07EB Antiallergic agents, excl. corticosteroids 2.16.840.1.113883.6.73 2017-01 A07EB01 2.16.840.1.113883.6.73 2017-01 A07EC Aminosalicylic acid and similar agents 2.16.840.1.113883.6.73 2017-01 A07EC01 2.16.840.1.113883.6.73 2017-01 A07EC02 2.16.840.1.113883.6.73 2017-01 A07EC03 2.16.840.1.113883.6.73 2017-01 A07EC04 2.16.840.1.113883.6.73 2017-01 A07F ANTIDIARRHEAL MICROORGANISMS 2.16.840.1.113883.6.73 2017-01 A07FA Antidiarrheal microorganisms 2.16.840.1.113883.6.73 2017-01 A07FA01 producing organisms 2.16.840.1.113883.6.73 2017-01 A07FA02 saccharomyces boulardii 2.16.840.1.113883.6.73 2017-01 A07FA51 lactic acid producing organisms, combinations 2.16.840.1.113883.6.73 2017-01 A07X OTHER ANTIDIARRHEALS 2.16.840.1.113883.6.73 2017-01 A07XA Other antidiarrheals 2.16.840.1.113883.6.73 2017-01 A07XA01 albumin tannate 2.16.840.1.113883.6.73 2017-01 A07XA02 ceratonia 2.16.840.1.113883.6.73 2017-01 A07XA03 calcium compounds 2.16.840.1.113883.6.73 2017-01 A07XA04 2.16.840.1.113883.6.73 2017-01 A07XA51 albumin tannate, combinations 2.16.840.1.113883.6.73 2017-01 A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS 2.16.840.1.113883.6.73 2017-01 A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 14 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A08AA Centrally acting antiobesity products 2.16.840.1.113883.6.73 2017-01 A08AA01 2.16.840.1.113883.6.73 2017-01 A08AA02 2.16.840.1.113883.6.73 2017-01 A08AA03 2.16.840.1.113883.6.73 2017-01 A08AA04 2.16.840.1.113883.6.73 2017-01 A08AA05 2.16.840.1.113883.6.73 2017-01 A08AA06 2.16.840.1.113883.6.73 2017-01 A08AA07 2.16.840.1.113883.6.73 2017-01 A08AA08 2.16.840.1.113883.6.73 2017-01 A08AA09 2.16.840.1.113883.6.73 2017-01 A08AA10 2.16.840.1.113883.6.73 2017-01 A08AA11 lorcaserin 2.16.840.1.113883.6.73 2017-01 A08AA56 , combinations 2.16.840.1.113883.6.73 2017-01 A08AA62 and 2.16.840.1.113883.6.73 2017-01 A08AB Peripherally acting antiobesity products 2.16.840.1.113883.6.73 2017-01 A08AB01 orlistat 2.16.840.1.113883.6.73 2017-01 A08AX Other antiobesity drugs 2.16.840.1.113883.6.73 2017-01 A08AX01 2.16.840.1.113883.6.73 2017-01 A09 DIGESTIVES, INCL. 2.16.840.1.113883.6.73 2017-01 A09A DIGESTIVES, INCL. ENZYMES 2.16.840.1.113883.6.73 2017-01 A09AA preparations 2.16.840.1.113883.6.73 2017-01 A09AA01 diastase 2.16.840.1.113883.6.73 2017-01 A09AA02 multienzymes (lipase, etc.) 2.16.840.1.113883.6.73 2017-01 A09AA03 pepsin 2.16.840.1.113883.6.73 2017-01 A09AA04 tilactase 2.16.840.1.113883.6.73 2017-01 A09AB Acid preparations 2.16.840.1.113883.6.73 2017-01 A09AB01 hydrochloride 2.16.840.1.113883.6.73 2017-01 A09AB02 betaine hydrochloride 2.16.840.1.113883.6.73 2017-01 A09AB03 2.16.840.1.113883.6.73 2017-01 A09AB04 2.16.840.1.113883.6.73 2017-01 A09AC Enzyme and acid preparations, combinations 2.16.840.1.113883.6.73 2017-01 A09AC01 pepsin and acid preparations 2.16.840.1.113883.6.73 2017-01 A09AC02 multienzymes and acid preparations 2.16.840.1.113883.6.73 2017-01 A10 DRUGS USED IN 2.16.840.1.113883.6.73 2017-01 A10A AND ANALOGUES 2.16.840.1.113883.6.73 2017-01 A10AB Insulins and analogues for , fast-acting 2.16.840.1.113883.6.73 2017-01 A10AB01 (human) 2.16.840.1.113883.6.73 2017-01 A10AB02 insulin (beef) 2.16.840.1.113883.6.73 2017-01 A10AB03 insulin (pork) 2.16.840.1.113883.6.73 2017-01 A10AB04 insulin lispro 2.16.840.1.113883.6.73 2017-01 A10AB05 insulin aspart 2.16.840.1.113883.6.73 2017-01 A10AB06 insulin glulisine 2.16.840.1.113883.6.73 2017-01 A10AB30 combinations © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 15 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A10AC Insulins and analogues for injection, intermediate-acting 2.16.840.1.113883.6.73 2017-01 A10AC01 insulin (human) 2.16.840.1.113883.6.73 2017-01 A10AC02 insulin (beef) 2.16.840.1.113883.6.73 2017-01 A10AC03 insulin (pork) 2.16.840.1.113883.6.73 2017-01 A10AC04 insulin lispro 2.16.840.1.113883.6.73 2017-01 A10AC30 combinations 2.16.840.1.113883.6.73 2017-01 A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting 2.16.840.1.113883.6.73 2017-01 A10AD01 insulin (human) 2.16.840.1.113883.6.73 2017-01 A10AD02 insulin (beef) 2.16.840.1.113883.6.73 2017-01 A10AD03 insulin (pork) 2.16.840.1.113883.6.73 2017-01 A10AD04 insulin lispro 2.16.840.1.113883.6.73 2017-01 A10AD05 insulin aspart 2.16.840.1.113883.6.73 2017-01 A10AD06 insulin degludec and insulin aspart 2.16.840.1.113883.6.73 2017-01 A10AD30 combinations 2.16.840.1.113883.6.73 2017-01 A10AE Insulins and analogues for injection, long-acting 2.16.840.1.113883.6.73 2017-01 A10AE01 insulin (human) 2.16.840.1.113883.6.73 2017-01 A10AE02 insulin (beef) 2.16.840.1.113883.6.73 2017-01 A10AE03 insulin (pork) 2.16.840.1.113883.6.73 2017-01 A10AE04 insulin glargine 2.16.840.1.113883.6.73 2017-01 A10AE05 insulin detemir 2.16.840.1.113883.6.73 2017-01 A10AE06 insulin degludec 2.16.840.1.113883.6.73 2017-01 A10AE30 combinations 2.16.840.1.113883.6.73 2017-01 A10AE56 insulin degludec and liraglutide 2.16.840.1.113883.6.73 2017-01 A10AF Insulins and analogues for inhalation 2.16.840.1.113883.6.73 2017-01 A10AF01 insulin (human) 2.16.840.1.113883.6.73 2017-01 A10B LOWERING DRUGS, EXCL. INSULINS 2.16.840.1.113883.6.73 2017-01 A10BA 2.16.840.1.113883.6.73 2017-01 A10BA01 phenformin 2.16.840.1.113883.6.73 2017-01 A10BA02 metformin 2.16.840.1.113883.6.73 2017-01 A10BA03 buformin 2.16.840.1.113883.6.73 2017-01 A10BB Sulfonylureas 2.16.840.1.113883.6.73 2017-01 A10BB01 2.16.840.1.113883.6.73 2017-01 A10BB02 2.16.840.1.113883.6.73 2017-01 A10BB03 2.16.840.1.113883.6.73 2017-01 A10BB04 2.16.840.1.113883.6.73 2017-01 A10BB05 2.16.840.1.113883.6.73 2017-01 A10BB06 2.16.840.1.113883.6.73 2017-01 A10BB07 2.16.840.1.113883.6.73 2017-01 A10BB08 2.16.840.1.113883.6.73 2017-01 A10BB09 2.16.840.1.113883.6.73 2017-01 A10BB10 2.16.840.1.113883.6.73 2017-01 A10BB11

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 16 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A10BB12 2.16.840.1.113883.6.73 2017-01 A10BB31 2.16.840.1.113883.6.73 2017-01 A10BC Sulfonamides (heterocyclic) 2.16.840.1.113883.6.73 2017-01 A10BC01 glymidine 2.16.840.1.113883.6.73 2017-01 A10BD Combinations of oral blood glucose lowering drugs 2.16.840.1.113883.6.73 2017-01 A10BD01 phenformin and sulfonylureas 2.16.840.1.113883.6.73 2017-01 A10BD02 metformin and sulfonylureas 2.16.840.1.113883.6.73 2017-01 A10BD03 metformin and 2.16.840.1.113883.6.73 2017-01 A10BD04 glimepiride and rosiglitazone 2.16.840.1.113883.6.73 2017-01 A10BD05 metformin and 2.16.840.1.113883.6.73 2017-01 A10BD06 glimepiride and pioglitazone 2.16.840.1.113883.6.73 2017-01 A10BD07 metformin and sitagliptin 2.16.840.1.113883.6.73 2017-01 A10BD08 metformin and vildagliptin 2.16.840.1.113883.6.73 2017-01 A10BD09 pioglitazone and alogliptin 2.16.840.1.113883.6.73 2017-01 A10BD10 metformin and saxagliptin 2.16.840.1.113883.6.73 2017-01 A10BD11 metformin and linagliptin 2.16.840.1.113883.6.73 2017-01 A10BD12 pioglitazone and sitagliptin 2.16.840.1.113883.6.73 2017-01 A10BD13 metformin and alogliptin 2.16.840.1.113883.6.73 2017-01 A10BD14 metformin and 2.16.840.1.113883.6.73 2017-01 A10BD15 metformin and dapagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD16 metformin and canagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD17 metformin and acarbose 2.16.840.1.113883.6.73 2017-01 A10BD18 metformin and gemigliptin 2.16.840.1.113883.6.73 2017-01 A10BD19 linagliptin and empagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD20 metformin and empagliflozin 2.16.840.1.113883.6.73 2017-01 A10BD21 saxagliptin and dapagliflozin 2.16.840.1.113883.6.73 2017-01 A10BF Alpha glucosidase inhibitors 2.16.840.1.113883.6.73 2017-01 A10BF01 acarbose 2.16.840.1.113883.6.73 2017-01 A10BF02 miglitol 2.16.840.1.113883.6.73 2017-01 A10BF03 voglibose 2.16.840.1.113883.6.73 2017-01 A10BG 2.16.840.1.113883.6.73 2017-01 A10BG01 2.16.840.1.113883.6.73 2017-01 A10BG02 rosiglitazone 2.16.840.1.113883.6.73 2017-01 A10BG03 pioglitazone 2.16.840.1.113883.6.73 2017-01 A10BH 4 (DPP-4) inhibitors 2.16.840.1.113883.6.73 2017-01 A10BH01 sitagliptin 2.16.840.1.113883.6.73 2017-01 A10BH02 vildagliptin 2.16.840.1.113883.6.73 2017-01 A10BH03 saxagliptin 2.16.840.1.113883.6.73 2017-01 A10BH04 alogliptin 2.16.840.1.113883.6.73 2017-01 A10BH05 linagliptin 2.16.840.1.113883.6.73 2017-01 A10BH06 gemigliptin 2.16.840.1.113883.6.73 2017-01 A10BH51 sitagliptin and 2.16.840.1.113883.6.73 2017-01 A10BJ Glucagon-like -1 (GLP-1) analogues © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 17 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A10BJ01 exenatide 2.16.840.1.113883.6.73 2017-01 A10BJ02 liraglutide 2.16.840.1.113883.6.73 2017-01 A10BJ03 lixisenatide 2.16.840.1.113883.6.73 2017-01 A10BJ04 albiglutide 2.16.840.1.113883.6.73 2017-01 A10BJ05 dulaglutide 2.16.840.1.113883.6.73 2017-01 A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors 2.16.840.1.113883.6.73 2017-01 A10BK01 dapagliflozin 2.16.840.1.113883.6.73 2017-01 A10BK02 canagliflozin 2.16.840.1.113883.6.73 2017-01 A10BK03 empagliflozin 2.16.840.1.113883.6.73 2017-01 A10BX Other blood glucose lowering drugs, excl. insulins 2.16.840.1.113883.6.73 2017-01 A10BX01 guar gum 2.16.840.1.113883.6.73 2017-01 A10BX02 repaglinide 2.16.840.1.113883.6.73 2017-01 A10BX03 2.16.840.1.113883.6.73 2017-01 A10BX05 pramlintide 2.16.840.1.113883.6.73 2017-01 A10BX06 2.16.840.1.113883.6.73 2017-01 A10BX08 2.16.840.1.113883.6.73 2017-01 A10X OTHER DRUGS USED IN DIABETES 2.16.840.1.113883.6.73 2017-01 A10XA Aldose reductase inhibitors 2.16.840.1.113883.6.73 2017-01 A10XA01 tolrestat 2.16.840.1.113883.6.73 2017-01 A11 2.16.840.1.113883.6.73 2017-01 A11A MULTIVITAMINS, COMBINATIONS 2.16.840.1.113883.6.73 2017-01 A11AA Multivitamins with minerals 2.16.840.1.113883.6.73 2017-01 A11AA01 multivitamins and 2.16.840.1.113883.6.73 2017-01 A11AA02 multivitamins and calcium 2.16.840.1.113883.6.73 2017-01 A11AA03 multivitamins and other minerals, incl. combinations 2.16.840.1.113883.6.73 2017-01 A11AA04 multivitamins and trace elements 2.16.840.1.113883.6.73 2017-01 A11AB Multivitamins, other combinations 2.16.840.1.113883.6.73 2017-01 A11B MULTIVITAMINS, PLAIN 2.16.840.1.113883.6.73 2017-01 A11BA Multivitamins, plain 2.16.840.1.113883.6.73 2017-01 A11C A AND D, INCL. COMBINATIONS OF THE TWO 2.16.840.1.113883.6.73 2017-01 A11CA Vitamin A, plain 2.16.840.1.113883.6.73 2017-01 A11CA01 retinol (vit A) 2.16.840.1.113883.6.73 2017-01 A11CA02 betacarotene 2.16.840.1.113883.6.73 2017-01 A11CB Vitamin A and D in combination 2.16.840.1.113883.6.73 2017-01 A11CC and analogues 2.16.840.1.113883.6.73 2017-01 A11CC01 2.16.840.1.113883.6.73 2017-01 A11CC02 dihydrotachysterol 2.16.840.1.113883.6.73 2017-01 A11CC03 alfacalcidol 2.16.840.1.113883.6.73 2017-01 A11CC04 2.16.840.1.113883.6.73 2017-01 A11CC05 colecalciferol 2.16.840.1.113883.6.73 2017-01 A11CC06 2.16.840.1.113883.6.73 2017-01 A11CC20 combinations

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 18 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A11D VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 2.16.840.1.113883.6.73 2017-01 A11DA Vitamin B1, plain 2.16.840.1.113883.6.73 2017-01 A11DA01 thiamine (vit B1) 2.16.840.1.113883.6.73 2017-01 A11DA02 sulbutiamine 2.16.840.1.113883.6.73 2017-01 A11DA03 benfotiamine 2.16.840.1.113883.6.73 2017-01 A11DB Vitamin B1 in combination with vitamin B6 and/or 2.16.840.1.113883.6.73 2017-01 A11E VITAMIN B-COMPLEX, INCL. COMBINATIONS 2.16.840.1.113883.6.73 2017-01 A11EA Vitamin B-complex, plain 2.16.840.1.113883.6.73 2017-01 A11EB Vitamin B-complex with 2.16.840.1.113883.6.73 2017-01 A11EC Vitamin B-complex with minerals 2.16.840.1.113883.6.73 2017-01 A11ED Vitamin B-complex with anabolic steroids 2.16.840.1.113883.6.73 2017-01 A11EX Vitamin B-complex, other combinations 2.16.840.1.113883.6.73 2017-01 A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS 2.16.840.1.113883.6.73 2017-01 A11GA Ascorbic acid (vitamin C), plain 2.16.840.1.113883.6.73 2017-01 A11GA01 ascorbic acid (vit C) 2.16.840.1.113883.6.73 2017-01 A11GB Ascorbic acid (vitamin C), combinations 2.16.840.1.113883.6.73 2017-01 A11GB01 ascorbic acid (vit C) and calcium 2.16.840.1.113883.6.73 2017-01 A11H OTHER PLAIN VITAMIN PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A11HA Other plain vitamin preparations 2.16.840.1.113883.6.73 2017-01 A11HA01 2.16.840.1.113883.6.73 2017-01 A11HA02 pyridoxine (vit B6) 2.16.840.1.113883.6.73 2017-01 A11HA03 tocopherol (vit E) 2.16.840.1.113883.6.73 2017-01 A11HA04 riboflavin (vit B2) 2.16.840.1.113883.6.73 2017-01 A11HA05 biotin 2.16.840.1.113883.6.73 2017-01 A11HA06 pyridoxal phosphate 2.16.840.1.113883.6.73 2017-01 A11HA07 2.16.840.1.113883.6.73 2017-01 A11HA08 tocofersolan 2.16.840.1.113883.6.73 2017-01 A11HA30 dexpanthenol 2.16.840.1.113883.6.73 2017-01 A11HA31 calcium pantothenate 2.16.840.1.113883.6.73 2017-01 A11HA32 pantethine 2.16.840.1.113883.6.73 2017-01 A11J OTHER VITAMIN PRODUCTS, COMBINATIONS 2.16.840.1.113883.6.73 2017-01 A11JA Combinations of vitamins 2.16.840.1.113883.6.73 2017-01 A11JB Vitamins with minerals 2.16.840.1.113883.6.73 2017-01 A11JC Vitamins, other combinations 2.16.840.1.113883.6.73 2017-01 A12 MINERAL SUPPLEMENTS 2.16.840.1.113883.6.73 2017-01 A12A CALCIUM 2.16.840.1.113883.6.73 2017-01 A12AA Calcium 2.16.840.1.113883.6.73 2017-01 A12AA01 calcium phosphate 2.16.840.1.113883.6.73 2017-01 A12AA02 calcium glubionate 2.16.840.1.113883.6.73 2017-01 A12AA03 2.16.840.1.113883.6.73 2017-01 A12AA04 calcium carbonate 2.16.840.1.113883.6.73 2017-01 A12AA05 calcium lactate

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 19 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A12AA06 calcium lactate gluconate 2.16.840.1.113883.6.73 2017-01 A12AA07 2.16.840.1.113883.6.73 2017-01 A12AA08 calcium glycerylphosphate 2.16.840.1.113883.6.73 2017-01 A12AA09 calcium citrate complex 2.16.840.1.113883.6.73 2017-01 A12AA10 calcium glucoheptonate 2.16.840.1.113883.6.73 2017-01 A12AA11 calcium pangamate 2.16.840.1.113883.6.73 2017-01 A12AA13 calcium citrate 2.16.840.1.113883.6.73 2017-01 A12AA20 calcium (different salts in combination) 2.16.840.1.113883.6.73 2017-01 A12AA30 calcium laevulate 2.16.840.1.113883.6.73 2017-01 A12AX Calcium, combinations with vitamin D and/or other drugs 2.16.840.1.113883.6.73 2017-01 A12B 2.16.840.1.113883.6.73 2017-01 A12BA Potassium 2.16.840.1.113883.6.73 2017-01 A12BA01 2.16.840.1.113883.6.73 2017-01 A12BA02 potassium citrate 2.16.840.1.113883.6.73 2017-01 A12BA03 potassium hydrogentartrate 2.16.840.1.113883.6.73 2017-01 A12BA04 potassium hydrogencarbonate 2.16.840.1.113883.6.73 2017-01 A12BA05 potassium gluconate 2.16.840.1.113883.6.73 2017-01 A12BA30 combinations 2.16.840.1.113883.6.73 2017-01 A12BA51 potassium chloride, combinations 2.16.840.1.113883.6.73 2017-01 A12C OTHER MINERAL SUPPLEMENTS 2.16.840.1.113883.6.73 2017-01 A12CA Sodium 2.16.840.1.113883.6.73 2017-01 A12CA01 2.16.840.1.113883.6.73 2017-01 A12CA02 sodium sulfate 2.16.840.1.113883.6.73 2017-01 A12CB 2.16.840.1.113883.6.73 2017-01 A12CB01 zinc sulfate 2.16.840.1.113883.6.73 2017-01 A12CB02 zinc gluconate 2.16.840.1.113883.6.73 2017-01 A12CB03 zinc protein complex 2.16.840.1.113883.6.73 2017-01 A12CC Magnesium 2.16.840.1.113883.6.73 2017-01 A12CC01 2.16.840.1.113883.6.73 2017-01 A12CC02 magnesium sulfate 2.16.840.1.113883.6.73 2017-01 A12CC03 magnesium gluconate 2.16.840.1.113883.6.73 2017-01 A12CC04 magnesium citrate 2.16.840.1.113883.6.73 2017-01 A12CC05 magnesium aspartate 2.16.840.1.113883.6.73 2017-01 A12CC06 magnesium lactate 2.16.840.1.113883.6.73 2017-01 A12CC07 magnesium levulinate 2.16.840.1.113883.6.73 2017-01 A12CC08 magnesium pidolate 2.16.840.1.113883.6.73 2017-01 A12CC09 magnesium orotate 2.16.840.1.113883.6.73 2017-01 A12CC10 magnesium oxide 2.16.840.1.113883.6.73 2017-01 A12CC30 magnesium (different salts in combination) 2.16.840.1.113883.6.73 2017-01 A12CD Fluoride 2.16.840.1.113883.6.73 2017-01 A12CD01 sodium fluoride 2.16.840.1.113883.6.73 2017-01 A12CD02 sodium monofluorophosphate 2.16.840.1.113883.6.73 2017-01 A12CD51 fluoride, combinations © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 20 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A12CE 2.16.840.1.113883.6.73 2017-01 A12CE01 sodium selenate 2.16.840.1.113883.6.73 2017-01 A12CE02 sodium selenite 2.16.840.1.113883.6.73 2017-01 A12CX Other mineral products 2.16.840.1.113883.6.73 2017-01 A13 TONICS 2.16.840.1.113883.6.73 2017-01 A13A TONICS 2.16.840.1.113883.6.73 2017-01 A14 ANABOLIC AGENTS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 A14A ANABOLIC STEROIDS 2.16.840.1.113883.6.73 2017-01 A14AA Androstan derivatives 2.16.840.1.113883.6.73 2017-01 A14AA01 2.16.840.1.113883.6.73 2017-01 A14AA02 2.16.840.1.113883.6.73 2017-01 A14AA03 2.16.840.1.113883.6.73 2017-01 A14AA04 metenolone 2.16.840.1.113883.6.73 2017-01 A14AA05 2.16.840.1.113883.6.73 2017-01 A14AA06 2.16.840.1.113883.6.73 2017-01 A14AA07 2.16.840.1.113883.6.73 2017-01 A14AA08 2.16.840.1.113883.6.73 2017-01 A14AA09 2.16.840.1.113883.6.73 2017-01 A14AB Estren derivatives 2.16.840.1.113883.6.73 2017-01 A14AB01 2.16.840.1.113883.6.73 2017-01 A14AB02 2.16.840.1.113883.6.73 2017-01 A14AB03 oxabolone cipionate 2.16.840.1.113883.6.73 2017-01 A14B OTHER ANABOLIC AGENTS 2.16.840.1.113883.6.73 2017-01 A15 APPETITE 2.16.840.1.113883.6.73 2017-01 A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS 2.16.840.1.113883.6.73 2017-01 A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS 2.16.840.1.113883.6.73 2017-01 A16AA Amino acids and derivatives 2.16.840.1.113883.6.73 2017-01 A16AA01 levocarnitine 2.16.840.1.113883.6.73 2017-01 A16AA02 ademetionine 2.16.840.1.113883.6.73 2017-01 A16AA03 2.16.840.1.113883.6.73 2017-01 A16AA04 mercaptamine 2.16.840.1.113883.6.73 2017-01 A16AA05 2.16.840.1.113883.6.73 2017-01 A16AA06 betaine 2.16.840.1.113883.6.73 2017-01 A16AA07 2.16.840.1.113883.6.73 2017-01 A16AB Enzymes 2.16.840.1.113883.6.73 2017-01 A16AB01 2.16.840.1.113883.6.73 2017-01 A16AB02 2.16.840.1.113883.6.73 2017-01 A16AB03 agalsidase alfa 2.16.840.1.113883.6.73 2017-01 A16AB04 agalsidase beta 2.16.840.1.113883.6.73 2017-01 A16AB05 laronidase 2.16.840.1.113883.6.73 2017-01 A16AB06 2.16.840.1.113883.6.73 2017-01 A16AB07 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 21 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 A16AB08 galsulfase 2.16.840.1.113883.6.73 2017-01 A16AB09 2.16.840.1.113883.6.73 2017-01 A16AB10 2.16.840.1.113883.6.73 2017-01 A16AB11 2.16.840.1.113883.6.73 2017-01 A16AB12 elosulfase alfa 2.16.840.1.113883.6.73 2017-01 A16AB13 2.16.840.1.113883.6.73 2017-01 A16AB14 2.16.840.1.113883.6.73 2017-01 A16AX Various alimentary tract and metabolism products 2.16.840.1.113883.6.73 2017-01 A16AX01 thioctic acid 2.16.840.1.113883.6.73 2017-01 A16AX02 trithione 2.16.840.1.113883.6.73 2017-01 A16AX03 2.16.840.1.113883.6.73 2017-01 A16AX04 2.16.840.1.113883.6.73 2017-01 A16AX05 zinc 2.16.840.1.113883.6.73 2017-01 A16AX06 2.16.840.1.113883.6.73 2017-01 A16AX07 sapropterin 2.16.840.1.113883.6.73 2017-01 A16AX08 2.16.840.1.113883.6.73 2017-01 A16AX09 2.16.840.1.113883.6.73 2017-01 A16AX10 2.16.840.1.113883.6.73 2017-01 A16AX11 2.16.840.1.113883.6.73 2017-01 A16AX12 trientine 2.16.840.1.113883.6.73 2017-01 A16AX13 triacetate 2.16.840.1.113883.6.73 2017-01 B BLOOD AND BLOOD FORMING ORGANS 2.16.840.1.113883.6.73 2017-01 B01 AGENTS 2.16.840.1.113883.6.73 2017-01 B01A ANTITHROMBOTIC AGENTS 2.16.840.1.113883.6.73 2017-01 B01AA antagonists 2.16.840.1.113883.6.73 2017-01 B01AA01 2.16.840.1.113883.6.73 2017-01 B01AA02 2.16.840.1.113883.6.73 2017-01 B01AA03 2.16.840.1.113883.6.73 2017-01 B01AA04 2.16.840.1.113883.6.73 2017-01 B01AA07 2.16.840.1.113883.6.73 2017-01 B01AA08 2.16.840.1.113883.6.73 2017-01 B01AA09 2.16.840.1.113883.6.73 2017-01 B01AA10 2.16.840.1.113883.6.73 2017-01 B01AA11 2.16.840.1.113883.6.73 2017-01 B01AA12 fluindione 2.16.840.1.113883.6.73 2017-01 B01AB group 2.16.840.1.113883.6.73 2017-01 B01AB01 heparin 2.16.840.1.113883.6.73 2017-01 B01AB02 III 2.16.840.1.113883.6.73 2017-01 B01AB04 dalteparin 2.16.840.1.113883.6.73 2017-01 B01AB05 enoxaparin 2.16.840.1.113883.6.73 2017-01 B01AB06 nadroparin 2.16.840.1.113883.6.73 2017-01 B01AB07 parnaparin 2.16.840.1.113883.6.73 2017-01 B01AB08 reviparin © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 22 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B01AB09 2.16.840.1.113883.6.73 2017-01 B01AB10 tinzaparin 2.16.840.1.113883.6.73 2017-01 B01AB11 2.16.840.1.113883.6.73 2017-01 B01AB12 bemiparin 2.16.840.1.113883.6.73 2017-01 B01AB51 heparin, combinations 2.16.840.1.113883.6.73 2017-01 B01AC aggregation inhibitors excl. heparin 2.16.840.1.113883.6.73 2017-01 B01AC01 2.16.840.1.113883.6.73 2017-01 B01AC02 2.16.840.1.113883.6.73 2017-01 B01AC03 2.16.840.1.113883.6.73 2017-01 B01AC04 2.16.840.1.113883.6.73 2017-01 B01AC05 2.16.840.1.113883.6.73 2017-01 B01AC06 acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 B01AC07 2.16.840.1.113883.6.73 2017-01 B01AC08 2.16.840.1.113883.6.73 2017-01 B01AC09 epoprostenol 2.16.840.1.113883.6.73 2017-01 B01AC10 2.16.840.1.113883.6.73 2017-01 B01AC11 2.16.840.1.113883.6.73 2017-01 B01AC13 2.16.840.1.113883.6.73 2017-01 B01AC15 2.16.840.1.113883.6.73 2017-01 B01AC16 2.16.840.1.113883.6.73 2017-01 B01AC17 2.16.840.1.113883.6.73 2017-01 B01AC18 2.16.840.1.113883.6.73 2017-01 B01AC19 2.16.840.1.113883.6.73 2017-01 B01AC21 2.16.840.1.113883.6.73 2017-01 B01AC22 2.16.840.1.113883.6.73 2017-01 B01AC23 2.16.840.1.113883.6.73 2017-01 B01AC24 2.16.840.1.113883.6.73 2017-01 B01AC25 2.16.840.1.113883.6.73 2017-01 B01AC26 2.16.840.1.113883.6.73 2017-01 B01AC27 selexipag 2.16.840.1.113883.6.73 2017-01 B01AC30 combinations 2.16.840.1.113883.6.73 2017-01 B01AC56 acetylsalicylic acid, combinations with proton pump inhibitors 2.16.840.1.113883.6.73 2017-01 B01AD Enzymes 2.16.840.1.113883.6.73 2017-01 B01AD01 2.16.840.1.113883.6.73 2017-01 B01AD02 2.16.840.1.113883.6.73 2017-01 B01AD03 2.16.840.1.113883.6.73 2017-01 B01AD04 2.16.840.1.113883.6.73 2017-01 B01AD05 2.16.840.1.113883.6.73 2017-01 B01AD06 brinase 2.16.840.1.113883.6.73 2017-01 B01AD07 2.16.840.1.113883.6.73 2017-01 B01AD08 2.16.840.1.113883.6.73 2017-01 B01AD09 2.16.840.1.113883.6.73 2017-01 B01AD10 (activated) © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 23 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B01AD11 2.16.840.1.113883.6.73 2017-01 B01AD12 2.16.840.1.113883.6.73 2017-01 B01AE Direct inhibitors 2.16.840.1.113883.6.73 2017-01 B01AE01 desirudin 2.16.840.1.113883.6.73 2017-01 B01AE02 2.16.840.1.113883.6.73 2017-01 B01AE03 2.16.840.1.113883.6.73 2017-01 B01AE04 melagatran 2.16.840.1.113883.6.73 2017-01 B01AE05 2.16.840.1.113883.6.73 2017-01 B01AE06 2.16.840.1.113883.6.73 2017-01 B01AE07 etexilate 2.16.840.1.113883.6.73 2017-01 B01AF Direct factor Xa inhibitors 2.16.840.1.113883.6.73 2017-01 B01AF01 2.16.840.1.113883.6.73 2017-01 B01AF02 2.16.840.1.113883.6.73 2017-01 B01AF03 2.16.840.1.113883.6.73 2017-01 B01AX Other antithrombotic agents 2.16.840.1.113883.6.73 2017-01 B01AX01 2.16.840.1.113883.6.73 2017-01 B01AX04 2.16.840.1.113883.6.73 2017-01 B01AX05 2.16.840.1.113883.6.73 2017-01 B02 2.16.840.1.113883.6.73 2017-01 B02A 2.16.840.1.113883.6.73 2017-01 B02AA Amino acids 2.16.840.1.113883.6.73 2017-01 B02AA01 2.16.840.1.113883.6.73 2017-01 B02AA02 2.16.840.1.113883.6.73 2017-01 B02AA03 2.16.840.1.113883.6.73 2017-01 B02AB Proteinase inhibitors 2.16.840.1.113883.6.73 2017-01 B02AB01 2.16.840.1.113883.6.73 2017-01 B02AB02 alfa1 antitrypsin 2.16.840.1.113883.6.73 2017-01 B02AB04 2.16.840.1.113883.6.73 2017-01 B02B VITAMIN K AND OTHER HEMOSTATICS 2.16.840.1.113883.6.73 2017-01 B02BA Vitamin K 2.16.840.1.113883.6.73 2017-01 B02BA01 2.16.840.1.113883.6.73 2017-01 B02BA02 2.16.840.1.113883.6.73 2017-01 B02BB 2.16.840.1.113883.6.73 2017-01 B02BB01 fibrinogen, human 2.16.840.1.113883.6.73 2017-01 B02BC Local hemostatics 2.16.840.1.113883.6.73 2017-01 B02BC01 absorbable gelatin sponge 2.16.840.1.113883.6.73 2017-01 B02BC02 2.16.840.1.113883.6.73 2017-01 B02BC03 tetragalacturonic acid hydroxymethylester 2.16.840.1.113883.6.73 2017-01 B02BC05 adrenalone 2.16.840.1.113883.6.73 2017-01 B02BC06 thrombin 2.16.840.1.113883.6.73 2017-01 B02BC07 collagen 2.16.840.1.113883.6.73 2017-01 B02BC08 calcium alginate 2.16.840.1.113883.6.73 2017-01 B02BC09 epinephrine © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 24 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B02BC30 combinations 2.16.840.1.113883.6.73 2017-01 B02BD Blood factors 2.16.840.1.113883.6.73 2017-01 B02BD01 coagulation factor IX, II, VII and X in combination 2.16.840.1.113883.6.73 2017-01 B02BD02 coagulation factor VIII 2.16.840.1.113883.6.73 2017-01 B02BD03 factor VIII inhibitor bypassing activity 2.16.840.1.113883.6.73 2017-01 B02BD04 coagulation factor IX 2.16.840.1.113883.6.73 2017-01 B02BD05 coagulation factor VII 2.16.840.1.113883.6.73 2017-01 B02BD06 von Willebrand factor and coagulation factor VIII in combination 2.16.840.1.113883.6.73 2017-01 B02BD07 coagulation factor XIII 2.16.840.1.113883.6.73 2017-01 B02BD08 eptacog alfa (activated) 2.16.840.1.113883.6.73 2017-01 B02BD10 von Willebrand factor 2.16.840.1.113883.6.73 2017-01 B02BD11 2.16.840.1.113883.6.73 2017-01 B02BD13 coagulation 2.16.840.1.113883.6.73 2017-01 B02BD14 2.16.840.1.113883.6.73 2017-01 B02BD30 thrombin 2.16.840.1.113883.6.73 2017-01 B02BX Other systemic hemostatics 2.16.840.1.113883.6.73 2017-01 B02BX01 2.16.840.1.113883.6.73 2017-01 B02BX02 2.16.840.1.113883.6.73 2017-01 B02BX03 2.16.840.1.113883.6.73 2017-01 B02BX04 2.16.840.1.113883.6.73 2017-01 B02BX05 2.16.840.1.113883.6.73 2017-01 B03 ANTIANEMIC PREPARATIONS 2.16.840.1.113883.6.73 2017-01 B03A IRON PREPARATIONS 2.16.840.1.113883.6.73 2017-01 B03AA Iron bivalent, oral preparations 2.16.840.1.113883.6.73 2017-01 B03AA01 ferrous sulfate 2.16.840.1.113883.6.73 2017-01 B03AA02 ferrous fumarate 2.16.840.1.113883.6.73 2017-01 B03AA03 ferrous gluconate 2.16.840.1.113883.6.73 2017-01 B03AA04 ferrous carbonate 2.16.840.1.113883.6.73 2017-01 B03AA05 ferrous chloride 2.16.840.1.113883.6.73 2017-01 B03AA06 ferrous succinate 2.16.840.1.113883.6.73 2017-01 B03AA07 ferrous sulfate 2.16.840.1.113883.6.73 2017-01 B03AA08 2.16.840.1.113883.6.73 2017-01 B03AA09 ferrous aspartate 2.16.840.1.113883.6.73 2017-01 B03AA10 ferrous ascorbate 2.16.840.1.113883.6.73 2017-01 B03AA11 ferrous 2.16.840.1.113883.6.73 2017-01 B03AB Iron trivalent, oral preparations 2.16.840.1.113883.6.73 2017-01 B03AB01 ferric sodium citrate 2.16.840.1.113883.6.73 2017-01 B03AB02 saccharated iron oxide 2.16.840.1.113883.6.73 2017-01 B03AB03 sodium feredetate 2.16.840.1.113883.6.73 2017-01 B03AB04 ferric hydroxide 2.16.840.1.113883.6.73 2017-01 B03AB05 ferric oxide polymaltose complexes 2.16.840.1.113883.6.73 2017-01 B03AB07 -iron complex 2.16.840.1.113883.6.73 2017-01 B03AB08 ferric acetyl transferrin © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 25 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B03AB09 ferric proteinsuccinylate 2.16.840.1.113883.6.73 2017-01 B03AB10 2.16.840.1.113883.6.73 2017-01 B03AC Iron, parenteral preparations 2.16.840.1.113883.6.73 2017-01 B03AD Iron in combination with folic acid 2.16.840.1.113883.6.73 2017-01 B03AD01 ferrous complex 2.16.840.1.113883.6.73 2017-01 B03AD02 ferrous fumarate 2.16.840.1.113883.6.73 2017-01 B03AD03 ferrous sulfate 2.16.840.1.113883.6.73 2017-01 B03AD04 ferric oxide polymaltose complexes 2.16.840.1.113883.6.73 2017-01 B03AE Iron in other combinations 2.16.840.1.113883.6.73 2017-01 B03AE01 iron, vitamin B12 and folic acid 2.16.840.1.113883.6.73 2017-01 B03AE02 iron, multivitamins and folic acid 2.16.840.1.113883.6.73 2017-01 B03AE03 iron and multivitamins 2.16.840.1.113883.6.73 2017-01 B03AE04 iron, multivitamins and minerals 2.16.840.1.113883.6.73 2017-01 B03AE10 various combinations 2.16.840.1.113883.6.73 2017-01 B03B VITAMIN B12 AND FOLIC ACID 2.16.840.1.113883.6.73 2017-01 B03BA Vitamin B12 ( and analogues) 2.16.840.1.113883.6.73 2017-01 B03BA01 cyanocobalamin 2.16.840.1.113883.6.73 2017-01 B03BA02 cyanocobalamin tannin complex 2.16.840.1.113883.6.73 2017-01 B03BA03 2.16.840.1.113883.6.73 2017-01 B03BA04 cobamamide 2.16.840.1.113883.6.73 2017-01 B03BA05 mecobalamin 2.16.840.1.113883.6.73 2017-01 B03BA51 cyanocobalamin, combinations 2.16.840.1.113883.6.73 2017-01 B03BA53 hydroxocobalamin, combinations 2.16.840.1.113883.6.73 2017-01 B03BB Folic acid and derivatives 2.16.840.1.113883.6.73 2017-01 B03BB01 folic acid 2.16.840.1.113883.6.73 2017-01 B03BB51 folic acid, combinations 2.16.840.1.113883.6.73 2017-01 B03X OTHER ANTIANEMIC PREPARATIONS 2.16.840.1.113883.6.73 2017-01 B03XA Other antianemic preparations 2.16.840.1.113883.6.73 2017-01 B03XA01 2.16.840.1.113883.6.73 2017-01 B03XA02 2.16.840.1.113883.6.73 2017-01 B03XA03 methoxy - 2.16.840.1.113883.6.73 2017-01 B03XA04 2.16.840.1.113883.6.73 2017-01 B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS 2.16.840.1.113883.6.73 2017-01 B05A BLOOD AND RELATED PRODUCTS 2.16.840.1.113883.6.73 2017-01 B05AA Blood substitutes and plasma protein fractions 2.16.840.1.113883.6.73 2017-01 B05AA01 albumin 2.16.840.1.113883.6.73 2017-01 B05AA02 other plasma protein fractions 2.16.840.1.113883.6.73 2017-01 B05AA03 fluorocarbon blood substitutes 2.16.840.1.113883.6.73 2017-01 B05AA05 2.16.840.1.113883.6.73 2017-01 B05AA06 gelatin agents 2.16.840.1.113883.6.73 2017-01 B05AA07 hydroxyethylstarch 2.16.840.1.113883.6.73 2017-01 B05AA08 hemoglobin crosfumaril 2.16.840.1.113883.6.73 2017-01 B05AA09 hemoglobin raffimer © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 26 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B05AA10 hemoglobin glutamer (bovine) 2.16.840.1.113883.6.73 2017-01 B05AX Other blood products 2.16.840.1.113883.6.73 2017-01 B05AX01 erythrocytes 2.16.840.1.113883.6.73 2017-01 B05AX02 thrombocytes 2.16.840.1.113883.6.73 2017-01 B05AX03 2.16.840.1.113883.6.73 2017-01 B05AX04 stem cells from umbilical 2.16.840.1.113883.6.73 2017-01 B05B I.V. SOLUTIONS 2.16.840.1.113883.6.73 2017-01 B05BA Solutions for parenteral 2.16.840.1.113883.6.73 2017-01 B05BA01 amino acids 2.16.840.1.113883.6.73 2017-01 B05BA02 fat emulsions 2.16.840.1.113883.6.73 2017-01 B05BA03 carbohydrates 2.16.840.1.113883.6.73 2017-01 B05BA04 protein hydrolysates 2.16.840.1.113883.6.73 2017-01 B05BA10 combinations 2.16.840.1.113883.6.73 2017-01 B05BB Solutions affecting the electrolyte balance 2.16.840.1.113883.6.73 2017-01 B05BB01 electrolytes 2.16.840.1.113883.6.73 2017-01 B05BB02 electrolytes with carbohydrates 2.16.840.1.113883.6.73 2017-01 B05BB03 trometamol 2.16.840.1.113883.6.73 2017-01 B05BB04 electrolytes in combination with other drugs 2.16.840.1.113883.6.73 2017-01 B05BC Solutions producing osmotic diuresis 2.16.840.1.113883.6.73 2017-01 B05BC01 mannitol 2.16.840.1.113883.6.73 2017-01 B05BC02 carbamide 2.16.840.1.113883.6.73 2017-01 B05C IRRIGATING SOLUTIONS 2.16.840.1.113883.6.73 2017-01 B05CA Antiinfectives 2.16.840.1.113883.6.73 2017-01 B05CA01 cetylpyridinium 2.16.840.1.113883.6.73 2017-01 B05CA02 chlorhexidine 2.16.840.1.113883.6.73 2017-01 B05CA03 nitrofural 2.16.840.1.113883.6.73 2017-01 B05CA04 2.16.840.1.113883.6.73 2017-01 B05CA05 2.16.840.1.113883.6.73 2017-01 B05CA06 mandelic acid 2.16.840.1.113883.6.73 2017-01 B05CA07 2.16.840.1.113883.6.73 2017-01 B05CA08 2.16.840.1.113883.6.73 2017-01 B05CA09 neomycin 2.16.840.1.113883.6.73 2017-01 B05CA10 combinations 2.16.840.1.113883.6.73 2017-01 B05CB Salt solutions 2.16.840.1.113883.6.73 2017-01 B05CB01 sodium chloride 2.16.840.1.113883.6.73 2017-01 B05CB02 sodium citrate 2.16.840.1.113883.6.73 2017-01 B05CB03 magnesium citrate 2.16.840.1.113883.6.73 2017-01 B05CB04 sodium bicarbonate 2.16.840.1.113883.6.73 2017-01 B05CB10 combinations 2.16.840.1.113883.6.73 2017-01 B05CX Other irrigating solutions 2.16.840.1.113883.6.73 2017-01 B05CX01 glucose 2.16.840.1.113883.6.73 2017-01 B05CX02 sorbitol 2.16.840.1.113883.6.73 2017-01 B05CX03 glycine © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 27 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B05CX04 mannitol 2.16.840.1.113883.6.73 2017-01 B05CX10 combinations 2.16.840.1.113883.6.73 2017-01 B05D PERITONEAL DIALYTICS 2.16.840.1.113883.6.73 2017-01 B05DA Isotonic solutions 2.16.840.1.113883.6.73 2017-01 B05DB Hypertonic solutions 2.16.840.1.113883.6.73 2017-01 B05X I.V. SOLUTION ADDITIVES 2.16.840.1.113883.6.73 2017-01 B05XA Electrolyte solutions 2.16.840.1.113883.6.73 2017-01 B05XA01 potassium chloride 2.16.840.1.113883.6.73 2017-01 B05XA02 sodium bicarbonate 2.16.840.1.113883.6.73 2017-01 B05XA03 sodium chloride 2.16.840.1.113883.6.73 2017-01 B05XA04 2.16.840.1.113883.6.73 2017-01 B05XA05 magnesium sulfate 2.16.840.1.113883.6.73 2017-01 B05XA06 potassium phosphate, incl. combinations with other potassium salts 2.16.840.1.113883.6.73 2017-01 B05XA07 calcium chloride 2.16.840.1.113883.6.73 2017-01 B05XA08 2.16.840.1.113883.6.73 2017-01 B05XA09 sodium phosphate 2.16.840.1.113883.6.73 2017-01 B05XA10 magnesium phosphate 2.16.840.1.113883.6.73 2017-01 B05XA11 magnesium chloride 2.16.840.1.113883.6.73 2017-01 B05XA12 2.16.840.1.113883.6.73 2017-01 B05XA13 hydrochloric acid 2.16.840.1.113883.6.73 2017-01 B05XA14 sodium glycerophosphate 2.16.840.1.113883.6.73 2017-01 B05XA15 potassium lactate 2.16.840.1.113883.6.73 2017-01 B05XA16 cardioplegia solutions 2.16.840.1.113883.6.73 2017-01 B05XA17 2.16.840.1.113883.6.73 2017-01 B05XA30 combinations of electrolytes 2.16.840.1.113883.6.73 2017-01 B05XA31 electrolytes in combination with other drugs 2.16.840.1.113883.6.73 2017-01 B05XB Amino acids 2.16.840.1.113883.6.73 2017-01 B05XB01 arginine hydrochloride 2.16.840.1.113883.6.73 2017-01 B05XB02 alanyl glutamine 2.16.840.1.113883.6.73 2017-01 B05XB03 lysine 2.16.840.1.113883.6.73 2017-01 B05XC Vitamins 2.16.840.1.113883.6.73 2017-01 B05XX Other i.v. solution additives 2.16.840.1.113883.6.73 2017-01 B05XX02 trometamol 2.16.840.1.113883.6.73 2017-01 B05Z HEMODIALYTICS AND HEMOFILTRATES 2.16.840.1.113883.6.73 2017-01 B05ZA Hemodialytics, concentrates 2.16.840.1.113883.6.73 2017-01 B05ZB Hemofiltrates 2.16.840.1.113883.6.73 2017-01 B06 OTHER HEMATOLOGICAL AGENTS 2.16.840.1.113883.6.73 2017-01 B06A OTHER HEMATOLOGICAL AGENTS 2.16.840.1.113883.6.73 2017-01 B06AA Enzymes 2.16.840.1.113883.6.73 2017-01 B06AA02 fibrinolysin and desoxyribonuclease 2.16.840.1.113883.6.73 2017-01 B06AA03 hyaluronidase 2.16.840.1.113883.6.73 2017-01 B06AA04 chymotrypsin

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 28 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 B06AA07 trypsin 2.16.840.1.113883.6.73 2017-01 B06AA10 desoxyribonuclease 2.16.840.1.113883.6.73 2017-01 B06AA55 streptokinase, combinations 2.16.840.1.113883.6.73 2017-01 B06AB Other hem products 2.16.840.1.113883.6.73 2017-01 B06AB01 hematin 2.16.840.1.113883.6.73 2017-01 B06AC Drugs used in hereditary angioedema 2.16.840.1.113883.6.73 2017-01 B06AC01 c1-inhibitor, plasma derived 2.16.840.1.113883.6.73 2017-01 B06AC02 icatibant 2.16.840.1.113883.6.73 2017-01 B06AC03 ecallantide 2.16.840.1.113883.6.73 2017-01 B06AC04 conestat alfa 2.16.840.1.113883.6.73 2017-01 C CARDIOVASCULAR SYSTEM 2.16.840.1.113883.6.73 2017-01 C01 CARDIAC THERAPY 2.16.840.1.113883.6.73 2017-01 C01A CARDIAC GLYCOSIDES 2.16.840.1.113883.6.73 2017-01 C01AA Digitalis glycosides 2.16.840.1.113883.6.73 2017-01 C01AA01 acetyldigitoxin 2.16.840.1.113883.6.73 2017-01 C01AA02 acetyldigoxin 2.16.840.1.113883.6.73 2017-01 C01AA03 digitalis leaves 2.16.840.1.113883.6.73 2017-01 C01AA04 2.16.840.1.113883.6.73 2017-01 C01AA05 2.16.840.1.113883.6.73 2017-01 C01AA06 2.16.840.1.113883.6.73 2017-01 C01AA07 2.16.840.1.113883.6.73 2017-01 C01AA08 2.16.840.1.113883.6.73 2017-01 C01AA09 2.16.840.1.113883.6.73 2017-01 C01AA52 acetyldigoxin, combinations 2.16.840.1.113883.6.73 2017-01 C01AB Scilla glycosides 2.16.840.1.113883.6.73 2017-01 C01AB01 2.16.840.1.113883.6.73 2017-01 C01AB51 proscillaridin, combinations 2.16.840.1.113883.6.73 2017-01 C01AC Strophanthus glycosides 2.16.840.1.113883.6.73 2017-01 C01AC01 g-strophanthin 2.16.840.1.113883.6.73 2017-01 C01AC03 2.16.840.1.113883.6.73 2017-01 C01AX Other cardiac glycosides 2.16.840.1.113883.6.73 2017-01 C01AX02 2.16.840.1.113883.6.73 2017-01 C01B ANTIARRHYTHMICS, CLASS I AND III 2.16.840.1.113883.6.73 2017-01 C01BA Antiarrhythmics, class Ia 2.16.840.1.113883.6.73 2017-01 C01BA01 2.16.840.1.113883.6.73 2017-01 C01BA02 2.16.840.1.113883.6.73 2017-01 C01BA03 2.16.840.1.113883.6.73 2017-01 C01BA04 2.16.840.1.113883.6.73 2017-01 C01BA05 2.16.840.1.113883.6.73 2017-01 C01BA08 prajmaline 2.16.840.1.113883.6.73 2017-01 C01BA12 2.16.840.1.113883.6.73 2017-01 C01BA13 hydroquinidine 2.16.840.1.113883.6.73 2017-01 C01BA51 quinidine, combinations excl. psycholeptics © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 29 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01BA71 quinidine, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 C01BB Antiarrhythmics, class Ib 2.16.840.1.113883.6.73 2017-01 C01BB01 2.16.840.1.113883.6.73 2017-01 C01BB02 2.16.840.1.113883.6.73 2017-01 C01BB03 2.16.840.1.113883.6.73 2017-01 C01BB04 2.16.840.1.113883.6.73 2017-01 C01BC Antiarrhythmics, class Ic 2.16.840.1.113883.6.73 2017-01 C01BC03 2.16.840.1.113883.6.73 2017-01 C01BC04 2.16.840.1.113883.6.73 2017-01 C01BC07 lorcainide 2.16.840.1.113883.6.73 2017-01 C01BC08 2.16.840.1.113883.6.73 2017-01 C01BC09 ethacizine 2.16.840.1.113883.6.73 2017-01 C01BD Antiarrhythmics, class III 2.16.840.1.113883.6.73 2017-01 C01BD01 2.16.840.1.113883.6.73 2017-01 C01BD02 tosilate 2.16.840.1.113883.6.73 2017-01 C01BD03 2.16.840.1.113883.6.73 2017-01 C01BD04 2.16.840.1.113883.6.73 2017-01 C01BD05 2.16.840.1.113883.6.73 2017-01 C01BD06 2.16.840.1.113883.6.73 2017-01 C01BD07 2.16.840.1.113883.6.73 2017-01 C01BG Other antiarrhythmics, class I and III 2.16.840.1.113883.6.73 2017-01 C01BG01 2.16.840.1.113883.6.73 2017-01 C01BG07 cibenzoline 2.16.840.1.113883.6.73 2017-01 C01BG11 2.16.840.1.113883.6.73 2017-01 C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES 2.16.840.1.113883.6.73 2017-01 C01CA and agents 2.16.840.1.113883.6.73 2017-01 C01CA01 2.16.840.1.113883.6.73 2017-01 C01CA02 2.16.840.1.113883.6.73 2017-01 C01CA03 2.16.840.1.113883.6.73 2017-01 C01CA04 2.16.840.1.113883.6.73 2017-01 C01CA05 2.16.840.1.113883.6.73 2017-01 C01CA06 2.16.840.1.113883.6.73 2017-01 C01CA07 2.16.840.1.113883.6.73 2017-01 C01CA08 oxedrine 2.16.840.1.113883.6.73 2017-01 C01CA09 2.16.840.1.113883.6.73 2017-01 C01CA10 2.16.840.1.113883.6.73 2017-01 C01CA11 2.16.840.1.113883.6.73 2017-01 C01CA12 2.16.840.1.113883.6.73 2017-01 C01CA13 2.16.840.1.113883.6.73 2017-01 C01CA14 2.16.840.1.113883.6.73 2017-01 C01CA15 2.16.840.1.113883.6.73 2017-01 C01CA16 2.16.840.1.113883.6.73 2017-01 C01CA17 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 30 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01CA18 2.16.840.1.113883.6.73 2017-01 C01CA19 2.16.840.1.113883.6.73 2017-01 C01CA21 2.16.840.1.113883.6.73 2017-01 C01CA22 2.16.840.1.113883.6.73 2017-01 C01CA23 2.16.840.1.113883.6.73 2017-01 C01CA24 epinephrine 2.16.840.1.113883.6.73 2017-01 C01CA25 2.16.840.1.113883.6.73 2017-01 C01CA26 ephedrine 2.16.840.1.113883.6.73 2017-01 C01CA27 2.16.840.1.113883.6.73 2017-01 C01CA30 combinations 2.16.840.1.113883.6.73 2017-01 C01CA51 etilefrine, combinations 2.16.840.1.113883.6.73 2017-01 C01CE Phosphodiesterase inhibitors 2.16.840.1.113883.6.73 2017-01 C01CE01 2.16.840.1.113883.6.73 2017-01 C01CE02 2.16.840.1.113883.6.73 2017-01 C01CE03 2.16.840.1.113883.6.73 2017-01 C01CE04 2.16.840.1.113883.6.73 2017-01 C01CX Other cardiac stimulants 2.16.840.1.113883.6.73 2017-01 C01CX06 2.16.840.1.113883.6.73 2017-01 C01CX07 2.16.840.1.113883.6.73 2017-01 C01CX08 2.16.840.1.113883.6.73 2017-01 C01D VASODILATORS USED IN CARDIAC DISEASES 2.16.840.1.113883.6.73 2017-01 C01DA Organic 2.16.840.1.113883.6.73 2017-01 C01DA02 glyceryl trinitrate 2.16.840.1.113883.6.73 2017-01 C01DA04 methylpropylpropanediol dinitrate 2.16.840.1.113883.6.73 2017-01 C01DA05 pentaerithrityl tetranitrate 2.16.840.1.113883.6.73 2017-01 C01DA07 2.16.840.1.113883.6.73 2017-01 C01DA08 2.16.840.1.113883.6.73 2017-01 C01DA09 2.16.840.1.113883.6.73 2017-01 C01DA13 eritrityl tetranitrate 2.16.840.1.113883.6.73 2017-01 C01DA14 2.16.840.1.113883.6.73 2017-01 C01DA20 organic nitrates in combination 2.16.840.1.113883.6.73 2017-01 C01DA38 2.16.840.1.113883.6.73 2017-01 C01DA52 glyceryl trinitrate, combinations 2.16.840.1.113883.6.73 2017-01 C01DA54 methylpropylpropanediol dinitrate, combinations 2.16.840.1.113883.6.73 2017-01 C01DA55 pentaerithrityl tetranitrate, combinations 2.16.840.1.113883.6.73 2017-01 C01DA57 propatylnitrate, combinations 2.16.840.1.113883.6.73 2017-01 C01DA58 isosorbide dinitrate, combinations 2.16.840.1.113883.6.73 2017-01 C01DA59 trolnitrate, combinations 2.16.840.1.113883.6.73 2017-01 C01DA63 eritrityl tetranitrate, combinations 2.16.840.1.113883.6.73 2017-01 C01DA70 organic nitrates in combination with psycholeptics 2.16.840.1.113883.6.73 2017-01 C01DB Quinolone vasodilators 2.16.840.1.113883.6.73 2017-01 C01DB01 2.16.840.1.113883.6.73 2017-01 C01DX Other vasodilators used in cardiac diseases © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 31 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01DX01 2.16.840.1.113883.6.73 2017-01 C01DX02 2.16.840.1.113883.6.73 2017-01 C01DX03 2.16.840.1.113883.6.73 2017-01 C01DX04 2.16.840.1.113883.6.73 2017-01 C01DX05 2.16.840.1.113883.6.73 2017-01 C01DX06 2.16.840.1.113883.6.73 2017-01 C01DX07 2.16.840.1.113883.6.73 2017-01 C01DX08 2.16.840.1.113883.6.73 2017-01 C01DX09 2.16.840.1.113883.6.73 2017-01 C01DX10 2.16.840.1.113883.6.73 2017-01 C01DX11 2.16.840.1.113883.6.73 2017-01 C01DX12 2.16.840.1.113883.6.73 2017-01 C01DX13 2.16.840.1.113883.6.73 2017-01 C01DX14 2.16.840.1.113883.6.73 2017-01 C01DX15 2.16.840.1.113883.6.73 2017-01 C01DX16 2.16.840.1.113883.6.73 2017-01 C01DX18 2.16.840.1.113883.6.73 2017-01 C01DX19 2.16.840.1.113883.6.73 2017-01 C01DX21 2.16.840.1.113883.6.73 2017-01 C01DX51 itramin tosilate, combinations 2.16.840.1.113883.6.73 2017-01 C01DX52 prenylamine, combinations 2.16.840.1.113883.6.73 2017-01 C01DX53 oxyfedrine, combinations 2.16.840.1.113883.6.73 2017-01 C01DX54 benziodarone, combinations 2.16.840.1.113883.6.73 2017-01 C01E OTHER CARDIAC PREPARATIONS 2.16.840.1.113883.6.73 2017-01 C01EA Prostaglandins 2.16.840.1.113883.6.73 2017-01 C01EA01 alprostadil 2.16.840.1.113883.6.73 2017-01 C01EB Other cardiac preparations 2.16.840.1.113883.6.73 2017-01 C01EB02 camphora 2.16.840.1.113883.6.73 2017-01 C01EB03 2.16.840.1.113883.6.73 2017-01 C01EB04 crataegus glycosides 2.16.840.1.113883.6.73 2017-01 C01EB05 creatinolfosfate 2.16.840.1.113883.6.73 2017-01 C01EB06 fosfocreatine 2.16.840.1.113883.6.73 2017-01 C01EB07 fructose 1,6-diphosphate 2.16.840.1.113883.6.73 2017-01 C01EB09 ubidecarenone 2.16.840.1.113883.6.73 2017-01 C01EB10 2.16.840.1.113883.6.73 2017-01 C01EB11 tiracizine 2.16.840.1.113883.6.73 2017-01 C01EB13 acadesine 2.16.840.1.113883.6.73 2017-01 C01EB15 trimetazidine 2.16.840.1.113883.6.73 2017-01 C01EB16 2.16.840.1.113883.6.73 2017-01 C01EB17 ivabradine 2.16.840.1.113883.6.73 2017-01 C01EB18 2.16.840.1.113883.6.73 2017-01 C01EB21 2.16.840.1.113883.6.73 2017-01 C01EB22 meldonium © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 32 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C01EB23 tiazotic acid 2.16.840.1.113883.6.73 2017-01 C01EX Other cardiac combination products 2.16.840.1.113883.6.73 2017-01 C02 ANTIHYPERTENSIVES 2.16.840.1.113883.6.73 2017-01 C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING 2.16.840.1.113883.6.73 2017-01 C02AA Rauwolfia alkaloids 2.16.840.1.113883.6.73 2017-01 C02AA01 rescinnamine 2.16.840.1.113883.6.73 2017-01 C02AA02 reserpine 2.16.840.1.113883.6.73 2017-01 C02AA03 combinations of rauwolfia alkaloids 2.16.840.1.113883.6.73 2017-01 C02AA04 rauwolfia alkaloids, whole root 2.16.840.1.113883.6.73 2017-01 C02AA05 deserpidine 2.16.840.1.113883.6.73 2017-01 C02AA06 methoserpidine 2.16.840.1.113883.6.73 2017-01 C02AA07 bietaserpine 2.16.840.1.113883.6.73 2017-01 C02AA52 reserpine, combinations 2.16.840.1.113883.6.73 2017-01 C02AA53 combinations of rauwolfia alkoloids, combinations 2.16.840.1.113883.6.73 2017-01 C02AA57 bietaserpine, combinations 2.16.840.1.113883.6.73 2017-01 C02AB 2.16.840.1.113883.6.73 2017-01 C02AB01 methyldopa (levorotatory) 2.16.840.1.113883.6.73 2017-01 C02AB02 methyldopa (racemic) 2.16.840.1.113883.6.73 2017-01 C02AC Imidazoline receptor agonists 2.16.840.1.113883.6.73 2017-01 C02AC01 2.16.840.1.113883.6.73 2017-01 C02AC02 2.16.840.1.113883.6.73 2017-01 C02AC04 2.16.840.1.113883.6.73 2017-01 C02AC05 moxonidine 2.16.840.1.113883.6.73 2017-01 C02AC06 2.16.840.1.113883.6.73 2017-01 C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING 2.16.840.1.113883.6.73 2017-01 C02BA Sulfonium derivatives 2.16.840.1.113883.6.73 2017-01 C02BA01 trimetaphan 2.16.840.1.113883.6.73 2017-01 C02BB Secondary and tertiary amines 2.16.840.1.113883.6.73 2017-01 C02BB01 2.16.840.1.113883.6.73 2017-01 C02BC Bisquaternary ammonium compounds 2.16.840.1.113883.6.73 2017-01 C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING 2.16.840.1.113883.6.73 2017-01 C02CA Alpha-adrenoreceptor antagonists 2.16.840.1.113883.6.73 2017-01 C02CA01 2.16.840.1.113883.6.73 2017-01 C02CA02 2.16.840.1.113883.6.73 2017-01 C02CA03 2.16.840.1.113883.6.73 2017-01 C02CA04 2.16.840.1.113883.6.73 2017-01 C02CA06 2.16.840.1.113883.6.73 2017-01 C02CC derivatives 2.16.840.1.113883.6.73 2017-01 C02CC01 betanidine 2.16.840.1.113883.6.73 2017-01 C02CC02 2.16.840.1.113883.6.73 2017-01 C02CC03 guanoxan 2.16.840.1.113883.6.73 2017-01 C02CC04 debrisoquine 2.16.840.1.113883.6.73 2017-01 C02CC05 guanoclor © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 33 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C02CC06 guanazodine 2.16.840.1.113883.6.73 2017-01 C02CC07 2.16.840.1.113883.6.73 2017-01 C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON 2.16.840.1.113883.6.73 2017-01 C02DA derivatives 2.16.840.1.113883.6.73 2017-01 C02DA01 2.16.840.1.113883.6.73 2017-01 C02DB derivatives 2.16.840.1.113883.6.73 2017-01 C02DB01 2.16.840.1.113883.6.73 2017-01 C02DB02 2.16.840.1.113883.6.73 2017-01 C02DB03 2.16.840.1.113883.6.73 2017-01 C02DB04 cadralazine 2.16.840.1.113883.6.73 2017-01 C02DC derivatives 2.16.840.1.113883.6.73 2017-01 C02DC01 2.16.840.1.113883.6.73 2017-01 C02DD Nitroferricyanide derivatives 2.16.840.1.113883.6.73 2017-01 C02DD01 nitroprusside 2.16.840.1.113883.6.73 2017-01 C02DG Guanidine derivatives 2.16.840.1.113883.6.73 2017-01 C02DG01 2.16.840.1.113883.6.73 2017-01 C02K OTHER ANTIHYPERTENSIVES 2.16.840.1.113883.6.73 2017-01 C02KA Alkaloids, excl. rauwolfia 2.16.840.1.113883.6.73 2017-01 C02KA01 veratrum 2.16.840.1.113883.6.73 2017-01 C02KB hydroxylase inhibitors 2.16.840.1.113883.6.73 2017-01 C02KB01 metirosine 2.16.840.1.113883.6.73 2017-01 C02KC MAO inhibitors 2.16.840.1.113883.6.73 2017-01 C02KC01 2.16.840.1.113883.6.73 2017-01 C02KD Serotonin antagonists 2.16.840.1.113883.6.73 2017-01 C02KD01 2.16.840.1.113883.6.73 2017-01 C02KX Antihypertensives for pulmonary arterial 2.16.840.1.113883.6.73 2017-01 C02KX01 bosentan 2.16.840.1.113883.6.73 2017-01 C02KX02 ambrisentan 2.16.840.1.113883.6.73 2017-01 C02KX03 sitaxentan 2.16.840.1.113883.6.73 2017-01 C02KX04 macitentan 2.16.840.1.113883.6.73 2017-01 C02KX05 riociguat 2.16.840.1.113883.6.73 2017-01 C02L ANTIHYPERTENSIVES AND IN COMBINATION 2.16.840.1.113883.6.73 2017-01 C02LA Rauwolfia alkaloids and diuretics in combination 2.16.840.1.113883.6.73 2017-01 C02LA01 reserpine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LA02 rescinnamine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LA03 deserpidine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LA04 methoserpidine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LA07 bietaserpine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LA08 rauwolfia alkaloids, whole root and diuretics 2.16.840.1.113883.6.73 2017-01 C02LA09 syrosingopine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LA50 combination of rauwolfia alkaloids and diuretics incl. other combinations 2.16.840.1.113883.6.73 2017-01 C02LA51 reserpine and diuretics, combinations with other drugs

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 34 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C02LA52 rescinnamine and diuretics, combinations with other drugs 2.16.840.1.113883.6.73 2017-01 C02LA71 reserpine and diuretics, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 C02LB Methyldopa and diuretics in combination 2.16.840.1.113883.6.73 2017-01 C02LB01 methyldopa (levorotatory) and diuretics 2.16.840.1.113883.6.73 2017-01 C02LC Imidazoline receptor agonists in combination with diuretics 2.16.840.1.113883.6.73 2017-01 C02LC01 clonidine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LC05 moxonidine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LC51 clonidine and diuretics, combinations with other drugs 2.16.840.1.113883.6.73 2017-01 C02LE Alpha-adrenoreceptor antagonists and diuretics 2.16.840.1.113883.6.73 2017-01 C02LE01 prazosin and diuretics 2.16.840.1.113883.6.73 2017-01 C02LF Guanidine derivatives and diuretics 2.16.840.1.113883.6.73 2017-01 C02LF01 guanethidine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LG Hydrazinophthalazine derivatives and diuretics 2.16.840.1.113883.6.73 2017-01 C02LG01 dihydralazine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LG02 hydralazine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LG03 picodralazine and diuretics 2.16.840.1.113883.6.73 2017-01 C02LG51 dihydralazine and diuretics, combinations with other drugs 2.16.840.1.113883.6.73 2017-01 C02LG73 picodralazine and diuretics, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 C02LK Alkaloids, excl. rauwolfia, in combination with diuretics 2.16.840.1.113883.6.73 2017-01 C02LK01 veratrum and diuretics 2.16.840.1.113883.6.73 2017-01 C02LL MAO inhibitors and diuretics 2.16.840.1.113883.6.73 2017-01 C02LL01 pargyline and diuretics 2.16.840.1.113883.6.73 2017-01 C02LN Serotonin antagonists and diuretics 2.16.840.1.113883.6.73 2017-01 C02LX Other antihypertensives and diuretics 2.16.840.1.113883.6.73 2017-01 C02LX01 pinacidil and diuretics 2.16.840.1.113883.6.73 2017-01 C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 2.16.840.1.113883.6.73 2017-01 C03 DIURETICS 2.16.840.1.113883.6.73 2017-01 C03A LOW-CEILING DIURETICS, 2.16.840.1.113883.6.73 2017-01 C03AA Thiazides, plain 2.16.840.1.113883.6.73 2017-01 C03AA01 2.16.840.1.113883.6.73 2017-01 C03AA02 2.16.840.1.113883.6.73 2017-01 C03AA03 2.16.840.1.113883.6.73 2017-01 C03AA04 2.16.840.1.113883.6.73 2017-01 C03AA05 2.16.840.1.113883.6.73 2017-01 C03AA06 2.16.840.1.113883.6.73 2017-01 C03AA07 2.16.840.1.113883.6.73 2017-01 C03AA08 2.16.840.1.113883.6.73 2017-01 C03AA09 2.16.840.1.113883.6.73 2017-01 C03AA13 2.16.840.1.113883.6.73 2017-01 C03AB Thiazides and potassium in combination 2.16.840.1.113883.6.73 2017-01 C03AB01 bendroflumethiazide and potassium 2.16.840.1.113883.6.73 2017-01 C03AB02 hydroflumethiazide and potassium 2.16.840.1.113883.6.73 2017-01 C03AB03 hydrochlorothiazide and potassium © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 35 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C03AB04 chlorothiazide and potassium 2.16.840.1.113883.6.73 2017-01 C03AB05 polythiazide and potassium 2.16.840.1.113883.6.73 2017-01 C03AB06 trichlormethiazide and potassium 2.16.840.1.113883.6.73 2017-01 C03AB07 cyclopenthiazide and potassium 2.16.840.1.113883.6.73 2017-01 C03AB08 methyclothiazide and potassium 2.16.840.1.113883.6.73 2017-01 C03AB09 cyclothiazide and potassium 2.16.840.1.113883.6.73 2017-01 C03AH Thiazides, combinations with psycholeptics and/or analgesics 2.16.840.1.113883.6.73 2017-01 C03AH01 chlorothiazide, combinations 2.16.840.1.113883.6.73 2017-01 C03AH02 hydroflumethiazide, combinations 2.16.840.1.113883.6.73 2017-01 C03AX Thiazides, combinations with other drugs 2.16.840.1.113883.6.73 2017-01 C03AX01 hydrochlorothiazide, combinations 2.16.840.1.113883.6.73 2017-01 C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES 2.16.840.1.113883.6.73 2017-01 C03BA Sulfonamides, plain 2.16.840.1.113883.6.73 2017-01 C03BA02 2.16.840.1.113883.6.73 2017-01 C03BA03 2.16.840.1.113883.6.73 2017-01 C03BA04 2.16.840.1.113883.6.73 2017-01 C03BA05 2.16.840.1.113883.6.73 2017-01 C03BA07 2.16.840.1.113883.6.73 2017-01 C03BA08 2.16.840.1.113883.6.73 2017-01 C03BA09 2.16.840.1.113883.6.73 2017-01 C03BA10 2.16.840.1.113883.6.73 2017-01 C03BA11 2.16.840.1.113883.6.73 2017-01 C03BA12 2.16.840.1.113883.6.73 2017-01 C03BA13 2.16.840.1.113883.6.73 2017-01 C03BA82 clorexolone, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 C03BB Sulfonamides and potassium in combination 2.16.840.1.113883.6.73 2017-01 C03BB02 quinethazone and potassium 2.16.840.1.113883.6.73 2017-01 C03BB03 clopamide and potassium 2.16.840.1.113883.6.73 2017-01 C03BB04 chlortalidone and potassium 2.16.840.1.113883.6.73 2017-01 C03BB05 mefruside and potassium 2.16.840.1.113883.6.73 2017-01 C03BB07 clofenamide and potassium 2.16.840.1.113883.6.73 2017-01 C03BC Mercurial diuretics 2.16.840.1.113883.6.73 2017-01 C03BC01 2.16.840.1.113883.6.73 2017-01 C03BD derivatives 2.16.840.1.113883.6.73 2017-01 C03BD01 2.16.840.1.113883.6.73 2017-01 C03BK Sulfonamides, combinations with other drugs 2.16.840.1.113883.6.73 2017-01 C03BX Other low-ceiling diuretics 2.16.840.1.113883.6.73 2017-01 C03BX03 2.16.840.1.113883.6.73 2017-01 C03C HIGH-CEILING DIURETICS 2.16.840.1.113883.6.73 2017-01 C03CA Sulfonamides, plain 2.16.840.1.113883.6.73 2017-01 C03CA01 2.16.840.1.113883.6.73 2017-01 C03CA02 2.16.840.1.113883.6.73 2017-01 C03CA03 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 36 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C03CA04 2.16.840.1.113883.6.73 2017-01 C03CB Sulfonamides and potassium in combination 2.16.840.1.113883.6.73 2017-01 C03CB01 furosemide and potassium 2.16.840.1.113883.6.73 2017-01 C03CB02 bumetanide and potassium 2.16.840.1.113883.6.73 2017-01 C03CC Aryloxyacetic acid derivatives 2.16.840.1.113883.6.73 2017-01 C03CC01 etacrynic acid 2.16.840.1.113883.6.73 2017-01 C03CC02 2.16.840.1.113883.6.73 2017-01 C03CD derivatives 2.16.840.1.113883.6.73 2017-01 C03CD01 2.16.840.1.113883.6.73 2017-01 C03CX Other high-ceiling diuretics 2.16.840.1.113883.6.73 2017-01 C03CX01 2.16.840.1.113883.6.73 2017-01 C03D POTASSIUM-SPARING AGENTS 2.16.840.1.113883.6.73 2017-01 C03DA antagonists 2.16.840.1.113883.6.73 2017-01 C03DA01 2.16.840.1.113883.6.73 2017-01 C03DA02 2.16.840.1.113883.6.73 2017-01 C03DA03 2.16.840.1.113883.6.73 2017-01 C03DA04 2.16.840.1.113883.6.73 2017-01 C03DB Other potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03DB01 2.16.840.1.113883.6.73 2017-01 C03DB02 2.16.840.1.113883.6.73 2017-01 C03E DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION 2.16.840.1.113883.6.73 2017-01 C03EA Low-ceiling diuretics and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EA01 hydrochlorothiazide and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EA02 trichlormethiazide and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EA03 and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EA04 and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EA05 mebutizide and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EA06 chlortalidone and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EA07 cyclopenthiazide and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EA12 metolazone and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EA13 bendroflumethiazide and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EA14 and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EB High-ceiling diuretics and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EB01 furosemide and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03EB02 bumetanide and potassium-sparing agents 2.16.840.1.113883.6.73 2017-01 C03X OTHER DIURETICS 2.16.840.1.113883.6.73 2017-01 C03XA Vasopressin antagonists 2.16.840.1.113883.6.73 2017-01 C03XA01 2.16.840.1.113883.6.73 2017-01 C03XA02 2.16.840.1.113883.6.73 2017-01 C04 PERIPHERAL VASODILATORS 2.16.840.1.113883.6.73 2017-01 C04A PERIPHERAL VASODILATORS 2.16.840.1.113883.6.73 2017-01 C04AA 2-amino-1-phenylethanol derivatives

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 37 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C04AA01 2.16.840.1.113883.6.73 2017-01 C04AA02 2.16.840.1.113883.6.73 2017-01 C04AA31 2.16.840.1.113883.6.73 2017-01 C04AB Imidazoline derivatives 2.16.840.1.113883.6.73 2017-01 C04AB01 2.16.840.1.113883.6.73 2017-01 C04AB02 2.16.840.1.113883.6.73 2017-01 C04AC Nicotinic acid and derivatives 2.16.840.1.113883.6.73 2017-01 C04AC01 nicotinic acid 2.16.840.1.113883.6.73 2017-01 C04AC02 nicotinyl (pyridylcarbinol) 2.16.840.1.113883.6.73 2017-01 C04AC03 2.16.840.1.113883.6.73 2017-01 C04AC07 2.16.840.1.113883.6.73 2017-01 C04AD derivatives 2.16.840.1.113883.6.73 2017-01 C04AD01 2.16.840.1.113883.6.73 2017-01 C04AD02 xantinol nicotinate 2.16.840.1.113883.6.73 2017-01 C04AD03 2.16.840.1.113883.6.73 2017-01 C04AD04 2.16.840.1.113883.6.73 2017-01 C04AE alkaloids 2.16.840.1.113883.6.73 2017-01 C04AE01 mesylates 2.16.840.1.113883.6.73 2017-01 C04AE02 2.16.840.1.113883.6.73 2017-01 C04AE04 2.16.840.1.113883.6.73 2017-01 C04AE51 ergoloid mesylates, combinations 2.16.840.1.113883.6.73 2017-01 C04AE54 dihydroergocristine, combinations 2.16.840.1.113883.6.73 2017-01 C04AF Enzymes 2.16.840.1.113883.6.73 2017-01 C04AF01 kallidinogenase 2.16.840.1.113883.6.73 2017-01 C04AX Other peripheral vasodilators 2.16.840.1.113883.6.73 2017-01 C04AX01 2.16.840.1.113883.6.73 2017-01 C04AX02 2.16.840.1.113883.6.73 2017-01 C04AX07 2.16.840.1.113883.6.73 2017-01 C04AX10 2.16.840.1.113883.6.73 2017-01 C04AX11 2.16.840.1.113883.6.73 2017-01 C04AX17 2.16.840.1.113883.6.73 2017-01 C04AX19 2.16.840.1.113883.6.73 2017-01 C04AX20 2.16.840.1.113883.6.73 2017-01 C04AX21 2.16.840.1.113883.6.73 2017-01 C04AX23 2.16.840.1.113883.6.73 2017-01 C04AX24 2.16.840.1.113883.6.73 2017-01 C04AX26 2.16.840.1.113883.6.73 2017-01 C04AX27 2.16.840.1.113883.6.73 2017-01 C04AX28 2.16.840.1.113883.6.73 2017-01 C04AX30 2.16.840.1.113883.6.73 2017-01 C04AX32 2.16.840.1.113883.6.73 2017-01 C05

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 38 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C05A AGENTS FOR TREATMENT OF AND ANAL FISSURES FOR TOPICAL USE 2.16.840.1.113883.6.73 2017-01 C05AA Corticosteroids 2.16.840.1.113883.6.73 2017-01 C05AA01 hydrocortisone 2.16.840.1.113883.6.73 2017-01 C05AA04 prednisolone 2.16.840.1.113883.6.73 2017-01 C05AA05 betamethasone 2.16.840.1.113883.6.73 2017-01 C05AA06 2.16.840.1.113883.6.73 2017-01 C05AA08 2.16.840.1.113883.6.73 2017-01 C05AA09 dexamethasone 2.16.840.1.113883.6.73 2017-01 C05AA10 acetonide 2.16.840.1.113883.6.73 2017-01 C05AA11 2.16.840.1.113883.6.73 2017-01 C05AA12 triamcinolone 2.16.840.1.113883.6.73 2017-01 C05AB Antibiotics 2.16.840.1.113883.6.73 2017-01 C05AD Local 2.16.840.1.113883.6.73 2017-01 C05AD01 lidocaine 2.16.840.1.113883.6.73 2017-01 C05AD02 2.16.840.1.113883.6.73 2017-01 C05AD03 2.16.840.1.113883.6.73 2017-01 C05AD04 2.16.840.1.113883.6.73 2017-01 C05AD05 2.16.840.1.113883.6.73 2017-01 C05AD06 2.16.840.1.113883.6.73 2017-01 C05AD07 2.16.840.1.113883.6.73 2017-01 C05AE Muscle relaxants 2.16.840.1.113883.6.73 2017-01 C05AE01 glyceryl trinitrate 2.16.840.1.113883.6.73 2017-01 C05AE02 isosorbide dinitrate 2.16.840.1.113883.6.73 2017-01 C05AE03 2.16.840.1.113883.6.73 2017-01 C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use 2.16.840.1.113883.6.73 2017-01 C05AX01 aluminium preparations 2.16.840.1.113883.6.73 2017-01 C05AX02 bismuth preparations, combinations 2.16.840.1.113883.6.73 2017-01 C05AX03 other preparations, combinations 2.16.840.1.113883.6.73 2017-01 C05AX04 zinc preparations 2.16.840.1.113883.6.73 2017-01 C05AX05 2.16.840.1.113883.6.73 2017-01 C05B ANTIVARICOSE THERAPY 2.16.840.1.113883.6.73 2017-01 C05BA or for topical use 2.16.840.1.113883.6.73 2017-01 C05BA01 organo- 2.16.840.1.113883.6.73 2017-01 C05BA02 2.16.840.1.113883.6.73 2017-01 C05BA03 heparin 2.16.840.1.113883.6.73 2017-01 C05BA04 sodium 2.16.840.1.113883.6.73 2017-01 C05BA51 heparinoid, combinations 2.16.840.1.113883.6.73 2017-01 C05BA53 heparin, combinations 2.16.840.1.113883.6.73 2017-01 C05BB Sclerosing agents for local injection 2.16.840.1.113883.6.73 2017-01 C05BB01 2.16.840.1.113883.6.73 2017-01 C05BB02 2.16.840.1.113883.6.73 2017-01 C05BB03 invert sugar © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 39 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C05BB04 sodium tetradecyl sulfate 2.16.840.1.113883.6.73 2017-01 C05BB05 2.16.840.1.113883.6.73 2017-01 C05BB56 glucose, combinations 2.16.840.1.113883.6.73 2017-01 C05BX Other sclerosing agents 2.16.840.1.113883.6.73 2017-01 C05BX01 2.16.840.1.113883.6.73 2017-01 C05BX51 calcium dobesilate, combinations 2.16.840.1.113883.6.73 2017-01 C05C CAPILLARY STABILIZING AGENTS 2.16.840.1.113883.6.73 2017-01 C05CA Bioflavonoids 2.16.840.1.113883.6.73 2017-01 C05CA01 rutoside 2.16.840.1.113883.6.73 2017-01 C05CA02 2.16.840.1.113883.6.73 2017-01 C05CA03 2.16.840.1.113883.6.73 2017-01 C05CA04 2.16.840.1.113883.6.73 2017-01 C05CA05 2.16.840.1.113883.6.73 2017-01 C05CA51 rutoside, combinations 2.16.840.1.113883.6.73 2017-01 C05CA53 diosmin, combinations 2.16.840.1.113883.6.73 2017-01 C05CA54 troxerutin, combinations 2.16.840.1.113883.6.73 2017-01 C05CX Other capillary stabilizing agents 2.16.840.1.113883.6.73 2017-01 C05CX01 tribenoside 2.16.840.1.113883.6.73 2017-01 C05CX02 naftazone 2.16.840.1.113883.6.73 2017-01 C05CX03 Hippocastani semen 2.16.840.1.113883.6.73 2017-01 C07 BETA BLOCKING AGENTS 2.16.840.1.113883.6.73 2017-01 C07A BETA BLOCKING AGENTS 2.16.840.1.113883.6.73 2017-01 C07AA Beta blocking agents, non-selective 2.16.840.1.113883.6.73 2017-01 C07AA01 2.16.840.1.113883.6.73 2017-01 C07AA02 2.16.840.1.113883.6.73 2017-01 C07AA03 2.16.840.1.113883.6.73 2017-01 C07AA05 2.16.840.1.113883.6.73 2017-01 C07AA06 2.16.840.1.113883.6.73 2017-01 C07AA07 2.16.840.1.113883.6.73 2017-01 C07AA12 2.16.840.1.113883.6.73 2017-01 C07AA14 2.16.840.1.113883.6.73 2017-01 C07AA15 2.16.840.1.113883.6.73 2017-01 C07AA16 2.16.840.1.113883.6.73 2017-01 C07AA17 2.16.840.1.113883.6.73 2017-01 C07AA19 2.16.840.1.113883.6.73 2017-01 C07AA23 2.16.840.1.113883.6.73 2017-01 C07AA27 2.16.840.1.113883.6.73 2017-01 C07AB Beta blocking agents, selective 2.16.840.1.113883.6.73 2017-01 C07AB01 2.16.840.1.113883.6.73 2017-01 C07AB02 2.16.840.1.113883.6.73 2017-01 C07AB03 2.16.840.1.113883.6.73 2017-01 C07AB04 2.16.840.1.113883.6.73 2017-01 C07AB05 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 40 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C07AB06 2.16.840.1.113883.6.73 2017-01 C07AB07 2.16.840.1.113883.6.73 2017-01 C07AB08 2.16.840.1.113883.6.73 2017-01 C07AB09 2.16.840.1.113883.6.73 2017-01 C07AB10 2.16.840.1.113883.6.73 2017-01 C07AB11 s-atenolol 2.16.840.1.113883.6.73 2017-01 C07AB12 2.16.840.1.113883.6.73 2017-01 C07AB13 2.16.840.1.113883.6.73 2017-01 C07AB14 2.16.840.1.113883.6.73 2017-01 C07AG Alpha and beta blocking agents 2.16.840.1.113883.6.73 2017-01 C07AG01 2.16.840.1.113883.6.73 2017-01 C07AG02 2.16.840.1.113883.6.73 2017-01 C07B BETA BLOCKING AGENTS AND THIAZIDES 2.16.840.1.113883.6.73 2017-01 C07BA Beta blocking agents, non-selective, and thiazides 2.16.840.1.113883.6.73 2017-01 C07BA02 oxprenolol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BA05 propranolol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BA06 timolol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BA07 sotalol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BA12 nadolol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BA68 and thiazides, combinations 2.16.840.1.113883.6.73 2017-01 C07BB Beta blocking agents, selective, and thiazides 2.16.840.1.113883.6.73 2017-01 C07BB02 metoprolol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BB03 atenolol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BB04 acebutolol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BB06 bevantolol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BB07 bisoprolol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BB12 nebivolol and thiazides 2.16.840.1.113883.6.73 2017-01 C07BB52 metoprolol and thiazides, combinations 2.16.840.1.113883.6.73 2017-01 C07BG Alpha and beta blocking agents and thiazides 2.16.840.1.113883.6.73 2017-01 C07BG01 labetalol and thiazides 2.16.840.1.113883.6.73 2017-01 C07C BETA BLOCKING AGENTS AND OTHER DIURETICS 2.16.840.1.113883.6.73 2017-01 C07CA Beta blocking agents, non-selective, and other diuretics 2.16.840.1.113883.6.73 2017-01 C07CA02 oxprenolol and other diuretics 2.16.840.1.113883.6.73 2017-01 C07CA03 pindolol and other diuretics 2.16.840.1.113883.6.73 2017-01 C07CA17 bopindolol and other diuretics 2.16.840.1.113883.6.73 2017-01 C07CA23 penbutolol and other diuretics 2.16.840.1.113883.6.73 2017-01 C07CB Beta blocking agents, selective, and other diuretics 2.16.840.1.113883.6.73 2017-01 C07CB02 metoprolol and other diuretics 2.16.840.1.113883.6.73 2017-01 C07CB03 atenolol and other diuretics 2.16.840.1.113883.6.73 2017-01 C07CB53 atenolol and other diuretics, combinations 2.16.840.1.113883.6.73 2017-01 C07CG Alpha and beta blocking agents and other diuretics 2.16.840.1.113883.6.73 2017-01 C07CG01 labetalol and other diuretics

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 41 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C07D BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS 2.16.840.1.113883.6.73 2017-01 C07DA Beta blocking agents, non-selective, thiazides and other diuretics 2.16.840.1.113883.6.73 2017-01 C07DA06 timolol, thiazides and other diuretics 2.16.840.1.113883.6.73 2017-01 C07DB Beta blocking agents, selective, thiazides and other diuretics 2.16.840.1.113883.6.73 2017-01 C07DB01 atenolol, thiazides and other diuretics 2.16.840.1.113883.6.73 2017-01 C07E BETA BLOCKING AGENTS AND VASODILATORS 2.16.840.1.113883.6.73 2017-01 C07EA Beta blocking agents, non-selective, and vasodilators 2.16.840.1.113883.6.73 2017-01 C07EB Beta blocking agents, selective, and vasodilators 2.16.840.1.113883.6.73 2017-01 C07F BETA BLOCKING AGENTS, OTHER COMBINATIONS 2.16.840.1.113883.6.73 2017-01 C07FB Beta blocking agents and blockers 2.16.840.1.113883.6.73 2017-01 C07FB02 metoprolol and 2.16.840.1.113883.6.73 2017-01 C07FB03 atenolol and 2.16.840.1.113883.6.73 2017-01 C07FB07 bisoprolol and 2.16.840.1.113883.6.73 2017-01 C07FB12 nevibolol and amlodipine 2.16.840.1.113883.6.73 2017-01 C07FB13 metoprolol and amlodipine 2.16.840.1.113883.6.73 2017-01 C07FX Beta blocking agents, other combinations 2.16.840.1.113883.6.73 2017-01 C07FX01 propranolol and other combinations 2.16.840.1.113883.6.73 2017-01 C07FX02 sotalol and acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 C07FX03 metoprolol and acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 C07FX04 bisoprolol and acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 C07FX05 metoprolol and ivabradine 2.16.840.1.113883.6.73 2017-01 C07FX06 carvedilol and ivabradine 2.16.840.1.113883.6.73 2017-01 C08 CALCIUM CHANNEL BLOCKERS 2.16.840.1.113883.6.73 2017-01 C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS 2.16.840.1.113883.6.73 2017-01 C08CA Dihydropyridine derivatives 2.16.840.1.113883.6.73 2017-01 C08CA01 amlodipine 2.16.840.1.113883.6.73 2017-01 C08CA02 felodipine 2.16.840.1.113883.6.73 2017-01 C08CA03 2.16.840.1.113883.6.73 2017-01 C08CA04 2.16.840.1.113883.6.73 2017-01 C08CA05 nifedipine 2.16.840.1.113883.6.73 2017-01 C08CA06 2.16.840.1.113883.6.73 2017-01 C08CA07 2.16.840.1.113883.6.73 2017-01 C08CA08 2.16.840.1.113883.6.73 2017-01 C08CA09 2.16.840.1.113883.6.73 2017-01 C08CA10 2.16.840.1.113883.6.73 2017-01 C08CA11 2.16.840.1.113883.6.73 2017-01 C08CA12 2.16.840.1.113883.6.73 2017-01 C08CA13 2.16.840.1.113883.6.73 2017-01 C08CA14 cilnidipine 2.16.840.1.113883.6.73 2017-01 C08CA15 2.16.840.1.113883.6.73 2017-01 C08CA16 2.16.840.1.113883.6.73 2017-01 C08CA55 nifedipine, combinations © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 42 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C08CX Other selective calcium channel blockers with mainly vascular effects 2.16.840.1.113883.6.73 2017-01 C08CX01 2.16.840.1.113883.6.73 2017-01 C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS 2.16.840.1.113883.6.73 2017-01 C08DA Phenylalkylamine derivatives 2.16.840.1.113883.6.73 2017-01 C08DA01 2.16.840.1.113883.6.73 2017-01 C08DA02 2.16.840.1.113883.6.73 2017-01 C08DA51 verapamil, combinations 2.16.840.1.113883.6.73 2017-01 C08DB Benzothiazepine derivatives 2.16.840.1.113883.6.73 2017-01 C08DB01 diltiazem 2.16.840.1.113883.6.73 2017-01 C08E NON-SELECTIVE CALCIUM CHANNEL BLOCKERS 2.16.840.1.113883.6.73 2017-01 C08EA Phenylalkylamine derivatives 2.16.840.1.113883.6.73 2017-01 C08EA01 2.16.840.1.113883.6.73 2017-01 C08EA02 2.16.840.1.113883.6.73 2017-01 C08EX Other non-selective calcium channel blockers 2.16.840.1.113883.6.73 2017-01 C08EX01 2.16.840.1.113883.6.73 2017-01 C08EX02 2.16.840.1.113883.6.73 2017-01 C08G CALCIUM CHANNEL BLOCKERS AND DIURETICS 2.16.840.1.113883.6.73 2017-01 C08GA Calcium channel blockers and diuretics 2.16.840.1.113883.6.73 2017-01 C08GA01 nifedipine and diuretics 2.16.840.1.113883.6.73 2017-01 C08GA02 amlodipine and diuretics 2.16.840.1.113883.6.73 2017-01 C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM 2.16.840.1.113883.6.73 2017-01 C09A ACE INHIBITORS, PLAIN 2.16.840.1.113883.6.73 2017-01 C09AA ACE inhibitors, plain 2.16.840.1.113883.6.73 2017-01 C09AA01 captopril 2.16.840.1.113883.6.73 2017-01 C09AA02 enalapril 2.16.840.1.113883.6.73 2017-01 C09AA03 lisinopril 2.16.840.1.113883.6.73 2017-01 C09AA04 perindopril 2.16.840.1.113883.6.73 2017-01 C09AA05 ramipril 2.16.840.1.113883.6.73 2017-01 C09AA06 quinapril 2.16.840.1.113883.6.73 2017-01 C09AA07 benazepril 2.16.840.1.113883.6.73 2017-01 C09AA08 cilazapril 2.16.840.1.113883.6.73 2017-01 C09AA09 fosinopril 2.16.840.1.113883.6.73 2017-01 C09AA10 trandolapril 2.16.840.1.113883.6.73 2017-01 C09AA11 spirapril 2.16.840.1.113883.6.73 2017-01 C09AA12 delapril 2.16.840.1.113883.6.73 2017-01 C09AA13 moexipril 2.16.840.1.113883.6.73 2017-01 C09AA14 temocapril 2.16.840.1.113883.6.73 2017-01 C09AA15 zofenopril 2.16.840.1.113883.6.73 2017-01 C09AA16 imidapril 2.16.840.1.113883.6.73 2017-01 C09B ACE INHIBITORS, COMBINATIONS 2.16.840.1.113883.6.73 2017-01 C09BA ACE inhibitors and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA01 captopril and diuretics © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 43 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C09BA02 enalapril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA03 lisinopril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA04 perindopril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA05 ramipril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA06 quinapril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA07 benazepril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA08 cilazapril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA09 fosinopril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA12 delapril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA13 moexipril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BA15 zofenopril and diuretics 2.16.840.1.113883.6.73 2017-01 C09BB ACE inhibitors and calcium channel blockers 2.16.840.1.113883.6.73 2017-01 C09BB02 enalapril and lercanidipine 2.16.840.1.113883.6.73 2017-01 C09BB03 lisinopril and amlodipine 2.16.840.1.113883.6.73 2017-01 C09BB04 perindopril and amlodipine 2.16.840.1.113883.6.73 2017-01 C09BB05 ramipril and felodipine 2.16.840.1.113883.6.73 2017-01 C09BB06 enalapril and nitrendipine 2.16.840.1.113883.6.73 2017-01 C09BB07 ramipril and amlodipine 2.16.840.1.113883.6.73 2017-01 C09BB10 trandolapril and verapamil 2.16.840.1.113883.6.73 2017-01 C09BB12 delapril and manidipine 2.16.840.1.113883.6.73 2017-01 C09BX ACE inhibitors, other combinations 2.16.840.1.113883.6.73 2017-01 C09BX01 perindopril, amlodipine and indapamide 2.16.840.1.113883.6.73 2017-01 C09BX02 perindopril and bisoprolol 2.16.840.1.113883.6.73 2017-01 C09C ANGIOTENSIN II ANTAGONISTS, PLAIN 2.16.840.1.113883.6.73 2017-01 C09CA Angiotensin II antagonists, plain 2.16.840.1.113883.6.73 2017-01 C09CA01 losartan 2.16.840.1.113883.6.73 2017-01 C09CA02 eprosartan 2.16.840.1.113883.6.73 2017-01 C09CA03 valsartan 2.16.840.1.113883.6.73 2017-01 C09CA04 irbesartan 2.16.840.1.113883.6.73 2017-01 C09CA05 tasosartan 2.16.840.1.113883.6.73 2017-01 C09CA06 candesartan 2.16.840.1.113883.6.73 2017-01 C09CA07 2.16.840.1.113883.6.73 2017-01 C09CA08 olmesartan medoxomil 2.16.840.1.113883.6.73 2017-01 C09CA09 azilsartan medoxomil 2.16.840.1.113883.6.73 2017-01 C09CA10 fimasartan 2.16.840.1.113883.6.73 2017-01 C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS 2.16.840.1.113883.6.73 2017-01 C09DA Angiotensin II antagonists and diuretics 2.16.840.1.113883.6.73 2017-01 C09DA01 losartan and diuretics 2.16.840.1.113883.6.73 2017-01 C09DA02 eprosartan and diuretics 2.16.840.1.113883.6.73 2017-01 C09DA03 valsartan and diuretics 2.16.840.1.113883.6.73 2017-01 C09DA04 irbesartan and diuretics 2.16.840.1.113883.6.73 2017-01 C09DA06 candesartan and diuretics 2.16.840.1.113883.6.73 2017-01 C09DA07 telmisartan and diuretics © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 44 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C09DA08 olmesartan medoxomil and diuretics 2.16.840.1.113883.6.73 2017-01 C09DA09 azilsartan medoxomil and diuretics 2.16.840.1.113883.6.73 2017-01 C09DB Angiotensin II antagonists and calcium channel blockers 2.16.840.1.113883.6.73 2017-01 C09DB01 valsartan and amlodipine 2.16.840.1.113883.6.73 2017-01 C09DB02 olmesartan medoxomil and amlodipine 2.16.840.1.113883.6.73 2017-01 C09DB04 telmisartan and amlodipine 2.16.840.1.113883.6.73 2017-01 C09DB05 irbesartan and amlodipine 2.16.840.1.113883.6.73 2017-01 C09DB06 losartan and amlodipine 2.16.840.1.113883.6.73 2017-01 C09DB07 candesartan and amlodipine 2.16.840.1.113883.6.73 2017-01 C09DB08 valsartan and lercanidipine 2.16.840.1.113883.6.73 2017-01 C09DX Angiotensin II antagonists, other combinations 2.16.840.1.113883.6.73 2017-01 C09DX01 valsartan, amlodipine and hydrochlorothiazide 2.16.840.1.113883.6.73 2017-01 C09DX02 valsartan and aliskiren 2.16.840.1.113883.6.73 2017-01 C09DX03 olmesartan medoxomil, amlodipine and hydrochlorothiazide 2.16.840.1.113883.6.73 2017-01 C09DX04 valsartan and sacubitril 2.16.840.1.113883.6.73 2017-01 C09X OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM 2.16.840.1.113883.6.73 2017-01 C09XA Renin-inhibitors 2.16.840.1.113883.6.73 2017-01 C09XA01 remikiren 2.16.840.1.113883.6.73 2017-01 C09XA02 aliskiren 2.16.840.1.113883.6.73 2017-01 C09XA52 aliskiren and hydrochlorothiazide 2.16.840.1.113883.6.73 2017-01 C09XA53 aliskiren and amlodipine 2.16.840.1.113883.6.73 2017-01 C09XA54 aliskiren, amlodipine and hydrochlorothiazide 2.16.840.1.113883.6.73 2017-01 C10 MODIFYING AGENTS 2.16.840.1.113883.6.73 2017-01 C10A LIPID MODIFYING AGENTS, PLAIN 2.16.840.1.113883.6.73 2017-01 C10AA HMG CoA reductase inhibitors 2.16.840.1.113883.6.73 2017-01 C10AA01 simvastatin 2.16.840.1.113883.6.73 2017-01 C10AA02 2.16.840.1.113883.6.73 2017-01 C10AA03 2.16.840.1.113883.6.73 2017-01 C10AA04 2.16.840.1.113883.6.73 2017-01 C10AA05 2.16.840.1.113883.6.73 2017-01 C10AA06 2.16.840.1.113883.6.73 2017-01 C10AA07 2.16.840.1.113883.6.73 2017-01 C10AA08 2.16.840.1.113883.6.73 2017-01 C10AB 2.16.840.1.113883.6.73 2017-01 C10AB01 2.16.840.1.113883.6.73 2017-01 C10AB02 2.16.840.1.113883.6.73 2017-01 C10AB03 2.16.840.1.113883.6.73 2017-01 C10AB04 2.16.840.1.113883.6.73 2017-01 C10AB05 2.16.840.1.113883.6.73 2017-01 C10AB06 2.16.840.1.113883.6.73 2017-01 C10AB07 2.16.840.1.113883.6.73 2017-01 C10AB08

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 45 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C10AB09 2.16.840.1.113883.6.73 2017-01 C10AB10 2.16.840.1.113883.6.73 2017-01 C10AB11 fenofibrate 2.16.840.1.113883.6.73 2017-01 C10AC Bile acid sequestrants 2.16.840.1.113883.6.73 2017-01 C10AC01 2.16.840.1.113883.6.73 2017-01 C10AC02 2.16.840.1.113883.6.73 2017-01 C10AC03 2.16.840.1.113883.6.73 2017-01 C10AC04 2.16.840.1.113883.6.73 2017-01 C10AD Nicotinic acid and derivatives 2.16.840.1.113883.6.73 2017-01 C10AD01 2.16.840.1.113883.6.73 2017-01 C10AD02 nicotinic acid 2.16.840.1.113883.6.73 2017-01 C10AD03 2.16.840.1.113883.6.73 2017-01 C10AD04 2.16.840.1.113883.6.73 2017-01 C10AD05 (pyridylcarbinol) 2.16.840.1.113883.6.73 2017-01 C10AD06 2.16.840.1.113883.6.73 2017-01 C10AD52 nicotinic acid, combinations 2.16.840.1.113883.6.73 2017-01 C10AX Other lipid modifying agents 2.16.840.1.113883.6.73 2017-01 C10AX01 2.16.840.1.113883.6.73 2017-01 C10AX02 2.16.840.1.113883.6.73 2017-01 C10AX03 2.16.840.1.113883.6.73 2017-01 C10AX05 2.16.840.1.113883.6.73 2017-01 C10AX06 omega-3-triglycerides incl. other esters and acids 2.16.840.1.113883.6.73 2017-01 C10AX07 magnesium pyridoxal 5-phosphate glutamate 2.16.840.1.113883.6.73 2017-01 C10AX08 2.16.840.1.113883.6.73 2017-01 C10AX09 2.16.840.1.113883.6.73 2017-01 C10AX10 2.16.840.1.113883.6.73 2017-01 C10AX11 2.16.840.1.113883.6.73 2017-01 C10AX12 2.16.840.1.113883.6.73 2017-01 C10AX13 2.16.840.1.113883.6.73 2017-01 C10AX14 2.16.840.1.113883.6.73 2017-01 C10B LIPID MODIFYING AGENTS, COMBINATIONS 2.16.840.1.113883.6.73 2017-01 C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents 2.16.840.1.113883.6.73 2017-01 C10BA01 lovastatin and nicotinic acid 2.16.840.1.113883.6.73 2017-01 C10BA02 simvastatin and ezetimibe 2.16.840.1.113883.6.73 2017-01 C10BA03 pravastatin and fenofibrate 2.16.840.1.113883.6.73 2017-01 C10BA04 simvastatin and fenofibrate 2.16.840.1.113883.6.73 2017-01 C10BA05 atorvastatin and ezetimibe 2.16.840.1.113883.6.73 2017-01 C10BA06 rosuvastatin and ezetimibe 2.16.840.1.113883.6.73 2017-01 C10BX HMG CoA reductase inhibitors, other combinations 2.16.840.1.113883.6.73 2017-01 C10BX01 simvastatin and acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 C10BX02 pravastatin and acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 C10BX03 atorvastatin and amlodipine

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 46 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 C10BX04 simvastatin, acetylsalicylic acid and ramipril 2.16.840.1.113883.6.73 2017-01 C10BX05 rosuvastatin and acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 C10BX06 atorvastatin, acetylsalicylic acid and ramipril 2.16.840.1.113883.6.73 2017-01 C10BX07 rosuvastatin, amlodipine and lisinopril 2.16.840.1.113883.6.73 2017-01 C10BX08 atorvastatin and acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 C10BX09 rosuvastatin and amlodipine 2.16.840.1.113883.6.73 2017-01 C10BX10 rosuvastatin and valsartan 2.16.840.1.113883.6.73 2017-01 C10BX11 atorvastatin, amlodipine and perindopril 2.16.840.1.113883.6.73 2017-01 C10BX12 atorvastatin, acetylsalicylic acid and perindopril 2.16.840.1.113883.6.73 2017-01 D DERMATOLOGICALS 2.16.840.1.113883.6.73 2017-01 D01 FOR DERMATOLOGICAL USE 2.16.840.1.113883.6.73 2017-01 D01A ANTIFUNGALS FOR TOPICAL USE 2.16.840.1.113883.6.73 2017-01 D01AA Antibiotics 2.16.840.1.113883.6.73 2017-01 D01AA01 nystatin 2.16.840.1.113883.6.73 2017-01 D01AA02 natamycin 2.16.840.1.113883.6.73 2017-01 D01AA03 2.16.840.1.113883.6.73 2017-01 D01AA04 pecilocin 2.16.840.1.113883.6.73 2017-01 D01AA06 mepartricin 2.16.840.1.113883.6.73 2017-01 D01AA07 pyrrolnitrin 2.16.840.1.113883.6.73 2017-01 D01AA08 2.16.840.1.113883.6.73 2017-01 D01AA20 combinations 2.16.840.1.113883.6.73 2017-01 D01AC Imidazole and derivatives 2.16.840.1.113883.6.73 2017-01 D01AC01 clotrimazole 2.16.840.1.113883.6.73 2017-01 D01AC02 miconazole 2.16.840.1.113883.6.73 2017-01 D01AC03 2.16.840.1.113883.6.73 2017-01 D01AC04 2.16.840.1.113883.6.73 2017-01 D01AC05 2.16.840.1.113883.6.73 2017-01 D01AC06 2.16.840.1.113883.6.73 2017-01 D01AC07 2.16.840.1.113883.6.73 2017-01 D01AC08 2.16.840.1.113883.6.73 2017-01 D01AC09 2.16.840.1.113883.6.73 2017-01 D01AC10 2.16.840.1.113883.6.73 2017-01 D01AC11 2.16.840.1.113883.6.73 2017-01 D01AC12 2.16.840.1.113883.6.73 2017-01 D01AC13 2.16.840.1.113883.6.73 2017-01 D01AC14 2.16.840.1.113883.6.73 2017-01 D01AC15 2.16.840.1.113883.6.73 2017-01 D01AC16 2.16.840.1.113883.6.73 2017-01 D01AC17 2.16.840.1.113883.6.73 2017-01 D01AC18 2.16.840.1.113883.6.73 2017-01 D01AC19 2.16.840.1.113883.6.73 2017-01 D01AC20 / in combination with corticosteroids 2.16.840.1.113883.6.73 2017-01 D01AC52 miconazole, combinations © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 47 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D01AC60 bifonazole, combinations 2.16.840.1.113883.6.73 2017-01 D01AE Other antifungals for topical use 2.16.840.1.113883.6.73 2017-01 D01AE01 bromochlorosalicylanilide 2.16.840.1.113883.6.73 2017-01 D01AE02 methylrosaniline 2.16.840.1.113883.6.73 2017-01 D01AE03 tribromometacresol 2.16.840.1.113883.6.73 2017-01 D01AE04 2.16.840.1.113883.6.73 2017-01 D01AE05 polynoxylin 2.16.840.1.113883.6.73 2017-01 D01AE06 2-(4-chlorphenoxy)- 2.16.840.1.113883.6.73 2017-01 D01AE07 chlorphenesin 2.16.840.1.113883.6.73 2017-01 D01AE08 2.16.840.1.113883.6.73 2017-01 D01AE09 2.16.840.1.113883.6.73 2017-01 D01AE10 ethyl hydroxybenzoate 2.16.840.1.113883.6.73 2017-01 D01AE11 2.16.840.1.113883.6.73 2017-01 D01AE12 2.16.840.1.113883.6.73 2017-01 D01AE13 selenium sulfide 2.16.840.1.113883.6.73 2017-01 D01AE14 2.16.840.1.113883.6.73 2017-01 D01AE15 2.16.840.1.113883.6.73 2017-01 D01AE16 2.16.840.1.113883.6.73 2017-01 D01AE17 2.16.840.1.113883.6.73 2017-01 D01AE18 2.16.840.1.113883.6.73 2017-01 D01AE19 2.16.840.1.113883.6.73 2017-01 D01AE20 combinations 2.16.840.1.113883.6.73 2017-01 D01AE21 2.16.840.1.113883.6.73 2017-01 D01AE22 2.16.840.1.113883.6.73 2017-01 D01AE23 2.16.840.1.113883.6.73 2017-01 D01AE54 undecylenic acid, combinations 2.16.840.1.113883.6.73 2017-01 D01B ANTIFUNGALS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 D01BA Antifungals for systemic use 2.16.840.1.113883.6.73 2017-01 D01BA01 griseofulvin 2.16.840.1.113883.6.73 2017-01 D01BA02 terbinafine 2.16.840.1.113883.6.73 2017-01 D02 EMOLLIENTS AND PROTECTIVES 2.16.840.1.113883.6.73 2017-01 D02A EMOLLIENTS AND PROTECTIVES 2.16.840.1.113883.6.73 2017-01 D02AA Silicone products 2.16.840.1.113883.6.73 2017-01 D02AB Zinc products 2.16.840.1.113883.6.73 2017-01 D02AC Soft paraffin and fat products 2.16.840.1.113883.6.73 2017-01 D02AD Liquid 2.16.840.1.113883.6.73 2017-01 D02AE Carbamide products 2.16.840.1.113883.6.73 2017-01 D02AE01 carbamide 2.16.840.1.113883.6.73 2017-01 D02AE51 carbamide, combinations 2.16.840.1.113883.6.73 2017-01 D02AF Salicylic acid preparations 2.16.840.1.113883.6.73 2017-01 D02AX Other emollients and protectives 2.16.840.1.113883.6.73 2017-01 D02B PROTECTIVES AGAINST UV-RADIATION 2.16.840.1.113883.6.73 2017-01 D02BA Protectives against UV-radiation for topical use © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 48 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D02BA01 aminobenzoic acid 2.16.840.1.113883.6.73 2017-01 D02BA02 octinoxate 2.16.840.1.113883.6.73 2017-01 D02BB Protectives against UV-radiation for systemic use 2.16.840.1.113883.6.73 2017-01 D02BB01 betacarotene 2.16.840.1.113883.6.73 2017-01 D02BB02 2.16.840.1.113883.6.73 2017-01 D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS 2.16.840.1.113883.6.73 2017-01 D03A CICATRIZANTS 2.16.840.1.113883.6.73 2017-01 D03AA Cod-liver oil ointments 2.16.840.1.113883.6.73 2017-01 D03AX Other cicatrizants 2.16.840.1.113883.6.73 2017-01 D03AX01 cadexomer iodine 2.16.840.1.113883.6.73 2017-01 D03AX02 2.16.840.1.113883.6.73 2017-01 D03AX03 dexpanthenol 2.16.840.1.113883.6.73 2017-01 D03AX04 calcium pantothenate 2.16.840.1.113883.6.73 2017-01 D03AX05 2.16.840.1.113883.6.73 2017-01 D03AX06 becaplermin 2.16.840.1.113883.6.73 2017-01 D03AX09 2.16.840.1.113883.6.73 2017-01 D03AX10 2.16.840.1.113883.6.73 2017-01 D03AX11 sodium chlorite 2.16.840.1.113883.6.73 2017-01 D03AX12 trolamine 2.16.840.1.113883.6.73 2017-01 D03AX13 Betulae cortex 2.16.840.1.113883.6.73 2017-01 D03B ENZYMES 2.16.840.1.113883.6.73 2017-01 D03BA Proteolytic enzymes 2.16.840.1.113883.6.73 2017-01 D03BA01 trypsin 2.16.840.1.113883.6.73 2017-01 D03BA02 collagenase 2.16.840.1.113883.6.73 2017-01 D03BA03 bromelains 2.16.840.1.113883.6.73 2017-01 D03BA52 collagenase, combinations 2.16.840.1.113883.6.73 2017-01 D04 ANTIPRURITICS, INCL. , ANESTHETICS, ETC. 2.16.840.1.113883.6.73 2017-01 D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. 2.16.840.1.113883.6.73 2017-01 D04AA Antihistamines for topical use 2.16.840.1.113883.6.73 2017-01 D04AA01 2.16.840.1.113883.6.73 2017-01 D04AA02 2.16.840.1.113883.6.73 2017-01 D04AA03 2.16.840.1.113883.6.73 2017-01 D04AA04 2.16.840.1.113883.6.73 2017-01 D04AA09 2.16.840.1.113883.6.73 2017-01 D04AA10 2.16.840.1.113883.6.73 2017-01 D04AA12 2.16.840.1.113883.6.73 2017-01 D04AA13 2.16.840.1.113883.6.73 2017-01 D04AA14 2.16.840.1.113883.6.73 2017-01 D04AA15 2.16.840.1.113883.6.73 2017-01 D04AA16 2.16.840.1.113883.6.73 2017-01 D04AA22

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 49 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D04AA32 2.16.840.1.113883.6.73 2017-01 D04AA33 diphenhydramine methylbromide 2.16.840.1.113883.6.73 2017-01 D04AA34 2.16.840.1.113883.6.73 2017-01 D04AB Anesthetics for topical use 2.16.840.1.113883.6.73 2017-01 D04AB01 lidocaine 2.16.840.1.113883.6.73 2017-01 D04AB02 cinchocaine 2.16.840.1.113883.6.73 2017-01 D04AB03 oxybuprocaine 2.16.840.1.113883.6.73 2017-01 D04AB04 benzocaine 2.16.840.1.113883.6.73 2017-01 D04AB05 quinisocaine 2.16.840.1.113883.6.73 2017-01 D04AB06 tetracaine 2.16.840.1.113883.6.73 2017-01 D04AB07 pramocaine 2.16.840.1.113883.6.73 2017-01 D04AX Other antipruritics 2.16.840.1.113883.6.73 2017-01 D05 ANTIPSORIATICS 2.16.840.1.113883.6.73 2017-01 D05A ANTIPSORIATICS FOR TOPICAL USE 2.16.840.1.113883.6.73 2017-01 D05AA Tars 2.16.840.1.113883.6.73 2017-01 D05AC Antracen derivatives 2.16.840.1.113883.6.73 2017-01 D05AC01 2.16.840.1.113883.6.73 2017-01 D05AC51 dithranol, combinations 2.16.840.1.113883.6.73 2017-01 D05AD for topical use 2.16.840.1.113883.6.73 2017-01 D05AD01 trioxysalen 2.16.840.1.113883.6.73 2017-01 D05AD02 2.16.840.1.113883.6.73 2017-01 D05AX Other antipsoriatics for topical use 2.16.840.1.113883.6.73 2017-01 D05AX01 2.16.840.1.113883.6.73 2017-01 D05AX02 2.16.840.1.113883.6.73 2017-01 D05AX03 calcitriol 2.16.840.1.113883.6.73 2017-01 D05AX04 2.16.840.1.113883.6.73 2017-01 D05AX05 2.16.840.1.113883.6.73 2017-01 D05AX52 calcipotriol, combinations 2.16.840.1.113883.6.73 2017-01 D05B ANTIPSORIATICS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 D05BA Psoralens for systemic use 2.16.840.1.113883.6.73 2017-01 D05BA01 trioxysalen 2.16.840.1.113883.6.73 2017-01 D05BA02 methoxsalen 2.16.840.1.113883.6.73 2017-01 D05BA03 bergapten 2.16.840.1.113883.6.73 2017-01 D05BB for treatment of 2.16.840.1.113883.6.73 2017-01 D05BB01 2.16.840.1.113883.6.73 2017-01 D05BB02 2.16.840.1.113883.6.73 2017-01 D05BX Other antipsoriatics for systemic use 2.16.840.1.113883.6.73 2017-01 D05BX51 fumaric acid derivatives, combinations 2.16.840.1.113883.6.73 2017-01 D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE 2.16.840.1.113883.6.73 2017-01 D06A ANTIBIOTICS FOR TOPICAL USE 2.16.840.1.113883.6.73 2017-01 D06AA Tetracycline and derivatives 2.16.840.1.113883.6.73 2017-01 D06AA01

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 50 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D06AA02 chlortetracycline 2.16.840.1.113883.6.73 2017-01 D06AA03 2.16.840.1.113883.6.73 2017-01 D06AA04 tetracycline 2.16.840.1.113883.6.73 2017-01 D06AX Other antibiotics for topical use 2.16.840.1.113883.6.73 2017-01 D06AX01 fusidic acid 2.16.840.1.113883.6.73 2017-01 D06AX02 2.16.840.1.113883.6.73 2017-01 D06AX04 neomycin 2.16.840.1.113883.6.73 2017-01 D06AX05 2.16.840.1.113883.6.73 2017-01 D06AX07 2.16.840.1.113883.6.73 2017-01 D06AX08 2.16.840.1.113883.6.73 2017-01 D06AX09 mupirocin 2.16.840.1.113883.6.73 2017-01 D06AX10 virginiamycin 2.16.840.1.113883.6.73 2017-01 D06AX11 rifaximin 2.16.840.1.113883.6.73 2017-01 D06AX12 2.16.840.1.113883.6.73 2017-01 D06AX13 retapamulin 2.16.840.1.113883.6.73 2017-01 D06B CHEMOTHERAPEUTICS FOR TOPICAL USE 2.16.840.1.113883.6.73 2017-01 D06BA Sulfonamides 2.16.840.1.113883.6.73 2017-01 D06BA01 2.16.840.1.113883.6.73 2017-01 D06BA02 2.16.840.1.113883.6.73 2017-01 D06BA03 mafenide 2.16.840.1.113883.6.73 2017-01 D06BA04 sulfamethizole 2.16.840.1.113883.6.73 2017-01 D06BA05 2.16.840.1.113883.6.73 2017-01 D06BA06 2.16.840.1.113883.6.73 2017-01 D06BA51 silver sulfadiazine, combinations 2.16.840.1.113883.6.73 2017-01 D06BB Antivirals 2.16.840.1.113883.6.73 2017-01 D06BB01 idoxuridine 2.16.840.1.113883.6.73 2017-01 D06BB02 tromantadine 2.16.840.1.113883.6.73 2017-01 D06BB03 aciclovir 2.16.840.1.113883.6.73 2017-01 D06BB04 podophyllotoxin 2.16.840.1.113883.6.73 2017-01 D06BB05 2.16.840.1.113883.6.73 2017-01 D06BB06 penciclovir 2.16.840.1.113883.6.73 2017-01 D06BB07 lysozyme 2.16.840.1.113883.6.73 2017-01 D06BB08 ibacitabine 2.16.840.1.113883.6.73 2017-01 D06BB09 edoxudine 2.16.840.1.113883.6.73 2017-01 D06BB10 imiquimod 2.16.840.1.113883.6.73 2017-01 D06BB11 docosanol 2.16.840.1.113883.6.73 2017-01 D06BB12 sinecatechins 2.16.840.1.113883.6.73 2017-01 D06BB53 aciclovir, combinations 2.16.840.1.113883.6.73 2017-01 D06BX Other chemotherapeutics 2.16.840.1.113883.6.73 2017-01 D06BX01 metronidazole 2.16.840.1.113883.6.73 2017-01 D06BX02 ingenol mebutate 2.16.840.1.113883.6.73 2017-01 D06C ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS 2.16.840.1.113883.6.73 2017-01 D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 51 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D07A CORTICOSTEROIDS, PLAIN 2.16.840.1.113883.6.73 2017-01 D07AA Corticosteroids, weak (group I) 2.16.840.1.113883.6.73 2017-01 D07AA01 2.16.840.1.113883.6.73 2017-01 D07AA02 hydrocortisone 2.16.840.1.113883.6.73 2017-01 D07AA03 prednisolone 2.16.840.1.113883.6.73 2017-01 D07AB Corticosteroids, moderately potent (group II) 2.16.840.1.113883.6.73 2017-01 D07AB01 2.16.840.1.113883.6.73 2017-01 D07AB02 2.16.840.1.113883.6.73 2017-01 D07AB03 2.16.840.1.113883.6.73 2017-01 D07AB04 2.16.840.1.113883.6.73 2017-01 D07AB05 2.16.840.1.113883.6.73 2017-01 D07AB06 fluorometholone 2.16.840.1.113883.6.73 2017-01 D07AB07 2.16.840.1.113883.6.73 2017-01 D07AB08 2.16.840.1.113883.6.73 2017-01 D07AB09 triamcinolone 2.16.840.1.113883.6.73 2017-01 D07AB10 2.16.840.1.113883.6.73 2017-01 D07AB11 2.16.840.1.113883.6.73 2017-01 D07AB19 dexamethasone 2.16.840.1.113883.6.73 2017-01 D07AB21 2.16.840.1.113883.6.73 2017-01 D07AB30 combinations of corticosteroids 2.16.840.1.113883.6.73 2017-01 D07AC Corticosteroids, potent (group III) 2.16.840.1.113883.6.73 2017-01 D07AC01 betamethasone 2.16.840.1.113883.6.73 2017-01 D07AC02 2.16.840.1.113883.6.73 2017-01 D07AC03 2.16.840.1.113883.6.73 2017-01 D07AC04 2.16.840.1.113883.6.73 2017-01 D07AC05 fluocortolone 2.16.840.1.113883.6.73 2017-01 D07AC06 2.16.840.1.113883.6.73 2017-01 D07AC07 2.16.840.1.113883.6.73 2017-01 D07AC08 fluocinonide 2.16.840.1.113883.6.73 2017-01 D07AC09 budesonide 2.16.840.1.113883.6.73 2017-01 D07AC10 2.16.840.1.113883.6.73 2017-01 D07AC11 2.16.840.1.113883.6.73 2017-01 D07AC12 2.16.840.1.113883.6.73 2017-01 D07AC13 2.16.840.1.113883.6.73 2017-01 D07AC14 methylprednisolone aceponate 2.16.840.1.113883.6.73 2017-01 D07AC15 beclometasone 2.16.840.1.113883.6.73 2017-01 D07AC16 2.16.840.1.113883.6.73 2017-01 D07AC17 2.16.840.1.113883.6.73 2017-01 D07AC18 2.16.840.1.113883.6.73 2017-01 D07AC19 2.16.840.1.113883.6.73 2017-01 D07AC21 2.16.840.1.113883.6.73 2017-01 D07AD Corticosteroids, very potent (group IV) 2.16.840.1.113883.6.73 2017-01 D07AD01 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 52 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D07AD02 2.16.840.1.113883.6.73 2017-01 D07B CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS 2.16.840.1.113883.6.73 2017-01 D07BA Corticosteroids, weak, combinations with antiseptics 2.16.840.1.113883.6.73 2017-01 D07BA01 prednisolone and antiseptics 2.16.840.1.113883.6.73 2017-01 D07BA04 hydrocortisone and antiseptics 2.16.840.1.113883.6.73 2017-01 D07BB Corticosteroids, moderately potent, combinations with antiseptics 2.16.840.1.113883.6.73 2017-01 D07BB01 flumetasone and antiseptics 2.16.840.1.113883.6.73 2017-01 D07BB02 desonide and antiseptics 2.16.840.1.113883.6.73 2017-01 D07BB03 triamcinolone and antiseptics 2.16.840.1.113883.6.73 2017-01 D07BB04 hydrocortisone butyrate and antiseptics 2.16.840.1.113883.6.73 2017-01 D07BC Corticosteroids, potent, combinations with antiseptics 2.16.840.1.113883.6.73 2017-01 D07BC01 betamethasone and antiseptics 2.16.840.1.113883.6.73 2017-01 D07BC02 fluocinolone acetonide and antiseptics 2.16.840.1.113883.6.73 2017-01 D07BC03 fluocortolone and antiseptics 2.16.840.1.113883.6.73 2017-01 D07BC04 diflucortolone and antiseptics 2.16.840.1.113883.6.73 2017-01 D07BD Corticosteroids, very potent, combinations with antiseptics 2.16.840.1.113883.6.73 2017-01 D07C CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS 2.16.840.1.113883.6.73 2017-01 D07CA Corticosteroids, weak, combinations with antibiotics 2.16.840.1.113883.6.73 2017-01 D07CA01 hydrocortisone and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CA02 methylprednisolone and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CA03 prednisolone and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CB Corticosteroids, moderately potent, combinations with antibiotics 2.16.840.1.113883.6.73 2017-01 D07CB01 triamcinolone and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CB02 fluprednidene and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CB03 fluorometholone and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CB04 dexamethasone and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CB05 flumetasone and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CC Corticosteroids, potent, combinations with antibiotics 2.16.840.1.113883.6.73 2017-01 D07CC01 betamethasone and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CC02 fluocinolone acetonide and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CC03 fludroxycortide and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CC04 beclometasone and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CC05 fluocinonide and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CC06 fluocortolone and antibiotics 2.16.840.1.113883.6.73 2017-01 D07CD Corticosteroids, very potent, combinations with antibiotics 2.16.840.1.113883.6.73 2017-01 D07CD01 clobetasol and antibiotics 2.16.840.1.113883.6.73 2017-01 D07X CORTICOSTEROIDS, OTHER COMBINATIONS 2.16.840.1.113883.6.73 2017-01 D07XA Corticosteroids, weak, other combinations 2.16.840.1.113883.6.73 2017-01 D07XA01 hydrocortisone 2.16.840.1.113883.6.73 2017-01 D07XA02 prednisolone 2.16.840.1.113883.6.73 2017-01 D07XB Corticosteroids, moderately potent, other combinations 2.16.840.1.113883.6.73 2017-01 D07XB01 flumetasone 2.16.840.1.113883.6.73 2017-01 D07XB02 triamcinolone © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 53 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D07XB03 fluprednidene 2.16.840.1.113883.6.73 2017-01 D07XB04 fluorometholone 2.16.840.1.113883.6.73 2017-01 D07XB05 dexamethasone 2.16.840.1.113883.6.73 2017-01 D07XB30 combinations of corticosteroids 2.16.840.1.113883.6.73 2017-01 D07XC Corticosteroids, potent, other combinations 2.16.840.1.113883.6.73 2017-01 D07XC01 betamethasone 2.16.840.1.113883.6.73 2017-01 D07XC02 desoximetasone 2.16.840.1.113883.6.73 2017-01 D07XC03 mometasone 2.16.840.1.113883.6.73 2017-01 D07XC04 diflucortolone 2.16.840.1.113883.6.73 2017-01 D07XC05 fluocortolone 2.16.840.1.113883.6.73 2017-01 D07XD Corticosteroids, very potent, other combinations 2.16.840.1.113883.6.73 2017-01 D08 ANTISEPTICS AND 2.16.840.1.113883.6.73 2017-01 D08A ANTISEPTICS AND DISINFECTANTS 2.16.840.1.113883.6.73 2017-01 D08AA derivatives 2.16.840.1.113883.6.73 2017-01 D08AA01 ethacridine lactate 2.16.840.1.113883.6.73 2017-01 D08AA02 aminoacridine 2.16.840.1.113883.6.73 2017-01 D08AA03 2.16.840.1.113883.6.73 2017-01 D08AB Aluminium agents 2.16.840.1.113883.6.73 2017-01 D08AC Biguanides and amidines 2.16.840.1.113883.6.73 2017-01 D08AC01 2.16.840.1.113883.6.73 2017-01 D08AC02 chlorhexidine 2.16.840.1.113883.6.73 2017-01 D08AC03 2.16.840.1.113883.6.73 2017-01 D08AC04 2.16.840.1.113883.6.73 2017-01 D08AC05 polihexanide 2.16.840.1.113883.6.73 2017-01 D08AC52 chlorhexidine, combinations 2.16.840.1.113883.6.73 2017-01 D08AD products 2.16.840.1.113883.6.73 2017-01 D08AE Phenol and derivatives 2.16.840.1.113883.6.73 2017-01 D08AE01 2.16.840.1.113883.6.73 2017-01 D08AE02 2.16.840.1.113883.6.73 2017-01 D08AE03 phenol 2.16.840.1.113883.6.73 2017-01 D08AE04 2.16.840.1.113883.6.73 2017-01 D08AE05 2.16.840.1.113883.6.73 2017-01 D08AE06 biphenylol 2.16.840.1.113883.6.73 2017-01 D08AF derivatives 2.16.840.1.113883.6.73 2017-01 D08AF01 nitrofural 2.16.840.1.113883.6.73 2017-01 D08AG Iodine products 2.16.840.1.113883.6.73 2017-01 D08AG01 iodine/octylphenoxypolyglycolether 2.16.840.1.113883.6.73 2017-01 D08AG02 povidone-iodine 2.16.840.1.113883.6.73 2017-01 D08AG03 iodine 2.16.840.1.113883.6.73 2017-01 D08AG04 diiodohydroxypropane 2.16.840.1.113883.6.73 2017-01 D08AH derivatives 2.16.840.1.113883.6.73 2017-01 D08AH01 2.16.840.1.113883.6.73 2017-01 D08AH02 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 54 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D08AH03 oxyquinoline 2.16.840.1.113883.6.73 2017-01 D08AH30 2.16.840.1.113883.6.73 2017-01 D08AJ Quaternary ammonium compounds 2.16.840.1.113883.6.73 2017-01 D08AJ01 benzalkonium 2.16.840.1.113883.6.73 2017-01 D08AJ02 2.16.840.1.113883.6.73 2017-01 D08AJ03 cetylpyridinium 2.16.840.1.113883.6.73 2017-01 D08AJ04 2.16.840.1.113883.6.73 2017-01 D08AJ05 benzoxonium chloride 2.16.840.1.113883.6.73 2017-01 D08AJ06 didecyldimethylammonium chloride 2.16.840.1.113883.6.73 2017-01 D08AJ08 2.16.840.1.113883.6.73 2017-01 D08AJ10 decamethoxine 2.16.840.1.113883.6.73 2017-01 D08AJ57 octenidine, combinations 2.16.840.1.113883.6.73 2017-01 D08AJ58 benzethonium chloride, combinations 2.16.840.1.113883.6.73 2017-01 D08AJ59 dodeclonium bromide, combinations 2.16.840.1.113883.6.73 2017-01 D08AK Mercurial products 2.16.840.1.113883.6.73 2017-01 D08AK01 mercuric amidochloride 2.16.840.1.113883.6.73 2017-01 D08AK02 2.16.840.1.113883.6.73 2017-01 D08AK03 mercuric chloride 2.16.840.1.113883.6.73 2017-01 D08AK04 mercurochrome 2.16.840.1.113883.6.73 2017-01 D08AK05 , metallic 2.16.840.1.113883.6.73 2017-01 D08AK06 2.16.840.1.113883.6.73 2017-01 D08AK30 mercuric iodide 2.16.840.1.113883.6.73 2017-01 D08AL Silver compounds 2.16.840.1.113883.6.73 2017-01 D08AL01 silver 2.16.840.1.113883.6.73 2017-01 D08AL30 silver 2.16.840.1.113883.6.73 2017-01 D08AX Other antiseptics and disinfectants 2.16.840.1.113883.6.73 2017-01 D08AX01 hydrogen peroxide 2.16.840.1.113883.6.73 2017-01 D08AX02 2.16.840.1.113883.6.73 2017-01 D08AX03 propanol 2.16.840.1.113883.6.73 2017-01 D08AX04 tosylchloramide sodium 2.16.840.1.113883.6.73 2017-01 D08AX05 isopropanol 2.16.840.1.113883.6.73 2017-01 D08AX06 2.16.840.1.113883.6.73 2017-01 D08AX07 2.16.840.1.113883.6.73 2017-01 D08AX08 ethanol 2.16.840.1.113883.6.73 2017-01 D08AX53 propanol, combinations 2.16.840.1.113883.6.73 2017-01 D09 MEDICATED DRESSINGS 2.16.840.1.113883.6.73 2017-01 D09A MEDICATED DRESSINGS 2.16.840.1.113883.6.73 2017-01 D09AA Medicated dressings with antiinfectives 2.16.840.1.113883.6.73 2017-01 D09AA01 framycetin 2.16.840.1.113883.6.73 2017-01 D09AA02 fusidic acid 2.16.840.1.113883.6.73 2017-01 D09AA03 nitrofural 2.16.840.1.113883.6.73 2017-01 D09AA04 phenylmercuric nitrate 2.16.840.1.113883.6.73 2017-01 D09AA05 benzododecinium © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 55 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D09AA06 triclosan 2.16.840.1.113883.6.73 2017-01 D09AA07 cetylpyridinium 2.16.840.1.113883.6.73 2017-01 D09AA08 aluminium chlorohydrate 2.16.840.1.113883.6.73 2017-01 D09AA09 povidone-iodine 2.16.840.1.113883.6.73 2017-01 D09AA10 clioquinol 2.16.840.1.113883.6.73 2017-01 D09AA11 benzalkonium 2.16.840.1.113883.6.73 2017-01 D09AA12 chlorhexidine 2.16.840.1.113883.6.73 2017-01 D09AA13 iodoform 2.16.840.1.113883.6.73 2017-01 D09AB Zinc bandages 2.16.840.1.113883.6.73 2017-01 D09AB01 zinc bandage without supplements 2.16.840.1.113883.6.73 2017-01 D09AB02 zinc bandage with supplements 2.16.840.1.113883.6.73 2017-01 D09AX Soft paraffin dressings 2.16.840.1.113883.6.73 2017-01 D10 ANTI-ACNE PREPARATIONS 2.16.840.1.113883.6.73 2017-01 D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE 2.16.840.1.113883.6.73 2017-01 D10AA Corticosteroids, combinations for treatment of acne 2.16.840.1.113883.6.73 2017-01 D10AA01 fluorometholone 2.16.840.1.113883.6.73 2017-01 D10AA02 methylprednisolone 2.16.840.1.113883.6.73 2017-01 D10AA03 dexamethasone 2.16.840.1.113883.6.73 2017-01 D10AB Preparations containing 2.16.840.1.113883.6.73 2017-01 D10AB01 bithionol 2.16.840.1.113883.6.73 2017-01 D10AB02 sulfur 2.16.840.1.113883.6.73 2017-01 D10AB03 tioxolone 2.16.840.1.113883.6.73 2017-01 D10AB05 2.16.840.1.113883.6.73 2017-01 D10AD Retinoids for topical use in acne 2.16.840.1.113883.6.73 2017-01 D10AD01 tretinoin 2.16.840.1.113883.6.73 2017-01 D10AD02 retinol 2.16.840.1.113883.6.73 2017-01 D10AD03 adapalene 2.16.840.1.113883.6.73 2017-01 D10AD04 2.16.840.1.113883.6.73 2017-01 D10AD05 motretinide 2.16.840.1.113883.6.73 2017-01 D10AD51 tretinoin, combinations 2.16.840.1.113883.6.73 2017-01 D10AD53 adapalene, combinations 2.16.840.1.113883.6.73 2017-01 D10AD54 isotretinoin, combinations 2.16.840.1.113883.6.73 2017-01 D10AE Peroxides 2.16.840.1.113883.6.73 2017-01 D10AE01 benzoyl peroxide 2.16.840.1.113883.6.73 2017-01 D10AE51 benzoyl peroxide, combinations 2.16.840.1.113883.6.73 2017-01 D10AF Antiinfectives for treatment of acne 2.16.840.1.113883.6.73 2017-01 D10AF01 2.16.840.1.113883.6.73 2017-01 D10AF02 2.16.840.1.113883.6.73 2017-01 D10AF03 chloramphenicol 2.16.840.1.113883.6.73 2017-01 D10AF04 meclocycline 2.16.840.1.113883.6.73 2017-01 D10AF05 2.16.840.1.113883.6.73 2017-01 D10AF06 2.16.840.1.113883.6.73 2017-01 D10AF51 clindamycin, combinations © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 56 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D10AF52 erythromycin, combinations 2.16.840.1.113883.6.73 2017-01 D10AX Other anti-acne preparations for topical use 2.16.840.1.113883.6.73 2017-01 D10AX01 aluminium chloride 2.16.840.1.113883.6.73 2017-01 D10AX02 2.16.840.1.113883.6.73 2017-01 D10AX03 azelaic acid 2.16.840.1.113883.6.73 2017-01 D10AX04 aluminium oxide 2.16.840.1.113883.6.73 2017-01 D10AX05 2.16.840.1.113883.6.73 2017-01 D10AX30 various combinations 2.16.840.1.113883.6.73 2017-01 D10B ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 D10BA Retinoids for treatment of acne 2.16.840.1.113883.6.73 2017-01 D10BA01 isotretinoin 2.16.840.1.113883.6.73 2017-01 D10BX Other anti-acne preparations for systemic use 2.16.840.1.113883.6.73 2017-01 D10BX01 ichtasol 2.16.840.1.113883.6.73 2017-01 D11 OTHER DERMATOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 D11A OTHER DERMATOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 D11AA Antihidrotics 2.16.840.1.113883.6.73 2017-01 D11AC Medicated shampoos 2.16.840.1.113883.6.73 2017-01 D11AC01 cetrimide 2.16.840.1.113883.6.73 2017-01 D11AC02 cadmium compounds 2.16.840.1.113883.6.73 2017-01 D11AC03 selenium compounds 2.16.840.1.113883.6.73 2017-01 D11AC06 povidone-iodine 2.16.840.1.113883.6.73 2017-01 D11AC08 sulfur compounds 2.16.840.1.113883.6.73 2017-01 D11AC09 xenysalate 2.16.840.1.113883.6.73 2017-01 D11AC30 others 2.16.840.1.113883.6.73 2017-01 D11AE for topical use 2.16.840.1.113883.6.73 2017-01 D11AE01 metandienone 2.16.840.1.113883.6.73 2017-01 D11AF Wart and anti-corn preparations 2.16.840.1.113883.6.73 2017-01 D11AH Agents for dermatitis, excluding corticosteroids 2.16.840.1.113883.6.73 2017-01 D11AH01 2.16.840.1.113883.6.73 2017-01 D11AH02 2.16.840.1.113883.6.73 2017-01 D11AH03 cromoglicic acid 2.16.840.1.113883.6.73 2017-01 D11AH04 2.16.840.1.113883.6.73 2017-01 D11AX Other dermatologicals 2.16.840.1.113883.6.73 2017-01 D11AX01 minoxidil 2.16.840.1.113883.6.73 2017-01 D11AX02 gamolenic acid 2.16.840.1.113883.6.73 2017-01 D11AX03 calcium gluconate 2.16.840.1.113883.6.73 2017-01 D11AX04 succinate 2.16.840.1.113883.6.73 2017-01 D11AX05 magnesium sulfate 2.16.840.1.113883.6.73 2017-01 D11AX06 2.16.840.1.113883.6.73 2017-01 D11AX08 2.16.840.1.113883.6.73 2017-01 D11AX09 2.16.840.1.113883.6.73 2017-01 D11AX10 2.16.840.1.113883.6.73 2017-01 D11AX11 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 57 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 D11AX12 pyrithione zinc 2.16.840.1.113883.6.73 2017-01 D11AX13 2.16.840.1.113883.6.73 2017-01 D11AX16 2.16.840.1.113883.6.73 2017-01 D11AX18 2.16.840.1.113883.6.73 2017-01 D11AX21 2.16.840.1.113883.6.73 2017-01 D11AX22 2.16.840.1.113883.6.73 2017-01 D11AX23 aminobenzoate potassium 2.16.840.1.113883.6.73 2017-01 D11AX24 deoxycholic acid 2.16.840.1.113883.6.73 2017-01 D11AX52 gamolenic acid, combinations 2.16.840.1.113883.6.73 2017-01 D11AX57 collagen, combinations 2.16.840.1.113883.6.73 2017-01 G GENITO AND SEX 2.16.840.1.113883.6.73 2017-01 G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS 2.16.840.1.113883.6.73 2017-01 G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS 2.16.840.1.113883.6.73 2017-01 G01AA Antibiotics 2.16.840.1.113883.6.73 2017-01 G01AA01 nystatin 2.16.840.1.113883.6.73 2017-01 G01AA02 natamycin 2.16.840.1.113883.6.73 2017-01 G01AA03 amphotericin B 2.16.840.1.113883.6.73 2017-01 G01AA04 2.16.840.1.113883.6.73 2017-01 G01AA05 chloramphenicol 2.16.840.1.113883.6.73 2017-01 G01AA06 hachimycin 2.16.840.1.113883.6.73 2017-01 G01AA07 oxytetracycline 2.16.840.1.113883.6.73 2017-01 G01AA08 2.16.840.1.113883.6.73 2017-01 G01AA09 mepartricin 2.16.840.1.113883.6.73 2017-01 G01AA10 clindamycin 2.16.840.1.113883.6.73 2017-01 G01AA11 2.16.840.1.113883.6.73 2017-01 G01AA51 nystatin, combinations 2.16.840.1.113883.6.73 2017-01 G01AB Arsenic compounds 2.16.840.1.113883.6.73 2017-01 G01AB01 acetarsol 2.16.840.1.113883.6.73 2017-01 G01AC Quinoline derivatives 2.16.840.1.113883.6.73 2017-01 G01AC01 2.16.840.1.113883.6.73 2017-01 G01AC02 clioquinol 2.16.840.1.113883.6.73 2017-01 G01AC03 chlorquinaldol 2.16.840.1.113883.6.73 2017-01 G01AC05 dequalinium 2.16.840.1.113883.6.73 2017-01 G01AC06 broxyquinoline 2.16.840.1.113883.6.73 2017-01 G01AC30 oxyquinoline 2.16.840.1.113883.6.73 2017-01 G01AD Organic acids 2.16.840.1.113883.6.73 2017-01 G01AD01 lactic acid 2.16.840.1.113883.6.73 2017-01 G01AD02 2.16.840.1.113883.6.73 2017-01 G01AD03 ascorbic acid 2.16.840.1.113883.6.73 2017-01 G01AE Sulfonamides 2.16.840.1.113883.6.73 2017-01 G01AE01 2.16.840.1.113883.6.73 2017-01 G01AE10 combinations of sulfonamides

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 58 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G01AF Imidazole derivatives 2.16.840.1.113883.6.73 2017-01 G01AF01 metronidazole 2.16.840.1.113883.6.73 2017-01 G01AF02 clotrimazole 2.16.840.1.113883.6.73 2017-01 G01AF04 miconazole 2.16.840.1.113883.6.73 2017-01 G01AF05 econazole 2.16.840.1.113883.6.73 2017-01 G01AF06 2.16.840.1.113883.6.73 2017-01 G01AF07 isoconazole 2.16.840.1.113883.6.73 2017-01 G01AF08 tioconazole 2.16.840.1.113883.6.73 2017-01 G01AF11 ketoconazole 2.16.840.1.113883.6.73 2017-01 G01AF12 fenticonazole 2.16.840.1.113883.6.73 2017-01 G01AF13 2.16.840.1.113883.6.73 2017-01 G01AF14 2.16.840.1.113883.6.73 2017-01 G01AF15 butoconazole 2.16.840.1.113883.6.73 2017-01 G01AF16 omoconazole 2.16.840.1.113883.6.73 2017-01 G01AF17 oxiconazole 2.16.840.1.113883.6.73 2017-01 G01AF18 flutrimazole 2.16.840.1.113883.6.73 2017-01 G01AF19 sertaconazole 2.16.840.1.113883.6.73 2017-01 G01AF20 combinations of imidazole derivatives 2.16.840.1.113883.6.73 2017-01 G01AG Triazole derivatives 2.16.840.1.113883.6.73 2017-01 G01AG02 2.16.840.1.113883.6.73 2017-01 G01AX Other antiinfectives and antiseptics 2.16.840.1.113883.6.73 2017-01 G01AX01 clodantoin 2.16.840.1.113883.6.73 2017-01 G01AX02 inosine 2.16.840.1.113883.6.73 2017-01 G01AX03 policresulen 2.16.840.1.113883.6.73 2017-01 G01AX05 2.16.840.1.113883.6.73 2017-01 G01AX06 2.16.840.1.113883.6.73 2017-01 G01AX09 methylrosaniline 2.16.840.1.113883.6.73 2017-01 G01AX11 povidone-iodine 2.16.840.1.113883.6.73 2017-01 G01AX12 ciclopirox 2.16.840.1.113883.6.73 2017-01 G01AX13 2.16.840.1.113883.6.73 2017-01 G01AX14 lactobacillus fermentum 2.16.840.1.113883.6.73 2017-01 G01AX15 2.16.840.1.113883.6.73 2017-01 G01AX16 hexetidine 2.16.840.1.113883.6.73 2017-01 G01AX66 octenidine, combinations 2.16.840.1.113883.6.73 2017-01 G01B ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS 2.16.840.1.113883.6.73 2017-01 G01BA Antibiotics and corticosteroids 2.16.840.1.113883.6.73 2017-01 G01BC Quinoline derivatives and corticosteroids 2.16.840.1.113883.6.73 2017-01 G01BD Antiseptics and corticosteroids 2.16.840.1.113883.6.73 2017-01 G01BE Sulfonamides and corticosteroids 2.16.840.1.113883.6.73 2017-01 G01BF Imidazole derivatives and corticosteroids 2.16.840.1.113883.6.73 2017-01 G02 OTHER GYNECOLOGICALS 2.16.840.1.113883.6.73 2017-01 G02A

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 59 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G02AB Ergot alkaloids 2.16.840.1.113883.6.73 2017-01 G02AB01 2.16.840.1.113883.6.73 2017-01 G02AB02 ergot alkaloids 2.16.840.1.113883.6.73 2017-01 G02AB03 2.16.840.1.113883.6.73 2017-01 G02AC Ergot alkaloids and incl. analogues, in combination 2.16.840.1.113883.6.73 2017-01 G02AC01 methylergometrine and oxytocin 2.16.840.1.113883.6.73 2017-01 G02AD Prostaglandins 2.16.840.1.113883.6.73 2017-01 G02AD01 dinoprost 2.16.840.1.113883.6.73 2017-01 G02AD02 dinoprostone 2.16.840.1.113883.6.73 2017-01 G02AD03 2.16.840.1.113883.6.73 2017-01 G02AD04 2.16.840.1.113883.6.73 2017-01 G02AD05 2.16.840.1.113883.6.73 2017-01 G02AD06 misoprostol 2.16.840.1.113883.6.73 2017-01 G02AX Other uterotonics 2.16.840.1.113883.6.73 2017-01 G02B CONTRACEPTIVES FOR TOPICAL USE 2.16.840.1.113883.6.73 2017-01 G02BA Intrauterine contraceptives 2.16.840.1.113883.6.73 2017-01 G02BA01 plastic IUD 2.16.840.1.113883.6.73 2017-01 G02BA02 plastic IUD with copper 2.16.840.1.113883.6.73 2017-01 G02BA03 plastic IUD with 2.16.840.1.113883.6.73 2017-01 G02BB Intravaginal contraceptives 2.16.840.1.113883.6.73 2017-01 G02BB01 with progestogen and 2.16.840.1.113883.6.73 2017-01 G02C OTHER GYNECOLOGICALS 2.16.840.1.113883.6.73 2017-01 G02CA Sympathomimetics, labour repressants 2.16.840.1.113883.6.73 2017-01 G02CA01 2.16.840.1.113883.6.73 2017-01 G02CA02 buphenine 2.16.840.1.113883.6.73 2017-01 G02CA03 2.16.840.1.113883.6.73 2017-01 G02CB Prolactine inhibitors 2.16.840.1.113883.6.73 2017-01 G02CB01 2.16.840.1.113883.6.73 2017-01 G02CB02 2.16.840.1.113883.6.73 2017-01 G02CB03 2.16.840.1.113883.6.73 2017-01 G02CB04 2.16.840.1.113883.6.73 2017-01 G02CB05 2.16.840.1.113883.6.73 2017-01 G02CB06 2.16.840.1.113883.6.73 2017-01 G02CC Antiinflammatory products for vaginal administration 2.16.840.1.113883.6.73 2017-01 G02CC01 ibuprofen 2.16.840.1.113883.6.73 2017-01 G02CC02 2.16.840.1.113883.6.73 2017-01 G02CC03 benzydamine 2.16.840.1.113883.6.73 2017-01 G02CC04 2.16.840.1.113883.6.73 2017-01 G02CX Other gynecologicals 2.16.840.1.113883.6.73 2017-01 G02CX01 2.16.840.1.113883.6.73 2017-01 G02CX02 2.16.840.1.113883.6.73 2017-01 G02CX03 Agni casti fructus 2.16.840.1.113883.6.73 2017-01 G02CX04 Cimicifugae rhizoma © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 60 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM 2.16.840.1.113883.6.73 2017-01 G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 G03AA and , fixed combinations 2.16.840.1.113883.6.73 2017-01 G03AA01 etynodiol and 2.16.840.1.113883.6.73 2017-01 G03AA02 quingestanol and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA03 and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA04 megestrol and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA05 and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA06 and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA07 and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA08 medroxyprogesterone and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA09 and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA10 and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA11 and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA12 and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA13 and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA14 nomegestrol and 2.16.840.1.113883.6.73 2017-01 G03AA15 chlormadinone and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AA16 and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB Progestogens and estrogens, sequential preparations 2.16.840.1.113883.6.73 2017-01 G03AB01 megestrol and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB02 lynestrenol and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB03 levonorgestrel and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB04 norethisterone and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB05 desogestrel and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB06 gestodene and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB07 chlormadinone and ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03AB08 dienogest and estradiol 2.16.840.1.113883.6.73 2017-01 G03AC Progestogens 2.16.840.1.113883.6.73 2017-01 G03AC01 norethisterone 2.16.840.1.113883.6.73 2017-01 G03AC02 lynestrenol 2.16.840.1.113883.6.73 2017-01 G03AC03 levonorgestrel 2.16.840.1.113883.6.73 2017-01 G03AC04 quingestanol 2.16.840.1.113883.6.73 2017-01 G03AC05 megestrol 2.16.840.1.113883.6.73 2017-01 G03AC06 medroxyprogesterone 2.16.840.1.113883.6.73 2017-01 G03AC07 2.16.840.1.113883.6.73 2017-01 G03AC08 2.16.840.1.113883.6.73 2017-01 G03AC09 desogestrel 2.16.840.1.113883.6.73 2017-01 G03AC10 drospirenone 2.16.840.1.113883.6.73 2017-01 G03AD Emergency contraceptives 2.16.840.1.113883.6.73 2017-01 G03AD01 levonorgestrel 2.16.840.1.113883.6.73 2017-01 G03AD02 ulipristal

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 61 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03B ANDROGENS 2.16.840.1.113883.6.73 2017-01 G03BA 3-oxoandrosten (4) derivatives 2.16.840.1.113883.6.73 2017-01 G03BA01 2.16.840.1.113883.6.73 2017-01 G03BA02 2.16.840.1.113883.6.73 2017-01 G03BA03 2.16.840.1.113883.6.73 2017-01 G03BB 5-androstanon (3) derivatives 2.16.840.1.113883.6.73 2017-01 G03BB01 2.16.840.1.113883.6.73 2017-01 G03BB02 androstanolone 2.16.840.1.113883.6.73 2017-01 G03C ESTROGENS 2.16.840.1.113883.6.73 2017-01 G03CA Natural and semisynthetic estrogens, plain 2.16.840.1.113883.6.73 2017-01 G03CA01 ethinylestradiol 2.16.840.1.113883.6.73 2017-01 G03CA03 estradiol 2.16.840.1.113883.6.73 2017-01 G03CA04 2.16.840.1.113883.6.73 2017-01 G03CA06 2.16.840.1.113883.6.73 2017-01 G03CA07 2.16.840.1.113883.6.73 2017-01 G03CA09 2.16.840.1.113883.6.73 2017-01 G03CA53 estradiol, combinations 2.16.840.1.113883.6.73 2017-01 G03CA57 2.16.840.1.113883.6.73 2017-01 G03CB Synthetic estrogens, plain 2.16.840.1.113883.6.73 2017-01 G03CB01 2.16.840.1.113883.6.73 2017-01 G03CB02 2.16.840.1.113883.6.73 2017-01 G03CB03 2.16.840.1.113883.6.73 2017-01 G03CB04 2.16.840.1.113883.6.73 2017-01 G03CC Estrogens, combinations with other drugs 2.16.840.1.113883.6.73 2017-01 G03CC02 dienestrol 2.16.840.1.113883.6.73 2017-01 G03CC03 methallenestril 2.16.840.1.113883.6.73 2017-01 G03CC04 estrone 2.16.840.1.113883.6.73 2017-01 G03CC05 diethylstilbestrol 2.16.840.1.113883.6.73 2017-01 G03CC06 estriol 2.16.840.1.113883.6.73 2017-01 G03CC07 conjugated estrogens and 2.16.840.1.113883.6.73 2017-01 G03CX Other estrogens 2.16.840.1.113883.6.73 2017-01 G03CX01 2.16.840.1.113883.6.73 2017-01 G03D PROGESTOGENS 2.16.840.1.113883.6.73 2017-01 G03DA Pregnen (4) derivatives 2.16.840.1.113883.6.73 2017-01 G03DA01 gestonorone 2.16.840.1.113883.6.73 2017-01 G03DA02 medroxyprogesterone 2.16.840.1.113883.6.73 2017-01 G03DA03 hydroxyprogesterone 2.16.840.1.113883.6.73 2017-01 G03DA04 2.16.840.1.113883.6.73 2017-01 G03DB Pregnadien derivatives 2.16.840.1.113883.6.73 2017-01 G03DB01 2.16.840.1.113883.6.73 2017-01 G03DB02 megestrol 2.16.840.1.113883.6.73 2017-01 G03DB03 2.16.840.1.113883.6.73 2017-01 G03DB04 nomegestrol © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 62 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03DB05 2.16.840.1.113883.6.73 2017-01 G03DB06 chlormadinone 2.16.840.1.113883.6.73 2017-01 G03DB07 2.16.840.1.113883.6.73 2017-01 G03DB08 dienogest 2.16.840.1.113883.6.73 2017-01 G03DC Estren derivatives 2.16.840.1.113883.6.73 2017-01 G03DC01 2.16.840.1.113883.6.73 2017-01 G03DC02 norethisterone 2.16.840.1.113883.6.73 2017-01 G03DC03 lynestrenol 2.16.840.1.113883.6.73 2017-01 G03DC04 2.16.840.1.113883.6.73 2017-01 G03DC06 etynodiol 2.16.840.1.113883.6.73 2017-01 G03DC31 methylestrenolone 2.16.840.1.113883.6.73 2017-01 G03E ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION 2.16.840.1.113883.6.73 2017-01 G03EA Androgens and estrogens 2.16.840.1.113883.6.73 2017-01 G03EA01 methyltestosterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03EA02 testosterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03EA03 prasterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03EB , progestogen and estrogen in combination 2.16.840.1.113883.6.73 2017-01 G03EK Androgens and female sex hormones in combination with other drugs 2.16.840.1.113883.6.73 2017-01 G03EK01 methyltestosterone 2.16.840.1.113883.6.73 2017-01 G03F PROGESTOGENS AND ESTROGENS IN COMBINATION 2.16.840.1.113883.6.73 2017-01 G03FA Progestogens and estrogens, fixed combinations 2.16.840.1.113883.6.73 2017-01 G03FA01 norethisterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA02 hydroxyprogesterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA03 ethisterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA04 progesterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA05 methylnortestosterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA06 etynodiol and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA07 lynestrenol and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA08 megestrol and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA09 and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA10 norgestrel and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA11 levonorgestrel and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA12 medroxyprogesterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA13 norgestimate and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA14 dydrogesterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA15 dienogest and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA16 and estrogen 2.16.840.1.113883.6.73 2017-01 G03FA17 drospirenone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB Progestogens and estrogens, sequential preparations 2.16.840.1.113883.6.73 2017-01 G03FB01 norgestrel and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB02 lynestrenol and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB03 chlormadinone and estrogen © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 63 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03FB04 megestrol and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB05 norethisterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB06 medroxyprogesterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB07 medrogestone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB08 dydrogesterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB09 levonorgestrel and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB10 desogestrel and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB11 trimegestone and estrogen 2.16.840.1.113883.6.73 2017-01 G03FB12 nomegestrol and estrogen 2.16.840.1.113883.6.73 2017-01 G03G AND OTHER OVULATION STIMULANTS 2.16.840.1.113883.6.73 2017-01 G03GA Gonadotropins 2.16.840.1.113883.6.73 2017-01 G03GA01 chorionic gonadotrophin 2.16.840.1.113883.6.73 2017-01 G03GA02 human menopausal gonadotrophin 2.16.840.1.113883.6.73 2017-01 G03GA03 serum gonadotrophin 2.16.840.1.113883.6.73 2017-01 G03GA04 2.16.840.1.113883.6.73 2017-01 G03GA05 follitropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA06 follitropin beta 2.16.840.1.113883.6.73 2017-01 G03GA07 lutropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA08 choriogonadotropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA09 corifollitropin alfa 2.16.840.1.113883.6.73 2017-01 G03GA10 follitropin delta 2.16.840.1.113883.6.73 2017-01 G03GA30 combinations 2.16.840.1.113883.6.73 2017-01 G03GB Ovulation stimulants, synthetic 2.16.840.1.113883.6.73 2017-01 G03GB01 2.16.840.1.113883.6.73 2017-01 G03GB02 2.16.840.1.113883.6.73 2017-01 G03GB03 2.16.840.1.113883.6.73 2017-01 G03H 2.16.840.1.113883.6.73 2017-01 G03HA Antiandrogens, plain 2.16.840.1.113883.6.73 2017-01 G03HA01 2.16.840.1.113883.6.73 2017-01 G03HB Antiandrogens and estrogens 2.16.840.1.113883.6.73 2017-01 G03HB01 cyproterone and estrogen 2.16.840.1.113883.6.73 2017-01 G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM 2.16.840.1.113883.6.73 2017-01 G03XA and similar agents 2.16.840.1.113883.6.73 2017-01 G03XA01 2.16.840.1.113883.6.73 2017-01 G03XA02 2.16.840.1.113883.6.73 2017-01 G03XB Progesterone receptor modulators 2.16.840.1.113883.6.73 2017-01 G03XB01 2.16.840.1.113883.6.73 2017-01 G03XB02 ulipristal 2.16.840.1.113883.6.73 2017-01 G03XB51 mifepristone, combinations 2.16.840.1.113883.6.73 2017-01 G03XC Selective estrogen receptor modulators 2.16.840.1.113883.6.73 2017-01 G03XC01 2.16.840.1.113883.6.73 2017-01 G03XC02 bazedoxifene

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 64 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G03XC03 2.16.840.1.113883.6.73 2017-01 G03XC04 2.16.840.1.113883.6.73 2017-01 G03XC05 2.16.840.1.113883.6.73 2017-01 G04 UROLOGICALS 2.16.840.1.113883.6.73 2017-01 G04B UROLOGICALS 2.16.840.1.113883.6.73 2017-01 G04BA 2.16.840.1.113883.6.73 2017-01 G04BA01 ammonium chloride 2.16.840.1.113883.6.73 2017-01 G04BA03 calcium chloride 2.16.840.1.113883.6.73 2017-01 G04BC Urinary concrement solvents 2.16.840.1.113883.6.73 2017-01 G04BD Drugs for urinary frequency and incontinence 2.16.840.1.113883.6.73 2017-01 G04BD01 emepronium 2.16.840.1.113883.6.73 2017-01 G04BD02 2.16.840.1.113883.6.73 2017-01 G04BD03 2.16.840.1.113883.6.73 2017-01 G04BD04 2.16.840.1.113883.6.73 2017-01 G04BD05 2.16.840.1.113883.6.73 2017-01 G04BD06 2.16.840.1.113883.6.73 2017-01 G04BD07 2.16.840.1.113883.6.73 2017-01 G04BD08 2.16.840.1.113883.6.73 2017-01 G04BD09 trospium 2.16.840.1.113883.6.73 2017-01 G04BD10 2.16.840.1.113883.6.73 2017-01 G04BD11 2.16.840.1.113883.6.73 2017-01 G04BD12 2.16.840.1.113883.6.73 2017-01 G04BD13 2.16.840.1.113883.6.73 2017-01 G04BE Drugs used in 2.16.840.1.113883.6.73 2017-01 G04BE01 alprostadil 2.16.840.1.113883.6.73 2017-01 G04BE02 papaverine 2.16.840.1.113883.6.73 2017-01 G04BE03 2.16.840.1.113883.6.73 2017-01 G04BE04 2.16.840.1.113883.6.73 2017-01 G04BE06 moxisylyte 2.16.840.1.113883.6.73 2017-01 G04BE07 2.16.840.1.113883.6.73 2017-01 G04BE08 2.16.840.1.113883.6.73 2017-01 G04BE09 2.16.840.1.113883.6.73 2017-01 G04BE10 2.16.840.1.113883.6.73 2017-01 G04BE11 2.16.840.1.113883.6.73 2017-01 G04BE30 combinations 2.16.840.1.113883.6.73 2017-01 G04BE52 papaverine, combinations 2.16.840.1.113883.6.73 2017-01 G04BX Other urologicals 2.16.840.1.113883.6.73 2017-01 G04BX01 magnesium hydroxide 2.16.840.1.113883.6.73 2017-01 G04BX03 2.16.840.1.113883.6.73 2017-01 G04BX06 2.16.840.1.113883.6.73 2017-01 G04BX10 2.16.840.1.113883.6.73 2017-01 G04BX11 collagen 2.16.840.1.113883.6.73 2017-01 G04BX12 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 65 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 G04BX13 2.16.840.1.113883.6.73 2017-01 G04BX14 2.16.840.1.113883.6.73 2017-01 G04BX15 pentosan polysulfate sodium 2.16.840.1.113883.6.73 2017-01 G04BX16 2.16.840.1.113883.6.73 2017-01 G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY 2.16.840.1.113883.6.73 2017-01 G04CA Alpha-adrenoreceptor antagonists 2.16.840.1.113883.6.73 2017-01 G04CA01 2.16.840.1.113883.6.73 2017-01 G04CA02 2.16.840.1.113883.6.73 2017-01 G04CA03 2.16.840.1.113883.6.73 2017-01 G04CA04 2.16.840.1.113883.6.73 2017-01 G04CA51 alfuzosin and finasteride 2.16.840.1.113883.6.73 2017-01 G04CA52 tamsulosin and 2.16.840.1.113883.6.73 2017-01 G04CA53 tamsulosin and solifenacin 2.16.840.1.113883.6.73 2017-01 G04CB Testosterone-5-alpha reductase inhibitors 2.16.840.1.113883.6.73 2017-01 G04CB01 finasteride 2.16.840.1.113883.6.73 2017-01 G04CB02 dutasteride 2.16.840.1.113883.6.73 2017-01 G04CX Other drugs used in benign prostatic hypertrophy 2.16.840.1.113883.6.73 2017-01 G04CX01 Prunus africanae cortex 2.16.840.1.113883.6.73 2017-01 G04CX02 Sabalis serrulatae fructus 2.16.840.1.113883.6.73 2017-01 G04CX03 mepartricin 2.16.840.1.113883.6.73 2017-01 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS 2.16.840.1.113883.6.73 2017-01 H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES 2.16.840.1.113883.6.73 2017-01 H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES 2.16.840.1.113883.6.73 2017-01 H01AA ACTH 2.16.840.1.113883.6.73 2017-01 H01AA01 corticotropin 2.16.840.1.113883.6.73 2017-01 H01AA02 tetracosactide 2.16.840.1.113883.6.73 2017-01 H01AB Thyrotropin 2.16.840.1.113883.6.73 2017-01 H01AB01 thyrotropin alfa 2.16.840.1.113883.6.73 2017-01 H01AC Somatropin and somatropin agonists 2.16.840.1.113883.6.73 2017-01 H01AC01 somatropin 2.16.840.1.113883.6.73 2017-01 H01AC02 somatrem 2.16.840.1.113883.6.73 2017-01 H01AC03 2.16.840.1.113883.6.73 2017-01 H01AC04 2.16.840.1.113883.6.73 2017-01 H01AC05 2.16.840.1.113883.6.73 2017-01 H01AC06 tesamorelin 2.16.840.1.113883.6.73 2017-01 H01AX Other anterior pituitary lobe hormones and analogues 2.16.840.1.113883.6.73 2017-01 H01AX01 pegvisomant 2.16.840.1.113883.6.73 2017-01 H01B POSTERIOR PITUITARY LOBE HORMONES 2.16.840.1.113883.6.73 2017-01 H01BA Vasopressin and analogues 2.16.840.1.113883.6.73 2017-01 H01BA01 vasopressin 2.16.840.1.113883.6.73 2017-01 H01BA02 desmopressin 2.16.840.1.113883.6.73 2017-01 H01BA03 lypressin © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 66 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 H01BA04 terlipressin 2.16.840.1.113883.6.73 2017-01 H01BA05 ornipressin 2.16.840.1.113883.6.73 2017-01 H01BA06 argipressin 2.16.840.1.113883.6.73 2017-01 H01BB Oxytocin and analogues 2.16.840.1.113883.6.73 2017-01 H01BB01 2.16.840.1.113883.6.73 2017-01 H01BB02 oxytocin 2.16.840.1.113883.6.73 2017-01 H01BB03 2.16.840.1.113883.6.73 2017-01 H01C HYPOTHALAMIC HORMONES 2.16.840.1.113883.6.73 2017-01 H01CA -releasing hormones 2.16.840.1.113883.6.73 2017-01 H01CA01 2.16.840.1.113883.6.73 2017-01 H01CA02 2.16.840.1.113883.6.73 2017-01 H01CB Somatostatin and analogues 2.16.840.1.113883.6.73 2017-01 H01CB01 somatostatin 2.16.840.1.113883.6.73 2017-01 H01CB02 2.16.840.1.113883.6.73 2017-01 H01CB03 lanreotide 2.16.840.1.113883.6.73 2017-01 H01CB04 vapreotide 2.16.840.1.113883.6.73 2017-01 H01CB05 pasireotide 2.16.840.1.113883.6.73 2017-01 H01CC Anti-gonadotropin-releasing hormones 2.16.840.1.113883.6.73 2017-01 H01CC01 2.16.840.1.113883.6.73 2017-01 H01CC02 2.16.840.1.113883.6.73 2017-01 H02 CORTICOSTEROIDS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN 2.16.840.1.113883.6.73 2017-01 H02AA 2.16.840.1.113883.6.73 2017-01 H02AA01 aldosterone 2.16.840.1.113883.6.73 2017-01 H02AA02 2.16.840.1.113883.6.73 2017-01 H02AA03 desoxycortone 2.16.840.1.113883.6.73 2017-01 H02AB 2.16.840.1.113883.6.73 2017-01 H02AB01 betamethasone 2.16.840.1.113883.6.73 2017-01 H02AB02 dexamethasone 2.16.840.1.113883.6.73 2017-01 H02AB03 fluocortolone 2.16.840.1.113883.6.73 2017-01 H02AB04 methylprednisolone 2.16.840.1.113883.6.73 2017-01 H02AB05 2.16.840.1.113883.6.73 2017-01 H02AB06 prednisolone 2.16.840.1.113883.6.73 2017-01 H02AB07 prednisone 2.16.840.1.113883.6.73 2017-01 H02AB08 triamcinolone 2.16.840.1.113883.6.73 2017-01 H02AB09 hydrocortisone 2.16.840.1.113883.6.73 2017-01 H02AB10 2.16.840.1.113883.6.73 2017-01 H02AB11 2.16.840.1.113883.6.73 2017-01 H02AB12 2.16.840.1.113883.6.73 2017-01 H02AB13 2.16.840.1.113883.6.73 2017-01 H02AB14 2.16.840.1.113883.6.73 2017-01 H02AB15 2.16.840.1.113883.6.73 2017-01 H02AB17 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 67 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 H02B CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS 2.16.840.1.113883.6.73 2017-01 H02BX Corticosteroids for systemic use, combinations 2.16.840.1.113883.6.73 2017-01 H02BX01 methylprednisolone, combinations 2.16.840.1.113883.6.73 2017-01 H02C ANTIADRENAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 H02CA Anticorticosteroids 2.16.840.1.113883.6.73 2017-01 H02CA01 2.16.840.1.113883.6.73 2017-01 H03 THERAPY 2.16.840.1.113883.6.73 2017-01 H03A THYROID PREPARATIONS 2.16.840.1.113883.6.73 2017-01 H03AA 2.16.840.1.113883.6.73 2017-01 H03AA01 sodium 2.16.840.1.113883.6.73 2017-01 H03AA02 sodium 2.16.840.1.113883.6.73 2017-01 H03AA03 combinations of levothyroxine and liothyronine 2.16.840.1.113883.6.73 2017-01 H03AA04 tiratricol 2.16.840.1.113883.6.73 2017-01 H03AA05 thyroid gland preparations 2.16.840.1.113883.6.73 2017-01 H03B ANTITHYROID PREPARATIONS 2.16.840.1.113883.6.73 2017-01 H03BA Thiouracils 2.16.840.1.113883.6.73 2017-01 H03BA01 2.16.840.1.113883.6.73 2017-01 H03BA02 2.16.840.1.113883.6.73 2017-01 H03BA03 benzylthiouracil 2.16.840.1.113883.6.73 2017-01 H03BB Sulfur-containing imidazole derivatives 2.16.840.1.113883.6.73 2017-01 H03BB01 2.16.840.1.113883.6.73 2017-01 H03BB02 2.16.840.1.113883.6.73 2017-01 H03BB52 thiamazole, combinations 2.16.840.1.113883.6.73 2017-01 H03BC 2.16.840.1.113883.6.73 2017-01 H03BC01 potassium 2.16.840.1.113883.6.73 2017-01 H03BX Other antithyroid preparations 2.16.840.1.113883.6.73 2017-01 H03BX01 2.16.840.1.113883.6.73 2017-01 H03BX02 2.16.840.1.113883.6.73 2017-01 H03C IODINE THERAPY 2.16.840.1.113883.6.73 2017-01 H03CA Iodine therapy 2.16.840.1.113883.6.73 2017-01 H04 PANCREATIC HORMONES 2.16.840.1.113883.6.73 2017-01 H04A GLYCOGENOLYTIC HORMONES 2.16.840.1.113883.6.73 2017-01 H04AA Glycogenolytic hormones 2.16.840.1.113883.6.73 2017-01 H04AA01 glucagon 2.16.840.1.113883.6.73 2017-01 H05 CALCIUM 2.16.840.1.113883.6.73 2017-01 H05A PARATHYROID HORMONES AND ANALOGUES 2.16.840.1.113883.6.73 2017-01 H05AA Parathyroid hormones and analogues 2.16.840.1.113883.6.73 2017-01 H05AA01 extract 2.16.840.1.113883.6.73 2017-01 H05AA02 2.16.840.1.113883.6.73 2017-01 H05AA03 parathyroid 2.16.840.1.113883.6.73 2017-01 H05B ANTI-PARATHYROID AGENTS 2.16.840.1.113883.6.73 2017-01 H05BA preparations 2.16.840.1.113883.6.73 2017-01 H05BA01 calcitonin (salmon synthetic) © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 68 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 H05BA02 calcitonin (pork natural) 2.16.840.1.113883.6.73 2017-01 H05BA03 calcitonin (human synthetic) 2.16.840.1.113883.6.73 2017-01 H05BA04 2.16.840.1.113883.6.73 2017-01 H05BX Other anti-parathyroid agents 2.16.840.1.113883.6.73 2017-01 H05BX01 2.16.840.1.113883.6.73 2017-01 H05BX02 2.16.840.1.113883.6.73 2017-01 H05BX03 2.16.840.1.113883.6.73 2017-01 H05BX04 2.16.840.1.113883.6.73 2017-01 J ANTIINFECTIVES FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 J01 ANTIBACTERIALS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 J01A 2.16.840.1.113883.6.73 2017-01 J01AA Tetracyclines 2.16.840.1.113883.6.73 2017-01 J01AA01 demeclocycline 2.16.840.1.113883.6.73 2017-01 J01AA02 doxycycline 2.16.840.1.113883.6.73 2017-01 J01AA03 chlortetracycline 2.16.840.1.113883.6.73 2017-01 J01AA04 lymecycline 2.16.840.1.113883.6.73 2017-01 J01AA05 metacycline 2.16.840.1.113883.6.73 2017-01 J01AA06 oxytetracycline 2.16.840.1.113883.6.73 2017-01 J01AA07 tetracycline 2.16.840.1.113883.6.73 2017-01 J01AA08 minocycline 2.16.840.1.113883.6.73 2017-01 J01AA09 rolitetracycline 2.16.840.1.113883.6.73 2017-01 J01AA10 penimepicycline 2.16.840.1.113883.6.73 2017-01 J01AA11 clomocycline 2.16.840.1.113883.6.73 2017-01 J01AA12 tigecycline 2.16.840.1.113883.6.73 2017-01 J01AA20 combinations of tetracyclines 2.16.840.1.113883.6.73 2017-01 J01AA56 oxytetracycline, combinations 2.16.840.1.113883.6.73 2017-01 J01B AMPHENICOLS 2.16.840.1.113883.6.73 2017-01 J01BA Amphenicols 2.16.840.1.113883.6.73 2017-01 J01BA01 chloramphenicol 2.16.840.1.113883.6.73 2017-01 J01BA02 thiamphenicol 2.16.840.1.113883.6.73 2017-01 J01BA52 thiamphenicol, combinations 2.16.840.1.113883.6.73 2017-01 J01C BETA-LACTAM ANTIBACTERIALS, 2.16.840.1.113883.6.73 2017-01 J01CA Penicillins with extended spectrum 2.16.840.1.113883.6.73 2017-01 J01CA01 ampicillin 2.16.840.1.113883.6.73 2017-01 J01CA02 pivampicillin 2.16.840.1.113883.6.73 2017-01 J01CA03 carbenicillin 2.16.840.1.113883.6.73 2017-01 J01CA04 amoxicillin 2.16.840.1.113883.6.73 2017-01 J01CA05 carindacillin 2.16.840.1.113883.6.73 2017-01 J01CA06 bacampicillin 2.16.840.1.113883.6.73 2017-01 J01CA07 epicillin 2.16.840.1.113883.6.73 2017-01 J01CA08 pivmecillinam 2.16.840.1.113883.6.73 2017-01 J01CA09 azlocillin 2.16.840.1.113883.6.73 2017-01 J01CA10 mezlocillin © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 69 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01CA11 mecillinam 2.16.840.1.113883.6.73 2017-01 J01CA12 piperacillin 2.16.840.1.113883.6.73 2017-01 J01CA13 ticarcillin 2.16.840.1.113883.6.73 2017-01 J01CA14 metampicillin 2.16.840.1.113883.6.73 2017-01 J01CA15 talampicillin 2.16.840.1.113883.6.73 2017-01 J01CA16 sulbenicillin 2.16.840.1.113883.6.73 2017-01 J01CA17 temocillin 2.16.840.1.113883.6.73 2017-01 J01CA18 hetacillin 2.16.840.1.113883.6.73 2017-01 J01CA19 aspoxicillin 2.16.840.1.113883.6.73 2017-01 J01CA20 combinations 2.16.840.1.113883.6.73 2017-01 J01CA51 ampicillin, combinations 2.16.840.1.113883.6.73 2017-01 J01CE Beta-lactamase sensitive penicillins 2.16.840.1.113883.6.73 2017-01 J01CE01 benzylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE02 phenoxymethylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE03 propicillin 2.16.840.1.113883.6.73 2017-01 J01CE04 azidocillin 2.16.840.1.113883.6.73 2017-01 J01CE05 pheneticillin 2.16.840.1.113883.6.73 2017-01 J01CE06 penamecillin 2.16.840.1.113883.6.73 2017-01 J01CE07 clometocillin 2.16.840.1.113883.6.73 2017-01 J01CE08 benzathine benzylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE09 procaine benzylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE10 benzathine phenoxymethylpenicillin 2.16.840.1.113883.6.73 2017-01 J01CE30 combinations 2.16.840.1.113883.6.73 2017-01 J01CF Beta-lactamase resistant penicillins 2.16.840.1.113883.6.73 2017-01 J01CF01 dicloxacillin 2.16.840.1.113883.6.73 2017-01 J01CF02 cloxacillin 2.16.840.1.113883.6.73 2017-01 J01CF03 meticillin 2.16.840.1.113883.6.73 2017-01 J01CF04 oxacillin 2.16.840.1.113883.6.73 2017-01 J01CF05 flucloxacillin 2.16.840.1.113883.6.73 2017-01 J01CF06 nafcillin 2.16.840.1.113883.6.73 2017-01 J01CG Beta-lactamase inhibitors 2.16.840.1.113883.6.73 2017-01 J01CG01 sulbactam 2.16.840.1.113883.6.73 2017-01 J01CG02 tazobactam 2.16.840.1.113883.6.73 2017-01 J01CR Combinations of penicillins, incl. beta-lactamase inhibitors 2.16.840.1.113883.6.73 2017-01 J01CR01 ampicillin and 2.16.840.1.113883.6.73 2017-01 J01CR02 amoxicillin and enzyme inhibitor 2.16.840.1.113883.6.73 2017-01 J01CR03 ticarcillin and enzyme inhibitor 2.16.840.1.113883.6.73 2017-01 J01CR04 sultamicillin 2.16.840.1.113883.6.73 2017-01 J01CR05 piperacillin and enzyme inhibitor 2.16.840.1.113883.6.73 2017-01 J01CR50 combinations of penicillins 2.16.840.1.113883.6.73 2017-01 J01D OTHER BETA-LACTAM ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01DB First-generation cephalosporins 2.16.840.1.113883.6.73 2017-01 J01DB01 cefalexin © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 70 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01DB02 cefaloridine 2.16.840.1.113883.6.73 2017-01 J01DB03 cefalotin 2.16.840.1.113883.6.73 2017-01 J01DB04 cefazolin 2.16.840.1.113883.6.73 2017-01 J01DB05 cefadroxil 2.16.840.1.113883.6.73 2017-01 J01DB06 cefazedone 2.16.840.1.113883.6.73 2017-01 J01DB07 cefatrizine 2.16.840.1.113883.6.73 2017-01 J01DB08 cefapirin 2.16.840.1.113883.6.73 2017-01 J01DB09 cefradine 2.16.840.1.113883.6.73 2017-01 J01DB10 cefacetrile 2.16.840.1.113883.6.73 2017-01 J01DB11 cefroxadine 2.16.840.1.113883.6.73 2017-01 J01DB12 ceftezole 2.16.840.1.113883.6.73 2017-01 J01DC Second-generation cephalosporins 2.16.840.1.113883.6.73 2017-01 J01DC01 cefoxitin 2.16.840.1.113883.6.73 2017-01 J01DC02 cefuroxime 2.16.840.1.113883.6.73 2017-01 J01DC03 cefamandole 2.16.840.1.113883.6.73 2017-01 J01DC04 cefaclor 2.16.840.1.113883.6.73 2017-01 J01DC05 cefotetan 2.16.840.1.113883.6.73 2017-01 J01DC06 cefonicid 2.16.840.1.113883.6.73 2017-01 J01DC07 cefotiam 2.16.840.1.113883.6.73 2017-01 J01DC08 loracarbef 2.16.840.1.113883.6.73 2017-01 J01DC09 cefmetazole 2.16.840.1.113883.6.73 2017-01 J01DC10 cefprozil 2.16.840.1.113883.6.73 2017-01 J01DC11 ceforanide 2.16.840.1.113883.6.73 2017-01 J01DC12 cefminox 2.16.840.1.113883.6.73 2017-01 J01DC13 cefbuperazone 2.16.840.1.113883.6.73 2017-01 J01DC14 flomoxef 2.16.840.1.113883.6.73 2017-01 J01DD Third-generation cephalosporins 2.16.840.1.113883.6.73 2017-01 J01DD01 cefotaxime 2.16.840.1.113883.6.73 2017-01 J01DD02 ceftazidime 2.16.840.1.113883.6.73 2017-01 J01DD03 cefsulodin 2.16.840.1.113883.6.73 2017-01 J01DD04 ceftriaxone 2.16.840.1.113883.6.73 2017-01 J01DD05 cefmenoxime 2.16.840.1.113883.6.73 2017-01 J01DD06 latamoxef 2.16.840.1.113883.6.73 2017-01 J01DD07 ceftizoxime 2.16.840.1.113883.6.73 2017-01 J01DD08 cefixime 2.16.840.1.113883.6.73 2017-01 J01DD09 cefodizime 2.16.840.1.113883.6.73 2017-01 J01DD10 cefetamet 2.16.840.1.113883.6.73 2017-01 J01DD11 cefpiramide 2.16.840.1.113883.6.73 2017-01 J01DD12 cefoperazone 2.16.840.1.113883.6.73 2017-01 J01DD13 cefpodoxime 2.16.840.1.113883.6.73 2017-01 J01DD14 ceftibuten 2.16.840.1.113883.6.73 2017-01 J01DD15 cefdinir 2.16.840.1.113883.6.73 2017-01 J01DD16 cefditoren © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 71 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01DD17 cefcapene 2.16.840.1.113883.6.73 2017-01 J01DD51 cefotaxime, combinations 2.16.840.1.113883.6.73 2017-01 J01DD52 ceftazidime, combinations 2.16.840.1.113883.6.73 2017-01 J01DD54 ceftriaxone, combinations 2.16.840.1.113883.6.73 2017-01 J01DD62 cefoperazone, combinations 2.16.840.1.113883.6.73 2017-01 J01DE Fourth-generation cephalosporins 2.16.840.1.113883.6.73 2017-01 J01DE01 cefepime 2.16.840.1.113883.6.73 2017-01 J01DE02 cefpirome 2.16.840.1.113883.6.73 2017-01 J01DE03 cefozopran 2.16.840.1.113883.6.73 2017-01 J01DF Monobactams 2.16.840.1.113883.6.73 2017-01 J01DF01 aztreonam 2.16.840.1.113883.6.73 2017-01 J01DF02 carumonam 2.16.840.1.113883.6.73 2017-01 J01DH Carbapenems 2.16.840.1.113883.6.73 2017-01 J01DH02 meropenem 2.16.840.1.113883.6.73 2017-01 J01DH03 ertapenem 2.16.840.1.113883.6.73 2017-01 J01DH04 doripenem 2.16.840.1.113883.6.73 2017-01 J01DH05 biapenem 2.16.840.1.113883.6.73 2017-01 J01DH51 and enzyme inhibitor 2.16.840.1.113883.6.73 2017-01 J01DH55 panipenem and betamipron 2.16.840.1.113883.6.73 2017-01 J01DI Other cephalosporins and penems 2.16.840.1.113883.6.73 2017-01 J01DI01 ceftobiprole medocaril 2.16.840.1.113883.6.73 2017-01 J01DI02 ceftaroline fosamil 2.16.840.1.113883.6.73 2017-01 J01DI03 faropenem 2.16.840.1.113883.6.73 2017-01 J01DI54 ceftolozane and enzyme inhibitor 2.16.840.1.113883.6.73 2017-01 J01E SULFONAMIDES AND 2.16.840.1.113883.6.73 2017-01 J01EA Trimethoprim and derivatives 2.16.840.1.113883.6.73 2017-01 J01EA01 trimethoprim 2.16.840.1.113883.6.73 2017-01 J01EA02 2.16.840.1.113883.6.73 2017-01 J01EA03 2.16.840.1.113883.6.73 2017-01 J01EB Short-acting sulfonamides 2.16.840.1.113883.6.73 2017-01 J01EB01 sulfaisodimidine 2.16.840.1.113883.6.73 2017-01 J01EB02 sulfamethizole 2.16.840.1.113883.6.73 2017-01 J01EB03 2.16.840.1.113883.6.73 2017-01 J01EB04 2.16.840.1.113883.6.73 2017-01 J01EB05 2.16.840.1.113883.6.73 2017-01 J01EB06 sulfanilamide 2.16.840.1.113883.6.73 2017-01 J01EB07 sulfathiazole 2.16.840.1.113883.6.73 2017-01 J01EB08 2.16.840.1.113883.6.73 2017-01 J01EB20 combinations 2.16.840.1.113883.6.73 2017-01 J01EC Intermediate-acting sulfonamides 2.16.840.1.113883.6.73 2017-01 J01EC01 2.16.840.1.113883.6.73 2017-01 J01EC02 sulfadiazine 2.16.840.1.113883.6.73 2017-01 J01EC03 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 72 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01EC20 combinations 2.16.840.1.113883.6.73 2017-01 J01ED Long-acting sulfonamides 2.16.840.1.113883.6.73 2017-01 J01ED01 2.16.840.1.113883.6.73 2017-01 J01ED02 2.16.840.1.113883.6.73 2017-01 J01ED03 2.16.840.1.113883.6.73 2017-01 J01ED04 2.16.840.1.113883.6.73 2017-01 J01ED05 2.16.840.1.113883.6.73 2017-01 J01ED06 2.16.840.1.113883.6.73 2017-01 J01ED07 sulfamerazine 2.16.840.1.113883.6.73 2017-01 J01ED08 2.16.840.1.113883.6.73 2017-01 J01ED09 2.16.840.1.113883.6.73 2017-01 J01ED20 combinations 2.16.840.1.113883.6.73 2017-01 J01EE Combinations of sulfonamides and trimethoprim, incl. derivatives 2.16.840.1.113883.6.73 2017-01 J01EE01 sulfamethoxazole and trimethoprim 2.16.840.1.113883.6.73 2017-01 J01EE02 sulfadiazine and trimethoprim 2.16.840.1.113883.6.73 2017-01 J01EE03 and trimethoprim 2.16.840.1.113883.6.73 2017-01 J01EE04 sulfamoxole and trimethoprim 2.16.840.1.113883.6.73 2017-01 J01EE05 sulfadimidine and trimethoprim 2.16.840.1.113883.6.73 2017-01 J01EE06 sulfadiazine and 2.16.840.1.113883.6.73 2017-01 J01EE07 sulfamerazine and trimethoprim 2.16.840.1.113883.6.73 2017-01 J01F , LINCOSAMIDES AND STREPTOGRAMINS 2.16.840.1.113883.6.73 2017-01 J01FA Macrolides 2.16.840.1.113883.6.73 2017-01 J01FA01 erythromycin 2.16.840.1.113883.6.73 2017-01 J01FA02 spiramycin 2.16.840.1.113883.6.73 2017-01 J01FA03 midecamycin 2.16.840.1.113883.6.73 2017-01 J01FA05 oleandomycin 2.16.840.1.113883.6.73 2017-01 J01FA06 roxithromycin 2.16.840.1.113883.6.73 2017-01 J01FA07 josamycin 2.16.840.1.113883.6.73 2017-01 J01FA08 troleandomycin 2.16.840.1.113883.6.73 2017-01 J01FA09 clarithromycin 2.16.840.1.113883.6.73 2017-01 J01FA10 azithromycin 2.16.840.1.113883.6.73 2017-01 J01FA11 miocamycin 2.16.840.1.113883.6.73 2017-01 J01FA12 rokitamycin 2.16.840.1.113883.6.73 2017-01 J01FA13 dirithromycin 2.16.840.1.113883.6.73 2017-01 J01FA14 flurithromycin 2.16.840.1.113883.6.73 2017-01 J01FA15 telithromycin 2.16.840.1.113883.6.73 2017-01 J01FA16 solithromycin 2.16.840.1.113883.6.73 2017-01 J01FF Lincosamides 2.16.840.1.113883.6.73 2017-01 J01FF01 clindamycin 2.16.840.1.113883.6.73 2017-01 J01FF02 lincomycin 2.16.840.1.113883.6.73 2017-01 J01FG Streptogramins 2.16.840.1.113883.6.73 2017-01 J01FG01 pristinamycin 2.16.840.1.113883.6.73 2017-01 J01FG02 quinupristin/dalfopristin © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 73 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01G ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01GA 2.16.840.1.113883.6.73 2017-01 J01GA01 streptomycin 2.16.840.1.113883.6.73 2017-01 J01GA02 streptoduocin 2.16.840.1.113883.6.73 2017-01 J01GB Other 2.16.840.1.113883.6.73 2017-01 J01GB01 tobramycin 2.16.840.1.113883.6.73 2017-01 J01GB03 gentamicin 2.16.840.1.113883.6.73 2017-01 J01GB04 kanamycin 2.16.840.1.113883.6.73 2017-01 J01GB05 neomycin 2.16.840.1.113883.6.73 2017-01 J01GB06 amikacin 2.16.840.1.113883.6.73 2017-01 J01GB07 netilmicin 2.16.840.1.113883.6.73 2017-01 J01GB08 sisomicin 2.16.840.1.113883.6.73 2017-01 J01GB09 dibekacin 2.16.840.1.113883.6.73 2017-01 J01GB10 ribostamycin 2.16.840.1.113883.6.73 2017-01 J01GB11 isepamicin 2.16.840.1.113883.6.73 2017-01 J01GB12 arbekacin 2.16.840.1.113883.6.73 2017-01 J01GB13 bekanamycin 2.16.840.1.113883.6.73 2017-01 J01M QUINOLONE ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01MA Fluoroquinolones 2.16.840.1.113883.6.73 2017-01 J01MA01 2.16.840.1.113883.6.73 2017-01 J01MA02 2.16.840.1.113883.6.73 2017-01 J01MA03 2.16.840.1.113883.6.73 2017-01 J01MA04 2.16.840.1.113883.6.73 2017-01 J01MA05 2.16.840.1.113883.6.73 2017-01 J01MA06 2.16.840.1.113883.6.73 2017-01 J01MA07 2.16.840.1.113883.6.73 2017-01 J01MA08 2.16.840.1.113883.6.73 2017-01 J01MA09 2.16.840.1.113883.6.73 2017-01 J01MA10 2.16.840.1.113883.6.73 2017-01 J01MA11 2.16.840.1.113883.6.73 2017-01 J01MA12 levofloxacin 2.16.840.1.113883.6.73 2017-01 J01MA13 2.16.840.1.113883.6.73 2017-01 J01MA14 2.16.840.1.113883.6.73 2017-01 J01MA15 2.16.840.1.113883.6.73 2017-01 J01MA16 2.16.840.1.113883.6.73 2017-01 J01MA17 2.16.840.1.113883.6.73 2017-01 J01MA18 2.16.840.1.113883.6.73 2017-01 J01MA19 2.16.840.1.113883.6.73 2017-01 J01MA21 2.16.840.1.113883.6.73 2017-01 J01MB Other quinolones 2.16.840.1.113883.6.73 2017-01 J01MB01 2.16.840.1.113883.6.73 2017-01 J01MB02 2.16.840.1.113883.6.73 2017-01 J01MB03 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 74 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01MB04 2.16.840.1.113883.6.73 2017-01 J01MB05 2.16.840.1.113883.6.73 2017-01 J01MB06 2.16.840.1.113883.6.73 2017-01 J01MB07 2.16.840.1.113883.6.73 2017-01 J01MB08 2.16.840.1.113883.6.73 2017-01 J01R COMBINATIONS OF ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01RA Combinations of antibacterials 2.16.840.1.113883.6.73 2017-01 J01RA01 penicillins, combinations with other antibacterials 2.16.840.1.113883.6.73 2017-01 J01RA02 sulfonamides, combinations with other antibacterials (excl. trimethoprim) 2.16.840.1.113883.6.73 2017-01 J01RA03 cefuroxime and metronidazole 2.16.840.1.113883.6.73 2017-01 J01RA04 spiramycin and metronidazole 2.16.840.1.113883.6.73 2017-01 J01RA05 levofloxacin and ornidazole 2.16.840.1.113883.6.73 2017-01 J01RA06 cefepime and amikacin 2.16.840.1.113883.6.73 2017-01 J01RA07 azithromycin, fluconazole and 2.16.840.1.113883.6.73 2017-01 J01RA08 tetracycline and oleandomycin 2.16.840.1.113883.6.73 2017-01 J01RA09 ofloxacin and ornidazole 2.16.840.1.113883.6.73 2017-01 J01RA10 ciprofloxacin and metronidazole 2.16.840.1.113883.6.73 2017-01 J01RA11 ciprofloxacin and tinidazole 2.16.840.1.113883.6.73 2017-01 J01RA12 ciprofloxacin and ornidazole 2.16.840.1.113883.6.73 2017-01 J01RA13 norfloxacin and tinidazole 2.16.840.1.113883.6.73 2017-01 J01X OTHER ANTIBACTERIALS 2.16.840.1.113883.6.73 2017-01 J01XA Glycopeptide antibacterials 2.16.840.1.113883.6.73 2017-01 J01XA01 vancomycin 2.16.840.1.113883.6.73 2017-01 J01XA02 teicoplanin 2.16.840.1.113883.6.73 2017-01 J01XA03 telavancin 2.16.840.1.113883.6.73 2017-01 J01XA04 dalbavancin 2.16.840.1.113883.6.73 2017-01 J01XA05 oritavancin 2.16.840.1.113883.6.73 2017-01 J01XB Polymyxins 2.16.840.1.113883.6.73 2017-01 J01XB01 colistin 2.16.840.1.113883.6.73 2017-01 J01XB02 polymyxin B 2.16.840.1.113883.6.73 2017-01 J01XC Steroid antibacterials 2.16.840.1.113883.6.73 2017-01 J01XC01 fusidic acid 2.16.840.1.113883.6.73 2017-01 J01XD Imidazole derivatives 2.16.840.1.113883.6.73 2017-01 J01XD01 metronidazole 2.16.840.1.113883.6.73 2017-01 J01XD02 tinidazole 2.16.840.1.113883.6.73 2017-01 J01XD03 ornidazole 2.16.840.1.113883.6.73 2017-01 J01XE Nitrofuran derivatives 2.16.840.1.113883.6.73 2017-01 J01XE01 2.16.840.1.113883.6.73 2017-01 J01XE02 2.16.840.1.113883.6.73 2017-01 J01XE03 furazidin 2.16.840.1.113883.6.73 2017-01 J01XE51 nitrofurantoin, combinations 2.16.840.1.113883.6.73 2017-01 J01XX Other antibacterials

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 75 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J01XX01 fosfomycin 2.16.840.1.113883.6.73 2017-01 J01XX02 xibornol 2.16.840.1.113883.6.73 2017-01 J01XX03 clofoctol 2.16.840.1.113883.6.73 2017-01 J01XX04 spectinomycin 2.16.840.1.113883.6.73 2017-01 J01XX05 methenamine 2.16.840.1.113883.6.73 2017-01 J01XX06 mandelic acid 2.16.840.1.113883.6.73 2017-01 J01XX07 nitroxoline 2.16.840.1.113883.6.73 2017-01 J01XX08 2.16.840.1.113883.6.73 2017-01 J01XX09 daptomycin 2.16.840.1.113883.6.73 2017-01 J01XX10 bacitracin 2.16.840.1.113883.6.73 2017-01 J01XX11 tedizolid 2.16.840.1.113883.6.73 2017-01 J02 ANTIMYCOTICS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 J02A ANTIMYCOTICS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 J02AA Antibiotics 2.16.840.1.113883.6.73 2017-01 J02AA01 amphotericin B 2.16.840.1.113883.6.73 2017-01 J02AA02 hachimycin 2.16.840.1.113883.6.73 2017-01 J02AB Imidazole derivatives 2.16.840.1.113883.6.73 2017-01 J02AB01 miconazole 2.16.840.1.113883.6.73 2017-01 J02AB02 ketoconazole 2.16.840.1.113883.6.73 2017-01 J02AC Triazole derivatives 2.16.840.1.113883.6.73 2017-01 J02AC01 fluconazole 2.16.840.1.113883.6.73 2017-01 J02AC02 2.16.840.1.113883.6.73 2017-01 J02AC03 2.16.840.1.113883.6.73 2017-01 J02AC04 2.16.840.1.113883.6.73 2017-01 J02AC05 isavuconazole 2.16.840.1.113883.6.73 2017-01 J02AX Other antimycotics for systemic use 2.16.840.1.113883.6.73 2017-01 J02AX01 flucytosine 2.16.840.1.113883.6.73 2017-01 J02AX04 2.16.840.1.113883.6.73 2017-01 J02AX05 2.16.840.1.113883.6.73 2017-01 J02AX06 2.16.840.1.113883.6.73 2017-01 J04 2.16.840.1.113883.6.73 2017-01 J04A DRUGS FOR TREATMENT OF 2.16.840.1.113883.6.73 2017-01 J04AA Aminosalicylic acid and derivatives 2.16.840.1.113883.6.73 2017-01 J04AA01 4-aminosalicylic acid 2.16.840.1.113883.6.73 2017-01 J04AA02 sodium 2.16.840.1.113883.6.73 2017-01 J04AA03 calcium aminosalicylate 2.16.840.1.113883.6.73 2017-01 J04AB Antibiotics 2.16.840.1.113883.6.73 2017-01 J04AB01 2.16.840.1.113883.6.73 2017-01 J04AB02 2.16.840.1.113883.6.73 2017-01 J04AB03 2.16.840.1.113883.6.73 2017-01 J04AB04 2.16.840.1.113883.6.73 2017-01 J04AB05 2.16.840.1.113883.6.73 2017-01 J04AB30 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 76 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J04AC 2.16.840.1.113883.6.73 2017-01 J04AC01 2.16.840.1.113883.6.73 2017-01 J04AC51 isoniazid, combinations 2.16.840.1.113883.6.73 2017-01 J04AD Thiocarbamide derivatives 2.16.840.1.113883.6.73 2017-01 J04AD01 protionamide 2.16.840.1.113883.6.73 2017-01 J04AD02 tiocarlide 2.16.840.1.113883.6.73 2017-01 J04AD03 2.16.840.1.113883.6.73 2017-01 J04AK Other drugs for treatment of tuberculosis 2.16.840.1.113883.6.73 2017-01 J04AK01 2.16.840.1.113883.6.73 2017-01 J04AK02 2.16.840.1.113883.6.73 2017-01 J04AK03 2.16.840.1.113883.6.73 2017-01 J04AK04 2.16.840.1.113883.6.73 2017-01 J04AK05 2.16.840.1.113883.6.73 2017-01 J04AK06 2.16.840.1.113883.6.73 2017-01 J04AK07 2.16.840.1.113883.6.73 2017-01 J04AM Combinations of drugs for treatment of tuberculosis 2.16.840.1.113883.6.73 2017-01 J04AM01 streptomycin and isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM02 rifampicin and isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM03 ethambutol and isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM04 thioacetazone and isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM05 rifampicin, pyrazinamide and isoniazid 2.16.840.1.113883.6.73 2017-01 J04AM06 rifampicin, pyrazinamide, ethambutol and isoniazid 2.16.840.1.113883.6.73 2017-01 J04B DRUGS FOR TREATMENT OF LEPRA 2.16.840.1.113883.6.73 2017-01 J04BA Drugs for treatment of lepra 2.16.840.1.113883.6.73 2017-01 J04BA01 2.16.840.1.113883.6.73 2017-01 J04BA02 dapsone 2.16.840.1.113883.6.73 2017-01 J04BA03 aldesulfone sodium 2.16.840.1.113883.6.73 2017-01 J05 ANTIVIRALS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 J05A DIRECT ACTING ANTIVIRALS 2.16.840.1.113883.6.73 2017-01 J05AA Thiosemicarbazones 2.16.840.1.113883.6.73 2017-01 J05AA01 metisazone 2.16.840.1.113883.6.73 2017-01 J05AB and excl. reverse transcriptase inhibitors 2.16.840.1.113883.6.73 2017-01 J05AB01 aciclovir 2.16.840.1.113883.6.73 2017-01 J05AB02 idoxuridine 2.16.840.1.113883.6.73 2017-01 J05AB03 vidarabine 2.16.840.1.113883.6.73 2017-01 J05AB04 ribavirin 2.16.840.1.113883.6.73 2017-01 J05AB06 ganciclovir 2.16.840.1.113883.6.73 2017-01 J05AB09 famciclovir 2.16.840.1.113883.6.73 2017-01 J05AB11 valaciclovir 2.16.840.1.113883.6.73 2017-01 J05AB12 cidofovir 2.16.840.1.113883.6.73 2017-01 J05AB13 penciclovir 2.16.840.1.113883.6.73 2017-01 J05AB14 valganciclovir

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 77 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J05AB15 brivudine 2.16.840.1.113883.6.73 2017-01 J05AC Cyclic amines 2.16.840.1.113883.6.73 2017-01 J05AC02 2.16.840.1.113883.6.73 2017-01 J05AC03 tromantadine 2.16.840.1.113883.6.73 2017-01 J05AD Phosphonic acid derivatives 2.16.840.1.113883.6.73 2017-01 J05AD01 foscarnet 2.16.840.1.113883.6.73 2017-01 J05AD02 fosfonet 2.16.840.1.113883.6.73 2017-01 J05AE Protease inhibitors 2.16.840.1.113883.6.73 2017-01 J05AE01 saquinavir 2.16.840.1.113883.6.73 2017-01 J05AE02 indinavir 2.16.840.1.113883.6.73 2017-01 J05AE03 ritonavir 2.16.840.1.113883.6.73 2017-01 J05AE04 nelfinavir 2.16.840.1.113883.6.73 2017-01 J05AE05 amprenavir 2.16.840.1.113883.6.73 2017-01 J05AE07 fosamprenavir 2.16.840.1.113883.6.73 2017-01 J05AE08 atazanavir 2.16.840.1.113883.6.73 2017-01 J05AE09 tipranavir 2.16.840.1.113883.6.73 2017-01 J05AE10 darunavir 2.16.840.1.113883.6.73 2017-01 J05AE11 telaprevir 2.16.840.1.113883.6.73 2017-01 J05AE12 boceprevir 2.16.840.1.113883.6.73 2017-01 J05AE13 faldaprevir 2.16.840.1.113883.6.73 2017-01 J05AE14 simeprevir 2.16.840.1.113883.6.73 2017-01 J05AE15 asunaprevir 2.16.840.1.113883.6.73 2017-01 J05AF and reverse transcriptase inhibitors 2.16.840.1.113883.6.73 2017-01 J05AF01 zidovudine 2.16.840.1.113883.6.73 2017-01 J05AF02 didanosine 2.16.840.1.113883.6.73 2017-01 J05AF03 zalcitabine 2.16.840.1.113883.6.73 2017-01 J05AF04 stavudine 2.16.840.1.113883.6.73 2017-01 J05AF05 lamivudine 2.16.840.1.113883.6.73 2017-01 J05AF06 abacavir 2.16.840.1.113883.6.73 2017-01 J05AF07 tenofovir disoproxil 2.16.840.1.113883.6.73 2017-01 J05AF08 adefovir dipivoxil 2.16.840.1.113883.6.73 2017-01 J05AF09 emtricitabine 2.16.840.1.113883.6.73 2017-01 J05AF10 entecavir 2.16.840.1.113883.6.73 2017-01 J05AF11 telbivudine 2.16.840.1.113883.6.73 2017-01 J05AF12 clevudine 2.16.840.1.113883.6.73 2017-01 J05AF13 tenofovir alafenamide 2.16.840.1.113883.6.73 2017-01 J05AG Non-nucleoside reverse transcriptase inhibitors 2.16.840.1.113883.6.73 2017-01 J05AG01 nevirapine 2.16.840.1.113883.6.73 2017-01 J05AG02 delavirdine 2.16.840.1.113883.6.73 2017-01 J05AG03 2.16.840.1.113883.6.73 2017-01 J05AG04 etravirine 2.16.840.1.113883.6.73 2017-01 J05AG05 rilpivirine 2.16.840.1.113883.6.73 2017-01 J05AH Neuraminidase inhibitors © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 78 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J05AH01 zanamivir 2.16.840.1.113883.6.73 2017-01 J05AH02 oseltamivir 2.16.840.1.113883.6.73 2017-01 J05AR Antivirals for treatment of HIV , combinations 2.16.840.1.113883.6.73 2017-01 J05AR01 zidovudine and lamivudine 2.16.840.1.113883.6.73 2017-01 J05AR02 lamivudine and abacavir 2.16.840.1.113883.6.73 2017-01 J05AR03 tenofovir disoproxil and emtricitabine 2.16.840.1.113883.6.73 2017-01 J05AR04 zidovudine, lamivudine and abacavir 2.16.840.1.113883.6.73 2017-01 J05AR05 zidovudine, lamivudine and nevirapine 2.16.840.1.113883.6.73 2017-01 J05AR06 emtricitabine, tenofovir disoproxil and efavirenz 2.16.840.1.113883.6.73 2017-01 J05AR07 stavudine, lamivudine and nevirapine 2.16.840.1.113883.6.73 2017-01 J05AR08 emtricitabine, tenofovir disoproxil and rilpivirine 2.16.840.1.113883.6.73 2017-01 J05AR09 emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat 2.16.840.1.113883.6.73 2017-01 J05AR10 lopinavir and ritonavir 2.16.840.1.113883.6.73 2017-01 J05AR11 lamivudine, tenofovir disoproxil and efavirenz 2.16.840.1.113883.6.73 2017-01 J05AR12 lamivudine and tenofovir disoproxil 2.16.840.1.113883.6.73 2017-01 J05AR13 lamivudine, abacavir and dolutegravir 2.16.840.1.113883.6.73 2017-01 J05AR14 darunavir and cobicistat 2.16.840.1.113883.6.73 2017-01 J05AR15 atazanavir and cobicistat 2.16.840.1.113883.6.73 2017-01 J05AR16 lamivudine and raltegravir 2.16.840.1.113883.6.73 2017-01 J05AR17 emtricitabine and tenofovir alafenamide 2.16.840.1.113883.6.73 2017-01 J05AR18 emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat 2.16.840.1.113883.6.73 2017-01 J05AR19 emtricitabine, tenofovir alafenamide and rilpivirine 2.16.840.1.113883.6.73 2017-01 J05AX Other antivirals 2.16.840.1.113883.6.73 2017-01 J05AX01 moroxydine 2.16.840.1.113883.6.73 2017-01 J05AX02 lysozyme 2.16.840.1.113883.6.73 2017-01 J05AX05 inosine pranobex 2.16.840.1.113883.6.73 2017-01 J05AX06 pleconaril 2.16.840.1.113883.6.73 2017-01 J05AX07 enfuvirtide 2.16.840.1.113883.6.73 2017-01 J05AX08 raltegravir 2.16.840.1.113883.6.73 2017-01 J05AX09 maraviroc 2.16.840.1.113883.6.73 2017-01 J05AX10 maribavir 2.16.840.1.113883.6.73 2017-01 J05AX11 elvitegravir 2.16.840.1.113883.6.73 2017-01 J05AX12 dolutegravir 2.16.840.1.113883.6.73 2017-01 J05AX13 umifenovir 2.16.840.1.113883.6.73 2017-01 J05AX14 daclatasvir 2.16.840.1.113883.6.73 2017-01 J05AX15 sofosbuvir 2.16.840.1.113883.6.73 2017-01 J05AX16 dasabuvir 2.16.840.1.113883.6.73 2017-01 J05AX65 sofosbuvir and ledipasvir 2.16.840.1.113883.6.73 2017-01 J05AX66 dasabuvir, ombitasvir, paritaprevir and ritonavir 2.16.840.1.113883.6.73 2017-01 J05AX67 ombitasvir, paritaprevir and ritonavir 2.16.840.1.113883.6.73 2017-01 J05AX68 elbasvir and grazoprevir 2.16.840.1.113883.6.73 2017-01 J06 IMMUNE SERA AND IMMUNOGLOBULINS 2.16.840.1.113883.6.73 2017-01 J06A IMMUNE SERA © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 79 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J06AA Immune sera 2.16.840.1.113883.6.73 2017-01 J06AA01 antitoxin 2.16.840.1.113883.6.73 2017-01 J06AA02 antitoxin 2.16.840.1.113883.6.73 2017-01 J06AA03 snake venom 2.16.840.1.113883.6.73 2017-01 J06AA04 botulinum antitoxin 2.16.840.1.113883.6.73 2017-01 J06AA05 gas-gangrene sera 2.16.840.1.113883.6.73 2017-01 J06AA06 serum 2.16.840.1.113883.6.73 2017-01 J06B IMMUNOGLOBULINS 2.16.840.1.113883.6.73 2017-01 J06BA Immunoglobulins, normal human 2.16.840.1.113883.6.73 2017-01 J06BA01 immunoglobulins, normal human, for extravascular adm. 2.16.840.1.113883.6.73 2017-01 J06BA02 immunoglobulins, normal human, for intravascular adm. 2.16.840.1.113883.6.73 2017-01 J06BB Specific immunoglobulins 2.16.840.1.113883.6.73 2017-01 J06BB01 anti-D (rh) immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB02 tetanus immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB03 varicella/zoster immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB04 hepatitis B immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB05 rabies immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB06 immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB07 immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB08 staphylococcus immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB09 cytomegalovirus immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB10 diphtheria immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB11 hepatitis A immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB12 encephalitis, tick borne immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB13 pertussis immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB14 immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB15 mumps immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB16 2.16.840.1.113883.6.73 2017-01 J06BB17 2.16.840.1.113883.6.73 2017-01 J06BB18 2.16.840.1.113883.6.73 2017-01 J06BB19 immunoglobulin 2.16.840.1.113883.6.73 2017-01 J06BB21 2.16.840.1.113883.6.73 2017-01 J06BB30 combinations 2.16.840.1.113883.6.73 2017-01 J06BC Other immunoglobulins 2.16.840.1.113883.6.73 2017-01 J06BC01 2.16.840.1.113883.6.73 2017-01 J07 2.16.840.1.113883.6.73 2017-01 J07A BACTERIAL VACCINES 2.16.840.1.113883.6.73 2017-01 J07AC Anthrax vaccines 2.16.840.1.113883.6.73 2017-01 J07AC01 anthrax 2.16.840.1.113883.6.73 2017-01 J07AD Brucellosis vaccines 2.16.840.1.113883.6.73 2017-01 J07AD01 brucella antigen 2.16.840.1.113883.6.73 2017-01 J07AE Cholera vaccines 2.16.840.1.113883.6.73 2017-01 J07AE01 cholera, inactivated, whole cell © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 80 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07AE02 cholera, live attenuated 2.16.840.1.113883.6.73 2017-01 J07AE51 cholera, combinations with typhoid , inactivated, whole cell 2.16.840.1.113883.6.73 2017-01 J07AF Diphtheria vaccines 2.16.840.1.113883.6.73 2017-01 J07AF01 diphtheria toxoid 2.16.840.1.113883.6.73 2017-01 J07AG Hemophilus influenzae B vaccines 2.16.840.1.113883.6.73 2017-01 J07AG01 hemophilus influenzae B, purified antigen conjugated 2.16.840.1.113883.6.73 2017-01 J07AG51 hemophilus influenzae B, combinations with toxoids 2.16.840.1.113883.6.73 2017-01 J07AG52 hemophilus influenzae B, combinations with pertussis and toxoids 2.16.840.1.113883.6.73 2017-01 J07AG53 hemophilus influenzae B, combinations with meningococcus C, conjugated 2.16.840.1.113883.6.73 2017-01 J07AH Meningococcal vaccines 2.16.840.1.113883.6.73 2017-01 J07AH01 meningococcus A, purified polysaccharides antigen 2.16.840.1.113883.6.73 2017-01 J07AH02 other meningococcal monovalent purified polysaccharides antigen 2.16.840.1.113883.6.73 2017-01 J07AH03 meningococcus A,C, bivalent purified polysaccharides antigen 2.16.840.1.113883.6.73 2017-01 J07AH04 meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen 2.16.840.1.113883.6.73 2017-01 J07AH05 other meningococcal polyvalent purified polysaccharides antigen 2.16.840.1.113883.6.73 2017-01 J07AH06 meningococcus B, outer membrane vesicle vaccine 2.16.840.1.113883.6.73 2017-01 J07AH07 meningococcus C, purified polysaccharides antigen conjugated 2.16.840.1.113883.6.73 2017-01 J07AH08 meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated 2.16.840.1.113883.6.73 2017-01 J07AH09 meningococcus B, multicomponent vaccine 2.16.840.1.113883.6.73 2017-01 J07AH10 meningococcus A, purified polysaccharides antigen conjugated 2.16.840.1.113883.6.73 2017-01 J07AJ Pertussis vaccines 2.16.840.1.113883.6.73 2017-01 J07AJ01 pertussis, inactivated, whole cell 2.16.840.1.113883.6.73 2017-01 J07AJ02 pertussis, purified antigen 2.16.840.1.113883.6.73 2017-01 J07AJ51 pertussis, inactivated, whole cell, combinations with toxoids 2.16.840.1.113883.6.73 2017-01 J07AJ52 pertussis, purified antigen, combinations with toxoids 2.16.840.1.113883.6.73 2017-01 J07AK Plague vaccines 2.16.840.1.113883.6.73 2017-01 J07AK01 plague, inactivated, whole cell 2.16.840.1.113883.6.73 2017-01 J07AL Pneumococcal vaccines 2.16.840.1.113883.6.73 2017-01 J07AL01 pneumococcus, purified polysaccharides antigen 2.16.840.1.113883.6.73 2017-01 J07AL02 pneumococcus, purified polysaccharides antigen conjugated 2.16.840.1.113883.6.73 2017-01 J07AL52 pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated 2.16.840.1.113883.6.73 2017-01 J07AM Tetanus vaccines 2.16.840.1.113883.6.73 2017-01 J07AM01 tetanus toxoid 2.16.840.1.113883.6.73 2017-01 J07AM51 tetanus toxoid, combinations with diphtheria toxoid 2.16.840.1.113883.6.73 2017-01 J07AM52 tetanus toxoid, combinations with tetanus immunoglobulin 2.16.840.1.113883.6.73 2017-01 J07AN Tuberculosis vaccines 2.16.840.1.113883.6.73 2017-01 J07AN01 tuberculosis, live attenuated 2.16.840.1.113883.6.73 2017-01 J07AP Typhoid vaccines

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 81 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07AP01 typhoid, oral, live attenuated 2.16.840.1.113883.6.73 2017-01 J07AP02 typhoid, inactivated, whole cell 2.16.840.1.113883.6.73 2017-01 J07AP03 typhoid, purified polysaccharide antigen 2.16.840.1.113883.6.73 2017-01 J07AP10 typhoid, combinations with paratyphi types 2.16.840.1.113883.6.73 2017-01 J07AR Typhus (exanthematicus) vaccines 2.16.840.1.113883.6.73 2017-01 J07AR01 typhus exanthematicus, inactivated, whole cell 2.16.840.1.113883.6.73 2017-01 J07AX Other bacterial vaccines 2.16.840.1.113883.6.73 2017-01 J07B VIRAL VACCINES 2.16.840.1.113883.6.73 2017-01 J07BA Encephalitis vaccines 2.16.840.1.113883.6.73 2017-01 J07BA01 encephalitis, tick borne, inactivated, whole virus 2.16.840.1.113883.6.73 2017-01 J07BA02 encephalitis, Japanese, inactivated, whole virus 2.16.840.1.113883.6.73 2017-01 J07BA03 encephalitis, Japanese, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BB Influenza vaccines 2.16.840.1.113883.6.73 2017-01 J07BB01 influenza, inactivated, whole virus 2.16.840.1.113883.6.73 2017-01 J07BB02 influenza, inactivated, split virus or surface antigen 2.16.840.1.113883.6.73 2017-01 J07BB03 influenza, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BC Hepatitis vaccines 2.16.840.1.113883.6.73 2017-01 J07BC01 hepatitis B, purified antigen 2.16.840.1.113883.6.73 2017-01 J07BC02 hepatitis A, inactivated, whole virus 2.16.840.1.113883.6.73 2017-01 J07BC20 combinations 2.16.840.1.113883.6.73 2017-01 J07BD Measles vaccines 2.16.840.1.113883.6.73 2017-01 J07BD01 measles, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BD51 measles, combinations with mumps, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BD52 measles, combinations with mumps and rubella, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BD53 measles, combinations with rubella, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BD54 measles, combinations with mumps, rubella and varicella, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BE Mumps vaccines 2.16.840.1.113883.6.73 2017-01 J07BE01 mumps, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BF Poliomyelitis vaccines 2.16.840.1.113883.6.73 2017-01 J07BF01 poliomyelitis oral, monovalent, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BF02 poliomyelitis oral, trivalent, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BF03 poliomyelitis, trivalent, inactivated, whole virus 2.16.840.1.113883.6.73 2017-01 J07BF04 poliomyelitis oral, bivalent, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BG Rabies vaccines 2.16.840.1.113883.6.73 2017-01 J07BG01 rabies, inactivated, whole virus 2.16.840.1.113883.6.73 2017-01 J07BH Rota virus diarrhea vaccines 2.16.840.1.113883.6.73 2017-01 J07BH01 rota virus, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BH02 rota virus, pentavalent, live, reassorted 2.16.840.1.113883.6.73 2017-01 J07BJ Rubella vaccines 2.16.840.1.113883.6.73 2017-01 J07BJ01 rubella, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BJ51 rubella, combinations with mumps, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BK Varicella zoster vaccines

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 82 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 J07BK01 varicella, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BK02 zoster, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BL Yellow fever vaccines 2.16.840.1.113883.6.73 2017-01 J07BL01 yellow fever, live attenuated 2.16.840.1.113883.6.73 2017-01 J07BM Papillomavirus vaccines 2.16.840.1.113883.6.73 2017-01 J07BM01 papillomavirus (human types 6, 11, 16, 18) 2.16.840.1.113883.6.73 2017-01 J07BM02 papillomavirus (human types 16, 18) 2.16.840.1.113883.6.73 2017-01 J07BM03 papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) 2.16.840.1.113883.6.73 2017-01 J07BX Other viral vaccines 2.16.840.1.113883.6.73 2017-01 J07BX01 smallpox, live attenuated 2.16.840.1.113883.6.73 2017-01 J07C BACTERIAL AND VIRAL VACCINES, COMBINED 2.16.840.1.113883.6.73 2017-01 J07CA Bacterial and viral vaccines, combined 2.16.840.1.113883.6.73 2017-01 J07CA01 diphtheria-poliomyelitis-tetanus 2.16.840.1.113883.6.73 2017-01 J07CA02 diphtheria-pertussis-poliomyelitis-tetanus 2.16.840.1.113883.6.73 2017-01 J07CA03 diphtheria-rubella-tetanus 2.16.840.1.113883.6.73 2017-01 J07CA04 hemophilus influenzae B and poliomyelitis 2.16.840.1.113883.6.73 2017-01 J07CA05 diphtheria-hepatitis B-pertussis-tetanus 2.16.840.1.113883.6.73 2017-01 J07CA06 diphtheria-hemophilus influenzae B-pertussis-poliomyelitis- tetanus 2.16.840.1.113883.6.73 2017-01 J07CA07 diphtheria-hepatitis B-tetanus 2.16.840.1.113883.6.73 2017-01 J07CA08 hemophilus influenzae B and hepatitis B 2.16.840.1.113883.6.73 2017-01 J07CA09 diphtheria-hemophilus influenzae B-pertussis-poliomyelitis- tetanus-hepatitis B 2.16.840.1.113883.6.73 2017-01 J07CA10 typhoid-hepatitis A 2.16.840.1.113883.6.73 2017-01 J07CA11 diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B 2.16.840.1.113883.6.73 2017-01 J07CA12 diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B 2.16.840.1.113883.6.73 2017-01 J07CA13 diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C 2.16.840.1.113883.6.73 2017-01 J07X OTHER VACCINES 2.16.840.1.113883.6.73 2017-01 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS 2.16.840.1.113883.6.73 2017-01 L01 ANTINEOPLASTIC AGENTS 2.16.840.1.113883.6.73 2017-01 L01A ALKYLATING AGENTS 2.16.840.1.113883.6.73 2017-01 L01AA mustard analogues 2.16.840.1.113883.6.73 2017-01 L01AA01 cyclophosphamide 2.16.840.1.113883.6.73 2017-01 L01AA02 chlorambucil 2.16.840.1.113883.6.73 2017-01 L01AA03 melphalan 2.16.840.1.113883.6.73 2017-01 L01AA05 chlormethine 2.16.840.1.113883.6.73 2017-01 L01AA06 ifosfamide 2.16.840.1.113883.6.73 2017-01 L01AA07 trofosfamide 2.16.840.1.113883.6.73 2017-01 L01AA08 2.16.840.1.113883.6.73 2017-01 L01AA09 bendamustine 2.16.840.1.113883.6.73 2017-01 L01AB Alkyl sulfonates 2.16.840.1.113883.6.73 2017-01 L01AB01 busulfan 2.16.840.1.113883.6.73 2017-01 L01AB02 treosulfan

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 83 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01AB03 mannosulfan 2.16.840.1.113883.6.73 2017-01 L01AC imines 2.16.840.1.113883.6.73 2017-01 L01AC01 thiotepa 2.16.840.1.113883.6.73 2017-01 L01AC02 triaziquone 2.16.840.1.113883.6.73 2017-01 L01AC03 carboquone 2.16.840.1.113883.6.73 2017-01 L01AD Nitrosoureas 2.16.840.1.113883.6.73 2017-01 L01AD01 carmustine 2.16.840.1.113883.6.73 2017-01 L01AD02 lomustine 2.16.840.1.113883.6.73 2017-01 L01AD03 semustine 2.16.840.1.113883.6.73 2017-01 L01AD04 streptozocin 2.16.840.1.113883.6.73 2017-01 L01AD05 fotemustine 2.16.840.1.113883.6.73 2017-01 L01AD06 nimustine 2.16.840.1.113883.6.73 2017-01 L01AD07 ranimustine 2.16.840.1.113883.6.73 2017-01 L01AG Epoxides 2.16.840.1.113883.6.73 2017-01 L01AG01 etoglucid 2.16.840.1.113883.6.73 2017-01 L01AX Other alkylating agents 2.16.840.1.113883.6.73 2017-01 L01AX01 mitobronitol 2.16.840.1.113883.6.73 2017-01 L01AX02 pipobroman 2.16.840.1.113883.6.73 2017-01 L01AX03 temozolomide 2.16.840.1.113883.6.73 2017-01 L01AX04 dacarbazine 2.16.840.1.113883.6.73 2017-01 L01B 2.16.840.1.113883.6.73 2017-01 L01BA Folic acid analogues 2.16.840.1.113883.6.73 2017-01 L01BA01 2.16.840.1.113883.6.73 2017-01 L01BA03 raltitrexed 2.16.840.1.113883.6.73 2017-01 L01BA04 2.16.840.1.113883.6.73 2017-01 L01BA05 2.16.840.1.113883.6.73 2017-01 L01BB Purine analogues 2.16.840.1.113883.6.73 2017-01 L01BB02 mercaptopurine 2.16.840.1.113883.6.73 2017-01 L01BB03 tioguanine 2.16.840.1.113883.6.73 2017-01 L01BB04 2.16.840.1.113883.6.73 2017-01 L01BB05 fludarabine 2.16.840.1.113883.6.73 2017-01 L01BB06 clofarabine 2.16.840.1.113883.6.73 2017-01 L01BB07 nelarabine 2.16.840.1.113883.6.73 2017-01 L01BC Pyrimidine analogues 2.16.840.1.113883.6.73 2017-01 L01BC01 cytarabine 2.16.840.1.113883.6.73 2017-01 L01BC02 fluorouracil 2.16.840.1.113883.6.73 2017-01 L01BC03 tegafur 2.16.840.1.113883.6.73 2017-01 L01BC04 carmofur 2.16.840.1.113883.6.73 2017-01 L01BC05 gemcitabine 2.16.840.1.113883.6.73 2017-01 L01BC06 capecitabine 2.16.840.1.113883.6.73 2017-01 L01BC07 azacitidine 2.16.840.1.113883.6.73 2017-01 L01BC08 decitabine 2.16.840.1.113883.6.73 2017-01 L01BC52 fluorouracil, combinations © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 84 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01BC53 tegafur, combinations 2.16.840.1.113883.6.73 2017-01 L01BC59 trifluridine, combinations 2.16.840.1.113883.6.73 2017-01 L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS 2.16.840.1.113883.6.73 2017-01 L01CA Vinca alkaloids and analogues 2.16.840.1.113883.6.73 2017-01 L01CA01 vinblastine 2.16.840.1.113883.6.73 2017-01 L01CA02 vincristine 2.16.840.1.113883.6.73 2017-01 L01CA03 vindesine 2.16.840.1.113883.6.73 2017-01 L01CA04 vinorelbine 2.16.840.1.113883.6.73 2017-01 L01CA05 vinflunine 2.16.840.1.113883.6.73 2017-01 L01CA06 vintafolide 2.16.840.1.113883.6.73 2017-01 L01CB Podophyllotoxin derivatives 2.16.840.1.113883.6.73 2017-01 L01CB01 etoposide 2.16.840.1.113883.6.73 2017-01 L01CB02 teniposide 2.16.840.1.113883.6.73 2017-01 L01CC Colchicine derivatives 2.16.840.1.113883.6.73 2017-01 L01CC01 demecolcine 2.16.840.1.113883.6.73 2017-01 L01CD Taxanes 2.16.840.1.113883.6.73 2017-01 L01CD01 paclitaxel 2.16.840.1.113883.6.73 2017-01 L01CD02 docetaxel 2.16.840.1.113883.6.73 2017-01 L01CD03 paclitaxel poliglumex 2.16.840.1.113883.6.73 2017-01 L01CD04 cabazitaxel 2.16.840.1.113883.6.73 2017-01 L01CX Other plant alkaloids and natural products 2.16.840.1.113883.6.73 2017-01 L01CX01 trabectedin 2.16.840.1.113883.6.73 2017-01 L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES 2.16.840.1.113883.6.73 2017-01 L01DA Actinomycines 2.16.840.1.113883.6.73 2017-01 L01DA01 dactinomycin 2.16.840.1.113883.6.73 2017-01 L01DB Anthracyclines and related substances 2.16.840.1.113883.6.73 2017-01 L01DB01 doxorubicin 2.16.840.1.113883.6.73 2017-01 L01DB02 daunorubicin 2.16.840.1.113883.6.73 2017-01 L01DB03 epirubicin 2.16.840.1.113883.6.73 2017-01 L01DB04 aclarubicin 2.16.840.1.113883.6.73 2017-01 L01DB05 zorubicin 2.16.840.1.113883.6.73 2017-01 L01DB06 idarubicin 2.16.840.1.113883.6.73 2017-01 L01DB07 mitoxantrone 2.16.840.1.113883.6.73 2017-01 L01DB08 pirarubicin 2.16.840.1.113883.6.73 2017-01 L01DB09 valrubicin 2.16.840.1.113883.6.73 2017-01 L01DB10 amrubicin 2.16.840.1.113883.6.73 2017-01 L01DB11 pixantrone 2.16.840.1.113883.6.73 2017-01 L01DC Other cytotoxic antibiotics 2.16.840.1.113883.6.73 2017-01 L01DC01 bleomycin 2.16.840.1.113883.6.73 2017-01 L01DC02 plicamycin 2.16.840.1.113883.6.73 2017-01 L01DC03 mitomycin 2.16.840.1.113883.6.73 2017-01 L01DC04 ixabepilone 2.16.840.1.113883.6.73 2017-01 L01X OTHER ANTINEOPLASTIC AGENTS © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 85 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01XA Platinum compounds 2.16.840.1.113883.6.73 2017-01 L01XA01 cisplatin 2.16.840.1.113883.6.73 2017-01 L01XA02 carboplatin 2.16.840.1.113883.6.73 2017-01 L01XA03 oxaliplatin 2.16.840.1.113883.6.73 2017-01 L01XA04 satraplatin 2.16.840.1.113883.6.73 2017-01 L01XA05 polyplatillen 2.16.840.1.113883.6.73 2017-01 L01XB Methylhydrazines 2.16.840.1.113883.6.73 2017-01 L01XB01 2.16.840.1.113883.6.73 2017-01 L01XC Monoclonal 2.16.840.1.113883.6.73 2017-01 L01XC01 edrecolomab 2.16.840.1.113883.6.73 2017-01 L01XC02 2.16.840.1.113883.6.73 2017-01 L01XC03 2.16.840.1.113883.6.73 2017-01 L01XC05 gemtuzumab 2.16.840.1.113883.6.73 2017-01 L01XC06 2.16.840.1.113883.6.73 2017-01 L01XC07 2.16.840.1.113883.6.73 2017-01 L01XC08 2.16.840.1.113883.6.73 2017-01 L01XC09 catumaxomab 2.16.840.1.113883.6.73 2017-01 L01XC10 ofatumumab 2.16.840.1.113883.6.73 2017-01 L01XC11 2.16.840.1.113883.6.73 2017-01 L01XC12 brentuximab vedotin 2.16.840.1.113883.6.73 2017-01 L01XC13 2.16.840.1.113883.6.73 2017-01 L01XC14 2.16.840.1.113883.6.73 2017-01 L01XC15 2.16.840.1.113883.6.73 2017-01 L01XC16 dinutuximab 2.16.840.1.113883.6.73 2017-01 L01XC17 2.16.840.1.113883.6.73 2017-01 L01XC18 2.16.840.1.113883.6.73 2017-01 L01XC19 blinatumomab 2.16.840.1.113883.6.73 2017-01 L01XC21 2.16.840.1.113883.6.73 2017-01 L01XC22 2.16.840.1.113883.6.73 2017-01 L01XC23 elotuzumab 2.16.840.1.113883.6.73 2017-01 L01XC24 daratumumab 2.16.840.1.113883.6.73 2017-01 L01XC25 2.16.840.1.113883.6.73 2017-01 L01XC26 inotuzumab ozogamicin 2.16.840.1.113883.6.73 2017-01 L01XD Sensitizers used in photodynamic/radiation therapy 2.16.840.1.113883.6.73 2017-01 L01XD01 porfimer sodium 2.16.840.1.113883.6.73 2017-01 L01XD03 methyl aminolevulinate 2.16.840.1.113883.6.73 2017-01 L01XD04 aminolevulinic acid 2.16.840.1.113883.6.73 2017-01 L01XD05 temoporfin 2.16.840.1.113883.6.73 2017-01 L01XD06 efaproxiral 2.16.840.1.113883.6.73 2017-01 L01XE Protein kinase inhibitors 2.16.840.1.113883.6.73 2017-01 L01XE01 2.16.840.1.113883.6.73 2017-01 L01XE02 2.16.840.1.113883.6.73 2017-01 L01XE03 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 86 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01XE04 2.16.840.1.113883.6.73 2017-01 L01XE05 2.16.840.1.113883.6.73 2017-01 L01XE06 2.16.840.1.113883.6.73 2017-01 L01XE07 2.16.840.1.113883.6.73 2017-01 L01XE08 2.16.840.1.113883.6.73 2017-01 L01XE09 2.16.840.1.113883.6.73 2017-01 L01XE10 2.16.840.1.113883.6.73 2017-01 L01XE11 2.16.840.1.113883.6.73 2017-01 L01XE12 2.16.840.1.113883.6.73 2017-01 L01XE13 2.16.840.1.113883.6.73 2017-01 L01XE14 2.16.840.1.113883.6.73 2017-01 L01XE15 2.16.840.1.113883.6.73 2017-01 L01XE16 2.16.840.1.113883.6.73 2017-01 L01XE17 2.16.840.1.113883.6.73 2017-01 L01XE18 ruxolitinib 2.16.840.1.113883.6.73 2017-01 L01XE19 2.16.840.1.113883.6.73 2017-01 L01XE21 2.16.840.1.113883.6.73 2017-01 L01XE22 2.16.840.1.113883.6.73 2017-01 L01XE23 2.16.840.1.113883.6.73 2017-01 L01XE24 2.16.840.1.113883.6.73 2017-01 L01XE25 2.16.840.1.113883.6.73 2017-01 L01XE26 2.16.840.1.113883.6.73 2017-01 L01XE27 ibrutinib 2.16.840.1.113883.6.73 2017-01 L01XE28 2.16.840.1.113883.6.73 2017-01 L01XE29 2.16.840.1.113883.6.73 2017-01 L01XE31 2.16.840.1.113883.6.73 2017-01 L01XE32 2.16.840.1.113883.6.73 2017-01 L01XE33 palbociclib 2.16.840.1.113883.6.73 2017-01 L01XE34 2.16.840.1.113883.6.73 2017-01 L01XE35 2.16.840.1.113883.6.73 2017-01 L01XE36 2.16.840.1.113883.6.73 2017-01 L01XE37 2.16.840.1.113883.6.73 2017-01 L01XE38 2.16.840.1.113883.6.73 2017-01 L01XE39 midostaurin 2.16.840.1.113883.6.73 2017-01 L01XE40 2.16.840.1.113883.6.73 2017-01 L01XX Other antineoplastic agents 2.16.840.1.113883.6.73 2017-01 L01XX01 amsacrine 2.16.840.1.113883.6.73 2017-01 L01XX02 asparaginase 2.16.840.1.113883.6.73 2017-01 L01XX03 altretamine 2.16.840.1.113883.6.73 2017-01 L01XX05 hydroxycarbamide 2.16.840.1.113883.6.73 2017-01 L01XX07 lonidamine 2.16.840.1.113883.6.73 2017-01 L01XX08 pentostatin 2.16.840.1.113883.6.73 2017-01 L01XX09 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 87 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L01XX10 masoprocol 2.16.840.1.113883.6.73 2017-01 L01XX11 estramustine 2.16.840.1.113883.6.73 2017-01 L01XX14 tretinoin 2.16.840.1.113883.6.73 2017-01 L01XX16 mitoguazone 2.16.840.1.113883.6.73 2017-01 L01XX17 topotecan 2.16.840.1.113883.6.73 2017-01 L01XX18 tiazofurine 2.16.840.1.113883.6.73 2017-01 L01XX19 irinotecan 2.16.840.1.113883.6.73 2017-01 L01XX22 alitretinoin 2.16.840.1.113883.6.73 2017-01 L01XX23 2.16.840.1.113883.6.73 2017-01 L01XX24 pegaspargase 2.16.840.1.113883.6.73 2017-01 L01XX25 bexarotene 2.16.840.1.113883.6.73 2017-01 L01XX27 arsenic trioxide 2.16.840.1.113883.6.73 2017-01 L01XX29 2.16.840.1.113883.6.73 2017-01 L01XX32 bortezomib 2.16.840.1.113883.6.73 2017-01 L01XX33 2.16.840.1.113883.6.73 2017-01 L01XX35 anagrelide 2.16.840.1.113883.6.73 2017-01 L01XX36 oblimersen 2.16.840.1.113883.6.73 2017-01 L01XX37 sitimagene ceradenovec 2.16.840.1.113883.6.73 2017-01 L01XX38 vorinostat 2.16.840.1.113883.6.73 2017-01 L01XX39 romidepsin 2.16.840.1.113883.6.73 2017-01 L01XX40 omacetaxine mepesuccinate 2.16.840.1.113883.6.73 2017-01 L01XX41 eribulin 2.16.840.1.113883.6.73 2017-01 L01XX42 panobinostat 2.16.840.1.113883.6.73 2017-01 L01XX43 vismodegib 2.16.840.1.113883.6.73 2017-01 L01XX44 2.16.840.1.113883.6.73 2017-01 L01XX45 carfilzomib 2.16.840.1.113883.6.73 2017-01 L01XX46 olaparib 2.16.840.1.113883.6.73 2017-01 L01XX47 idelalisib 2.16.840.1.113883.6.73 2017-01 L01XX48 sonidegib 2.16.840.1.113883.6.73 2017-01 L01XX49 belinostat 2.16.840.1.113883.6.73 2017-01 L01XX50 ixazomib 2.16.840.1.113883.6.73 2017-01 L01XX51 talimogene laherparepvec 2.16.840.1.113883.6.73 2017-01 L01XX52 venetoclax 2.16.840.1.113883.6.73 2017-01 L01XX53 vosaroxin 2.16.840.1.113883.6.73 2017-01 L01XY Combinations of antineoplastic agents 2.16.840.1.113883.6.73 2017-01 L02 ENDOCRINE THERAPY 2.16.840.1.113883.6.73 2017-01 L02A HORMONES AND RELATED AGENTS 2.16.840.1.113883.6.73 2017-01 L02AA Estrogens 2.16.840.1.113883.6.73 2017-01 L02AA01 diethylstilbestrol 2.16.840.1.113883.6.73 2017-01 L02AA02 2.16.840.1.113883.6.73 2017-01 L02AA03 ethinylestradiol 2.16.840.1.113883.6.73 2017-01 L02AA04 2.16.840.1.113883.6.73 2017-01 L02AB Progestogens © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 88 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L02AB01 megestrol 2.16.840.1.113883.6.73 2017-01 L02AB02 medroxyprogesterone 2.16.840.1.113883.6.73 2017-01 L02AB03 gestonorone 2.16.840.1.113883.6.73 2017-01 L02AE Gonadotropin releasing hormone analogues 2.16.840.1.113883.6.73 2017-01 L02AE01 2.16.840.1.113883.6.73 2017-01 L02AE02 2.16.840.1.113883.6.73 2017-01 L02AE03 2.16.840.1.113883.6.73 2017-01 L02AE04 2.16.840.1.113883.6.73 2017-01 L02AE05 2.16.840.1.113883.6.73 2017-01 L02AX Other hormones 2.16.840.1.113883.6.73 2017-01 L02B HORMONE ANTAGONISTS AND RELATED AGENTS 2.16.840.1.113883.6.73 2017-01 L02BA Anti-estrogens 2.16.840.1.113883.6.73 2017-01 L02BA01 2.16.840.1.113883.6.73 2017-01 L02BA02 2.16.840.1.113883.6.73 2017-01 L02BA03 2.16.840.1.113883.6.73 2017-01 L02BB Anti-androgens 2.16.840.1.113883.6.73 2017-01 L02BB01 2.16.840.1.113883.6.73 2017-01 L02BB02 2.16.840.1.113883.6.73 2017-01 L02BB03 2.16.840.1.113883.6.73 2017-01 L02BB04 2.16.840.1.113883.6.73 2017-01 L02BG Aromatase inhibitors 2.16.840.1.113883.6.73 2017-01 L02BG01 2.16.840.1.113883.6.73 2017-01 L02BG02 2.16.840.1.113883.6.73 2017-01 L02BG03 2.16.840.1.113883.6.73 2017-01 L02BG04 2.16.840.1.113883.6.73 2017-01 L02BG05 2.16.840.1.113883.6.73 2017-01 L02BG06 2.16.840.1.113883.6.73 2017-01 L02BX Other hormone antagonists and related agents 2.16.840.1.113883.6.73 2017-01 L02BX01 2.16.840.1.113883.6.73 2017-01 L02BX02 2.16.840.1.113883.6.73 2017-01 L02BX03 abiraterone 2.16.840.1.113883.6.73 2017-01 L03 2.16.840.1.113883.6.73 2017-01 L03A IMMUNOSTIMULANTS 2.16.840.1.113883.6.73 2017-01 L03AA Colony stimulating factors 2.16.840.1.113883.6.73 2017-01 L03AA02 2.16.840.1.113883.6.73 2017-01 L03AA03 2.16.840.1.113883.6.73 2017-01 L03AA09 2.16.840.1.113883.6.73 2017-01 L03AA10 2.16.840.1.113883.6.73 2017-01 L03AA12 2.16.840.1.113883.6.73 2017-01 L03AA13 2.16.840.1.113883.6.73 2017-01 L03AA14 2.16.840.1.113883.6.73 2017-01 L03AA15 balugrastim 2.16.840.1.113883.6.73 2017-01 L03AA16 empegfilgrastim © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 89 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L03AB 2.16.840.1.113883.6.73 2017-01 L03AB01 alfa natural 2.16.840.1.113883.6.73 2017-01 L03AB02 interferon beta natural 2.16.840.1.113883.6.73 2017-01 L03AB03 2.16.840.1.113883.6.73 2017-01 L03AB04 -2a 2.16.840.1.113883.6.73 2017-01 L03AB05 interferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB06 interferon alfa-n1 2.16.840.1.113883.6.73 2017-01 L03AB07 interferon beta-1a 2.16.840.1.113883.6.73 2017-01 L03AB08 interferon beta-1b 2.16.840.1.113883.6.73 2017-01 L03AB09 interferon alfacon-1 2.16.840.1.113883.6.73 2017-01 L03AB10 peginterferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB11 peginterferon alfa-2a 2.16.840.1.113883.6.73 2017-01 L03AB12 alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB13 peginterferon beta-1a 2.16.840.1.113883.6.73 2017-01 L03AB14 cepeginterferon alfa-2b 2.16.840.1.113883.6.73 2017-01 L03AB60 peginterferon alfa-2b, combinations 2.16.840.1.113883.6.73 2017-01 L03AB61 peginterferon alfa-2a, combinations 2.16.840.1.113883.6.73 2017-01 L03AC 2.16.840.1.113883.6.73 2017-01 L03AC01 aldesleukin 2.16.840.1.113883.6.73 2017-01 L03AC02 2.16.840.1.113883.6.73 2017-01 L03AX Other immunostimulants 2.16.840.1.113883.6.73 2017-01 L03AX01 2.16.840.1.113883.6.73 2017-01 L03AX02 2.16.840.1.113883.6.73 2017-01 L03AX03 BCG vaccine 2.16.840.1.113883.6.73 2017-01 L03AX04 pegademase 2.16.840.1.113883.6.73 2017-01 L03AX05 2.16.840.1.113883.6.73 2017-01 L03AX07 poly I:C 2.16.840.1.113883.6.73 2017-01 L03AX08 poly ICLC 2.16.840.1.113883.6.73 2017-01 L03AX09 2.16.840.1.113883.6.73 2017-01 L03AX10 immunocyanin 2.16.840.1.113883.6.73 2017-01 L03AX11 tasonermin 2.16.840.1.113883.6.73 2017-01 L03AX12 melanoma vaccine 2.16.840.1.113883.6.73 2017-01 L03AX13 2.16.840.1.113883.6.73 2017-01 L03AX14 dihydrochloride 2.16.840.1.113883.6.73 2017-01 L03AX15 2.16.840.1.113883.6.73 2017-01 L03AX16 2.16.840.1.113883.6.73 2017-01 L03AX17 sipuleucel-T 2.16.840.1.113883.6.73 2017-01 L03AX18 cridanimod 2.16.840.1.113883.6.73 2017-01 L03AX19 dasiprotimut-T 2.16.840.1.113883.6.73 2017-01 L04 IMMUNOSUPPRESSANTS 2.16.840.1.113883.6.73 2017-01 L04A IMMUNOSUPPRESSANTS 2.16.840.1.113883.6.73 2017-01 L04AA Selective immunosuppressants 2.16.840.1.113883.6.73 2017-01 L04AA02 muromonab-CD3 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 90 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L04AA03 antilymphocyte immunoglobulin (horse) 2.16.840.1.113883.6.73 2017-01 L04AA04 antithymocyte immunoglobulin (rabbit) 2.16.840.1.113883.6.73 2017-01 L04AA06 2.16.840.1.113883.6.73 2017-01 L04AA10 2.16.840.1.113883.6.73 2017-01 L04AA13 2.16.840.1.113883.6.73 2017-01 L04AA15 2.16.840.1.113883.6.73 2017-01 L04AA18 everolimus 2.16.840.1.113883.6.73 2017-01 L04AA19 2.16.840.1.113883.6.73 2017-01 L04AA21 2.16.840.1.113883.6.73 2017-01 L04AA22 abetimus 2.16.840.1.113883.6.73 2017-01 L04AA23 2.16.840.1.113883.6.73 2017-01 L04AA24 2.16.840.1.113883.6.73 2017-01 L04AA25 2.16.840.1.113883.6.73 2017-01 L04AA26 2.16.840.1.113883.6.73 2017-01 L04AA27 2.16.840.1.113883.6.73 2017-01 L04AA28 2.16.840.1.113883.6.73 2017-01 L04AA29 2.16.840.1.113883.6.73 2017-01 L04AA31 2.16.840.1.113883.6.73 2017-01 L04AA32 2.16.840.1.113883.6.73 2017-01 L04AA33 2.16.840.1.113883.6.73 2017-01 L04AA34 2.16.840.1.113883.6.73 2017-01 L04AA35 begelomab 2.16.840.1.113883.6.73 2017-01 L04AA36 2.16.840.1.113883.6.73 2017-01 L04AA37 2.16.840.1.113883.6.73 2017-01 L04AB alpha (TNF-) inhibitors 2.16.840.1.113883.6.73 2017-01 L04AB01 2.16.840.1.113883.6.73 2017-01 L04AB02 2.16.840.1.113883.6.73 2017-01 L04AB03 2.16.840.1.113883.6.73 2017-01 L04AB04 2.16.840.1.113883.6.73 2017-01 L04AB05 2.16.840.1.113883.6.73 2017-01 L04AB06 2.16.840.1.113883.6.73 2017-01 L04AC inhibitors 2.16.840.1.113883.6.73 2017-01 L04AC01 2.16.840.1.113883.6.73 2017-01 L04AC02 2.16.840.1.113883.6.73 2017-01 L04AC03 2.16.840.1.113883.6.73 2017-01 L04AC04 2.16.840.1.113883.6.73 2017-01 L04AC05 2.16.840.1.113883.6.73 2017-01 L04AC07 2.16.840.1.113883.6.73 2017-01 L04AC08 2.16.840.1.113883.6.73 2017-01 L04AC09 briakinumab 2.16.840.1.113883.6.73 2017-01 L04AC10 2.16.840.1.113883.6.73 2017-01 L04AC11 2.16.840.1.113883.6.73 2017-01 L04AC12 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 91 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 L04AC13 2.16.840.1.113883.6.73 2017-01 L04AC14 2.16.840.1.113883.6.73 2017-01 L04AD inhibitors 2.16.840.1.113883.6.73 2017-01 L04AD01 2.16.840.1.113883.6.73 2017-01 L04AD02 tacrolimus 2.16.840.1.113883.6.73 2017-01 L04AD03 2.16.840.1.113883.6.73 2017-01 L04AX Other immunosuppressants 2.16.840.1.113883.6.73 2017-01 L04AX01 2.16.840.1.113883.6.73 2017-01 L04AX02 2.16.840.1.113883.6.73 2017-01 L04AX03 methotrexate 2.16.840.1.113883.6.73 2017-01 L04AX04 2.16.840.1.113883.6.73 2017-01 L04AX05 2.16.840.1.113883.6.73 2017-01 L04AX06 2.16.840.1.113883.6.73 2017-01 M MUSCULO-SKELETAL SYSTEM 2.16.840.1.113883.6.73 2017-01 M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS 2.16.840.1.113883.6.73 2017-01 M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS 2.16.840.1.113883.6.73 2017-01 M01AA Butylpyrazolidines 2.16.840.1.113883.6.73 2017-01 M01AA01 2.16.840.1.113883.6.73 2017-01 M01AA02 2.16.840.1.113883.6.73 2017-01 M01AA03 2.16.840.1.113883.6.73 2017-01 M01AA05 2.16.840.1.113883.6.73 2017-01 M01AA06 2.16.840.1.113883.6.73 2017-01 M01AB Acetic acid derivatives and related substances 2.16.840.1.113883.6.73 2017-01 M01AB01 indometacin 2.16.840.1.113883.6.73 2017-01 M01AB02 2.16.840.1.113883.6.73 2017-01 M01AB03 2.16.840.1.113883.6.73 2017-01 M01AB04 2.16.840.1.113883.6.73 2017-01 M01AB05 diclofenac 2.16.840.1.113883.6.73 2017-01 M01AB06 2.16.840.1.113883.6.73 2017-01 M01AB07 2.16.840.1.113883.6.73 2017-01 M01AB08 2.16.840.1.113883.6.73 2017-01 M01AB09 2.16.840.1.113883.6.73 2017-01 M01AB10 2.16.840.1.113883.6.73 2017-01 M01AB11 2.16.840.1.113883.6.73 2017-01 M01AB12 2.16.840.1.113883.6.73 2017-01 M01AB13 2.16.840.1.113883.6.73 2017-01 M01AB14 2.16.840.1.113883.6.73 2017-01 M01AB15 2.16.840.1.113883.6.73 2017-01 M01AB16 2.16.840.1.113883.6.73 2017-01 M01AB17 2.16.840.1.113883.6.73 2017-01 M01AB51 indometacin, combinations 2.16.840.1.113883.6.73 2017-01 M01AB55 diclofenac, combinations

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 92 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M01AC 2.16.840.1.113883.6.73 2017-01 M01AC01 2.16.840.1.113883.6.73 2017-01 M01AC02 2.16.840.1.113883.6.73 2017-01 M01AC04 2.16.840.1.113883.6.73 2017-01 M01AC05 2.16.840.1.113883.6.73 2017-01 M01AC06 2.16.840.1.113883.6.73 2017-01 M01AC56 meloxicam, combinations 2.16.840.1.113883.6.73 2017-01 M01AE Propionic acid derivatives 2.16.840.1.113883.6.73 2017-01 M01AE01 ibuprofen 2.16.840.1.113883.6.73 2017-01 M01AE02 naproxen 2.16.840.1.113883.6.73 2017-01 M01AE03 2.16.840.1.113883.6.73 2017-01 M01AE04 2.16.840.1.113883.6.73 2017-01 M01AE05 2.16.840.1.113883.6.73 2017-01 M01AE06 2.16.840.1.113883.6.73 2017-01 M01AE07 2.16.840.1.113883.6.73 2017-01 M01AE08 2.16.840.1.113883.6.73 2017-01 M01AE09 2.16.840.1.113883.6.73 2017-01 M01AE10 2.16.840.1.113883.6.73 2017-01 M01AE11 2.16.840.1.113883.6.73 2017-01 M01AE12 2.16.840.1.113883.6.73 2017-01 M01AE13 2.16.840.1.113883.6.73 2017-01 M01AE14 2.16.840.1.113883.6.73 2017-01 M01AE15 flunoxaprofen 2.16.840.1.113883.6.73 2017-01 M01AE16 2.16.840.1.113883.6.73 2017-01 M01AE17 2.16.840.1.113883.6.73 2017-01 M01AE18 2.16.840.1.113883.6.73 2017-01 M01AE51 ibuprofen, combinations 2.16.840.1.113883.6.73 2017-01 M01AE52 naproxen and esomeprazole 2.16.840.1.113883.6.73 2017-01 M01AE53 ketoprofen, combinations 2.16.840.1.113883.6.73 2017-01 M01AE56 naproxen and misoprostol 2.16.840.1.113883.6.73 2017-01 M01AG Fenamates 2.16.840.1.113883.6.73 2017-01 M01AG01 2.16.840.1.113883.6.73 2017-01 M01AG02 2.16.840.1.113883.6.73 2017-01 M01AG03 2.16.840.1.113883.6.73 2017-01 M01AG04 2.16.840.1.113883.6.73 2017-01 M01AH Coxibs 2.16.840.1.113883.6.73 2017-01 M01AH01 celecoxib 2.16.840.1.113883.6.73 2017-01 M01AH02 2.16.840.1.113883.6.73 2017-01 M01AH03 2.16.840.1.113883.6.73 2017-01 M01AH04 2.16.840.1.113883.6.73 2017-01 M01AH05 2.16.840.1.113883.6.73 2017-01 M01AH06 2.16.840.1.113883.6.73 2017-01 M01AX Other antiinflammatory and antirheumatic agents, non-steroids © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 93 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M01AX01 2.16.840.1.113883.6.73 2017-01 M01AX02 2.16.840.1.113883.6.73 2017-01 M01AX04 2.16.840.1.113883.6.73 2017-01 M01AX05 2.16.840.1.113883.6.73 2017-01 M01AX07 benzydamine 2.16.840.1.113883.6.73 2017-01 M01AX12 glucosaminoglycan polysulfate 2.16.840.1.113883.6.73 2017-01 M01AX13 2.16.840.1.113883.6.73 2017-01 M01AX14 orgotein 2.16.840.1.113883.6.73 2017-01 M01AX17 2.16.840.1.113883.6.73 2017-01 M01AX18 2.16.840.1.113883.6.73 2017-01 M01AX21 2.16.840.1.113883.6.73 2017-01 M01AX22 2.16.840.1.113883.6.73 2017-01 M01AX23 2.16.840.1.113883.6.73 2017-01 M01AX24 oxaceprol 2.16.840.1.113883.6.73 2017-01 M01AX25 chondroitin sulfate 2.16.840.1.113883.6.73 2017-01 M01AX26 avocado and soyabean oil, unsaponifiables 2.16.840.1.113883.6.73 2017-01 M01AX68 feprazone, combinations 2.16.840.1.113883.6.73 2017-01 M01B ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION 2.16.840.1.113883.6.73 2017-01 M01BA Antiinflammatory/antirheumatic agents in combination with corticosteroids 2.16.840.1.113883.6.73 2017-01 M01BA01 phenylbutazone and corticosteroids 2.16.840.1.113883.6.73 2017-01 M01BA02 and corticosteroids 2.16.840.1.113883.6.73 2017-01 M01BA03 acetylsalicylic acid and corticosteroids 2.16.840.1.113883.6.73 2017-01 M01BX Other antiinflammatory/antirheumatic agents in combination with other drugs 2.16.840.1.113883.6.73 2017-01 M01C SPECIFIC ANTIRHEUMATIC AGENTS 2.16.840.1.113883.6.73 2017-01 M01CA 2.16.840.1.113883.6.73 2017-01 M01CA03 2.16.840.1.113883.6.73 2017-01 M01CB Gold preparations 2.16.840.1.113883.6.73 2017-01 M01CB01 2.16.840.1.113883.6.73 2017-01 M01CB02 sodium aurotiosulfate 2.16.840.1.113883.6.73 2017-01 M01CB03 2.16.840.1.113883.6.73 2017-01 M01CB04 2.16.840.1.113883.6.73 2017-01 M01CB05 2.16.840.1.113883.6.73 2017-01 M01CC and similar agents 2.16.840.1.113883.6.73 2017-01 M01CC01 penicillamine 2.16.840.1.113883.6.73 2017-01 M01CC02 bucillamine 2.16.840.1.113883.6.73 2017-01 M01CX Other specific antirheumatic agents 2.16.840.1.113883.6.73 2017-01 M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN 2.16.840.1.113883.6.73 2017-01 M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN 2.16.840.1.113883.6.73 2017-01 M02AA Antiinflammatory preparations, non-steroids for topical use 2.16.840.1.113883.6.73 2017-01 M02AA01 phenylbutazone 2.16.840.1.113883.6.73 2017-01 M02AA02 mofebutazone

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 94 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M02AA03 clofezone 2.16.840.1.113883.6.73 2017-01 M02AA04 oxyphenbutazone 2.16.840.1.113883.6.73 2017-01 M02AA05 benzydamine 2.16.840.1.113883.6.73 2017-01 M02AA06 2.16.840.1.113883.6.73 2017-01 M02AA07 piroxicam 2.16.840.1.113883.6.73 2017-01 M02AA08 2.16.840.1.113883.6.73 2017-01 M02AA09 bufexamac 2.16.840.1.113883.6.73 2017-01 M02AA10 ketoprofen 2.16.840.1.113883.6.73 2017-01 M02AA11 2.16.840.1.113883.6.73 2017-01 M02AA12 naproxen 2.16.840.1.113883.6.73 2017-01 M02AA13 ibuprofen 2.16.840.1.113883.6.73 2017-01 M02AA14 fentiazac 2.16.840.1.113883.6.73 2017-01 M02AA15 diclofenac 2.16.840.1.113883.6.73 2017-01 M02AA16 feprazone 2.16.840.1.113883.6.73 2017-01 M02AA17 niflumic acid 2.16.840.1.113883.6.73 2017-01 M02AA18 meclofenamic acid 2.16.840.1.113883.6.73 2017-01 M02AA19 flurbiprofen 2.16.840.1.113883.6.73 2017-01 M02AA21 tolmetin 2.16.840.1.113883.6.73 2017-01 M02AA22 2.16.840.1.113883.6.73 2017-01 M02AA23 indometacin 2.16.840.1.113883.6.73 2017-01 M02AA24 2.16.840.1.113883.6.73 2017-01 M02AA25 aceclofenac 2.16.840.1.113883.6.73 2017-01 M02AA26 nimesulide 2.16.840.1.113883.6.73 2017-01 M02AA27 dexketoprofen 2.16.840.1.113883.6.73 2017-01 M02AA28 piketoprofen 2.16.840.1.113883.6.73 2017-01 M02AB and similar agents 2.16.840.1.113883.6.73 2017-01 M02AB01 capsaicin 2.16.840.1.113883.6.73 2017-01 M02AB02 zucapsaicin 2.16.840.1.113883.6.73 2017-01 M02AC Preparations with salicylic acid derivatives 2.16.840.1.113883.6.73 2017-01 M02AX Other topical products for joint and muscular pain 2.16.840.1.113883.6.73 2017-01 M02AX02 tolazoline 2.16.840.1.113883.6.73 2017-01 M02AX03 dimethyl sulfoxide 2.16.840.1.113883.6.73 2017-01 M02AX05 idrocilamide 2.16.840.1.113883.6.73 2017-01 M02AX06 2.16.840.1.113883.6.73 2017-01 M02AX10 various 2.16.840.1.113883.6.73 2017-01 M03 MUSCLE RELAXANTS 2.16.840.1.113883.6.73 2017-01 M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS 2.16.840.1.113883.6.73 2017-01 M03AA alkaloids 2.16.840.1.113883.6.73 2017-01 M03AA01 alcuronium 2.16.840.1.113883.6.73 2017-01 M03AA02 tubocurarine 2.16.840.1.113883.6.73 2017-01 M03AA04 dimethyltubocurarine 2.16.840.1.113883.6.73 2017-01 M03AB Choline derivatives 2.16.840.1.113883.6.73 2017-01 M03AB01 suxamethonium © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 95 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M03AC Other quaternary ammonium compounds 2.16.840.1.113883.6.73 2017-01 M03AC01 pancuronium 2.16.840.1.113883.6.73 2017-01 M03AC02 gallamine 2.16.840.1.113883.6.73 2017-01 M03AC03 vecuronium 2.16.840.1.113883.6.73 2017-01 M03AC04 atracurium 2.16.840.1.113883.6.73 2017-01 M03AC05 hexafluronium 2.16.840.1.113883.6.73 2017-01 M03AC06 2.16.840.1.113883.6.73 2017-01 M03AC07 2.16.840.1.113883.6.73 2017-01 M03AC08 2.16.840.1.113883.6.73 2017-01 M03AC09 2.16.840.1.113883.6.73 2017-01 M03AC10 2.16.840.1.113883.6.73 2017-01 M03AC11 cisatracurium 2.16.840.1.113883.6.73 2017-01 M03AX Other muscle relaxants, peripherally acting agents 2.16.840.1.113883.6.73 2017-01 M03AX01 botulinum toxin 2.16.840.1.113883.6.73 2017-01 M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS 2.16.840.1.113883.6.73 2017-01 M03BA Carbamic acid esters 2.16.840.1.113883.6.73 2017-01 M03BA01 2.16.840.1.113883.6.73 2017-01 M03BA02 2.16.840.1.113883.6.73 2017-01 M03BA03 2.16.840.1.113883.6.73 2017-01 M03BA04 2.16.840.1.113883.6.73 2017-01 M03BA05 2.16.840.1.113883.6.73 2017-01 M03BA51 phenprobamate, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 M03BA52 carisoprodol, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 M03BA53 methocarbamol, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 M03BA71 phenprobamate, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 M03BA72 carisoprodol, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 M03BA73 methocarbamol, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 M03BB Oxazol, thiazine, and triazine derivatives 2.16.840.1.113883.6.73 2017-01 M03BB02 2.16.840.1.113883.6.73 2017-01 M03BB03 2.16.840.1.113883.6.73 2017-01 M03BB52 chlormezanone, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 M03BB53 chlorzoxazone, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 M03BB72 chlormezanone, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 M03BB73 chlorzoxazone, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 M03BC Ethers, chemically close to antihistamines 2.16.840.1.113883.6.73 2017-01 M03BC01 (citrate) 2.16.840.1.113883.6.73 2017-01 M03BC51 orphenadrine, combinations 2.16.840.1.113883.6.73 2017-01 M03BX Other centrally acting agents 2.16.840.1.113883.6.73 2017-01 M03BX01 2.16.840.1.113883.6.73 2017-01 M03BX02 2.16.840.1.113883.6.73 2017-01 M03BX03 2.16.840.1.113883.6.73 2017-01 M03BX04 tolperisone 2.16.840.1.113883.6.73 2017-01 M03BX05 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 96 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M03BX06 2.16.840.1.113883.6.73 2017-01 M03BX07 2.16.840.1.113883.6.73 2017-01 M03BX08 2.16.840.1.113883.6.73 2017-01 M03BX09 2.16.840.1.113883.6.73 2017-01 M03BX30 fenyramidol 2.16.840.1.113883.6.73 2017-01 M03BX55 thiocolchicoside, combinations 2.16.840.1.113883.6.73 2017-01 M03C MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS 2.16.840.1.113883.6.73 2017-01 M03CA Dantrolene and derivatives 2.16.840.1.113883.6.73 2017-01 M03CA01 dantrolene 2.16.840.1.113883.6.73 2017-01 M04 ANTIGOUT PREPARATIONS 2.16.840.1.113883.6.73 2017-01 M04A ANTIGOUT PREPARATIONS 2.16.840.1.113883.6.73 2017-01 M04AA Preparations inhibiting production 2.16.840.1.113883.6.73 2017-01 M04AA01 2.16.840.1.113883.6.73 2017-01 M04AA02 2.16.840.1.113883.6.73 2017-01 M04AA03 2.16.840.1.113883.6.73 2017-01 M04AA51 allopurinol, combinations 2.16.840.1.113883.6.73 2017-01 M04AB Preparations increasing uric acid 2.16.840.1.113883.6.73 2017-01 M04AB01 probenecid 2.16.840.1.113883.6.73 2017-01 M04AB02 2.16.840.1.113883.6.73 2017-01 M04AB03 2.16.840.1.113883.6.73 2017-01 M04AB04 isobromindione 2.16.840.1.113883.6.73 2017-01 M04AB05 lesinurad 2.16.840.1.113883.6.73 2017-01 M04AC Preparations with no effect on uric acid metabolism 2.16.840.1.113883.6.73 2017-01 M04AC01 colchicine 2.16.840.1.113883.6.73 2017-01 M04AC02 cinchophen 2.16.840.1.113883.6.73 2017-01 M04AX Other antigout preparations 2.16.840.1.113883.6.73 2017-01 M04AX01 urate oxidase 2.16.840.1.113883.6.73 2017-01 M04AX02 pegloticase 2.16.840.1.113883.6.73 2017-01 M05 DRUGS FOR TREATMENT OF DISEASES 2.16.840.1.113883.6.73 2017-01 M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION 2.16.840.1.113883.6.73 2017-01 M05BA Bisphosphonates 2.16.840.1.113883.6.73 2017-01 M05BA01 etidronic acid 2.16.840.1.113883.6.73 2017-01 M05BA02 clodronic acid 2.16.840.1.113883.6.73 2017-01 M05BA03 pamidronic acid 2.16.840.1.113883.6.73 2017-01 M05BA04 alendronic acid 2.16.840.1.113883.6.73 2017-01 M05BA05 tiludronic acid 2.16.840.1.113883.6.73 2017-01 M05BA06 ibandronic acid 2.16.840.1.113883.6.73 2017-01 M05BA07 risedronic acid 2.16.840.1.113883.6.73 2017-01 M05BA08 zoledronic acid 2.16.840.1.113883.6.73 2017-01 M05BB Bisphosphonates, combinations 2.16.840.1.113883.6.73 2017-01 M05BB01 etidronic acid and calcium, sequential 2.16.840.1.113883.6.73 2017-01 M05BB02 risedronic acid and calcium, sequential

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 97 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 M05BB03 alendronic acid and colecalciferol 2.16.840.1.113883.6.73 2017-01 M05BB04 risedronic acid, calcium and colecalciferol, sequential 2.16.840.1.113883.6.73 2017-01 M05BB05 alendronic acid, calcium and colecalciferol, sequential 2.16.840.1.113883.6.73 2017-01 M05BB06 alendronic acid and alfacalcidol, sequential 2.16.840.1.113883.6.73 2017-01 M05BB07 risedronic acid and colecalciferol 2.16.840.1.113883.6.73 2017-01 M05BB08 zoledronic acid, calcium and colecalciferol, sequential 2.16.840.1.113883.6.73 2017-01 M05BC Bone morphogenetic proteins 2.16.840.1.113883.6.73 2017-01 M05BC01 dibotermin alfa 2.16.840.1.113883.6.73 2017-01 M05BC02 eptotermin alfa 2.16.840.1.113883.6.73 2017-01 M05BX Other drugs affecting bone structure and mineralization 2.16.840.1.113883.6.73 2017-01 M05BX01 ipriflavone 2.16.840.1.113883.6.73 2017-01 M05BX02 aluminium chlorohydrate 2.16.840.1.113883.6.73 2017-01 M05BX03 strontium ranelate 2.16.840.1.113883.6.73 2017-01 M05BX04 2.16.840.1.113883.6.73 2017-01 M05BX05 burosumab 2.16.840.1.113883.6.73 2017-01 M05BX53 strontium ranelate and colecalciferol 2.16.840.1.113883.6.73 2017-01 M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO- SKELETAL SYSTEM 2.16.840.1.113883.6.73 2017-01 M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO- SKELETAL SYSTEM 2.16.840.1.113883.6.73 2017-01 M09AA Quinine and derivatives 2.16.840.1.113883.6.73 2017-01 M09AA01 hydroquinine 2.16.840.1.113883.6.73 2017-01 M09AA72 quinine, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 M09AB Enzymes 2.16.840.1.113883.6.73 2017-01 M09AB01 chymopapain 2.16.840.1.113883.6.73 2017-01 M09AB02 collagenase clostridium histolyticum 2.16.840.1.113883.6.73 2017-01 M09AB03 bromelains 2.16.840.1.113883.6.73 2017-01 M09AB52 trypsin, combinations 2.16.840.1.113883.6.73 2017-01 M09AX Other drugs for disorders of the musculo-skeletal system 2.16.840.1.113883.6.73 2017-01 M09AX01 hyaluronic acid 2.16.840.1.113883.6.73 2017-01 M09AX02 chondrocytes, autologous 2.16.840.1.113883.6.73 2017-01 M09AX03 ataluren 2.16.840.1.113883.6.73 2017-01 M09AX04 drisapersen 2.16.840.1.113883.6.73 2017-01 M09AX05 aceneuramic acid 2.16.840.1.113883.6.73 2017-01 N NERVOUS SYSTEM 2.16.840.1.113883.6.73 2017-01 N01 ANESTHETICS 2.16.840.1.113883.6.73 2017-01 N01A ANESTHETICS, GENERAL 2.16.840.1.113883.6.73 2017-01 N01AA Ethers 2.16.840.1.113883.6.73 2017-01 N01AA01 2.16.840.1.113883.6.73 2017-01 N01AA02 vinyl ether 2.16.840.1.113883.6.73 2017-01 N01AB Halogenated hydrocarbons 2.16.840.1.113883.6.73 2017-01 N01AB01 2.16.840.1.113883.6.73 2017-01 N01AB02 2.16.840.1.113883.6.73 2017-01 N01AB04 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 98 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N01AB05 2.16.840.1.113883.6.73 2017-01 N01AB06 2.16.840.1.113883.6.73 2017-01 N01AB07 2.16.840.1.113883.6.73 2017-01 N01AB08 2.16.840.1.113883.6.73 2017-01 N01AF , plain 2.16.840.1.113883.6.73 2017-01 N01AF01 2.16.840.1.113883.6.73 2017-01 N01AF02 2.16.840.1.113883.6.73 2017-01 N01AF03 thiopental 2.16.840.1.113883.6.73 2017-01 N01AG Barbiturates in combination with other drugs 2.16.840.1.113883.6.73 2017-01 N01AG01 2.16.840.1.113883.6.73 2017-01 N01AH Opioid anesthetics 2.16.840.1.113883.6.73 2017-01 N01AH01 2.16.840.1.113883.6.73 2017-01 N01AH02 2.16.840.1.113883.6.73 2017-01 N01AH03 2.16.840.1.113883.6.73 2017-01 N01AH04 2.16.840.1.113883.6.73 2017-01 N01AH05 2.16.840.1.113883.6.73 2017-01 N01AH06 2.16.840.1.113883.6.73 2017-01 N01AH51 fentanyl, combinations 2.16.840.1.113883.6.73 2017-01 N01AX Other general anesthetics 2.16.840.1.113883.6.73 2017-01 N01AX03 2.16.840.1.113883.6.73 2017-01 N01AX04 2.16.840.1.113883.6.73 2017-01 N01AX05 2.16.840.1.113883.6.73 2017-01 N01AX07 2.16.840.1.113883.6.73 2017-01 N01AX10 2.16.840.1.113883.6.73 2017-01 N01AX11 2.16.840.1.113883.6.73 2017-01 N01AX13 2.16.840.1.113883.6.73 2017-01 N01AX14 2.16.840.1.113883.6.73 2017-01 N01AX15 xenon 2.16.840.1.113883.6.73 2017-01 N01AX63 nitrous oxide, combinations 2.16.840.1.113883.6.73 2017-01 N01B ANESTHETICS, LOCAL 2.16.840.1.113883.6.73 2017-01 N01BA Esters of aminobenzoic acid 2.16.840.1.113883.6.73 2017-01 N01BA01 2.16.840.1.113883.6.73 2017-01 N01BA02 procaine 2.16.840.1.113883.6.73 2017-01 N01BA03 tetracaine 2.16.840.1.113883.6.73 2017-01 N01BA04 2.16.840.1.113883.6.73 2017-01 N01BA05 benzocaine 2.16.840.1.113883.6.73 2017-01 N01BA52 procaine, combinations 2.16.840.1.113883.6.73 2017-01 N01BB Amides 2.16.840.1.113883.6.73 2017-01 N01BB01 2.16.840.1.113883.6.73 2017-01 N01BB02 lidocaine 2.16.840.1.113883.6.73 2017-01 N01BB03 2.16.840.1.113883.6.73 2017-01 N01BB04 2.16.840.1.113883.6.73 2017-01 N01BB05 butanilicaine © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 99 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N01BB06 cinchocaine 2.16.840.1.113883.6.73 2017-01 N01BB07 2.16.840.1.113883.6.73 2017-01 N01BB08 2.16.840.1.113883.6.73 2017-01 N01BB09 2.16.840.1.113883.6.73 2017-01 N01BB10 2.16.840.1.113883.6.73 2017-01 N01BB20 combinations 2.16.840.1.113883.6.73 2017-01 N01BB51 bupivacaine, combinations 2.16.840.1.113883.6.73 2017-01 N01BB52 lidocaine, combinations 2.16.840.1.113883.6.73 2017-01 N01BB53 mepivacaine, combinations 2.16.840.1.113883.6.73 2017-01 N01BB54 prilocaine, combinations 2.16.840.1.113883.6.73 2017-01 N01BB57 etidocaine, combinations 2.16.840.1.113883.6.73 2017-01 N01BB58 articaine, combinations 2.16.840.1.113883.6.73 2017-01 N01BC Esters of 2.16.840.1.113883.6.73 2017-01 N01BC01 2.16.840.1.113883.6.73 2017-01 N01BX Other local anesthetics 2.16.840.1.113883.6.73 2017-01 N01BX01 ethyl chloride 2.16.840.1.113883.6.73 2017-01 N01BX02 2.16.840.1.113883.6.73 2017-01 N01BX03 phenol 2.16.840.1.113883.6.73 2017-01 N01BX04 capsaicin 2.16.840.1.113883.6.73 2017-01 N02 ANALGESICS 2.16.840.1.113883.6.73 2017-01 N02A 2.16.840.1.113883.6.73 2017-01 N02AA Natural opium alkaloids 2.16.840.1.113883.6.73 2017-01 N02AA01 morphine 2.16.840.1.113883.6.73 2017-01 N02AA02 opium 2.16.840.1.113883.6.73 2017-01 N02AA03 2.16.840.1.113883.6.73 2017-01 N02AA04 2.16.840.1.113883.6.73 2017-01 N02AA05 2.16.840.1.113883.6.73 2017-01 N02AA08 2.16.840.1.113883.6.73 2017-01 N02AA10 2.16.840.1.113883.6.73 2017-01 N02AA51 morphine, combinations 2.16.840.1.113883.6.73 2017-01 N02AA55 oxycodone and naloxone 2.16.840.1.113883.6.73 2017-01 N02AA58 dihydrocodeine, combinations 2.16.840.1.113883.6.73 2017-01 N02AA59 , combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02AA79 codeine, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02AB Phenylpiperidine derivatives 2.16.840.1.113883.6.73 2017-01 N02AB01 2.16.840.1.113883.6.73 2017-01 N02AB02 2.16.840.1.113883.6.73 2017-01 N02AB03 fentanyl 2.16.840.1.113883.6.73 2017-01 N02AB52 pethidine, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02AB72 pethidine, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02AC Diphenylpropylamine derivatives 2.16.840.1.113883.6.73 2017-01 N02AC01 2.16.840.1.113883.6.73 2017-01 N02AC03 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 100 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02AC04 2.16.840.1.113883.6.73 2017-01 N02AC05 2.16.840.1.113883.6.73 2017-01 N02AC52 , combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02AC54 dextropropoxyphene, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02AC74 dextropropoxyphene, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02AD derivatives 2.16.840.1.113883.6.73 2017-01 N02AD01 2.16.840.1.113883.6.73 2017-01 N02AD02 2.16.840.1.113883.6.73 2017-01 N02AE derivatives 2.16.840.1.113883.6.73 2017-01 N02AE01 2.16.840.1.113883.6.73 2017-01 N02AF derivatives 2.16.840.1.113883.6.73 2017-01 N02AF01 2.16.840.1.113883.6.73 2017-01 N02AF02 2.16.840.1.113883.6.73 2017-01 N02AG Opioids in combination with antispasmodics 2.16.840.1.113883.6.73 2017-01 N02AG01 morphine and antispasmodics 2.16.840.1.113883.6.73 2017-01 N02AG02 ketobemidone and antispasmodics 2.16.840.1.113883.6.73 2017-01 N02AG03 pethidine and antispasmodics 2.16.840.1.113883.6.73 2017-01 N02AG04 hydromorphone and antispasmodics 2.16.840.1.113883.6.73 2017-01 N02AJ Opioids in combination with non-opioid analgesics 2.16.840.1.113883.6.73 2017-01 N02AJ01 dihydrocodeine and 2.16.840.1.113883.6.73 2017-01 N02AJ02 dihydrocodeine and acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 N02AJ03 dihydrocodeine and other non-opioid analgesics 2.16.840.1.113883.6.73 2017-01 N02AJ06 codeine and paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ07 codeine and acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 N02AJ08 codeine and ibuprofen 2.16.840.1.113883.6.73 2017-01 N02AJ09 codeine and other non-opioid analgesics 2.16.840.1.113883.6.73 2017-01 N02AJ13 and paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ14 tramadol and dexketoprofen 2.16.840.1.113883.6.73 2017-01 N02AJ15 tramadol and other non-opioid analgesics 2.16.840.1.113883.6.73 2017-01 N02AJ17 oxycodone and paracetamol 2.16.840.1.113883.6.73 2017-01 N02AJ18 oxycodone and acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 N02AJ19 oxycodone and ibuprofen 2.16.840.1.113883.6.73 2017-01 N02AX Other opioids 2.16.840.1.113883.6.73 2017-01 N02AX01 2.16.840.1.113883.6.73 2017-01 N02AX02 tramadol 2.16.840.1.113883.6.73 2017-01 N02AX03 2.16.840.1.113883.6.73 2017-01 N02AX05 2.16.840.1.113883.6.73 2017-01 N02AX06 2.16.840.1.113883.6.73 2017-01 N02B OTHER ANALGESICS AND 2.16.840.1.113883.6.73 2017-01 N02BA Salicylic acid and derivatives 2.16.840.1.113883.6.73 2017-01 N02BA01 acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 N02BA02 aloxiprin 2.16.840.1.113883.6.73 2017-01 N02BA03 choline salicylate © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 101 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02BA04 2.16.840.1.113883.6.73 2017-01 N02BA05 2.16.840.1.113883.6.73 2017-01 N02BA06 2.16.840.1.113883.6.73 2017-01 N02BA07 2.16.840.1.113883.6.73 2017-01 N02BA08 morpholine salicylate 2.16.840.1.113883.6.73 2017-01 N02BA09 dipyrocetyl 2.16.840.1.113883.6.73 2017-01 N02BA10 2.16.840.1.113883.6.73 2017-01 N02BA11 2.16.840.1.113883.6.73 2017-01 N02BA12 2.16.840.1.113883.6.73 2017-01 N02BA14 2.16.840.1.113883.6.73 2017-01 N02BA15 carbasalate calcium 2.16.840.1.113883.6.73 2017-01 N02BA16 2.16.840.1.113883.6.73 2017-01 N02BA51 acetylsalicylic acid, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BA55 salicylamide, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BA57 ethenzamide, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BA59 dipyrocetyl, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BA65 carbasalate calcium combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BA71 acetylsalicylic acid, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BA75 salicylamide, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BA77 ethenzamide, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BA79 dipyrocetyl, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BB 2.16.840.1.113883.6.73 2017-01 N02BB01 2.16.840.1.113883.6.73 2017-01 N02BB02 sodium 2.16.840.1.113883.6.73 2017-01 N02BB03 2.16.840.1.113883.6.73 2017-01 N02BB04 2.16.840.1.113883.6.73 2017-01 N02BB05 nifenazone 2.16.840.1.113883.6.73 2017-01 N02BB51 phenazone, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BB52 metamizole sodium, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BB53 aminophenazone, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BB54 propyphenazone, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BB71 phenazone, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BB72 metamizole sodium, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BB73 aminophenazone, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BB74 propyphenazone, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BE Anilides 2.16.840.1.113883.6.73 2017-01 N02BE01 paracetamol 2.16.840.1.113883.6.73 2017-01 N02BE03 2.16.840.1.113883.6.73 2017-01 N02BE04 2.16.840.1.113883.6.73 2017-01 N02BE05 2.16.840.1.113883.6.73 2017-01 N02BE51 paracetamol, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BE53 phenacetin, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BE54 bucetin, combinations excl. psycholeptics © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 102 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N02BE71 paracetamol, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BE73 phenacetin, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BE74 bucetin, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02BG Other analgesics and antipyretics 2.16.840.1.113883.6.73 2017-01 N02BG02 2.16.840.1.113883.6.73 2017-01 N02BG03 2.16.840.1.113883.6.73 2017-01 N02BG04 2.16.840.1.113883.6.73 2017-01 N02BG05 2.16.840.1.113883.6.73 2017-01 N02BG06 2.16.840.1.113883.6.73 2017-01 N02BG07 2.16.840.1.113883.6.73 2017-01 N02BG08 2.16.840.1.113883.6.73 2017-01 N02BG09 2.16.840.1.113883.6.73 2017-01 N02BG10 2.16.840.1.113883.6.73 2017-01 N02C ANTIMIGRAINE PREPARATIONS 2.16.840.1.113883.6.73 2017-01 N02CA Ergot alkaloids 2.16.840.1.113883.6.73 2017-01 N02CA01 2.16.840.1.113883.6.73 2017-01 N02CA02 2.16.840.1.113883.6.73 2017-01 N02CA04 2.16.840.1.113883.6.73 2017-01 N02CA07 lisuride 2.16.840.1.113883.6.73 2017-01 N02CA51 dihydroergotamine, combinations 2.16.840.1.113883.6.73 2017-01 N02CA52 ergotamine, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 N02CA72 ergotamine, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 N02CB derivatives 2.16.840.1.113883.6.73 2017-01 N02CB01 flumedroxone 2.16.840.1.113883.6.73 2017-01 N02CC Selective serotonin (5HT1) agonists 2.16.840.1.113883.6.73 2017-01 N02CC01 2.16.840.1.113883.6.73 2017-01 N02CC02 2.16.840.1.113883.6.73 2017-01 N02CC03 2.16.840.1.113883.6.73 2017-01 N02CC04 2.16.840.1.113883.6.73 2017-01 N02CC05 2.16.840.1.113883.6.73 2017-01 N02CC06 2.16.840.1.113883.6.73 2017-01 N02CC07 2.16.840.1.113883.6.73 2017-01 N02CX Other antimigraine preparations 2.16.840.1.113883.6.73 2017-01 N02CX01 2.16.840.1.113883.6.73 2017-01 N02CX02 clonidine 2.16.840.1.113883.6.73 2017-01 N02CX03 2.16.840.1.113883.6.73 2017-01 N02CX05 2.16.840.1.113883.6.73 2017-01 N02CX06 2.16.840.1.113883.6.73 2017-01 N03 ANTIEPILEPTICS 2.16.840.1.113883.6.73 2017-01 N03A ANTIEPILEPTICS 2.16.840.1.113883.6.73 2017-01 N03AA Barbiturates and derivatives 2.16.840.1.113883.6.73 2017-01 N03AA01 2.16.840.1.113883.6.73 2017-01 N03AA02 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 103 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N03AA03 2.16.840.1.113883.6.73 2017-01 N03AA04 2.16.840.1.113883.6.73 2017-01 N03AA30 2.16.840.1.113883.6.73 2017-01 N03AB derivatives 2.16.840.1.113883.6.73 2017-01 N03AB01 2.16.840.1.113883.6.73 2017-01 N03AB02 2.16.840.1.113883.6.73 2017-01 N03AB03 amino(diphenylhydantoin) valeric acid 2.16.840.1.113883.6.73 2017-01 N03AB04 2.16.840.1.113883.6.73 2017-01 N03AB05 2.16.840.1.113883.6.73 2017-01 N03AB52 phenytoin, combinations 2.16.840.1.113883.6.73 2017-01 N03AB54 mephenytoin, combinations 2.16.840.1.113883.6.73 2017-01 N03AC Oxazolidine derivatives 2.16.840.1.113883.6.73 2017-01 N03AC01 2.16.840.1.113883.6.73 2017-01 N03AC02 2.16.840.1.113883.6.73 2017-01 N03AC03 2.16.840.1.113883.6.73 2017-01 N03AD Succinimide derivatives 2.16.840.1.113883.6.73 2017-01 N03AD01 2.16.840.1.113883.6.73 2017-01 N03AD02 2.16.840.1.113883.6.73 2017-01 N03AD03 2.16.840.1.113883.6.73 2017-01 N03AD51 ethosuximide, combinations 2.16.840.1.113883.6.73 2017-01 N03AE derivatives 2.16.840.1.113883.6.73 2017-01 N03AE01 2.16.840.1.113883.6.73 2017-01 N03AF Carboxamide derivatives 2.16.840.1.113883.6.73 2017-01 N03AF01 2.16.840.1.113883.6.73 2017-01 N03AF02 2.16.840.1.113883.6.73 2017-01 N03AF03 2.16.840.1.113883.6.73 2017-01 N03AF04 eslicarbazepine 2.16.840.1.113883.6.73 2017-01 N03AG derivatives 2.16.840.1.113883.6.73 2017-01 N03AG01 valproic acid 2.16.840.1.113883.6.73 2017-01 N03AG02 2.16.840.1.113883.6.73 2017-01 N03AG03 aminobutyric acid 2.16.840.1.113883.6.73 2017-01 N03AG04 2.16.840.1.113883.6.73 2017-01 N03AG05 2.16.840.1.113883.6.73 2017-01 N03AG06 2.16.840.1.113883.6.73 2017-01 N03AX Other antiepileptics 2.16.840.1.113883.6.73 2017-01 N03AX03 2.16.840.1.113883.6.73 2017-01 N03AX07 2.16.840.1.113883.6.73 2017-01 N03AX09 2.16.840.1.113883.6.73 2017-01 N03AX10 2.16.840.1.113883.6.73 2017-01 N03AX11 2.16.840.1.113883.6.73 2017-01 N03AX12 2.16.840.1.113883.6.73 2017-01 N03AX13 2.16.840.1.113883.6.73 2017-01 N03AX14 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 104 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N03AX15 2.16.840.1.113883.6.73 2017-01 N03AX16 2.16.840.1.113883.6.73 2017-01 N03AX17 2.16.840.1.113883.6.73 2017-01 N03AX18 2.16.840.1.113883.6.73 2017-01 N03AX19 2.16.840.1.113883.6.73 2017-01 N03AX21 2.16.840.1.113883.6.73 2017-01 N03AX22 2.16.840.1.113883.6.73 2017-01 N03AX23 2.16.840.1.113883.6.73 2017-01 N03AX30 2.16.840.1.113883.6.73 2017-01 N04 ANTI-PARKINSON DRUGS 2.16.840.1.113883.6.73 2017-01 N04A ANTICHOLINERGIC AGENTS 2.16.840.1.113883.6.73 2017-01 N04AA Tertiary amines 2.16.840.1.113883.6.73 2017-01 N04AA01 2.16.840.1.113883.6.73 2017-01 N04AA02 2.16.840.1.113883.6.73 2017-01 N04AA03 2.16.840.1.113883.6.73 2017-01 N04AA04 2.16.840.1.113883.6.73 2017-01 N04AA05 2.16.840.1.113883.6.73 2017-01 N04AA08 2.16.840.1.113883.6.73 2017-01 N04AA09 2.16.840.1.113883.6.73 2017-01 N04AA10 2.16.840.1.113883.6.73 2017-01 N04AA11 2.16.840.1.113883.6.73 2017-01 N04AA12 2.16.840.1.113883.6.73 2017-01 N04AB Ethers chemically close to antihistamines 2.16.840.1.113883.6.73 2017-01 N04AB01 2.16.840.1.113883.6.73 2017-01 N04AB02 orphenadrine (chloride) 2.16.840.1.113883.6.73 2017-01 N04AC Ethers of tropine or tropine derivatives 2.16.840.1.113883.6.73 2017-01 N04AC01 2.16.840.1.113883.6.73 2017-01 N04AC30 2.16.840.1.113883.6.73 2017-01 N04B DOPAMINERGIC AGENTS 2.16.840.1.113883.6.73 2017-01 N04BA Dopa and dopa derivatives 2.16.840.1.113883.6.73 2017-01 N04BA01 levodopa 2.16.840.1.113883.6.73 2017-01 N04BA02 levodopa and decarboxylase inhibitor 2.16.840.1.113883.6.73 2017-01 N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor 2.16.840.1.113883.6.73 2017-01 N04BA04 2.16.840.1.113883.6.73 2017-01 N04BA05 melevodopa and decarboxylase inhibitor 2.16.840.1.113883.6.73 2017-01 N04BA06 and decarboxylase inhibitor 2.16.840.1.113883.6.73 2017-01 N04BB derivatives 2.16.840.1.113883.6.73 2017-01 N04BB01 2.16.840.1.113883.6.73 2017-01 N04BC Dopamine agonists 2.16.840.1.113883.6.73 2017-01 N04BC01 bromocriptine 2.16.840.1.113883.6.73 2017-01 N04BC02 2.16.840.1.113883.6.73 2017-01 N04BC03 mesylate 2.16.840.1.113883.6.73 2017-01 N04BC04 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 105 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N04BC05 2.16.840.1.113883.6.73 2017-01 N04BC06 cabergoline 2.16.840.1.113883.6.73 2017-01 N04BC07 apomorphine 2.16.840.1.113883.6.73 2017-01 N04BC08 2.16.840.1.113883.6.73 2017-01 N04BC09 2.16.840.1.113883.6.73 2017-01 N04BD Monoamine oxidase B inhibitors 2.16.840.1.113883.6.73 2017-01 N04BD01 2.16.840.1.113883.6.73 2017-01 N04BD02 2.16.840.1.113883.6.73 2017-01 N04BD03 2.16.840.1.113883.6.73 2017-01 N04BX Other dopaminergic agents 2.16.840.1.113883.6.73 2017-01 N04BX01 2.16.840.1.113883.6.73 2017-01 N04BX02 2.16.840.1.113883.6.73 2017-01 N04BX03 2.16.840.1.113883.6.73 2017-01 N05 PSYCHOLEPTICS 2.16.840.1.113883.6.73 2017-01 N05A 2.16.840.1.113883.6.73 2017-01 N05AA with aliphatic side-chain 2.16.840.1.113883.6.73 2017-01 N05AA01 2.16.840.1.113883.6.73 2017-01 N05AA02 2.16.840.1.113883.6.73 2017-01 N05AA03 2.16.840.1.113883.6.73 2017-01 N05AA04 2.16.840.1.113883.6.73 2017-01 N05AA05 2.16.840.1.113883.6.73 2017-01 N05AA06 2.16.840.1.113883.6.73 2017-01 N05AA07 2.16.840.1.113883.6.73 2017-01 N05AB Phenothiazines with structure 2.16.840.1.113883.6.73 2017-01 N05AB01 2.16.840.1.113883.6.73 2017-01 N05AB02 2.16.840.1.113883.6.73 2017-01 N05AB03 2.16.840.1.113883.6.73 2017-01 N05AB04 2.16.840.1.113883.6.73 2017-01 N05AB05 2.16.840.1.113883.6.73 2017-01 N05AB06 2.16.840.1.113883.6.73 2017-01 N05AB07 2.16.840.1.113883.6.73 2017-01 N05AB08 2.16.840.1.113883.6.73 2017-01 N05AB09 2.16.840.1.113883.6.73 2017-01 N05AB10 2.16.840.1.113883.6.73 2017-01 N05AC Phenothiazines with structure 2.16.840.1.113883.6.73 2017-01 N05AC01 2.16.840.1.113883.6.73 2017-01 N05AC02 2.16.840.1.113883.6.73 2017-01 N05AC03 2.16.840.1.113883.6.73 2017-01 N05AC04 2.16.840.1.113883.6.73 2017-01 N05AD Butyrophenone derivatives 2.16.840.1.113883.6.73 2017-01 N05AD01 2.16.840.1.113883.6.73 2017-01 N05AD02 2.16.840.1.113883.6.73 2017-01 N05AD03 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 106 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05AD04 2.16.840.1.113883.6.73 2017-01 N05AD05 2.16.840.1.113883.6.73 2017-01 N05AD06 2.16.840.1.113883.6.73 2017-01 N05AD07 2.16.840.1.113883.6.73 2017-01 N05AD08 2.16.840.1.113883.6.73 2017-01 N05AD09 2.16.840.1.113883.6.73 2017-01 N05AE Indole derivatives 2.16.840.1.113883.6.73 2017-01 N05AE01 oxypertine 2.16.840.1.113883.6.73 2017-01 N05AE02 2.16.840.1.113883.6.73 2017-01 N05AE03 2.16.840.1.113883.6.73 2017-01 N05AE04 2.16.840.1.113883.6.73 2017-01 N05AE05 2.16.840.1.113883.6.73 2017-01 N05AF derivatives 2.16.840.1.113883.6.73 2017-01 N05AF01 2.16.840.1.113883.6.73 2017-01 N05AF02 2.16.840.1.113883.6.73 2017-01 N05AF03 2.16.840.1.113883.6.73 2017-01 N05AF04 2.16.840.1.113883.6.73 2017-01 N05AF05 2.16.840.1.113883.6.73 2017-01 N05AG Diphenylbutylpiperidine derivatives 2.16.840.1.113883.6.73 2017-01 N05AG01 2.16.840.1.113883.6.73 2017-01 N05AG02 2.16.840.1.113883.6.73 2017-01 N05AG03 2.16.840.1.113883.6.73 2017-01 N05AH Diazepines, oxazepines, thiazepines and oxepines 2.16.840.1.113883.6.73 2017-01 N05AH01 2.16.840.1.113883.6.73 2017-01 N05AH02 2.16.840.1.113883.6.73 2017-01 N05AH03 2.16.840.1.113883.6.73 2017-01 N05AH04 2.16.840.1.113883.6.73 2017-01 N05AH05 2.16.840.1.113883.6.73 2017-01 N05AH06 2.16.840.1.113883.6.73 2017-01 N05AL 2.16.840.1.113883.6.73 2017-01 N05AL01 2.16.840.1.113883.6.73 2017-01 N05AL02 2.16.840.1.113883.6.73 2017-01 N05AL03 2.16.840.1.113883.6.73 2017-01 N05AL04 2.16.840.1.113883.6.73 2017-01 N05AL05 2.16.840.1.113883.6.73 2017-01 N05AL06 2.16.840.1.113883.6.73 2017-01 N05AL07 2.16.840.1.113883.6.73 2017-01 N05AN Lithium 2.16.840.1.113883.6.73 2017-01 N05AN01 lithium 2.16.840.1.113883.6.73 2017-01 N05AX Other antipsychotics 2.16.840.1.113883.6.73 2017-01 N05AX07 2.16.840.1.113883.6.73 2017-01 N05AX08 2.16.840.1.113883.6.73 2017-01 N05AX10 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 107 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05AX11 2.16.840.1.113883.6.73 2017-01 N05AX12 2.16.840.1.113883.6.73 2017-01 N05AX13 2.16.840.1.113883.6.73 2017-01 N05AX14 2.16.840.1.113883.6.73 2017-01 N05AX15 2.16.840.1.113883.6.73 2017-01 N05AX16 2.16.840.1.113883.6.73 2017-01 N05AX17 pimavanserin 2.16.840.1.113883.6.73 2017-01 N05B ANXIOLYTICS 2.16.840.1.113883.6.73 2017-01 N05BA Benzodiazepine derivatives 2.16.840.1.113883.6.73 2017-01 N05BA01 2.16.840.1.113883.6.73 2017-01 N05BA02 2.16.840.1.113883.6.73 2017-01 N05BA03 2.16.840.1.113883.6.73 2017-01 N05BA04 2.16.840.1.113883.6.73 2017-01 N05BA05 potassium 2.16.840.1.113883.6.73 2017-01 N05BA06 2.16.840.1.113883.6.73 2017-01 N05BA07 2.16.840.1.113883.6.73 2017-01 N05BA08 2.16.840.1.113883.6.73 2017-01 N05BA09 2.16.840.1.113883.6.73 2017-01 N05BA10 2.16.840.1.113883.6.73 2017-01 N05BA11 2.16.840.1.113883.6.73 2017-01 N05BA12 2.16.840.1.113883.6.73 2017-01 N05BA13 2.16.840.1.113883.6.73 2017-01 N05BA14 2.16.840.1.113883.6.73 2017-01 N05BA15 2.16.840.1.113883.6.73 2017-01 N05BA16 2.16.840.1.113883.6.73 2017-01 N05BA17 2.16.840.1.113883.6.73 2017-01 N05BA18 2.16.840.1.113883.6.73 2017-01 N05BA19 2.16.840.1.113883.6.73 2017-01 N05BA21 2.16.840.1.113883.6.73 2017-01 N05BA22 2.16.840.1.113883.6.73 2017-01 N05BA23 tofisopam 2.16.840.1.113883.6.73 2017-01 N05BA24 2.16.840.1.113883.6.73 2017-01 N05BA56 lorazepam, combinations 2.16.840.1.113883.6.73 2017-01 N05BB derivatives 2.16.840.1.113883.6.73 2017-01 N05BB01 2.16.840.1.113883.6.73 2017-01 N05BB02 2.16.840.1.113883.6.73 2017-01 N05BB51 hydroxyzine, combinations 2.16.840.1.113883.6.73 2017-01 N05BC 2.16.840.1.113883.6.73 2017-01 N05BC01 2.16.840.1.113883.6.73 2017-01 N05BC03 2.16.840.1.113883.6.73 2017-01 N05BC04 2.16.840.1.113883.6.73 2017-01 N05BC51 meprobamate, combinations 2.16.840.1.113883.6.73 2017-01 N05BD Dibenzo-bicyclo-octadiene derivatives © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 108 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05BD01 2.16.840.1.113883.6.73 2017-01 N05BE Azaspirodecanedione derivatives 2.16.840.1.113883.6.73 2017-01 N05BE01 2.16.840.1.113883.6.73 2017-01 N05BX Other anxiolytics 2.16.840.1.113883.6.73 2017-01 N05BX01 2.16.840.1.113883.6.73 2017-01 N05BX02 2.16.840.1.113883.6.73 2017-01 N05BX03 2.16.840.1.113883.6.73 2017-01 N05BX04 fabomotizole 2.16.840.1.113883.6.73 2017-01 N05C AND 2.16.840.1.113883.6.73 2017-01 N05CA Barbiturates, plain 2.16.840.1.113883.6.73 2017-01 N05CA01 2.16.840.1.113883.6.73 2017-01 N05CA02 2.16.840.1.113883.6.73 2017-01 N05CA03 2.16.840.1.113883.6.73 2017-01 N05CA04 2.16.840.1.113883.6.73 2017-01 N05CA05 2.16.840.1.113883.6.73 2017-01 N05CA06 2.16.840.1.113883.6.73 2017-01 N05CA07 2.16.840.1.113883.6.73 2017-01 N05CA08 2.16.840.1.113883.6.73 2017-01 N05CA09 2.16.840.1.113883.6.73 2017-01 N05CA10 2.16.840.1.113883.6.73 2017-01 N05CA11 heptabarbital 2.16.840.1.113883.6.73 2017-01 N05CA12 2.16.840.1.113883.6.73 2017-01 N05CA15 methohexital 2.16.840.1.113883.6.73 2017-01 N05CA16 hexobarbital 2.16.840.1.113883.6.73 2017-01 N05CA19 thiopental 2.16.840.1.113883.6.73 2017-01 N05CA20 etallobarbital 2.16.840.1.113883.6.73 2017-01 N05CA21 2.16.840.1.113883.6.73 2017-01 N05CA22 proxibarbal 2.16.840.1.113883.6.73 2017-01 N05CB Barbiturates, combinations 2.16.840.1.113883.6.73 2017-01 N05CB01 combinations of barbiturates 2.16.840.1.113883.6.73 2017-01 N05CB02 barbiturates in combination with other drugs 2.16.840.1.113883.6.73 2017-01 N05CC Aldehydes and derivatives 2.16.840.1.113883.6.73 2017-01 N05CC01 hydrate 2.16.840.1.113883.6.73 2017-01 N05CC02 2.16.840.1.113883.6.73 2017-01 N05CC03 acetylglycinamide 2.16.840.1.113883.6.73 2017-01 N05CC04 2.16.840.1.113883.6.73 2017-01 N05CC05 2.16.840.1.113883.6.73 2017-01 N05CD Benzodiazepine derivatives 2.16.840.1.113883.6.73 2017-01 N05CD01 2.16.840.1.113883.6.73 2017-01 N05CD02 2.16.840.1.113883.6.73 2017-01 N05CD03 2.16.840.1.113883.6.73 2017-01 N05CD04 2.16.840.1.113883.6.73 2017-01 N05CD05 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 109 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05CD06 2.16.840.1.113883.6.73 2017-01 N05CD07 2.16.840.1.113883.6.73 2017-01 N05CD08 2.16.840.1.113883.6.73 2017-01 N05CD09 2.16.840.1.113883.6.73 2017-01 N05CD10 2.16.840.1.113883.6.73 2017-01 N05CD11 2.16.840.1.113883.6.73 2017-01 N05CD12 2.16.840.1.113883.6.73 2017-01 N05CD13 2.16.840.1.113883.6.73 2017-01 N05CE Piperidinedione derivatives 2.16.840.1.113883.6.73 2017-01 N05CE01 2.16.840.1.113883.6.73 2017-01 N05CE02 2.16.840.1.113883.6.73 2017-01 N05CE03 2.16.840.1.113883.6.73 2017-01 N05CF Benzodiazepine related drugs 2.16.840.1.113883.6.73 2017-01 N05CF01 2.16.840.1.113883.6.73 2017-01 N05CF02 2.16.840.1.113883.6.73 2017-01 N05CF03 2.16.840.1.113883.6.73 2017-01 N05CF04 2.16.840.1.113883.6.73 2017-01 N05CH receptor agonists 2.16.840.1.113883.6.73 2017-01 N05CH01 melatonin 2.16.840.1.113883.6.73 2017-01 N05CH02 2.16.840.1.113883.6.73 2017-01 N05CH03 2.16.840.1.113883.6.73 2017-01 N05CM Other hypnotics and sedatives 2.16.840.1.113883.6.73 2017-01 N05CM01 2.16.840.1.113883.6.73 2017-01 N05CM02 2.16.840.1.113883.6.73 2017-01 N05CM03 2.16.840.1.113883.6.73 2017-01 N05CM04 2.16.840.1.113883.6.73 2017-01 N05CM05 scopolamine 2.16.840.1.113883.6.73 2017-01 N05CM06 2.16.840.1.113883.6.73 2017-01 N05CM07 2.16.840.1.113883.6.73 2017-01 N05CM08 2.16.840.1.113883.6.73 2017-01 N05CM09 Valerianae radix 2.16.840.1.113883.6.73 2017-01 N05CM10 2.16.840.1.113883.6.73 2017-01 N05CM11 2.16.840.1.113883.6.73 2017-01 N05CM12 2.16.840.1.113883.6.73 2017-01 N05CM13 2.16.840.1.113883.6.73 2017-01 N05CM15 2.16.840.1.113883.6.73 2017-01 N05CM16 2.16.840.1.113883.6.73 2017-01 N05CM18 2.16.840.1.113883.6.73 2017-01 N05CX Hypnotics and sedatives in combination, excl. barbiturates 2.16.840.1.113883.6.73 2017-01 N05CX01 meprobamate, combinations 2.16.840.1.113883.6.73 2017-01 N05CX02 methaqualone, combinations 2.16.840.1.113883.6.73 2017-01 N05CX03 methylpentynol, combinations 2.16.840.1.113883.6.73 2017-01 N05CX04 clomethiazole, combinations © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 110 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N05CX05 emepronium, combinations 2.16.840.1.113883.6.73 2017-01 N05CX06 dipiperonylaminoethanol, combinations 2.16.840.1.113883.6.73 2017-01 N06 PSYCHOANALEPTICS 2.16.840.1.113883.6.73 2017-01 N06A 2.16.840.1.113883.6.73 2017-01 N06AA Non-selective monoamine reuptake inhibitors 2.16.840.1.113883.6.73 2017-01 N06AA01 2.16.840.1.113883.6.73 2017-01 N06AA02 2.16.840.1.113883.6.73 2017-01 N06AA03 imipramine oxide 2.16.840.1.113883.6.73 2017-01 N06AA04 2.16.840.1.113883.6.73 2017-01 N06AA05 2.16.840.1.113883.6.73 2017-01 N06AA06 2.16.840.1.113883.6.73 2017-01 N06AA07 2.16.840.1.113883.6.73 2017-01 N06AA08 2.16.840.1.113883.6.73 2017-01 N06AA09 2.16.840.1.113883.6.73 2017-01 N06AA10 2.16.840.1.113883.6.73 2017-01 N06AA11 2.16.840.1.113883.6.73 2017-01 N06AA12 2.16.840.1.113883.6.73 2017-01 N06AA13 2.16.840.1.113883.6.73 2017-01 N06AA14 2.16.840.1.113883.6.73 2017-01 N06AA15 2.16.840.1.113883.6.73 2017-01 N06AA16 2.16.840.1.113883.6.73 2017-01 N06AA17 2.16.840.1.113883.6.73 2017-01 N06AA18 2.16.840.1.113883.6.73 2017-01 N06AA19 2.16.840.1.113883.6.73 2017-01 N06AA21 2.16.840.1.113883.6.73 2017-01 N06AA23 2.16.840.1.113883.6.73 2017-01 N06AB Selective serotonin reuptake inhibitors 2.16.840.1.113883.6.73 2017-01 N06AB02 zimeldine 2.16.840.1.113883.6.73 2017-01 N06AB03 2.16.840.1.113883.6.73 2017-01 N06AB04 citalopram 2.16.840.1.113883.6.73 2017-01 N06AB05 2.16.840.1.113883.6.73 2017-01 N06AB06 sertraline 2.16.840.1.113883.6.73 2017-01 N06AB07 alaproclate 2.16.840.1.113883.6.73 2017-01 N06AB08 fluvoxamine 2.16.840.1.113883.6.73 2017-01 N06AB09 2.16.840.1.113883.6.73 2017-01 N06AB10 escitalopram 2.16.840.1.113883.6.73 2017-01 N06AF Monoamine oxidase inhibitors, non-selective 2.16.840.1.113883.6.73 2017-01 N06AF01 2.16.840.1.113883.6.73 2017-01 N06AF02 2.16.840.1.113883.6.73 2017-01 N06AF03 2.16.840.1.113883.6.73 2017-01 N06AF04 2.16.840.1.113883.6.73 2017-01 N06AF05 iproniazide 2.16.840.1.113883.6.73 2017-01 N06AF06 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 111 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N06AG Monoamine oxidase A inhibitors 2.16.840.1.113883.6.73 2017-01 N06AG02 moclobemide 2.16.840.1.113883.6.73 2017-01 N06AG03 toloxatone 2.16.840.1.113883.6.73 2017-01 N06AX Other antidepressants 2.16.840.1.113883.6.73 2017-01 N06AX01 oxitriptan 2.16.840.1.113883.6.73 2017-01 N06AX02 tryptophan 2.16.840.1.113883.6.73 2017-01 N06AX03 2.16.840.1.113883.6.73 2017-01 N06AX04 2.16.840.1.113883.6.73 2017-01 N06AX05 2.16.840.1.113883.6.73 2017-01 N06AX06 2.16.840.1.113883.6.73 2017-01 N06AX07 minaprine 2.16.840.1.113883.6.73 2017-01 N06AX08 2.16.840.1.113883.6.73 2017-01 N06AX09 2.16.840.1.113883.6.73 2017-01 N06AX10 2.16.840.1.113883.6.73 2017-01 N06AX11 2.16.840.1.113883.6.73 2017-01 N06AX12 bupropion 2.16.840.1.113883.6.73 2017-01 N06AX13 2.16.840.1.113883.6.73 2017-01 N06AX14 2.16.840.1.113883.6.73 2017-01 N06AX15 pivagabine 2.16.840.1.113883.6.73 2017-01 N06AX16 venlafaxine 2.16.840.1.113883.6.73 2017-01 N06AX17 milnacipran 2.16.840.1.113883.6.73 2017-01 N06AX18 2.16.840.1.113883.6.73 2017-01 N06AX19 2.16.840.1.113883.6.73 2017-01 N06AX21 duloxetine 2.16.840.1.113883.6.73 2017-01 N06AX22 2.16.840.1.113883.6.73 2017-01 N06AX23 desvenlafaxine 2.16.840.1.113883.6.73 2017-01 N06AX24 vilazodone 2.16.840.1.113883.6.73 2017-01 N06AX25 Hyperici herba 2.16.840.1.113883.6.73 2017-01 N06AX26 vortioxetine 2.16.840.1.113883.6.73 2017-01 N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS 2.16.840.1.113883.6.73 2017-01 N06BA Centrally acting sympathomimetics 2.16.840.1.113883.6.73 2017-01 N06BA01 amfetamine 2.16.840.1.113883.6.73 2017-01 N06BA02 dexamfetamine 2.16.840.1.113883.6.73 2017-01 N06BA03 metamfetamine 2.16.840.1.113883.6.73 2017-01 N06BA04 2.16.840.1.113883.6.73 2017-01 N06BA05 2.16.840.1.113883.6.73 2017-01 N06BA06 2.16.840.1.113883.6.73 2017-01 N06BA07 2.16.840.1.113883.6.73 2017-01 N06BA08 2.16.840.1.113883.6.73 2017-01 N06BA09 2.16.840.1.113883.6.73 2017-01 N06BA10 fenetylline 2.16.840.1.113883.6.73 2017-01 N06BA11

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 112 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N06BA12 2.16.840.1.113883.6.73 2017-01 N06BA13 2.16.840.1.113883.6.73 2017-01 N06BC Xanthine derivatives 2.16.840.1.113883.6.73 2017-01 N06BC01 2.16.840.1.113883.6.73 2017-01 N06BC02 2.16.840.1.113883.6.73 2017-01 N06BX Other psychostimulants and nootropics 2.16.840.1.113883.6.73 2017-01 N06BX01 2.16.840.1.113883.6.73 2017-01 N06BX02 2.16.840.1.113883.6.73 2017-01 N06BX03 2.16.840.1.113883.6.73 2017-01 N06BX04 deanol 2.16.840.1.113883.6.73 2017-01 N06BX05 fipexide 2.16.840.1.113883.6.73 2017-01 N06BX06 2.16.840.1.113883.6.73 2017-01 N06BX07 2.16.840.1.113883.6.73 2017-01 N06BX08 2.16.840.1.113883.6.73 2017-01 N06BX09 2.16.840.1.113883.6.73 2017-01 N06BX10 nizofenone 2.16.840.1.113883.6.73 2017-01 N06BX11 aniracetam 2.16.840.1.113883.6.73 2017-01 N06BX12 2.16.840.1.113883.6.73 2017-01 N06BX13 idebenone 2.16.840.1.113883.6.73 2017-01 N06BX14 2.16.840.1.113883.6.73 2017-01 N06BX15 2.16.840.1.113883.6.73 2017-01 N06BX16 pramiracetam 2.16.840.1.113883.6.73 2017-01 N06BX17 2.16.840.1.113883.6.73 2017-01 N06BX18 vinpocetine 2.16.840.1.113883.6.73 2017-01 N06BX21 mebicar 2.16.840.1.113883.6.73 2017-01 N06BX22 2.16.840.1.113883.6.73 2017-01 N06C PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION 2.16.840.1.113883.6.73 2017-01 N06CA Antidepressants in combination with psycholeptics 2.16.840.1.113883.6.73 2017-01 N06CA01 amitriptyline and psycholeptics 2.16.840.1.113883.6.73 2017-01 N06CA02 melitracen and psycholeptics 2.16.840.1.113883.6.73 2017-01 N06CA03 fluoxetine and psycholeptics 2.16.840.1.113883.6.73 2017-01 N06CB Psychostimulants in combination with psycholeptics 2.16.840.1.113883.6.73 2017-01 N06D ANTI-DEMENTIA DRUGS 2.16.840.1.113883.6.73 2017-01 N06DA Anticholinesterases 2.16.840.1.113883.6.73 2017-01 N06DA01 tacrine 2.16.840.1.113883.6.73 2017-01 N06DA02 donepezil 2.16.840.1.113883.6.73 2017-01 N06DA03 rivastigmine 2.16.840.1.113883.6.73 2017-01 N06DA04 2.16.840.1.113883.6.73 2017-01 N06DA05 ipidacrine 2.16.840.1.113883.6.73 2017-01 N06DA52 donepezil and 2.16.840.1.113883.6.73 2017-01 N06DA53 donepezil, memantine and Ginkgo folium 2.16.840.1.113883.6.73 2017-01 N06DX Other anti-dementia drugs

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 113 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N06DX01 memantine 2.16.840.1.113883.6.73 2017-01 N06DX02 Ginkgo folium 2.16.840.1.113883.6.73 2017-01 N06DX30 combinations 2.16.840.1.113883.6.73 2017-01 N07 OTHER NERVOUS SYSTEM DRUGS 2.16.840.1.113883.6.73 2017-01 N07A PARASYMPATHOMIMETICS 2.16.840.1.113883.6.73 2017-01 N07AA Anticholinesterases 2.16.840.1.113883.6.73 2017-01 N07AA01 2.16.840.1.113883.6.73 2017-01 N07AA02 2.16.840.1.113883.6.73 2017-01 N07AA03 2.16.840.1.113883.6.73 2017-01 N07AA30 ambenonium 2.16.840.1.113883.6.73 2017-01 N07AA51 neostigmine, combinations 2.16.840.1.113883.6.73 2017-01 N07AB Choline esters 2.16.840.1.113883.6.73 2017-01 N07AB01 2.16.840.1.113883.6.73 2017-01 N07AB02 2.16.840.1.113883.6.73 2017-01 N07AX Other parasympathomimetics 2.16.840.1.113883.6.73 2017-01 N07AX01 2.16.840.1.113883.6.73 2017-01 N07AX02 choline alfoscerate 2.16.840.1.113883.6.73 2017-01 N07AX03 2.16.840.1.113883.6.73 2017-01 N07B DRUGS USED IN ADDICTIVE DISORDERS 2.16.840.1.113883.6.73 2017-01 N07BA Drugs used in dependence 2.16.840.1.113883.6.73 2017-01 N07BA01 nicotine 2.16.840.1.113883.6.73 2017-01 N07BA03 2.16.840.1.113883.6.73 2017-01 N07BB Drugs used in 2.16.840.1.113883.6.73 2017-01 N07BB01 2.16.840.1.113883.6.73 2017-01 N07BB02 calcium carbimide 2.16.840.1.113883.6.73 2017-01 N07BB03 2.16.840.1.113883.6.73 2017-01 N07BB04 naltrexone 2.16.840.1.113883.6.73 2017-01 N07BB05 2.16.840.1.113883.6.73 2017-01 N07BC Drugs used in opioid dependence 2.16.840.1.113883.6.73 2017-01 N07BC01 buprenorphine 2.16.840.1.113883.6.73 2017-01 N07BC02 methadone 2.16.840.1.113883.6.73 2017-01 N07BC03 2.16.840.1.113883.6.73 2017-01 N07BC04 2.16.840.1.113883.6.73 2017-01 N07BC05 2.16.840.1.113883.6.73 2017-01 N07BC06 diamorphine 2.16.840.1.113883.6.73 2017-01 N07BC51 buprenorphine, combinations 2.16.840.1.113883.6.73 2017-01 N07C ANTIVERTIGO PREPARATIONS 2.16.840.1.113883.6.73 2017-01 N07CA Antivertigo preparations 2.16.840.1.113883.6.73 2017-01 N07CA01 2.16.840.1.113883.6.73 2017-01 N07CA02 2.16.840.1.113883.6.73 2017-01 N07CA03 2.16.840.1.113883.6.73 2017-01 N07CA04 2.16.840.1.113883.6.73 2017-01 N07CA52 cinnarizine, combinations © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 114 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 N07X OTHER NERVOUS SYSTEM DRUGS 2.16.840.1.113883.6.73 2017-01 N07XA Gangliosides and ganglioside derivatives 2.16.840.1.113883.6.73 2017-01 N07XX Other nervous system drugs 2.16.840.1.113883.6.73 2017-01 N07XX01 2.16.840.1.113883.6.73 2017-01 N07XX02 2.16.840.1.113883.6.73 2017-01 N07XX03 2.16.840.1.113883.6.73 2017-01 N07XX04 sodium oxybate 2.16.840.1.113883.6.73 2017-01 N07XX05 2.16.840.1.113883.6.73 2017-01 N07XX06 2.16.840.1.113883.6.73 2017-01 N07XX07 fampridine 2.16.840.1.113883.6.73 2017-01 N07XX08 2.16.840.1.113883.6.73 2017-01 N07XX09 2.16.840.1.113883.6.73 2017-01 N07XX10 2.16.840.1.113883.6.73 2017-01 N07XX11 2.16.840.1.113883.6.73 2017-01 N07XX59 , combinations 2.16.840.1.113883.6.73 2017-01 P PRODUCTS, AND REPELLENTS 2.16.840.1.113883.6.73 2017-01 P01 2.16.840.1.113883.6.73 2017-01 P01A AGENTS AGAINST AND OTHER PROTOZOAL DISEASES 2.16.840.1.113883.6.73 2017-01 P01AA Hydroxyquinoline derivatives 2.16.840.1.113883.6.73 2017-01 P01AA01 broxyquinoline 2.16.840.1.113883.6.73 2017-01 P01AA02 clioquinol 2.16.840.1.113883.6.73 2017-01 P01AA04 chlorquinaldol 2.16.840.1.113883.6.73 2017-01 P01AA05 2.16.840.1.113883.6.73 2017-01 P01AA52 clioquinol, combinations 2.16.840.1.113883.6.73 2017-01 P01AB derivatives 2.16.840.1.113883.6.73 2017-01 P01AB01 metronidazole 2.16.840.1.113883.6.73 2017-01 P01AB02 tinidazole 2.16.840.1.113883.6.73 2017-01 P01AB03 ornidazole 2.16.840.1.113883.6.73 2017-01 P01AB04 azanidazole 2.16.840.1.113883.6.73 2017-01 P01AB05 propenidazole 2.16.840.1.113883.6.73 2017-01 P01AB06 2.16.840.1.113883.6.73 2017-01 P01AB07 secnidazole 2.16.840.1.113883.6.73 2017-01 P01AB51 metronidazole, combinations 2.16.840.1.113883.6.73 2017-01 P01AC derivatives 2.16.840.1.113883.6.73 2017-01 P01AC01 2.16.840.1.113883.6.73 2017-01 P01AC02 2.16.840.1.113883.6.73 2017-01 P01AC03 2.16.840.1.113883.6.73 2017-01 P01AC04 2.16.840.1.113883.6.73 2017-01 P01AR Arsenic compounds 2.16.840.1.113883.6.73 2017-01 P01AR01 arsthinol 2.16.840.1.113883.6.73 2017-01 P01AR02 2.16.840.1.113883.6.73 2017-01 P01AR03 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 115 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P01AR53 glycobiarsol, combinations 2.16.840.1.113883.6.73 2017-01 P01AX Other agents against amoebiasis and other protozoal diseases 2.16.840.1.113883.6.73 2017-01 P01AX01 2.16.840.1.113883.6.73 2017-01 P01AX02 2.16.840.1.113883.6.73 2017-01 P01AX04 2.16.840.1.113883.6.73 2017-01 P01AX05 2.16.840.1.113883.6.73 2017-01 P01AX06 2.16.840.1.113883.6.73 2017-01 P01AX07 2.16.840.1.113883.6.73 2017-01 P01AX08 2.16.840.1.113883.6.73 2017-01 P01AX09 2.16.840.1.113883.6.73 2017-01 P01AX10 2.16.840.1.113883.6.73 2017-01 P01AX11 nitazoxanide 2.16.840.1.113883.6.73 2017-01 P01AX52 emetine, combinations 2.16.840.1.113883.6.73 2017-01 P01B ANTIMALARIALS 2.16.840.1.113883.6.73 2017-01 P01BA Aminoquinolines 2.16.840.1.113883.6.73 2017-01 P01BA01 2.16.840.1.113883.6.73 2017-01 P01BA02 2.16.840.1.113883.6.73 2017-01 P01BA03 primaquine 2.16.840.1.113883.6.73 2017-01 P01BA06 amodiaquine 2.16.840.1.113883.6.73 2017-01 P01BB Biguanides 2.16.840.1.113883.6.73 2017-01 P01BB01 proguanil 2.16.840.1.113883.6.73 2017-01 P01BB02 cycloguanil embonate 2.16.840.1.113883.6.73 2017-01 P01BB51 proguanil, combinations 2.16.840.1.113883.6.73 2017-01 P01BC Methanolquinolines 2.16.840.1.113883.6.73 2017-01 P01BC01 quinine 2.16.840.1.113883.6.73 2017-01 P01BC02 mefloquine 2.16.840.1.113883.6.73 2017-01 P01BD Diaminopyrimidines 2.16.840.1.113883.6.73 2017-01 P01BD01 pyrimethamine 2.16.840.1.113883.6.73 2017-01 P01BD51 pyrimethamine, combinations 2.16.840.1.113883.6.73 2017-01 P01BE Artemisinin and derivatives, plain 2.16.840.1.113883.6.73 2017-01 P01BE01 artemisinin 2.16.840.1.113883.6.73 2017-01 P01BE02 artemether 2.16.840.1.113883.6.73 2017-01 P01BE03 artesunate 2.16.840.1.113883.6.73 2017-01 P01BE04 artemotil 2.16.840.1.113883.6.73 2017-01 P01BE05 artenimol 2.16.840.1.113883.6.73 2017-01 P01BF Artemisinin and derivatives, combinations 2.16.840.1.113883.6.73 2017-01 P01BF01 artemether and lumefantrine 2.16.840.1.113883.6.73 2017-01 P01BF02 artesunate and mefloquine 2.16.840.1.113883.6.73 2017-01 P01BF03 artesunate and amodiaquine 2.16.840.1.113883.6.73 2017-01 P01BF04 artesunate, sulphamethopyrazine and pyrimethamine 2.16.840.1.113883.6.73 2017-01 P01BF05 artenimol and piperaquine 2.16.840.1.113883.6.73 2017-01 P01BF06 artesunate and pyronaridine 2.16.840.1.113883.6.73 2017-01 P01BX Other antimalarials © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 116 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P01BX01 halofantrine 2.16.840.1.113883.6.73 2017-01 P01BX02 arterolane and piperaquine 2.16.840.1.113883.6.73 2017-01 P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS 2.16.840.1.113883.6.73 2017-01 P01CA Nitroimidazole derivatives 2.16.840.1.113883.6.73 2017-01 P01CA02 benznidazole 2.16.840.1.113883.6.73 2017-01 P01CB Antimony compounds 2.16.840.1.113883.6.73 2017-01 P01CB01 antimonate 2.16.840.1.113883.6.73 2017-01 P01CB02 sodium stibogluconate 2.16.840.1.113883.6.73 2017-01 P01CC Nitrofuran derivatives 2.16.840.1.113883.6.73 2017-01 P01CC01 nifurtimox 2.16.840.1.113883.6.73 2017-01 P01CC02 nitrofural 2.16.840.1.113883.6.73 2017-01 P01CD Arsenic compounds 2.16.840.1.113883.6.73 2017-01 P01CD01 melarsoprol 2.16.840.1.113883.6.73 2017-01 P01CD02 acetarsol 2.16.840.1.113883.6.73 2017-01 P01CX Other agents against leishmaniasis and trypanosomiasis 2.16.840.1.113883.6.73 2017-01 P01CX01 isethionate 2.16.840.1.113883.6.73 2017-01 P01CX02 sodium 2.16.840.1.113883.6.73 2017-01 P01CX03 eflornithine 2.16.840.1.113883.6.73 2017-01 P02 ANTHELMINTICS 2.16.840.1.113883.6.73 2017-01 P02B ANTITREMATODALS 2.16.840.1.113883.6.73 2017-01 P02BA Quinoline derivatives and related substances 2.16.840.1.113883.6.73 2017-01 P02BA01 praziquantel 2.16.840.1.113883.6.73 2017-01 P02BA02 oxamniquine 2.16.840.1.113883.6.73 2017-01 P02BB Organophosphorous compounds 2.16.840.1.113883.6.73 2017-01 P02BB01 2.16.840.1.113883.6.73 2017-01 P02BX Other antitrematodal agents 2.16.840.1.113883.6.73 2017-01 P02BX01 bithionol 2.16.840.1.113883.6.73 2017-01 P02BX02 niridazole 2.16.840.1.113883.6.73 2017-01 P02BX03 stibophen 2.16.840.1.113883.6.73 2017-01 P02BX04 triclabendazole 2.16.840.1.113883.6.73 2017-01 P02C ANTINEMATODAL AGENTS 2.16.840.1.113883.6.73 2017-01 P02CA derivatives 2.16.840.1.113883.6.73 2017-01 P02CA01 mebendazole 2.16.840.1.113883.6.73 2017-01 P02CA02 tiabendazole 2.16.840.1.113883.6.73 2017-01 P02CA03 albendazole 2.16.840.1.113883.6.73 2017-01 P02CA04 ciclobendazole 2.16.840.1.113883.6.73 2017-01 P02CA05 flubendazole 2.16.840.1.113883.6.73 2017-01 P02CA06 fenbendazole 2.16.840.1.113883.6.73 2017-01 P02CA51 mebendazole, combinations 2.16.840.1.113883.6.73 2017-01 P02CB Piperazine and derivatives 2.16.840.1.113883.6.73 2017-01 P02CB01 piperazine 2.16.840.1.113883.6.73 2017-01 P02CB02 diethylcarbamazine

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 117 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P02CC Tetrahydropyrimidine derivatives 2.16.840.1.113883.6.73 2017-01 P02CC01 2.16.840.1.113883.6.73 2017-01 P02CC02 oxantel 2.16.840.1.113883.6.73 2017-01 P02CE Imidazothiazole derivatives 2.16.840.1.113883.6.73 2017-01 P02CE01 2.16.840.1.113883.6.73 2017-01 P02CF Avermectines 2.16.840.1.113883.6.73 2017-01 P02CF01 ivermectin 2.16.840.1.113883.6.73 2017-01 P02CX Other antinematodals 2.16.840.1.113883.6.73 2017-01 P02CX01 pyrvinium 2.16.840.1.113883.6.73 2017-01 P02CX02 bephenium 2.16.840.1.113883.6.73 2017-01 P02D ANTICESTODALS 2.16.840.1.113883.6.73 2017-01 P02DA Salicylic acid derivatives 2.16.840.1.113883.6.73 2017-01 P02DA01 niclosamide 2.16.840.1.113883.6.73 2017-01 P02DX Other anticestodals 2.16.840.1.113883.6.73 2017-01 P02DX01 desaspidin 2.16.840.1.113883.6.73 2017-01 P02DX02 dichlorophen 2.16.840.1.113883.6.73 2017-01 P03 , INCL. SCABICIDES, INSECTICIDES AND REPELLENTS 2.16.840.1.113883.6.73 2017-01 P03A ECTOPARASITICIDES, INCL. SCABICIDES 2.16.840.1.113883.6.73 2017-01 P03AA Sulfur containing products 2.16.840.1.113883.6.73 2017-01 P03AA01 2.16.840.1.113883.6.73 2017-01 P03AA02 potassium polysulfide 2.16.840.1.113883.6.73 2017-01 P03AA03 mesulfen 2.16.840.1.113883.6.73 2017-01 P03AA04 disulfiram 2.16.840.1.113883.6.73 2017-01 P03AA05 2.16.840.1.113883.6.73 2017-01 P03AA54 disulfiram, combinations 2.16.840.1.113883.6.73 2017-01 P03AB containing products 2.16.840.1.113883.6.73 2017-01 P03AB01 clofenotane 2.16.840.1.113883.6.73 2017-01 P03AB02 2.16.840.1.113883.6.73 2017-01 P03AB51 clofenotane, combinations 2.16.840.1.113883.6.73 2017-01 P03AC Pyrethrines, incl. synthetic compounds 2.16.840.1.113883.6.73 2017-01 P03AC01 2.16.840.1.113883.6.73 2017-01 P03AC02 bioallethrin 2.16.840.1.113883.6.73 2017-01 P03AC03 2.16.840.1.113883.6.73 2017-01 P03AC04 2.16.840.1.113883.6.73 2017-01 P03AC51 pyrethrum, combinations 2.16.840.1.113883.6.73 2017-01 P03AC52 bioallethrin, combinations 2.16.840.1.113883.6.73 2017-01 P03AC53 phenothrin, combinations 2.16.840.1.113883.6.73 2017-01 P03AC54 permethrin, combinations 2.16.840.1.113883.6.73 2017-01 P03AX Other ectoparasiticides, incl. scabicides 2.16.840.1.113883.6.73 2017-01 P03AX01 2.16.840.1.113883.6.73 2017-01 P03AX02 copper oleinate 2.16.840.1.113883.6.73 2017-01 P03AX03

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 118 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 P03AX04 quassia 2.16.840.1.113883.6.73 2017-01 P03AX05 dimeticone 2.16.840.1.113883.6.73 2017-01 P03AX06 benzyl alcohol 2.16.840.1.113883.6.73 2017-01 P03B INSECTICIDES AND REPELLENTS 2.16.840.1.113883.6.73 2017-01 P03BA Pyrethrines 2.16.840.1.113883.6.73 2017-01 P03BA01 2.16.840.1.113883.6.73 2017-01 P03BA02 2.16.840.1.113883.6.73 2017-01 P03BA03 decamethrin 2.16.840.1.113883.6.73 2017-01 P03BA04 2.16.840.1.113883.6.73 2017-01 P03BX Other insecticides and repellents 2.16.840.1.113883.6.73 2017-01 P03BX01 diethyltoluamide 2.16.840.1.113883.6.73 2017-01 P03BX02 dimethylphthalate 2.16.840.1.113883.6.73 2017-01 P03BX03 dibutylphthalate 2.16.840.1.113883.6.73 2017-01 P03BX04 dibutylsuccinate 2.16.840.1.113883.6.73 2017-01 P03BX05 dimethylcarbate 2.16.840.1.113883.6.73 2017-01 P03BX06 etohexadiol 2.16.840.1.113883.6.73 2017-01 R RESPIRATORY SYSTEM 2.16.840.1.113883.6.73 2017-01 R01 NASAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE 2.16.840.1.113883.6.73 2017-01 R01AA Sympathomimetics, plain 2.16.840.1.113883.6.73 2017-01 R01AA02 2.16.840.1.113883.6.73 2017-01 R01AA03 ephedrine 2.16.840.1.113883.6.73 2017-01 R01AA04 phenylephrine 2.16.840.1.113883.6.73 2017-01 R01AA05 2.16.840.1.113883.6.73 2017-01 R01AA06 2.16.840.1.113883.6.73 2017-01 R01AA07 2.16.840.1.113883.6.73 2017-01 R01AA08 2.16.840.1.113883.6.73 2017-01 R01AA09 tramazoline 2.16.840.1.113883.6.73 2017-01 R01AA10 metizoline 2.16.840.1.113883.6.73 2017-01 R01AA11 2.16.840.1.113883.6.73 2017-01 R01AA12 fenoxazoline 2.16.840.1.113883.6.73 2017-01 R01AA13 tymazoline 2.16.840.1.113883.6.73 2017-01 R01AA14 epinephrine 2.16.840.1.113883.6.73 2017-01 R01AA15 indanazoline 2.16.840.1.113883.6.73 2017-01 R01AB Sympathomimetics, combinations excl. corticosteroids 2.16.840.1.113883.6.73 2017-01 R01AB01 phenylephrine 2.16.840.1.113883.6.73 2017-01 R01AB02 naphazoline 2.16.840.1.113883.6.73 2017-01 R01AB03 tetryzoline 2.16.840.1.113883.6.73 2017-01 R01AB05 ephedrine 2.16.840.1.113883.6.73 2017-01 R01AB06 xylometazoline 2.16.840.1.113883.6.73 2017-01 R01AB07 oxymetazoline 2.16.840.1.113883.6.73 2017-01 R01AB08 tuaminoheptane

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 119 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R01AC Antiallergic agents, excl. corticosteroids 2.16.840.1.113883.6.73 2017-01 R01AC01 cromoglicic acid 2.16.840.1.113883.6.73 2017-01 R01AC02 2.16.840.1.113883.6.73 2017-01 R01AC03 2.16.840.1.113883.6.73 2017-01 R01AC04 2.16.840.1.113883.6.73 2017-01 R01AC05 spaglumic acid 2.16.840.1.113883.6.73 2017-01 R01AC06 thonzylamine 2.16.840.1.113883.6.73 2017-01 R01AC07 2.16.840.1.113883.6.73 2017-01 R01AC08 2.16.840.1.113883.6.73 2017-01 R01AC51 cromoglicic acid, combinations 2.16.840.1.113883.6.73 2017-01 R01AD Corticosteroids 2.16.840.1.113883.6.73 2017-01 R01AD01 beclometasone 2.16.840.1.113883.6.73 2017-01 R01AD02 prednisolone 2.16.840.1.113883.6.73 2017-01 R01AD03 dexamethasone 2.16.840.1.113883.6.73 2017-01 R01AD04 2.16.840.1.113883.6.73 2017-01 R01AD05 budesonide 2.16.840.1.113883.6.73 2017-01 R01AD06 betamethasone 2.16.840.1.113883.6.73 2017-01 R01AD07 tixocortol 2.16.840.1.113883.6.73 2017-01 R01AD08 fluticasone 2.16.840.1.113883.6.73 2017-01 R01AD09 mometasone 2.16.840.1.113883.6.73 2017-01 R01AD11 triamcinolone 2.16.840.1.113883.6.73 2017-01 R01AD12 2.16.840.1.113883.6.73 2017-01 R01AD13 2.16.840.1.113883.6.73 2017-01 R01AD52 prednisolone, combinations 2.16.840.1.113883.6.73 2017-01 R01AD53 dexamethasone, combinations 2.16.840.1.113883.6.73 2017-01 R01AD57 tixocortol, combinations 2.16.840.1.113883.6.73 2017-01 R01AD58 fluticasone, combinations 2.16.840.1.113883.6.73 2017-01 R01AD60 hydrocortisone, combinations 2.16.840.1.113883.6.73 2017-01 R01AX Other nasal preparations 2.16.840.1.113883.6.73 2017-01 R01AX01 calcium hexamine 2.16.840.1.113883.6.73 2017-01 R01AX02 retinol 2.16.840.1.113883.6.73 2017-01 R01AX03 2.16.840.1.113883.6.73 2017-01 R01AX05 ritiometan 2.16.840.1.113883.6.73 2017-01 R01AX06 mupirocin 2.16.840.1.113883.6.73 2017-01 R01AX07 hexamidine 2.16.840.1.113883.6.73 2017-01 R01AX08 framycetin 2.16.840.1.113883.6.73 2017-01 R01AX09 hyaluronic acid 2.16.840.1.113883.6.73 2017-01 R01AX10 various 2.16.840.1.113883.6.73 2017-01 R01AX30 combinations 2.16.840.1.113883.6.73 2017-01 R01B NASAL DECONGESTANTS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 R01BA Sympathomimetics 2.16.840.1.113883.6.73 2017-01 R01BA01 2.16.840.1.113883.6.73 2017-01 R01BA02 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 120 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R01BA03 phenylephrine 2.16.840.1.113883.6.73 2017-01 R01BA51 phenylpropanolamine, combinations 2.16.840.1.113883.6.73 2017-01 R01BA52 pseudoephedrine, combinations 2.16.840.1.113883.6.73 2017-01 R01BA53 phenylephrine, combinations 2.16.840.1.113883.6.73 2017-01 R02 THROAT PREPARATIONS 2.16.840.1.113883.6.73 2017-01 R02A THROAT PREPARATIONS 2.16.840.1.113883.6.73 2017-01 R02AA Antiseptics 2.16.840.1.113883.6.73 2017-01 R02AA01 2.16.840.1.113883.6.73 2017-01 R02AA02 dequalinium 2.16.840.1.113883.6.73 2017-01 R02AA03 dichlorobenzyl alcohol 2.16.840.1.113883.6.73 2017-01 R02AA05 chlorhexidine 2.16.840.1.113883.6.73 2017-01 R02AA06 cetylpyridinium 2.16.840.1.113883.6.73 2017-01 R02AA09 benzethonium 2.16.840.1.113883.6.73 2017-01 R02AA10 myristyl-benzalkonium 2.16.840.1.113883.6.73 2017-01 R02AA11 chlorquinaldol 2.16.840.1.113883.6.73 2017-01 R02AA12 2.16.840.1.113883.6.73 2017-01 R02AA13 acriflavinium chloride 2.16.840.1.113883.6.73 2017-01 R02AA14 oxyquinoline 2.16.840.1.113883.6.73 2017-01 R02AA15 povidone-iodine 2.16.840.1.113883.6.73 2017-01 R02AA16 benzalkonium 2.16.840.1.113883.6.73 2017-01 R02AA17 cetrimonium 2.16.840.1.113883.6.73 2017-01 R02AA18 hexamidine 2.16.840.1.113883.6.73 2017-01 R02AA19 phenol 2.16.840.1.113883.6.73 2017-01 R02AA20 various 2.16.840.1.113883.6.73 2017-01 R02AA21 octenidine 2.16.840.1.113883.6.73 2017-01 R02AB Antibiotics 2.16.840.1.113883.6.73 2017-01 R02AB01 neomycin 2.16.840.1.113883.6.73 2017-01 R02AB02 tyrothricin 2.16.840.1.113883.6.73 2017-01 R02AB03 2.16.840.1.113883.6.73 2017-01 R02AB04 bacitracin 2.16.840.1.113883.6.73 2017-01 R02AB30 2.16.840.1.113883.6.73 2017-01 R02AD Anesthetics, local 2.16.840.1.113883.6.73 2017-01 R02AD01 benzocaine 2.16.840.1.113883.6.73 2017-01 R02AD02 lidocaine 2.16.840.1.113883.6.73 2017-01 R02AD03 cocaine 2.16.840.1.113883.6.73 2017-01 R02AD04 dyclonine 2.16.840.1.113883.6.73 2017-01 R02AX Other throat preparations 2.16.840.1.113883.6.73 2017-01 R02AX01 flurbiprofen 2.16.840.1.113883.6.73 2017-01 R02AX02 ibuprofen 2.16.840.1.113883.6.73 2017-01 R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES 2.16.840.1.113883.6.73 2017-01 R03A , 2.16.840.1.113883.6.73 2017-01 R03AA Alpha- and beta-adrenoreceptor agonists 2.16.840.1.113883.6.73 2017-01 R03AA01 epinephrine © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 121 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03AB Non-selective beta-adrenoreceptor agonists 2.16.840.1.113883.6.73 2017-01 R03AB02 isoprenaline 2.16.840.1.113883.6.73 2017-01 R03AB03 2.16.840.1.113883.6.73 2017-01 R03AC Selective beta-2-adrenoreceptor agonists 2.16.840.1.113883.6.73 2017-01 R03AC02 2.16.840.1.113883.6.73 2017-01 R03AC03 2.16.840.1.113883.6.73 2017-01 R03AC04 fenoterol 2.16.840.1.113883.6.73 2017-01 R03AC05 2.16.840.1.113883.6.73 2017-01 R03AC06 2.16.840.1.113883.6.73 2017-01 R03AC07 2.16.840.1.113883.6.73 2017-01 R03AC08 2.16.840.1.113883.6.73 2017-01 R03AC09 2.16.840.1.113883.6.73 2017-01 R03AC10 2.16.840.1.113883.6.73 2017-01 R03AC11 2.16.840.1.113883.6.73 2017-01 R03AC12 2.16.840.1.113883.6.73 2017-01 R03AC13 2.16.840.1.113883.6.73 2017-01 R03AC14 2.16.840.1.113883.6.73 2017-01 R03AC15 2.16.840.1.113883.6.73 2017-01 R03AC16 2.16.840.1.113883.6.73 2017-01 R03AC17 2.16.840.1.113883.6.73 2017-01 R03AC18 2.16.840.1.113883.6.73 2017-01 R03AC19 2.16.840.1.113883.6.73 2017-01 R03AH Combinations of adrenergics 2.16.840.1.113883.6.73 2017-01 R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics 2.16.840.1.113883.6.73 2017-01 R03AK01 epinephrine and other drugs for obstructive airway diseases 2.16.840.1.113883.6.73 2017-01 R03AK02 isoprenaline and other drugs for obstructive airway diseases 2.16.840.1.113883.6.73 2017-01 R03AK04 salbutamol and sodium cromoglicate 2.16.840.1.113883.6.73 2017-01 R03AK05 reproterol and sodium cromoglicate 2.16.840.1.113883.6.73 2017-01 R03AK06 salmeterol and fluticasone 2.16.840.1.113883.6.73 2017-01 R03AK07 formoterol and budesonide 2.16.840.1.113883.6.73 2017-01 R03AK08 formoterol and beclometasone 2.16.840.1.113883.6.73 2017-01 R03AK09 formoterol and mometasone 2.16.840.1.113883.6.73 2017-01 R03AK10 and fluticasone furoate 2.16.840.1.113883.6.73 2017-01 R03AK11 formoterol and fluticasone 2.16.840.1.113883.6.73 2017-01 R03AK12 salmeterol and budesonide 2.16.840.1.113883.6.73 2017-01 R03AK13 salbutamol and beclometasone 2.16.840.1.113883.6.73 2017-01 R03AL Adrenergics in combination with anticholinergics 2.16.840.1.113883.6.73 2017-01 R03AL01 fenoterol and ipratropium bromide 2.16.840.1.113883.6.73 2017-01 R03AL02 salbutamol and ipratropium bromide 2.16.840.1.113883.6.73 2017-01 R03AL03 vilanterol and 2.16.840.1.113883.6.73 2017-01 R03AL04 indacaterol and glycopyrronium bromide 2.16.840.1.113883.6.73 2017-01 R03AL05 formoterol and

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 122 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03AL06 olodaterol and 2.16.840.1.113883.6.73 2017-01 R03AL07 formoterol and glycopyrronium bromide 2.16.840.1.113883.6.73 2017-01 R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS 2.16.840.1.113883.6.73 2017-01 R03BA Glucocorticoids 2.16.840.1.113883.6.73 2017-01 R03BA01 beclometasone 2.16.840.1.113883.6.73 2017-01 R03BA02 budesonide 2.16.840.1.113883.6.73 2017-01 R03BA03 flunisolide 2.16.840.1.113883.6.73 2017-01 R03BA04 betamethasone 2.16.840.1.113883.6.73 2017-01 R03BA05 fluticasone 2.16.840.1.113883.6.73 2017-01 R03BA06 triamcinolone 2.16.840.1.113883.6.73 2017-01 R03BA07 mometasone 2.16.840.1.113883.6.73 2017-01 R03BA08 ciclesonide 2.16.840.1.113883.6.73 2017-01 R03BA09 fluticasone furoate 2.16.840.1.113883.6.73 2017-01 R03BB Anticholinergics 2.16.840.1.113883.6.73 2017-01 R03BB01 ipratropium bromide 2.16.840.1.113883.6.73 2017-01 R03BB02 2.16.840.1.113883.6.73 2017-01 R03BB03 stramoni preparations 2.16.840.1.113883.6.73 2017-01 R03BB04 tiotropium bromide 2.16.840.1.113883.6.73 2017-01 R03BB05 aclidinium bromide 2.16.840.1.113883.6.73 2017-01 R03BB06 glycopyrronium bromide 2.16.840.1.113883.6.73 2017-01 R03BB07 umeclidinium bromide 2.16.840.1.113883.6.73 2017-01 R03BB54 tiotropium bromide, combinations 2.16.840.1.113883.6.73 2017-01 R03BC Antiallergic agents, excl. corticosteroids 2.16.840.1.113883.6.73 2017-01 R03BC01 cromoglicic acid 2.16.840.1.113883.6.73 2017-01 R03BC03 nedocromil 2.16.840.1.113883.6.73 2017-01 R03BX Other drugs for obstructive airway diseases, inhalants 2.16.840.1.113883.6.73 2017-01 R03BX01 2.16.840.1.113883.6.73 2017-01 R03C ADRENERGICS FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 R03CA Alpha- and beta-adrenoreceptor agonists 2.16.840.1.113883.6.73 2017-01 R03CA02 ephedrine 2.16.840.1.113883.6.73 2017-01 R03CB Non-selective beta-adrenoreceptor agonists 2.16.840.1.113883.6.73 2017-01 R03CB01 isoprenaline 2.16.840.1.113883.6.73 2017-01 R03CB02 2.16.840.1.113883.6.73 2017-01 R03CB03 orciprenaline 2.16.840.1.113883.6.73 2017-01 R03CB51 isoprenaline, combinations 2.16.840.1.113883.6.73 2017-01 R03CB53 orciprenaline, combinations 2.16.840.1.113883.6.73 2017-01 R03CC Selective beta-2-adrenoreceptor agonists 2.16.840.1.113883.6.73 2017-01 R03CC02 salbutamol 2.16.840.1.113883.6.73 2017-01 R03CC03 terbutaline 2.16.840.1.113883.6.73 2017-01 R03CC04 fenoterol 2.16.840.1.113883.6.73 2017-01 R03CC05 hexoprenaline 2.16.840.1.113883.6.73 2017-01 R03CC06 isoetarine

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 123 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03CC07 pirbuterol 2.16.840.1.113883.6.73 2017-01 R03CC08 procaterol 2.16.840.1.113883.6.73 2017-01 R03CC09 tretoquinol 2.16.840.1.113883.6.73 2017-01 R03CC10 carbuterol 2.16.840.1.113883.6.73 2017-01 R03CC11 tulobuterol 2.16.840.1.113883.6.73 2017-01 R03CC12 2.16.840.1.113883.6.73 2017-01 R03CC13 clenbuterol 2.16.840.1.113883.6.73 2017-01 R03CC14 reproterol 2.16.840.1.113883.6.73 2017-01 R03CC53 terbutaline, combinations 2.16.840.1.113883.6.73 2017-01 R03CK Adrenergics and other drugs for obstructive airway diseases 2.16.840.1.113883.6.73 2017-01 R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES 2.16.840.1.113883.6.73 2017-01 R03DA 2.16.840.1.113883.6.73 2017-01 R03DA01 2.16.840.1.113883.6.73 2017-01 R03DA02 2.16.840.1.113883.6.73 2017-01 R03DA03 2.16.840.1.113883.6.73 2017-01 R03DA04 2.16.840.1.113883.6.73 2017-01 R03DA05 2.16.840.1.113883.6.73 2017-01 R03DA06 2.16.840.1.113883.6.73 2017-01 R03DA07 theobromine 2.16.840.1.113883.6.73 2017-01 R03DA08 2.16.840.1.113883.6.73 2017-01 R03DA09 acefylline piperazine 2.16.840.1.113883.6.73 2017-01 R03DA10 bufylline 2.16.840.1.113883.6.73 2017-01 R03DA11 2.16.840.1.113883.6.73 2017-01 R03DA20 combinations of xanthines 2.16.840.1.113883.6.73 2017-01 R03DA51 diprophylline, combinations 2.16.840.1.113883.6.73 2017-01 R03DA54 theophylline, combinations excl. psycholeptics 2.16.840.1.113883.6.73 2017-01 R03DA55 aminophylline, combinations 2.16.840.1.113883.6.73 2017-01 R03DA57 theobromine, combinations 2.16.840.1.113883.6.73 2017-01 R03DA74 theophylline, combinations with psycholeptics 2.16.840.1.113883.6.73 2017-01 R03DB Xanthines and adrenergics 2.16.840.1.113883.6.73 2017-01 R03DB01 diprophylline and adrenergics 2.16.840.1.113883.6.73 2017-01 R03DB02 choline theophyllinate and adrenergics 2.16.840.1.113883.6.73 2017-01 R03DB03 proxyphylline and adrenergics 2.16.840.1.113883.6.73 2017-01 R03DB04 theophylline and adrenergics 2.16.840.1.113883.6.73 2017-01 R03DB05 aminophylline and adrenergics 2.16.840.1.113883.6.73 2017-01 R03DB06 etamiphylline and adrenergics 2.16.840.1.113883.6.73 2017-01 R03DC Leukotriene receptor antagonists 2.16.840.1.113883.6.73 2017-01 R03DC01 2.16.840.1.113883.6.73 2017-01 R03DC02 2.16.840.1.113883.6.73 2017-01 R03DC03 2.16.840.1.113883.6.73 2017-01 R03DC04 2.16.840.1.113883.6.73 2017-01 R03DC53 montelukast, combinations

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 124 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R03DX Other systemic drugs for obstructive airway diseases 2.16.840.1.113883.6.73 2017-01 R03DX01 amlexanox 2.16.840.1.113883.6.73 2017-01 R03DX02 2.16.840.1.113883.6.73 2017-01 R03DX03 fenspiride 2.16.840.1.113883.6.73 2017-01 R03DX05 2.16.840.1.113883.6.73 2017-01 R03DX06 2.16.840.1.113883.6.73 2017-01 R03DX07 2.16.840.1.113883.6.73 2017-01 R03DX08 2.16.840.1.113883.6.73 2017-01 R03DX09 2.16.840.1.113883.6.73 2017-01 R05 COUGH AND COLD PREPARATIONS 2.16.840.1.113883.6.73 2017-01 R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS 2.16.840.1.113883.6.73 2017-01 R05CA Expectorants 2.16.840.1.113883.6.73 2017-01 R05CA01 2.16.840.1.113883.6.73 2017-01 R05CA02 2.16.840.1.113883.6.73 2017-01 R05CA03 2.16.840.1.113883.6.73 2017-01 R05CA04 ipecacuanha 2.16.840.1.113883.6.73 2017-01 R05CA05 althea root 2.16.840.1.113883.6.73 2017-01 R05CA06 senega 2.16.840.1.113883.6.73 2017-01 R05CA07 2.16.840.1.113883.6.73 2017-01 R05CA08 2.16.840.1.113883.6.73 2017-01 R05CA09 2.16.840.1.113883.6.73 2017-01 R05CA10 combinations 2.16.840.1.113883.6.73 2017-01 R05CA11 levoverbenone 2.16.840.1.113883.6.73 2017-01 R05CA12 Hederae helicis folium 2.16.840.1.113883.6.73 2017-01 R05CA13 cineole 2.16.840.1.113883.6.73 2017-01 R05CB Mucolytics 2.16.840.1.113883.6.73 2017-01 R05CB01 2.16.840.1.113883.6.73 2017-01 R05CB02 2.16.840.1.113883.6.73 2017-01 R05CB03 2.16.840.1.113883.6.73 2017-01 R05CB04 2.16.840.1.113883.6.73 2017-01 R05CB05 2.16.840.1.113883.6.73 2017-01 R05CB06 2.16.840.1.113883.6.73 2017-01 R05CB07 2.16.840.1.113883.6.73 2017-01 R05CB08 2.16.840.1.113883.6.73 2017-01 R05CB09 2.16.840.1.113883.6.73 2017-01 R05CB10 combinations 2.16.840.1.113883.6.73 2017-01 R05CB11 2.16.840.1.113883.6.73 2017-01 R05CB13 (desoxyribonuclease) 2.16.840.1.113883.6.73 2017-01 R05CB14 2.16.840.1.113883.6.73 2017-01 R05CB15 2.16.840.1.113883.6.73 2017-01 R05CB16 mannitol 2.16.840.1.113883.6.73 2017-01 R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 125 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R05DA Opium alkaloids and derivatives 2.16.840.1.113883.6.73 2017-01 R05DA01 2.16.840.1.113883.6.73 2017-01 R05DA03 2.16.840.1.113883.6.73 2017-01 R05DA04 codeine 2.16.840.1.113883.6.73 2017-01 R05DA05 opium alkaloids with morphine 2.16.840.1.113883.6.73 2017-01 R05DA06 2.16.840.1.113883.6.73 2017-01 R05DA07 2.16.840.1.113883.6.73 2017-01 R05DA08 2.16.840.1.113883.6.73 2017-01 R05DA09 dextromethorphan 2.16.840.1.113883.6.73 2017-01 R05DA10 2.16.840.1.113883.6.73 2017-01 R05DA11 2.16.840.1.113883.6.73 2017-01 R05DA12 2.16.840.1.113883.6.73 2017-01 R05DA20 combinations 2.16.840.1.113883.6.73 2017-01 R05DB Other cough suppressants 2.16.840.1.113883.6.73 2017-01 R05DB01 2.16.840.1.113883.6.73 2017-01 R05DB02 2.16.840.1.113883.6.73 2017-01 R05DB03 2.16.840.1.113883.6.73 2017-01 R05DB04 2.16.840.1.113883.6.73 2017-01 R05DB05 2.16.840.1.113883.6.73 2017-01 R05DB07 2.16.840.1.113883.6.73 2017-01 R05DB09 2.16.840.1.113883.6.73 2017-01 R05DB10 2.16.840.1.113883.6.73 2017-01 R05DB11 2.16.840.1.113883.6.73 2017-01 R05DB12 2.16.840.1.113883.6.73 2017-01 R05DB13 2.16.840.1.113883.6.73 2017-01 R05DB14 2.16.840.1.113883.6.73 2017-01 R05DB15 2.16.840.1.113883.6.73 2017-01 R05DB16 2.16.840.1.113883.6.73 2017-01 R05DB17 2.16.840.1.113883.6.73 2017-01 R05DB18 2.16.840.1.113883.6.73 2017-01 R05DB19 2.16.840.1.113883.6.73 2017-01 R05DB20 combinations 2.16.840.1.113883.6.73 2017-01 R05DB21 2.16.840.1.113883.6.73 2017-01 R05DB22 2.16.840.1.113883.6.73 2017-01 R05DB23 2.16.840.1.113883.6.73 2017-01 R05DB24 2.16.840.1.113883.6.73 2017-01 R05DB25 2.16.840.1.113883.6.73 2017-01 R05DB26 2.16.840.1.113883.6.73 2017-01 R05DB27 2.16.840.1.113883.6.73 2017-01 R05DB28 2.16.840.1.113883.6.73 2017-01 R05F COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS 2.16.840.1.113883.6.73 2017-01 R05FA Opium derivatives and expectorants

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 126 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R05FA01 opium derivatives and mucolytics 2.16.840.1.113883.6.73 2017-01 R05FA02 opium derivatives and expectorants 2.16.840.1.113883.6.73 2017-01 R05FB Other cough suppressants and expectorants 2.16.840.1.113883.6.73 2017-01 R05FB01 cough suppressants and mucolytics 2.16.840.1.113883.6.73 2017-01 R05FB02 cough suppressants and expectorants 2.16.840.1.113883.6.73 2017-01 R05X OTHER COLD PREPARATIONS 2.16.840.1.113883.6.73 2017-01 R06 ANTIHISTAMINES FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 R06A ANTIHISTAMINES FOR SYSTEMIC USE 2.16.840.1.113883.6.73 2017-01 R06AA Aminoalkyl ethers 2.16.840.1.113883.6.73 2017-01 R06AA01 2.16.840.1.113883.6.73 2017-01 R06AA02 diphenhydramine 2.16.840.1.113883.6.73 2017-01 R06AA04 clemastine 2.16.840.1.113883.6.73 2017-01 R06AA06 chlorphenoxamine 2.16.840.1.113883.6.73 2017-01 R06AA07 2.16.840.1.113883.6.73 2017-01 R06AA08 2.16.840.1.113883.6.73 2017-01 R06AA09 2.16.840.1.113883.6.73 2017-01 R06AA10 2.16.840.1.113883.6.73 2017-01 R06AA52 diphenhydramine, combinations 2.16.840.1.113883.6.73 2017-01 R06AA54 clemastine, combinations 2.16.840.1.113883.6.73 2017-01 R06AA56 chlorphenoxamine, combinations 2.16.840.1.113883.6.73 2017-01 R06AA57 diphenylpyraline, combinations 2.16.840.1.113883.6.73 2017-01 R06AA59 doxylamine, combinations 2.16.840.1.113883.6.73 2017-01 R06AB Substituted alkylamines 2.16.840.1.113883.6.73 2017-01 R06AB01 2.16.840.1.113883.6.73 2017-01 R06AB02 2.16.840.1.113883.6.73 2017-01 R06AB03 dimetindene 2.16.840.1.113883.6.73 2017-01 R06AB04 2.16.840.1.113883.6.73 2017-01 R06AB05 pheniramine 2.16.840.1.113883.6.73 2017-01 R06AB06 2.16.840.1.113883.6.73 2017-01 R06AB07 2.16.840.1.113883.6.73 2017-01 R06AB51 brompheniramine, combinations 2.16.840.1.113883.6.73 2017-01 R06AB52 dexchlorpheniramine, combinations 2.16.840.1.113883.6.73 2017-01 R06AB54 chlorphenamine, combinations 2.16.840.1.113883.6.73 2017-01 R06AB56 dexbrompheniramine, combinations 2.16.840.1.113883.6.73 2017-01 R06AC Substituted ethylene diamines 2.16.840.1.113883.6.73 2017-01 R06AC01 mepyramine 2.16.840.1.113883.6.73 2017-01 R06AC02 2.16.840.1.113883.6.73 2017-01 R06AC03 chloropyramine 2.16.840.1.113883.6.73 2017-01 R06AC04 tripelennamine 2.16.840.1.113883.6.73 2017-01 R06AC05 2.16.840.1.113883.6.73 2017-01 R06AC06 thonzylamine 2.16.840.1.113883.6.73 2017-01 R06AC52 histapyrrodine, combinations 2.16.840.1.113883.6.73 2017-01 R06AC53 chloropyramine, combinations © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 127 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R06AD derivatives 2.16.840.1.113883.6.73 2017-01 R06AD01 2.16.840.1.113883.6.73 2017-01 R06AD02 promethazine 2.16.840.1.113883.6.73 2017-01 R06AD03 2.16.840.1.113883.6.73 2017-01 R06AD04 2.16.840.1.113883.6.73 2017-01 R06AD05 2.16.840.1.113883.6.73 2017-01 R06AD06 thiazinam 2.16.840.1.113883.6.73 2017-01 R06AD07 2.16.840.1.113883.6.73 2017-01 R06AD08 2.16.840.1.113883.6.73 2017-01 R06AD09 isothipendyl 2.16.840.1.113883.6.73 2017-01 R06AD52 promethazine, combinations 2.16.840.1.113883.6.73 2017-01 R06AD55 hydroxyethylpromethazine, combinations 2.16.840.1.113883.6.73 2017-01 R06AE Piperazine derivatives 2.16.840.1.113883.6.73 2017-01 R06AE01 2.16.840.1.113883.6.73 2017-01 R06AE03 2.16.840.1.113883.6.73 2017-01 R06AE04 2.16.840.1.113883.6.73 2017-01 R06AE05 meclozine 2.16.840.1.113883.6.73 2017-01 R06AE06 2.16.840.1.113883.6.73 2017-01 R06AE07 2.16.840.1.113883.6.73 2017-01 R06AE09 2.16.840.1.113883.6.73 2017-01 R06AE51 buclizine, combinations 2.16.840.1.113883.6.73 2017-01 R06AE53 cyclizine, combinations 2.16.840.1.113883.6.73 2017-01 R06AE55 meclozine, combinations 2.16.840.1.113883.6.73 2017-01 R06AK Combinations of antihistamines 2.16.840.1.113883.6.73 2017-01 R06AX Other antihistamines for systemic use 2.16.840.1.113883.6.73 2017-01 R06AX01 bamipine 2.16.840.1.113883.6.73 2017-01 R06AX02 2.16.840.1.113883.6.73 2017-01 R06AX03 thenalidine 2.16.840.1.113883.6.73 2017-01 R06AX04 2.16.840.1.113883.6.73 2017-01 R06AX05 antazoline 2.16.840.1.113883.6.73 2017-01 R06AX07 2.16.840.1.113883.6.73 2017-01 R06AX08 2.16.840.1.113883.6.73 2017-01 R06AX09 2.16.840.1.113883.6.73 2017-01 R06AX11 2.16.840.1.113883.6.73 2017-01 R06AX12 2.16.840.1.113883.6.73 2017-01 R06AX13 2.16.840.1.113883.6.73 2017-01 R06AX15 2.16.840.1.113883.6.73 2017-01 R06AX16 2.16.840.1.113883.6.73 2017-01 R06AX17 2.16.840.1.113883.6.73 2017-01 R06AX18 2.16.840.1.113883.6.73 2017-01 R06AX19 azelastine 2.16.840.1.113883.6.73 2017-01 R06AX21 tritoqualine 2.16.840.1.113883.6.73 2017-01 R06AX22 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 128 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 R06AX23 2.16.840.1.113883.6.73 2017-01 R06AX24 2.16.840.1.113883.6.73 2017-01 R06AX25 2.16.840.1.113883.6.73 2017-01 R06AX26 2.16.840.1.113883.6.73 2017-01 R06AX27 2.16.840.1.113883.6.73 2017-01 R06AX28 2.16.840.1.113883.6.73 2017-01 R06AX29 2.16.840.1.113883.6.73 2017-01 R06AX31 2.16.840.1.113883.6.73 2017-01 R06AX32 sequifenadine 2.16.840.1.113883.6.73 2017-01 R06AX53 thenalidine, combinations 2.16.840.1.113883.6.73 2017-01 R06AX58 pyrrobutamine, combinations 2.16.840.1.113883.6.73 2017-01 R07 OTHER RESPIRATORY SYSTEM PRODUCTS 2.16.840.1.113883.6.73 2017-01 R07A OTHER RESPIRATORY SYSTEM PRODUCTS 2.16.840.1.113883.6.73 2017-01 R07AA Lung 2.16.840.1.113883.6.73 2017-01 R07AA01 2.16.840.1.113883.6.73 2017-01 R07AA02 natural phospholipids 2.16.840.1.113883.6.73 2017-01 R07AA30 combinations 2.16.840.1.113883.6.73 2017-01 R07AB Respiratory stimulants 2.16.840.1.113883.6.73 2017-01 R07AB01 2.16.840.1.113883.6.73 2017-01 R07AB02 2.16.840.1.113883.6.73 2017-01 R07AB03 pentetrazol 2.16.840.1.113883.6.73 2017-01 R07AB04 2.16.840.1.113883.6.73 2017-01 R07AB05 2.16.840.1.113883.6.73 2017-01 R07AB06 2.16.840.1.113883.6.73 2017-01 R07AB07 2.16.840.1.113883.6.73 2017-01 R07AB08 2.16.840.1.113883.6.73 2017-01 R07AB09 2.16.840.1.113883.6.73 2017-01 R07AB52 nikethamide, combinations 2.16.840.1.113883.6.73 2017-01 R07AB53 pentetrazol, combinations 2.16.840.1.113883.6.73 2017-01 R07AX Other respiratory system products 2.16.840.1.113883.6.73 2017-01 R07AX01 2.16.840.1.113883.6.73 2017-01 R07AX02 2.16.840.1.113883.6.73 2017-01 R07AX30 ivacaftor and 2.16.840.1.113883.6.73 2017-01 S SENSORY ORGANS 2.16.840.1.113883.6.73 2017-01 S01 OPHTHALMOLOGICALS 2.16.840.1.113883.6.73 2017-01 S01A ANTIINFECTIVES 2.16.840.1.113883.6.73 2017-01 S01AA Antibiotics 2.16.840.1.113883.6.73 2017-01 S01AA01 chloramphenicol 2.16.840.1.113883.6.73 2017-01 S01AA02 chlortetracycline 2.16.840.1.113883.6.73 2017-01 S01AA03 neomycin 2.16.840.1.113883.6.73 2017-01 S01AA04 oxytetracycline 2.16.840.1.113883.6.73 2017-01 S01AA05 tyrothricin 2.16.840.1.113883.6.73 2017-01 S01AA07 framycetin © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 129 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01AA09 tetracycline 2.16.840.1.113883.6.73 2017-01 S01AA10 natamycin 2.16.840.1.113883.6.73 2017-01 S01AA11 gentamicin 2.16.840.1.113883.6.73 2017-01 S01AA12 tobramycin 2.16.840.1.113883.6.73 2017-01 S01AA13 fusidic acid 2.16.840.1.113883.6.73 2017-01 S01AA14 benzylpenicillin 2.16.840.1.113883.6.73 2017-01 S01AA15 dihydrostreptomycin 2.16.840.1.113883.6.73 2017-01 S01AA16 rifamycin 2.16.840.1.113883.6.73 2017-01 S01AA17 erythromycin 2.16.840.1.113883.6.73 2017-01 S01AA18 polymyxin B 2.16.840.1.113883.6.73 2017-01 S01AA19 ampicillin 2.16.840.1.113883.6.73 2017-01 S01AA20 antibiotics in combination with other drugs 2.16.840.1.113883.6.73 2017-01 S01AA21 amikacin 2.16.840.1.113883.6.73 2017-01 S01AA22 micronomicin 2.16.840.1.113883.6.73 2017-01 S01AA23 netilmicin 2.16.840.1.113883.6.73 2017-01 S01AA24 kanamycin 2.16.840.1.113883.6.73 2017-01 S01AA25 azidamfenicol 2.16.840.1.113883.6.73 2017-01 S01AA26 azithromycin 2.16.840.1.113883.6.73 2017-01 S01AA27 cefuroxime 2.16.840.1.113883.6.73 2017-01 S01AA30 combinations of different antibiotics 2.16.840.1.113883.6.73 2017-01 S01AB Sulfonamides 2.16.840.1.113883.6.73 2017-01 S01AB01 sulfamethizole 2.16.840.1.113883.6.73 2017-01 S01AB02 sulfafurazole 2.16.840.1.113883.6.73 2017-01 S01AB03 2.16.840.1.113883.6.73 2017-01 S01AB04 sulfacetamide 2.16.840.1.113883.6.73 2017-01 S01AB05 sulfafenazol 2.16.840.1.113883.6.73 2017-01 S01AD Antivirals 2.16.840.1.113883.6.73 2017-01 S01AD01 idoxuridine 2.16.840.1.113883.6.73 2017-01 S01AD02 trifluridine 2.16.840.1.113883.6.73 2017-01 S01AD03 aciclovir 2.16.840.1.113883.6.73 2017-01 S01AD05 interferon 2.16.840.1.113883.6.73 2017-01 S01AD06 vidarabine 2.16.840.1.113883.6.73 2017-01 S01AD07 famciclovir 2.16.840.1.113883.6.73 2017-01 S01AD08 fomivirsen 2.16.840.1.113883.6.73 2017-01 S01AD09 ganciclovir 2.16.840.1.113883.6.73 2017-01 S01AE Fluoroquinolones 2.16.840.1.113883.6.73 2017-01 S01AE01 ofloxacin 2.16.840.1.113883.6.73 2017-01 S01AE02 norfloxacin 2.16.840.1.113883.6.73 2017-01 S01AE03 ciprofloxacin 2.16.840.1.113883.6.73 2017-01 S01AE04 lomefloxacin 2.16.840.1.113883.6.73 2017-01 S01AE05 levofloxacin 2.16.840.1.113883.6.73 2017-01 S01AE06 gatifloxacin 2.16.840.1.113883.6.73 2017-01 S01AE07 moxifloxacin © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 130 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01AE08 2.16.840.1.113883.6.73 2017-01 S01AX Other antiinfectives 2.16.840.1.113883.6.73 2017-01 S01AX01 mercury compounds 2.16.840.1.113883.6.73 2017-01 S01AX02 silver compounds 2.16.840.1.113883.6.73 2017-01 S01AX03 zinc compounds 2.16.840.1.113883.6.73 2017-01 S01AX04 nitrofural 2.16.840.1.113883.6.73 2017-01 S01AX05 bibrocathol 2.16.840.1.113883.6.73 2017-01 S01AX06 resorcinol 2.16.840.1.113883.6.73 2017-01 S01AX07 sodium borate 2.16.840.1.113883.6.73 2017-01 S01AX08 hexamidine 2.16.840.1.113883.6.73 2017-01 S01AX09 chlorhexidine 2.16.840.1.113883.6.73 2017-01 S01AX10 sodium propionate 2.16.840.1.113883.6.73 2017-01 S01AX14 dibrompropamidine 2.16.840.1.113883.6.73 2017-01 S01AX15 propamidine 2.16.840.1.113883.6.73 2017-01 S01AX16 picloxydine 2.16.840.1.113883.6.73 2017-01 S01AX18 povidone-iodine 2.16.840.1.113883.6.73 2017-01 S01B ANTIINFLAMMATORY AGENTS 2.16.840.1.113883.6.73 2017-01 S01BA Corticosteroids, plain 2.16.840.1.113883.6.73 2017-01 S01BA01 dexamethasone 2.16.840.1.113883.6.73 2017-01 S01BA02 hydrocortisone 2.16.840.1.113883.6.73 2017-01 S01BA03 cortisone 2.16.840.1.113883.6.73 2017-01 S01BA04 prednisolone 2.16.840.1.113883.6.73 2017-01 S01BA05 triamcinolone 2.16.840.1.113883.6.73 2017-01 S01BA06 betamethasone 2.16.840.1.113883.6.73 2017-01 S01BA07 fluorometholone 2.16.840.1.113883.6.73 2017-01 S01BA08 2.16.840.1.113883.6.73 2017-01 S01BA09 clobetasone 2.16.840.1.113883.6.73 2017-01 S01BA10 alclometasone 2.16.840.1.113883.6.73 2017-01 S01BA11 desonide 2.16.840.1.113883.6.73 2017-01 S01BA12 2.16.840.1.113883.6.73 2017-01 S01BA13 rimexolone 2.16.840.1.113883.6.73 2017-01 S01BA14 2.16.840.1.113883.6.73 2017-01 S01BA15 fluocinolone acetonide 2.16.840.1.113883.6.73 2017-01 S01BB Corticosteroids and mydriatics in combination 2.16.840.1.113883.6.73 2017-01 S01BB01 hydrocortisone and mydriatics 2.16.840.1.113883.6.73 2017-01 S01BB02 prednisolone and mydriatics 2.16.840.1.113883.6.73 2017-01 S01BB03 fluorometholone and mydriatics 2.16.840.1.113883.6.73 2017-01 S01BB04 betamethasone and mydriatics 2.16.840.1.113883.6.73 2017-01 S01BC Antiinflammatory agents, non-steroids 2.16.840.1.113883.6.73 2017-01 S01BC01 indometacin 2.16.840.1.113883.6.73 2017-01 S01BC02 oxyphenbutazone 2.16.840.1.113883.6.73 2017-01 S01BC03 diclofenac 2.16.840.1.113883.6.73 2017-01 S01BC04 flurbiprofen © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 131 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01BC05 ketorolac 2.16.840.1.113883.6.73 2017-01 S01BC06 piroxicam 2.16.840.1.113883.6.73 2017-01 S01BC07 bendazac 2.16.840.1.113883.6.73 2017-01 S01BC08 salicylic acid 2.16.840.1.113883.6.73 2017-01 S01BC09 2.16.840.1.113883.6.73 2017-01 S01BC10 2.16.840.1.113883.6.73 2017-01 S01BC11 2.16.840.1.113883.6.73 2017-01 S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION 2.16.840.1.113883.6.73 2017-01 S01CA Corticosteroids and antiinfectives in combination 2.16.840.1.113883.6.73 2017-01 S01CA01 dexamethasone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CA02 prednisolone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CA03 hydrocortisone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CA04 fluocortolone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CA05 betamethasone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CA06 fludrocortisone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CA07 fluorometholone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CA08 methylprednisolone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CA09 and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CA10 fluocinolone acetonide and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CA11 clobetasone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CB Corticosteroids/antiinfectives/mydriatics in combination 2.16.840.1.113883.6.73 2017-01 S01CB01 dexamethasone 2.16.840.1.113883.6.73 2017-01 S01CB02 prednisolone 2.16.840.1.113883.6.73 2017-01 S01CB03 hydrocortisone 2.16.840.1.113883.6.73 2017-01 S01CB04 betamethasone 2.16.840.1.113883.6.73 2017-01 S01CB05 fluorometholone 2.16.840.1.113883.6.73 2017-01 S01CC Antiinflammatory agents, non-steroids and antiinfectives in combination 2.16.840.1.113883.6.73 2017-01 S01CC01 diclofenac and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01CC02 indometacin and antiinfectives 2.16.840.1.113883.6.73 2017-01 S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS 2.16.840.1.113883.6.73 2017-01 S01EA Sympathomimetics in glaucoma therapy1) 2.16.840.1.113883.6.73 2017-01 S01EA01 epinephrine 2.16.840.1.113883.6.73 2017-01 S01EA02 dipivefrine 2.16.840.1.113883.6.73 2017-01 S01EA03 2.16.840.1.113883.6.73 2017-01 S01EA04 clonidine 2.16.840.1.113883.6.73 2017-01 S01EA05 brimonidine 2.16.840.1.113883.6.73 2017-01 S01EA51 epinephrine, combinations 2.16.840.1.113883.6.73 2017-01 S01EB Parasympathomimetics 2.16.840.1.113883.6.73 2017-01 S01EB01 pilocarpine 2.16.840.1.113883.6.73 2017-01 S01EB02 carbachol 2.16.840.1.113883.6.73 2017-01 S01EB03 ecothiopate 2.16.840.1.113883.6.73 2017-01 S01EB04 demecarium © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 132 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01EB05 2.16.840.1.113883.6.73 2017-01 S01EB06 neostigmine 2.16.840.1.113883.6.73 2017-01 S01EB07 fluostigmine 2.16.840.1.113883.6.73 2017-01 S01EB08 2.16.840.1.113883.6.73 2017-01 S01EB09 2.16.840.1.113883.6.73 2017-01 S01EB10 2.16.840.1.113883.6.73 2017-01 S01EB51 pilocarpine, combinations 2.16.840.1.113883.6.73 2017-01 S01EB58 aceclidine, combinations 2.16.840.1.113883.6.73 2017-01 S01EC Carbonic anhydrase inhibitors 2.16.840.1.113883.6.73 2017-01 S01EC01 2.16.840.1.113883.6.73 2017-01 S01EC02 diclofenamide 2.16.840.1.113883.6.73 2017-01 S01EC03 dorzolamide 2.16.840.1.113883.6.73 2017-01 S01EC04 brinzolamide 2.16.840.1.113883.6.73 2017-01 S01EC05 methazolamide 2.16.840.1.113883.6.73 2017-01 S01EC54 brinzolamide, combinations 2.16.840.1.113883.6.73 2017-01 S01ED Beta blocking agents1) 2.16.840.1.113883.6.73 2017-01 S01ED01 timolol 2.16.840.1.113883.6.73 2017-01 S01ED02 betaxolol 2.16.840.1.113883.6.73 2017-01 S01ED03 2.16.840.1.113883.6.73 2017-01 S01ED04 metipranolol 2.16.840.1.113883.6.73 2017-01 S01ED05 carteolol 2.16.840.1.113883.6.73 2017-01 S01ED06 2.16.840.1.113883.6.73 2017-01 S01ED51 timolol, combinations 2.16.840.1.113883.6.73 2017-01 S01ED52 betaxolol, combinations 2.16.840.1.113883.6.73 2017-01 S01ED54 metipranolol, combinations 2.16.840.1.113883.6.73 2017-01 S01ED55 carteolol, combinations 2.16.840.1.113883.6.73 2017-01 S01EE analogues1) 2.16.840.1.113883.6.73 2017-01 S01EE01 latanoprost 2.16.840.1.113883.6.73 2017-01 S01EE02 unoprostone 2.16.840.1.113883.6.73 2017-01 S01EE03 bimatoprost 2.16.840.1.113883.6.73 2017-01 S01EE04 travoprost 2.16.840.1.113883.6.73 2017-01 S01EE05 tafluprost 2.16.840.1.113883.6.73 2017-01 S01EX Other antiglaucoma preparations 2.16.840.1.113883.6.73 2017-01 S01EX01 guanethidine 2.16.840.1.113883.6.73 2017-01 S01EX02 2.16.840.1.113883.6.73 2017-01 S01F MYDRIATICS AND CYCLOPLEGICS 2.16.840.1.113883.6.73 2017-01 S01FA Anticholinergics 2.16.840.1.113883.6.73 2017-01 S01FA01 atropine 2.16.840.1.113883.6.73 2017-01 S01FA02 scopolamine 2.16.840.1.113883.6.73 2017-01 S01FA03 methylscopolamine 2.16.840.1.113883.6.73 2017-01 S01FA04 2.16.840.1.113883.6.73 2017-01 S01FA05 2.16.840.1.113883.6.73 2017-01 S01FA06 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 133 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01FA54 cyclopentolate, combinations 2.16.840.1.113883.6.73 2017-01 S01FA56 tropicamide, combinations 2.16.840.1.113883.6.73 2017-01 S01FB Sympathomimetics excl. antiglaucoma preparations 2.16.840.1.113883.6.73 2017-01 S01FB01 phenylephrine 2.16.840.1.113883.6.73 2017-01 S01FB02 ephedrine 2.16.840.1.113883.6.73 2017-01 S01FB03 ibopamine 2.16.840.1.113883.6.73 2017-01 S01FB51 phenylephrine and ketorolac 2.16.840.1.113883.6.73 2017-01 S01G DECONGESTANTS AND ANTIALLERGICS 2.16.840.1.113883.6.73 2017-01 S01GA Sympathomimetics used as decongestants 2.16.840.1.113883.6.73 2017-01 S01GA01 naphazoline 2.16.840.1.113883.6.73 2017-01 S01GA02 tetryzoline 2.16.840.1.113883.6.73 2017-01 S01GA03 xylometazoline 2.16.840.1.113883.6.73 2017-01 S01GA04 oxymetazoline 2.16.840.1.113883.6.73 2017-01 S01GA05 phenylephrine 2.16.840.1.113883.6.73 2017-01 S01GA06 oxedrine 2.16.840.1.113883.6.73 2017-01 S01GA51 naphazoline, combinations 2.16.840.1.113883.6.73 2017-01 S01GA52 tetryzoline, combinations 2.16.840.1.113883.6.73 2017-01 S01GA53 xylometazoline, combinations 2.16.840.1.113883.6.73 2017-01 S01GA55 phenylephrine, combinations 2.16.840.1.113883.6.73 2017-01 S01GA56 oxedrine, combinations 2.16.840.1.113883.6.73 2017-01 S01GX Other antiallergics 2.16.840.1.113883.6.73 2017-01 S01GX01 cromoglicic acid 2.16.840.1.113883.6.73 2017-01 S01GX02 levocabastine 2.16.840.1.113883.6.73 2017-01 S01GX03 spaglumic acid 2.16.840.1.113883.6.73 2017-01 S01GX04 nedocromil 2.16.840.1.113883.6.73 2017-01 S01GX05 lodoxamide 2.16.840.1.113883.6.73 2017-01 S01GX06 2.16.840.1.113883.6.73 2017-01 S01GX07 azelastine 2.16.840.1.113883.6.73 2017-01 S01GX08 ketotifen 2.16.840.1.113883.6.73 2017-01 S01GX09 olopatadine 2.16.840.1.113883.6.73 2017-01 S01GX10 epinastine 2.16.840.1.113883.6.73 2017-01 S01GX11 alcaftadine 2.16.840.1.113883.6.73 2017-01 S01GX51 cromoglicic acid, combinations 2.16.840.1.113883.6.73 2017-01 S01H LOCAL ANESTHETICS 2.16.840.1.113883.6.73 2017-01 S01HA Local anesthetics 2.16.840.1.113883.6.73 2017-01 S01HA01 cocaine 2.16.840.1.113883.6.73 2017-01 S01HA02 oxybuprocaine 2.16.840.1.113883.6.73 2017-01 S01HA03 tetracaine 2.16.840.1.113883.6.73 2017-01 S01HA04 2.16.840.1.113883.6.73 2017-01 S01HA05 procaine 2.16.840.1.113883.6.73 2017-01 S01HA06 cinchocaine 2.16.840.1.113883.6.73 2017-01 S01HA07 lidocaine 2.16.840.1.113883.6.73 2017-01 S01HA30 combinations © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 134 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S01J DIAGNOSTIC AGENTS 2.16.840.1.113883.6.73 2017-01 S01JA Colouring agents 2.16.840.1.113883.6.73 2017-01 S01JA01 fluorescein 2.16.840.1.113883.6.73 2017-01 S01JA02 rose bengal sodium 2.16.840.1.113883.6.73 2017-01 S01JA51 fluorescein, combinations 2.16.840.1.113883.6.73 2017-01 S01JX Other ophthalmological diagnostic agents 2.16.840.1.113883.6.73 2017-01 S01K SURGICAL AIDS 2.16.840.1.113883.6.73 2017-01 S01KA Viscoelastic substances 2.16.840.1.113883.6.73 2017-01 S01KA01 hyaluronic acid 2.16.840.1.113883.6.73 2017-01 S01KA02 hypromellose 2.16.840.1.113883.6.73 2017-01 S01KA51 hyaluronic acid, combinations 2.16.840.1.113883.6.73 2017-01 S01KX Other surgical aids 2.16.840.1.113883.6.73 2017-01 S01KX01 chymotrypsin 2.16.840.1.113883.6.73 2017-01 S01L OCULAR VASCULAR DISORDER AGENTS 2.16.840.1.113883.6.73 2017-01 S01LA Antineovascularisation agents 2.16.840.1.113883.6.73 2017-01 S01LA01 verteporfin 2.16.840.1.113883.6.73 2017-01 S01LA02 anecortave 2.16.840.1.113883.6.73 2017-01 S01LA03 2.16.840.1.113883.6.73 2017-01 S01LA04 2.16.840.1.113883.6.73 2017-01 S01LA05 aflibercept 2.16.840.1.113883.6.73 2017-01 S01X OTHER OPHTHALMOLOGICALS 2.16.840.1.113883.6.73 2017-01 S01XA Other ophthalmologicals 2.16.840.1.113883.6.73 2017-01 S01XA01 guaiazulen 2.16.840.1.113883.6.73 2017-01 S01XA02 retinol 2.16.840.1.113883.6.73 2017-01 S01XA03 sodium chloride, hypertonic 2.16.840.1.113883.6.73 2017-01 S01XA04 potassium iodide 2.16.840.1.113883.6.73 2017-01 S01XA05 sodium edetate 2.16.840.1.113883.6.73 2017-01 S01XA06 ethylmorphine 2.16.840.1.113883.6.73 2017-01 S01XA07 alum 2.16.840.1.113883.6.73 2017-01 S01XA08 acetylcysteine 2.16.840.1.113883.6.73 2017-01 S01XA09 iodoheparinate 2.16.840.1.113883.6.73 2017-01 S01XA10 inosine 2.16.840.1.113883.6.73 2017-01 S01XA11 nandrolone 2.16.840.1.113883.6.73 2017-01 S01XA12 dexpanthenol 2.16.840.1.113883.6.73 2017-01 S01XA13 alteplase 2.16.840.1.113883.6.73 2017-01 S01XA14 heparin 2.16.840.1.113883.6.73 2017-01 S01XA15 ascorbic acid 2.16.840.1.113883.6.73 2017-01 S01XA18 ciclosporin 2.16.840.1.113883.6.73 2017-01 S01XA19 limbal stems cells, autologous 2.16.840.1.113883.6.73 2017-01 S01XA20 artificial tears and other indifferent preparations 2.16.840.1.113883.6.73 2017-01 S01XA21 mercaptamine 2.16.840.1.113883.6.73 2017-01 S01XA22 ocriplasmin 2.16.840.1.113883.6.73 2017-01 S01XA23 sirolimus © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 135 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S02 OTOLOGICALS 2.16.840.1.113883.6.73 2017-01 S02A ANTIINFECTIVES 2.16.840.1.113883.6.73 2017-01 S02AA Antiinfectives 2.16.840.1.113883.6.73 2017-01 S02AA01 chloramphenicol 2.16.840.1.113883.6.73 2017-01 S02AA02 nitrofural 2.16.840.1.113883.6.73 2017-01 S02AA03 boric acid 2.16.840.1.113883.6.73 2017-01 S02AA04 2.16.840.1.113883.6.73 2017-01 S02AA05 clioquinol 2.16.840.1.113883.6.73 2017-01 S02AA06 hydrogen peroxide 2.16.840.1.113883.6.73 2017-01 S02AA07 neomycin 2.16.840.1.113883.6.73 2017-01 S02AA08 tetracycline 2.16.840.1.113883.6.73 2017-01 S02AA09 chlorhexidine 2.16.840.1.113883.6.73 2017-01 S02AA10 acetic acid 2.16.840.1.113883.6.73 2017-01 S02AA11 polymyxin B 2.16.840.1.113883.6.73 2017-01 S02AA12 rifamycin 2.16.840.1.113883.6.73 2017-01 S02AA13 miconazole 2.16.840.1.113883.6.73 2017-01 S02AA14 gentamicin 2.16.840.1.113883.6.73 2017-01 S02AA15 ciprofloxacin 2.16.840.1.113883.6.73 2017-01 S02AA16 ofloxacin 2.16.840.1.113883.6.73 2017-01 S02AA30 antiinfectives, combinations 2.16.840.1.113883.6.73 2017-01 S02B CORTICOSTEROIDS 2.16.840.1.113883.6.73 2017-01 S02BA Corticosteroids 2.16.840.1.113883.6.73 2017-01 S02BA01 hydrocortisone 2.16.840.1.113883.6.73 2017-01 S02BA03 prednisolone 2.16.840.1.113883.6.73 2017-01 S02BA06 dexamethasone 2.16.840.1.113883.6.73 2017-01 S02BA07 betamethasone 2.16.840.1.113883.6.73 2017-01 S02BA08 fluocinolone acetonide 2.16.840.1.113883.6.73 2017-01 S02C CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION 2.16.840.1.113883.6.73 2017-01 S02CA Corticosteroids and antiinfectives in combination 2.16.840.1.113883.6.73 2017-01 S02CA01 prednisolone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S02CA02 flumetasone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S02CA03 hydrocortisone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S02CA04 triamcinolone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S02CA05 fluocinolone acetonide and antiinfectives 2.16.840.1.113883.6.73 2017-01 S02CA06 dexamethasone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S02CA07 fludrocortisone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S02D OTHER OTOLOGICALS 2.16.840.1.113883.6.73 2017-01 S02DA Analgesics and anesthetics 2.16.840.1.113883.6.73 2017-01 S02DA01 lidocaine 2.16.840.1.113883.6.73 2017-01 S02DA02 cocaine 2.16.840.1.113883.6.73 2017-01 S02DA03 phenazone 2.16.840.1.113883.6.73 2017-01 S02DA04 cinchocaine

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 136 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 S02DA30 combinations 2.16.840.1.113883.6.73 2017-01 S02DC Indifferent preparations 2.16.840.1.113883.6.73 2017-01 S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 S03A ANTIINFECTIVES 2.16.840.1.113883.6.73 2017-01 S03AA Antiinfectives 2.16.840.1.113883.6.73 2017-01 S03AA01 neomycin 2.16.840.1.113883.6.73 2017-01 S03AA02 tetracycline 2.16.840.1.113883.6.73 2017-01 S03AA03 polymyxin B 2.16.840.1.113883.6.73 2017-01 S03AA04 chlorhexidine 2.16.840.1.113883.6.73 2017-01 S03AA05 hexamidine 2.16.840.1.113883.6.73 2017-01 S03AA06 gentamicin 2.16.840.1.113883.6.73 2017-01 S03AA07 ciprofloxacin 2.16.840.1.113883.6.73 2017-01 S03AA08 chloramphenicol 2.16.840.1.113883.6.73 2017-01 S03AA30 antiinfectives, combinations 2.16.840.1.113883.6.73 2017-01 S03B CORTICOSTEROIDS 2.16.840.1.113883.6.73 2017-01 S03BA Corticosteroids 2.16.840.1.113883.6.73 2017-01 S03BA01 dexamethasone 2.16.840.1.113883.6.73 2017-01 S03BA02 prednisolone 2.16.840.1.113883.6.73 2017-01 S03BA03 betamethasone 2.16.840.1.113883.6.73 2017-01 S03C CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION 2.16.840.1.113883.6.73 2017-01 S03CA Corticosteroids and antiinfectives in combination 2.16.840.1.113883.6.73 2017-01 S03CA01 dexamethasone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S03CA02 prednisolone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S03CA04 hydrocortisone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S03CA05 fludrocortisone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S03CA06 betamethasone and antiinfectives 2.16.840.1.113883.6.73 2017-01 S03D OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 V VARIOUS 2.16.840.1.113883.6.73 2017-01 V01 ALLERGENS 2.16.840.1.113883.6.73 2017-01 V01A ALLERGENS 2.16.840.1.113883.6.73 2017-01 V01AA Allergen extracts 2.16.840.1.113883.6.73 2017-01 V01AA01 feather 2.16.840.1.113883.6.73 2017-01 V01AA02 grass pollen 2.16.840.1.113883.6.73 2017-01 V01AA03 house dust mites 2.16.840.1.113883.6.73 2017-01 V01AA04 mould fungus and yeast fungus 2.16.840.1.113883.6.73 2017-01 V01AA05 tree pollen 2.16.840.1.113883.6.73 2017-01 V01AA07 insects 2.16.840.1.113883.6.73 2017-01 V01AA08 food 2.16.840.1.113883.6.73 2017-01 V01AA09 textiles 2.16.840.1.113883.6.73 2017-01 V01AA10 flowers 2.16.840.1.113883.6.73 2017-01 V01AA11 animals 2.16.840.1.113883.6.73 2017-01 V01AA20 various © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 137 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V03 ALL OTHER THERAPEUTIC PRODUCTS 2.16.840.1.113883.6.73 2017-01 V03A ALL OTHER THERAPEUTIC PRODUCTS 2.16.840.1.113883.6.73 2017-01 V03AB 2.16.840.1.113883.6.73 2017-01 V03AB01 ipecacuanha 2.16.840.1.113883.6.73 2017-01 V03AB02 2.16.840.1.113883.6.73 2017-01 V03AB03 edetates 2.16.840.1.113883.6.73 2017-01 V03AB04 2.16.840.1.113883.6.73 2017-01 V03AB05 prednisolone and promethazine 2.16.840.1.113883.6.73 2017-01 V03AB06 2.16.840.1.113883.6.73 2017-01 V03AB08 2.16.840.1.113883.6.73 2017-01 V03AB09 2.16.840.1.113883.6.73 2017-01 V03AB13 2.16.840.1.113883.6.73 2017-01 V03AB14 2.16.840.1.113883.6.73 2017-01 V03AB15 naloxone 2.16.840.1.113883.6.73 2017-01 V03AB16 ethanol 2.16.840.1.113883.6.73 2017-01 V03AB17 methylthioninium chloride 2.16.840.1.113883.6.73 2017-01 V03AB18 potassium permanganate 2.16.840.1.113883.6.73 2017-01 V03AB19 physostigmine 2.16.840.1.113883.6.73 2017-01 V03AB20 copper sulfate 2.16.840.1.113883.6.73 2017-01 V03AB21 potassium iodide 2.16.840.1.113883.6.73 2017-01 V03AB22 2.16.840.1.113883.6.73 2017-01 V03AB23 acetylcysteine 2.16.840.1.113883.6.73 2017-01 V03AB24 digitalis antitoxin 2.16.840.1.113883.6.73 2017-01 V03AB25 2.16.840.1.113883.6.73 2017-01 V03AB26 2.16.840.1.113883.6.73 2017-01 V03AB27 4-dimethylaminophenol 2.16.840.1.113883.6.73 2017-01 V03AB29 2.16.840.1.113883.6.73 2017-01 V03AB31 2.16.840.1.113883.6.73 2017-01 V03AB32 2.16.840.1.113883.6.73 2017-01 V03AB33 hydroxocobalamin 2.16.840.1.113883.6.73 2017-01 V03AB34 2.16.840.1.113883.6.73 2017-01 V03AB35 2.16.840.1.113883.6.73 2017-01 V03AB36 phentolamine 2.16.840.1.113883.6.73 2017-01 V03AB37 2.16.840.1.113883.6.73 2017-01 V03AC Iron chelating agents 2.16.840.1.113883.6.73 2017-01 V03AC01 deferoxamine 2.16.840.1.113883.6.73 2017-01 V03AC02 deferiprone 2.16.840.1.113883.6.73 2017-01 V03AC03 deferasirox 2.16.840.1.113883.6.73 2017-01 V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia 2.16.840.1.113883.6.73 2017-01 V03AE01 polystyrene sulfonate 2.16.840.1.113883.6.73 2017-01 V03AE02 sevelamer 2.16.840.1.113883.6.73 2017-01 V03AE03 carbonate 2.16.840.1.113883.6.73 2017-01 V03AE04 and magnesium carbonate © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 138 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V03AE05 sucroferric oxyhydroxide 2.16.840.1.113883.6.73 2017-01 V03AE06 2.16.840.1.113883.6.73 2017-01 V03AE07 calcium acetate 2.16.840.1.113883.6.73 2017-01 V03AE08 ferric citrate 2.16.840.1.113883.6.73 2017-01 V03AE09 patiromer calcium 2.16.840.1.113883.6.73 2017-01 V03AF Detoxifying agents for antineoplastic treatment 2.16.840.1.113883.6.73 2017-01 V03AF01 mesna 2.16.840.1.113883.6.73 2017-01 V03AF02 dexrazoxane 2.16.840.1.113883.6.73 2017-01 V03AF03 calcium folinate 2.16.840.1.113883.6.73 2017-01 V03AF04 calcium levofolinate 2.16.840.1.113883.6.73 2017-01 V03AF05 amifostine 2.16.840.1.113883.6.73 2017-01 V03AF06 sodium folinate 2.16.840.1.113883.6.73 2017-01 V03AF07 rasburicase 2.16.840.1.113883.6.73 2017-01 V03AF08 2.16.840.1.113883.6.73 2017-01 V03AF09 glucarpidase 2.16.840.1.113883.6.73 2017-01 V03AF10 sodium levofolinate 2.16.840.1.113883.6.73 2017-01 V03AG Drugs for treatment of hypercalcemia 2.16.840.1.113883.6.73 2017-01 V03AG01 sodium cellulose phosphate 2.16.840.1.113883.6.73 2017-01 V03AH Drugs for treatment of hypoglycemia 2.16.840.1.113883.6.73 2017-01 V03AH01 diazoxide 2.16.840.1.113883.6.73 2017-01 V03AK Tissue adhesives 2.16.840.1.113883.6.73 2017-01 V03AM Drugs for embolisation 2.16.840.1.113883.6.73 2017-01 V03AN Medical gases 2.16.840.1.113883.6.73 2017-01 V03AN01 oxygen 2.16.840.1.113883.6.73 2017-01 V03AN02 carbon dioxide 2.16.840.1.113883.6.73 2017-01 V03AN03 helium 2.16.840.1.113883.6.73 2017-01 V03AN04 nitrogen 2.16.840.1.113883.6.73 2017-01 V03AN05 medical air 2.16.840.1.113883.6.73 2017-01 V03AX Other therapeutic products 2.16.840.1.113883.6.73 2017-01 V03AX02 2.16.840.1.113883.6.73 2017-01 V03AX03 cobicistat 2.16.840.1.113883.6.73 2017-01 V03AZ Nerve 2.16.840.1.113883.6.73 2017-01 V03AZ01 ethanol 2.16.840.1.113883.6.73 2017-01 V04 DIAGNOSTIC AGENTS 2.16.840.1.113883.6.73 2017-01 V04B URINE TESTS 2.16.840.1.113883.6.73 2017-01 V04C OTHER DIAGNOSTIC AGENTS 2.16.840.1.113883.6.73 2017-01 V04CA Tests for diabetes 2.16.840.1.113883.6.73 2017-01 V04CA01 tolbutamide 2.16.840.1.113883.6.73 2017-01 V04CA02 glucose 2.16.840.1.113883.6.73 2017-01 V04CB Tests for fat absorption 2.16.840.1.113883.6.73 2017-01 V04CB01 vitamin A concentrates 2.16.840.1.113883.6.73 2017-01 V04CC Tests for bile duct patency 2.16.840.1.113883.6.73 2017-01 V04CC01 sorbitol © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 139 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V04CC02 magnesium sulfate 2.16.840.1.113883.6.73 2017-01 V04CC03 2.16.840.1.113883.6.73 2017-01 V04CC04 2.16.840.1.113883.6.73 2017-01 V04CD Tests for pituitary function 2.16.840.1.113883.6.73 2017-01 V04CD01 2.16.840.1.113883.6.73 2017-01 V04CD03 sermorelin 2.16.840.1.113883.6.73 2017-01 V04CD04 2.16.840.1.113883.6.73 2017-01 V04CD05 2.16.840.1.113883.6.73 2017-01 V04CD06 macimorelin 2.16.840.1.113883.6.73 2017-01 V04CE Tests for liver functional capacity 2.16.840.1.113883.6.73 2017-01 V04CE01 2.16.840.1.113883.6.73 2017-01 V04CE02 sulfobromophthalein 2.16.840.1.113883.6.73 2017-01 V04CE03 methacetin (13C) 2.16.840.1.113883.6.73 2017-01 V04CF Tuberculosis diagnostics 2.16.840.1.113883.6.73 2017-01 V04CF01 tuberculin 2.16.840.1.113883.6.73 2017-01 V04CG Tests for gastric secretion 2.16.840.1.113883.6.73 2017-01 V04CG01 cation exchange resins 2.16.840.1.113883.6.73 2017-01 V04CG02 2.16.840.1.113883.6.73 2017-01 V04CG03 histamine phosphate 2.16.840.1.113883.6.73 2017-01 V04CG04 2.16.840.1.113883.6.73 2017-01 V04CG05 methylthioninium chloride 2.16.840.1.113883.6.73 2017-01 V04CG30 caffeine and sodium benzoate 2.16.840.1.113883.6.73 2017-01 V04CH Tests for renal function and ureteral injuries 2.16.840.1.113883.6.73 2017-01 V04CH01 and other polyfructosans 2.16.840.1.113883.6.73 2017-01 V04CH02 2.16.840.1.113883.6.73 2017-01 V04CH03 phenolsulfonphthalein 2.16.840.1.113883.6.73 2017-01 V04CH04 2.16.840.1.113883.6.73 2017-01 V04CH30 2.16.840.1.113883.6.73 2017-01 V04CJ Tests for thyreoidea function 2.16.840.1.113883.6.73 2017-01 V04CJ01 thyrotropin 2.16.840.1.113883.6.73 2017-01 V04CJ02 protirelin 2.16.840.1.113883.6.73 2017-01 V04CK Tests for pancreatic function 2.16.840.1.113883.6.73 2017-01 V04CK01 2.16.840.1.113883.6.73 2017-01 V04CK02 pancreozymin () 2.16.840.1.113883.6.73 2017-01 V04CK03 2.16.840.1.113883.6.73 2017-01 V04CL Tests for allergic diseases 2.16.840.1.113883.6.73 2017-01 V04CM Tests for fertility disturbances 2.16.840.1.113883.6.73 2017-01 V04CM01 gonadorelin 2.16.840.1.113883.6.73 2017-01 V04CX Other diagnostic agents 2.16.840.1.113883.6.73 2017-01 V06 GENERAL NUTRIENTS 2.16.840.1.113883.6.73 2017-01 V06A DIET FORMULATIONS FOR TREATMENT OF OBESITY 2.16.840.1.113883.6.73 2017-01 V06AA Low-energy diets 2.16.840.1.113883.6.73 2017-01 V06B PROTEIN SUPPLEMENTS © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 140 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V06C INFANT FORMULAS 2.16.840.1.113883.6.73 2017-01 V06CA Nutrients without 2.16.840.1.113883.6.73 2017-01 V06D OTHER NUTRIENTS 2.16.840.1.113883.6.73 2017-01 V06DA Carbohydrates/proteins/minerals/vitamins, combinations 2.16.840.1.113883.6.73 2017-01 V06DB Fat/carbohydrates/proteins/minerals/vitamins, combinations 2.16.840.1.113883.6.73 2017-01 V06DC Carbohydrates 2.16.840.1.113883.6.73 2017-01 V06DC01 glucose 2.16.840.1.113883.6.73 2017-01 V06DC02 fructose 2.16.840.1.113883.6.73 2017-01 V06DD Amino acids, incl. combinations with polypeptides 2.16.840.1.113883.6.73 2017-01 V06DE Amino acids/carbohydrates/minerals/vitamins, combinations 2.16.840.1.113883.6.73 2017-01 V06DF Milk substitutes 2.16.840.1.113883.6.73 2017-01 V06DX Other combinations of nutrients 2.16.840.1.113883.6.73 2017-01 V07 ALL OTHER NON-THERAPEUTIC PRODUCTS 2.16.840.1.113883.6.73 2017-01 V07A ALL OTHER NON-THERAPEUTIC PRODUCTS 2.16.840.1.113883.6.73 2017-01 V07AA Plasters 2.16.840.1.113883.6.73 2017-01 V07AB Solvents and diluting agents, incl. irrigating solutions 2.16.840.1.113883.6.73 2017-01 V07AC Blood transfusion, auxiliary products 2.16.840.1.113883.6.73 2017-01 V07AD Blood tests, auxiliary products 2.16.840.1.113883.6.73 2017-01 V07AN Incontinence equipment 2.16.840.1.113883.6.73 2017-01 V07AR Sensitivity tests, discs and tablets 2.16.840.1.113883.6.73 2017-01 V07AS Stomi equipment 2.16.840.1.113883.6.73 2017-01 V07AT 2.16.840.1.113883.6.73 2017-01 V07AV Technical disinfectants 2.16.840.1.113883.6.73 2017-01 V07AX Washing agents etc. 2.16.840.1.113883.6.73 2017-01 V07AY Other non-therapeutic auxiliary products 2.16.840.1.113883.6.73 2017-01 V07AZ Chemicals and reagents for analysis 2.16.840.1.113883.6.73 2017-01 V08 CONTRAST MEDIA 2.16.840.1.113883.6.73 2017-01 V08A X-RAY CONTRAST MEDIA, IODINATED 2.16.840.1.113883.6.73 2017-01 V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media 2.16.840.1.113883.6.73 2017-01 V08AA01 diatrizoic acid 2.16.840.1.113883.6.73 2017-01 V08AA02 2.16.840.1.113883.6.73 2017-01 V08AA03 2.16.840.1.113883.6.73 2017-01 V08AA04 2.16.840.1.113883.6.73 2017-01 V08AA05 2.16.840.1.113883.6.73 2017-01 V08AA06 ioglicic acid 2.16.840.1.113883.6.73 2017-01 V08AA07 2.16.840.1.113883.6.73 2017-01 V08AA08 2.16.840.1.113883.6.73 2017-01 V08AA09 2.16.840.1.113883.6.73 2017-01 V08AA10 2.16.840.1.113883.6.73 2017-01 V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media 2.16.840.1.113883.6.73 2017-01 V08AB01 2.16.840.1.113883.6.73 2017-01 V08AB02 2.16.840.1.113883.6.73 2017-01 V08AB03 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 141 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V08AB04 2.16.840.1.113883.6.73 2017-01 V08AB05 2.16.840.1.113883.6.73 2017-01 V08AB06 2.16.840.1.113883.6.73 2017-01 V08AB07 2.16.840.1.113883.6.73 2017-01 V08AB08 2.16.840.1.113883.6.73 2017-01 V08AB09 2.16.840.1.113883.6.73 2017-01 V08AB10 2.16.840.1.113883.6.73 2017-01 V08AB11 2.16.840.1.113883.6.73 2017-01 V08AB12 2.16.840.1.113883.6.73 2017-01 V08AC Watersoluble, hepatotropic X-ray contrast media 2.16.840.1.113883.6.73 2017-01 V08AC01 2.16.840.1.113883.6.73 2017-01 V08AC02 2.16.840.1.113883.6.73 2017-01 V08AC03 ioglycamic acid 2.16.840.1.113883.6.73 2017-01 V08AC04 2.16.840.1.113883.6.73 2017-01 V08AC05 2.16.840.1.113883.6.73 2017-01 V08AC06 2.16.840.1.113883.6.73 2017-01 V08AC07 2.16.840.1.113883.6.73 2017-01 V08AC08 sodium iopodate 2.16.840.1.113883.6.73 2017-01 V08AC09 tyropanoic acid 2.16.840.1.113883.6.73 2017-01 V08AC10 calcium iopodate 2.16.840.1.113883.6.73 2017-01 V08AD Non-watersoluble X-ray contrast media 2.16.840.1.113883.6.73 2017-01 V08AD01 ethyl esters of iodised fatty acids 2.16.840.1.113883.6.73 2017-01 V08AD02 2.16.840.1.113883.6.73 2017-01 V08AD03 2.16.840.1.113883.6.73 2017-01 V08AD04 2.16.840.1.113883.6.73 2017-01 V08B X-RAY CONTRAST MEDIA, NON-IODINATED 2.16.840.1.113883.6.73 2017-01 V08BA containing X-ray contrast media 2.16.840.1.113883.6.73 2017-01 V08BA01 barium sulfate with suspending agents 2.16.840.1.113883.6.73 2017-01 V08BA02 barium sulfate without suspending agents 2.16.840.1.113883.6.73 2017-01 V08C MAGNETIC RESONANCE IMAGING CONTRAST MEDIA 2.16.840.1.113883.6.73 2017-01 V08CA Paramagnetic contrast media 2.16.840.1.113883.6.73 2017-01 V08CA01 2.16.840.1.113883.6.73 2017-01 V08CA02 2.16.840.1.113883.6.73 2017-01 V08CA03 2.16.840.1.113883.6.73 2017-01 V08CA04 2.16.840.1.113883.6.73 2017-01 V08CA05 2.16.840.1.113883.6.73 2017-01 V08CA06 2.16.840.1.113883.6.73 2017-01 V08CA07 ferric ammonium citrate 2.16.840.1.113883.6.73 2017-01 V08CA08 2.16.840.1.113883.6.73 2017-01 V08CA09 2.16.840.1.113883.6.73 2017-01 V08CA10 2.16.840.1.113883.6.73 2017-01 V08CA11 2.16.840.1.113883.6.73 2017-01 V08CB Superparamagnetic contrast media © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 142 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V08CB01 ferumoxsil 2.16.840.1.113883.6.73 2017-01 V08CB02 ferristene 2.16.840.1.113883.6.73 2017-01 V08CB03 iron oxide, 2.16.840.1.113883.6.73 2017-01 V08CX Other magnetic resonance imaging contrast media 2.16.840.1.113883.6.73 2017-01 V08CX01 2.16.840.1.113883.6.73 2017-01 V08D ULTRASOUND CONTRAST MEDIA 2.16.840.1.113883.6.73 2017-01 V08DA Ultrasound contrast media 2.16.840.1.113883.6.73 2017-01 V08DA01 microspheres of human albumin 2.16.840.1.113883.6.73 2017-01 V08DA02 microparticles of galactose 2.16.840.1.113883.6.73 2017-01 V08DA03 2.16.840.1.113883.6.73 2017-01 V08DA04 microspheres of phospholipids 2.16.840.1.113883.6.73 2017-01 V08DA05 2.16.840.1.113883.6.73 2017-01 V08DA06 perflubutane polymer microspheres 2.16.840.1.113883.6.73 2017-01 V09 DIAGNOSTIC RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V09A CENTRAL NERVOUS SYSTEM 2.16.840.1.113883.6.73 2017-01 V09AA Technetium (99mTc) compounds 2.16.840.1.113883.6.73 2017-01 V09AA01 technetium (99mTc) exametazime 2.16.840.1.113883.6.73 2017-01 V09AA02 technetium (99mTc) bicisate 2.16.840.1.113883.6.73 2017-01 V09AB Iodine (123I) compounds 2.16.840.1.113883.6.73 2017-01 V09AB01 iodine (123I) 2.16.840.1.113883.6.73 2017-01 V09AB02 iodine iolopride (123I) 2.16.840.1.113883.6.73 2017-01 V09AB03 iodine (123I) 2.16.840.1.113883.6.73 2017-01 V09AX Other central nervous system diagnostic radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V09AX01 indium (111In) pentetic acid 2.16.840.1.113883.6.73 2017-01 V09AX03 iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)- 2.16.840.1.113883.6.73 2017-01 V09AX04 flutemetamol (18F) 2.16.840.1.113883.6.73 2017-01 V09AX05 florbetapir (18F) 2.16.840.1.113883.6.73 2017-01 V09AX06 florbetaben (18F) 2.16.840.1.113883.6.73 2017-01 V09B SKELETON 2.16.840.1.113883.6.73 2017-01 V09BA Technetium (99mTc) compounds 2.16.840.1.113883.6.73 2017-01 V09BA01 technetium (99mTc) oxidronic acid 2.16.840.1.113883.6.73 2017-01 V09BA02 technetium (99mTc) medronic acid 2.16.840.1.113883.6.73 2017-01 V09BA03 technetium (99mTc) pyrophosphate 2.16.840.1.113883.6.73 2017-01 V09BA04 technetium (99mTc) butedronic acid 2.16.840.1.113883.6.73 2017-01 V09C RENAL SYSTEM 2.16.840.1.113883.6.73 2017-01 V09CA Technetium (99mTc) compounds 2.16.840.1.113883.6.73 2017-01 V09CA01 technetium (99mTc) pentetic acid 2.16.840.1.113883.6.73 2017-01 V09CA02 technetium (99mTc) succimer 2.16.840.1.113883.6.73 2017-01 V09CA03 technetium (99mTc) mertiatide 2.16.840.1.113883.6.73 2017-01 V09CA04 technetium (99mTc) gluceptate 2.16.840.1.113883.6.73 2017-01 V09CA05 technetium (99mTc) gluconate 2.16.840.1.113883.6.73 2017-01 V09CA06 technetium (99mTc) ethylenedicysteine 2.16.840.1.113883.6.73 2017-01 V09CX Other renal system diagnostic radiopharmaceuticals © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 143 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09CX01 sodium iodohippurate (123I) 2.16.840.1.113883.6.73 2017-01 V09CX02 sodium iodohippurate (131I) 2.16.840.1.113883.6.73 2017-01 V09CX03 sodium iothalamate (125I) 2.16.840.1.113883.6.73 2017-01 V09CX04 chromium (51Cr) edetate 2.16.840.1.113883.6.73 2017-01 V09D HEPATIC AND RETICULO ENDOTHELIAL SYSTEM 2.16.840.1.113883.6.73 2017-01 V09DA Technetium (99mTc) compounds 2.16.840.1.113883.6.73 2017-01 V09DA01 technetium (99mTc) disofenin 2.16.840.1.113883.6.73 2017-01 V09DA02 technetium (99mTc) etifenin 2.16.840.1.113883.6.73 2017-01 V09DA03 technetium (99mTc) lidofenin 2.16.840.1.113883.6.73 2017-01 V09DA04 technetium (99mTc) mebrofenin 2.16.840.1.113883.6.73 2017-01 V09DA05 technetium (99mTc) galtifenin 2.16.840.1.113883.6.73 2017-01 V09DB Technetium (99mTc), particles and colloids 2.16.840.1.113883.6.73 2017-01 V09DB01 technetium (99mTc) nanocolloid 2.16.840.1.113883.6.73 2017-01 V09DB02 technetium (99mTc) microcolloid 2.16.840.1.113883.6.73 2017-01 V09DB03 technetium (99mTc) millimicrospheres 2.16.840.1.113883.6.73 2017-01 V09DB04 technetium (99mTc) tin colloid 2.16.840.1.113883.6.73 2017-01 V09DB05 technetium (99mTc) sulfur colloid 2.16.840.1.113883.6.73 2017-01 V09DB06 technetium (99mTc) rheniumsulfide colloid 2.16.840.1.113883.6.73 2017-01 V09DB07 technetium (99mTc) phytate 2.16.840.1.113883.6.73 2017-01 V09DX Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V09DX01 selenium (75Se) tauroselcholic acid 2.16.840.1.113883.6.73 2017-01 V09E RESPIRATORY SYSTEM 2.16.840.1.113883.6.73 2017-01 V09EA Technetium (99mTc), inhalants 2.16.840.1.113883.6.73 2017-01 V09EA01 technetium (99mTc) pentetic acid 2.16.840.1.113883.6.73 2017-01 V09EA02 technetium (99mTc) technegas 2.16.840.1.113883.6.73 2017-01 V09EA03 technetium (99mTc) nanocolloid 2.16.840.1.113883.6.73 2017-01 V09EB Technetium (99mTc), particles for injection 2.16.840.1.113883.6.73 2017-01 V09EB01 technetium (99mTc) macrosalb 2.16.840.1.113883.6.73 2017-01 V09EB02 technetium (99mTc) microspheres 2.16.840.1.113883.6.73 2017-01 V09EX Other respiratory system diagnostic radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V09EX01 krypton (81mKr) gas 2.16.840.1.113883.6.73 2017-01 V09EX02 xenon (127Xe) gas 2.16.840.1.113883.6.73 2017-01 V09EX03 xenon (133Xe) gas 2.16.840.1.113883.6.73 2017-01 V09F THYROID 2.16.840.1.113883.6.73 2017-01 V09FX Various thyroid diagnostic radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V09FX01 technetium (99mTc) 2.16.840.1.113883.6.73 2017-01 V09FX02 sodium iodide (123I) 2.16.840.1.113883.6.73 2017-01 V09FX03 sodium iodide (131I) 2.16.840.1.113883.6.73 2017-01 V09FX04 sodium iodide (124I) 2.16.840.1.113883.6.73 2017-01 V09G CARDIOVASCULAR SYSTEM 2.16.840.1.113883.6.73 2017-01 V09GA Technetium (99mTc) compounds 2.16.840.1.113883.6.73 2017-01 V09GA01 technetium (99mTc) sestamibi

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 144 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09GA02 technetium (99mTc) tetrofosmin 2.16.840.1.113883.6.73 2017-01 V09GA03 technetium (99mTc) teboroxime 2.16.840.1.113883.6.73 2017-01 V09GA04 technetium (99mTc) human albumin 2.16.840.1.113883.6.73 2017-01 V09GA05 technetium (99mTc) furifosmin 2.16.840.1.113883.6.73 2017-01 V09GA06 technetium (99mTc) stannous agent labelled cells 2.16.840.1.113883.6.73 2017-01 V09GA07 technetium (99mTc) apcitide 2.16.840.1.113883.6.73 2017-01 V09GB Iodine (125I) compounds 2.16.840.1.113883.6.73 2017-01 V09GB01 fibrinogen (125I) 2.16.840.1.113883.6.73 2017-01 V09GB02 iodine (125I) human albumin 2.16.840.1.113883.6.73 2017-01 V09GX Other cardiovascular system diagnostic radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V09GX01 thallium (201Tl) chloride 2.16.840.1.113883.6.73 2017-01 V09GX02 indium (111In) imciromab 2.16.840.1.113883.6.73 2017-01 V09GX03 chromium (51Cr) chromate labelled cells 2.16.840.1.113883.6.73 2017-01 V09GX04 rubidium (82Rb) chloride 2.16.840.1.113883.6.73 2017-01 V09H INFLAMMATION AND DETECTION 2.16.840.1.113883.6.73 2017-01 V09HA Technetium (99mTc) compounds 2.16.840.1.113883.6.73 2017-01 V09HA01 technetium (99mTc) human immunoglobulin 2.16.840.1.113883.6.73 2017-01 V09HA02 technetium (99mTc) exametazime labelled cells 2.16.840.1.113883.6.73 2017-01 V09HA03 technetium (99mTc) antigranulocyte 2.16.840.1.113883.6.73 2017-01 V09HA04 technetium (99mTc) sulesomab 2.16.840.1.113883.6.73 2017-01 V09HB Indium (111In) compounds 2.16.840.1.113883.6.73 2017-01 V09HB01 indium (111In) oxinate labelled cells 2.16.840.1.113883.6.73 2017-01 V09HB02 indium (111In) tropolonate labelled cells 2.16.840.1.113883.6.73 2017-01 V09HX Other diagnostic radiopharmaceuticals for inflammation and infection detection 2.16.840.1.113883.6.73 2017-01 V09HX01 gallium (67Ga) citrate 2.16.840.1.113883.6.73 2017-01 V09I TUMOUR DETECTION 2.16.840.1.113883.6.73 2017-01 V09IA Technetium (99mTc) compounds 2.16.840.1.113883.6.73 2017-01 V09IA01 technetium (99mTc) antiCarcinoEmbryonicAntigen antibody 2.16.840.1.113883.6.73 2017-01 V09IA02 technetium (99mTc) antimelanoma antibody 2.16.840.1.113883.6.73 2017-01 V09IA03 technetium (99mTc) pentavalent succimer 2.16.840.1.113883.6.73 2017-01 V09IA04 technetium (99mTc) votumumab 2.16.840.1.113883.6.73 2017-01 V09IA05 technetium (99mTc) depreotide 2.16.840.1.113883.6.73 2017-01 V09IA06 technetium (99mTc) arcitumomab 2.16.840.1.113883.6.73 2017-01 V09IA07 technetium (99mTc) hynic-octreotide 2.16.840.1.113883.6.73 2017-01 V09IA08 technetium (99mTc) etarfolatide 2.16.840.1.113883.6.73 2017-01 V09IA09 technetium (99mTc) tilmanocept 2.16.840.1.113883.6.73 2017-01 V09IB Indium (111In) compounds 2.16.840.1.113883.6.73 2017-01 V09IB01 indium (111In) pentetreotide 2.16.840.1.113883.6.73 2017-01 V09IB02 indium (111In) satumomab pendetide 2.16.840.1.113883.6.73 2017-01 V09IB03 indium (111In) antiovariumcarcinoma antibody 2.16.840.1.113883.6.73 2017-01 V09IB04 indium (111In) capromab pendetide 2.16.840.1.113883.6.73 2017-01 V09IX Other diagnostic radiopharmaceuticals for tumour detection

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 145 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V09IX01 iobenguane (123I) 2.16.840.1.113883.6.73 2017-01 V09IX02 iobenguane (131I) 2.16.840.1.113883.6.73 2017-01 V09IX03 iodine (125I) CC49- 2.16.840.1.113883.6.73 2017-01 V09IX04 fludeoxyglucose (18F) 2.16.840.1.113883.6.73 2017-01 V09IX05 fluorodopa (18F) 2.16.840.1.113883.6.73 2017-01 V09IX06 sodium fluoride (18F) 2.16.840.1.113883.6.73 2017-01 V09IX07 fluoromethylcholine (18F) 2.16.840.1.113883.6.73 2017-01 V09IX08 fluoroethylcholine (18F) 2.16.840.1.113883.6.73 2017-01 V09IX09 gallium (68Ga) edotreotide 2.16.840.1.113883.6.73 2017-01 V09IX10 fluoroethyl-L-tyrosine (18F) 2.16.840.1.113883.6.73 2017-01 V09IX11 fluoroestradiol (18F) 2.16.840.1.113883.6.73 2017-01 V09IX12 fluciclovine (18F) 2.16.840.1.113883.6.73 2017-01 V09X OTHER DIAGNOSTIC RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V09XA Iodine (131I) compounds 2.16.840.1.113883.6.73 2017-01 V09XA01 iodine (131I) norcholesterol 2.16.840.1.113883.6.73 2017-01 V09XA02 iodocholesterol (131I) 2.16.840.1.113883.6.73 2017-01 V09XA03 iodine (131I) human albumin 2.16.840.1.113883.6.73 2017-01 V09XX Various diagnostic radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V09XX01 cobalt (57Co) cyanocobalamine 2.16.840.1.113883.6.73 2017-01 V09XX02 cobalt (58Co) cyanocobalamine 2.16.840.1.113883.6.73 2017-01 V09XX03 selenium (75Se) norcholesterol 2.16.840.1.113883.6.73 2017-01 V09XX04 ferric (59Fe) citrate 2.16.840.1.113883.6.73 2017-01 V10 THERAPEUTIC RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V10A ANTIINFLAMMATORY AGENTS 2.16.840.1.113883.6.73 2017-01 V10AA Yttrium (90Y) compounds 2.16.840.1.113883.6.73 2017-01 V10AA01 yttrium (90Y) citrate colloid 2.16.840.1.113883.6.73 2017-01 V10AA02 yttrium (90Y) ferrihydroxide colloid 2.16.840.1.113883.6.73 2017-01 V10AA03 yttrium (90Y) silicate colloid 2.16.840.1.113883.6.73 2017-01 V10AX Other antiinflammatory therapeutic radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V10AX01 phosphorous (32P) chromicphosphate colloid 2.16.840.1.113883.6.73 2017-01 V10AX02 samarium (153Sm) hydroxyapatite colloid 2.16.840.1.113883.6.73 2017-01 V10AX03 dysprosium (165Dy) colloid 2.16.840.1.113883.6.73 2017-01 V10AX04 erbium (169Er) citrate colloid 2.16.840.1.113883.6.73 2017-01 V10AX05 rhenium (186Re) sulfide colloid 2.16.840.1.113883.6.73 2017-01 V10AX06 gold (198Au) colloidal 2.16.840.1.113883.6.73 2017-01 V10B PAIN PALLIATION (BONE SEEKING AGENTS) 2.16.840.1.113883.6.73 2017-01 V10BX Various pain palliation radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V10BX01 strontium (89Sr) chloride 2.16.840.1.113883.6.73 2017-01 V10BX02 samarium (153Sm) lexidronam 2.16.840.1.113883.6.73 2017-01 V10BX03 rhenium (186Re) etidronic acid 2.16.840.1.113883.6.73 2017-01 V10X OTHER THERAPEUTIC RADIOPHARMACEUTICALS 2.16.840.1.113883.6.73 2017-01 V10XA Iodine (131I) compounds 2.16.840.1.113883.6.73 2017-01 V10XA01 sodium iodide (131I) © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 146 of 490 MTC epSOSActiveIngredient

2.16.840.1.113883.6.73 2017-01 V10XA02 iobenguane (131I) 2.16.840.1.113883.6.73 2017-01 V10XA53 tositumomab/iodine (131I) tositumomab 2.16.840.1.113883.6.73 2017-01 V10XX Various therapeutic radiopharmaceuticals 2.16.840.1.113883.6.73 2017-01 V10XX01 sodium phosphate (32P) 2.16.840.1.113883.6.73 2017-01 V10XX02 ibritumomab tiuxetan (90Y) 2.16.840.1.113883.6.73 2017-01 V10XX03 radium (223Ra) dichloride 2.16.840.1.113883.6.73 2017-01 V20 SURGICAL DRESSINGS

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 147 of 490 MTC epSOSAdministrativeGender

epSOSAdministrativeGender

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.34

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.5.1 913-20091020 F Female 2.16.840.1.113883.5.1 913-20091020 M Male 2.16.840.1.113883.5.1 913-20091020 UN Undifferentiated

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 148 of 490 MTC epSOSAdverseEventType

epSOSAdverseEventType

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.18

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 235719002 Food intolerance 2.16.840.1.113883.6.96 2016-07 29544009 Intolerance 2.16.840.1.113883.6.96 2016-07 414285001 Food allergy 2.16.840.1.113883.6.96 2016-07 416098002 allergy 2.16.840.1.113883.6.96 2016-07 418038007 Propensity to adverse reactions to substance 2.16.840.1.113883.6.96 2016-07 418471000 Propensity to adverse reactions to food 2.16.840.1.113883.6.96 2016-07 419199007 Allergy to substance 2.16.840.1.113883.6.96 2016-07 419511003 Propensity to adverse reactions to drug 2.16.840.1.113883.6.96 2016-07 420134006 Propensity to adverse reactions 2.16.840.1.113883.6.96 2016-07 59037007 Drug intolerance

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 149 of 490 MTC epSOSAllergenNoDrugs

epSOSAllergenNoDrugs

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.19

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 102259006 fruit 2.16.840.1.113883.6.96 2016-07 102261002 Strawberry 2.16.840.1.113883.6.96 2016-07 102262009 Chocolate 2.16.840.1.113883.6.96 2016-07 102263004 Eggs (edible) 2.16.840.1.113883.6.96 2016-07 102264005 Cheese 2.16.840.1.113883.6.96 2016-07 111088007 Latex 2.16.840.1.113883.6.96 2016-07 11526002 Aspartame 2.16.840.1.113883.6.96 2016-07 115589000 Ethanolamine 2.16.840.1.113883.6.96 2016-07 116273005 Dietary substance 2.16.840.1.113883.6.96 2016-07 116549003 Organochlorine pesticide 2.16.840.1.113883.6.96 2016-07 116637007 Fungal antigen 2.16.840.1.113883.6.96 2016-07 11894001 Clostridium botulinum toxin 2.16.840.1.113883.6.96 2016-07 119417004 2.16.840.1.113883.6.96 2016-07 12503006 Aluminium 2.16.840.1.113883.6.96 2016-07 12510000 Eucalyptus oil 2.16.840.1.113883.6.96 2016-07 128488006 House dust 2.16.840.1.113883.6.96 2016-07 128489003 Sand 2.16.840.1.113883.6.96 2016-07 13577000 Nut 2.16.840.1.113883.6.96 2016-07 13652007 Silicone 2.16.840.1.113883.6.96 2016-07 14402002 Wood 2.16.840.1.113883.6.96 2016-07 14423008 Adhesive bandage 2.16.840.1.113883.6.96 2016-07 226359003 Fish oil - dietary 2.16.840.1.113883.6.96 2016-07 226491003 Apple juice 2.16.840.1.113883.6.96 2016-07 226760005 Dairy foods 2.16.840.1.113883.6.96 2016-07 226915003 Red meat 2.16.840.1.113883.6.96 2016-07 226934003 Pork 2.16.840.1.113883.6.96 2016-07 227037002 Fish - dietary 2.16.840.1.113883.6.96 2016-07 227144008 Tuna fish 2.16.840.1.113883.6.96 2016-07 227146005 Shellfish - dietary 2.16.840.1.113883.6.96 2016-07 227161006 Octopus - dietary 2.16.840.1.113883.6.96 2016-07 227163009 Squid - dietary 2.16.840.1.113883.6.96 2016-07 227252000 Mushroom - dietary

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 150 of 490 MTC epSOSAllergenNoDrugs

2.16.840.1.113883.6.96 2016-07 227313005 Pulse vegetables 2.16.840.1.113883.6.96 2016-07 227344001 Broad bean - dietary 2.16.840.1.113883.6.96 2016-07 227374009 Herbs and spices 2.16.840.1.113883.6.96 2016-07 227388008 Cinnamon 2.16.840.1.113883.6.96 2016-07 227425007 Figs 2.16.840.1.113883.6.96 2016-07 227444000 Raspberries 2.16.840.1.113883.6.96 2016-07 230031005 Lobster - dietary 2.16.840.1.113883.6.96 2016-07 230032003 Oyster - dietary 2.16.840.1.113883.6.96 2016-07 230034002 Nuts and seeds 2.16.840.1.113883.6.96 2016-07 2309006 Gold 2.16.840.1.113883.6.96 2016-07 23182003 Cereal 2.16.840.1.113883.6.96 2016-07 255640000 Biocide 2.16.840.1.113883.6.96 2016-07 255667006 Paraffin 2.16.840.1.113883.6.96 2016-07 256259004 Pollen 2.16.840.1.113883.6.96 2016-07 256260009 Tree and shrub pollen 2.16.840.1.113883.6.96 2016-07 256277009 Grass pollen 2.16.840.1.113883.6.96 2016-07 256292005 Flower and weed pollen 2.16.840.1.113883.6.96 2016-07 256303006 Ragweed pollen 2.16.840.1.113883.6.96 2016-07 256305004 Tree resin 2.16.840.1.113883.6.96 2016-07 256307007 Banana 2.16.840.1.113883.6.96 2016-07 256309005 Peach - dietary 2.16.840.1.113883.6.96 2016-07 256310000 Cherry - dietary 2.16.840.1.113883.6.96 2016-07 256311001 Apple - dietary 2.16.840.1.113883.6.96 2016-07 256319004 Carrot 2.16.840.1.113883.6.96 2016-07 256323007 Onion - dietary 2.16.840.1.113883.6.96 2016-07 256326004 Celery 2.16.840.1.113883.6.96 2016-07 256327008 Tomato - dietary 2.16.840.1.113883.6.96 2016-07 256349002 Peanut - dietary 2.16.840.1.113883.6.96 2016-07 256352005 Walnut - nut 2.16.840.1.113883.6.96 2016-07 256355007 Soya bean 2.16.840.1.113883.6.96 2016-07 256417003 Horse dander 2.16.840.1.113883.6.96 2016-07 256419000 Mouse epithelium 2.16.840.1.113883.6.96 2016-07 256435007 Feathers 2.16.840.1.113883.6.96 2016-07 256440004 Wasp venom 2.16.840.1.113883.6.96 2016-07 256443002 Egg white 2.16.840.1.113883.6.96 2016-07 256504004 Polycarbonate dental material 2.16.840.1.113883.6.96 2016-07 260118006 Wall pellitory pollen 2.16.840.1.113883.6.96 2016-07 260126003 Olive pollen 2.16.840.1.113883.6.96 2016-07 260152009 Cat dander 2.16.840.1.113883.6.96 2016-07 260153004 Cow dander 2.16.840.1.113883.6.96 2016-07 260154005 Dog dander 2.16.840.1.113883.6.96 2016-07 260156007 Mouse urine proteins 2.16.840.1.113883.6.96 2016-07 260167008 Sesame seed © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 151 of 490 MTC epSOSAllergenNoDrugs

2.16.840.1.113883.6.96 2016-07 260170007 Potato - dietary 2.16.840.1.113883.6.96 2016-07 260172004 Garlic - dietary 2.16.840.1.113883.6.96 2016-07 260176001 Kiwi fruit 2.16.840.1.113883.6.96 2016-07 260177005 Melon 2.16.840.1.113883.6.96 2016-07 261243003 Brass 2.16.840.1.113883.6.96 2016-07 264287008 Animal dander 2.16.840.1.113883.6.96 2016-07 264295007 Cow's milk protein 2.16.840.1.113883.6.96 2016-07 264337003 Seed 2.16.840.1.113883.6.96 2016-07 276310004 Animal hair 2.16.840.1.113883.6.96 2016-07 278840001 Shrimp product 2.16.840.1.113883.6.96 2016-07 2799001 Methylbenzethonium chloride 2.16.840.1.113883.6.96 2016-07 280939008 Insect venom 2.16.840.1.113883.6.96 2016-07 28230009 Poultry 2.16.840.1.113883.6.96 2016-07 28647000 Meat 2.16.840.1.113883.6.96 2016-07 288328004 Bee venom 2.16.840.1.113883.6.96 2016-07 289122001 Cosmetic material 2.16.840.1.113883.6.96 2016-07 289949002 Cypress pollen 2.16.840.1.113883.6.96 2016-07 303300008 Egg protein 2.16.840.1.113883.6.96 2016-07 303314008 Scorpion venom 2.16.840.1.113883.6.96 2016-07 303315009 Spider venom 2.16.840.1.113883.6.96 2016-07 31006001 Kingdom Plantae 2.16.840.1.113883.6.96 2016-07 311846002 insecticide 2.16.840.1.113883.6.96 2016-07 311984009 Chemical or external agent 2.16.840.1.113883.6.96 2016-07 33008008 Dust 2.16.840.1.113883.6.96 2016-07 33396006 Nickel 2.16.840.1.113883.6.96 2016-07 37017009 Helminth 2.16.840.1.113883.6.96 2016-07 3829006 Iron 2.16.840.1.113883.6.96 2016-07 386936005 Azelaic acid 2.16.840.1.113883.6.96 2016-07 387293003 Dithranol 2.16.840.1.113883.6.96 2016-07 387398009 Podophyllum resin 2.16.840.1.113883.6.96 2016-07 391737006 Almond oil 2.16.840.1.113883.6.96 2016-07 395922006 Wool 2.16.840.1.113883.6.96 2016-07 396031000 Dimeticone 2.16.840.1.113883.6.96 2016-07 406466009 House dust allergen 2.16.840.1.113883.6.96 2016-07 406470001 Insect allergen 2.16.840.1.113883.6.96 2016-07 406472009 Animal protein and epidermal allergen 2.16.840.1.113883.6.96 2016-07 406473004 Contact allergen 2.16.840.1.113883.6.96 2016-07 406771001 Sulphite and/or sulphite derivative 2.16.840.1.113883.6.96 2016-07 406774009 Fish derived omega 3 fatty acid 2.16.840.1.113883.6.96 2016-07 410853002 Perfluorochemical 2.16.840.1.113883.6.96 2016-07 412061001 Blueberries 2.16.840.1.113883.6.96 2016-07 412068007 Rye 2.16.840.1.113883.6.96 2016-07 412069004 Flavouring agent © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 152 of 490 MTC epSOSAllergenNoDrugs

2.16.840.1.113883.6.96 2016-07 412071004 Wheat 2.16.840.1.113883.6.96 2016-07 412145001 Hair dye 2.16.840.1.113883.6.96 2016-07 412153009 Rabbit dander 2.16.840.1.113883.6.96 2016-07 412156001 Silk 2.16.840.1.113883.6.96 2016-07 412160003 Suture allergen 2.16.840.1.113883.6.96 2016-07 412161004 Wool 2.16.840.1.113883.6.96 2016-07 412357001 Corn 2.16.840.1.113883.6.96 2016-07 415710007 Terpene 2.16.840.1.113883.6.96 2016-07 418266005 Yellow paraffin 2.16.840.1.113883.6.96 2016-07 418504009 Oats 2.16.840.1.113883.6.96 2016-07 418785009 Perfume 2.16.840.1.113883.6.96 2016-07 418920007 Adhesive agent 2.16.840.1.113883.6.96 2016-07 419420009 Watermelon 2.16.840.1.113883.6.96 2016-07 419604006 Weed pollen 2.16.840.1.113883.6.96 2016-07 419633007 White paraffin 2.16.840.1.113883.6.96 2016-07 41967008 Silver 2.16.840.1.113883.6.96 2016-07 420111002 Contact metal agent 2.16.840.1.113883.6.96 2016-07 42416001 Lanolin 2.16.840.1.113883.6.96 2016-07 430503006 Glutamate 2.16.840.1.113883.6.96 2016-07 43230003 Rubber 2.16.840.1.113883.6.96 2016-07 43735007 Sulphur 2.16.840.1.113883.6.96 2016-07 44027008 Seafood 2.16.840.1.113883.6.96 2016-07 47703008 Lactose 2.16.840.1.113883.6.96 2016-07 51905005 Mustard 2.16.840.1.113883.6.96 2016-07 52454007 Albumin 2.16.840.1.113883.6.96 2016-07 57126000 Glue 2.16.840.1.113883.6.96 2016-07 59351004 Citrate 2.16.840.1.113883.6.96 2016-07 59533004 2.16.840.1.113883.6.96 2016-07 59545008 Pesticide 2.16.840.1.113883.6.96 2016-07 61789006 Dye 2.16.840.1.113883.6.96 2016-07 66925006 Copper 2.16.840.1.113883.6.96 2016-07 67324005 Rice 2.16.840.1.113883.6.96 2016-07 72511004 Fruit 2.16.840.1.113883.6.96 2016-07 7791007 Soy protein 2.16.840.1.113883.6.96 2016-07 80237000 Cocoa butter 2.16.840.1.113883.6.96 2016-07 83619009 Polyvinyl alcohol 2.16.840.1.113883.6.96 2016-07 89811004 Gluten 2.16.840.1.113883.6.96 2016-07 89889006 Cotton fibre 2.16.840.1.113883.6.96 2016-07 9021002 2.16.840.1.113883.6.96 2016-07 91598004 Benzoyl peroxide

TRANSCODINGS

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 153 of 490 MTC epSOSAllergenNoDrugs

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 154 of 490 MTC epSOSBloodGroup

epSOSBloodGroup

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.20

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 112144000 Blood group A 2.16.840.1.113883.6.96 2016-07 112149005 Blood group B 2.16.840.1.113883.6.96 2016-07 165743006 Blood group AB 2.16.840.1.113883.6.96 2016-07 278147001 Blood group O Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278148006 Blood group O Rh(D) negative 2.16.840.1.113883.6.96 2016-07 278149003 Blood group A Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278150003 Blood group B Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278151004 Blood group AB Rh(D) positive 2.16.840.1.113883.6.96 2016-07 278152006 Blood group A Rh(D) negative 2.16.840.1.113883.6.96 2016-07 278153001 Blood group B Rh(D) negative 2.16.840.1.113883.6.96 2016-07 278154007 Blood group AB Rh(D) negative 2.16.840.1.113883.6.96 2016-07 58460004 Blood group O

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 155 of 490 MTC epSOSBloodPressure

epSOSBloodPressure

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.21

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.1 2.59 8462-4 Diastolic blood pressure 2.16.840.1.113883.6.1 2.59 8480-6 Systolic blood pressure

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 156 of 490 MTC epSOSCodeNoMedication

epSOSCodeNoMedication

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.22

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 182849000 No drug therapy prescribed 2.16.840.1.113883.6.96 2016-07 182904002 Drug treatment unknown 2.16.840.1.113883.6.96 2016-07 408350003 Patient not on self-medication

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 157 of 490 MTC epSOSCodeProb

epSOSCodeProb

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.23

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 248536006 Finding of functional performance and activity 2.16.840.1.113883.6.96 2016-07 282291009 Diagnosis interpretation 2.16.840.1.113883.6.96 2016-07 404684003 Clinical finding 2.16.840.1.113883.6.96 2016-07 409586006 Complaint 2.16.840.1.113883.6.96 2016-07 418799008 Finding reported by subject or history provider 2.16.840.1.113883.6.96 2016-07 55607006 Problem 2.16.840.1.113883.6.96 2016-07 64572001 Disease

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 158 of 490 MTC epSOSConfidentiality

epSOSConfidentiality

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.31

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.5.25 913-20091020 N normal 2.16.840.1.113883.5.25 913-20091020 R restricted 2.16.840.1.113883.5.25 913-20091020 V very restricted

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 159 of 490 MTC epSOSCountry

epSOSCountry

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.4

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 1.0.3166.1 2006-2nd AD ANDORRA 1.0.3166.1 2006-2nd AE UNITED ARAB EMIRATES 1.0.3166.1 2006-2nd AF AFGHANISTAN 1.0.3166.1 2006-2nd AG ANTIGUA AND BARBUDA 1.0.3166.1 2006-2nd AI ANGUILLA 1.0.3166.1 2006-2nd AL ALBANIA 1.0.3166.1 2006-2nd AM ARMENIA 1.0.3166.1 2006-2nd AO ANGOLA 1.0.3166.1 2006-2nd AQ ANTARCTICA 1.0.3166.1 2006-2nd AR ARGENTINA 1.0.3166.1 2006-2nd AS AMERICAN SAMOA 1.0.3166.1 2006-2nd AT AUSTRIA 1.0.3166.1 2006-2nd AU AUSTRALIA 1.0.3166.1 2006-2nd AW ARUBA 1.0.3166.1 2006-2nd AX ÅLAND ISLANDS 1.0.3166.1 2006-2nd AZ AZERBAIJAN 1.0.3166.1 2006-2nd BA BOSNIA AND HERZEGOVINA 1.0.3166.1 2006-2nd BB BARBADOS 1.0.3166.1 2006-2nd BD BANGLADESH 1.0.3166.1 2006-2nd BE BELGIUM 1.0.3166.1 2006-2nd BF BURKINA FASO 1.0.3166.1 2006-2nd BG BULGARIA 1.0.3166.1 2006-2nd BH BAHRAIN 1.0.3166.1 2006-2nd BI BURUNDI 1.0.3166.1 2006-2nd BJ BENIN 1.0.3166.1 2006-2nd BL SAINT BARTHÉLEMY 1.0.3166.1 2006-2nd BM BERMUDA 1.0.3166.1 2006-2nd BN BRUNEI DARUSSALAM 1.0.3166.1 2006-2nd BO BOLIVIA (PLURINATIONAL STATE OF) 1.0.3166.1 2006-2nd BQ BONAIRE, SINT EUSTATIUS AND SABA 1.0.3166.1 2006-2nd BR BRAZIL 1.0.3166.1 2006-2nd BS BAHAMAS

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 160 of 490 MTC epSOSCountry

1.0.3166.1 2006-2nd BT BHUTAN 1.0.3166.1 2006-2nd BV BOUVET ISLAND 1.0.3166.1 2006-2nd BW BOTSWANA 1.0.3166.1 2006-2nd BY BELARUS 1.0.3166.1 2006-2nd BZ BELIZE 1.0.3166.1 2006-2nd CA CANADA 1.0.3166.1 2006-2nd CC COCOS (KEELING) ISLANDS 1.0.3166.1 2006-2nd CD CONGO, DEMOCRATIC REPUBLIC OF 1.0.3166.1 2006-2nd CF CENTRAL AFRICAN REPUBLIC 1.0.3166.1 2006-2nd CG CONGO 1.0.3166.1 2006-2nd CH SWITZERLAND 1.0.3166.1 2006-2nd CI COTE D'IVOIRE 1.0.3166.1 2006-2nd CK COOK ISLANDS 1.0.3166.1 2006-2nd CL CHILE 1.0.3166.1 2006-2nd CM CAMEROON 1.0.3166.1 2006-2nd CN CHINA 1.0.3166.1 2006-2nd CO COLOMBIA 1.0.3166.1 2006-2nd CR COSTA RICA 1.0.3166.1 2006-2nd CU CUBA 1.0.3166.1 2006-2nd CV CAPE VERDE 1.0.3166.1 2006-2nd CW CURACAO 1.0.3166.1 2006-2nd CX CHRISTMAS ISLAND 1.0.3166.1 2006-2nd CY CYPRUS 1.0.3166.1 2006-2nd CZ CZECH REPUBLIC 1.0.3166.1 2006-2nd DE GERMANY 1.0.3166.1 2006-2nd DJ DJIBOUTI 1.0.3166.1 2006-2nd DK DENMARK 1.0.3166.1 2006-2nd DM DOMINICA 1.0.3166.1 2006-2nd DO DOMINICAN REPUBLIC 1.0.3166.1 2006-2nd DZ ALGERIA 1.0.3166.1 2006-2nd EC ECUADOR 1.0.3166.1 2006-2nd EE ESTONIA 1.0.3166.1 2006-2nd EG EGYPT 1.0.3166.1 2006-2nd EH WESTERN SAHARA 1.0.3166.1 2006-2nd ER ERITREA 1.0.3166.1 2006-2nd ES SPAIN 1.0.3166.1 2006-2nd ET ETHIOPIA 1.0.3166.1 2006-2nd FI FINLAND 1.0.3166.1 2006-2nd FJ FIJI 1.0.3166.1 2006-2nd FK FALKLAND ISLANDS (MALVINAS) 1.0.3166.1 2006-2nd FM MICRONESIA (FEDERATED STATES OF) 1.0.3166.1 2006-2nd FO FAROE ISLANDS 1.0.3166.1 2006-2nd FR FRANCE © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 161 of 490 MTC epSOSCountry

1.0.3166.1 2006-2nd GA GABON 1.0.3166.1 2006-2nd GB UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND 1.0.3166.1 2006-2nd GD GRENADA 1.0.3166.1 2006-2nd GE GEORGIA 1.0.3166.1 2006-2nd GF FRENCH GUIANA 1.0.3166.1 2006-2nd GG GUERNSEY 1.0.3166.1 2006-2nd GH GHANA 1.0.3166.1 2006-2nd GI GIBRALTAR 1.0.3166.1 2006-2nd GL GREENLAND 1.0.3166.1 2006-2nd GM GAMBIA 1.0.3166.1 2006-2nd GN GUINEA 1.0.3166.1 2006-2nd GP GUADELOUPE 1.0.3166.1 2006-2nd GQ EQUATORIAL GUINEA 1.0.3166.1 2006-2nd GR GREECE 1.0.3166.1 2006-2nd GS SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS 1.0.3166.1 2006-2nd GT GUATEMALA 1.0.3166.1 2006-2nd GU GUAM 1.0.3166.1 2006-2nd GW GUINEA-BISSAU 1.0.3166.1 2006-2nd GY GUYANA 1.0.3166.1 2006-2nd HK HONG KONG 1.0.3166.1 2006-2nd HM HEARD ISLAND AND MCDONALD ISLANDS 1.0.3166.1 2006-2nd HN HONDURAS 1.0.3166.1 2006-2nd HR CROATIA 1.0.3166.1 2006-2nd HT HAITI 1.0.3166.1 2006-2nd HU HUNGARY 1.0.3166.1 2006-2nd ID INDONESIA 1.0.3166.1 2006-2nd IE IRELAND 1.0.3166.1 2006-2nd IL ISRAEL 1.0.3166.1 2006-2nd IM ISLE OF MAN 1.0.3166.1 2006-2nd IN INDIA 1.0.3166.1 2006-2nd IO BRITISH INDIAN OCEAN TERRITORY 1.0.3166.1 2006-2nd IQ IRAQ 1.0.3166.1 2006-2nd IR IRAN (ISLAMIC REPUBLIC OF) 1.0.3166.1 2006-2nd IS ICELAND 1.0.3166.1 2006-2nd IT ITALY 1.0.3166.1 2006-2nd JE JERSEY 1.0.3166.1 2006-2nd JM JAMAICA 1.0.3166.1 2006-2nd JO JORDAN 1.0.3166.1 2006-2nd JP JAPAN 1.0.3166.1 2006-2nd KE KENYA 1.0.3166.1 2006-2nd KG KYRGYZSTAN 1.0.3166.1 2006-2nd KH CAMBODIA

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 162 of 490 MTC epSOSCountry

1.0.3166.1 2006-2nd KI KIRIBATI 1.0.3166.1 2006-2nd KM COMOROS 1.0.3166.1 2006-2nd KN SAINT KITTS AND NEVIS 1.0.3166.1 2006-2nd KP KOREA (DEMOCRATIC PEOPLE'S REPUBLIC OF) 1.0.3166.1 2006-2nd KR KOREA, REPUBLIC OF 1.0.3166.1 2006-2nd KW KUWAIT 1.0.3166.1 2006-2nd KY CAYMAN ISLANDS 1.0.3166.1 2006-2nd KZ KAZAKHSTAN 1.0.3166.1 2006-2nd LA LAO PEOPLE'S DEMOCRATIC REPUBLIC 1.0.3166.1 2006-2nd LB LEBANON 1.0.3166.1 2006-2nd LC SAINT LUCIA 1.0.3166.1 2006-2nd LI LIECHTENSTEIN 1.0.3166.1 2006-2nd LK SRI LANKA 1.0.3166.1 2006-2nd LR LIBERIA 1.0.3166.1 2006-2nd LS LESOTHO 1.0.3166.1 2006-2nd LT LITHUANIA 1.0.3166.1 2006-2nd LU LUXEMBOURG 1.0.3166.1 2006-2nd LV LATVIA 1.0.3166.1 2006-2nd LY LIBYA 1.0.3166.1 2006-2nd MA MOROCCO 1.0.3166.1 2006-2nd MC MONACO 1.0.3166.1 2006-2nd MD MOLDOVA, REPUBLIC OF 1.0.3166.1 2006-2nd ME MONTENEGRO 1.0.3166.1 2006-2nd MF SAINT MARTIN (FRENCH PART) 1.0.3166.1 2006-2nd MG MADAGASCAR 1.0.3166.1 2006-2nd MH MARSHALL ISLANDS 1.0.3166.1 2006-2nd MK MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF 1.0.3166.1 2006-2nd ML MALI 1.0.3166.1 2006-2nd MM MYANMAR 1.0.3166.1 2006-2nd MN MONGOLIA 1.0.3166.1 2006-2nd MO MACAO 1.0.3166.1 2006-2nd MP NORTHERN MARIANA ISLANDS 1.0.3166.1 2006-2nd MQ MARTINIQUE 1.0.3166.1 2006-2nd MR MAURITANIA 1.0.3166.1 2006-2nd MS MONTSERRAT 1.0.3166.1 2006-2nd MT MALTA 1.0.3166.1 2006-2nd MU MAURITIUS 1.0.3166.1 2006-2nd MV MALDIVES 1.0.3166.1 2006-2nd MW MALAWI 1.0.3166.1 2006-2nd MX MEXICO 1.0.3166.1 2006-2nd MY MALAYSIA 1.0.3166.1 2006-2nd MZ MOZAMBIQUE 1.0.3166.1 2006-2nd NA NAMIBIA © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 163 of 490 MTC epSOSCountry

1.0.3166.1 2006-2nd NC NEW CALEDONIA 1.0.3166.1 2006-2nd NE NIGER 1.0.3166.1 2006-2nd NF NORFOLK ISLAND 1.0.3166.1 2006-2nd NG NIGERIA 1.0.3166.1 2006-2nd NI NICARAGUA 1.0.3166.1 2006-2nd NL NETHERLANDS 1.0.3166.1 2006-2nd NO NORWAY 1.0.3166.1 2006-2nd NP NEPAL 1.0.3166.1 2006-2nd NR NAURU 1.0.3166.1 2006-2nd NU NIUE 1.0.3166.1 2006-2nd NZ NEW ZEALAND 1.0.3166.1 2006-2nd OM OMAN 1.0.3166.1 2006-2nd PA PANAMA 1.0.3166.1 2006-2nd PE PERU 1.0.3166.1 2006-2nd PF FRENCH POLYNESIA 1.0.3166.1 2006-2nd PG PAPUA NEW GUINEA 1.0.3166.1 2006-2nd PH PHILIPPINES 1.0.3166.1 2006-2nd PK PAKISTAN 1.0.3166.1 2006-2nd PL POLAND 1.0.3166.1 2006-2nd PM SAINT PIERRE AND MIQUELON 1.0.3166.1 2006-2nd PN PITCAIRN 1.0.3166.1 2006-2nd PR PUERTO RICO 1.0.3166.1 2006-2nd PS PALESTINE, STATE OF 1.0.3166.1 2006-2nd PT PORTUGAL 1.0.3166.1 2006-2nd PW PALAU 1.0.3166.1 2006-2nd PY PARAGUAY 1.0.3166.1 2006-2nd QA QATAR 1.0.3166.1 2006-2nd RE REUNION 1.0.3166.1 2006-2nd RO ROMANIA 1.0.3166.1 2006-2nd RS SERBIA 1.0.3166.1 2006-2nd RU RUSSIAN FEDERATION 1.0.3166.1 2006-2nd RW RWANDA 1.0.3166.1 2006-2nd SA SAUDI ARABIA 1.0.3166.1 2006-2nd SB SOLOMON ISLANDS 1.0.3166.1 2006-2nd SC SEYCHELLES 1.0.3166.1 2006-2nd SD SUDAN 1.0.3166.1 2006-2nd SE SWEDEN 1.0.3166.1 2006-2nd SG SINGAPORE 1.0.3166.1 2006-2nd SH SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA 1.0.3166.1 2006-2nd SI SLOVENIA 1.0.3166.1 2006-2nd SJ SVALBARD AND JAN MAYEN 1.0.3166.1 2006-2nd SK SLOVAKIA 1.0.3166.1 2006-2nd SL SIERRA LEONE © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 164 of 490 MTC epSOSCountry

1.0.3166.1 2006-2nd SM SAN MARINO 1.0.3166.1 2006-2nd SN SENEGAL 1.0.3166.1 2006-2nd SO SOMALIA 1.0.3166.1 2006-2nd SR SURINAME 1.0.3166.1 2006-2nd SS SOUTH SUDAN 1.0.3166.1 2006-2nd ST SAO TOME AND PRINCIPE 1.0.3166.1 2006-2nd SV EL SALVADOR 1.0.3166.1 2006-2nd SX SINT MAARTEN (DUTCH PART) 1.0.3166.1 2006-2nd SY SYRIAN ARAB REPUBLIC 1.0.3166.1 2006-2nd SZ SWAZILAND 1.0.3166.1 2006-2nd TC TURKS AND CAICOS ISLANDS 1.0.3166.1 2006-2nd TD CHAD 1.0.3166.1 2006-2nd TF FRENCH SOUTHERN TERRITORIES 1.0.3166.1 2006-2nd TG TOGO 1.0.3166.1 2006-2nd TH THAILAND 1.0.3166.1 2006-2nd TJ TAJIKISTAN 1.0.3166.1 2006-2nd TK TOKELAU 1.0.3166.1 2006-2nd TL TIMOR-LESTE 1.0.3166.1 2006-2nd TM TURKMENISTAN 1.0.3166.1 2006-2nd TN TUNISIA 1.0.3166.1 2006-2nd TO TONGA 1.0.3166.1 2006-2nd TR TURKEY 1.0.3166.1 2006-2nd TT TRINIDAD AND TOBAGO 1.0.3166.1 2006-2nd TV TUVALU 1.0.3166.1 2006-2nd TW TAIWAN, PROVINCE OF CHINA 1.0.3166.1 2006-2nd TZ TANZANIA, UNITED REPUBLIC OF 1.0.3166.1 2006-2nd UA UKRAINE 1.0.3166.1 2006-2nd UG UGANDA 1.0.3166.1 2006-2nd UM UNITED STATES MINOR OUTLYING ISLANDS 1.0.3166.1 2006-2nd US UNITED STATES OF AMERICA 1.0.3166.1 2006-2nd UY URUGUAY 1.0.3166.1 2006-2nd UZ UZBEKISTAN 1.0.3166.1 2006-2nd VA HOLY SEE 1.0.3166.1 2006-2nd VC SAINT VINCENT AND THE GRENADINES 1.0.3166.1 2006-2nd VE VENEZUELA (BOLIVARIAN REPUBLIC OF) 1.0.3166.1 2006-2nd VG VIRGIN ISLANDS, BRITISH 1.0.3166.1 2006-2nd VI VIRGIN ISLANDS, U.S. 1.0.3166.1 2006-2nd VN VIET NAM 1.0.3166.1 2006-2nd VU VANUATU 1.0.3166.1 2006-2nd WF WALLIS AND FUTUNA 1.0.3166.1 2006-2nd WS SAMOA 1.0.3166.1 2006-2nd YE YEMEN 1.0.3166.1 2006-2nd YT MAYOTTE © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 165 of 490 MTC epSOSCountry

1.0.3166.1 2006-2nd ZA SOUTH AFRICA 1.0.3166.1 2006-2nd ZM ZAMBIA 1.0.3166.1 2006-2nd ZW ZIMBABWE

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 166 of 490 MTC epSOSDisplayLabel

epSOSDisplayLabel

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.46

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 1 Active Ingredient 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 10 Clinical Manifestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 100 +/- 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 107 I confirm that the patient -data subject has consented to the following statement: 'I agree that my Patient Summary may be transferred to a registered Health Professional in [COUNTRY B] for the purposes of providing me with medical care and/or medication' 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 11 Closed/Inactive Problem 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 12 Contact Information 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 13 Country 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 14 Country A Medicinal Product Code 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 15 Creation Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 16 Custodian 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 17 Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 18 Date To 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 19 Date of Birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 2 Active Problem 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 20 Date of Prescription 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 202 Mark the checkbox if brand name (when allowed) has been substituted or package size has been changed 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 21 Device/Implant 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 22 Dispense 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 23 Dispensed Package Size 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 24 Dispensed Product 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 25 Dose Form 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 26 End Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 27 Every 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 28 Facility ID 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 29 Facility Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 3 Address 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 30 Family Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 31 for 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 32 Frequency of Intakes © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 167 of 490 MTC epSOSDisplayLabel

1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 33 Gender 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 34 Given Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 35 Guardian 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 36 Implant Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 37 Instructions to patient 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 38 Is substitution of brand name allowed? 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 39 Last Update 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 4 Advise to the dispenser 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 40 Legal Authenticator 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 41 National Insurance Number 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 42 No 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 43 Number of packages 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 44 Observation Type 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 45 Onset Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 46 Organisation Identifier 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 47 Organisation Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 48 Other Active Ingredients 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 49 Other Contacts 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 5 Agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 50 Package Size 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 51 Patient 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 52 Patient IDs 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 53 per unit 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 54 Preferred HCP/Legal organization to contact 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 55 Prefix 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 56 Prescriber 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 57 Prescriber details 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 58 Prescription ID 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 59 Prescription Item Details 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 6 at 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 60 Prescription Item ID 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 61 Prescription Items List 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 62 Procedure 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 63 Procedure Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 64 Profession 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 65 Reaction Type 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 66 Regional/National Health ID 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 67 Route of Administration 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 68 See details 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 69 Specialty 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 7 Author (HCP) 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 70 Strength 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 71 Substitute © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 168 of 490 MTC epSOSDisplayLabel

1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 72 The Active Problem section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 73 The Allergies, adverse reactions, alerts section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 74 The Medical Devices and implants section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 75 The Medication Summary section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 76 The History of Procedures section is missing ! 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 77 unit(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 78 Units per intake 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 79 Vaccination 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 8 Authoring Device 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 80 Vaccination Date 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 81 Yes 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 82 I have identified the patient-data subject 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 83 I confirm that the patient -data subject has consented to the following statement: 'I agree that my ePrescription may be transferred to a registered Health Professional in [COUNTRY B] for the purposes of providing me with medical care and/or medication' 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 84 Observation Value 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 85 Date From 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 9 Brand Name 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 1.1 99 Physical Findings

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 169 of 490 MTC epSOSDocumentCode

epSOSDocumentCode

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.32

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.1 2.59 34133-9 Summary of episode note 2.16.840.1.113883.6.1 2.59 56445-0 Medication summary Document 2.16.840.1.113883.6.1 2.59 57016-8 Privacy policy acknowledgment Document 2.16.840.1.113883.6.1 2.59 57833-6 Prescription for medication 2.16.840.1.113883.6.1 2.59 60591-5 Patient summary Document 2.16.840.1.113883.6.1 2.59 60593-1 Medication dispensed.extended Document

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 170 of 490 MTC epSOSDoseForm

epSOSDoseForm

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.2

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 0.4.0.127.0.16.1.1.2.1 2017-04-14 10100500 Concentrate for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10101000 Oral drops, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10102000 Oral drops, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10103000 Oral drops, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10104000 Oral liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 10105000 Oral solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10106000 Oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10107000 Oral emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10108000 Oral gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10109000 Oral paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 10110000 Powder for oral solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10111000 Powder for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10112000 Granules for oral solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10113000 Granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10114000 Powder and solvent for oral solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10115000 Powder and solvent for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10115500 Powder and solvent for syrup 0.4.0.127.0.16.1.1.2.1 2017-04-14 10117000 Syrup 0.4.0.127.0.16.1.1.2.1 2017-04-14 10118000 Powder for syrup 0.4.0.127.0.16.1.1.2.1 2017-04-14 10119000 Granules for syrup 0.4.0.127.0.16.1.1.2.1 2017-04-14 10120000 Soluble tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10121000 Dispersible tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10121500 Dispersible tablets for dose dispenser 0.4.0.127.0.16.1.1.2.1 2017-04-14 10122000 Herbal tea 0.4.0.127.0.16.1.1.2.1 2017-04-14 10201000 Oral powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 10202000 Instant herbal tea 0.4.0.127.0.16.1.1.2.1 2017-04-14 10203000 Effervescent powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 10204000 Granules 0.4.0.127.0.16.1.1.2.1 2017-04-14 10205000 Effervescent granules 0.4.0.127.0.16.1.1.2.1 2017-04-14 10206000 Gastro-resistant granules 0.4.0.127.0.16.1.1.2.1 2017-04-14 10207000 Prolonged-release granules 0.4.0.127.0.16.1.1.2.1 2017-04-14 10208000 Modified-release granules

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 171 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10209000 Cachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10210000 Capsule, hard 0.4.0.127.0.16.1.1.2.1 2017-04-14 10211000 Capsule, soft 0.4.0.127.0.16.1.1.2.1 2017-04-14 10212000 Gastro-resistant capsule, hard 0.4.0.127.0.16.1.1.2.1 2017-04-14 10213000 Gastro-resistant capsule, soft 0.4.0.127.0.16.1.1.2.1 2017-04-14 10214000 Chewable capsule, soft 0.4.0.127.0.16.1.1.2.1 2017-04-14 10215000 Prolonged-release capsule, hard 0.4.0.127.0.16.1.1.2.1 2017-04-14 10216000 Prolonged-release capsule, soft 0.4.0.127.0.16.1.1.2.1 2017-04-14 10217000 Modified-release capsule, hard 0.4.0.127.0.16.1.1.2.1 2017-04-14 10218000 Modified-release capsule, soft 0.4.0.127.0.16.1.1.2.1 2017-04-14 10219000 Tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10220000 Coated tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10221000 Film-coated tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10222000 Effervescent tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10223000 Orodispersible tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10224000 Oral lyophilisate 0.4.0.127.0.16.1.1.2.1 2017-04-14 10225000 Gastro-resistant tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10226000 Prolonged-release tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10227000 Modified-release tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10228000 Chewable tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10229000 Medicated chewing-gum 0.4.0.127.0.16.1.1.2.1 2017-04-14 10230000 Oral gum 0.4.0.127.0.16.1.1.2.1 2017-04-14 10231000 Pillules 0.4.0.127.0.16.1.1.2.1 2017-04-14 10236100 Orodispersible film 0.4.0.127.0.16.1.1.2.1 2017-04-14 10301000 Gargle 0.4.0.127.0.16.1.1.2.1 2017-04-14 10302000 Concentrate for gargle 0.4.0.127.0.16.1.1.2.1 2017-04-14 10303000 Gargle, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10304000 Gargle, tablet for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10305000 Oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10306000 Oromucosal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10307000 Oromucosal drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 10308100 Oromucosal spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10308200 Oromucosal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10308300 Oromucosal spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10309100 Sublingual spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10309200 Sublingual spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10309300 Sublingual spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10310000 0.4.0.127.0.16.1.1.2.1 2017-04-14 10311000 Mouthwash, tablet for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10312000 Gingival solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10313000 Oromucosal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10314000 Oromucosal paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 10314005 Oromucosal ointment © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 172 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10314010 Oromucosal cream 0.4.0.127.0.16.1.1.2.1 2017-04-14 10314011 Buccal film 0.4.0.127.0.16.1.1.2.1 2017-04-14 10315000 Gingival gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10316000 Gingival paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 10317000 Oromucosal capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 10317500 Sublingual film 0.4.0.127.0.16.1.1.2.1 2017-04-14 10318000 Sublingual tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10319000 Muco-adhesive buccal tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10320000 Buccal tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10321000 Lozenge 0.4.0.127.0.16.1.1.2.1 2017-04-14 10322000 Compressed lozenge 0.4.0.127.0.16.1.1.2.1 2017-04-14 10323000 Pastille 0.4.0.127.0.16.1.1.2.1 2017-04-14 10401000 Periodontal powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 10401500 Dental 0.4.0.127.0.16.1.1.2.1 2017-04-14 10402000 Dental gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10403000 Dental stick 0.4.0.127.0.16.1.1.2.1 2017-04-14 10405000 Dental powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 10406000 Dental solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10407000 Dental suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10408000 Dental emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10409000 Toothpaste 0.4.0.127.0.16.1.1.2.1 2017-04-14 10410000 Periodontal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10411000 Periodontal insert 0.4.0.127.0.16.1.1.2.1 2017-04-14 10412000 Powder and solution for dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10413000 Powder for dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10414000 Solution for dental cement 0.4.0.127.0.16.1.1.2.1 2017-04-14 10501000 Bath additive 0.4.0.127.0.16.1.1.2.1 2017-04-14 10502000 Cream 0.4.0.127.0.16.1.1.2.1 2017-04-14 10503000 Gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10504000 Ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 10505000 Cutaneous paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 10506000 Medicated 0.4.0.127.0.16.1.1.2.1 2017-04-14 10507000 Cutaneous foam 0.4.0.127.0.16.1.1.2.1 2017-04-14 10508000 Shampoo 0.4.0.127.0.16.1.1.2.1 2017-04-14 10509000 Cutaneous spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10510000 Cutaneous spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10511000 Cutaneous spray, powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 10512000 Cutaneous liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 10513000 Cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10514000 Concentrate for cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10514500 Powder for cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10515000 Cutaneous suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10516000 Cutaneous emulsion © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 173 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10517000 Cutaneous powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 10517500 Cutaneous patch 0.4.0.127.0.16.1.1.2.1 2017-04-14 10518000 Solution for iontophoresis 0.4.0.127.0.16.1.1.2.1 2017-04-14 10518500 Powder for solution for iontophoresis 0.4.0.127.0.16.1.1.2.1 2017-04-14 10519000 Transdermal patch 0.4.0.127.0.16.1.1.2.1 2017-04-14 10520000 Collodion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10521000 Medicated nail lacquer 0.4.0.127.0.16.1.1.2.1 2017-04-14 10522000 Poultice 0.4.0.127.0.16.1.1.2.1 2017-04-14 10523000 Cutaneous stick 0.4.0.127.0.16.1.1.2.1 2017-04-14 10525000 Impregnated dressing 0.4.0.127.0.16.1.1.2.1 2017-04-14 10546250 Transdermal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10546400 Transdermal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10546500 Transdermal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10547000 Transdermal system 0.4.0.127.0.16.1.1.2.1 2017-04-14 10548000 Solution for skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 10549000 Solution for skin-scratch test 0.4.0.127.0.16.1.1.2.1 2017-04-14 10550000 Plaster for provocation test 0.4.0.127.0.16.1.1.2.1 2017-04-14 10600500 Concentrate for solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 10601000 Eye cream 0.4.0.127.0.16.1.1.2.1 2017-04-14 10602000 Eye gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10603000 Eye ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 10604000 Eye drops, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10604500 Eye drops, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10605000 Eye drops, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10606000 Eye drops, powder and solvent for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10607000 Eye drops, powder and solvent for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10608000 Eye drops, solvent for reconstitution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10609000 Eye drops, prolonged-release 0.4.0.127.0.16.1.1.2.1 2017-04-14 10610000 Eye lotion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10611000 Eye lotion, solvent for reconstitution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10612000 Ophthalmic insert 0.4.0.127.0.16.1.1.2.1 2017-04-14 10613000 Ophthalmic strip 0.4.0.127.0.16.1.1.2.1 2017-04-14 10701000 Ear cream 0.4.0.127.0.16.1.1.2.1 2017-04-14 10702000 Ear gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10703000 Ear ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 10704000 Ear drops, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10705000 Ear drops, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10706000 Ear drops, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10707000 Ear drops, powder and solvent for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10708000 Ear powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 10709000 Ear spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10710000 Ear spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10711000 Ear spray, emulsion © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 174 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 10712000 Ear wash, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10713000 Ear wash, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10714000 Ear 0.4.0.127.0.16.1.1.2.1 2017-04-14 10715000 Ear stick 0.4.0.127.0.16.1.1.2.1 2017-04-14 10801000 Nasal cream 0.4.0.127.0.16.1.1.2.1 2017-04-14 10802000 Nasal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10803000 Nasal ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 10804000 Nasal drops, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10805000 Nasal drops, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10806000 Nasal drops, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10807000 Nasal powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 10808000 Nasal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10809000 Nasal spray, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10810000 Nasal spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10811000 Nasal wash 0.4.0.127.0.16.1.1.2.1 2017-04-14 10812000 Nasal stick 0.4.0.127.0.16.1.1.2.1 2017-04-14 10901000 Vaginal cream 0.4.0.127.0.16.1.1.2.1 2017-04-14 10902000 Vaginal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 10903000 Vaginal ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 10904000 Vaginal foam 0.4.0.127.0.16.1.1.2.1 2017-04-14 10905000 Vaginal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10906000 Vaginal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 10907000 Vaginal emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 10908000 Tablet for vaginal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 10909000 Pessary 0.4.0.127.0.16.1.1.2.1 2017-04-14 10910000 Vaginal capsule, hard 0.4.0.127.0.16.1.1.2.1 2017-04-14 10911000 Vaginal capsule, soft 0.4.0.127.0.16.1.1.2.1 2017-04-14 10912000 Vaginal tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10913000 Effervescent vaginal tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 10914000 Medicated vaginal tampon 0.4.0.127.0.16.1.1.2.1 2017-04-14 10915000 Vaginal delivery system 0.4.0.127.0.16.1.1.2.1 2017-04-14 11001000 Rectal cream 0.4.0.127.0.16.1.1.2.1 2017-04-14 11002000 Rectal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11003000 Rectal ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 11004000 Rectal foam 0.4.0.127.0.16.1.1.2.1 2017-04-14 11005000 Rectal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11006000 Rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11007000 Rectal emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11008000 Concentrate for rectal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11009000 Powder for rectal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11010 Oral drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 11010000 Powder for rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11011000 Tablet for rectal solution © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 175 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 11012000 Tablet for rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11013000 Suppository 0.4.0.127.0.16.1.1.2.1 2017-04-14 11014000 Rectal capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 11015000 Rectal tampon 0.4.0.127.0.16.1.1.2.1 2017-04-14 11101000 Nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11102000 Nebuliser suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11103000 Powder for nebuliser suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11104000 Powder for nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11105000 Nebuliser emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11106000 Pressurised inhalation, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11107000 Pressurised inhalation, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11108000 Pressurised inhalation, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11109000 Inhalation powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 11110000 Inhalation powder, hard capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 11111000 Inhalation powder, pre-dispensed 0.4.0.127.0.16.1.1.2.1 2017-04-14 11112000 Inhalation vapour, powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 11113000 Inhalation vapour, capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 11114000 Inhalation vapour, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11115000 Inhalation vapour, tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 11116000 Inhalation vapour, ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 11117000 Inhalation vapour, liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 11201000 Solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11202000 Suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11203000 Emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11204000 Gel for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11205000 Powder for solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11206000 Powder for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11207000 Powder and solvent for solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11208000 Powder and solvent for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11208400 Powder for prolonged-release suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11208500 Prolonged-release suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11209000 Concentrate for solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 11209500 Solution for cardioplegia 0.4.0.127.0.16.1.1.2.1 2017-04-14 11210000 Solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11210500 Solution for infusion in administration system 0.4.0.127.0.16.1.1.2.1 2017-04-14 11211000 Emulsion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11211500 Powder for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11212000 Powder for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11213000 Concentrate for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11214000 Powder and solvent for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 11216000 Solvent for parenteral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 11301000 Implant 0.4.0.127.0.16.1.1.2.1 2017-04-14 11302000 Implantation tablet © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 176 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 11303000 Implantation chain 0.4.0.127.0.16.1.1.2.1 2017-04-14 11303300 Implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 11303500 Implantation suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11304000 Powder and solvent for implantation paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 11401000 Solution for peritoneal dialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 11402000 Solution for haemofiltration 0.4.0.127.0.16.1.1.2.1 2017-04-14 11403000 Solution for haemodiafiltration 0.4.0.127.0.16.1.1.2.1 2017-04-14 11404000 Solution for haemodialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 11405000 Concentrate for solution for haemodialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 11502000 Bladder irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 11502500 Intravesical solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11503000 Powder for bladder irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 11504000 Urethral gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11505000 Urethral stick 0.4.0.127.0.16.1.1.2.1 2017-04-14 11601000 Endotracheopulmonary instillation, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11602000 Endotracheopulmonary instillation, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11603000 Endotracheopulmonary instillation, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11604000 Endotracheopulmonary instillation, powder and solvent for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 11605000 Endotracheopulmonary instillation, powder and solvent for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 11701000 Endocervical gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11702000 Powder and solvent for endocervical gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 11901000 Intrauterine delivery system 0.4.0.127.0.16.1.1.2.1 2017-04-14 12100 Capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 12101000 Denture lacquer 0.4.0.127.0.16.1.1.2.1 2017-04-14 12102000 and solution for blood 0.4.0.127.0.16.1.1.2.1 2017-04-14 12103000 Solution for blood fraction modification 0.4.0.127.0.16.1.1.2.1 2017-04-14 12104000 Wound stick 0.4.0.127.0.16.1.1.2.1 2017-04-14 12105000 Radiopharmaceutical precursor 0.4.0.127.0.16.1.1.2.1 2017-04-14 12106000 Radionuclide generator 0.4.0.127.0.16.1.1.2.1 2017-04-14 12107000 Kit for radiopharmaceutical preparation 0.4.0.127.0.16.1.1.2.1 2017-04-14 12108000 Gastroenteral solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 12110000 Gastroenteral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 12111000 Gastroenteral emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 12111500 Intraperitoneal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 12112000 Solution for organ preservation 0.4.0.127.0.16.1.1.2.1 2017-04-14 12113000 Irrigation solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 12114000 irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 12115000 Sealant 0.4.0.127.0.16.1.1.2.1 2017-04-14 12115100 Sealant matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 12115200 Sealant powder 0.4.0.127.0.16.1.1.2.1 2017-04-14 12116000 Powder and solvent for sealant 0.4.0.127.0.16.1.1.2.1 2017-04-14 12117000 Impregnated pad © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 177 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 12117500 Impregnated plug 0.4.0.127.0.16.1.1.2.1 2017-04-14 12118000 Living tissue equivalent 0.4.0.127.0.16.1.1.2.1 2017-04-14 12119000 Medicated sponge 0.4.0.127.0.16.1.1.2.1 2017-04-14 12120 Gastro-resistant capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 12120000 Intestinal gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 12130000 Medicated thread 0.4.0.127.0.16.1.1.2.1 2017-04-14 12131000 Solution for provocation test 0.4.0.127.0.16.1.1.2.1 2017-04-14 12150 Prolonged-release capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 12301000 Medicinal gas, compressed 0.4.0.127.0.16.1.1.2.1 2017-04-14 12302000 Medicinal gas, cryogenic 0.4.0.127.0.16.1.1.2.1 2017-04-14 12303000 Medicinal gas, liquefied 0.4.0.127.0.16.1.1.2.1 2017-04-14 13001000 Concentrate for concentrate for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13002000 Concentrate for nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13003000 Concentrate for oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13004000 Concentrate for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13005000 Dispersion for concentrate for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13006000 Ear drops, powder for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13007000 Effervescent granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13008000 Emulsion for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13009000 Endotracheopulmonary instillation, powder for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13010000 Eye drops, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13011000 Eye drops, powder for suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13012000 Gas for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13013000 Gas for dispersion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13014000 Gel for gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13015000 Granules for rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13016000 Laryngopharyngeal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13017000 Laryngopharyngeal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13018000 Matrix for implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 13020000 Nasal drops, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13021000 Powder for gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13022000 Powder for dental gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13023000 Powder for dispersion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13024000 Powder for endocervical gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13025000 Powder for endosinusial solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13026000 Powder for gingival gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 13027000 Powder for implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 13028000 Powder for implantation paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 13029000 Powder for intraocular instillation solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13031000 Powder for sealant 0.4.0.127.0.16.1.1.2.1 2017-04-14 13032000 Powder for solution for skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 13033000 Solution for solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13035000 Solvent for... © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 178 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 13036000 Suspension for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13037000 Suspension for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13039000 Suspension for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13040000 Powder for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13041000 Endosinusial solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13042000 Epilesional solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13043000 Implantation paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 13044000 Intraocular instillation solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 13045000 Intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 13046000 Coated granules 0.4.0.127.0.16.1.1.2.1 2017-04-14 13047000 Solution for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13048000 Granules for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 13049000 Dispersion for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13050 Oromucosal liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 13050000 Gas for dispersion for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 13051000 Solution for injection/skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 13052000 Powder for solution for injection/skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 13053000 Solution for injection in administration system 0.4.0.127.0.16.1.1.2.1 2017-04-14 13057000 Powder and solvent for prolonged-release suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 13060000 Powder for oral/rectal suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 14050 Dental liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 15090 Cutaneous spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 16040 Eye drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 17040 Ear drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 17090 Ear spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 17120 Ear wash 0.4.0.127.0.16.1.1.2.1 2017-04-14 18040 Nasal drops 0.4.0.127.0.16.1.1.2.1 2017-04-14 18080 Nasal spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 19050 Vaginal liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 19100 Vaginal capsule 0.4.0.127.0.16.1.1.2.1 2017-04-14 20050 0.4.0.127.0.16.1.1.2.1 2017-04-14 21010 Nebuliser liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 21060 Pressurised inhalation 0.4.0.127.0.16.1.1.2.1 2017-04-14 21140 Inhalation vapour 0.4.0.127.0.16.1.1.2.1 2017-04-14 22010 Injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 22030 Powder for concentrate 0.4.0.127.0.16.1.1.2.1 2017-04-14 22050 Powder for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 22060 Powder for prolonged-release injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 22090 Sterile concentrate 0.4.0.127.0.16.1.1.2.1 2017-04-14 22100 Infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 22120 Powder for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 26010 Endotracheopulmonary instillation

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 179 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 30047500 Pouch 0.4.0.127.0.16.1.1.2.1 2017-04-14 31030 Blood fraction modifier 0.4.0.127.0.16.1.1.2.1 2017-04-14 31080 Gastroenteral liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 50001000 Chewable/dispersible tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50001250 Coated granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50002000 Concentrate and solvent for concentrate for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50003000 Concentrate and solvent for cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50006000 Concentrate and solvent for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50007000 Concentrate and solvent for solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50007500 Concentrate and solvent for solution for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50008000 Concentrate and solvent for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009000 Concentrate for cutaneous spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009300 Concentrate for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009500 Concentrate for emulsion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50009750 Concentrate for intravesical solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50010000 Concentrate for oral solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50011000 Concentrate for oral/rectal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50013250 Concentrate for solution for peritoneal dialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 50015200 Cutaneous/nasal ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 50015450 Cutaneous solution/concentrate for oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50015500 Cutaneous spray, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50016000 Cutaneous spray, ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017000 Dental paste 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017200 Ear drops, solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017500 Dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50017550 Ear drops, suspension in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50018000 Ear/eye drops, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50018500 Ear/eye drops, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50019000 Ear/eye ointment 0.4.0.127.0.16.1.1.2.1 2017-04-14 50019500 Ear/eye/nasal drops, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50020200 Ear/nasal drops, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50021000 Emulsion for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50021250 Emulsion for injection/infusion in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50021500 Emulsion and suspension for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50022000 Endosinusial wash, suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50022500 Eye drops, prolonged-release solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023000 Eye drops, solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023100 Eye drops, suspension in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023300 Eye gel in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023400 Eye ointment in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50023700 Film-coated tablet and gastro-resistant granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50024000 Gargle/mouthwash 0.4.0.127.0.16.1.1.2.1 2017-04-14 50024500 Gargle/nasal wash © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 180 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50026000 Gastro-resistant granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026150 Gastro-resistant granules for oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026400 Gel in pressurised container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50026500 Granules and solvent for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50027000 Granules and solvent for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029150 Granules for oral/rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029170 Granules for oral solution in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029200 Granules for oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029500 Granules for vaginal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029550 Granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029700 Herbal tea in bag 0.4.0.127.0.16.1.1.2.1 2017-04-14 50029750 Implant in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50030000 Inhalation powder, tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50031000 Inhalation vapour, effervescent tablet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50032000 Inhalation vapour, emulsion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033000 Inhalation vapour, impregnated pad 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033100 Inhalation vapour, impregnated plug 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033400 Intravesical solution/solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50033500 Intravitreal implant in applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036000 Modified-release granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036050 Mouthwash, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036200 Nasal drops, solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036500 Nasal/oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50036700 Nasal/oromucosal spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037100 Nasal spray, powder for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037250 Nasal spray, solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037400 Nasal spray, solution/oromucosal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037500 Oral drops, granules for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037600 Oral emulsion in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037700 Oral paste in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037750 Oral drops, liquid 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037800 Oral powder in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50037900 Oral/rectal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038000 Oral/rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038500 Oral solution/concentrate for nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038600 Oral solution in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038650 Oral solution in single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 50038700 Oral suspension in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50039000 Oromucosal patch 0.4.0.127.0.16.1.1.2.1 2017-04-14 50039300 Oromucosal powder in pouch 0.4.0.127.0.16.1.1.2.1 2017-04-14 50039500 Oromucosal/laryngopharyngeal solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50040500 Oromucosal/laryngopharyngeal solution/spray, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50041000 Pillules in single-dose container © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 181 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50041200 Powder and gel for gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 50041500 Powder and solution for solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50042000 Powder and solvent for concentrate for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50043000 Powder for concentrate for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50044000 Powder and solvent for cutaneous solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50044500 Powder and solvent for dispersion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50044700 Powder and solvent for emulsion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50045000 Powder and solvent for endosinusial solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50045500 Powder and solvent for epilesional solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50046000 Powder and solvent for gingival gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047000 Powder and solvent for intraocular instillation solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047500 Powder and solvent for intravesical solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047600 Powder and solvent for intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047650 Nasal drops, powder and solvent for solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50047700 Powder and solvent for nebuliser solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048000 Powder and solvent for prolonged-release suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048010 Powder and solvent for prolonged-release suspension for injection in pre-filled pen 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048050 Powder and solvent for solution for injection in cartridge 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048150 Powder and solvent for solution for injection in pre-filled pen 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048250 Powder and solvent for solution for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048270 Powder and solvent for solution for injection/skin-prick test 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048300 Powder and solvent for suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048500 Powder and suspension for suspension for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048600 Powder, dispersion and solvent for concentrate for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50048750 Powder for concentrate for dispersion for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049100 Powder for concentrate for intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049200 Powder for concentrate for solution for haemodialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049250 Powder for concentrate for solution for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049270 Powder for dental solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049300 Powder for epilesional solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50049500 Powder for implantation suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50050000 Powder for intravesical solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50050500 Powder for intravesical solution/solution for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50051000 Powder for intravesical suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50052000 Powder for oral/rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50052500 Powder for oral solution in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50053500 Powder for solution for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50055350 Powder, solvent and matrix for implantation matrix 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056000 Prolonged-release granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056150 Prolonged-release granules for oral suspension in sachet

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 182 of 490 MTC epSOSDoseForm

0.4.0.127.0.16.1.1.2.1 2017-04-14 50056200 Prolonged-release granules in sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056250 Prolonged-release suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056500 Radiopharmaceutical precursor, solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50056600 Solution and suspension for suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50057000 Solution for haemodialysis/haemofiltration 0.4.0.127.0.16.1.1.2.1 2017-04-14 50058500 Solution for infusion in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060000 Solution for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060100 Solution for injection in cartridge 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060150 Solution for injection in needle-free injector 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060200 Solution for injection in pre-filled pen 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060300 Solution for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50060500 Solution for injection/infusion in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50061500 Solution for sealant 0.4.0.127.0.16.1.1.2.1 2017-04-14 50062000 Suspension and effervescent granules for oral suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50062500 Suspension and solution for spray 0.4.0.127.0.16.1.1.2.1 2017-04-14 50063100 Suspension for injection in cartridge 0.4.0.127.0.16.1.1.2.1 2017-04-14 50063200 Suspension for injection in pre-filled pen 0.4.0.127.0.16.1.1.2.1 2017-04-14 50063300 Suspension for injection in pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 50064000 Tablet and solvent for rectal suspension 0.4.0.127.0.16.1.1.2.1 2017-04-14 50065000 Tablet and powder for oral solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50071000 Powder and solvent for dental gel 0.4.0.127.0.16.1.1.2.1 2017-04-14 50073000 Powder for solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50073500 Solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50074000 Solvent for solution for intraocular irrigation 0.4.0.127.0.16.1.1.2.1 2017-04-14 50076000 Solvent for solution for infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50077000 Dispersion for injection 0.4.0.127.0.16.1.1.2.1 2017-04-14 50078000 Gas and solvent for dispersion for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50079000 Concentrate for solution for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50080000 Powder and solvent for solution for injection/infusion 0.4.0.127.0.16.1.1.2.1 2017-04-14 50081000 Inhalation solution 0.4.0.127.0.16.1.1.2.1 2017-04-14 50082000 Oral drops, powder for suspension

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 183 of 490 MTC epSOSHealthcareProfessionalRoles

epSOSHealthcareProfessionalRoles

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.1

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.2.9.6.2.7 2008 22 Health professionals 2.16.840.1.113883.2.9.6.2.7 2008 221 Medical doctors 2.16.840.1.113883.2.9.6.2.7 2008 2211 Generalist medical practitioners 2.16.840.1.113883.2.9.6.2.7 2008 2212 Specialist medical practitioners 2.16.840.1.113883.2.9.6.2.7 2008 222 Nursing and midwifery professionals 2.16.840.1.113883.2.9.6.2.7 2008 2221 Nursing professionals 2.16.840.1.113883.2.9.6.2.7 2008 2222 Midwifery professionals 2.16.840.1.113883.2.9.6.2.7 2008 223 Traditional and complementary medicine professionals 2.16.840.1.113883.2.9.6.2.7 2008 224 Paramedical practitioners 2.16.840.1.113883.2.9.6.2.7 2008 225 Veterinarians 2.16.840.1.113883.2.9.6.2.7 2008 226 Other health professionals 2.16.840.1.113883.2.9.6.2.7 2008 2261 Dentists 2.16.840.1.113883.2.9.6.2.7 2008 2262 Pharmacists 2.16.840.1.113883.2.9.6.2.7 2008 2263 Environmental and occupational health and hygiene professionals 2.16.840.1.113883.2.9.6.2.7 2008 2264 Physiotherapists 2.16.840.1.113883.2.9.6.2.7 2008 2265 Dieticians and nutritionists 2.16.840.1.113883.2.9.6.2.7 2008 2266 Audiologists and speech therapists 2.16.840.1.113883.2.9.6.2.7 2008 2267 Optometrists and ophthalmic opticians 2.16.840.1.113883.2.9.6.2.7 2008 2269 Health professionals not elsewhere classified 2.16.840.1.113883.2.9.6.2.7 2008 32 Health associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 321 Medical and pharmaceutical technicians 2.16.840.1.113883.2.9.6.2.7 2008 3211 Medical imaging and therapeutic equipment technicians 2.16.840.1.113883.2.9.6.2.7 2008 3212 Medical and pathology laboratory technicians 2.16.840.1.113883.2.9.6.2.7 2008 3213 Pharmaceutical technicians and assistants 2.16.840.1.113883.2.9.6.2.7 2008 3214 Medical and dental prosthetic technicians 2.16.840.1.113883.2.9.6.2.7 2008 322 Nursing and midwifery associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 3221 Nursing associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 3222 Midwifery associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 323 Traditional and complementary medicine associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 325 Other health associate professionals 2.16.840.1.113883.2.9.6.2.7 2008 3251 Dental assistants and therapists

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 184 of 490 MTC epSOSHealthcareProfessionalRoles

2.16.840.1.113883.2.9.6.2.7 2008 3252 Medical records and health information technicians 2.16.840.1.113883.2.9.6.2.7 2008 3253 Community health workers 2.16.840.1.113883.2.9.6.2.7 2008 3254 Dispensing opticians 2.16.840.1.113883.2.9.6.2.7 2008 3255 Physiotherapy technicians and assistants 2.16.840.1.113883.2.9.6.2.7 2008 3256 Medical assistants 2.16.840.1.113883.2.9.6.2.7 2008 3257 Environmental and occupational health inspectors and associates 2.16.840.1.113883.2.9.6.2.7 2008 3258 Ambulance workers 2.16.840.1.113883.2.9.6.2.7 2008 3259 Health associate professionals not elsewhere classified

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 185 of 490 MTC epSOSIllnessesandDisorders

epSOSIllnessesandDisorders

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.5

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00 Cholera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00-A09 Intestinal infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00.1 Cholera due to Vibrio cholerae 01, biovar eltor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A00.9 Cholera, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01 Typhoid and paratyphoid fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.0 Typhoid fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.1 Paratyphoid fever A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.2 Paratyphoid fever B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.3 Paratyphoid fever C 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A01.4 Paratyphoid fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02 Other infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.0 Salmonella enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.1 Salmonella sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.2 Localized salmonella infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.8 Other specified salmonella infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A02.9 Salmonella infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03 Shigellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.0 Shigellosis due to Shigella dysenteriae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.1 Shigellosis due to Shigella flexneri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.2 Shigellosis due to Shigella boydii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.3 Shigellosis due to Shigella sonnei 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.8 Other shigellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A03.9 Shigellosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04 Other bacterial intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.0 Enteropathogenic Escherichia coli infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.1 Enterotoxigenic Escherichia coli infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.2 Enteroinvasive Escherichia coli infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.3 Enterohaemorrhagic Escherichia coli infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.4 Other intestinal Escherichia coli infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.5 Campylobacter enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.6 Enteritis due to Yersinia enterocolitica

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 186 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.7 Enterocolitis due to Clostridium difficile 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.8 Other specified bacterial intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A04.9 Bacterial intestinal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05 Other bacterial foodborne intoxications, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.0 Foodborne staphylococcal intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.2 Foodborne Clostridium perfringens [Clostridium welchii] intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.3 Foodborne Vibrio parahaemolyticus intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.4 Foodborne Bacillus cereus intoxication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.8 Other specified bacterial foodborne intoxications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A05.9 Bacterial foodborne intoxication, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06 Amoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.0 Acute amoebic dysentery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.1 Chronic intestinal amoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.2 Amoebic nondysenteric colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.3 Amoeboma of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.4 Amoebic liver abscessK77.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.5 Amoebic lung abscessJ99.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.6 Amoebic brain abscessG07 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.7 Cutaneous amoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.8 Amoebic infection of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A06.9 Amoebiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07 Other protozoal intestinal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.0 Balantidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.1 Giardiasis [lambliasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.2 Cryptosporidiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.3 Isosporiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.8 Other specified protozoal intestinal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A07.9 Protozoal intestinal disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08 Viral and other specified intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.0 Rotaviral enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.1 Acute gastroenteropathy due to Norwalk agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.2 Adenoviral enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.3 Other viral enteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.4 Viral intestinal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A08.5 Other specified intestinal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A09 Other gastroenteritis and colitis of infectious and unspecified origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A09.0 Other and unspecified gastroenteritis and colitis of infectious origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A09.9 Gastroenteritis and colitis of unspecified origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15 Respiratory tuberculosis, bacteriologically and histologically confirmed

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 187 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15-A19 Tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.0 Tuberculosis of lung, confirmed by sputum microscopy with or without culture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.1 Tuberculosis of lung, confirmed by culture only 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.2 Tuberculosis of lung, confirmed histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.3 Tuberculosis of lung, confirmed by unspecified means 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.4 Tuberculosis of intrathoracic lymph nodes, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.5 Tuberculosis of larynx, trachea and bronchus, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.6 Tuberculous pleurisy, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.7 Primary respiratory tuberculosis, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.8 Other respiratory tuberculosis, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A15.9 Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.0 Tuberculosis of lung, bacteriologically and histologically negative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.1 Tuberculosis of lung, bacteriological and histological examination not done 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.2 Tuberculosis of lung, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.3 Tuberculosis of intrathoracic lymph nodes, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.4 Tuberculosis of larynx, trachea and bronchus, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.5 Tuberculous pleurisy, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.7 Primary respiratory tuberculosis without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.8 Other respiratory tuberculosis, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A16.9 Respiratory tuberculosis unspecified, without mention of bacteriological or histological confirmation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17 Tuberculosis of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.0 Tuberculous meningitisG01 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.1 Meningeal tuberculomaG07 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.8 Other tuberculosis of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A17.9 Tuberculosis of nervous system, unspecifiedG99.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18 Tuberculosis of other organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.0 Tuberculosis of and joints 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.1 Tuberculosis of 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.2 Tuberculous peripheral lymphadenopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.3 Tuberculosis of intestines, peritoneum and mesenteric glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.4 Tuberculosis of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.5 Tuberculosis of eye © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 188 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.6 Tuberculosis of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.7 Tuberculosis of adrenal glandsE35.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A18.8 Tuberculosis of other specified organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19 Miliary tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.0 Acute miliary tuberculosis of a single specified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.1 Acute miliary tuberculosis of multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.2 Acute miliary tuberculosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.8 Other miliary tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A19.9 Miliary tuberculosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20 Plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20-A28 Certain zoonotic bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.0 Bubonic plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.1 Cellulocutaneous plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.2 Pneumonic plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.3 Plague meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.7 Septicaemic plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.8 Other forms of plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A20.9 Plague, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21 Tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.0 Ulceroglandular tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.1 Oculoglandular tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.2 Pulmonary tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.3 Gastrointestinal tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.7 Generalized tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.8 Other forms of tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A21.9 Tularaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22 Anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.0 Cutaneous anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.1 Pulmonary anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.2 Gastrointestinal anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.7 Anthrax sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.8 Other forms of anthrax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A22.9 Anthrax, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23 Brucellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.0 Brucellosis due to Brucella melitensis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.1 Brucellosis due to Brucella abortus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.2 Brucellosis due to Brucella suis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.3 Brucellosis due to Brucella canis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.8 Other brucellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A23.9 Brucellosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24 Glanders and melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.0 Glanders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.1 Acute and fulminating melioidosis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 189 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.2 Subacute and chronic melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.3 Other melioidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A24.4 Melioidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25 Rat-bite fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25.0 Spirillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25.1 Streptobacillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A25.9 Rat-bite fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26 Erysipeloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.0 Cutaneous erysipeloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.7 Erysipelothrix sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.8 Other forms of erysipeloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A26.9 Erysipeloid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27 Leptospirosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27.0 Leptospirosis icterohaemorrhagica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27.8 Other forms of leptospirosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A27.9 Leptospirosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28 Other zoonotic bacterial diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.0 Pasteurellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.1 Cat-scratch disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.2 Extraintestinal yersiniosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.8 Other specified zoonotic bacterial diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A28.9 Zoonotic bacterial disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30 [Hansen disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30-A49 Other bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.0 Indeterminate leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.1 Tuberculoid leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.2 Borderline tuberculoid leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.3 Borderline leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.4 Borderline lepromatous leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.5 Lepromatous leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.8 Other forms of leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A30.9 Leprosy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31 Infection due to other mycobacteria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.0 Pulmonary mycobacterial infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.1 Cutaneous mycobacterial infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.8 Other mycobacterial infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A31.9 Mycobacterial infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32 Listeriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.0 Cutaneous listeriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.1 Listerial meningitis and meningoencephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.7 Listerial sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.8 Other forms of listeriosis

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 190 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A32.9 Listeriosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A33 Tetanus neonatorum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A34 Obstetrical tetanus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A35 Other tetanus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36 Diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.0 Pharyngeal diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.1 Nasopharyngeal diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.2 Laryngeal diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.3 Cutaneous diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.8 Other diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A36.9 Diphtheria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37 Whooping cough 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.0 Whooping cough due to Bordetella pertussis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.1 Whooping cough due to Bordetella parapertussis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.8 Whooping cough due to other Bordetella species 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A37.9 Whooping cough, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A38 Scarlet fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39 Meningococcal infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.0 Meningococcal meningitisG01 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.1 Waterhouse-Friderichsen syndromeE35.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.2 Acute meningococcaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.3 Chronic meningococcaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.4 Meningococcaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.5 Meningococcal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.8 Other meningococcal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A39.9 Meningococcal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40 Streptococcal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.0 Sepsis due to , group A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.1 Sepsis due to streptococcus, group B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.2 Sepsis due to streptococcus, group D 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.3 Sepsis due to 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.8 Other streptococcal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A40.9 Streptococcal sepsis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41 Other sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.0 Sepsis due to Staphylococcus aureus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.1 Sepsis due to other specified staphylococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.2 Sepsis due to unspecified staphylococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.3 Sepsis due to Haemophilus influenzae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.4 Sepsis due to anaerobes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.5 Sepsis due to other Gram-negative organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.8 Other specified sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A41.9 Sepsis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42 Actinomycosis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 191 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.0 Pulmonary actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.1 Abdominal actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.2 Cervicofacial actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.7 Actinomycotic sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.8 Other forms of actinomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A42.9 Actinomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43 Nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.0 Pulmonary nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.1 Cutaneous nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.8 Other forms of nocardiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A43.9 Nocardiosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44 Bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.0 Systemic bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.1 Cutaneous and mucocutaneous bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.8 Other forms of bartonellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A44.9 Bartonellosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A46 Erysipelas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48 Other bacterial diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.0 Gas gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.1 Legionnaires disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.2 Nonpneumonic Legionnaires disease [Pontiac fever] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.3 Toxic shock syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.4 Brazilian purpuric fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A48.8 Other specified bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49 Bacterial infection of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.0 Staphylococcal infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.1 Streptococcal and enterococcal infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.2 Haemophilus influenzae infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.3 Mycoplasma infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.8 Other bacterial infections of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A49.9 Bacterial infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50 Congenital syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50-A64 Infections with a predominantly sexual mode of transmission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.0 Early congenital syphilis, symptomatic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.1 Early congenital syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.2 Early congenital syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.3 Late congenital syphilitic oculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.4 Late congenital neurosyphilis [juvenile neurosyphilis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.5 Other late congenital syphilis, symptomatic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.6 Late congenital syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.7 Late congenital syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A50.9 Congenital syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51 Early syphilis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 192 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.0 Primary genital syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.1 Primary anal syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.2 Primary syphilis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.3 Secondary syphilis of skin and mucous membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.4 Other secondary syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.5 Early syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A51.9 Early syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52 Late syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.0 Cardiovascular syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.1 Symptomatic neurosyphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.2 Asymptomatic neurosyphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.3 Neurosyphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.7 Other symptomatic late syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.8 Late syphilis, latent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A52.9 Late syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A53 Other and unspecified syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A53.0 Latent syphilis, unspecified as early or late 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A53.9 Syphilis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54 Gonococcal infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.0 Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.1 Gonococcal infection of lower genitourinary tract with periurethral and accessory gland abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.2 Gonococcal pelviperitonitis and other gonococcal genitourinary infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.3 Gonococcal infection of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.4 Gonococcal infection of musculoskeletal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.5 Gonococcal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.6 Gonococcal infection of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.8 Other gonococcal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A54.9 Gonococcal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A55 Chlamydial lymphogranuloma (venereum) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56 Other sexually transmitted chlamydial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.0 Chlamydial infection of lower genitourinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.1 Chlamydial infection of pelviperitoneum and other genitourinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.2 Chlamydial infection of genitourinary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.3 Chlamydial infection of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.4 Chlamydial infection of pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A56.8 Sexually transmitted chlamydial infection of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A57 Chancroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A58 Granuloma inguinale 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59 Trichomoniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59.0 Urogenital trichomoniasis

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 193 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59.8 Trichomoniasis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A59.9 Trichomoniasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60 Anogenital herpesviral [herpes simplex] infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60.0 Herpesviral infection of genitalia and urogenital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60.1 Herpesviral infection of perianal skin and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A60.9 Anogenital herpesviral infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A63 Other predominantly sexually transmitted diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A63.0 Anogenital (venereal) warts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A63.8 Other specified predominantly sexually transmitted diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A64 Unspecified sexually transmitted disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A65 Nonvenereal syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A65-A69 Other spirochaetal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66 Yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.0 Initial lesions of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.1 Multiple papillomata and wet crab yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.2 Other early skin lesions of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.3 Hyperkeratosis of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.4 Gummata and ulcers of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.5 Gangosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.6 Bone and joint lesions of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.7 Other manifestations of yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.8 Latent yaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A66.9 Yaws, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67 Pinta [carate] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.0 Primary lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.1 Intermediate lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.2 Late lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.3 Mixed lesions of pinta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A67.9 Pinta, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68 Relapsing fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68.0 Louse-borne relapsing fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68.1 Tick-borne relapsing fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A68.9 Relapsing fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69 Other spirochaetal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.0 Necrotizing ulcerative stomatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.1 Other Vincent infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.2 Lyme disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.8 Other specified spirochaetal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A69.9 Spirochaetal infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A70 Chlamydia psittaci infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A70-A74 Other diseases caused by chlamydiae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71 Trachoma

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 194 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71.0 Initial stage of trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71.1 Active stage of trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A71.9 Trachoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74 Other diseases caused by chlamydiae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74.0 Chlamydial conjunctivitisH13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74.8 Other chlamydial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A74.9 Chlamydial infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75 Typhus fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75-A79 Rickettsioses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.0 Epidemic louse-borne typhus fever due to Rickettsia prowazekii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.1 Recrudescent typhus [Brill disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.2 Typhus fever due to Rickettsia typhi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.3 Typhus fever due to Rickettsia tsutsugamushi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A75.9 Typhus fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77 Spotted fever [tick-borne rickettsioses] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.0 Spotted fever due to Rickettsia rickettsii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.1 Spotted fever due to Rickettsia conorii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.2 Spotted fever due to Rickettsia sibirica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.3 Spotted fever due to Rickettsia australis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.8 Other spotted fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A77.9 Spotted fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A78 Q fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79 Other rickettsioses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.0 Trench fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.1 Rickettsialpox due to Rickettsia akari 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.8 Other specified rickettsioses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A79.9 Rickettsiosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80 Acute poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80-A89 Viral infections of the central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.0 Acute paralytic poliomyelitis, vaccine-associated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.1 Acute paralytic poliomyelitis, wild virus, imported 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.2 Acute paralytic poliomyelitis, wild virus, indigenous 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.3 Acute paralytic poliomyelitis, other and unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.4 Acute nonparalytic poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A80.9 Acute poliomyelitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81 Atypical virus infections of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.0 Creutzfeldt-Jakob disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.1 Subacute sclerosing panencephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.2 Progressive multifocal leukoencephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.8 Other atypical virus infections of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A81.9 Atypical virus infection of central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82 Rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82.0 Sylvatic rabies © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 195 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82.1 Urban rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A82.9 Rabies, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83 Mosquito-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.0 Japanese encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.1 Western equine encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.2 Eastern equine encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.3 St Louis encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.4 Australian encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.5 California encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.6 Rocio virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.8 Other mosquito-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A83.9 Mosquito-borne viral encephalitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84 Tick-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.0 Far Eastern tick-borne encephalitis [Russian spring-summer encephalitis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.1 Central European tick-borne encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.8 Other tick-borne viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A84.9 Tick-borne viral encephalitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85 Other viral encephalitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.0 Enteroviral encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.1 Adenoviral encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.2 Arthropod-borne viral encephalitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A85.8 Other specified viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A86 Unspecified viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87 Viral meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.0 Enteroviral meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.1 Adenoviral meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.2 Lymphocytic choriomeningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.8 Other viral meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A87.9 Viral meningitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88 Other viral infections of central nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88.0 Enteroviral exanthematous fever [Boston exanthem] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88.1 Epidemic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A88.8 Other specified viral infections of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A89 Unspecified viral infection of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92 Other mosquito-borne viral fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.0 Chikungunya virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.1 O'nyong-nyong fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.2 Venezuelan equine fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.3 West Nile virus infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.4 Rift Valley fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.8 Other specified mosquito-borne viral fevers © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 196 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A92.9 Mosquito-borne viral fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93 Other arthropod-borne viral fevers, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.0 Oropouche virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.1 Sandfly fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.2 Colorado tick fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A93.8 Other specified arthropod-borne viral fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A94 Unspecified arthropod-borne viral fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95 Yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95.0 Sylvatic yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95.1 Urban yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A95.9 Yellow fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96 Arenaviral haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.0 Junin haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.1 Machupo haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.2 Lassa fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.8 Other arenaviral haemorrhagic fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A96.9 Arenaviral haemorrhagic fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97 Dengue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.0 Dengue without warning signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.1 Dengue with warning signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.2 Severe Dengue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A97.9 Dengue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98 Other viral haemorrhagic fevers, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.0 Crimean-Congo haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.1 Omsk haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.2 Kyasanur Forest disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.3 Marburg virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.4 Ebola virus disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.5 Haemorrhagic fever with renal syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A98.8 Other specified viral haemorrhagic fevers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 A99 Unspecified viral haemorrhagic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00 Herpesviral [herpes simplex] infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00-B09 Viral infections characterized by skin and mucous membrane lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.0 Eczema herpeticum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.1 Herpesviral vesicular dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.3 Herpesviral meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.4 Herpesviral encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.5 Herpesviral ocular disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.7 Disseminated herpesviral disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.8 Other forms of herpesviral infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B00.9 Herpesviral infection, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 197 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01 Varicella [chickenpox] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.0 Varicella meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.1 Varicella encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.2 Varicella pneumoniaJ17.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.8 Varicella with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B01.9 Varicella without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02 Zoster [herpes zoster] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.0 Zoster encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.1 Zoster meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.2 Zoster with other nervous system involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.3 Zoster ocular disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.7 Disseminated zoster 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.8 Zoster with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B02.9 Zoster without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B03 Smallpox 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B04 Monkeypox 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05 Measles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.0 Measles complicated by encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.1 Measles complicated by meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.2 Measles complicated by pneumoniaJ17.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.3 Measles complicated by otitis mediaH67.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.4 Measles with intestinal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.8 Measles with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B05.9 Measles without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06 Rubella [German measles] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06.0 Rubella with neurological complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06.8 Rubella with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B06.9 Rubella without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B07 Viral warts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08 Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.0 Other orthopoxvirus infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.1 Molluscum contagiosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.2 Exanthema subitum [sixth disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.3 Erythema infectiosum [fifth disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.4 Enteroviral vesicular stomatitis with exanthem 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.5 Enteroviral vesicular pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B08.8 Other specified viral infections characterized by skin and mucous membrane lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B09 Unspecified viral infection characterized by skin and mucous membrane lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B15 Acute hepatitis A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B15-B19 Viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B15.0 Hepatitis A with hepatic coma

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 198 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B15.9 Hepatitis A without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16 Acute hepatitis B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.2 Acute hepatitis B without delta-agent with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B16.9 Acute hepatitis B without delta-agent and without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17 Other acute viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.0 Acute delta-(super)infection of hepatitis B carrier 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.1 Acute hepatitis C 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.2 Acute hepatitis E 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.8 Other specified acute viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B17.9 Acute viral hepatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18 Chronic viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.0 Chronic viral hepatitis B with delta-agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.1 Chronic viral hepatitis B without delta-agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.2 Chronic viral hepatitis C 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.8 Other chronic viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B18.9 Chronic viral hepatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B19 Unspecified viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B19.0 Unspecified viral hepatitis with hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B19.9 Unspecified viral hepatitis without hepatic coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20-B24 Human immunodeficiency virus [HIV] disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.0 HIV disease resulting in mycobacterial infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.1 HIV disease resulting in other bacterial infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.2 HIV disease resulting in cytomegaloviral disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.3 HIV disease resulting in other viral infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.4 HIV disease resulting in candidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.5 HIV disease resulting in other mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.6 HIV disease resulting in Pneumocystis jirovecii pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.7 HIV disease resulting in multiple infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.8 HIV disease resulting in other infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B20.9 HIV disease resulting in unspecified infectious or parasitic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.0 HIV disease resulting in Kaposi sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.1 HIV disease resulting in Burkitt lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.2 HIV disease resulting in other types of non-Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.3 HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.7 HIV disease resulting in multiple malignant neoplasms

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 199 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.8 HIV disease resulting in other malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B21.9 HIV disease resulting in unspecified malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.0 HIV disease resulting in encephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.1 HIV disease resulting in lymphoid interstitial pneumonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.2 HIV disease resulting in wasting syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B22.7 HIV disease resulting in multiple diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23 Human immunodeficiency virus [HIV] disease resulting in other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.0 Acute HIV infection syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.1 HIV disease resulting in (persistent) generalized lymphadenopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.2 HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B23.8 HIV disease resulting in other specified conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B24 Unspecified human immunodeficiency virus [HIV] disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25 Cytomegaloviral disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25-B34 Other viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.0 Cytomegaloviral pneumonitisJ17.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.1 Cytomegaloviral hepatitisK77.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.2 Cytomegaloviral pancreatitisK87.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.8 Other cytomegaloviral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B25.9 Cytomegaloviral disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26 Mumps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.0 Mumps orchitisN51.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.1 Mumps meningitisG02.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.2 Mumps encephalitisG05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.3 Mumps pancreatitisK87.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.8 Mumps with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B26.9 Mumps without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27 Infectious mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.0 Gammaherpesviral mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.1 Cytomegaloviral mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.8 Other infectious mononucleosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B27.9 Infectious mononucleosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30 Viral conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.0 Keratoconjunctivitis due to adenovirusH19.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.1 Conjunctivitis due to adenovirusH13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.2 Viral pharyngoconjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)H13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.8 Other viral conjunctivitisH13.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B30.9 Viral conjunctivitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33 Other viral diseases, not elsewhere classified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 200 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.0 Epidemic myalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.1 Ross River disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.2 Viral carditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.3 Retrovirus infections, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]J17.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B33.8 Other specified viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34 Viral infection of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.0 Adenovirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.1 Enterovirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.2 Coronavirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.3 Parvovirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.4 Papovavirus infection, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.8 Other viral infections of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B34.9 Viral infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35 Dermatophytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35-B49 Mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.0 Tinea barbae and tinea capitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.1 Tinea unguium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.2 Tinea manuum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.3 Tinea pedis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.4 Tinea corporis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.5 Tinea imbricata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.6 Tinea inguinalis [Tinea cruris] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.8 Other dermatophytoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B35.9 Dermatophytosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36 Other superficial mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.0 Pityriasis versicolor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.1 Tinea nigra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.2 White piedra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.3 Black piedra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.8 Other specified superficial mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B36.9 Superficial mycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37 Candidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.0 Candidal stomatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.1 Pulmonary candidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.2 Candidiasis of skin and nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.3 Candidiasis of vulva and vaginaN77.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.4 Candidiasis of other urogenital sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.5 Candidal meningitisG02.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.6 Candidal endocarditisI39.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.7 Candidal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.8 Candidiasis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B37.9 Candidiasis, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 201 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38 Coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.0 Acute pulmonary coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.1 Chronic pulmonary coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.2 Pulmonary coccidioidomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.3 Cutaneous coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.4 Coccidioidomycosis meningitisG02.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.7 Disseminated coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.8 Other forms of coccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B38.9 Coccidioidomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39 Histoplasmosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.0 Acute pulmonary histoplasmosis capsulati 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.1 Chronic pulmonary histoplasmosis capsulati 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.2 Pulmonary histoplasmosis capsulati, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.3 Disseminated histoplasmosis capsulati 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.4 Histoplasmosis capsulati, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.5 Histoplasmosis duboisii 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B39.9 Histoplasmosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40 Blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.0 Acute pulmonary blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.1 Chronic pulmonary blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.2 Pulmonary blastomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.3 Cutaneous blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.7 Disseminated blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.8 Other forms of blastomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B40.9 Blastomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41 Paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.0 Pulmonary paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.7 Disseminated paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.8 Other forms of paracoccidioidomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B41.9 Paracoccidioidomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42 Sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.0 Pulmonary sporotrichosisJ99.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.1 Lymphocutaneous sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.7 Disseminated sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.8 Other forms of sporotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B42.9 Sporotrichosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43 Chromomycosis and phaeomycotic abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.0 Cutaneous chromomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.1 Phaeomycotic brain abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.2 Subcutaneous phaeomycotic abscess and cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.8 Other forms of chromomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B43.9 Chromomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44 Aspergillosis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 202 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.0 Invasive pulmonary aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.1 Other pulmonary aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.2 Tonsillar aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.7 Disseminated aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.8 Other forms of aspergillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B44.9 Aspergillosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45 Cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.0 Pulmonary cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.1 Cerebral cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.2 Cutaneous cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.3 Osseous cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.7 Disseminated cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.8 Other forms of cryptococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B45.9 Cryptococcosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46 Zygomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.0 Pulmonary mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.1 Rhinocerebral mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.2 Gastrointestinal mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.3 Cutaneous mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.4 Disseminated mucormycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.5 Mucormycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.8 Other zygomycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B46.9 Zygomycosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47 Mycetoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47.0 Eumycetoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47.1 Actinomycetoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B47.9 Mycetoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48 Other mycoses, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.0 Lobomycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.1 Rhinosporidiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.2 Allescheriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.3 Geotrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.4 Penicillosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.7 Opportunistic mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B48.8 Other specified mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B49 Unspecified mycosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50 Plasmodium falciparum malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50-B64 Protozoal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50.0 Plasmodium falciparum malaria with cerebral complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50.8 Other severe and complicated Plasmodium falciparum malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B50.9 Plasmodium falciparum malaria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51 Plasmodium vivax malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51.0 Plasmodium vivax malaria with rupture of spleen © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 203 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51.8 Plasmodium vivax malaria with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B51.9 Plasmodium vivax malaria without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52 Plasmodium malariae malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52.0 Plasmodium malariae malaria with nephropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52.8 Plasmodium malariae malaria with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B52.9 Plasmodium malariae malaria without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53 Other parasitologically confirmed malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53.0 Plasmodium ovale malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53.1 Malaria due to simian plasmodia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B53.8 Other parasitologically confirmed malaria, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B54 Unspecified malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55 Leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.0 Visceral leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.1 Cutaneous leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.2 Mucocutaneous leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B55.9 Leishmaniasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56 African trypanosomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56.0 Gambiense trypanosomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56.1 Rhodesiense trypanosomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B56.9 African trypanosomiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57 Chagas disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.0 Acute Chagas disease with heart involvementI41.2I98.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.1 Acute Chagas disease without heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.2 Chagas disease (chronic) with heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.3 Chagas disease (chronic) with digestive system involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.4 Chagas disease (chronic) with nervous system involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B57.5 Chagas disease (chronic) with other organ involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58 Toxoplasmosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.0 Toxoplasma oculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.1 Toxoplasma hepatitisK77.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.2 Toxoplasma meningoencephalitisG05.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.3 Pulmonary toxoplasmosisJ17.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.8 Toxoplasmosis with other organ involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B58.9 Toxoplasmosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B59 PneumocystosisJ17.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60 Other protozoal diseases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.0 Babesiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.1 Acanthamoebiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.2 Naegleriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B60.8 Other specified protozoal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B64 Unspecified protozoal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65 Schistosomiasis [bilharziasis]

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 204 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65-B83 Helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.0 Schistosomiasis due to Schistosoma haematobium [urinary schistosomiasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.1 Schistosomiasis due to Schistosoma mansoni [intestinal schistosomiasis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.2 Schistosomiasis due to Schistosoma japonicum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.3 Cercarial dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.8 Other schistosomiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B65.9 Schistosomiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66 Other fluke infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.0 Opisthorchiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.1 Clonorchiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.2 Dicrocoeliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.3 Fascioliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.4 Paragonimiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.5 Fasciolopsiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.8 Other specified fluke infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B66.9 Fluke infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67 Echinococcosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.0 Echinococcus granulosus infection of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.1 Echinococcus granulosus infection of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.2 Echinococcus granulosus infection of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.3 Echinococcus granulosus infection, other and multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.4 Echinococcus granulosus infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.5 Echinococcus multilocularis infection of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.6 Echinococcus multilocularis infection, other and multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.7 Echinococcus multilocularis infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.8 Echinococcosis, unspecified, of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B67.9 Echinococcosis, other and unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68 Taeniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68.0 Taenia solium taeniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68.1 Taenia saginata taeniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B68.9 Taeniasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69 Cysticercosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.0 Cysticercosis of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.1 Cysticercosis of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.8 Cysticercosis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B69.9 Cysticercosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B70 Diphyllobothriasis and sparganosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B70.0 Diphyllobothriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B70.1 Sparganosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71 Other cestode infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.0 Hymenolepiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.1 Dipylidiasis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 205 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.8 Other specified cestode infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B71.9 Cestode infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B72 Dracunculiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B73 Onchocerciasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74 Filariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.0 Filariasis due to Wuchereria bancrofti 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.1 Filariasis due to Brugia malayi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.2 Filariasis due to Brugia timori 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.3 Loiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.4 Mansonelliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.8 Other filariases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B74.9 Filariasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B75 Trichinellosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76 Hookworm diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.0 Ancylostomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.1 Necatoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.8 Other hookworm diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B76.9 Hookworm disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77 Ascariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77.0 Ascariasis with intestinal complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77.8 Ascariasis with other complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B77.9 Ascariasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78 Strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.0 Intestinal strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.1 Cutaneous strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.7 Disseminated strongyloidiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B78.9 Strongyloidiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B79 Trichuriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B80 Enterobiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81 Other intestinal helminthiases, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.0 Anisakiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.1 Intestinal capillariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.2 Trichostrongyliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.3 Intestinal angiostrongyliasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.4 Mixed intestinal helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B81.8 Other specified intestinal helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B82 Unspecified intestinal parasitism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B82.0 Intestinal helminthiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B82.9 Intestinal parasitism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83 Other helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.0 Visceral larva migrans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.1 Gnathostomiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.2 Angiostrongyliasis due to Parastrongylus cantonensis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 206 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.3 Syngamiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.4 Internal hirudiniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.8 Other specified helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B83.9 Helminthiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85 Pediculosis and phthiriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85-B89 Pediculosis, acariasis and other infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.0 Pediculosis due to Pediculus humanus capitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.1 Pediculosis due to Pediculus humanus corporis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.2 Pediculosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.3 Phthiriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B85.4 Mixed pediculosis and phthiriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B86 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87 Myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.0 Cutaneous myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.1 Wound myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.2 Ocular myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.3 Nasopharyngeal myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.4 Aural myiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.8 Myiasis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B87.9 Myiasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88 Other infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.0 Other acariasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.1 Tungiasis [sandflea infestation] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.2 Other arthropod infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.3 External hirudiniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.8 Other specified infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B88.9 Infestation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B89 Unspecified parasitic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90 Sequelae of tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90-B94 Sequelae of infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.0 Sequelae of central nervous system tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.1 Sequelae of genitourinary tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.2 Sequelae of tuberculosis of bones and joints 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.8 Sequelae of tuberculosis of other organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B90.9 Sequelae of respiratory and unspecified tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B91 Sequelae of poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B92 Sequelae of leprosy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94 Sequelae of other and unspecified infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.0 Sequelae of trachoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.1 Sequelae of viral encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.2 Sequelae of viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.8 Sequelae of other specified infectious and parasitic diseases

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 207 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B94.9 Sequelae of unspecified infectious or parasitic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95-B98 Bacterial, viral and other infectious agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.2 Streptococcus group D and enterococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.4 Other streptococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.7 Other staphylococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96 Other specified bacterial agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.5 Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.6 Bacillus fragilis [B. fragilis] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B96.8 Other specified bacterial agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97 Viral agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.0 Adenovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.1 Enterovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.2 Coronavirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.3 Retrovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.4 Respiratory syncytial virus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.5 Reovirus as the cause of diseases classified to other chapters © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 208 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.6 Parvovirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.7 Papillomavirus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B97.8 Other viral agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B98 Other specified infectious agents as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B98.1 Vibrio vulnificus as the cause of diseases classified to other chapters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B99 Other and unspecified infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 B99-B99 Other infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00 Malignant neoplasm of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00-C14 Malignant neoplasms of lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00-C75 Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00-C97 Malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.0 Malignant neoplasm: External upper lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.1 Malignant neoplasm: External lower lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.2 Malignant neoplasm: External lip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.3 Malignant neoplasm: Upper lip, inner aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.4 Malignant neoplasm: Lower lip, inner aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.5 Malignant neoplasm: Lip, unspecified, inner aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.6 Malignant neoplasm: Commissure of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.8 Malignant neoplasm: Overlapping lesion of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C00.9 Malignant neoplasm: Lip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C01 Malignant neoplasm of base of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02 Malignant neoplasm of other and unspecified parts of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.0 Malignant neoplasm: Dorsal surface of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.1 Malignant neoplasm: Border of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.2 Malignant neoplasm: Ventral surface of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.3 Malignant neoplasm: Anterior two-thirds of tongue, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.4 Malignant neoplasm: Lingual tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.8 Malignant neoplasm: Overlapping lesion of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C02.9 Malignant neoplasm: Tongue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03 Malignant neoplasm of gum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03.0 Malignant neoplasm: Upper gum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03.1 Malignant neoplasm: Lower gum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C03.9 Malignant neoplasm: Gum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04 Malignant neoplasm of floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.0 Malignant neoplasm: Anterior floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.1 Malignant neoplasm: Lateral floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.8 Malignant neoplasm: Overlapping lesion of floor of mouth © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 209 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C04.9 Malignant neoplasm: Floor of mouth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05 Malignant neoplasm of palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.0 Malignant neoplasm: Hard palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.1 Malignant neoplasm: Soft palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.2 Malignant neoplasm: Uvula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.8 Malignant neoplasm: Overlapping lesion of palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C05.9 Malignant neoplasm: Palate, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06 Malignant neoplasm of other and unspecified parts of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.0 Malignant neoplasm: Cheek mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.1 Malignant neoplasm: Vestibule of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.2 Malignant neoplasm: Retromolar area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.8 Malignant neoplasm: Overlapping lesion of other and unspecified parts of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C06.9 Malignant neoplasm: Mouth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C07 Malignant neoplasm of parotid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08 Malignant neoplasm of other and unspecified major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.0 Malignant neoplasm: Submandibular gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.1 Malignant neoplasm: Sublingual gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.8 Malignant neoplasm: Overlapping lesion of major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C08.9 Malignant neoplasm: Major salivary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09 Malignant neoplasm of tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.0 Malignant neoplasm: Tonsillar fossa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.1 Malignant neoplasm: Tonsillar pillar (anterior)(posterior) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.8 Malignant neoplasm: Overlapping lesion of tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C09.9 Malignant neoplasm: Tonsil, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10 Malignant neoplasm of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.0 Malignant neoplasm: Vallecula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.1 Malignant neoplasm: Anterior surface of epiglottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.2 Malignant neoplasm: Lateral wall of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.3 Malignant neoplasm: Posterior wall of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.4 Malignant neoplasm: Branchial cleft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.8 Malignant neoplasm: Overlapping lesion of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C10.9 Malignant neoplasm: Oropharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11 Malignant neoplasm of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.0 Malignant neoplasm: Superior wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.1 Malignant neoplasm: Posterior wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.2 Malignant neoplasm: Lateral wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.3 Malignant neoplasm: Anterior wall of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.8 Malignant neoplasm: Overlapping lesion of nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C11.9 Malignant neoplasm: Nasopharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C12 Malignant neoplasm of piriform sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13 Malignant neoplasm of hypopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.0 Malignant neoplasm: Postcricoid region © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 210 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.1 Malignant neoplasm: Aryepiglottic fold, hypopharyngeal aspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.2 Malignant neoplasm: Posterior wall of hypopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.8 Malignant neoplasm: Overlapping lesion of hypopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C13.9 Malignant neoplasm: Hypopharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14.0 Malignant neoplasm: Pharynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14.2 Malignant neoplasm: Waldeyer ring 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C14.8 Malignant neoplasm: Overlapping lesion of lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15 Malignant neoplasm of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15-C26 Malignant neoplasms of digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.0 Malignant neoplasm: Cervical part of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.1 Malignant neoplasm: Thoracic part of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.2 Malignant neoplasm: Abdominal part of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.3 Malignant neoplasm: Upper third of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.4 Malignant neoplasm: Middle third of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.5 Malignant neoplasm: Lower third of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.8 Malignant neoplasm: Overlapping lesion of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C15.9 Malignant neoplasm: Oesophagus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16 Malignant neoplasm of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.0 Malignant neoplasm: Cardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.1 Malignant neoplasm: Fundus of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.2 Malignant neoplasm: Body of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.3 Malignant neoplasm: Pyloric antrum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.4 Malignant neoplasm: Pylorus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.5 Malignant neoplasm: Lesser curvature of stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.6 Malignant neoplasm: Greater curvature of stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.8 Malignant neoplasm: Overlapping lesion of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C16.9 Malignant neoplasm: Stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17 Malignant neoplasm of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.0 Malignant neoplasm: Duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.1 Malignant neoplasm: Jejunum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.2 Malignant neoplasm: Ileum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.3 Malignant neoplasm: Meckel diverticulum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.8 Malignant neoplasm: Overlapping lesion of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C17.9 Malignant neoplasm: Small intestine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18 Malignant neoplasm of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.0 Malignant neoplasm: Caecum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.1 Malignant neoplasm: Appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.2 Malignant neoplasm: Ascending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.3 Malignant neoplasm: Hepatic flexure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.4 Malignant neoplasm: Transverse colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.5 Malignant neoplasm: Splenic flexure © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 211 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.6 Malignant neoplasm: Descending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.7 Malignant neoplasm: Sigmoid colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.8 Malignant neoplasm: Overlapping lesion of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C18.9 Malignant neoplasm: Colon, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C19 Malignant neoplasm of rectosigmoid junction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C20 Malignant neoplasm of rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21 Malignant neoplasm of anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.0 Malignant neoplasm: Anus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.1 Malignant neoplasm: Anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.2 Malignant neoplasm: Cloacogenic zone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C21.8 Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22 Malignant neoplasm of liver and intrahepatic bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.0 Malignant neoplasm: Liver cell carcinoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.1 Malignant neoplasm: Intrahepatic bile duct carcinoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.2 Malignant neoplasm: Hepatoblastoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.3 Malignant neoplasm: Angiosarcoma of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.4 Malignant neoplasm: Other sarcomas of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.7 Malignant neoplasm: Other specified carcinomas of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C22.9 Malignant neoplasm: Liver, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C23 Malignant neoplasm of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24 Malignant neoplasm of other and unspecified parts of biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.0 Malignant neoplasm: Extrahepatic bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.1 Malignant neoplasm: Ampulla of Vater 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.8 Malignant neoplasm: Overlapping lesion of biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C24.9 Malignant neoplasm: Biliary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25 Malignant neoplasm of 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.0 Malignant neoplasm: Head of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.1 Malignant neoplasm: Body of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.2 Malignant neoplasm: Tail of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.3 Malignant neoplasm: Pancreatic duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.4 Malignant neoplasm: Endocrine pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.7 Malignant neoplasm: Other parts of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.8 Malignant neoplasm: Overlapping lesion of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C25.9 Malignant neoplasm: Pancreas, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26 Malignant neoplasm of other and ill-defined digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.0 Malignant neoplasm: Intestinal tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.1 Malignant neoplasm: Spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.8 Malignant neoplasm: Overlapping lesion of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C26.9 Malignant neoplasm: Ill-defined sites within the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C30 Malignant neoplasm of nasal cavity and middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C30-C39 Malignant neoplasms of respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C30.0 Malignant neoplasm: Nasal cavity

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 212 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C30.1 Malignant neoplasm: Middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31 Malignant neoplasm of accessory sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.0 Malignant neoplasm: Maxillary sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.1 Malignant neoplasm: Ethmoidal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.2 Malignant neoplasm: Frontal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.3 Malignant neoplasm: Sphenoidal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.8 Malignant neoplasm: Overlapping lesion of accessory sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C31.9 Malignant neoplasm: Accessory sinus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32 Malignant neoplasm of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.0 Malignant neoplasm: Glottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.1 Malignant neoplasm: Supraglottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.2 Malignant neoplasm: Subglottis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.3 Malignant neoplasm: Laryngeal cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.8 Malignant neoplasm: Overlapping lesion of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C32.9 Malignant neoplasm: Larynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C33 Malignant neoplasm of trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34 Malignant neoplasm of bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.0 Malignant neoplasm: Main bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.1 Malignant neoplasm: Upper lobe, bronchus or lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.2 Malignant neoplasm: Middle lobe, bronchus or lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.3 Malignant neoplasm: Lower lobe, bronchus or lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.8 Malignant neoplasm: Overlapping lesion of bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C34.9 Malignant neoplasm: Bronchus or lung, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C37 Malignant neoplasm of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38 Malignant neoplasm of heart, mediastinum and pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.0 Malignant neoplasm: Heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.1 Malignant neoplasm: Anterior mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.2 Malignant neoplasm: Posterior mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.3 Malignant neoplasm: Mediastinum, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.4 Malignant neoplasm: Pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C38.8 Malignant neoplasm: Overlapping lesion of heart, mediastinum and pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39.0 Malignant neoplasm: Upper respiratory tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39.8 Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C39.9 Malignant neoplasm: Ill-defined sites within the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40 Malignant neoplasm of bone and articular cartilage of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40-C41 Malignant neoplasms of bone and articular cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.0 Malignant neoplasm: Scapula and long bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.1 Malignant neoplasm: Short bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.2 Malignant neoplasm: Long bones of lower limb

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 213 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.3 Malignant neoplasm: Short bones of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.8 Malignant neoplasm: Overlapping lesion of bone and articular cartilage of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C40.9 Malignant neoplasm: Bone and articular cartilage of limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.0 Malignant neoplasm: Bones of skull and face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.1 Malignant neoplasm: Mandible 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.2 Malignant neoplasm: Vertebral column 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.3 Malignant neoplasm: Ribs, sternum and clavicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.4 Malignant neoplasm: Pelvic bones, sacrum and coccyx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.8 Malignant neoplasm: Overlapping lesion of bone and articular cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C41.9 Malignant neoplasm: Bone and articular cartilage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43 Malignant melanoma of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43-C44 Melanoma and other malignant neoplasms of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.0 Malignant neoplasm: Malignant melanoma of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.1 Malignant neoplasm: Malignant melanoma of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.2 Malignant neoplasm: Malignant melanoma of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.3 Malignant neoplasm: Malignant melanoma of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.4 Malignant neoplasm: Malignant melanoma of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.5 Malignant neoplasm: Malignant melanoma of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.6 Malignant neoplasm: Malignant melanoma of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.7 Malignant neoplasm: Malignant melanoma of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.8 Malignant neoplasm: Overlapping malignant melanoma of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C43.9 Malignant neoplasm: Malignant melanoma of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44 Other malignant neoplasms of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.0 Malignant neoplasm: Skin of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.1 Malignant neoplasm: Skin of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.2 Malignant neoplasm: Skin of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.3 Malignant neoplasm: Skin of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.4 Malignant neoplasm: Skin of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.5 Malignant neoplasm: Skin of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.6 Malignant neoplasm: Skin of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.7 Malignant neoplasm: Skin of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.8 Malignant neoplasm: Overlapping lesion of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C44.9 Malignant neoplasm: Malignant neoplasm of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45 Mesothelioma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45-C49 Malignant neoplasms of mesothelial and soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.0 Mesothelioma of pleura

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 214 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.1 Mesothelioma of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.2 Mesothelioma of pericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.7 Mesothelioma of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C45.9 Mesothelioma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46 Kaposi sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.0 Kaposi sarcoma of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.1 Kaposi sarcoma of soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.2 Kaposi sarcoma of palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.3 Kaposi sarcoma of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.7 Kaposi sarcoma of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.8 Kaposi sarcoma of multiple organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C46.9 Kaposi sarcoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47 Malignant neoplasm of peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.0 Malignant neoplasm: Peripheral nerves of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.1 Malignant neoplasm: Peripheral nerves of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.2 Malignant neoplasm: Peripheral nerves of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.3 Malignant neoplasm: Peripheral nerves of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.4 Malignant neoplasm: Peripheral nerves of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.5 Malignant neoplasm: Peripheral nerves of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.6 Malignant neoplasm: Peripheral nerves of trunk, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.8 Malignant neoplasm: Overlapping lesion of peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C47.9 Malignant neoplasm: Peripheral nerves and autonomic nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48 Malignant neoplasm of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.0 Malignant neoplasm: Retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.1 Malignant neoplasm: Specified parts of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.2 Malignant neoplasm: Peritoneum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C48.8 Malignant neoplasm: Overlapping lesion of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49 Malignant neoplasm of other connective and soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.0 Malignant neoplasm: Connective and soft tissue of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.1 Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.2 Malignant neoplasm: Connective and soft tissue of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.3 Malignant neoplasm: Connective and soft tissue of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.4 Malignant neoplasm: Connective and soft tissue of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.5 Malignant neoplasm: Connective and soft tissue of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.6 Malignant neoplasm: Connective and soft tissue of trunk, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.8 Malignant neoplasm: Overlapping lesion of connective and soft tissue © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 215 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C49.9 Malignant neoplasm: Connective and soft tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50 Malignant neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50-C50 Malignant neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.0 Malignant neoplasm: Nipple and areola 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.1 Malignant neoplasm: Central portion of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.2 Malignant neoplasm: Upper-inner quadrant of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.3 Malignant neoplasm: Lower-inner quadrant of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.4 Malignant neoplasm: Upper-outer quadrant of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.5 Malignant neoplasm: Lower-outer quadrant of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.6 Malignant neoplasm: Axillary tail of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.8 Malignant neoplasm: Overlapping lesion of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C50.9 Malignant neoplasm: Breast, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51 Malignant neoplasm of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51-C58 Malignant neoplasms of female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.0 Malignant neoplasm: Labium majus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.1 Malignant neoplasm: Labium minus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.2 Malignant neoplasm: Clitoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.8 Malignant neoplasm: Overlapping lesion of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C51.9 Malignant neoplasm: Vulva, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C52 Malignant neoplasm of 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53 Malignant neoplasm of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.0 Malignant neoplasm: Endocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.1 Malignant neoplasm: Exocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.8 Malignant neoplasm: Overlapping lesion of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C53.9 Malignant neoplasm: Cervix uteri, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54 Malignant neoplasm of corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.0 Malignant neoplasm: Isthmus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.1 Malignant neoplasm: Endometrium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.2 Malignant neoplasm: Myometrium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.3 Malignant neoplasm: Fundus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.8 Malignant neoplasm: Overlapping lesion of corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C54.9 Malignant neoplasm: Corpus uteri, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C55 Malignant neoplasm of uterus, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C56 Malignant neoplasm of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57 Malignant neoplasm of other and unspecified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.0 Malignant neoplasm: Fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.1 Malignant neoplasm: Broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.2 Malignant neoplasm: Round ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.3 Malignant neoplasm: Parametrium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.4 Malignant neoplasm: Uterine adnexa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.7 Malignant neoplasm: Other specified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.8 Malignant neoplasm: Overlapping lesion of female genital organs

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 216 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C57.9 Malignant neoplasm: Female genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C58 Malignant neoplasm of placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60 Malignant neoplasm of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60-C63 Malignant neoplasms of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.0 Malignant neoplasm: Prepuce 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.1 Malignant neoplasm: Glans penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.2 Malignant neoplasm: Body of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.8 Malignant neoplasm: Overlapping lesion of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C60.9 Malignant neoplasm: Penis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C61 Malignant neoplasm of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62 Malignant neoplasm of testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62.0 Malignant neoplasm: Undescended testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62.1 Malignant neoplasm: Descended testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C62.9 Malignant neoplasm: Testis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63 Malignant neoplasm of other and unspecified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.0 Malignant neoplasm: Epididymis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.1 Malignant neoplasm: Spermatic cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.2 Malignant neoplasm: Scrotum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.7 Malignant neoplasm: Other specified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.8 Malignant neoplasm: Overlapping lesion of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C63.9 Malignant neoplasm: Male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C64 Malignant neoplasm of kidney, except renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C64-C68 Malignant neoplasms of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C65 Malignant neoplasm of renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C66 Malignant neoplasm of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67 Malignant neoplasm of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.0 Malignant neoplasm: Trigone of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.1 Malignant neoplasm: Dome of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.2 Malignant neoplasm: Lateral wall of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.3 Malignant neoplasm: Anterior wall of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.4 Malignant neoplasm: Posterior wall of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.5 Malignant neoplasm: Bladder neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.6 Malignant neoplasm: Ureteric orifice 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.7 Malignant neoplasm: Urachus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.8 Malignant neoplasm: Overlapping lesion of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C67.9 Malignant neoplasm: Bladder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68 Malignant neoplasm of other and unspecified urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.0 Malignant neoplasm: Urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.1 Malignant neoplasm: Paraurethral gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.8 Malignant neoplasm: Overlapping lesion of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C68.9 Malignant neoplasm: Urinary organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69 Malignant neoplasm of eye and adnexa

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 217 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.0 Malignant neoplasm: Conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.1 Malignant neoplasm: Cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.2 Malignant neoplasm: Retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.3 Malignant neoplasm: Choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.4 Malignant neoplasm: Ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.5 Malignant neoplasm: Lacrimal gland and duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.6 Malignant neoplasm: Orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.8 Malignant neoplasm: Overlapping lesion of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C69.9 Malignant neoplasm: Eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70 Malignant neoplasm of meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70.0 Malignant neoplasm: Cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70.1 Malignant neoplasm: Spinal meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C70.9 Malignant neoplasm: Meninges, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71 Malignant neoplasm of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.0 Malignant neoplasm: Cerebrum, except lobes and ventricles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.1 Malignant neoplasm: Frontal lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.2 Malignant neoplasm: Temporal lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.3 Malignant neoplasm: Parietal lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.4 Malignant neoplasm: Occipital lobe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.5 Malignant neoplasm: Cerebral ventricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.6 Malignant neoplasm: Cerebellum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.7 Malignant neoplasm: Brain stem 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.8 Malignant neoplasm: Overlapping lesion of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C71.9 Malignant neoplasm: Brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.0 Malignant neoplasm: Spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.1 Malignant neoplasm: Cauda equina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.2 Malignant neoplasm: Olfactory nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.3 Malignant neoplasm: Optic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.4 Malignant neoplasm: Acoustic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.5 Malignant neoplasm: Other and unspecified cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.8 Malignant neoplasm: Overlapping lesion of brain and other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C72.9 Malignant neoplasm: Central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C73 Malignant neoplasm of thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C73-C75 Malignant neoplasms of thyroid and other endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74 Malignant neoplasm of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74.0 Malignant neoplasm: Cortex of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74.1 Malignant neoplasm: Medulla of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C74.9 Malignant neoplasm: Adrenal gland, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 218 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75 Malignant neoplasm of other endocrine glands and related structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.0 Malignant neoplasm: Parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.1 Malignant neoplasm: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.2 Malignant neoplasm: Craniopharyngeal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.3 Malignant neoplasm: Pineal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.4 Malignant neoplasm: Carotid body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.5 Malignant neoplasm: Aortic body and other paraganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.8 Malignant neoplasm: Pluriglandular involvement, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C75.9 Malignant neoplasm: Endocrine gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76 Malignant neoplasm of other and ill-defined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.0 Malignant neoplasm of other and ill-defined sites: Head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.1 Malignant neoplasm of other and ill-defined sites: Thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.2 Malignant neoplasm of other and ill-defined sites: Abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.3 Malignant neoplasm of other and ill-defined sites: Pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.4 Malignant neoplasm of other and ill-defined sites: Upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.5 Malignant neoplasm of other and ill-defined sites: Lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.7 Malignant neoplasm of other and ill-defined sites: Other ill- defined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C76.8 Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77 Secondary and unspecified malignant neoplasm of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.0 Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.1 Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.2 Secondary and unspecified malignant neoplasm: Intra- abdominal lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.3 Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.4 Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.5 Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.8 Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C77.9 Secondary and unspecified malignant neoplasm: Lymph node, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78 Secondary malignant neoplasm of respiratory and digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.0 Secondary malignant neoplasm of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.1 Secondary malignant neoplasm of mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.2 Secondary malignant neoplasm of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 219 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.4 Secondary malignant neoplasm of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.5 Secondary malignant neoplasm of large intestine and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C78.8 Secondary malignant neoplasm of other and unspecified digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79 Secondary malignant neoplasm of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.0 Secondary malignant neoplasm of kidney and renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.2 Secondary malignant neoplasm of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.3 Secondary malignant neoplasm of brain and cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.5 Secondary malignant neoplasm of bone and bone marrow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.6 Secondary malignant neoplasm of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.7 Secondary malignant neoplasm of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.8 Secondary malignant neoplasm of other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C79.9 Secondary malignant neoplasm, unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C80 Malignant neoplasm, without specification of site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C80.0 Malignant neoplasm, primary site unknown, so stated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C80.9 Malignant neoplasm, primary site unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81 Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.0 Nodular lymphocyte predominant Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.1 Nodular sclerosis classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.2 Mixed cellularity classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.3 Lymphocyte depleted classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.4 Lymphocyte-rich (classical) Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.7 Other classical Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C81.9 Hodgkin lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82 Follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.0 Follicular lymphoma grade I 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.1 Follicular lymphoma grade II 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.2 Follicular lymphoma grade III, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.3 Follicular lymphoma grade IIIa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.4 Follicular lymphoma grade IIIb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.5 Diffuse follicle centre lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.6 Cutaneous follicle centre lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.7 Other types of follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C82.9 Follicular lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83 Non-follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.0 Small cell B-cell lymphoma © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 220 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.1 Mantle cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.3 Diffuse large B-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.5 Lymphoblastic (diffuse) lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.7 Burkitt lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.8 Other non-follicular lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C83.9 Non-follicular (diffuse) lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84 Mature T/NK-cell lymphomas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.0 Mycosis fungoides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.1 Sézary disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.4 Peripheral T-cell lymphoma, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.5 Other mature T/NK-cell lymphomas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.6 Anaplastic large cell lymphoma, ALK-positive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.7 Anaplastic large cell lymphoma, ALK-negative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.8 Cutaneous T-cell lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C84.9 Mature T/NK-cell lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85 Other and unspecified types of non-Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.1 B-cell lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.2 Mediastinal (thymic) large B-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.7 Other specified types of non-Hodgkin lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C85.9 Non-Hodgkin lymphoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86 Other specified types of T/NK-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.0 Extranodal NK/T-cell lymphoma, nasal type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.1 Hepatosplenic T-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.2 Enteropathy-type (intestinal) T-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.3 Subcutaneous panniculitis-like T-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.4 Blastic NK-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.5 Angioimmunoblastic T-cell lymphoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C86.6 Primary cutaneous CD30-positive T-cell proliferations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88 Malignant immunoproliferative diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.0 Waldenström macroglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.2 Other heavy chain disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.3 Immunoproliferative small intestinal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.4 Extranodal marginal zone B-cell lymphoma of mucosa- associated lymphoid tissue [MALT-lyphoma] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.7 Other malignant immunoproliferative diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C88.9 Malignant immunoproliferative disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90 Multiple myeloma and malignant plasma cell neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.0 Multiple myeloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.1 Plasma cell leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.2 Extramedullary plasmacytoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C90.3 Solitary plasmacytoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91 Lymphoid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.0 Acute lymphoblastic leukaemia [ALL]

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 221 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.1 Chronic lymphocytic leukaemia of B-cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.3 Prolymphocytic leukaemia of B-cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.4 Hairy-cell leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.5 Adult T-cell lymphoma/leukaemia [HTLV-1-associated] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.6 Prolymphocytic leukaemia of T-cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.7 Other lymphoid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.8 Mature B-cell leukaemia Burkitt-type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C91.9 Lymphoid leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92 Myeloid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.0 Acute myeloblastic leukaemia [AML] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.1 Chronic myeloid leukaemia [CML], BCR/ABL-positive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.2 Atypical chronic myeloid leukaemia, BCR/ABL- negative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.3 Myeloid sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.4 Acute promyelocytic leukaemia [PML] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.5 Acute myelomonocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.6 Acute myeloid leukaemia with 11q23-abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.7 Other myeloid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.8 Acute myeloid leukaemia with multilineage dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C92.9 Myeloid leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93 Monocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.0 Acute monoblastic/monocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.1 Chronic myelomonocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.3 Juvenile myelomonocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.7 Other monocytic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C93.9 Monocytic leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94 Other leukaemias of specified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.0 Acute erythroid leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.2 Acute megakaryoblastic leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.3 Mast cell leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.4 Acute panmyelosis with myelofibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C94.7 Other specified leukaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95 Leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.0 Acute leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.1 Chronic leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.7 Other leukaemia of unspecified cell type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C95.9 Leukaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.0 Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis [Letterer-Siwe disease] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.2 Malignant mast cell tumour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.4 Sarcoma of dendritic cells (accessory cells)

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 222 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.6 Unifocal Langerhans-cell histiocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.8 Histiocytic sarcoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C96.9 Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C97 Malignant neoplasms of independent (primary) multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 C97-C97 Malignant neoplasms of independent (primary) multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00 Carcinoma in situ of oral cavity, oesophagus and stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00-D09 In situ neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00.0 Carcinoma in situ: Lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00.1 Carcinoma in situ: Oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D00.2 Carcinoma in situ: Stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01 Carcinoma in situ of other and unspecified digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.0 Carcinoma in situ: Colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.1 Carcinoma in situ: Rectosigmoid junction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.2 Carcinoma in situ: Rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.3 Carcinoma in situ: Anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.4 Carcinoma in situ: Other and unspecified parts of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.5 Carcinoma in situ: Liver, gallbladder and bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.7 Carcinoma in situ: Other specified digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D01.9 Carcinoma in situ: Digestive organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02 Carcinoma in situ of middle ear and respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.0 Carcinoma in situ: Larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.1 Carcinoma in situ: Trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.2 Carcinoma in situ: Bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.3 Carcinoma in situ: Other parts of respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D02.4 Carcinoma in situ: Respiratory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03 Melanoma in situ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.0 Melanoma in situ of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.1 Melanoma in situ of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.2 Melanoma in situ of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.3 Melanoma in situ of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.4 Melanoma in situ of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.5 Melanoma in situ of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.6 Melanoma in situ of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.7 Melanoma in situ of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.8 Melanoma in situ of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D03.9 Melanoma in situ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04 Carcinoma in situ of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.0 Carcinoma in situ: Skin of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.1 Carcinoma in situ: Skin of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.2 Carcinoma in situ: Skin of ear and external auricular canal © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 223 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.3 Carcinoma in situ: Skin of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.4 Carcinoma in situ: Skin of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.5 Carcinoma in situ: Skin of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.6 Carcinoma in situ: Skin of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.7 Carcinoma in situ: Skin of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.8 Carcinoma in situ: Skin of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D04.9 Carcinoma in situ: Skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05 Carcinoma in situ of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.0 Lobular carcinoma in situ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.1 Intraductal carcinoma in situ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.7 Other carcinoma in situ of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D05.9 Carcinoma in situ of breast, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06 Carcinoma in situ of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.0 Carcinoma in situ: Endocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.1 Carcinoma in situ: Exocervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.7 Carcinoma in situ: Other parts of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D06.9 Carcinoma in situ: Cervix, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07 Carcinoma in situ of other and unspecified genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.0 Carcinoma in situ: Endometrium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.1 Carcinoma in situ: Vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.2 Carcinoma in situ: Vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.3 Carcinoma in situ: Other and unspecified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.4 Carcinoma in situ: Penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.5 Carcinoma in situ: Prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D07.6 Carcinoma in situ: Other and unspecified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09 Carcinoma in situ of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.0 Carcinoma in situ: Bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.1 Carcinoma in situ: Other and unspecified urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.2 Carcinoma in situ: Eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.3 Carcinoma in situ: Thyroid and other endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.7 Carcinoma in situ of other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D09.9 Carcinoma in situ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10 Benign neoplasm of mouth and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10-D36 Benign neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.0 Benign neoplasm: Lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.1 Benign neoplasm: Tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.2 Benign neoplasm: Floor of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.3 Benign neoplasm: Other and unspecified parts of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.4 Benign neoplasm: Tonsil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.5 Benign neoplasm: Other parts of oropharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.6 Benign neoplasm: Nasopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.7 Benign neoplasm: Hypopharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D10.9 Benign neoplasm: Pharynx, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 224 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11 Benign neoplasm of major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11.0 Benign neoplasm: Parotid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11.7 Benign neoplasm: Other major salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D11.9 Benign neoplasm: Major salivary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12 Benign neoplasm of colon, rectum, anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.0 Benign neoplasm: Caecum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.1 Benign neoplasm: Appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.2 Benign neoplasm: Ascending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.3 Benign neoplasm: Transverse colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.4 Benign neoplasm: Descending colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.5 Benign neoplasm: Sigmoid colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.6 Benign neoplasm: Colon, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.7 Benign neoplasm: Rectosigmoid junction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.8 Benign neoplasm: Rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D12.9 Benign neoplasm: Anus and anal canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13 Benign neoplasm of other and ill-defined parts of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.0 Benign neoplasm: Oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.1 Benign neoplasm: Stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.2 Benign neoplasm: Duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.3 Benign neoplasm: Other and unspecified parts of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.4 Benign neoplasm: Liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.5 Benign neoplasm: Extrahepatic bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.6 Benign neoplasm: Pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.7 Benign neoplasm: Endocrine pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D13.9 Benign neoplasm: Ill-defined sites within the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14 Benign neoplasm of middle ear and respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.0 Benign neoplasm: Middle ear, nasal cavity and accessory sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.1 Benign neoplasm: Larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.2 Benign neoplasm: Trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.3 Benign neoplasm: Bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D14.4 Benign neoplasm: Respiratory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15 Benign neoplasm of other and unspecified intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.0 Benign neoplasm: Thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.1 Benign neoplasm: Heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.2 Benign neoplasm: Mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.7 Benign neoplasm: Other specified intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D15.9 Benign neoplasm: Intrathoracic organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16 Benign neoplasm of bone and articular cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.0 Benign neoplasm: Scapula and long bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.1 Benign neoplasm: Short bones of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.2 Benign neoplasm: Long bones of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.3 Benign neoplasm: Short bones of lower limb © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 225 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.4 Benign neoplasm: Bones of skull and face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.5 Benign neoplasm: Lower jaw bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.6 Benign neoplasm: Vertebral column 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.7 Benign neoplasm: Ribs, sternum and clavicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.8 Benign neoplasm: Pelvic bones, sacrum and coccyx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D16.9 Benign neoplasm: Bone and articular cartilage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17 Benign lipomatous neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.4 Benign lipomatous neoplasm of intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.5 Benign lipomatous neoplasm of intra-abdominal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.6 Benign lipomatous neoplasm of spermatic cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.7 Benign lipomatous neoplasm of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D17.9 Benign lipomatous neoplasm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D18 Haemangioma and lymphangioma, any site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D18.0 Haemangioma, any site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D18.1 Lymphangioma, any site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19 Benign neoplasm of mesothelial tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.0 Benign neoplasm: Mesothelial tissue of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.1 Benign neoplasm: Mesothelial tissue of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.7 Benign neoplasm: Mesothelial tissue of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D19.9 Benign neoplasm: Mesothelial tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D20.0 Benign neoplasm: Retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D20.1 Benign neoplasm: Peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21 Other benign neoplasms of connective and other soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.0 Benign neoplasm: Connective and other soft tissue of head, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.1 Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.2 Benign neoplasm: Connective and other soft tissue of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.3 Benign neoplasm: Connective and other soft tissue of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.4 Benign neoplasm: Connective and other soft tissue of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.5 Benign neoplasm: Connective and other soft tissue of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.6 Benign neoplasm: Connective and other soft tissue of trunk, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D21.9 Benign neoplasm: Connective and other soft tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22 Melanocytic naevi

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 226 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.0 Melanocytic naevi of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.1 Melanocytic naevi of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.2 Melanocytic naevi of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.3 Melanocytic naevi of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.4 Melanocytic naevi of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.5 Melanocytic naevi of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.6 Melanocytic naevi of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.7 Melanocytic naevi of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D22.9 Melanocytic naevi, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23 Other benign neoplasms of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.0 Benign neoplasm: Skin of lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.1 Benign neoplasm: Skin of eyelid, including canthus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.2 Benign neoplasm: Skin of ear and external auricular canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.3 Benign neoplasm: Skin of other and unspecified parts of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.4 Benign neoplasm: Skin of scalp and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.5 Benign neoplasm: Skin of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.6 Benign neoplasm: Skin of upper limb, including shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.7 Benign neoplasm: Skin of lower limb, including hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D23.9 Benign neoplasm: Skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D24 Benign neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25 Leiomyoma of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.0 Submucous leiomyoma of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.1 Intramural leiomyoma of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.2 Subserosal leiomyoma of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D25.9 Leiomyoma of uterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26 Other benign neoplasms of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.0 Other benign neoplasm: Cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.1 Other benign neoplasm: Corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.7 Other benign neoplasm: Other parts of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D26.9 Other benign neoplasm: Uterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D27 Benign neoplasm of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28 Benign neoplasm of other and unspecified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.0 Benign neoplasm: Vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.1 Benign neoplasm: Vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.2 Benign neoplasm: Uterine tubes and ligaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.7 Benign neoplasm: Other specified female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D28.9 Benign neoplasm: Female genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29 Benign neoplasm of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.0 Benign neoplasm: Penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.1 Benign neoplasm: Prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.2 Benign neoplasm: Testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.3 Benign neoplasm: Epididymis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.4 Benign neoplasm: Scrotum © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 227 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.7 Benign neoplasm: Other male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D29.9 Benign neoplasm: Male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30 Benign neoplasm of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.0 Benign neoplasm: Kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.1 Benign neoplasm: Renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.2 Benign neoplasm: Ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.3 Benign neoplasm: Bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.4 Benign neoplasm: Urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.7 Benign neoplasm: Other urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D30.9 Benign neoplasm: Urinary organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31 Benign neoplasm of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.0 Benign neoplasm: Conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.1 Benign neoplasm: Cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.2 Benign neoplasm: Retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.3 Benign neoplasm: Choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.4 Benign neoplasm: Ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.5 Benign neoplasm: Lacrimal gland and duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.6 Benign neoplasm: Orbit, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D31.9 Benign neoplasm: Eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32 Benign neoplasm of meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32.0 Benign neoplasm: Cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32.1 Benign neoplasm: Spinal meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D32.9 Benign neoplasm: Meninges, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33 Benign neoplasm of brain and other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.0 Benign neoplasm: Brain, supratentorial 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.1 Benign neoplasm: Brain, infratentorial 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.2 Benign neoplasm: Brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.3 Benign neoplasm: Cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.4 Benign neoplasm: Spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.7 Benign neoplasm: Other specified parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D33.9 Benign neoplasm: Central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D34 Benign neoplasm of thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35 Benign neoplasm of other and unspecified endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.0 Benign neoplasm: Adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.1 Benign neoplasm: Parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.2 Benign neoplasm: Pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.3 Benign neoplasm: Craniopharyngeal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.4 Benign neoplasm: Pineal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.5 Benign neoplasm: Carotid body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.6 Benign neoplasm: Aortic body and other paraganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.7 Benign neoplasm: Other specified endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.8 Benign neoplasm: Pluriglandular involvement © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 228 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D35.9 Benign neoplasm: Endocrine gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36 Benign neoplasm of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.0 Benign neoplasm: Lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.1 Benign neoplasm: Peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.7 Benign neoplasm: Other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D36.9 Benign neoplasm: Benign neoplasm of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37-D48 Neoplasms of uncertain or unknown behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.0 Neoplasm of uncertain or unknown behaviour: Lip, oral cavity and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.1 Neoplasm of uncertain or unknown behaviour: Stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.2 Neoplasm of uncertain or unknown behaviour: Small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.3 Neoplasm of uncertain or unknown behaviour: Appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.4 Neoplasm of uncertain or unknown behaviour: Colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.5 Neoplasm of uncertain or unknown behaviour: Rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.6 Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.7 Neoplasm of uncertain or unknown behaviour: Other digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D37.9 Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.0 Neoplasm of uncertain or unknown behaviour: Larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.1 Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.2 Neoplasm of uncertain or unknown behaviour: Pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.3 Neoplasm of uncertain or unknown behaviour: Mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.4 Neoplasm of uncertain or unknown behaviour: Thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.5 Neoplasm of uncertain or unknown behaviour: Other respiratory organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D38.6 Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39 Neoplasm of uncertain or unknown behaviour of female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.0 Neoplasm of uncertain or unknown behaviour: Uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.1 Neoplasm of uncertain or unknown behaviour: Ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.2 Neoplasm of uncertain or unknown behaviour: Placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.7 Neoplasm of uncertain or unknown behaviour: Other female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D39.9 Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40 Neoplasm of uncertain or unknown behaviour of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.0 Neoplasm of uncertain or unknown behaviour: Prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.1 Neoplasm of uncertain or unknown behaviour: Testis

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 229 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.7 Neoplasm of uncertain or unknown behaviour: Other male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D40.9 Neoplasm of uncertain or unknown behaviour: Male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41 Neoplasm of uncertain or unknown behaviour of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.0 Neoplasm of uncertain or unknown behaviour: Kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.1 Neoplasm of uncertain or unknown behaviour: Renal pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.2 Neoplasm of uncertain or unknown behaviour: Ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.3 Neoplasm of uncertain or unknown behaviour: Urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.4 Neoplasm of uncertain or unknown behaviour: Bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.7 Neoplasm of uncertain or unknown behaviour: Other urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D41.9 Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42 Neoplasm of uncertain or unknown behaviour of meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42.0 Neoplasm of uncertain or unknown behaviour: Cerebral meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42.1 Neoplasm of uncertain or unknown behaviour: Spinal meninges 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D42.9 Neoplasm of uncertain or unknown behaviour: Meninges, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.0 Neoplasm of uncertain or unknown behaviour: Brain, supratentorial 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.1 Neoplasm of uncertain or unknown behaviour: Brain, infratentorial 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.2 Neoplasm of uncertain or unknown behaviour: Brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.3 Neoplasm of uncertain or unknown behaviour: Cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.4 Neoplasm of uncertain or unknown behaviour: Spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.7 Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D43.9 Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44 Neoplasm of uncertain or unknown behaviour of endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.0 Neoplasm of uncertain or unknown behaviour: Thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.1 Neoplasm of uncertain or unknown behaviour: Adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.2 Neoplasm of uncertain or unknown behaviour: Parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.3 Neoplasm of uncertain or unknown behaviour: Pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.4 Neoplasm of uncertain or unknown behaviour: Craniopharyngeal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.5 Neoplasm of uncertain or unknown behaviour: Pineal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.6 Neoplasm of uncertain or unknown behaviour: Carotid body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.7 Neoplasm of uncertain or unknown behaviour: Aortic body and other paraganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.8 Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D44.9 Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 230 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D45 Polycythaemia vera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46 Myelodysplastic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.0 Refractory anaemia without ring sideroblasts, so stated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.1 Refractory anaemia with ring sideroblasts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.2 Refractory anaemia with excess of blasts [RAEB] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.4 Refractory anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.5 Refractory anaemia with multi-lineage dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.7 Other myelodysplastic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D46.9 Myelodysplastic syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.1 Chronic myeloproliferative disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.2 Monoclonal gammopathy of undetermined significance (MGUS) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.3 Essential (haemorrhagic) thrombocythaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.4 Osteomyelofibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.0 Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.1 Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.2 Neoplasm of uncertain or unknown behaviour: Peripheral nerves and autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.3 Neoplasm of uncertain or unknown behaviour: Retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.4 Neoplasm of uncertain or unknown behaviour: Peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.5 Neoplasm of uncertain or unknown behaviour: Skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.6 Neoplasm of uncertain or unknown behaviour: Breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.7 Neoplasm of uncertain or unknown behaviour: Other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D48.9 Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50 Iron deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50-D53 Nutritional anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.0 Iron deficiency anaemia secondary to blood loss (chronic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.1 Sideropenic dysphagia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.8 Other iron deficiency anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D50.9 Iron deficiency anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51 Vitamin B12deficiency anaemia © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 231 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.0 Vitamin B12deficiency anaemia due to intrinsic factor deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.1 Vitamin B12deficiency anaemia due to selective vitamin B12malabsorption with proteinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.2 Transcobalamin II deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.3 Other dietary vitamin B12deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.8 Other vitamin B12deficiency anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D51.9 Vitamin B12deficiency anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52 deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.0 Dietary folate deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.1 Drug-induced folate deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.8 Other folate deficiency anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D52.9 Folate deficiency anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53 Other nutritional anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.0 Protein deficiency anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.1 Other megaloblastic anaemias, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.2 Scorbutic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.8 Other specified nutritional anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D53.9 Nutritional anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55 Anaemia due to enzyme disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55-D59 Haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.1 Anaemia due to other disorders of glutathione metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.2 Anaemia due to disorders of glycolytic enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.3 Anaemia due to disorders of nucleotide metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.8 Other anaemias due to enzyme disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D55.9 Anaemia due to enzyme disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56 Thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.0 Alpha thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.1 Beta thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.2 Delta-beta thalassaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.3 Thalassaemia trait 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.4 Hereditary persistence of fetal haemoglobin [HPFH] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.8 Other thalassaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D56.9 Thalassaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57 Sickle-cell disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.0 Sickle-cell anaemia with crisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.1 Sickle-cell anaemia without crisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.2 Double heterozygous sickling disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.3 Sickle-cell trait 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D57.8 Other sickle-cell disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58 Other hereditary haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.0 Hereditary spherocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.1 Hereditary elliptocytosis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 232 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.2 Other haemoglobinopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.8 Other specified hereditary haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D58.9 Hereditary haemolytic anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59 Acquired haemolytic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.0 Drug-induced autoimmune haemolytic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.1 Other autoimmune haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.2 Drug-induced nonautoimmune haemolytic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.3 Haemolytic-uraemic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.4 Other nonautoimmune haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.6 Haemoglobinuria due to haemolysis from other external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.8 Other acquired haemolytic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D59.9 Acquired haemolytic anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60 Acquired pure red cell aplasia [erythroblastopenia] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60-D64 Aplastic and other anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.0 Chronic acquired pure red cell aplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.1 Transient acquired pure red cell aplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.8 Other acquired pure red cell aplasias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D60.9 Acquired pure red cell aplasia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61 Other aplastic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.0 Constitutional aplastic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.1 Drug-induced aplastic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.2 Aplastic anaemia due to other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.3 Idiopathic aplastic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.8 Other specified aplastic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D61.9 Aplastic anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D62 Acute posthaemorrhagic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D63 Anaemia in chronic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D63.0 Anaemia in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D63.8 Anaemia in other chronic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64 Other anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.0 Hereditary sideroblastic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.1 Secondary sideroblastic anaemia due to disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.2 Secondary sideroblastic anaemia due to drugs and toxins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.3 Other sideroblastic anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.4 Congenital dyserythropoietic anaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.8 Other specified anaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D64.9 Anaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D65 Disseminated intravascular coagulation [defibrination syndrome] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D65-D69 Coagulation defects, purpura and other haemorrhagic conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D66 Hereditary factor VIII deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D67 Hereditary factor IX deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68 Other coagulation defects © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 233 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.0 Von Willebrand disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.1 Hereditary factor XI deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.2 Hereditary deficiency of other clotting factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.3 Haemorrhagic disorder due to circulating 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.4 Acquired coagulation factor deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.5 Primary thrombophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.6 Other thrombophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.8 Other specified coagulation defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D68.9 Coagulation defect, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69 Purpura and other haemorrhagic conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.0 Allergic purpura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.1 Qualitative platelet defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.2 Other nonthrombocytopenic purpura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.3 Idiopathic thrombocytopenic purpura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.4 Other primary thrombocytopenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.5 Secondary thrombocytopenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.6 Thrombocytopenia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.8 Other specified haemorrhagic conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D69.9 Haemorrhagic condition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D70 Agranulocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D70-D77 Other diseases of blood and blood-forming organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D71 Functional disorders of polymorphonuclear neutrophils 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72 Other disorders of white blood cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.0 Genetic anomalies of leukocytes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.1 Eosinophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.8 Other specified disorders of white blood cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D72.9 Disorder of white blood cells, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73 Diseases of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.0 Hyposplenism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.1 Hypersplenism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.2 Chronic congestive splenomegaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.3 Abscess of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.4 Cyst of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.5 Infarction of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.8 Other diseases of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D73.9 Disease of spleen, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74 Methaemoglobinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74.0 Congenital methaemoglobinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74.8 Other methaemoglobinaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D74.9 Methaemoglobinaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75 Other diseases of blood and blood-forming organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.0 Familial erythrocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.1 Secondary polycythaemia © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 234 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.8 Other specified diseases of blood and blood-forming organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D75.9 Disease of blood and blood-forming organs, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76 Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76.1 Haemophagocytic lymphohistiocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76.2 Haemophagocytic syndrome, infection-associated 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D76.3 Other histiocytosis syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80 Immunodeficiency with predominantly antibody defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80-D89 Certain disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.0 Hereditary hypogammaglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.1 Nonfamilial hypogammaglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.2 Selective deficiency of immunoglobulin A [IgA] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.4 Selective deficiency of immunoglobulin M [IgM] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.5 Immunodeficiency with increased immunoglobulin M [IgM] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.7 Transient hypogammaglobulinaemia of infancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.8 Other immunodeficiencies with predominantly antibody defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D80.9 Immunodeficiency with predominantly antibody defects, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81 Combined immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.1 Severe combined immunodeficiency [SCID] with low T- and B- cell numbers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.3 Adenosine deaminase [ADA] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.4 Nezelof syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.5 Purine nucleoside phosphorylase [PNP] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.6 Major histocompatibility complex class I deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.7 Major histocompatibility complex class II deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.8 Other combined immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D81.9 Combined immunodeficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82 Immunodeficiency associated with other major defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.0 Wiskott-Aldrich syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.1 Di George syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.2 Immunodeficiency with short-limbed stature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.4 Hyperimmunoglobulin E [IgE] syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.8 Immunodeficiency associated with other specified major defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D82.9 Immunodeficiency associated with major defect, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 235 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83 Common variable immunodeficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.8 Other common variable immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D83.9 Common variable immunodeficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84 Other immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.0 Lymphocyte function antigen-1 [LFA-1] defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.1 Defects in the complement system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.8 Other specified immunodeficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D84.9 Immunodeficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86 Sarcoidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.0 Sarcoidosis of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.1 Sarcoidosis of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.3 Sarcoidosis of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.8 Sarcoidosis of other and combined sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D86.9 Sarcoidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89 Other disorders involving the immune mechanism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.0 Polyclonal hypergammaglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.1 Cryoglobulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.2 Hypergammaglobulinaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.3 Immune reconstitution syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 D89.9 Disorder involving the immune mechanism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00 Congenital iodine-deficiency syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00-E07 Disorders of thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.0 Congenital iodine-deficiency syndrome, neurological type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.1 Congenital iodine-deficiency syndrome, myxoedematous type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.2 Congenital iodine-deficiency syndrome, mixed type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E00.9 Congenital iodine-deficiency syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01 Iodine-deficiency-related thyroid disorders and allied conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.0 Iodine-deficiency-related diffuse (endemic) goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.1 Iodine-deficiency-related multinodular (endemic) goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.2 Iodine-deficiency-related (endemic) goitre, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E02 Subclinical iodine-deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03 Other hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.0 Congenital hypothyroidism with diffuse goitre

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 236 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.1 Congenital hypothyroidism without goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.2 Hypothyroidism due to medicaments and other exogenous substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.3 Postinfectious hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.4 Atrophy of thyroid (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.5 Myxoedema coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.8 Other specified hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E03.9 Hypothyroidism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04 Other nontoxic goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.0 Nontoxic diffuse goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.1 Nontoxic single thyroid nodule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.2 Nontoxic multinodular goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.8 Other specified nontoxic goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E04.9 Nontoxic goitre, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05 Thyrotoxicosis [hyperthyroidism] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.0 Thyrotoxicosis with diffuse goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.1 Thyrotoxicosis with toxic single thyroid nodule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.2 Thyrotoxicosis with toxic multinodular goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.3 Thyrotoxicosis from ectopic thyroid tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.4 Thyrotoxicosis factitia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.5 Thyroid crisis or storm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.8 Other thyrotoxicosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E05.9 Thyrotoxicosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06 Thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.0 Acute thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.1 Subacute thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.2 Chronic thyroiditis with transient thyrotoxicosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.3 Autoimmune thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.4 Drug-induced thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.5 Other chronic thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E06.9 Thyroiditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07 Other disorders of thyroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.0 Hypersecretion of calcitonin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.1 Dyshormogenetic goitre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.8 Other specified disorders of thyroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E07.9 Disorder of thyroid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10 Type 1 diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E10-E14 Diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E11 Type 2 diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E12 Malnutrition-related diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E13 Other specified diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E14 Unspecified diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E15 Nondiabetic hypoglycaemic coma

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 237 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E15-E16 Other disorders of glucose regulation and pancreatic internal secretion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16 Other disorders of pancreatic internal secretion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.0 Drug-induced hypoglycaemia without coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.1 Other hypoglycaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.2 Hypoglycaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.3 Increased secretion of glucagon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.4 Abnormal secretion of gastrin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.8 Other specified disorders of pancreatic internal secretion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E16.9 Disorder of pancreatic internal secretion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20 Hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20-E35 Disorders of other endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.0 Idiopathic hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.1 Pseudohypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.8 Other hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E20.9 Hypoparathyroidism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21 Hyperparathyroidism and other disorders of parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.0 Primary hyperparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.1 Secondary hyperparathyroidism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.2 Other hyperparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.3 Hyperparathyroidism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.4 Other specified disorders of parathyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E21.5 Disorder of parathyroid gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22 Hyperfunction of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.0 Acromegaly and pituitary gigantism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.1 Hyperprolactinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.2 Syndrome of inappropriate secretion of antidiuretic hormone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.8 Other hyperfunction of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E22.9 Hyperfunction of pituitary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23 Hypofunction and other disorders of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.0 Hypopituitarism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.1 Drug-induced hypopituitarism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.2 Diabetes insipidus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.3 Hypothalamic dysfunction, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.6 Other disorders of pituitary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E23.7 Disorder of pituitary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24 Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.0 Pituitary-dependent Cushing disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.1 Nelson syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.2 Drug-induced Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.3 Ectopic ACTH syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.4 Alcohol-induced pseudo-Cushing syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.8 Other Cushing syndrome

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 238 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E24.9 Cushing syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25 Adrenogenital disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25.0 Congenital adrenogenital disorders associated with enzyme deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25.8 Other adrenogenital disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E25.9 Adrenogenital disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26 Hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.0 Primary hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.1 Secondary hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.8 Other hyperaldosteronism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E26.9 Hyperaldosteronism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27 Other disorders of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.0 Other adrenocortical overactivity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.1 Primary adrenocortical insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.2 Addisonian crisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.3 Drug-induced adrenocortical insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.4 Other and unspecified adrenocortical insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.5 Adrenomedullary hyperfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.8 Other specified disorders of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E27.9 Disorder of adrenal gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28 Ovarian dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.0 Ovarian dysfunction: Estrogen excess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.1 Ovarian dysfunction: Androgen excess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.2 Polycystic ovarian syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.3 Primary ovarian failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.8 Other ovarian dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E28.9 Ovarian dysfunction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29 Testicular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.0 Testicular hyperfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.1 Testicular hypofunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.8 Other testicular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E29.9 Testicular dysfunction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30 Disorders of puberty, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.0 Delayed puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.1 Precocious puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.8 Other disorders of puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E30.9 Disorder of puberty, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31 Polyglandular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.0 Autoimmune polyglandular failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.1 Polyglandular hyperfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.8 Other polyglandular dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E31.9 Polyglandular dysfunction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32 Diseases of thymus

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 239 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.0 Persistent hyperplasia of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.1 Abscess of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.8 Other diseases of thymus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E32.9 Disease of thymus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34 Other endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.0 Carcinoid syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.1 Other hypersecretion of intestinal hormones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.2 Ectopic hormone secretion, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.3 Short stature, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.4 Constitutional tall stature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.5 Androgen resistance syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.8 Other specified endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E34.9 Endocrine disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35 Disorders of endocrine glands in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35.0 Disorders of thyroid gland in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35.1 Disorders of adrenal glands in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E35.8 Disorders of other endocrine glands in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E40 Kwashiorkor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E40-E46 Malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E41 Nutritional marasmus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E42 Marasmic kwashiorkor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E43 Unspecified severe protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E44 Protein-energy malnutrition of moderate and mild degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E44.0 Moderate protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E44.1 Mild protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E45 Retarded development following protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E46 Unspecified protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50 Vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50-E64 Other nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.0 Vitamin A deficiency with conjunctival xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.1 Vitamin A deficiency with Bitot spot and conjunctival xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.2 Vitamin A deficiency with corneal xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.3 Vitamin A deficiency with corneal ulceration and xerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.4 Vitamin A deficiency with keratomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.5 Vitamin A deficiency with night blindness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.6 Vitamin A deficiency with xerophthalmic scars of cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.7 Other ocular manifestations of vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.8 Other manifestations of vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E50.9 Vitamin A deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51 Thiamine deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.1 Beriberi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.2 Wernicke encephalopathy

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 240 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.8 Other manifestations of thiamine deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E51.9 Thiamine deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E52 deficiency [pellagra] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53 Deficiency of other B group vitamins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.0 Riboflavin deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.1 Pyridoxine deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.8 Deficiency of other specified B group vitamins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E53.9 Vitamin B deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E54 Ascorbic acid deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E55 Vitamin D deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E55.0 Rickets, active 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E55.9 Vitamin D deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56 Other vitamin deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.0 Deficiency of vitamin E 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.1 Deficiency of vitamin K 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.8 Deficiency of other vitamins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E56.9 Vitamin deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E58 Dietary calcium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E59 Dietary selenium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E60 Dietary zinc deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61 Deficiency of other nutrient elements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.0 Copper deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.1 Iron deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.2 Magnesium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.3 Manganese deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.4 Chromium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.5 Molybdenum deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.6 Vanadium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.7 Deficiency of multiple nutrient elements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.8 Deficiency of other specified nutrient elements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E61.9 Deficiency of nutrient element, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63 Other nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.0 Essential fatty acid [EFA] deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.1 Imbalance of constituents of food intake 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.8 Other specified nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E63.9 Nutritional deficiency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64 Sequelae of malnutrition and other nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.0 Sequelae of protein-energy malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.1 Sequelae of vitamin A deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.2 Sequelae of vitamin C deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.3 Sequelae of rickets 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.8 Sequelae of other nutritional deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E64.9 Sequelae of unspecified nutritional deficiency © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 241 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E65 Localized adiposity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E65-E68 Obesity and other hyperalimentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66 Obesity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.0 Obesity due to excess calories 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.1 Drug-induced obesity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.2 Extreme obesity with alveolar 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.8 Other obesity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E66.9 Obesity, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67 Other hyperalimentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.0 Hypervitaminosis A 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.1 Hypercarotenaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.2 Megavitamin-B6syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.3 Hypervitaminosis D 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E67.8 Other specified hyperalimentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E68 Sequelae of hyperalimentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70 Disorders of aromatic amino-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70-E90 Metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.0 Classical phenylketonuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.1 Other hyperphenylalaninaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.2 Disorders of tyrosine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.3 Albinism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.8 Other disorders of aromatic amino-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E70.9 Disorder of aromatic amino-acid metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71 Disorders of branched-chain amino-acid metabolism and fatty- acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.0 Maple-syrup-urine disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.1 Other disorders of branched-chain amino-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.2 Disorder of branched-chain amino-acid metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E71.3 Disorders of fatty-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72 Other disorders of amino-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.0 Disorders of amino-acid transport 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.1 Disorders of sulfur-bearing amino-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.2 Disorders of cycle metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.3 Disorders of lysine and hydroxylysine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.4 Disorders of ornithine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.5 Disorders of glycine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.8 Other specified disorders of amino-acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E72.9 Disorder of amino-acid metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73 Lactose intolerance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.0 Congenital lactase deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.1 Secondary lactase deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.8 Other lactose intolerance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E73.9 Lactose intolerance, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 242 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74 Other disorders of metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.0 Glycogen storage disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.1 Disorders of fructose metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.2 Disorders of galactose metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.3 Other disorders of intestinal carbohydrate absorption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.4 Disorders of pyruvate metabolism and gluconeogenesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.8 Other specified disorders of 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E74.9 Disorder of carbohydrate metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75 Disorders of metabolism and other lipid storage disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.0 GM2gangliosidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.1 Other gangliosidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.2 Other sphingolipidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.3 Sphingolipidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.4 Neuronal ceroid lipofuscinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.5 Other lipid storage disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E75.6 Lipid storage disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76 Disorders of glycosaminoglycan metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.0 Mucopolysaccharidosis, type I 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.1 Mucopolysaccharidosis, type II 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.2 Other mucopolysaccharidoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.3 Mucopolysaccharidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.8 Other disorders of glucosaminoglycan metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E76.9 Disorder of glucosaminoglycan metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77 Disorders of glycoprotein metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.0 Defects in post-translational modification of lysosomal enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.1 Defects in glycoprotein degradation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.8 Other disorders of glycoprotein metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E77.9 Disorder of glycoprotein metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78 Disorders of lipoprotein metabolism and other lipidaemias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.0 Pure hypercholesterolaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.1 Pure hyperglyceridaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.2 Mixed hyperlipidaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.3 Hyperchylomicronaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.4 Other hyperlipidaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.5 Hyperlipidaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.6 Lipoprotein deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.8 Other disorders of lipoprotein metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E78.9 Disorder of lipoprotein metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79 Disorders of purine and pyrimidine metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.1 Lesch-Nyhan syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.8 Other disorders of purine and pyrimidine metabolism © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 243 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E79.9 Disorder of purine and pyrimidine metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80 Disorders of porphyrin and bilirubin metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.0 Hereditary erythropoietic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.1 Porphyria cutanea tarda 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.2 Other porphyria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.3 Defects of catalase and peroxidase 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.4 Gilbert syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.5 Crigler-Najjar syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.6 Other disorders of bilirubin metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E80.7 Disorder of bilirubin metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83 Disorders of mineral metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.0 Disorders of copper metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.1 Disorders of iron metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.2 Disorders of zinc metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.3 Disorders of phosphorus metabolism and phosphatases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.4 Disorders of magnesium metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.5 Disorders of 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.8 Other disorders of mineral metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E83.9 Disorder of mineral metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84 Cystic fibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.0 Cystic fibrosis with pulmonary manifestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.1 Cystic fibrosis with intestinal manifestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.8 Cystic fibrosis with other manifestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E84.9 Cystic fibrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85 Amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.0 Non-neuropathic heredofamilial amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.1 Neuropathic heredofamilial amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.2 Heredofamilial amyloidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.3 Secondary systemic amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.4 Organ-limited amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.8 Other amyloidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E85.9 Amyloidosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E86 Volume depletion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87 Other disorders of fluid, electrolyte and acid-base balance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.0 Hyperosmolality and hypernatraemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.1 Hypo-osmolality and hyponatraemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.2 Acidosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.3 Alkalosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.4 Mixed disorder of acid-base balance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.5 Hyperkalaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.6 Hypokalaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.7 Fluid overload

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 244 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88 Other metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.0 Disorders of plasma-protein metabolism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.1 Lipodystrophy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.2 Lipomatosis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.3 Tumour lysis syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.8 Other specified metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E88.9 Metabolic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.0 Postprocedural hypothyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.1 Postprocedural hypoinsulinaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.2 Postprocedural hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.3 Postprocedural hypopituitarism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.4 Postprocedural ovarian failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.5 Postprocedural testicular hypofunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.6 Postprocedural adrenocortical(-medullary) hypofunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.8 Other postprocedural endocrine and metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E89.9 Postprocedural endocrine and metabolic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 E90 Nutritional and metabolic disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00 Dementia in Alzheimer diseaseG30.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00-F09 Organic, including symptomatic, mental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.0 Dementia in Alzheimer disease with early onsetG30.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.1 Dementia in Alzheimer disease with late onsetG30.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.2 Dementia in Alzheimer disease, atypical or mixed typeG30.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F00.9 Dementia in Alzheimer disease, unspecifiedG30.9 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01 Vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.0 Vascular dementia of acute onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.1 Multi-infarct dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.2 Subcortical vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.3 Mixed cortical and subcortical vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.8 Other vascular dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F01.9 Vascular dementia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02 Dementia in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.0 Dementia in Pick diseaseG31.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.1 Dementia in Creutzfeldt-Jakob diseaseA81.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.2 Dementia in Huntington diseaseG10 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.3 Dementia in Parkinson diseaseG20 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.4 Dementia in human immunodeficiency virus [HIV] diseaseB22.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F02.8 Dementia in other specified diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F03 Unspecified dementia

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 245 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05 Delirium, not induced by alcohol and other psychoactive substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.0 Delirium not superimposed on dementia, so described 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.1 Delirium superimposed on dementia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.8 Other delirium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F05.9 Delirium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06 Other mental disorders due to brain damage and dysfunction and to physical disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.0 Organic hallucinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.1 Organic catatonic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.2 Organic delusional [schizophrenia-like] disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.3 Organic mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.4 Organic anxiety disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.5 Organic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.6 Organic emotionally labile [asthenic] disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.7 Mild cognitive disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07 Personality and behavioural disorders due to brain disease, damage and dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.0 Organic personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.1 Postencephalitic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.2 Postconcussional syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F09 Unspecified organic or symptomatic mental disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10 Mental and behavioural disorders due to use of alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F10-F19 Mental and behavioural disorders due to psychoactive substance use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F11 Mental and behavioural disorders due to use of opioids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F12 Mental and behavioural disorders due to use of cannabinoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F13 Mental and behavioural disorders due to use of sedatives or hypnotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F14 Mental and behavioural disorders due to use of cocaine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F15 Mental and behavioural disorders due to use of other stimulants, including caffeine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F16 Mental and behavioural disorders due to use of hallucinogens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F17 Mental and behavioural disorders due to use of 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F18 Mental and behavioural disorders due to use of volatile solvents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 246 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20 Schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20-F29 Schizophrenia, schizotypal and delusional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.0 Paranoid schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.1 Hebephrenic schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.2 Catatonic schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.3 Undifferentiated schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.4 Post-schizophrenic depression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.5 Residual schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.6 Simple schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.8 Other schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F20.9 Schizophrenia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F21 Schizotypal disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22 Persistent delusional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22.0 Delusional disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22.8 Other persistent delusional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F22.9 Persistent delusional disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23 Acute and transient psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.2 Acute schizophrenia-like psychotic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.3 Other acute predominantly delusional psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.8 Other acute and transient psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F23.9 Acute and transient psychotic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F24 Induced delusional disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25 Schizoaffective disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.0 Schizoaffective disorder, manic type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.1 Schizoaffective disorder, depressive type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.2 Schizoaffective disorder, mixed type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.8 Other schizoaffective disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F25.9 Schizoaffective disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F28 Other nonorganic psychotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F29 Unspecified nonorganic psychosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30 Manic episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30-F39 Mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.0 Hypomania 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.1 Mania without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.2 Mania with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.8 Other manic episodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F30.9 Manic episode, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31 Bipolar affective disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.0 Bipolar affective disorder, current episode hypomanic

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 247 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.3 Bipolar affective disorder, current episode mild or moderate depression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.6 Bipolar affective disorder, current episode mixed 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.7 Bipolar affective disorder, currently in remission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.8 Other bipolar affective disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F31.9 Bipolar affective disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32 Depressive episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.0 Mild depressive episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.1 Moderate depressive episode 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.2 Severe depressive episode without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.3 Severe depressive episode with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.8 Other depressive episodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F32.9 Depressive episode, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33 Recurrent depressive disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.0 Recurrent depressive disorder, current episode mild 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.1 Recurrent depressive disorder, current episode moderate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.4 Recurrent depressive disorder, currently in remission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.8 Other recurrent depressive disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F33.9 Recurrent depressive disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34 Persistent mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.0 Cyclothymia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.1 Dysthymia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.8 Other persistent mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F34.9 Persistent mood [affective] disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38 Other mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38.0 Other single mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38.1 Other recurrent mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F38.8 Other specified mood [affective] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F39 Unspecified mood [affective] disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40 Phobic anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40-F48 Neurotic, stress-related and somatoform disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.0 Agoraphobia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.1 Social phobias

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 248 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.2 Specific (isolated) phobias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.8 Other phobic anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F40.9 Phobic anxiety disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41 Other anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.0 Panic disorder [episodic paroxysmal anxiety] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.1 Generalized anxiety disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.2 Mixed anxiety and depressive disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.3 Other mixed anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.8 Other specified anxiety disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F41.9 Anxiety disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42 Obsessive-compulsive disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.0 Predominantly obsessional thoughts or ruminations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.1 Predominantly compulsive acts [obsessional rituals] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.2 Mixed obsessional thoughts and acts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.8 Other obsessive-compulsive disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F42.9 Obsessive-compulsive disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43 Reaction to severe stress, and adjustment disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.0 Acute stress reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.1 Post-traumatic stress disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.2 Adjustment disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.8 Other reactions to severe stress 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F43.9 Reaction to severe stress, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44 Dissociative [conversion] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.0 Dissociative amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.1 Dissociative fugue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.2 Dissociative stupor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.3 Trance and possession disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.4 Dissociative motor disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.5 Dissociative convulsions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.6 Dissociative anaesthesia and sensory loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.7 Mixed dissociative [conversion] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.8 Other dissociative [conversion] disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F44.9 Dissociative [conversion] disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45 Somatoform disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.0 Somatization disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.1 Undifferentiated somatoform disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.2 Hypochondriacal disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.3 Somatoform autonomic dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.4 Persistent somatoform pain disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.8 Other somatoform disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F45.9 Somatoform disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48 Other neurotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.0 Neurasthenia © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 249 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.1 Depersonalization-derealization syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.8 Other specified neurotic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F48.9 Neurotic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50 Eating disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.0 Anorexia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.1 Atypical anorexia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.2 Bulimia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.3 Atypical bulimia nervosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.4 Overeating associated with other psychological disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.5 Vomiting associated with other psychological disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.8 Other eating disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F50.9 Eating disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51 Nonorganic sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.0 Nonorganic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.1 Nonorganic hypersomnia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.2 Nonorganic disorder of the sleep-wake schedule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.3 Sleepwalking [somnambulism] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.4 Sleep terrors [night terrors] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.5 Nightmares 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.8 Other nonorganic sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F51.9 Nonorganic sleep disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52 Sexual dysfunction, not caused by organic disorder or disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.0 Lack or loss of sexual desire 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.1 Sexual aversion and lack of sexual enjoyment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.2 Failure of genital response 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.3 Orgasmic dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.5 Nonorganic vaginismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.6 Nonorganic dyspareunia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.7 Excessive sexual drive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.8 Other sexual dysfunction, not caused by organic disorder or disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.1 Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.8 Other mental and behavioural disorders associated with the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F53.9 Puerperal mental disorder, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 250 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F55 Abuse of non-dependence-producing substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60 Specific personality disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60-F69 Disorders of adult personality and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.0 Paranoid personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.1 Schizoid personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.2 Dissocial personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.3 Emotionally unstable personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.4 Histrionic personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.5 Anankastic personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.6 Anxious [avoidant] personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.7 Dependent personality disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.8 Other specific personality disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F60.9 Personality disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F61 Mixed and other personality disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62 Enduring personality changes, not attributable to brain damage and disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.0 Enduring personality change after catastrophic experience 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.1 Enduring personality change after psychiatric illness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.8 Other enduring personality changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F62.9 Enduring personality change, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63 Habit and impulse disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.0 Pathological gambling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.1 Pathological fire-setting [pyromania] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.2 Pathological stealing [kleptomania] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.3 Trichotillomania 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.8 Other habit and impulse disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F63.9 Habit and impulse disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64 Gender identity disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.0 Transsexualism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.1 Dual-role transvestism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.2 Gender identity disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.8 Other gender identity disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F64.9 Gender identity disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65 Disorders of sexual preference 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.0 Fetishism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.1 Fetishistic transvestism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.2 Exhibitionism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.3 Voyeurism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.4 Paedophilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.5 Sadomasochism

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 251 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.6 Multiple disorders of sexual preference 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.8 Other disorders of sexual preference 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F65.9 Disorder of sexual preference, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66 Psychological and behavioural disorders associated with sexual development and orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.0 Sexual maturation disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.1 Egodystonic sexual orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.2 Sexual relationship disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.8 Other psychosexual development disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F66.9 Psychosexual development disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68 Other disorders of adult personality and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68.0 Elaboration of physical symptoms for psychological reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F68.8 Other specified disorders of adult personality and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F69 Unspecified disorder of adult personality and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70 Mild mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F70-F79 Mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F71 Moderate mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F72 Severe mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F73 Profound mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F78 Other mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F79 Unspecified mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80 Specific developmental disorders of speech and language 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80-F89 Disorders of psychological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.0 Specific speech articulation disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.1 Expressive language disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.2 Receptive language disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.3 Acquired aphasia with epilepsy [Landau-Kleffner] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.8 Other developmental disorders of speech and language 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F80.9 Developmental disorder of speech and language, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81 Specific developmental disorders of scholastic skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.0 Specific reading disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.1 Specific spelling disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.2 Specific disorder of arithmetical skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.3 Mixed disorder of scholastic skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.8 Other developmental disorders of scholastic skills 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F81.9 Developmental disorder of scholastic skills, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F82 Specific developmental disorder of motor function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F83 Mixed specific developmental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84 Pervasive developmental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.0 Childhood autism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.1 Atypical autism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.2 Rett syndrome © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 252 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.3 Other childhood disintegrative disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.4 Overactive disorder associated with mental retardation and stereotyped movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.5 Asperger syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.8 Other pervasive developmental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F84.9 Pervasive developmental disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F88 Other disorders of psychological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F89 Unspecified disorder of psychological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90 Hyperkinetic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.0 Disturbance of activity and attention 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.1 Hyperkinetic conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.8 Other hyperkinetic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F90.9 Hyperkinetic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91 Conduct disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.0 Conduct disorder confined to the family context 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.1 Unsocialized conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.2 Socialized conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.3 Oppositional defiant disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.8 Other conduct disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F91.9 Conduct disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92 Mixed disorders of conduct and emotions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92.0 Depressive conduct disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92.8 Other mixed disorders of conduct and emotions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F92.9 Mixed disorder of conduct and emotions, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93 Emotional disorders with onset specific to childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.0 Separation anxiety disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.1 Phobic anxiety disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.2 Social anxiety disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.3 Sibling rivalry disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.8 Other childhood emotional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F93.9 Childhood emotional disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94 Disorders of social functioning with onset specific to childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.0 Elective mutism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.1 Reactive attachment disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.2 Disinhibited attachment disorder of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.8 Other childhood disorders of social functioning 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F94.9 Childhood disorder of social functioning, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95 Tic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.0 Transient tic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.1 Chronic motor or vocal tic disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.2 Combined vocal and multiple motor tic disorder [de la Tourette]

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 253 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.8 Other tic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F95.9 Tic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.0 Nonorganic enuresis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.1 Nonorganic encopresis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.2 Feeding disorder of infancy and childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.3 Pica of infancy and childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.4 Stereotyped movement disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.5 Stuttering [stammering] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.6 Cluttering 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.8 Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F98.9 Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F99 Mental disorder, not otherwise specified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 F99-F99 Unspecified mental disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00 Bacterial meningitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00-G09 Inflammatory diseases of the central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.0 Haemophilus meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.1 Pneumococcal meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.2 Streptococcal meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.3 Staphylococcal meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.8 Other bacterial meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G00.9 Bacterial meningitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G01 Meningitis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02 Meningitis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02.0 Meningitis in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02.1 Meningitis in mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03 Meningitis due to other and unspecified causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.0 Nonpyogenic meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.1 Chronic meningitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.2 Benign recurrent meningitis [Mollaret] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.8 Meningitis due to other specified causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G03.9 Meningitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04 Encephalitis, myelitis and encephalomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.0 Acute disseminated encephalitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.1 Tropical spastic paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.8 Other encephalitis, myelitis and encephalomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 254 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06 Intracranial and intraspinal abscess and granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06.0 Intracranial abscess and granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06.1 Intraspinal abscess and granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G06.2 Extradural and subdural abscess, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G08 Intracranial and intraspinal phlebitis and thrombophlebitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G09 Sequelae of inflammatory diseases of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G10 Huntington disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G10-G14 Systemic atrophies primarily affecting the central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11 Hereditary ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.0 Congenital nonprogressive ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.1 Early-onset cerebellar ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.2 Late-onset cerebellar ataxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.3 Cerebellar ataxia with defective DNA repair 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.4 Hereditary spastic paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.8 Other hereditary ataxias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G11.9 Hereditary ataxia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12 Spinal muscular atrophy and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.1 Other inherited spinal muscular atrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.2 Motor neuron disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.8 Other spinal muscular atrophies and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G12.9 Spinal muscular atrophy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.0 Paraneoplastic neuromyopathy and neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.2 Systemic atrophy primarily affecting central nervous system in myxoedemaE00.1E03.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G14 Postpolio syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G20 Parkinson disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G20-G26 Extrapyramidal and movement disorders © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 255 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21 Secondary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.0 Malignant neuroleptic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.1 Other drug-induced secondary parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.2 Secondary parkinsonism due to other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.3 Postencephalitic parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.4 Vascular parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.8 Other secondary parkinsonism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G21.9 Secondary parkinsonism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G22 Parkinsonism in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23 Other degenerative diseases of basal ganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.0 Hallervorden-Spatz disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson- Olszewski] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.2 Multiple system atrophy, parkinsonian type [MSA-P] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.3 Multiple system atrophy, cerebellar type [MSA-C] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.8 Other specified degenerative diseases of basal ganglia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G23.9 Degenerative disease of basal ganglia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24 Dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.0 Drug-induced dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.1 Idiopathic familial dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.2 Idiopathic nonfamilial dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.3 Spasmodic torticollis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.4 Idiopathic orofacial dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.5 Blepharospasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.8 Other dystonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G24.9 Dystonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25 Other extrapyramidal and movement disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.0 Essential tremor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.1 Drug-induced tremor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.2 Other specified forms of tremor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.3 Myoclonus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.4 Drug-induced chorea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.5 Other chorea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.6 Drug-induced tics and other tics of organic origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.8 Other specified extrapyramidal and movement disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G25.9 Extrapyramidal and movement disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G26 Extrapyramidal and movement disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30 Alzheimer disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30-G32 Other degenerative diseases of the nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.0 Alzheimer disease with early onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.1 Alzheimer disease with late onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.8 Other Alzheimer disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G30.9 Alzheimer disease, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 256 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31 Other degenerative diseases of nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.0 Circumscribed brain atrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.1 Senile degeneration of brain, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.2 Degeneration of nervous system due to alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.8 Other specified degenerative diseases of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G31.9 Degenerative disease of nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G32 Other degenerative disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G35 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G35-G37 Demyelinating diseases of the central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36 Other acute disseminated demyelination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.0 Neuromyelitis optica [Devic] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.8 Other specified acute disseminated demyelination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G36.9 Acute disseminated demyelination, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37 Other demyelinating diseases of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.0 Diffuse sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.1 Central demyelination of corpus callosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.2 Central pontine myelinolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.3 Acute transverse myelitis in demyelinating disease of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.4 Subacute necrotizing myelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.5 Concentric sclerosis [Baló] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.8 Other specified demyelinating diseases of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G37.9 Demyelinating disease of central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40 Epilepsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40-G47 Episodic and paroxysmal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.0 Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with of localized onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.1 Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.2 Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.3 Generalized idiopathic epilepsy and epileptic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.4 Other generalized epilepsy and epileptic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.5 Special epileptic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.6 Grand mal seizures, unspecified (with or without petit mal) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.7 Petit mal, unspecified, without grand mal seizures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.8 Other epilepsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G40.9 Epilepsy, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 257 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41 Status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.0 Grand mal status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.1 Petit mal status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.2 Complex partial status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.8 Other status epilepticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G41.9 Status epilepticus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.0 Migraine without aura [common migraine] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.1 Migraine with aura [classical migraine] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.2 Status migrainosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.3 Complicated migraine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.8 Other migraine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G43.9 Migraine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44 Other headache syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.0 Cluster headache syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.1 Vascular headache, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.2 Tension-type headache 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.3 Chronic post-traumatic headache 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.4 Drug-induced headache, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G44.8 Other specified headache syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45 Transient cerebral ischaemic attacks and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.0 Vertebro-basilar artery syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.1 Carotid artery syndrome (hemispheric) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.2 Multiple and bilateral precerebral artery syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.3 Amaurosis fugax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.4 Transient global amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.8 Other transient cerebral ischaemic attacks and related syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G45.9 Transient cerebral ischaemic attack, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46 Vascular syndromes of brain in cerebrovascular diseasesI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.0 Middle cerebral artery syndromeI66.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.1 Anterior cerebral artery syndromeI66.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.2 Posterior cerebral artery syndromeI66.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.3 Brain stem syndromeI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.4 Cerebellar stroke syndromeI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.5 Pure motor lacunar syndromeI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.6 Pure sensory lacunar syndromeI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.7 Other lacunar syndromesI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G46.8 Other vascular syndromes of brain in cerebrovascular diseasesI60-I67 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47 Sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.0 Disorders of initiating and maintaining sleep [insomnias] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.1 Disorders of excessive somnolence [hypersomnias] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.2 Disorders of the sleep-wake schedule © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 258 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.3 Sleep apnoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.4 Narcolepsy and cataplexy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.8 Other sleep disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G47.9 Sleep disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50 Disorders of trigeminal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50-G59 Nerve, nerve root and plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.0 Trigeminal neuralgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.1 Atypical facial pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.8 Other disorders of trigeminal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G50.9 Disorder of trigeminal nerve, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51 Facial nerve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.0 Bell palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.1 Geniculate ganglionitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.2 Melkersson syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.3 Clonic hemifacial spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.4 Facial myokymia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.8 Other disorders of facial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G51.9 Disorder of facial nerve, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52 Disorders of other cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.0 Disorders of olfactory nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.1 Disorders of glossopharyngeal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.2 Disorders of vagus nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.3 Disorders of hypoglossal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.7 Disorders of multiple cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.8 Disorders of other specified cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G52.9 Cranial nerve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53 Cranial nerve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.0 Postzoster neuralgiaB02.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.1 Multiple cranial nerve palsies in infectious and parasitic diseases classified elsewhereA00-B99 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.2 Multiple cranial nerve palsies in sarcoidosisD86.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.3 Multiple cranial nerve palsies in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G53.8 Other cranial nerve disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54 Nerve root and plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.0 Brachial plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.1 Lumbosacral plexus disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.2 Cervical root disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.3 Thoracic root disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.4 Lumbosacral root disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.5 Neuralgic amyotrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.6 Phantom limb syndrome with pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.7 Phantom limb syndrome without pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.8 Other nerve root and plexus disorders © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 259 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G54.9 Nerve root and plexus disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55 Nerve root and plexus compressions in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.0 Nerve root and plexus compressions in neoplastic diseaseC00- D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.1 Nerve root and plexus compressions in intervertebral disc disordersM50-M51 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.2 Nerve root and plexus compressions in spondylosisM47.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.3 Nerve root and plexus compressions in other dorsopathiesM45- M46M48.-M53-M54 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G55.8 Nerve root and plexus compressions in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56 Mononeuropathies of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.0 Carpal tunnel syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.1 Other lesions of median nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.2 Lesion of ulnar nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.3 Lesion of radial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.4 Causalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.8 Other mononeuropathies of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G56.9 Mononeuropathy of upper limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57 Mononeuropathies of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.0 Lesion of sciatic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.1 Meralgia paraesthetica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.2 Lesion of femoral nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.3 Lesion of lateral popliteal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.4 Lesion of medial popliteal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.5 Tarsal tunnel syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.6 Lesion of plantar nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.8 Other mononeuropathies of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G57.9 Mononeuropathy of lower limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58 Other mononeuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.0 Intercostal neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.7 Mononeuritis multiplex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.8 Other specified mononeuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G58.9 Mononeuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G59 Mononeuropathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G59.0 Diabetic mononeuropathyE10-E14 with common fourth character .4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G59.8 Other mononeuropathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60 Hereditary and idiopathic neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60-G64 Polyneuropathies and other disorders of the peripheral nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.0 Hereditary motor and sensory neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.1 Refsum disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.2 Neuropathy in association with hereditary ataxia

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 260 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.3 Idiopathic progressive neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.8 Other hereditary and idiopathic neuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G60.9 Hereditary and idiopathic neuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61 Inflammatory polyneuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.0 Guillain-Barré syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.1 Serum neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.8 Other inflammatory polyneuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G61.9 Inflammatory polyneuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62 Other polyneuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.0 Drug-induced polyneuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.1 Alcoholic polyneuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.2 Polyneuropathy due to other toxic agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.8 Other specified polyneuropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G62.9 Polyneuropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63 Polyneuropathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.1 Polyneuropathy in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.2 Diabetic polyneuropathyE10-E14 with common fourth character .4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.3 Polyneuropathy in other endocrine and metabolic diseasesE00- E07E15-E16E20-E34E70-E89 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.4 Polyneuropathy in nutritional deficiencyE40-E64 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.5 Polyneuropathy in systemic connective tissue disordersM30-M35 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.6 Polyneuropathy in other musculoskeletal disordersM00- M25M40-M96 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G63.8 Polyneuropathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G64 Other disorders of peripheral nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70 Myasthenia gravis and other myoneural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70-G73 Diseases of myoneural junction and muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.0 Myasthenia gravis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.1 Toxic myoneural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.2 Congenital and developmental myasthenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.8 Other specified myoneural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G70.9 Myoneural disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71 Primary disorders of muscles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.0 Muscular dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.1 Myotonic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.2 Congenital myopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.3 Mitochondrial myopathy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.8 Other primary disorders of muscles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G71.9 Primary disorder of muscle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72 Other myopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.0 Drug-induced myopathy

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 261 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.1 Alcoholic myopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.2 Myopathy due to other toxic agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.3 Periodic paralysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.4 Inflammatory myopathy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.8 Other specified myopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G72.9 Myopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73 Disorders of myoneural junction and muscle in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.0 Myasthenic syndromes in endocrine diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.1 Lambert-Eaton syndromeC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.2 Other myasthenic syndromes in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.3 Myasthenic syndromes in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.4 Myopathy in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.5 Myopathy in endocrine diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.6 Myopathy in metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G73.7 Myopathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80 Cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80-G83 Cerebral palsy and other paralytic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.0 Spastic quadriplegic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.1 Spastic diplegic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.2 Spastic hemiplegic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.3 Dyskinetic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.4 Ataxic cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.8 Other cerebral palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G80.9 Cerebral palsy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81 Hemiplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81.0 Flaccid hemiplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81.1 Spastic hemiplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G81.9 Hemiplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82 Paraplegia and tetraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.0 Flaccid paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.1 Spastic paraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.2 Paraplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.3 Flaccid tetraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.4 Spastic tetraplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G82.5 Tetraplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83 Other paralytic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.0 Diplegia of upper limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.1 Monoplegia of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.2 Monoplegia of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.3 Monoplegia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.4 Cauda equina syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.5 Locked-in syndrome © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 262 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.8 Other specified paralytic syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G83.9 Paralytic syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90 Disorders of autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90-G99 Other disorders of the nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.0 Idiopathic peripheral autonomic neuropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.1 Familial dysautonomia [Riley-Day] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.2 Horner syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.4 Autonomic dysreflexia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.8 Other disorders of autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G90.9 Disorder of autonomic nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91 Hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.0 Communicating hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.1 Obstructive hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.2 Normal-pressure hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.3 Post-traumatic hydrocephalus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.8 Other hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G91.9 Hydrocephalus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G92 Toxic encephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93 Other disorders of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.0 Cerebral cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.1 Anoxic brain damage, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.2 Benign intracranial hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.3 Postviral fatigue syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.4 Encephalopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.5 Compression of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.6 Cerebral oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.7 Reye syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.8 Other specified disorders of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G93.9 Disorder of brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94 Other disorders of brain in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhereA00-B99 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.1 Hydrocephalus in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.2 Hydrocephalus in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G94.8 Other specified disorders of brain in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95 Other diseases of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.0 Syringomyelia and syringobulbia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.1 Vascular myelopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.2 Cord compression, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.8 Other specified diseases of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G95.9 Disease of spinal cord, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96 Other disorders of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.0 Cerebrospinal fluid leak © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 263 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.1 Disorders of meninges, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.8 Other specified disorders of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G96.9 Disorder of central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97 Postprocedural disorders of nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.0 Cerebrospinal fluid leak from spinal puncture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.1 Other reaction to spinal and lumbar puncture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.2 Intracranial hypotension following ventricular shunting 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.8 Other postprocedural disorders of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G97.9 Postprocedural disorder of nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G98 Other disorders of nervous system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99 Other disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.0 Autonomic neuropathy in endocrine and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.2 Myelopathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 G99.8 Other specified disorders of nervous system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H00 Hordeolum and chalazion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H00-H06 Disorders of eyelid, lacrimal system and orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H00.0 Hordeolum and other deep inflammation of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H00.1 Chalazion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01 Other inflammation of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.0 Blepharitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.1 Noninfectious dermatoses of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.8 Other specified inflammation of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H01.9 Inflammation of eyelid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02 Other disorders of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.0 Entropion and trichiasis of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.1 Ectropion of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.2 Lagophthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.3 Blepharochalasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.4 Ptosis of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.5 Other disorders affecting eyelid function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.6 Xanthelasma of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.7 Other degenerative disorders of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.8 Other specified disorders of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H02.9 Disorder of eyelid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03 Disorders of eyelid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03.0 Parasitic infestation of eyelid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03.1 Involvement of eyelid in other infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H03.8 Involvement of eyelid in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04 Disorders of lacrimal system © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 264 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.0 Dacryoadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.1 Other disorders of lacrimal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.2 Epiphora 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.3 Acute and unspecified inflammation of lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.4 Chronic inflammation of lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.5 Stenosis and insufficiency of lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.6 Other changes in lacrimal passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.8 Other disorders of lacrimal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H04.9 Disorder of lacrimal system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05 Disorders of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.0 Acute inflammation of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.1 Chronic inflammatory disorders of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.2 Exophthalmic conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.3 Deformity of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.4 Enophthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.5 Retained (old) foreign body following penetrating wound of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.8 Other disorders of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H05.9 Disorder of orbit, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06 Disorders of lacrimal system and orbit in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.0 Disorders of lacrimal system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.1 Parasitic infestation of orbit in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.2 Dysthyroid exophthalmosE05.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H06.3 Other disorders of orbit in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10 Conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10-H13 Disorders of conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.0 Mucopurulent conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.1 Acute atopic conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.2 Other acute conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.3 Acute conjunctivitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.4 Chronic conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.5 Blepharoconjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.8 Other conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H10.9 Conjunctivitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11 Other disorders of conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.0 Pterygium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.1 Conjunctival degenerations and deposits 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.2 Conjunctival scars 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.3 Conjunctival haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.4 Other conjunctival vascular disorders and cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.8 Other specified disorders of conjunctiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H11.9 Disorder of conjunctiva, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13 Disorders of conjunctiva in diseases classified elsewhere

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 265 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.0 Filarial infection of conjunctivaB74.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.2 Conjunctivitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.3 Ocular pemphigoidL12.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H13.8 Other disorders of conjunctiva in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15 Disorders of sclera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15-H22 Disorders of sclera, cornea, iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.0 Scleritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.1 Episcleritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.8 Other disorders of sclera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H15.9 Disorder of sclera, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16 Keratitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.0 Corneal ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.1 Other superficial keratitis without conjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.2 Keratoconjunctivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.3 Interstitial and deep keratitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.4 Corneal neovascularization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.8 Other keratitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H16.9 Keratitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17 Corneal scars and opacities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.0 Adherent leukoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.1 Other central corneal opacity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.8 Other corneal scars and opacities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H17.9 Corneal scar and opacity, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18 Other disorders of cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.0 Corneal pigmentations and deposits 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.1 Bullous keratopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.2 Other corneal oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.3 Changes in corneal membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.4 Corneal degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.5 Hereditary corneal dystrophies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.6 Keratoconus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.7 Other corneal deformities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.8 Other specified disorders of cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H18.9 Disorder of cornea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19 Disorders of sclera and cornea in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.0 Scleritis and episcleritis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.1 Herpesviral keratitis and keratoconjunctivitisB00.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 266 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H19.8 Other disorders of sclera and cornea in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20 Iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.0 Acute and subacute iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.1 Chronic iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.2 Lens-induced iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.8 Other iridocyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H20.9 Iridocyclitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21 Other disorders of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.0 Hyphaema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.1 Other vascular disorders of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.2 Degeneration of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.3 Cyst of iris, ciliary body and anterior chamber 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.4 Pupillary membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.5 Other adhesions and disruptions of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.8 Other specified disorders of iris and ciliary body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H21.9 Disorder of iris and ciliary body, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22 Disorders of iris and ciliary body in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22.1 Iridocyclitis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25 Senile cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25-H28 Disorders of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.0 Senile incipient cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.1 Senile nuclear cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.2 Senile cataract, morgagnian type 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.8 Other senile cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H25.9 Senile cataract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26 Other cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.0 Infantile, juvenile and presenile cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.1 Traumatic cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.2 Complicated cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.3 Drug-induced cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.4 After-cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.8 Other specified cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H26.9 Cataract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27 Other disorders of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.0 Aphakia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.1 Dislocation of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.8 Other specified disorders of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H27.9 Disorder of lens, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 267 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28 Cataract and other disorders of lens in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.0 Diabetic cataractE10-E14 with common fourth character .3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.1 Cataract in other endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.2 Cataract in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H28.8 Other disorders of lens in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30 Chorioretinal inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30-H36 Disorders of choroid and retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.0 Focal chorioretinal inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.1 Disseminated chorioretinal inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.2 Posterior cyclitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.8 Other chorioretinal inflammations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H30.9 Chorioretinal inflammation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31 Other disorders of choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.0 Chorioretinal scars 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.1 Choroidal degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.2 Hereditary choroidal dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.3 Choroidal haemorrhage and rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.4 Choroidal detachment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.8 Other specified disorders of choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H31.9 Disorder of choroid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H32 Chorioretinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H32.8 Other chorioretinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33 Retinal detachments and breaks 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.0 Retinal detachment with retinal break 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.1 Retinoschisis and retinal cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.2 Serous retinal detachment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.3 Retinal breaks without detachment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.4 Traction detachment of retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H33.5 Other retinal detachments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34 Retinal vascular occlusions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.0 Transient retinal artery occlusion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.1 Central retinal artery occlusion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.2 Other retinal artery occlusions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.8 Other retinal vascular occlusions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H34.9 Retinal vascular occlusion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35 Other retinal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.0 Background retinopathy and retinal vascular changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.1 Retinopathy of prematurity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.2 Other proliferative retinopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.3 Degeneration of macula and posterior pole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.4 Peripheral retinal degeneration © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 268 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.5 Hereditary retinal dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.6 Retinal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.7 Separation of retinal layers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.8 Other specified retinal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H35.9 Retinal disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H36 Retinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H36.0 Diabetic retinopathyE10-E14 with common fourth character .3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H36.8 Other retinal disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40 Glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40-H42 Glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.0 Glaucoma suspect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.1 Primary open-angle glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.2 Primary angle-closure glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.3 Glaucoma secondary to eye trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.4 Glaucoma secondary to eye inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.5 Glaucoma secondary to other eye disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.6 Glaucoma secondary to drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.8 Other glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H40.9 Glaucoma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H42 Glaucoma in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H42.0 Glaucoma in endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H42.8 Glaucoma in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43 Disorders of vitreous body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43-H45 Disorders of vitreous body and globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.0 Vitreous prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.1 Vitreous haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.2 Crystalline deposits in vitreous body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.3 Other vitreous opacities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.8 Other disorders of vitreous body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H43.9 Disorder of vitreous body, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44 Disorders of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.0 Purulent endophthalmitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.1 Other endophthalmitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.2 Degenerative myopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.3 Other degenerative disorders of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.4 Hypotony of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.5 Degenerated conditions of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.6 Retained (old) intraocular foreign body, magnetic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.7 Retained (old) intraocular foreign body, nonmagnetic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.8 Other disorders of globe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H44.9 Disorder of globe, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45 Disorders of vitreous body and globe in diseases classified elsewhere

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 269 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45.0 Vitreous haemorrhage in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45.1 Endophthalmitis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H46 Optic neuritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H46-H48 Disorders of optic nerve and visual pathways 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47 Other disorders of optic [2nd] nerve and visual pathways 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.0 Disorders of optic nerve, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.1 Papilloedema, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.2 Optic atrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.3 Other disorders of optic disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.4 Disorders of optic chiasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.5 Disorders of other visual pathways 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.6 Disorders of visual cortex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H47.7 Disorder of visual pathways, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48.0 Optic atrophy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48.1 Retrobulbar neuritis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49 Paralytic strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.0 Third [oculomotor] nerve palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.1 Fourth [trochlear] nerve palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.2 Sixth [abducent] nerve palsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.3 Total (external) ophthalmoplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.4 Progressive external ophthalmoplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.8 Other paralytic strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H49.9 Paralytic strabismus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50 Other strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.0 Convergent concomitant strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.1 Divergent concomitant strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.2 Vertical strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.3 Intermittent heterotropia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.4 Other and unspecified heterotropia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.5 Heterophoria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.6 Mechanical strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.8 Other specified strabismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H50.9 Strabismus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51 Other disorders of binocular movement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.0 Palsy of conjugate gaze 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.1 Convergence insufficiency and excess

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 270 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.2 Internuclear ophthalmoplegia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.8 Other specified disorders of binocular movement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H51.9 Disorder of binocular movement, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52 Disorders of refraction and accommodation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.0 Hypermetropia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.1 Myopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.2 Astigmatism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.3 Anisometropia and aniseikonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.4 Presbyopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.5 Disorders of accommodation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.6 Other disorders of refraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H52.7 Disorder of refraction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53 Visual disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53-H54 Visual disturbances and blindness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.0 Amblyopia ex anopsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.1 Subjective visual disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.2 Diplopia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.3 Other disorders of binocular vision 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.4 Visual field defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.5 Colour vision deficiencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.6 Night blindness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.8 Other visual disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H53.9 Visual disturbance, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54 Visual impairment including blindness (binocular or monocular) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.0 Blindness, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.1 Severe visual impairment, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.2 Moderate visual impairment, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.3 Mild or no visual impairment, binocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.4 Blindness, monocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.5 Severe visual impairment, monocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.6 Moderate visual impairment, monocular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H54.9 Unspecified visual impairment (binocular) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H55 Nystagmus and other irregular eye movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H55-H59 Other disorders of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57 Other disorders of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.0 Anomalies of pupillary function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.1 Ocular pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.8 Other specified disorders of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H57.9 Disorder of eye and adnexa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58 Other disorders of eye and adnexa in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58.0 Anomalies of pupillary function in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58.1 Visual disturbances in diseases classified elsewhere

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 271 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H58.8 Other specified disorders of eye and adnexa in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59 Postprocedural disorders of eye and adnexa, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59.0 Keratopathy (bullous aphakic) following cataract surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59.8 Other postprocedural disorders of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H59.9 Postprocedural disorder of eye and adnexa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60 Otitis externa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60-H62 Diseases of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.0 Abscess of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.1 Cellulitis of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.2 Malignant otitis externa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.3 Other infective otitis externa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.4 Cholesteatoma of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.5 Acute otitis externa, noninfective 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.8 Other otitis externa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H60.9 Otitis externa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61 Other disorders of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.0 Perichondritis of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.1 Noninfective disorders of pinna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.2 Impacted cerumen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.3 Acquired stenosis of external ear canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.8 Other specified disorders of external ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H61.9 Disorder of external ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62 Disorders of external ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.0 Otitis externa in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.1 Otitis externa in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.2 Otitis externa in mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.4 Otitis externa in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H62.8 Other disorders of external ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65 Nonsuppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65-H75 Diseases of middle ear and mastoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.0 Acute serous otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.1 Other acute nonsuppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.2 Chronic serous otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.3 Chronic mucoid otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.4 Other chronic nonsuppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H65.9 Nonsuppurative otitis media, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66 Suppurative and unspecified otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.0 Acute suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.1 Chronic tubotympanic suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.2 Chronic atticoantral suppurative otitis media

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 272 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.3 Other chronic suppurative otitis media 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.4 Suppurative otitis media, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H66.9 Otitis media, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67 Otitis media in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67.0 Otitis media in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67.1 Otitis media in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H67.8 Otitis media in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H68 Eustachian salpingitis and obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H68.0 Eustachian salpingitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H68.1 Obstruction of Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69 Other disorders of Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69.0 Patulous Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69.8 Other specified disorders of Eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H69.9 Eustachian tube disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70 Mastoiditis and related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.0 Acute mastoiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.1 Chronic mastoiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.2 Petrositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.8 Other mastoiditis and related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H70.9 Mastoiditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H71 Cholesteatoma of middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72 Perforation of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.0 Central perforation of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.1 Attic perforation of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.2 Other marginal perforations of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.8 Other perforations of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H72.9 Perforation of tympanic membrane, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73 Other disorders of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.0 Acute myringitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.1 Chronic myringitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.8 Other specified disorders of tympanic membrane 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H73.9 Disorder of tympanic membrane, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74 Other disorders of middle ear and mastoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.0 Tympanosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.1 Adhesive middle ear disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.2 Discontinuity and dislocation of ear ossicles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.3 Other acquired abnormalities of ear ossicles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.4 Polyp of middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.8 Other specified disorders of middle ear and mastoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H74.9 Disorder of middle ear and mastoid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H75 Other disorders of middle ear and mastoid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 273 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80 Otosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80-H83 Diseases of inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.0 Otosclerosis involving oval window, nonobliterative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.1 Otosclerosis involving oval window, obliterative 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.2 Cochlear otosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.8 Other otosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H80.9 Otosclerosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81 Disorders of vestibular function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.0 Ménière disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.1 Benign paroxysmal vertigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.2 Vestibular neuronitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.3 Other peripheral vertigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.4 Vertigo of central origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.8 Other disorders of vestibular function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H81.9 Disorder of vestibular function, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H82 Vertiginous syndromes in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83 Other diseases of inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.0 Labyrinthitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.1 Labyrinthine fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.2 Labyrinthine dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.3 Noise effects on inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.8 Other specified diseases of inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H83.9 Disease of inner ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90 Conductive and sensorineural hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90-H95 Other disorders of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.0 Conductive hearing loss, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.2 Conductive hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.3 Sensorineural hearing loss, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.5 Sensorineural hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.6 Mixed conductive and sensorineural hearing loss, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H90.8 Mixed conductive and sensorineural hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91 Other hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.0 Ototoxic hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.1 Presbycusis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.2 Sudden idiopathic hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.3 Deaf mutism, not elsewhere classified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 274 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.8 Other specified hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H91.9 Hearing loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92 Otalgia and effusion of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92.0 Otalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92.1 Otorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H92.2 Otorrhagia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93 Other disorders of ear, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.0 Degenerative and vascular disorders of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.1 Tinnitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.2 Other abnormal auditory perceptions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.3 Disorders of acoustic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.8 Other specified disorders of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H93.9 Disorder of ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H94 Other disorders of ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H94.8 Other specified disorders of ear in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.0 Recurrent cholesteatoma of postmastoidectomy cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.1 Other disorders following mastoidectomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.8 Other postprocedural disorders of ear and mastoid process 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 H95.9 Postprocedural disorder of ear and mastoid process, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I Certain infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I00 Rheumatic fever without mention of heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I00-I02 Acute rheumatic fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01 Rheumatic fever with heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.0 Acute rheumatic pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.1 Acute rheumatic endocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.2 Acute rheumatic myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.8 Other acute rheumatic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I01.9 Acute rheumatic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I02 Rheumatic chorea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I02.0 Rheumatic chorea with heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I02.9 Rheumatic chorea without heart involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05 Rheumatic mitral valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05-I09 Chronic rheumatic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.0 Mitral stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.1 Rheumatic mitral insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.2 Mitral stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.8 Other mitral valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I05.9 Mitral valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06 Rheumatic aortic valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.0 Rheumatic aortic stenosis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 275 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.1 Rheumatic aortic insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.2 Rheumatic aortic stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.8 Other rheumatic aortic valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I06.9 Rheumatic aortic valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07 Rheumatic tricuspid valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.0 Tricuspid stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.1 Tricuspid insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.2 Tricuspid stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.8 Other tricuspid valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I07.9 Tricuspid valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08 Multiple valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.0 Disorders of both mitral and aortic valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.1 Disorders of both mitral and tricuspid valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.2 Disorders of both aortic and tricuspid valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.3 Combined disorders of mitral, aortic and tricuspid valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.8 Other multiple valve diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I08.9 Multiple valve disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09 Other rheumatic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.0 Rheumatic myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.1 Rheumatic diseases of endocardium, valve unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.2 Chronic rheumatic pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.8 Other specified rheumatic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I09.9 Rheumatic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I10 Essential (primary) hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I10-I15 Hypertensive diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I11 Hypertensive heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I11.0 Hypertensive heart disease with (congestive) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I11.9 Hypertensive heart disease without (congestive) heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I12 Hypertensive renal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I12.0 Hypertensive renal disease with renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I12.9 Hypertensive renal disease without renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13 Hypertensive heart and renal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.0 Hypertensive heart and renal disease with (congestive) heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.1 Hypertensive heart and renal disease with renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I13.9 Hypertensive heart and renal disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15 Secondary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.0 Renovascular hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.1 Hypertension secondary to other renal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.2 Hypertension secondary to endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.8 Other secondary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I15.9 Secondary hypertension, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 276 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20 Angina pectoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20-I25 Ischaemic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.0 Unstable angina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.1 Angina pectoris with documented spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.8 Other forms of angina pectoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I20.9 Angina pectoris, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21 Acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.0 Acute transmural myocardial infarction of anterior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.1 Acute transmural myocardial infarction of inferior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.2 Acute transmural myocardial infarction of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.3 Acute transmural myocardial infarction of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.4 Acute subendocardial myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I21.9 Acute myocardial infarction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22 Subsequent myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.0 Subsequent myocardial infarction of anterior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.1 Subsequent myocardial infarction of inferior wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.8 Subsequent myocardial infarction of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I22.9 Subsequent myocardial infarction of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23 Certain current complications following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.0 Haemopericardium as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.1 Atrial septal defect as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.2 Ventricular septal defect as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.6 Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I23.8 Other current complications following acute myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24 Other acute ischaemic heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.0 Coronary thrombosis not resulting in myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.1 Dressler syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.8 Other forms of acute ischaemic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I24.9 Acute ischaemic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25 Chronic ischaemic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.0 Atherosclerotic cardiovascular disease, so described 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.1 Atherosclerotic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.2 Old myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.3 Aneurysm of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.4 Coronary artery aneurysm and dissection © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 277 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.5 Ischaemic cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.6 Silent myocardial ischaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.8 Other forms of chronic ischaemic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I25.9 Chronic ischaemic heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I26 Pulmonary embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I26-I28 Pulmonary heart disease and diseases of pulmonary circulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I26.0 Pulmonary embolism with mention of acute cor pulmonale 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I26.9 Pulmonary embolism without mention of acute cor pulmonale 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27 Other pulmonary heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.0 Primary pulmonary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.1 Kyphoscoliotic heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.2 Other secondary pulmonary hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.8 Other specified pulmonary heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I27.9 Pulmonary heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28 Other diseases of pulmonary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.0 Arteriovenous fistula of pulmonary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.1 Aneurysm of pulmonary artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.8 Other specified diseases of pulmonary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I28.9 Disease of pulmonary vessels, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30 Acute pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30-I52 Other forms of heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.0 Acute nonspecific idiopathic pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.1 Infective pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.8 Other forms of acute pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I30.9 Acute pericarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31 Other diseases of pericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.0 Chronic adhesive pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.1 Chronic constrictive pericarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.2 Haemopericardium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.3 Pericardial effusion (noninflammatory) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.8 Other specified diseases of pericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I31.9 Disease of pericardium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32 Pericarditis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32.0 Pericarditis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32.1 Pericarditis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I32.8 Pericarditis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I33 Acute and subacute endocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I33.0 Acute and subacute infective endocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I33.9 Acute endocarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34 Nonrheumatic mitral valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.0 Mitral (valve) insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.1 Mitral (valve) prolapse

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 278 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.2 Nonrheumatic mitral (valve) stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.8 Other nonrheumatic mitral valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I34.9 Nonrheumatic mitral valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35 Nonrheumatic aortic valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.0 Aortic (valve) stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.1 Aortic (valve) insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.2 Aortic (valve) stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.8 Other aortic valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I35.9 Aortic valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36 Nonrheumatic tricuspid valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.0 Nonrheumatic tricuspid (valve) stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.1 Nonrheumatic tricuspid (valve) insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.2 Nonrheumatic tricuspid (valve) stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.8 Other nonrheumatic tricuspid valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I36.9 Nonrheumatic tricuspid valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37 Pulmonary valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.0 Pulmonary valve stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.1 Pulmonary valve insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.2 Pulmonary valve stenosis with insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.8 Other pulmonary valve disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I37.9 Pulmonary valve disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I38 Endocarditis, valve unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39 Endocarditis and heart valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.0 Mitral valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.1 Aortic valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.2 Tricuspid valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.3 Pulmonary valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.4 Multiple valve disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I39.8 Endocarditis, valve unspecified, in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40 Acute myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.0 Infective myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.1 Isolated myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.8 Other acute myocarditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I40.9 Acute myocarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41 Myocarditis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.0 Myocarditis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.1 Myocarditis in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.2 Myocarditis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I41.8 Myocarditis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42 Cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.0 Dilated cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.1 Obstructive hypertrophic cardiomyopathy © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 279 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.2 Other hypertrophic cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.3 Endomyocardial (eosinophilic) disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.4 Endocardial fibroelastosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.5 Other restrictive cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.6 Alcoholic cardiomyopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.7 Cardiomyopathy due to drugs and other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.8 Other cardiomyopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I42.9 Cardiomyopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43 Cardiomyopathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.0 Cardiomyopathy in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.1 Cardiomyopathy in metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.2 Cardiomyopathy in nutritional diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I43.8 Cardiomyopathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44 Atrioventricular and left bundle-branch block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.0 Atrioventricular block, first degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.1 Atrioventricular block, second degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.2 Atrioventricular block, complete 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.3 Other and unspecified atrioventricular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.4 Left anterior fascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.5 Left posterior fascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.6 Other and unspecified fascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I44.7 Left bundle-branch block, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45 Other conduction disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.0 Right fascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.1 Other and unspecified right bundle-branch block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.2 Bifascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.3 Trifascicular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.4 Nonspecific intraventricular block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.5 Other specified heart block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.6 Pre-excitation syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.8 Other specified conduction disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I45.9 Conduction disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I46 Cardiac arrest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I46.0 Cardiac arrest with successful resuscitation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I46.1 Sudden cardiac death, so described 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I46.9 Cardiac arrest, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I47 Paroxysmal tachycardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I47.0 Re-entry ventricular arrhythmia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I47.1 Supraventricular tachycardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I47.2 Ventricular tachycardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I47.9 Paroxysmal tachycardia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48 Atrial fibrillation and flutter

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 280 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.0 Paroxysmal atrial fibrillation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.1 Persistent atrial fibrillation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.2 Chronic atrial fibrillation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.3 Typical atrial flutter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.4 Atypical atrial flutter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I48.9 Atrial fibrillation and atrial flutter, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49 Other cardiac arrhythmias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.0 Ventricular fibrillation and flutter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.1 Atrial premature depolarization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.2 Junctional premature depolarization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.3 Ventricular premature depolarization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.4 Other and unspecified premature depolarization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.5 Sick sinus syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.8 Other specified cardiac arrhythmias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I49.9 Cardiac arrhythmia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I50 Heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I50.0 Congestive heart failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I50.1 Left ventricular failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I50.9 Heart failure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51 Complications and ill-defined descriptions of heart disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.0 Cardiac septal defect, acquired 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.1 Rupture of chordae tendineae, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.2 Rupture of papillary muscle, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.3 Intracardiac thrombosis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.4 Myocarditis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.5 Myocardial degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.6 Cardiovascular disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.7 Cardiomegaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.8 Other ill-defined heart diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I51.9 Heart disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I52 Other heart disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I52.0 Other heart disorders in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I52.1 Other heart disorders in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I52.8 Other heart disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60 Subarachnoid haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60-I69 Cerebrovascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.1 Subarachnoid haemorrhage from middle cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.2 Subarachnoid haemorrhage from anterior communicating artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.3 Subarachnoid haemorrhage from posterior communicating artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.4 Subarachnoid haemorrhage from basilar artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.5 Subarachnoid haemorrhage from vertebral artery

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 281 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.6 Subarachnoid haemorrhage from other intracranial arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.8 Other subarachnoid haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I60.9 Subarachnoid haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61 Intracerebral haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.0 Intracerebral haemorrhage in hemisphere, subcortical 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.1 Intracerebral haemorrhage in hemisphere, cortical 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.2 Intracerebral haemorrhage in hemisphere, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.3 Intracerebral haemorrhage in brain stem 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.4 Intracerebral haemorrhage in cerebellum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.5 Intracerebral haemorrhage, intraventricular 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.6 Intracerebral haemorrhage, multiple localized 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.8 Other intracerebral haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I61.9 Intracerebral haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I62 Other nontraumatic intracranial haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I62.0 Subdural haemorrhage (acute)(nontraumatic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I62.1 Nontraumatic extradural haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I62.9 Intracranial haemorrhage (nontraumatic), unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63 Cerebral infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.0 Cerebral infarction due to thrombosis of precerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.1 Cerebral infarction due to embolism of precerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.3 Cerebral infarction due to thrombosis of cerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.4 Cerebral infarction due to embolism of cerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.8 Other cerebral infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I63.9 Cerebral infarction, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I64 Stroke, not specified as haemorrhage or infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.0 Occlusion and stenosis of vertebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.1 Occlusion and stenosis of basilar artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.2 Occlusion and stenosis of carotid artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.8 Occlusion and stenosis of other precerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I65.9 Occlusion and stenosis of unspecified precerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.0 Occlusion and stenosis of middle cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.1 Occlusion and stenosis of anterior cerebral artery

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 282 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.2 Occlusion and stenosis of posterior cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.3 Occlusion and stenosis of cerebellar arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.8 Occlusion and stenosis of other cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I66.9 Occlusion and stenosis of unspecified cerebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67 Other cerebrovascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.0 Dissection of cerebral arteries, nonruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.1 Cerebral aneurysm, nonruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.2 Cerebral atherosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.3 Progressive vascular leukoencephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.4 Hypertensive encephalopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.5 Moyamoya disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.6 Nonpyogenic thrombosis of intracranial venous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.7 Cerebral arteritis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.8 Other specified cerebrovascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I67.9 Cerebrovascular disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I68 Cerebrovascular disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I68.0 Cerebral amyloid angiopathyE85.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I68.2 Cerebral arteritis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I68.8 Other cerebrovascular disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69 Sequelae of cerebrovascular disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.0 Sequelae of subarachnoid haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.1 Sequelae of intracerebral haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.2 Sequelae of other nontraumatic intracranial haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.3 Sequelae of cerebral infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.4 Sequelae of stroke, not specified as haemorrhage or infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I69.8 Sequelae of other and unspecified cerebrovascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70 Atherosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70-I79 Diseases of arteries, arterioles and capillaries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70.0 Atherosclerosis of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70.1 Atherosclerosis of renal artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70.2 Atherosclerosis of arteries of extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70.8 Atherosclerosis of other arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I70.9 Generalized and unspecified atherosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71 Aortic aneurysm and dissection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.0 Dissection of aorta [any part] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.1 Thoracic aortic aneurysm, ruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.2 Thoracic aortic aneurysm, without mention of rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.3 Abdominal aortic aneurysm, ruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.4 Abdominal aortic aneurysm, without mention of rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.5 Thoracoabdominal aortic aneurysm, ruptured © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 283 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.8 Aortic aneurysm of unspecified site, ruptured 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I71.9 Aortic aneurysm of unspecified site, without mention of rupture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72 Other aneurysm and dissection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.0 Aneurysm and dissection of carotid artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.1 Aneurysm and dissection of artery of upper extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.2 Aneurysm and dissection of renal artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.3 Aneurysm and dissection of iliac artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.4 Aneurysm and dissection of artery of lower extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.5 Aneurysm and dissection of other precerebral arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.6 Aneurysm and dissection of vertebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.8 Aneurysm and dissection of other specified arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I72.9 Aneurysm and dissection of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I73 Other peripheral vascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I73.0 Raynaud syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I73.1 Thromboangiitis obliterans [Buerger] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I73.8 Other specified peripheral vascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I73.9 Peripheral vascular disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74 Arterial embolism and thrombosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.0 Embolism and thrombosis of abdominal aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.1 Embolism and thrombosis of other and unspecified parts of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.2 Embolism and thrombosis of arteries of upper extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.3 Embolism and thrombosis of arteries of lower extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.4 Embolism and thrombosis of arteries of extremities, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.5 Embolism and thrombosis of iliac artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.8 Embolism and thrombosis of other arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I74.9 Embolism and thrombosis of unspecified artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77 Other disorders of arteries and arterioles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.0 Arteriovenous fistula, acquired 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.1 Stricture of artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.2 Rupture of artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.3 Arterial fibromuscular dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.4 Coeliac artery compression syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.5 Necrosis of artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.6 Arteritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.8 Other specified disorders of arteries and arterioles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I77.9 Disorder of arteries and arterioles, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I78 Diseases of capillaries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I78.0 Hereditary haemorrhagic telangiectasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I78.1 Naevus, non-neoplastic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I78.8 Other diseases of capillaries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I78.9 Disease of capillaries, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 284 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I79.0 Aneurysm of aorta in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I79.1 Aortitis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I79.2 Peripheral angiopathy in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80 Phlebitis and thrombophlebitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.1 Phlebitis and thrombophlebitis of femoral vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.8 Phlebitis and thrombophlebitis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I80.9 Phlebitis and thrombophlebitis of unspecified site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I81 Portal vein thrombosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82 Other venous embolism and thrombosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.0 Budd-Chiari syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.1 Thrombophlebitis migrans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.2 Embolism and thrombosis of vena cava 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.3 Embolism and thrombosis of renal vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.8 Embolism and thrombosis of other specified veins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I82.9 Embolism and thrombosis of unspecified vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I83 of lower extremities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I83.0 Varicose veins of lower extremities with ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I83.1 Varicose veins of lower extremities with inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I83.2 Varicose veins of lower extremities with both ulcer and inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I83.9 Varicose veins of lower extremities without ulcer or inflammation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I85 Oesophageal varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I85.0 Oesophageal varices with bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I85.9 Oesophageal varices without bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86 Varicose veins of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.0 Sublingual varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.1 Scrotal varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.2 Pelvic varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.3 Vulval varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.4 Gastric varices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I86.8 Varicose veins of other specified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87 Other disorders of veins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87.0 Postthrombotic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87.1 Compression of vein

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 285 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87.2 Venous insufficiency (chronic)(peripheral) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87.8 Other specified disorders of veins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I87.9 Disorder of vein, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I88 Nonspecific lymphadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I88.0 Nonspecific mesenteric lymphadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I88.1 Chronic lymphadenitis, except mesenteric 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I88.8 Other nonspecific lymphadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I88.9 Nonspecific lymphadenitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I89 Other noninfective disorders of lymphatic vessels and lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I89.0 Lymphoedema, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I89.1 Lymphangitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I89.8 Other specified noninfective disorders of lymphatic vessels and lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I89.9 Noninfective disorder of lymphatic vessels and lymph nodes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95 Hypotension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95-I99 Other and unspecified disorders of the 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95.0 Idiopathic hypotension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95.1 Orthostatic hypotension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95.2 Hypotension due to drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95.8 Other hypotension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I95.9 Hypotension, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97 Postprocedural disorders of circulatory system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97.0 Postcardiotomy syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97.1 Other functional disturbances following cardiac surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97.2 Postmastectomy lymphoedema syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I97.9 Postprocedural disorder of circulatory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98 Other disorders of circulatory system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98.0 Cardiovascular syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98.2 Oesophageal varices without bleeding in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98.3 Oesophageal varices with bleeding in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I98.8 Other specified disorders of circulatory system in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 I99 Other and unspecified disorders of circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 II Neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 IV Endocrine, nutritional and metabolic diseases © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 286 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 IX Diseases of the circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J00 Acute nasopharyngitis [common cold] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J00-J06 Acute upper respiratory infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01 Acute sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.0 Acute maxillary sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.1 Acute frontal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.2 Acute ethmoidal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.3 Acute sphenoidal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.4 Acute pansinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.8 Other acute sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J01.9 Acute sinusitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J02 Acute pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J02.0 Streptococcal pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J02.8 Acute pharyngitis due to other specified organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J02.9 Acute pharyngitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J03 Acute tonsillitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J03.0 Streptococcal tonsillitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J03.8 Acute tonsillitis due to other specified organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J03.9 Acute tonsillitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J04 Acute laryngitis and tracheitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J04.0 Acute laryngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J04.1 Acute tracheitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J04.2 Acute laryngotracheitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J05 Acute obstructive laryngitis [croup] and epiglottitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J05.0 Acute obstructive laryngitis [croup] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J05.1 Acute epiglottitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J06 Acute upper respiratory infections of multiple and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J06.0 Acute laryngopharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J06.8 Other acute upper respiratory infections of multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J06.9 Acute upper respiratory infection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J09 Influenza due to identified zoonotic or pandemic influenza virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J09-J18 Influenza and pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J10 influenza due to identified seasonal influenza virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J10.0 Influenza with pneumonia, seasonal influenza virus identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J10.1 Influenza with other respiratory manifestations, seasonal influenza virus identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J10.8 Influenza with other manifestations, seasonal influenza virus identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J11 Influenza, virus not identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J11.0 Influenza with pneumonia, virus not identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J11.1 Influenza with other respiratory manifestations, virus not identified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J11.8 Influenza with other manifestations, virus not identified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 287 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12 Viral pneumonia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.0 Adenoviral pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.1 Respiratory syncytial virus pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.2 Parainfluenza virus pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.3 Human metapneumovirus pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.8 Other viral pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J12.9 Viral pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J13 Pneumonia due to Streptococcus pneumoniae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J14 Pneumonia due to Haemophilus influenzae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15 Bacterial pneumonia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.0 Pneumonia due to Klebsiella pneumoniae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.1 Pneumonia due to Pseudomonas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.2 Pneumonia due to staphylococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.3 Pneumonia due to streptococcus, group B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.4 Pneumonia due to other streptococci 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.5 Pneumonia due to Escherichia coli 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.6 Pneumonia due to other Gram-negative bacteria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.7 Pneumonia due to Mycoplasma pneumoniae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.8 Other bacterial pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J15.9 Bacterial pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J16 Pneumonia due to other infectious organisms, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J16.0 Chlamydial pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J16.8 Pneumonia due to other specified infectious organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17 Pneumonia in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17.0 Pneumonia in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17.1 Pneumonia in viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17.2 Pneumonia in mycoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17.3 Pneumonia in parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J17.8 Pneumonia in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18 Pneumonia, organism unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18.0 Bronchopneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18.1 Lobar pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18.2 Hypostatic pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18.8 Other pneumonia, organism unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J18.9 Pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20 Acute bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20-J22 Other acute lower respiratory infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.0 Acute bronchitis due to Mycoplasma pneumoniae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.1 Acute bronchitis due to Haemophilus influenzae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.2 Acute bronchitis due to streptococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.3 Acute bronchitis due to coxsackievirus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.4 Acute bronchitis due to parainfluenza virus

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 288 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.5 Acute bronchitis due to respiratory syncytial virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.6 Acute bronchitis due to rhinovirus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.7 Acute bronchitis due to echovirus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.8 Acute bronchitis due to other specified organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J20.9 Acute bronchitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J21 Acute bronchiolitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J21.0 Acute bronchiolitis due to respiratory syncytial virus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J21.1 Acute bronchiolitis due to human metapneumovirus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J21.8 Acute bronchiolitis due to other specified organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J21.9 Acute bronchiolitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J22 Unspecified acute lower respiratory infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30 Vasomotor and allergic rhinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30-J39 Other diseases of upper respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30.0 Vasomotor rhinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30.1 Allergic rhinitis due to pollen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30.2 Other seasonal allergic rhinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30.3 Other allergic rhinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J30.4 Allergic rhinitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J31 Chronic rhinitis, nasopharyngitis and pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J31.0 Chronic rhinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J31.1 Chronic nasopharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J31.2 Chronic pharyngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32 Chronic sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.0 Chronic maxillary sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.1 Chronic frontal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.2 Chronic ethmoidal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.3 Chronic sphenoidal sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.4 Chronic pansinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.8 Other chronic sinusitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J32.9 Chronic sinusitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J33 Nasal polyp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J33.0 Polyp of nasal cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J33.1 Polypoid sinus degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J33.8 Other polyp of sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J33.9 Nasal polyp, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34 Other disorders of nose and nasal sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34.0 Abscess, furuncle and carbuncle of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34.1 Cyst and mucocele of nose and nasal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34.2 Deviated nasal septum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34.3 Hypertrophy of nasal turbinates 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J34.8 Other specified disorders of nose and nasal sinuses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35 Chronic diseases of tonsils and adenoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.0 Chronic tonsillitis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 289 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.1 Hypertrophy of tonsils 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.2 Hypertrophy of adenoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.3 Hypertrophy of tonsils with hypertrophy of adenoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.8 Other chronic diseases of tonsils and adenoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J35.9 Chronic disease of tonsils and adenoids, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J36 Peritonsillar abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J37 Chronic laryngitis and laryngotracheitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J37.0 Chronic laryngitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J37.1 Chronic laryngotracheitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38 Diseases of vocal cords and larynx, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.0 Paralysis of vocal cords and larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.1 Polyp of vocal cord and larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.2 Nodules of vocal cords 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.3 Other diseases of vocal cords 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.4 Oedema of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.5 Laryngeal spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.6 Stenosis of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J38.7 Other diseases of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39 Other diseases of upper respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.0 Retropharyngeal and parapharyngeal abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.1 Other abscess of pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.2 Other diseases of pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.8 Other specified diseases of upper respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J39.9 Disease of upper respiratory tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J40 Bronchitis, not specified as acute or chronic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J40-J47 Chronic lower respiratory diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J41 Simple and mucopurulent chronic bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J41.0 Simple chronic bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J41.1 Mucopurulent chronic bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J41.8 Mixed simple and mucopurulent chronic bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J42 Unspecified chronic bronchitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43 Emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43.0 MacLeod syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43.1 Panlobular emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43.2 Centrilobular emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43.8 Other emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J43.9 Emphysema, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J44 Other chronic obstructive pulmonary disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J44.8 Other specified chronic obstructive pulmonary disease © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 290 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J44.9 Chronic obstructive pulmonary disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J45 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J45.0 Predominantly allergic asthma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J45.1 Nonallergic asthma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J45.8 Mixed asthma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J45.9 Asthma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J46 Status asthmaticus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J47 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J60 Coalworker pneumoconiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J60-J70 Lung diseases due to external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J61 Pneumoconiosis due to and other mineral fibres 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J62 Pneumoconiosis due to dust containing silica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J62.0 Pneumoconiosis due to dust 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J62.8 Pneumoconiosis due to other dust containing silica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63 Pneumoconiosis due to other inorganic dusts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.0 Aluminosis (of lung) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.1 Bauxite fibrosis (of lung) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.2 Berylliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.3 Graphite fibrosis (of lung) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.4 Siderosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.5 Stannosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J63.8 Pneumoconiosis due to other specified inorganic dusts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J64 Unspecified pneumoconiosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J65 Pneumoconiosis associated with tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J66 Airway disease due to specific organic dust 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J66.0 Byssinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J66.1 Flax-dresser disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J66.2 Cannabinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J66.8 Airway disease due to other specific organic dusts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67 Hypersensitivity pneumonitis due to organic dust 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.0 Farmer lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.1 Bagassosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.2 Bird fancier lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.3 Suberosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.4 Maltworker lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.5 Mushroom-worker lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.6 Maple-bark-stripper lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.7 Air-conditioner and humidifier lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.8 Hypersensitivity pneumonitis due to other organic dusts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J67.9 Hypersensitivity pneumonitis due to unspecified organic dust 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 291 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.1 Pulmonary oedema due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J69 Pneumonitis due to solids and liquids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J69.0 Pneumonitis due to food and vomit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J69.1 Pneumonitis due to oils and essences 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J69.8 Pneumonitis due to other solids and liquids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70 Respiratory conditions due to other external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.0 Acute pulmonary manifestations due to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.1 Chronic and other pulmonary manifestations due to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.2 Acute drug-induced interstitial lung disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.3 Chronic drug-induced interstitial lung disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.4 Drug-induced interstitial lung disorders, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.8 Respiratory conditions due to other specified external agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J70.9 Respiratory conditions due to unspecified external agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J80 Adult respiratory distress syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J80-J84 Other respiratory diseases principally affecting the interstitium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J81 Pulmonary oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J82 Pulmonary eosinophilia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J84 Other interstitial pulmonary diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J84.0 Alveolar and parietoalveolar conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J84.1 Other interstitial pulmonary diseases with fibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J84.8 Other specified interstitial pulmonary diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J84.9 Interstitial pulmonary disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85 Abscess of lung and mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85-J86 Suppurative and necrotic conditions of lower respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85.0 Gangrene and necrosis of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85.1 Abscess of lung with pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85.2 Abscess of lung without pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J85.3 Abscess of mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J86 Pyothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J86.0 Pyothorax with fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J86.9 Pyothorax without fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J90 Pleural effusion, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J90-J94 Other diseases of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J91 Pleural effusion in conditions classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J92 Pleural plaque © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 292 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J92.0 Pleural plaque with presence of asbestos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J92.9 Pleural plaque without asbestos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J93 Pneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J93.0 Spontaneous tension pneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J93.1 Other spontaneous pneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J93.8 Other pneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J93.9 Pneumothorax, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94 Other pleural conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94.0 Chylous effusion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94.1 Fibrothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94.2 Haemothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94.8 Other specified pleural conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J94.9 Pleural condition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95 Postprocedural respiratory disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95-J99 Other diseases of the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.0 Tracheostomy malfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.1 Acute pulmonary insufficiency following thoracic surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.2 Acute pulmonary insufficiency following nonthoracic surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.3 Chronic pulmonary insufficiency following surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.4 Mendelson syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.5 Postprocedural subglottic stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.8 Other postprocedural respiratory disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J95.9 Postprocedural respiratory disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J96 Respiratory failure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J96.0 Acute respiratory failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J96.1 Chronic respiratory failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J96.9 Respiratory failure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98 Other respiratory disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.0 Diseases of bronchus, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.1 Pulmonary collapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.2 Interstitial emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.3 Compensatory emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.4 Other disorders of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.5 Diseases of mediastinum, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.6 Disorders of diaphragm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.8 Other specified respiratory disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J98.9 Respiratory disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J99 Respiratory disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J99.0 Rheumatoid lung diseaseM05.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J99.1 Respiratory disorders in other diffuse connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 J99.8 Respiratory disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00 Disorders of tooth development and eruption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00-K14 Diseases of oral cavity, salivary glands and jaws © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 293 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.0 Anodontia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.1 Supernumerary teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.2 Abnormalities of size and form of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.3 Mottled teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.4 Disturbances in tooth formation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.5 Hereditary disturbances in tooth structure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.6 Disturbances in tooth eruption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.7 Teething syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.8 Other disorders of tooth development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K00.9 Disorder of tooth development, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K01 Embedded and impacted teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K01.0 Embedded teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K01.1 Impacted teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02 Dental caries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.0 Caries limited to enamel 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.1 Caries of dentine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.2 Caries of cementum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.3 Arrested dental caries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.4 Odontoclasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.5 Caries with pulp exposure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.8 Other dental caries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K02.9 Dental caries, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03 Other diseases of hard tissues of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.0 Excessive attrition of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.1 Abrasion of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.2 Erosion of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.3 Pathological resorption of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.4 Hypercementosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.5 Ankylosis of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.6 Deposits [accretions] on teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.7 Posteruptive colour changes of dental hard tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.8 Other specified diseases of hard tissues of teeth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K03.9 Disease of hard tissues of teeth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04 Diseases of pulp and periapical tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.0 Pulpitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.1 Necrosis of pulp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.2 Pulp degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.3 Abnormal hard tissue formation in pulp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.4 Acute apical periodontitis of pulpal origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.5 Chronic apical periodontitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.6 Periapical abscess with sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.7 Periapical abscess without sinus

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 294 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.8 Radicular cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K04.9 Other and unspecified diseases of pulp and periapical tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05 Gingivitis and periodontal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.0 Acute gingivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.1 Chronic gingivitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.2 Acute periodontitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.3 Chronic periodontitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.4 Periodontosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.5 Other periodontal diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K05.6 Periodontal disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06 Other disorders of gingiva and edentulous alveolar ridge 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06.0 Gingival recession 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06.1 Gingival enlargement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06.2 Gingival and edentulous alveolar ridge lesions associated with trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06.8 Other specified disorders of gingiva and edentulous alveolar ridge 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K06.9 Disorder of gingiva and edentulous alveolar ridge, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07 Dentofacial anomalies [including malocclusion] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.0 Major anomalies of jaw size 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.1 Anomalies of jaw-cranial base relationship 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.2 Anomalies of dental arch relationship 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.3 Anomalies of tooth position 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.4 Malocclusion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.5 Dentofacial functional abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.6 Temporomandibular joint disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.8 Other dentofacial anomalies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K07.9 Dentofacial anomaly, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08 Other disorders of teeth and supporting structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.0 Exfoliation of teeth due to systemic causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.1 Loss of teeth due to accident, extraction or local periodontal disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.2 Atrophy of edentulous alveolar ridge 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.3 Retained dental root 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.8 Other specified disorders of teeth and supporting structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K08.9 Disorder of teeth and supporting structures, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09 Cysts of oral region, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09.0 Developmental odontogenic cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09.1 Developmental (nonodontogenic) cysts of oral region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09.2 Other cysts of jaw 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09.8 Other cysts of oral region, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K09.9 Cyst of oral region, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10 Other diseases of jaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.0 Developmental disorders of jaws

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 295 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.1 Giant cell granuloma, central 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.2 Inflammatory conditions of jaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.3 Alveolitis of jaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.8 Other specified diseases of jaws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K10.9 Disease of jaws, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11 Diseases of salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.0 Atrophy of salivary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.1 Hypertrophy of salivary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.2 Sialoadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.3 Abscess of salivary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.4 Fistula of salivary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.5 Sialolithiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.6 Mucocele of salivary gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.7 Disturbances of salivary secretion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.8 Other diseases of salivary glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K11.9 Disease of salivary gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K12 Stomatitis and related lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K12.0 Recurrent oral aphthae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K12.1 Other forms of stomatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K12.2 Cellulitis and abscess of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K12.3 Oral mucositis (ulcerative) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13 Other diseases of lip and oral mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.0 Diseases of lips 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.1 Cheek and lip biting 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.2 Leukoplakia and other disturbances of oral epithelium, including tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.3 Hairy leukoplakia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.4 Granuloma and granuloma-like lesions of oral mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.5 Oral submucous fibrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.6 Irritative hyperplasia of oral mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K13.7 Other and unspecified lesions of oral mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14 Diseases of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.0 Glossitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.1 Geographic tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.2 Median rhomboid glossitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.3 Hypertrophy of tongue papillae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.4 Atrophy of tongue papillae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.5 Plicated tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.6 Glossodynia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.8 Other diseases of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K14.9 Disease of tongue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K20 Oesophagitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K20-K31 Diseases of oesophagus, stomach and duodenum

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 296 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K21 Gastro-oesophageal reflux disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K21.0 Gastro-oesophageal reflux disease with oesophagitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K21.9 Gastro-oesophageal reflux disease without oesophagitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22 Other diseases of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.0 Achalasia of cardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.1 Ulcer of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.2 Oesophageal obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.3 Perforation of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.4 Dyskinesia of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.5 Diverticulum of oesophagus, acquired 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.6 Gastro-oesophageal laceration-haemorrhage syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.7 Barrett oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.8 Other specified diseases of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K22.9 Disease of oesophagus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K23 Disorders of oesophagus in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K23.0 Tuberculous oesophagitisA18.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K23.1 Megaoesophagus in Chagas diseaseB57.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K23.8 Disorders of oesophagus in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K25 Gastric ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K26 Duodenal ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K27 Peptic ulcer, site unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K28 Gastrojejunal ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29 Gastritis and duodenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.0 Acute haemorrhagic gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.1 Other acute gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.2 Alcoholic gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.3 Chronic superficial gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.4 Chronic atrophic gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.5 Chronic gastritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.6 Other gastritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.7 Gastritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.8 Duodenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K29.9 Gastroduodenitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K30 Functional dyspepsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31 Other diseases of stomach and duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.0 Acute dilatation of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.1 Adult hypertrophic pyloric stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.2 Hourglass stricture and stenosis of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.3 Pylorospasm, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.4 Gastric diverticulum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.5 Obstruction of duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.6 Fistula of stomach and duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.7 Polyp of stomach and duodenum © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 297 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.8 Other specified diseases of stomach and duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K31.9 Disease of stomach and duodenum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K35 Acute appendicitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K35-K38 Diseases of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K35.2 Acute appendicitis with generalized peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K35.3 Acute appendicitis with localized peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K35.8 Acute appendicitis, other and unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K36 Other appendicitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K37 Unspecified appendicitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38 Other diseases of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.0 Hyperplasia of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.1 Appendicular concretions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.2 Diverticulum of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.3 Fistula of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.8 Other specified diseases of appendix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K38.9 Disease of appendix, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40 Inguinal hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40-K46 Hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.0 Bilateral inguinal hernia, with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.1 Bilateral inguinal hernia, with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.2 Bilateral inguinal hernia, without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.4 Unilateral or unspecified inguinal hernia, with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41 Femoral hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.0 Bilateral femoral hernia, with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.1 Bilateral femoral hernia, with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.2 Bilateral femoral hernia, without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.4 Unilateral or unspecified femoral hernia, with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K42 Umbilical hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K42.0 Umbilical hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K42.1 Umbilical hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K42.9 Umbilical hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43 Ventral hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.0 Incisional hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.1 Incisional hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.2 Incisional hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.3 Parastomal hernia with obstruction, without gangrene

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 298 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.4 Parastomal hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.5 Parastomal hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.6 Other and unspecified ventral hernia with obstruction without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.7 Other and unspecified ventral hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K43.9 Other and unspecified ventral hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K44 Diaphragmatic hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K44.0 Diaphragmatic hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K44.1 Diaphragmatic hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K44.9 Diaphragmatic hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K45 Other abdominal hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K45.0 Other specified abdominal hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K45.1 Other specified abdominal hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K45.8 Other specified abdominal hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K46 Unspecified abdominal hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K46.0 Unspecified abdominal hernia with obstruction, without gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K46.1 Unspecified abdominal hernia with gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K46.9 Unspecified abdominal hernia without obstruction or gangrene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50 Crohn disease [regional enteritis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50-K52 Noninfective enteritis and colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50.0 Crohn disease of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50.1 Crohn disease of large intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50.8 Other Crohn disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K50.9 Crohn disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51 Ulcerative colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.0 Ulcerative (chronic) pancolitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.2 Ulcerative (chronic) proctitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.3 Ulcerative (chronic) rectosigmoiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.4 Inflammatory polyps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.5 Left sided colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.8 Other ulcerative colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K51.9 Ulcerative colitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52 Other noninfective gastroenteritis and colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.0 Gastroenteritis and colitis due to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.1 Toxic gastroenteritis and colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.2 Allergic and dietetic gastroenteritis and colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.3 Indeterminate colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.8 Other specified noninfective gastroenteritis and colitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K52.9 Noninfective gastroenteritis and colitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55 Vascular disorders of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55-K64 Other diseases of intestines

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 299 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55.0 Acute vascular disorders of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55.1 Chronic vascular disorders of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55.2 Angiodysplasia of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55.8 Other vascular disorders of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K55.9 Vascular disorder of intestine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56 Paralytic ileus and intestinal obstruction without hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.0 Paralytic ileus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.1 Intussusception 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.2 Volvulus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.3 Gallstone ileus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.4 Other impaction of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.5 Intestinal adhesions [bands] with obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.6 Other and unspecified intestinal obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K56.7 Ileus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57 Diverticular disease of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.0 Diverticular disease of small intestine with perforation and abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.1 Diverticular disease of small intestine without perforation or abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.2 Diverticular disease of large intestine with perforation and abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.3 Diverticular disease of large intestine without perforation or abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.4 Diverticular disease of both small and large intestine with perforation and abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.5 Diverticular disease of both small and large intestine without perforation or abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.8 Diverticular disease of intestine, part unspecified, with perforation and abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K57.9 Diverticular disease of intestine, part unspecified, without perforation or abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K58 Irritable bowel syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K58.0 Irritable bowel syndrome with diarrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K58.9 Irritable bowel syndrome without diarrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59 Other functional intestinal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.0 Constipation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.1 Functional diarrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.2 Neurogenic bowel, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.3 Megacolon, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.4 Anal spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.8 Other specified functional intestinal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K59.9 Functional intestinal disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60 Fissure and fistula of anal and rectal regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.0 Acute anal fissure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.1 Chronic anal fissure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.2 Anal fissure, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 300 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.3 Anal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.4 Rectal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K60.5 Anorectal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61 Abscess of anal and rectal regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61.0 Anal abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61.1 Rectal abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61.2 Anorectal abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61.3 Ischiorectal abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K61.4 Intrasphincteric abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62 Other diseases of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.0 Anal polyp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.1 Rectal polyp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.2 Anal prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.3 Rectal prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.4 Stenosis of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.5 Haemorrhage of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.6 Ulcer of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.7 Radiation proctitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.8 Other specified diseases of anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K62.9 Disease of anus and rectum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63 Other diseases of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.0 Abscess of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.1 Perforation of intestine (nontraumatic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.2 Fistula of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.3 Ulcer of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.4 Enteroptosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.5 Polyp of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.8 Other specified diseases of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K63.9 Disease of intestine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64 Haemorrhoids and perianal venous thrombosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.0 First degree haemorrhoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.1 Second degree haemorrhoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.2 Third degree haemorrhoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.3 Fourth degree haemorrhoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.4 Residual haemorrhoidal skin tags 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.5 Perianal venous thrombosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.8 Other specified haemorrhoids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K64.9 Haemorrhoids, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K65 Peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K65-K67 Diseases of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K65.0 Acute peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K65.8 Other peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K65.9 Peritonitis, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 301 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K66 Other disorders of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K66.0 Peritoneal adhesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K66.1 Haemoperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K66.8 Other specified disorders of peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K66.9 Disorder of peritoneum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67 Disorders of peritoneum in infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67.0 Chlamydial peritonitisA74.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67.1 Gonococcal peritonitisA54.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67.2 Syphilitic peritonitisA52.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67.3 Tuberculous peritonitisA18.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K67.8 Other disorders of peritoneum in infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70 Alcoholic liver disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70-K77 Diseases of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.0 Alcoholic fatty liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.1 Alcoholic hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.2 Alcoholic fibrosis and sclerosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.3 Alcoholic cirrhosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.4 Alcoholic hepatic failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K70.9 Alcoholic liver disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71 Toxic liver disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.0 Toxic liver disease with cholestasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.1 Toxic liver disease with hepatic necrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.2 Toxic liver disease with acute hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.3 Toxic liver disease with chronic persistent hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.4 Toxic liver disease with chronic lobular hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.5 Toxic liver disease with chronic active hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.6 Toxic liver disease with hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.7 Toxic liver disease with fibrosis and cirrhosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.8 Toxic liver disease with other disorders of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K71.9 Toxic liver disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K72 Hepatic failure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K72.0 Acute and subacute hepatic failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K72.1 Chronic hepatic failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K72.9 Hepatic failure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73 Chronic hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73.0 Chronic persistent hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73.1 Chronic lobular hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73.2 Chronic active hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73.8 Other chronic hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K73.9 Chronic hepatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74 Fibrosis and cirrhosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.0 Hepatic fibrosis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 302 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.1 Hepatic sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.2 Hepatic fibrosis with hepatic sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.3 Primary biliary cirrhosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.4 Secondary biliary cirrhosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.5 Biliary cirrhosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K74.6 Other and unspecified cirrhosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75 Other inflammatory liver diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.0 Abscess of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.1 Phlebitis of portal vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.2 Nonspecific reactive hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.3 Granulomatous hepatitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.4 Autoimmune hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.8 Other specified inflammatory liver diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K75.9 Inflammatory liver disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76 Other diseases of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.0 Fatty (change of) liver, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.1 Chronic passive congestion of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.2 Central haemorrhagic necrosis of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.3 Infarction of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.4 Peliosis hepatis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.5 Hepatic veno-occlusive disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.6 Portal hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.7 Hepatorenal syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.8 Other specified diseases of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K76.9 Liver disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K77 Liver disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K77.8 Liver disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80 Cholelithiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80-K87 Disorders of gallbladder, biliary tract and pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.0 Calculus of gallbladder with acute cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.1 Calculus of gallbladder with other cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.2 Calculus of gallbladder without cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.3 Calculus of bile duct with cholangitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.4 Calculus of bile duct with cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.5 Calculus of bile duct without cholangitis or cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K80.8 Other cholelithiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K81 Cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K81.0 Acute cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K81.1 Chronic cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K81.8 Other cholecystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K81.9 Cholecystitis, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 303 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82 Other diseases of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.0 Obstruction of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.1 Hydrops of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.2 Perforation of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.3 Fistula of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.4 Cholesterolosis of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.8 Other specified diseases of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K82.9 Disease of gallbladder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83 Other diseases of biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.0 Cholangitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.1 Obstruction of bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.2 Perforation of bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.3 Fistula of bile duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.4 Spasm of sphincter of Oddi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.5 Biliary cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.8 Other specified diseases of biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K83.9 Disease of biliary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85 Acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.0 Idiopathic acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.1 Biliary acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.2 Alcohol-induced acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.3 Drug-induced acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.8 Other acute pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K85.9 Acute pancreatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86 Other diseases of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.0 Alcohol-induced 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.1 Other chronic pancreatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.2 Cyst of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.3 Pseudocyst of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.8 Other specified diseases of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K86.9 Disease of pancreas, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K87.1 Disorders of pancreas in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90 Intestinal malabsorption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90-K93 Other diseases of the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.0 Coeliac disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.1 Tropical sprue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.2 Blind loop syndrome, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.3 Pancreatic steatorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.4 Malabsorption due to intolerance, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.8 Other intestinal malabsorption © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 304 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K90.9 Intestinal malabsorption, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91 Postprocedural disorders of digestive system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.0 Vomiting following gastrointestinal surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.1 Postgastric surgery syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.2 Postsurgical malabsorption, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.3 Postoperative intestinal obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.4 Colostomy and enterostomy malfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.5 Postcholecystectomy syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.8 Other postprocedural disorders of digestive system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K91.9 Postprocedural disorder of digestive system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92 Other diseases of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92.0 Haematemesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92.1 Melaena 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92.2 Gastrointestinal haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92.8 Other specified diseases of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K92.9 Disease of digestive system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K93 Disorders of other digestive organs in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glandsA18.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K93.1 Megacolon in Chagas diseaseB57.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 K93.8 Disorders of other specified digestive organs in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L00 Staphylococcal scalded skin syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L00-L08 Infections of the skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L01 Impetigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L01.0 Impetigo [any organism] [any site] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L01.1 Impetiginization of other dermatoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02 Cutaneous abscess, furuncle and carbuncle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.0 Cutaneous abscess, furuncle and carbuncle of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.1 Cutaneous abscess, furuncle and carbuncle of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.2 Cutaneous abscess, furuncle and carbuncle of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.3 Cutaneous abscess, furuncle and carbuncle of buttock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.4 Cutaneous abscess, furuncle and carbuncle of limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.8 Cutaneous abscess, furuncle and carbuncle of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03 Cellulitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.0 Cellulitis of finger and toe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.1 Cellulitis of other parts of limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.2 Cellulitis of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.3 Cellulitis of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.8 Cellulitis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L03.9 Cellulitis, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 305 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04 Acute lymphadenitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.0 Acute lymphadenitis of face, head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.1 Acute lymphadenitis of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.2 Acute lymphadenitis of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.3 Acute lymphadenitis of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.8 Acute lymphadenitis of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L04.9 Acute lymphadenitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L05 Pilonidal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L05.0 Pilonidal cyst with abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L05.9 Pilonidal cyst without abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L08 Other local infections of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L08.0 Pyoderma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L08.1 Erythrasma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L08.8 Other specified local infections of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L08.9 Local infection of skin and subcutaneous tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10 Pemphigus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10-L14 Bullous disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.0 Pemphigus vulgaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.1 Pemphigus vegetans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.2 Pemphigus foliaceus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.3 Brazilian pemphigus [fogo selvagem] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.4 Pemphigus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.5 Drug-induced pemphigus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.8 Other pemphigus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L10.9 Pemphigus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L11 Other acantholytic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L11.0 Acquired keratosis follicularis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L11.1 Transient acantholytic dermatosis [Grover] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L11.8 Other specified acantholytic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L11.9 Acantholytic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12 Pemphigoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.0 Bullous pemphigoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.1 Cicatricial pemphigoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.2 Chronic bullous disease of childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.3 Acquired epidermolysis bullosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.8 Other pemphigoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L12.9 Pemphigoid, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L13 Other bullous disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L13.0 Dermatitis herpetiformis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L13.1 Subcorneal pustular dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L13.8 Other specified bullous disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L13.9 Bullous disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L14 Bullous disorders in diseases classified elsewhere © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 306 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L20 Atopic dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L20-L30 Dermatitis and eczema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L20.0 Besnier prurigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L20.8 Other atopic dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L20.9 Atopic dermatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L21 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L21.0 Seborrhoea capitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L21.1 Seborrhoeic infantile dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L21.8 Other seborrhoeic dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L21.9 Seborrhoeic dermatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L22 Diaper [napkin] dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23 Allergic contact dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.0 Allergic contact dermatitis due to metals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.1 Allergic contact dermatitis due to adhesives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.2 Allergic contact dermatitis due to cosmetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.3 Allergic contact dermatitis due to drugs in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.4 Allergic contact dermatitis due to dyes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.5 Allergic contact dermatitis due to other chemical products 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.6 Allergic contact dermatitis due to food in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.7 Allergic contact dermatitis due to plants, except food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.8 Allergic contact dermatitis due to other agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L23.9 Allergic contact dermatitis, unspecified cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24 Irritant contact dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.0 Irritant contact dermatitis due to detergents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.1 Irritant contact dermatitis due to oils and greases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.2 Irritant contact dermatitis due to solvents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.3 Irritant contact dermatitis due to cosmetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.4 Irritant contact dermatitis due to drugs in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.5 Irritant contact dermatitis due to other chemical products 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.6 Irritant contact dermatitis due to food in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.7 Irritant contact dermatitis due to plants, except food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.8 Irritant contact dermatitis due to other agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L24.9 Irritant contact dermatitis, unspecified cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25 Unspecified contact dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.0 Unspecified contact dermatitis due to cosmetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.1 Unspecified contact dermatitis due to drugs in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.2 Unspecified contact dermatitis due to dyes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.3 Unspecified contact dermatitis due to other chemical products 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.4 Unspecified contact dermatitis due to food in contact with skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.5 Unspecified contact dermatitis due to plants, except food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.8 Unspecified contact dermatitis due to other agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L25.9 Unspecified contact dermatitis, unspecified cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L26 Exfoliative dermatitis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 307 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27 Dermatitis due to substances taken internally 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27.0 Generalized skin eruption due to drugs and medicaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27.1 Localized skin eruption due to drugs and medicaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27.2 Dermatitis due to ingested food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27.8 Dermatitis due to other substances taken internally 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L27.9 Dermatitis due to unspecified substance taken internally 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L28 Lichen simplex chronicus and prurigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L28.0 Lichen simplex chronicus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L28.1 Prurigo nodularis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L28.2 Other prurigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29 Pruritus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.0 Pruritus ani 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.1 Pruritus scroti 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.2 Pruritus vulvae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.3 Anogenital pruritus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.8 Other pruritus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L29.9 Pruritus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30 Other dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.0 Nummular dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.1 Dyshidrosis [pompholyx] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.2 Cutaneous autosensitization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.3 Infective dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.4 Erythema intertrigo 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.5 Pityriasis alba 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.8 Other specified dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L30.9 Dermatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40 Psoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40-L45 Papulosquamous disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.0 Psoriasis vulgaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.1 Generalized pustular psoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.2 Acrodermatitis continua 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.3 Pustulosis palmaris et plantaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.4 Guttate psoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.5 Arthropathic psoriasisM07.0-M07.3M09.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.8 Other psoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L40.9 Psoriasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41 Parapsoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.0 Pityriasis lichenoides et varioliformis acuta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.1 Pityriasis lichenoides chronica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.3 Small plaque parapsoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.4 Large plaque parapsoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.5 Retiform parapsoriasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.8 Other parapsoriasis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 308 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L41.9 Parapsoriasis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L42 Pityriasis rosea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43 Lichen planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.0 Hypertrophic lichen planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.1 Bullous lichen planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.2 Lichenoid drug reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.3 Subacute (active) lichen planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.8 Other lichen planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L43.9 Lichen planus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44 Other papulosquamous disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.0 Pityriasis rubra pilaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.1 Lichen nitidus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.2 Lichen striatus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.3 Lichen ruber moniliformis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.4 Infantile papular acrodermatitis [Giannotti-Crosti] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.8 Other specified papulosquamous disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L44.9 Papulosquamous disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L45 Papulosquamous disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50 Urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50-L54 Urticaria and erythema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.0 Allergic urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.1 Idiopathic urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.2 Urticaria due to cold and heat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.3 Dermatographic urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.4 Vibratory urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.5 urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.6 Contact urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.8 Other urticaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L50.9 Urticaria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51 Erythema multiforme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51.0 Nonbullous erythema multiforme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51.1 Bullous erythema multiforme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51.2 Toxic epidermal necrolysis [Lyell] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51.8 Other erythema multiforme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L51.9 Erythema multiforme, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L52 Erythema nodosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53 Other erythematous conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.0 Toxic erythema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.1 Erythema annulare centrifugum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.2 Erythema marginatum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.3 Other chronic figurate erythema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.8 Other specified erythematous conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L53.9 Erythematous condition, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 309 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L54 Erythema in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L54.0 Erythema marginatum in acute rheumatic feverI00 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L54.8 Erythema in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55 Sunburn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55-L59 Radiation-related disorders of the skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55.0 Sunburn of first degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55.1 Sunburn of second degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55.2 Sunburn of third degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55.8 Other sunburn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L55.9 Sunburn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56 Other acute skin changes due to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.0 Drug phototoxic response 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.1 Drug photoallergic response 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.2 Photocontact dermatitis [berloque dermatitis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.4 Polymorphous light eruption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.8 Other specified acute skin changes due to ultraviolet radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L56.9 Acute skin change due to ultraviolet radiation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57 Skin changes due to chronic exposure to nonionizing radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.1 Actinic reticuloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.2 Cutis rhomboidalis nuchae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.3 Poikiloderma of Civatte 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.4 Cutis laxa senilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.5 Actinic granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.8 Other skin changes due to chronic exposure to nonionizing radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L57.9 Skin changes due to chronic exposure to nonionizing radiation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L58 Radiodermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L58.0 Acute radiodermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L58.1 Chronic radiodermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L58.9 Radiodermatitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L59 Other disorders of skin and subcutaneous tissue related to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L59.0 Erythema ab igne [dermatitis ab igne] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60 Nail disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60-L75 Disorders of skin appendages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.0 Ingrowing nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.1 Onycholysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.2 Onychogryphosis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 310 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.3 Nail dystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.4 Beau lines 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.5 Yellow nail syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.8 Other nail disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L60.9 Nail disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L62 Nail disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L62.0 Clubbed nail pachydermoperiostosisM89.4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L62.8 Nail disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63 Alopecia areata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63.0 Alopecia (capitis) totalis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63.1 Alopecia universalis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63.2 Ophiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63.8 Other alopecia areata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L63.9 Alopecia areata, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L64 Androgenic alopecia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L64.0 Drug-induced androgenic alopecia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L64.8 Other androgenic alopecia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L64.9 Androgenic alopecia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65 Other nonscarring hair loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65.0 Telogen effluvium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65.1 Anagen effluvium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65.2 Alopecia mucinosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65.8 Other specified nonscarring hair loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L65.9 Nonscarring hair loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66 Cicatricial alopecia [scarring hair loss] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.0 Pseudopelade 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.1 Lichen planopilaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.2 Folliculitis decalvans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.3 Perifolliculitis capitis abscedens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.4 Folliculitis ulerythematosa reticulata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.8 Other cicatricial alopecia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L66.9 Cicatricial alopecia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L67 Hair colour and hair shaft abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L67.0 Trichorrhexis nodosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L67.1 Variations in hair colour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L67.8 Other hair colour and hair shaft abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L67.9 Hair colour and hair shaft abnormality, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.0 Hirsutism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.1 Acquired hypertrichosis lanuginosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.2 Localized hypertrichosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.3 Polytrichia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.8 Other hypertrichosis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 311 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L68.9 Hypertrichosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70 Acne 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.0 Acne vulgaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.1 Acne conglobata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.2 Acne varioliformis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.3 Acne tropica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.4 Infantile acne 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.5 Acné excoriée 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.8 Other acne 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L70.9 Acne, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L71 Rosacea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L71.0 Perioral dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L71.1 Rhinophyma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L71.8 Other rosacea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L71.9 Rosacea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72 Follicular cysts of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72.0 Epidermal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72.1 Trichilemmal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72.2 Steatocystoma multiplex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72.8 Other follicular cysts of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73 Other follicular disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73.0 Acne keloid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73.1 Pseudofolliculitis barbae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73.2 Hidradenitis suppurativa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73.8 Other specified follicular disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L73.9 Follicular disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74 Eccrine sweat disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.0 Miliaria rubra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.1 Miliaria crystallina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.2 Miliaria profunda 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.3 Miliaria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.4 Anhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.8 Other eccrine sweat disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L74.9 Eccrine sweat disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75 Apocrine sweat disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75.0 Bromhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75.1 Chromhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75.2 Apocrine miliaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75.8 Other apocrine sweat disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L75.9 Apocrine sweat disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L80 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L80-L99 Other disorders of the skin and subcutaneous tissue © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 312 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81 Other disorders of pigmentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.0 Postinflammatory hyperpigmentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.1 Chloasma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.2 Freckles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.3 Café au lait spots 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.4 Other hyperpigmentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.5 Leukoderma, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.6 Other disorders of diminished melanin formation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.7 Pigmented purpuric dermatosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.8 Other specified disorders of pigmentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L81.9 Disorder of pigmentation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L82 Seborrhoeic keratosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L83 Acanthosis nigricans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L84 Corns and callosities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85 Other epidermal thickening 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.0 Acquired ichthyosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.1 Acquired keratosis [keratoderma] palmaris et plantaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.2 Keratosis punctata (palmaris et plantaris) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.3 Xerosis cutis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.8 Other specified epidermal thickening 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L85.9 Epidermal thickening, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L86 Keratoderma in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87 Transepidermal elimination disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87.0 Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87.1 Reactive perforating collagenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87.2 Elastosis perforans serpiginosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87.8 Other transepidermal elimination disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L87.9 Transepidermal elimination disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L88 Pyoderma gangrenosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89 Decubitus ulcer and pressure area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89.0 Stage I decubitus ulcer and pressure area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89.1 Stage II decubitus ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89.2 Stage III decubitus ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89.3 Stage IV decubitus ulcer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L89.9 Decubitus ulcer and pressure area, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90 Atrophic disorders of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.0 Lichen sclerosus et atrophicus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.1 Anetoderma of Schweninger-Buzzi 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.2 Anetoderma of Jadassohn-Pellizzari 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.3 Atrophoderma of Pasini and Pierini 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.4 Acrodermatitis chronica atrophicans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.5 Scar conditions and fibrosis of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.6 Striae atrophicae © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 313 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.8 Other atrophic disorders of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L90.9 Atrophic disorder of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L91 Hypertrophic disorders of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L91.0 Hypertrophic scar 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L91.8 Other hypertrophic disorders of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L91.9 Hypertrophic disorder of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92 Granulomatous disorders of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.0 Granuloma annulare 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.1 Necrobiosis lipoidica, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.2 Granuloma faciale [eosinophilic granuloma of skin] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.3 Foreign body granuloma of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.8 Other granulomatous disorders of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L93 erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L93.0 Discoid lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L93.1 Subacute cutaneous lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L93.2 Other local lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94 Other localized connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.0 Localized scleroderma [morphea] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.1 Linear scleroderma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.2 Calcinosis cutis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.3 Sclerodactyly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.4 Gottron papules 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.5 Poikiloderma vasculare atrophicans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.6 Ainhum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.8 Other specified localized connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L94.9 Localized connective tissue disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L95 Vasculitis limited to skin, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L95.0 Livedoid vasculitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L95.1 Erythema elevatum diutinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L95.8 Other vasculitis limited to skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L95.9 Vasculitis limited to skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L97 Ulcer of lower limb, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.0 Pyogenic granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.1 Factitial dermatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.2 Febrile neutrophilic dermatosis [Sweet] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.3 Eosinophilic cellulitis [Wells] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.4 Chronic ulcer of skin, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.5 Mucinosis of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.6 Other infiltrative disorders of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.7 Excessive and redundant skin and subcutaneous tissue © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 314 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.8 Other specified disorders of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L98.9 Disorder of skin and subcutaneous tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L99.0 Amyloidosis of skinE85.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 L99.8 Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00 Pyogenic arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00-M03 Infectious arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00-M25 Arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00.0 Staphylococcal arthritis and polyarthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00.1 Pneumococcal arthritis and polyarthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00.2 Other streptococcal arthritis and polyarthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00.8 Arthritis and polyarthritis due to other specified bacterial agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M00.9 Pyogenic arthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01 Direct infections of joint in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.0 Meningococcal arthritisA39.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.1 Tuberculous arthritisA18.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.2 Arthritis in Lyme diseaseA69.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.3 Arthritis in other bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.4 Rubella arthritisB06.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.5 Arthritis in other viral diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.6 Arthritis in mycosesB35-B49 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M01.8 Arthritis in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02 Reactive arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.0 Arthropathy following intestinal bypass 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.1 Postdysenteric arthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.2 Postimmunization arthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.3 Reiter disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.8 Other reactive arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M02.9 Reactive arthropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M03 Postinfective and reactive arthropathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M03.0 Postmeningococcal arthritisA39.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M03.1 Postinfective arthropathy in syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M03.2 Other postinfectious arthropathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M03.6 Reactive arthropathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05 Seropositive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05-M14 Inflammatory polyarthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.0 Felty syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.1 Rheumatoid lung diseaseJ99.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.2 Rheumatoid vasculitis

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 315 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.3 Rheumatoid arthritis with involvement of other organs and systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.8 Other seropositive rheumatoid arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M05.9 Seropositive rheumatoid arthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06 Other rheumatoid arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.0 Seronegative rheumatoid arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.1 Adult-onset Still disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.2 Rheumatoid bursitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.3 Rheumatoid nodule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.4 Inflammatory polyarthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.8 Other specified rheumatoid arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M06.9 Rheumatoid arthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07 Psoriatic and enteropathic arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.0 Distal interphalangeal psoriatic arthropathyL40.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.1 Arthritis mutilansL40.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.2 Psoriatic spondylitisL40.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.3 Other psoriatic arthropathiesL40.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.4 Arthropathy in Crohn disease [regional enteritis]K50.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.5 Arthropathy in ulcerative colitisK51.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M07.6 Other enteropathic arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08 Juvenile arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.0 Juvenile rheumatoid arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.1 Juvenile ankylosing spondylitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.2 Juvenile arthritis with systemic onset 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.3 Juvenile polyarthritis (seronegative) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.4 Pauciarticular juvenile arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.8 Other juvenile arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M08.9 Juvenile arthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M09 Juvenile arthritis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M09.0 Juvenile arthritis in psoriasisL40.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M09.1 Juvenile arthritis in Crohn disease [regional enteritis]K50.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M09.2 Juvenile arthritis in ulcerative colitisK51.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M09.8 Juvenile arthritis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10 Gout 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.0 Idiopathic gout 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.1 Lead-induced gout 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.2 Drug-induced gout 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.3 Gout due to impairment of renal function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.4 Other secondary gout 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M10.9 Gout, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11 Other crystal arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11.0 Hydroxyapatite deposition disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11.1 Familial chondrocalcinosis

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 316 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11.2 Other chondrocalcinosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11.8 Other specified crystal arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M11.9 Crystal arthropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12 Other specific arthropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.0 Chronic postrheumatic arthropathy [Jaccoud] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.1 Kaschin-Beck disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.2 Villonodular synovitis (pigmented) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.3 Palindromic rheumatism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.4 Intermittent hydrarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.5 Traumatic arthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M12.8 Other specific arthropathies, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M13 Other arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M13.0 Polyarthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M13.1 Monoarthritis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M13.8 Other specified arthritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M13.9 Arthritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14 Arthropathies in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.0 Gouty arthropathy due to enzyme defects and other inherited disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.1 Crystal arthropathy in other metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.2 Diabetic arthropathyE10-E14 with common fourth character .6 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.3 Lipoid dermatoarthritisE78.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.4 Arthropathy in amyloidosisE85.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.5 Arthropathies in other endocrine, nutritional and metabolic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.6 Neuropathic arthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M14.8 Arthropathies in other specified diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15 Polyarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15-M19 Arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.0 Primary generalized (osteo)arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.1 Heberden nodes (with arthropathy) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.2 Bouchard nodes (with arthropathy) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.3 Secondary multiple arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.4 Erosive (osteo)arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.8 Other polyarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M15.9 Polyarthrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16 Coxarthrosis [arthrosis of hip] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.0 Primary coxarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.1 Other primary coxarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.2 Coxarthrosis resulting from dysplasia, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.3 Other dysplastic coxarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.4 Post-traumatic coxarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.5 Other post-traumatic coxarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.6 Other secondary coxarthrosis, bilateral © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 317 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.7 Other secondary coxarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M16.9 Coxarthrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17 Gonarthrosis [arthrosis of knee] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.0 Primary gonarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.1 Other primary gonarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.2 Post-traumatic gonarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.3 Other post-traumatic gonarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.4 Other secondary gonarthrosis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.5 Other secondary gonarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M17.9 Gonarthrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18 Arthrosis of first carpometacarpal joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.0 Primary arthrosis of first carpometacarpal joints, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.1 Other primary arthrosis of first carpometacarpal joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.2 Post-traumatic arthrosis of first carpometacarpal joints, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.3 Other post-traumatic arthrosis of first carpometacarpal joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.4 Other secondary arthrosis of first carpometacarpal joints, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.5 Other secondary arthrosis of first carpometacarpal joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M18.9 Arthrosis of first carpometacarpal joint, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19 Other arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19.0 Primary arthrosis of other joints 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19.1 Post-traumatic arthrosis of other joints 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19.2 Other secondary arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19.8 Other specified arthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M19.9 Arthrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20 Acquired deformities of fingers and toes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20-M25 Other joint disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.0 Deformity of finger(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.1 Hallux valgus (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.2 Hallux rigidus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.3 Other deformity of hallux (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.4 Other hammer toe(s) (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.5 Other deformities of toe(s) (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M20.6 Acquired deformity of toe(s), unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21 Other acquired deformities of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.0 Valgus deformity, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.1 Varus deformity, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.2 Flexion deformity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.3 Wrist or foot drop (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.4 Flat foot [pes planus] (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.6 Other acquired deformities of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.7 Unequal limb length (acquired)

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 318 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.8 Other specified acquired deformities of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M21.9 Acquired deformity of limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22 Disorders of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.0 Recurrent dislocation of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.1 Recurrent subluxation of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.2 Patellofemoral disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.3 Other derangements of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.4 Chondromalacia patellae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.8 Other disorders of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M22.9 Disorder of patella, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23 Internal derangement of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.0 Cystic meniscus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.1 Discoid meniscus (congenital) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.2 Derangement of meniscus due to old tear or injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.3 Other meniscus derangements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.4 Loose body in knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.5 Chronic instability of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.6 Other spontaneous disruption of ligament(s) of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.8 Other internal derangements of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M23.9 Internal derangement of knee, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24 Other specific joint derangements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.0 Loose body in joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.1 Other articular cartilage disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.2 Disorder of ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.3 Pathological dislocation and subluxation of joint, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.4 Recurrent dislocation and subluxation of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.5 Contracture of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.6 Ankylosis of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.7 Protrusio acetabuli 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.8 Other specific joint derangements, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M24.9 Joint derangement, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25 Other joint disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.0 Haemarthrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.1 Fistula of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.2 Flail joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.3 Other instability of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.4 Effusion of joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.5 Pain in joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.6 Stiffness of joint, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.7 Osteophyte 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.8 Other specified joint disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M25.9 Joint disorder, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 319 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30 Polyarteritis nodosa and related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30-M36 Systemic connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30.0 Polyarteritis nodosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30.1 Polyarteritis with lung involvement [Churg-Strauss] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30.2 Juvenile polyarteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30.3 Mucocutaneous lymph node syndrome [Kawasaki] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M30.8 Other conditions related to polyarteritis nodosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31 Other necrotizing vasculopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.0 Hypersensitivity angiitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.1 Thrombotic microangiopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.2 Lethal midline granuloma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.3 Wegener granulomatosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.4 Aortic arch syndrome [Takayasu] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.5 Giant cell arteritis with polymyalgia rheumatica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.6 Other giant cell arteritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.7 Microscopic polyangiitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.8 Other specified necrotizing vasculopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M31.9 Necrotizing vasculopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M32 Systemic lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M32.0 Drug-induced systemic lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M32.1 Systemic lupus erythematosus with organ or system involvement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M32.8 Other forms of systemic lupus erythematosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M32.9 Systemic lupus erythematosus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M33 Dermatopolymyositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M33.0 Juvenile dermatomyositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M33.1 Other dermatomyositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M33.2 Polymyositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M33.9 Dermatopolymyositis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34 Systemic sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34.0 Progressive systemic sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34.1 CR(E)ST syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34.2 Systemic sclerosis induced by drugs and chemicals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34.8 Other forms of systemic sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M34.9 Systemic sclerosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35 Other systemic involvement of connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.0 Sicca syndrome [Sjögren] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.1 Other overlap syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.2 Behçet disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.3 Polymyalgia rheumatica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.4 Diffuse (eosinophilic) fasciitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.5 Multifocal fibrosclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.6 Relapsing panniculitis [Weber-Christian] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.7 Hypermobility syndrome © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 320 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.8 Other specified systemic involvement of connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M35.9 Systemic involvement of connective tissue, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36 Systemic disorders of connective tissue in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.0 Dermato(poly)myositis in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.1 Arthropathy in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.2 Haemophilic arthropathyD66-D68 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.3 Arthropathy in other blood disordersD50-D76 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.4 Arthropathy in hypersensitivity reactions classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M36.8 Systemic disorders of connective tissue in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40 Kyphosis and lordosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40-M43 Deforming dorsopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40-M54 Dorsopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.0 Postural kyphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.1 Other secondary kyphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.2 Other and unspecified kyphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.3 Flatback syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.4 Other lordosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M40.5 Lordosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41 Scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.0 Infantile idiopathic scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.1 Juvenile idiopathic scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.2 Other idiopathic scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.3 Thoracogenic scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.4 Neuromuscular scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.5 Other secondary scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.8 Other forms of scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M41.9 Scoliosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M42 Spinal osteochondrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M42.0 Juvenile osteochondrosis of spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M42.1 Adult osteochondrosis of spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M42.9 Spinal osteochondrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43 Other deforming dorsopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.0 Spondylolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.1 Spondylolisthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.2 Other fusion of spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.3 Recurrent atlantoaxial subluxation with myelopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.4 Other recurrent atlantoaxial subluxation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.5 Other recurrent vertebral subluxation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.6 Torticollis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.8 Other specified deforming dorsopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M43.9 Deforming dorsopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M45 Ankylosing spondylitis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 321 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M45-M49 Spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46 Other inflammatory spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.0 Spinal enthesopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.1 Sacroiliitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.2 Osteomyelitis of vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.3 Infection of intervertebral disc (pyogenic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.4 Discitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.5 Other infective spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.8 Other specified inflammatory spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M46.9 Inflammatory spondylopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47 Spondylosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47.0 Anterior spinal and vertebral artery compression syndromesG99.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47.1 Other spondylosis with myelopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47.2 Other spondylosis with radiculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47.8 Other spondylosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M47.9 Spondylosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48 Other spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.0 Spinal stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.1 Ankylosing hyperostosis [Forestier] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.2 Kissing spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.3 Traumatic spondylopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.4 Fatigue fracture of vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.5 Collapsed vertebra, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.8 Other specified spondylopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M48.9 Spondylopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49 Spondylopathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.0 Tuberculosis of spineA18.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.1 Brucella spondylitisA23.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.2 Enterobacterial spondylitisA01-A04 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.3 Spondylopathy in other infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.4 Neuropathic spondylopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.5 Collapsed vertebra in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M49.8 Spondylopathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50 Cervical disc disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50-M54 Other dorsopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.0 Cervical disc disorder with myelopathyG99.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.1 Cervical disc disorder with radiculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.2 Other cervical disc displacement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.3 Other cervical disc degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.8 Other cervical disc disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M50.9 Cervical disc disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51 Other intervertebral disc disorders © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 322 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.0 Lumbar and other intervertebral disc disorders with myelopathyG99.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.1 Lumbar and other intervertebral disc disorders with radiculopathyG55.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.2 Other specified intervertebral disc displacement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.3 Other specified intervertebral disc degeneration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.4 Schmorl nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.8 Other specified intervertebral disc disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M51.9 Intervertebral disc disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53 Other dorsopathies, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.0 Cervicocranial syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.1 Cervicobrachial syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.2 Spinal instabilities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.3 Sacrococcygeal disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.8 Other specified dorsopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M53.9 Dorsopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54 Dorsalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.0 Panniculitis affecting regions of neck and back 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.1 Radiculopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.2 Cervicalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.3 Sciatica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.4 Lumbago with sciatica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.5 Low back pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.6 Pain in thoracic spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.8 Other dorsalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M54.9 Dorsalgia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60 Myositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60-M63 Disorders of muscles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60-M79 Soft tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60.0 Infective myositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60.1 Interstitial myositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60.2 Foreign body granuloma of soft tissue, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60.8 Other myositis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M60.9 Myositis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61 Calcification and ossification of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.0 Myositis ossificans traumatica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.1 Myositis ossificans progressiva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.2 Paralytic calcification and ossification of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.3 Calcification and ossification of muscles associated with burns 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.4 Other calcification of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.5 Other ossification of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M61.9 Calcification and ossification of muscle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62 Other disorders of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.0 Diastasis of muscle © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 323 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.1 Other rupture of muscle (nontraumatic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.2 Ischaemic infarction of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.3 Immobility syndrome (paraplegic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.4 Contracture of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.5 Muscle wasting and atrophy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.6 Muscle strain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.8 Other specified disorders of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M62.9 Disorder of muscle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63 Disorders of muscle in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63.0 Myositis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63.1 Myositis in protozoal and parasitic infections classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63.2 Myositis in other infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63.3 Myositis in sarcoidosisD86.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M63.8 Other disorders of muscle in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65 Synovitis and tenosynovitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65-M68 Disorders of synovium and tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.0 Abscess of tendon sheath 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.1 Other infective (teno)synovitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.2 Calcific tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.3 Trigger finger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.4 Radial styloid tenosynovitis [de Quervain] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.8 Other synovitis and tenosynovitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M65.9 Synovitis and tenosynovitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66 Spontaneous rupture of synovium and tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.0 Rupture of popliteal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.1 Rupture of synovium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.2 Spontaneous rupture of extensor tendons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.3 Spontaneous rupture of flexor tendons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.4 Spontaneous rupture of other tendons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M66.5 Spontaneous rupture of unspecified tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67 Other disorders of synovium and tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.0 Short Achilles tendon (acquired) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.1 Other contracture of tendon (sheath) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.2 Synovial hypertrophy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.3 Transient synovitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.4 Ganglion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.8 Other specified disorders of synovium and tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M67.9 Disorder of synovium and tendon, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M68 Disorders of synovium and tendon in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M68.0 Synovitis and tenosynovitis in bacterial diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M68.8 Other disorders of synovium and tendon in diseases classified elsewhere

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 324 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70 Soft tissue disorders related to use, overuse and pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70-M79 Other soft tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.0 Chronic crepitant synovitis of hand and wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.1 Bursitis of hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.2 Olecranon bursitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.3 Other bursitis of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.4 Prepatellar bursitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.5 Other bursitis of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.6 Trochanteric bursitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.7 Other bursitis of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.8 Other soft tissue disorders related to use, overuse and pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M70.9 Unspecified soft tissue disorder related to use, overuse and pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71 Other bursopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.0 Abscess of bursa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.1 Other infective bursitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.2 Synovial cyst of popliteal space [Baker] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.3 Other bursal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.4 Calcium deposit in bursa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.5 Other bursitis, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.8 Other specified bursopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M71.9 Bursopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72 Fibroblastic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.0 Palmar fascial fibromatosis [Dupuytren] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.1 Knuckle pads 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.2 Plantar fascial fibromatosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.4 Pseudosarcomatous fibromatosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.6 Necrotizing fasciitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.8 Other fibroblastic disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M72.9 Fibroblastic disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M73 Soft tissue disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M73.0 Gonococcal bursitisA54.4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M73.1 Syphilitic bursitisA52.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M73.8 Other soft tissue disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75 Shoulder lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.0 Adhesive capsulitis of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.1 Rotator cuff syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.2 Bicipital tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.3 Calcific tendinitis of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.4 Impingement syndrome of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.5 Bursitis of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.8 Other shoulder lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M75.9 Shoulder lesion, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 325 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76 Enthesopathies of lower limb, excluding foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.0 Gluteal tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.1 Psoas tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.2 Iliac crest spur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.3 Iliotibial band syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.4 Tibial collateral bursitis [Pellegrini-Stieda] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.5 Patellar tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.6 Achilles tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.7 Peroneal tendinitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.8 Other enthesopathies of lower limb, excluding foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M76.9 Enthesopathy of lower limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77 Other enthesopathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.0 Medial epicondylitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.1 Lateral epicondylitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.2 Periarthritis of wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.3 Calcaneal spur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.4 Metatarsalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.5 Other enthesopathy of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.8 Other enthesopathies, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M77.9 Enthesopathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79 Other soft tissue disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.0 Rheumatism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.1 Myalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.2 Neuralgia and neuritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.3 Panniculitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.4 Hypertrophy of (infrapatellar) fat pad 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.5 Residual foreign body in soft tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.6 Pain in limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.7 Fibromyalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.8 Other specified soft tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M79.9 Soft tissue disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80 Osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80-M85 Disorders of bone and structure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80-M94 Osteopathies and chondropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.0 Postmenopausal osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.1 Postoophorectomy osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.2 Osteoporosis of disuse with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.3 Postsurgical malabsorption osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.4 Drug-induced osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.5 Idiopathic osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.8 Other osteoporosis with pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M80.9 Unspecified osteoporosis with pathological fracture

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 326 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81 Osteoporosis without pathological fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.0 Postmenopausal osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.1 Postoophorectomy osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.2 Osteoporosis of disuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.3 Postsurgical malabsorption osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.4 Drug-induced osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.5 Idiopathic osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.6 Localized osteoporosis [Lequesne] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.8 Other osteoporosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M81.9 Osteoporosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M82 Osteoporosis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M82.0 Osteoporosis in multiple myelomatosisC90.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M82.1 Osteoporosis in endocrine disordersE00-E34 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M82.8 Osteoporosis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83 Adult osteomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.0 Puerperal osteomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.1 Senile osteomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.2 Adult osteomalacia due to malabsorption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.3 Adult osteomalacia due to malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.4 Aluminium bone disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.5 Other drug-induced osteomalacia in adults 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.8 Other adult osteomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M83.9 Adult osteomalacia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84 Disorders of continuity of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.0 Malunion of fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.1 Nonunion of fracture [pseudarthrosis] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.2 Delayed union of fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.3 Stress fracture, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.4 Pathological fracture, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.8 Other disorders of continuity of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M84.9 Disorder of continuity of bone, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85 Other disorders of bone density and structure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.0 Fibrous dysplasia (monostotic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.1 Skeletal fluorosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.2 Hyperostosis of skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.3 Osteitis condensans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.4 Solitary bone cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.5 Aneurysmal bone cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.6 Other cyst of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.8 Other specified disorders of bone density and structure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M85.9 Disorder of bone density and structure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86 Osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86-M90 Other osteopathies © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 327 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.0 Acute haematogenous osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.1 Other acute osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.2 Subacute osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.3 Chronic multifocal osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.4 Chronic osteomyelitis with draining sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.5 Other chronic haematogenous osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.6 Other chronic osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.8 Other osteomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M86.9 Osteomyelitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87 Osteonecrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.0 Idiopathic aseptic necrosis of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.1 Osteonecrosis due to drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.2 Osteonecrosis due to previous trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.3 Other secondary osteonecrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.8 Other osteonecrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M87.9 Osteonecrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M88 Paget disease of bone [osteitis deformans] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M88.0 Paget disease of skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M88.8 Paget disease of other bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M88.9 Paget disease of bone, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89 Other disorders of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.0 Algoneurodystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.1 Epiphyseal arrest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.2 Other disorders of bone development and growth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.3 Hypertrophy of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.4 Other hypertrophic osteoarthropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.5 Osteolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.6 Osteopathy after poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.8 Other specified disorders of bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M89.9 Disorder of bone, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90 Osteopathies in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.0 Tuberculosis of boneA18.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.1 Periostitis in other infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.2 Osteopathy in other infectious diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.3 Osteonecrosis in caisson diseaseT70.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.4 Osteonecrosis due to haemoglobinopathyD50-D64 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.5 Osteonecrosis in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.6 Osteitis deformans in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.7 Fracture of bone in neoplastic diseaseC00-D48 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M90.8 Osteopathy in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91 Juvenile osteochondrosis of hip and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91-M94 Chondropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.0 Juvenile osteochondrosis of pelvis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 328 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.1 Juvenile osteochondrosis of head of femur [Legg-Calvé-Perthes] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.2 Coxa plana 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.3 Pseudocoxalgia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.8 Other juvenile osteochondrosis of hip and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M91.9 Juvenile osteochondrosis of hip and pelvis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92 Other juvenile osteochondrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.0 Juvenile osteochondrosis of humerus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.1 Juvenile osteochondrosis of radius and ulna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.2 Juvenile osteochondrosis of hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.3 Other juvenile osteochondrosis of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.4 Juvenile osteochondrosis of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.5 Juvenile osteochondrosis of tibia and fibula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.6 Juvenile osteochondrosis of tarsus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.7 Juvenile osteochondrosis of metatarsus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.8 Other specified juvenile osteochondrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M92.9 Juvenile osteochondrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93 Other osteochondropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93.0 Slipped upper femoral epiphysis (nontraumatic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93.1 Kienböck disease of adults 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93.2 Osteochondritis dissecans 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93.8 Other specified osteochondropathies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M93.9 Osteochondropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94 Other disorders of cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.0 Chondrocostal junction syndrome [Tietze] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.1 Relapsing polychondritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.2 Chondromalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.3 Chondrolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.8 Other specified disorders of cartilage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M94.9 Disorder of cartilage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95 Other acquired deformities of musculoskeletal system and connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95-M99 Other disorders of the musculoskeletal system and connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.0 Acquired deformity of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.1 Cauliflower ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.2 Other acquired deformity of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.3 Acquired deformity of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.4 Acquired deformity of chest and rib 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.5 Acquired deformity of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.8 Other specified acquired deformities of musculoskeletal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M95.9 Acquired deformity of musculoskeletal system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96 Postprocedural musculoskeletal disorders, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.0 Pseudarthrosis after fusion or arthrodesis

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 329 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.1 Postlaminectomy syndrome, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.2 Postradiation kyphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.3 Postlaminectomy kyphosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.4 Postsurgical lordosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.5 Postradiation scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.8 Other postprocedural musculoskeletal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M96.9 Postprocedural musculoskeletal disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99 Biomechanical lesions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.0 Segmental and somatic dysfunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.1 Subluxation complex (vertebral) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.2 Subluxation stenosis of neural canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.3 Osseous stenosis of neural canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.4 Connective tissue stenosis of neural canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.5 Intervertebral disc stenosis of neural canal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.6 Osseous and subluxation stenosis of intervertebral foramina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.7 Connective tissue and disc stenosis of intervertebral foramina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.8 Other biomechanical lesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 M99.9 Biomechanical lesion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00 Acute nephritic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N00-N08 Glomerular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N01 Rapidly progressive nephritic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N02 Recurrent and persistent haematuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N03 Chronic nephritic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N04 Nephrotic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N05 Unspecified nephritic syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N06 Isolated proteinuria with specified morphological lesion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N07 Hereditary nephropathy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08 Glomerular disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.1 Glomerular disorders in neoplastic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.3 Glomerular disorders in diabetes mellitusE10-E14 with common fourth character .2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.5 Glomerular disorders in systemic connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N08.8 Glomerular disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N10 Acute tubulo-interstitial nephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N10-N16 Renal tubulo-interstitial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N11 Chronic tubulo-interstitial nephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N11.0 Nonobstructive reflux-associated chronic pyelonephritis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 330 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N11.1 Chronic obstructive pyelonephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N11.8 Other chronic tubulo-interstitial nephritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N11.9 Chronic tubulo-interstitial nephritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N12 Tubulo-interstitial nephritis, not specified as acute or chronic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13 Obstructive and reflux uropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.0 Hydronephrosis with ureteropelvic junction obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.2 Hydronephrosis with renal and ureteral calculous obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.3 Other and unspecified hydronephrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.4 Hydroureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.5 Kinking and stricture of ureter without hydronephrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.6 Pyonephrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.7 Vesicoureteral-reflux-associated uropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.8 Other obstructive and reflux uropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N13.9 Obstructive and reflux uropathy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14.0 nephropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14.1 Nephropathy induced by other drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14.2 Nephropathy induced by unspecified drug, medicament or biological substance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14.3 Nephropathy induced by heavy metals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N14.4 Toxic nephropathy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N15 Other renal tubulo-interstitial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N15.0 Balkan nephropathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N15.1 Renal and perinephric abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N15.8 Other specified renal tubulo-interstitial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N15.9 Renal tubulo-interstitial disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16 Renal tubulo-interstitial disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.1 Renal tubulo-interstitial disorders in neoplastic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.3 Renal tubulo-interstitial disorders in metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.5 Renal tubulo-interstitial disorders in transplant rejectionT86.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17 Acute renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17-N19 Renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17.0 Acute renal failure with tubular necrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17.1 Acute renal failure with acute cortical necrosis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 331 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17.2 Acute renal failure with medullary necrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17.8 Other acute renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N17.9 Acute renal failure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18 Chronic kidney disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.1 Chronic kidney disease, stage 1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.2 Chronic kidney disease, stage 2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.3 Chronic kidney disease, stage 3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.4 Chronic kidney disease, stage 4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.5 Chronic kidney disease, stage 5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N18.9 Chronic kidney disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N19 Unspecified kidney failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20 Calculus of kidney and ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20-N23 Urolithiasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20.0 Calculus of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20.1 Calculus of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20.2 Calculus of kidney with calculus of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N20.9 Urinary calculus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N21 Calculus of lower urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N21.0 Calculus in bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N21.1 Calculus in urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N21.8 Other lower urinary tract calculus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N21.9 Calculus of lower urinary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N22 Calculus of urinary tract in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N22.0 Urinary calculus in schistosomiasis [bilharziasis]B65.- 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N22.8 Calculus of urinary tract in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N23 Unspecified renal colic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25 Disorders resulting from impaired renal tubular function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25-N29 Other disorders of kidney and ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25.0 Renal osteodystrophy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25.1 Nephrogenic diabetes insipidus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25.8 Other disorders resulting from impaired renal tubular function 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N25.9 Disorder resulting from impaired renal tubular function, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N26 Unspecified contracted kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N27 Small kidney of unknown cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N27.0 Small kidney, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N27.1 Small kidney, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N27.9 Small kidney, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N28 Other disorders of kidney and ureter, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N28.0 Ischaemia and infarction of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N28.1 Cyst of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N28.8 Other specified disorders of kidney and ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N28.9 Disorder of kidney and ureter, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 332 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N29 Other disorders of kidney and ureter in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N29.0 Late syphilis of kidneyA52.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N29.1 Other disorders of kidney and ureter in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N29.8 Other disorders of kidney and ureter in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30 Cystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30-N39 Other diseases of urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.0 Acute cystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.1 Interstitial cystitis (chronic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.2 Other chronic cystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.3 Trigonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.4 Irradiation cystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.8 Other cystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N30.9 Cystitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31 Neuromuscular dysfunction of bladder, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31.0 Uninhibited neuropathic bladder, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31.1 Reflex neuropathic bladder, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31.2 Flaccid neuropathic bladder, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31.8 Other neuromuscular dysfunction of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N31.9 Neuromuscular dysfunction of bladder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32 Other disorders of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.0 Bladder-neck obstruction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.1 Vesicointestinal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.2 Vesical fistula, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.3 Diverticulum of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.4 Rupture of bladder, nontraumatic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.8 Other specified disorders of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N32.9 Bladder disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N33 Bladder disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N33.0 Tuberculous cystitisA18.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N33.8 Bladder disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N34 Urethritis and urethral syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N34.0 Urethral abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N34.1 Nonspecific urethritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N34.2 Other urethritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N34.3 Urethral syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N35 Urethral stricture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N35.0 Post-traumatic urethral stricture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N35.1 Postinfective urethral stricture, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N35.8 Other urethral stricture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N35.9 Urethral stricture, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36 Other disorders of urethra

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 333 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.0 Urethral fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.1 Urethral diverticulum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.2 Urethral caruncle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.3 Prolapsed urethral mucosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.8 Other specified disorders of urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N36.9 Urethral disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N37 Urethral disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N37.0 Urethritis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N37.8 Other urethral disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39 Other disorders of urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.0 Urinary tract infection, site not specified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.1 Persistent proteinuria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.2 Orthostatic proteinuria, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.3 Stress incontinence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.4 Other specified urinary incontinence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.8 Other specified disorders of urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N39.9 Disorder of urinary system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N40 Hyperplasia of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N40-N51 Diseases of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41 Inflammatory diseases of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.0 Acute prostatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.1 Chronic prostatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.2 Abscess of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.3 Prostatocystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.8 Other inflammatory diseases of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N41.9 Inflammatory disease of prostate, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42 Other disorders of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.0 Calculus of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.1 Congestion and haemorrhage of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.2 Atrophy of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.3 Dysplasia of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.8 Other specified disorders of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N42.9 Disorder of prostate, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43 Hydrocele and spermatocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43.0 Encysted hydrocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43.1 Infected hydrocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43.2 Other hydrocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43.3 Hydrocele, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N43.4 Spermatocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N44 Torsion of testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N45 Orchitis and epididymitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 334 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N46 Male infertility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N47 Redundant prepuce, phimosis and paraphimosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48 Other disorders of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.0 Leukoplakia of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.1 Balanoposthitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.2 Other inflammatory disorders of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.3 Priapism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.4 Impotence of organic origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.5 Ulcer of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.6 Induratio penis plastica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.8 Other specified disorders of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N48.9 Disorder of penis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49 Inflammatory disorders of male genital organs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49.0 Inflammatory disorders of seminal vesicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49.2 Inflammatory disorders of scrotum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49.8 Inflammatory disorders of other specified male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N49.9 Inflammatory disorder of unspecified male genital organ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N50 Other disorders of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N50.0 Atrophy of testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N50.1 Vascular disorders of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N50.8 Other specified disorders of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N50.9 Disorder of male genital organs, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N51 Disorders of male genital organs in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N51.0 Disorders of prostate in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N51.1 Disorders of testis and epididymis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N51.2 Balanitis in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N51.8 Other disorders of male genital organs in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60 Benign mammary dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60-N64 Disorders of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.0 Solitary cyst of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.1 Diffuse cystic mastopathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.2 Fibroadenosis of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.3 Fibrosclerosis of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.4 Mammary duct ectasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.8 Other benign mammary dysplasias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N60.9 Benign mammary dysplasia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N61 Inflammatory disorders of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N62 Hypertrophy of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N63 Unspecified lump in breast © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 335 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64 Other disorders of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.0 Fissure and fistula of nipple 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.1 Fat necrosis of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.2 Atrophy of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.3 Galactorrhoea not associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.4 Mastodynia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.5 Other signs and symptoms in breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.8 Other specified disorders of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N64.9 Disorder of breast, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N70 Salpingitis and oophoritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N70-N77 Inflammatory diseases of female pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N70.0 Acute salpingitis and oophoritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N70.1 Chronic salpingitis and oophoritis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N70.9 Salpingitis and oophoritis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N71 Inflammatory disease of uterus, except cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N71.0 Acute inflammatory disease of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N71.1 Chronic inflammatory disease of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N71.9 Inflammatory disease of uterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N72 Inflammatory disease of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73 Other female pelvic inflammatory diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.0 Acute parametritis and pelvic cellulitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.1 Chronic parametritis and pelvic cellulitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.2 Unspecified parametritis and pelvic cellulitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.3 Female acute pelvic peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.4 Female chronic pelvic peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.5 Female pelvic peritonitis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.6 Female pelvic peritoneal adhesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.8 Other specified female pelvic inflammatory diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N73.9 Female pelvic inflammatory disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74 Female pelvic inflammatory disorders in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.0 Tuberculous infection of cervix uteriA18.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.1 Female tuberculous pelvic inflammatory diseaseA18.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.2 Female syphilitic pelvic inflammatory diseaseA51.4A52.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.3 Female gonococcal pelvic inflammatory diseaseA54.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.4 Female chlamydial pelvic inflammatory diseaseA56.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N75 Diseases of Bartholin gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N75.0 Cyst of Bartholin gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N75.1 Abscess of Bartholin gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N75.8 Other diseases of Bartholin gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N75.9 Disease of Bartholin gland, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76 Other inflammation of vagina and vulva © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 336 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.0 Acute vaginitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.1 Subacute and chronic vaginitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.2 Acute vulvitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.3 Subacute and chronic vulvitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.4 Abscess of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.5 Ulceration of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.6 Ulceration of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N76.8 Other specified inflammation of vagina and vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80 Endometriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80-N98 Noninflammatory disorders of female genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.0 Endometriosis of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.1 Endometriosis of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.2 Endometriosis of fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.3 Endometriosis of pelvic peritoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.4 Endometriosis of rectovaginal septum and vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.5 Endometriosis of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.6 Endometriosis in cutaneous scar 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.8 Other endometriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N80.9 Endometriosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81 Female genital prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.0 Female urethrocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.1 Cystocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.2 Incomplete uterovaginal prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.3 Complete uterovaginal prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.4 Uterovaginal prolapse, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.5 Vaginal enterocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.6 Rectocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.8 Other female genital prolapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N81.9 Female genital prolapse, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82 Fistulae involving female genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.0 Vesicovaginal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.1 Other female urinary-genital tract fistulae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.2 Fistula of vagina to small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.3 Fistula of vagina to large intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.4 Other female intestinal-genital tract fistulae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.5 Female genital tract-skin fistulae

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 337 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.8 Other female genital tract fistulae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N82.9 Female genital tract fistula, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83 Noninflammatory disorders of ovary, fallopian tube and broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.0 Follicular cyst of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.1 Corpus luteum cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.2 Other and unspecified ovarian cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.3 Acquired atrophy of ovary and fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.4 Prolapse and hernia of ovary and fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.5 Torsion of ovary, ovarian pedicle and fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.6 Haematosalpinx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.7 Haematoma of broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.8 Other noninflammatory disorders of ovary, fallopian tube and broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N83.9 Noninflammatory disorder of ovary, fallopian tube and broad ligament, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84 Polyp of female genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.0 Polyp of corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.1 Polyp of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.2 Polyp of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.3 Polyp of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.8 Polyp of other parts of female genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N84.9 Polyp of female genital tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85 Other noninflammatory disorders of uterus, except cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.0 Endometrial glandular hyperplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.1 Endometrial adenomatous hyperplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.2 Hypertrophy of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.3 Subinvolution of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.4 Malposition of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.5 Inversion of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.6 Intrauterine synechiae 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.7 Haematometra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.8 Other specified noninflammatory disorders of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N85.9 Noninflammatory disorder of uterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N86 Erosion and ectropion of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N87 Dysplasia of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N87.0 Mild cervical dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N87.1 Moderate cervical dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N87.2 Severe cervical dysplasia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N87.9 Dysplasia of cervix uteri, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88 Other noninflammatory disorders of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.0 Leukoplakia of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.1 Old laceration of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.2 Stricture and stenosis of cervix uteri

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 338 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.3 Incompetence of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.4 Hypertrophic elongation of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.8 Other specified noninflammatory disorders of cervix uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N88.9 Noninflammatory disorder of cervix uteri, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89 Other noninflammatory disorders of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.0 Mild vaginal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.1 Moderate vaginal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.2 Severe vaginal dysplasia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.3 Dysplasia of vagina, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.4 Leukoplakia of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.5 Stricture and atresia of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.6 Tight hymenal ring 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.7 Haematocolpos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.8 Other specified noninflammatory disorders of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N89.9 Noninflammatory disorder of vagina, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90 Other noninflammatory disorders of vulva and perineum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.0 Mild vulvar dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.1 Moderate vulvar dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.2 Severe vulvar dysplasia, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.3 Dysplasia of vulva, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.4 Leukoplakia of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.5 Atrophy of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.6 Hypertrophy of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.7 Vulvar cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.8 Other specified noninflammatory disorders of vulva and perineum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N90.9 Noninflammatory disorder of vulva and perineum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91 Absent, scanty and rare menstruation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.0 Primary amenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.1 Secondary amenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.2 Amenorrhoea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.3 Primary oligomenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.4 Secondary oligomenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N91.5 Oligomenorrhoea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92 Excessive, frequent and irregular menstruation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.0 Excessive and frequent menstruation with regular cycle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.1 Excessive and frequent menstruation with irregular cycle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.2 Excessive menstruation at puberty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.3 Ovulation bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.4 Excessive bleeding in the premenopausal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.5 Other specified irregular menstruation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N92.6 Irregular menstruation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N93 Other abnormal uterine and vaginal bleeding

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 339 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N93.0 Postcoital and contact bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N93.8 Other specified abnormal uterine and vaginal bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N93.9 Abnormal uterine and vaginal bleeding, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94 Pain and other conditions associated with female genital organs and menstrual cycle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.0 Mittelschmerz 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.1 Dyspareunia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.2 Vaginismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.3 Premenstrual tension syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.4 Primary dysmenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.5 Secondary dysmenorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.6 Dysmenorrhoea, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.8 Other specified conditions associated with female genital organs and menstrual cycle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N94.9 Unspecified condition associated with female genital organs and menstrual cycle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95 Menopausal and other perimenopausal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.0 Postmenopausal bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.1 Menopausal and female climacteric states 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.2 Postmenopausal atrophic vaginitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.3 States associated with artificial menopause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.8 Other specified menopausal and perimenopausal disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N95.9 Menopausal and perimenopausal disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N96 Habitual aborter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97 Female infertility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.0 Female infertility associated with anovulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.1 Female infertility of tubal origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.2 Female infertility of uterine origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.3 Female infertility of cervical origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.4 Female infertility associated with male factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.8 Female infertility of other origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N97.9 Female infertility, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98 Complications associated with artificial fertilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.0 Infection associated with artificial insemination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.1 Hyperstimulation of ovaries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.2 Complications of attempted introduction of fertilized ovum following in vitro fertilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.3 Complications of attempted introduction of embryo in embryo transfer 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.8 Other complications associated with artificial fertilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N98.9 Complication associated with artificial fertilization, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99 Postprocedural disorders of genitourinary system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99-N99 Other disorders of the genitourinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.0 Postprocedural renal failure

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 340 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.1 Postprocedural urethral stricture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.2 Postoperative adhesions of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.3 Prolapse of vaginal vault after hysterectomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.4 Postprocedural pelvic peritoneal adhesions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.5 Malfunction of external stoma of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.8 Other postprocedural disorders of genitourinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 N99.9 Postprocedural disorder of genitourinary system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00 Ectopic pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00-O08 Pregnancy with abortive outcome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00.0 Abdominal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00.1 Tubal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00.2 Ovarian pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00.8 Other ectopic pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O00.9 Ectopic pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O01 Hydatidiform mole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O01.0 Classical hydatidiform mole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O01.1 Incomplete and partial hydatidiform mole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O01.9 Hydatidiform mole, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O02 Other abnormal products of conception 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O02.0 Blighted ovum and nonhydatidiform mole 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O02.1 Missed 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O02.8 Other specified abnormal products of conception 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O02.9 Abnormal product of conception, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O03 Spontaneous abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O04 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O05 Other abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O06 Unspecified abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07 Failed attempted abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.0 Failed medical abortion, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.1 Failed medical abortion, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.2 Failed medical abortion, complicated by embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.3 Failed medical abortion, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.4 Failed medical abortion, without complication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.5 Other and unspecified failed attempted abortion, complicated by genital tract and pelvic infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.6 Other and unspecified failed attempted abortion, complicated by delayed or excessive haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.7 Other and unspecified failed attempted abortion, complicated by embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.8 Other and unspecified failed attempted abortion, with other and unspecified complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O07.9 Other and unspecified failed attempted abortion, without complication © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 341 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08 Complications following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.0 Genital tract and pelvic infection following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.1 Delayed or excessive haemorrhage following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.2 Embolism following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.3 Shock following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.4 Renal failure following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.5 Metabolic disorders following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.6 Damage to pelvic organs and tissues following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.7 Other venous complications following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.8 Other complications following abortion and ectopic and molar pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O08.9 Complication following abortion and ectopic and molar pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.0 Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.1 Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.2 Pre-existing hypertensive renal disease complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.3 Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.4 Pre-existing secondary hypertension complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O10.9 Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O11 Pre-eclampsia superimposed on chronic hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O12.0 Gestational oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O12.1 Gestational proteinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O12.2 Gestational oedema with proteinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O13 Gestational [pregnancy-induced] hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O14 Pre-eclampsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O14.0 Mild to moderate pre-eclampsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O14.1 Severe pre-eclampsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O14.2 HELLP syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O14.9 Pre-eclampsia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O15 Eclampsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O15.0 Eclampsia in pregnancy

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 342 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O15.1 Eclampsia in labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O15.2 Eclampsia in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O15.9 Eclampsia, unspecified as to time period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O16 Unspecified maternal hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O20 Haemorrhage in early pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O20-O29 Other maternal disorders predominantly related to pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O20.0 Threatened abortion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O20.8 Other haemorrhage in early pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O20.9 Haemorrhage in early pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21 Excessive vomiting in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21.0 Mild hyperemesis gravidarum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21.1 Hyperemesis gravidarum with metabolic disturbance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21.2 Late vomiting of pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21.8 Other vomiting complicating pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O21.9 Vomiting of pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22 Venous complications and haemorrhoids in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.0 Varicose veins of lower extremity in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.1 Genital varices in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.2 Superficial thrombophlebitis in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.3 Deep phlebothrombosis in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.4 Haemorrhoids in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.5 Cerebral venous thrombosis in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.8 Other venous complications in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O22.9 Venous complication in pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23 Infections of genitourinary tract in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.0 Infections of kidney in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.1 Infections of bladder in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.2 Infections of urethra in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.3 Infections of other parts of urinary tract in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.4 Unspecified infection of urinary tract in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.5 Infections of the genital tract in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O23.9 Other and unspecified genitourinary tract infection in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24 Diabetes mellitus in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.0 Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.1 Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.2 Diabetes mellitus in pregnancy: Pre-existing malnutrition-related diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.3 Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.4 Diabetes mellitus arising in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O24.9 Diabetes mellitus in pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O25 Malnutrition in pregnancy

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 343 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26 Maternal care for other conditions predominantly related to pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.0 Excessive weight gain in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.1 Low weight gain in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.2 Pregnancy care of habitual aborter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.3 Retained intrauterine contraceptive device in pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.4 Herpes gestationis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.5 Maternal hypotension syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.6 Liver disorders in pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.7 Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.8 Other specified pregnancy-related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O26.9 Pregnancy-related condition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28 Abnormal findings on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.0 Abnormal haematological finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.1 Abnormal biochemical finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.2 Abnormal cytological finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.3 Abnormal ultrasonic finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.4 Abnormal radiological finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.5 Abnormal chromosomal and genetic finding on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.8 Other abnormal findings on antenatal screening of mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O28.9 Abnormal finding on antenatal screening of mother, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29 Complications of anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.0 Pulmonary complications of anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.1 Cardiac complications of anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.2 Central nervous system complications of anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.3 Toxic reaction to local anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.4 Spinal and epidural anaesthesia-induced headache during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.5 Other complications of spinal and epidural anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.6 Failed or difficult intubation during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.8 Other complications of anaesthesia during pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O29.9 Complication of anaesthesia during pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30 Multiple gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30.0 Twin pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30.1 Triplet pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30.2 Quadruplet pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30.8 Other multiple gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O30.9 Multiple gestation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O31 Complications specific to multiple gestation © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 344 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O31.0 Papyraceous fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O31.1 Continuing pregnancy after abortion of one fetus or more 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O31.2 Continuing pregnancy after intrauterine death of one fetus or more 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O31.8 Other complications specific to multiple gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32 Maternal care for known or suspected malpresentation of fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.0 Maternal care for unstable lie 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.1 Maternal care for breech presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.2 Maternal care for transverse and oblique lie 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.3 Maternal care for face, brow and chin presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.4 Maternal care for high head at term 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.5 Maternal care for multiple gestation with malpresentation of one fetus or more 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.6 Maternal care for compound presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.8 Maternal care for other malpresentation of fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O32.9 Maternal care for malpresentation of fetus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33 Maternal care for known or suspected disproportion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.0 Maternal care for disproportion due to deformity of maternal pelvic bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.1 Maternal care for disproportion due to generally contracted pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.2 Maternal care for disproportion due to inlet contraction of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.3 Maternal care for disproportion due to outlet contraction of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.4 Maternal care for disproportion of mixed maternal and fetal origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.5 Maternal care for disproportion due to unusually large fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.6 Maternal care for disproportion due to hydrocephalic fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.7 Maternal care for disproportion due to other fetal deformities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.8 Maternal care for disproportion of other origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O33.9 Maternal care for disproportion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34 Maternal care for known or suspected abnormality of pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.0 Maternal care for congenital malformation of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.1 Maternal care for tumour of corpus uteri 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.2 Maternal care due to uterine scar from previous surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.3 Maternal care for cervical incompetence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.4 Maternal care for other abnormalities of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.5 Maternal care for other abnormalities of gravid uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.6 Maternal care for abnormality of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.7 Maternal care for abnormality of vulva and perineum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.8 Maternal care for other abnormalities of pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O34.9 Maternal care for abnormality of pelvic organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35 Maternal care for known or suspected fetal abnormality and damage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.0 Maternal care for (suspected) central nervous system malformation in fetus

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 345 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.1 Maternal care for (suspected) chromosomal abnormality in fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.2 Maternal care for (suspected) hereditary disease in fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.3 Maternal care for (suspected) damage to fetus from viral disease in mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.4 Maternal care for (suspected) damage to fetus from alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.5 Maternal care for (suspected) damage to fetus by drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.6 Maternal care for (suspected) damage to fetus by radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.7 Maternal care for (suspected) damage to fetus by other medical procedures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.8 Maternal care for other (suspected) fetal abnormality and damage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O35.9 Maternal care for (suspected) fetal abnormality and damage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36 Maternal care for other known or suspected fetal problems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.0 Maternal care for rhesus isoimmunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.1 Maternal care for other isoimmunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.2 Maternal care for hydrops fetalis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.3 Maternal care for signs of fetal hypoxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.4 Maternal care for intrauterine death 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.5 Maternal care for poor fetal growth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.6 Maternal care for excessive fetal growth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.7 Maternal care for viable fetus in abdominal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.8 Maternal care for other specified fetal problems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O36.9 Maternal care for fetal problem, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O40 Polyhydramnios 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O41 Other disorders of amniotic fluid and membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O41.0 Oligohydramnios 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O41.1 Infection of amniotic sac and membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O41.8 Other specified disorders of amniotic fluid and membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O41.9 Disorder of amniotic fluid and membranes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O42 Premature rupture of membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O42.0 Premature rupture of membranes, onset of labour within 24 hours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O42.1 Premature rupture of membranes, onset of labour after 24 hours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O42.2 Premature rupture of membranes, labour delayed by therapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O42.9 Premature rupture of membranes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43 Placental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43.0 Placental transfusion syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43.1 Malformation of placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43.2 Morbidly adherent placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43.8 Other placental disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O43.9 Placental disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O44 Placenta praevia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O44.0 Placenta praevia specified as without haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O44.1 Placenta praevia with haemorrhage © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 346 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O45 Premature separation of placenta [abruptio placentae] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O45.0 Premature separation of placenta with coagulation defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O45.8 Other premature separation of placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O45.9 Premature separation of placenta, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O46 Antepartum haemorrhage, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O46.0 Antepartum haemorrhage with coagulation defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O46.8 Other antepartum haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O46.9 Antepartum haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O47 False labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O47.0 False labour before 37 completed weeks of gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O47.1 False labour at or after 37 completed weeks of gestation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O47.9 False labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O48 Prolonged pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60 Preterm labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60-O75 Complications of labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60.0 Preterm labour without delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60.1 Preterm spontaneous labour with preterm delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60.2 Preterm spontaneous labour with term delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O60.3 Preterm delivery without spontaneous labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O61 Failed induction of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O61.0 Failed medical induction of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O61.1 Failed instrumental induction of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O61.8 Other failed induction of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O61.9 Failed induction of labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62 Abnormalities of forces of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.0 Primary inadequate contractions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.1 Secondary uterine inertia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.2 Other uterine inertia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.3 Precipitate labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.4 Hypertonic, incoordinate, and prolonged uterine contractions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.8 Other abnormalities of forces of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O62.9 Abnormality of forces of labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O63 Long labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O63.0 Prolonged first stage (of labour) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O63.1 Prolonged second stage (of labour) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O63.2 Delayed delivery of second twin, triplet, etc. 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O63.9 Long labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64 Obstructed labour due to malposition and malpresentation of fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.0 Obstructed labour due to incomplete rotation of fetal head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.1 Obstructed labour due to breech presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.2 Obstructed labour due to face presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.3 Obstructed labour due to brow presentation

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 347 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.4 Obstructed labour due to shoulder presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.5 Obstructed labour due to compound presentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.8 Obstructed labour due to other malposition and malpresentation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O64.9 Obstructed labour due to malposition and malpresentation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65 Obstructed labour due to maternal pelvic abnormality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.0 Obstructed labour due to deformed pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.1 Obstructed labour due to generally contracted pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.2 Obstructed labour due to pelvic inlet contraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.3 Obstructed labour due to pelvic outlet and mid-cavity contraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.4 Obstructed labour due to fetopelvic disproportion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.5 Obstructed labour due to abnormality of maternal pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.8 Obstructed labour due to other maternal pelvic abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O65.9 Obstructed labour due to maternal pelvic abnormality, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66 Other obstructed labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.0 Obstructed labour due to shoulder dystocia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.1 Obstructed labour due to locked twins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.2 Obstructed labour due to unusually large fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.3 Obstructed labour due to other abnormalities of fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.4 Failed trial of labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.5 Failed application of vacuum extractor and forceps, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.8 Other specified obstructed labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O66.9 Obstructed labour, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O67.0 Intrapartum haemorrhage with coagulation defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O67.8 Other intrapartum haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O67.9 Intrapartum haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68 Labour and delivery complicated by fetal stress [distress] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.0 Labour and delivery complicated by fetal heart rate anomaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.1 Labour and delivery complicated by meconium in amniotic fluid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.2 Labour and delivery complicated by fetal heart rate anomaly with meconium in amniotic fluid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.3 Labour and delivery complicated by biochemical evidence of fetal stress 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.8 Labour and delivery complicated by other evidence of fetal stress 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O68.9 Labour and delivery complicated by fetal stress, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69 Labour and delivery complicated by umbilical cord complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.0 Labour and delivery complicated by prolapse of cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.1 Labour and delivery complicated by cord around neck, with compression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.2 Labour and delivery complicated by other cord entanglement, with compression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.3 Labour and delivery complicated by short cord © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 348 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.4 Labour and delivery complicated by vasa praevia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.5 Labour and delivery complicated by vascular lesion of cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.8 Labour and delivery complicated by other cord complications 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O69.9 Labour and delivery complicated by cord complication, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70 Perineal laceration during delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70.0 First degree perineal laceration during delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70.1 Second degree perineal laceration during delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70.2 Third degree perineal laceration during delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70.3 Fourth degree perineal laceration during delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O70.9 Perineal laceration during delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71 Other obstetric trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.0 Rupture of uterus before onset of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.1 Rupture of uterus during labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.2 Postpartum inversion of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.3 Obstetric laceration of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.4 Obstetric high vaginal laceration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.5 Other obstetric injury to pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.6 Obstetric damage to pelvic joints and ligaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.7 Obstetric haematoma of pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.8 Other specified obstetric trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O71.9 Obstetric trauma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O72 Postpartum haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O72.0 Third-stage haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O72.1 Other immediate postpartum haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O72.2 Delayed and secondary postpartum haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O72.3 Postpartum coagulation defects 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O73 Retained placenta and membranes, without haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O73.0 Retained placenta without haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O73.1 Retained portions of placenta and membranes, without haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74 Complications of anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.0 Aspiration pneumonitis due to anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.1 Other pulmonary complications of anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.2 Cardiac complications of anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.3 Central nervous system complications of anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.4 Toxic reaction to local anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.5 Spinal and epidural anaesthesia-induced headache during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.6 Other complications of spinal and epidural anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.7 Failed or difficult intubation during labour and delivery

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 349 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.8 Other complications of anaesthesia during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O74.9 Complication of anaesthesia during labour and delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75 Other complications of labour and delivery, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.0 Maternal distress during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.1 Shock during or following labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.2 Pyrexia during labour, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.3 Other infection during labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.4 Other complications of obstetric surgery and procedures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.5 Delayed delivery after artificial rupture of membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.7 Vaginal delivery following previous caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.8 Other specified complications of labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O75.9 Complication of labour and delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80 Single spontaneous delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80-O84 Delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80.0 Spontaneous vertex delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80.1 Spontaneous breech delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80.8 Other single spontaneous delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O80.9 Single spontaneous delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81 Single delivery by forceps and vacuum extractor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.0 Low forceps delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.1 Mid-cavity forceps delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.2 Mid-cavity forceps with rotation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.3 Other and unspecified forceps delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.4 Vacuum extractor delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O81.5 Delivery by combination of forceps and vacuum extractor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82 Single delivery by caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82.0 Delivery by elective caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82.1 Delivery by emergency caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82.2 Delivery by caesarean hysterectomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82.8 Other single delivery by caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O82.9 Delivery by caesarean section, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83 Other assisted single delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.0 Breech extraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.1 Other assisted breech delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.2 Other manipulation-assisted delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.3 Delivery of viable fetus in abdominal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.4 Destructive operation for delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.8 Other specified assisted single delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O83.9 Assisted single delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84 Multiple delivery

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 350 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84.0 Multiple delivery, all spontaneous 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84.1 Multiple delivery, all by forceps and vacuum extractor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84.2 Multiple delivery, all by caesarean section 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84.8 Other multiple delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O84.9 Multiple delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O85 Puerperal sepsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O85-O92 Complications predominantly related to the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86 Other puerperal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.0 Infection of obstetric surgical wound 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.1 Other infection of genital tract following delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.2 Urinary tract infection following delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.3 Other genitourinary tract infections following delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.4 Pyrexia of unknown origin following delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O86.8 Other specified puerperal infections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87 Venous complications and haemorrhoids in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.0 Superficial thrombophlebitis in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.1 Deep phlebothrombosis in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.2 Haemorrhoids in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.3 Cerebral venous thrombosis in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.8 Other venous complications in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O87.9 Venous complication in the puerperium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88 Obstetric embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88.0 Obstetric air embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88.1 Amniotic fluid embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88.2 Obstetric blood-clot embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88.3 Obstetric pyaemic and septic embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O88.8 Other obstetric embolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89 Complications of anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.0 Pulmonary complications of anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.1 Cardiac complications of anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.2 Central nervous system complications of anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.3 Toxic reaction to local anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.4 Spinal and epidural anaesthesia-induced headache during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.5 Other complications of spinal and epidural anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.6 Failed or difficult intubation during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.8 Other complications of anaesthesia during the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O89.9 Complication of anaesthesia during the puerperium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90 Complications of the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.0 Disruption of caesarean section wound 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.1 Disruption of perineal obstetric wound 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.2 Haematoma of obstetric wound

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 351 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.3 Cardiomyopathy in the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.4 Postpartum acute renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.5 Postpartum thyroiditis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.8 Other complications of the puerperium, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O90.9 Complication of the puerperium, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O91 Infections of breast associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O91.0 Infection of nipple associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O91.1 Abscess of breast associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O91.2 Nonpurulent mastitis associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92 Other disorders of breast and lactation associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.0 Retracted nipple associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.1 Cracked nipple associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.2 Other and unspecified disorders of breast associated with childbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.3 Agalactia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.4 Hypogalactia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.5 Suppressed lactation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.6 Galactorrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O92.7 Other and unspecified disorders of lactation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O94 Sequelae of complication of pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O94-O99 Other obstetric conditions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O95 Obstetric death of unspecified cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O96.0 Death from direct obstetric cause occurring more than 42 days but less than one year after delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O96.1 Death from indirect obstetric cause occurring more than 42 days but less than one year after delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O96.9 Death from unspecified obstetric cause occurring more than 42 days but less than one year after delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O97 Death from sequelae of obstetric causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O97.0 Death from sequelae of direct obstetric cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O97.1 Death from sequelae of indirect obstetric cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O97.9 Death from sequelae of obstetric cause, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.0 Tuberculosis complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.1 Syphilis complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.2 Gonorrhoea complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.3 Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.4 Viral hepatitis complicating pregnancy, childbirth and the puerperium

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 352 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.5 Other viral diseases complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.6 Protozoal diseases complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.7 Human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.8 Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O98.9 Unspecified maternal infectious or parasitic disease complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.0 Anaemia complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00 Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00-P04 Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.0 Fetus and newborn affected by maternal hypertensive disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.1 Fetus and newborn affected by maternal renal and urinary tract diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.2 Fetus and newborn affected by maternal infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.3 Fetus and newborn affected by other maternal circulatory and respiratory diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.4 Fetus and newborn affected by maternal nutritional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.5 Fetus and newborn affected by maternal injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.6 Fetus and newborn affected by surgical procedure on mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.7 Fetus and newborn affected by other medical procedures on mother, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.8 Fetus and newborn affected by other maternal conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P00.9 Fetus and newborn affected by unspecified maternal condition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01 Fetus and newborn affected by maternal complications of pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.0 Fetus and newborn affected by incompetent cervix © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 353 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.1 Fetus and newborn affected by premature rupture of membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.2 Fetus and newborn affected by oligohydramnios 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.3 Fetus and newborn affected by polyhydramnios 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.4 Fetus and newborn affected by ectopic pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.5 Fetus and newborn affected by multiple pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.6 Fetus and newborn affected by maternal death 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.7 Fetus and newborn affected by malpresentation before labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.8 Fetus and newborn affected by other maternal complications of pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P01.9 Fetus and newborn affected by maternal complication of pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02 Fetus and newborn affected by complications of placenta, cord and membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.0 Fetus and newborn affected by placenta praevia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.1 Fetus and newborn affected by other forms of placental separation and haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.2 Fetus and newborn affected by other and unspecified morphological and functional abnormalities of placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.3 Fetus and newborn affected by placental transfusion syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.4 Fetus and newborn affected by prolapsed cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.5 Fetus and newborn affected by other compression of umbilical cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.6 Fetus and newborn affected by other and unspecified conditions of umbilical cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.7 Fetus and newborn affected by chorioamnionitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.8 Fetus and newborn affected by other abnormalities of membranes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P02.9 Fetus and newborn affected by abnormality of membranes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03 Fetus and newborn affected by other complications of labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.0 Fetus and newborn affected by breech delivery and extraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.1 Fetus and newborn affected by other malpresentation, malposition and disproportion during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.2 Fetus and newborn affected by forceps delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.3 Fetus and newborn affected by delivery by vacuum extractor [ventouse] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.4 Fetus and newborn affected by caesarean delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.5 Fetus and newborn affected by precipitate delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.6 Fetus and newborn affected by abnormal uterine contractions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.8 Fetus and newborn affected by other specified complications of labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P03.9 Fetus and newborn affected by complication of labour and delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04 Fetus and newborn affected by noxious influences transmitted via placenta or breast milk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.0 Fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.1 Fetus and newborn affected by other maternal medication © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 354 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.2 Fetus and newborn affected by maternal use of tobacco 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.3 Fetus and newborn affected by maternal use of alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.4 Fetus and newborn affected by maternal use of drugs of addiction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.5 Fetus and newborn affected by maternal use of nutritional chemical substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.6 Fetus and newborn affected by maternal exposure to environmental chemical substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.8 Fetus and newborn affected by other maternal noxious influences 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P04.9 Fetus and newborn affected by maternal noxious influence, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05 Slow fetal growth and fetal malnutrition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05-P08 Disorders related to length of gestation and fetal growth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05.0 Light for gestational age 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05.1 Small for gestational age 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05.2 Fetal malnutrition without mention of light or small for gestational age 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P05.9 Slow fetal growth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P07 Disorders related to short gestation and low birth weight, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P07.0 Extremely low birth weight 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P07.1 Other low birth weight 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P07.2 Extreme immaturity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P07.3 Other preterm infants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P08 Disorders related to long gestation and high birth weight 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P08.0 Exceptionally large baby 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P08.1 Other heavy for gestational age infants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P08.2 Post-term infant, not heavy for gestational age 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10 Intracranial laceration and haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10-P15 Birth trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.0 Subdural haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.1 Cerebral haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.2 Intraventricular haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.3 Subarachnoid haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.4 Tentorial tear due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.8 Other intracranial lacerations and haemorrhages due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P10.9 Unspecified intracranial laceration and haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11 Other birth injuries to central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.0 Cerebral oedema due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.1 Other specified brain damage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.2 Unspecified brain damage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.3 Birth injury to facial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.4 Birth injury to other cranial nerves

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 355 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.5 Birth injury to spine and spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P11.9 Birth injury to central nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12 Birth injury to scalp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.0 Cephalhaematoma due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.1 Chignon due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.2 Epicranial subaponeurotic haemorrhage due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.3 Bruising of scalp due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.4 Monitoring injury of scalp of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.8 Other birth injuries to scalp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P12.9 Birth injury to scalp, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13 Birth injury to skeleton 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.0 Fracture of skull due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.1 Other birth injuries to skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.2 Birth injury to femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.3 Birth injury to other long bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.4 Fracture of clavicle due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.8 Birth injuries to other parts of skeleton 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P13.9 Birth injury to skeleton, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14 Birth injury to peripheral nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.0 Erb paralysis due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.1 Klumpke paralysis due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.2 Phrenic nerve paralysis due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.3 Other brachial plexus birth injuries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.8 Birth injuries to other parts of peripheral nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P14.9 Birth injury to peripheral nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15 Other birth injuries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.0 Birth injury to liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.1 Birth injury to spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.2 Sternomastoid injury due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.3 Birth injury to eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.4 Birth injury to face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.5 Birth injury to external genitalia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.6 Subcutaneous fat necrosis due to birth injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.8 Other specified birth injuries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P15.9 Birth injury, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P20 Intrauterine hypoxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P20-P29 Respiratory and cardiovascular disorders specific to the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P20.0 Intrauterine hypoxia first noted before onset of labour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P20.1 Intrauterine hypoxia first noted during labour and delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P20.9 Intrauterine hypoxia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P21 Birth asphyxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P21.0 Severe birth asphyxia

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 356 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P21.1 Mild and moderate birth asphyxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P21.9 Birth asphyxia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P22 Respiratory distress of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P22.0 Respiratory distress syndrome of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P22.1 Transient tachypnoea of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P22.8 Other respiratory distress of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P22.9 Respiratory distress of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23 Congenital pneumonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.0 Congenital pneumonia due to viral agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.1 Congenital pneumonia due to Chlamydia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.2 Congenital pneumonia due to staphylococcus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.3 Congenital pneumonia due to streptococcus, group B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.4 Congenital pneumonia due to Escherichia coli 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.5 Congenital pneumonia due to Pseudomonas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.6 Congenital pneumonia due to other bacterial agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.8 Congenital pneumonia due to other organisms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P23.9 Congenital pneumonia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24 Neonatal aspiration syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.0 Neonatal aspiration of meconium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.1 Neonatal aspiration of amniotic fluid and mucus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.2 Neonatal aspiration of blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.3 Neonatal aspiration of milk and regurgitated food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.8 Other neonatal aspiration syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P24.9 Neonatal aspiration syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25 Interstitial emphysema and related conditions originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25.0 Interstitial emphysema originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25.1 Pneumothorax originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25.2 Pneumomediastinum originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25.3 Pneumopericardium originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P25.8 Other conditions related to interstitial emphysema originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P26 Pulmonary haemorrhage originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P26.0 Tracheobronchial haemorrhage originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P26.1 Massive pulmonary haemorrhage originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P26.8 Other pulmonary haemorrhages originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P26.9 Unspecified pulmonary haemorrhage originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P27 Chronic respiratory disease originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P27.0 Wilson-Mikity syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P27.1 Bronchopulmonary dysplasia originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P27.8 Other chronic respiratory diseases originating in the perinatal period

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 357 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P27.9 Unspecified chronic respiratory disease originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28 Other respiratory conditions originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.0 Primary atelectasis of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.1 Other and unspecified atelectasis of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.2 Cyanotic attacks of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.3 Primary sleep apnoea of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.4 Other apnoea of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.5 Respiratory failure of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.8 Other specified respiratory conditions of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P28.9 Respiratory condition of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29 Cardiovascular disorders originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.0 Neonatal cardiac failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.1 Neonatal cardiac dysrhythmia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.2 Neonatal hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.3 Persistent fetal circulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.4 Transient myocardial ischaemia of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.8 Other cardiovascular disorders originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P29.9 Cardiovascular disorder originating in the perinatal period, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35 Congenital viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35-P39 Infections specific to the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.0 Congenital rubella syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.1 Congenital cytomegalovirus infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.2 Congenital herpesviral [herpes simplex] infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.3 Congenital viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.8 Other congenital viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P35.9 Congenital viral disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36 Bacterial sepsis of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.0 Sepsis of newborn due to streptococcus, group B 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.1 Sepsis of newborn due to other and unspecified streptococci 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.2 Sepsis of newborn due to Staphylococcus aureus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.3 Sepsis of newborn due to other and unspecified staphylococci 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.4 Sepsis of newborn due to Escherichia coli 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.5 Sepsis of newborn due to anaerobes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.8 Other bacterial sepsis of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P36.9 Bacterial sepsis of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37 Other congenital infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.0 Congenital tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.1 Congenital toxoplasmosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.2 Neonatal (disseminated) listeriosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.3 Congenital falciparum malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.4 Other congenital malaria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.5 Neonatal candidiasis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 358 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.8 Other specified congenital infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P37.9 Congenital infectious and parasitic disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P38 Omphalitis of newborn with or without mild haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39 Other infections specific to the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.0 Neonatal infective mastitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.1 Neonatal conjunctivitis and dacryocystitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.2 Intra-amniotic infection of fetus, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.3 Neonatal urinary tract infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.4 Neonatal skin infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.8 Other specified infections specific to the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P39.9 Infection specific to the perinatal period, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50 Fetal blood loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50-P61 Haemorrhagic and haematological disorders of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.0 Fetal blood loss from vasa praevia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.1 Fetal blood loss from ruptured cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.2 Fetal blood loss from placenta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.3 Haemorrhage into co-twin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.4 Haemorrhage into maternal circulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.5 Fetal blood loss from cut end of co-twin's cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.8 Other fetal blood loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P50.9 Fetal blood loss, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P51 Umbilical haemorrhage of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P51.0 Massive umbilical haemorrhage of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P51.8 Other umbilical haemorrhages of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P51.9 Umbilical haemorrhage of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52 Intracranial nontraumatic haemorrhage of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.0 Intraventricular (nontraumatic) haemorrhage, grade 1, of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.1 Intraventricular (nontraumatic) haemorrhage, grade 2, of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.2 Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.3 Unspecified intraventricular (nontraumatic) haemorrhage of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.4 Intracerebral (nontraumatic) haemorrhage of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.5 Subarachnoid (nontraumatic) haemorrhage of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.6 Cerebellar (nontraumatic) and posterior fossa haemorrhage of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.8 Other intracranial (nontraumatic) haemorrhages of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P52.9 Intracranial (nontraumatic) haemorrhage of fetus and newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P53 Haemorrhagic disease of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54 Other neonatal haemorrhages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.0 Neonatal haematemesis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 359 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.1 Neonatal melaena 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.2 Neonatal rectal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.3 Other neonatal gastrointestinal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.4 Neonatal adrenal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.5 Neonatal cutaneous haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.6 Neonatal vaginal haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.8 Other specified neonatal haemorrhages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P54.9 Neonatal haemorrhage, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P55 Haemolytic disease of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P55.0 Rh isoimmunization of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P55.1 ABO isoimmunization of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P55.8 Other haemolytic diseases of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P55.9 Haemolytic disease of fetus and newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P56 Hydrops fetalis due to haemolytic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P56.0 Hydrops fetalis due to isoimmunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P56.9 Hydrops fetalis due to other and unspecified haemolytic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P57 Kernicterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P57.0 Kernicterus due to isoimmunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P57.8 Other specified kernicterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P57.9 Kernicterus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58 Neonatal jaundice due to other excessive haemolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.0 Neonatal jaundice due to bruising 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.1 Neonatal jaundice due to bleeding 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.2 Neonatal jaundice due to infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.3 Neonatal jaundice due to polycythaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.4 Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.5 Neonatal jaundice due to swallowed maternal blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.8 Neonatal jaundice due to other specified excessive haemolysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P58.9 Neonatal jaundice due to excessive haemolysis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59 Neonatal jaundice from other and unspecified causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.0 Neonatal jaundice associated with preterm delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.1 Inspissated bile syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.2 Neonatal jaundice from other and unspecified hepatocellular damage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.3 Neonatal jaundice from breast milk inhibitor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.8 Neonatal jaundice from other specified causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P59.9 Neonatal jaundice, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P60 Disseminated intravascular coagulation of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61 Other perinatal haematological disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.0 Transient neonatal thrombocytopenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.1 Polycythaemia neonatorum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.2 Anaemia of prematurity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.3 Congenital anaemia from fetal blood loss © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 360 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.4 Other congenital anaemias, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.5 Transient neonatal neutropenia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.6 Other transient neonatal disorders of coagulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.8 Other specified perinatal haematological disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P61.9 Perinatal haematological disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70 Transitory disorders of carbohydrate metabolism specific to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70-P74 Transitory endocrine and metabolic disorders specific to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.0 Syndrome of infant of mother with gestational diabetes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.1 Syndrome of infant of a diabetic mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.2 Neonatal diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.3 Iatrogenic neonatal hypoglycaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.4 Other neonatal hypoglycaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.8 Other transitory disorders of carbohydrate metabolism of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P70.9 Transitory disorder of carbohydrate metabolism of fetus and newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71 Transitory neonatal disorders of calcium and magnesium metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.0 Cow milk hypocalcaemia in newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.1 Other neonatal hypocalcaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.2 Neonatal hypomagnesaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.3 Neonatal tetany without calcium or magnesium deficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.4 Transitory neonatal hypoparathyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.8 Other transitory neonatal disorders of calcium and magnesium metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P71.9 Transitory neonatal disorder of calcium and magnesium metabolism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72 Other transitory neonatal endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72.0 Neonatal goitre, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72.1 Transitory neonatal hyperthyroidism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72.2 Other transitory neonatal disorders of thyroid function, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72.8 Other specified transitory neonatal endocrine disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P72.9 Transitory neonatal endocrine disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74 Other transitory neonatal electrolyte and metabolic disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.0 Late metabolic acidosis of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.1 Dehydration of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.2 Disturbances of sodium balance of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.3 Disturbances of potassium balance of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.4 Other transitory electrolyte disturbances of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.5 Transitory tyrosinaemia of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.8 Other transitory metabolic disturbances of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P74.9 Transitory metabolic disturbance of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P75 Meconium ileus in cystic fibrosisE84.1 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 361 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P75-P78 Digestive system disorders of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76 Other intestinal obstruction of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76.0 Meconium plug syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76.1 Transitory ileus of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76.2 Intestinal obstruction due to inspissated milk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76.8 Other specified intestinal obstruction of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P76.9 Intestinal obstruction of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P77 Necrotizing enterocolitis of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78 Other perinatal digestive system disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.0 Perinatal intestinal perforation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.1 Other neonatal peritonitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.2 Neonatal haematemesis and melaena due to swallowed maternal blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.3 Noninfective neonatal diarrhoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.8 Other specified perinatal digestive system disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P78.9 Perinatal digestive system disorder, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P80 Hypothermia of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P80-P83 Conditions involving the integument and temperature regulation of fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P80.0 Cold injury syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P80.8 Other hypothermia of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P80.9 Hypothermia of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P81 Other disturbances of temperature regulation of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P81.0 Environmental hyperthermia of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P81.8 Other specified disturbances of temperature regulation of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P81.9 Disturbance of temperature regulation of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83 Other conditions of integument specific to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.0 Sclerema neonatorum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.1 Neonatal erythema toxicum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.2 Hydrops fetalis not due to haemolytic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.3 Other and unspecified oedema specific to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.4 Breast engorgement of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.5 Congenital hydrocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.6 Umbilical polyp of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.8 Other specified conditions of integument specific to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P83.9 Condition of integument specific to fetus and newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P90 Convulsions of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P90-P96 Other disorders originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91 Other disturbances of cerebral status of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.0 Neonatal cerebral ischaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.1 Acquired periventricular cysts of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.2 Neonatal cerebral leukomalacia © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 362 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.3 Neonatal cerebral irritability 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.4 Neonatal cerebral depression 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.5 Neonatal coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.6 Hypoxic ischaemic encephalopathy of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.7 Acquired hydrocephalus of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.8 Other specified disturbances of cerebral status of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P91.9 Disturbance of cerebral status of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92 Feeding problems of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.0 Vomiting in newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.1 Regurgitation and rumination in newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.2 Slow feeding of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.3 Underfeeding of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.4 Overfeeding of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.5 Neonatal difficulty in feeding at breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.8 Other feeding problems of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P92.9 Feeding problem of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P93 Reactions and intoxications due to drugs administered to fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94 Disorders of muscle tone of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94.0 Transient neonatal myasthenia gravis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94.1 Congenital hypertonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94.2 Congenital hypotonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94.8 Other disorders of muscle tone of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P94.9 Disorder of muscle tone of newborn, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P95 Fetal death of unspecified cause 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96 Other conditions originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.0 Congenital renal failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.1 Neonatal withdrawal symptoms from maternal use of drugs of addiction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.2 Withdrawal symptoms from therapeutic use of drugs in newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.3 Wide cranial sutures of newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.4 Termination of pregnancy, affecting fetus and newborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.5 Complications of intrauterine procedures, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.8 Other specified conditions originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 P96.9 Condition originating in the perinatal period, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q00 Anencephaly and similar malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q00-Q07 Congenital malformations of the nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q00.0 Anencephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q00.1 Craniorachischisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q00.2 Iniencephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01 Encephalocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01.0 Frontal encephalocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01.1 Nasofrontal encephalocele

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 363 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01.2 Occipital encephalocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01.8 Encephalocele of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q01.9 Encephalocele, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q02 Microcephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q03 Congenital hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q03.0 Malformations of aqueduct of Sylvius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q03.1 Atresia of foramina of Magendie and Luschka 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q03.8 Other congenital hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q03.9 Congenital hydrocephalus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04 Other congenital malformations of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.0 Congenital malformations of corpus callosum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.1 Arhinencephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.2 Holoprosencephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.3 Other reduction deformities of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.4 Septo-optic dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.5 Megalencephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.6 Congenital cerebral cysts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.8 Other specified congenital malformations of brain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q04.9 Congenital malformation of brain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05 Spina bifida 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.0 Cervical spina bifida with hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.1 Thoracic spina bifida with hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.2 Lumbar spina bifida with hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.3 Sacral spina bifida with hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.4 Unspecified spina bifida with hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.5 Cervical spina bifida without hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.6 Thoracic spina bifida without hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.7 Lumbar spina bifida without hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.8 Sacral spina bifida without hydrocephalus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q05.9 Spina bifida, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06 Other congenital malformations of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.0 Amyelia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.1 Hypoplasia and dysplasia of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.2 Diastematomyelia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.3 Other congenital cauda equina malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.4 Hydromyelia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.8 Other specified congenital malformations of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q06.9 Congenital malformation of spinal cord, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q07 Other congenital malformations of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q07.0 Arnold-Chiari syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q07.8 Other specified congenital malformations of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q07.9 Congenital malformation of nervous system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10 Congenital malformations of eyelid, lacrimal apparatus and orbit © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 364 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10-Q18 Congenital malformations of eye, ear, face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.0 Congenital ptosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.1 Congenital ectropion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.2 Congenital entropion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.3 Other congenital malformations of eyelid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.4 Absence and agenesis of lacrimal apparatus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.5 Congenital stenosis and stricture of lacrimal duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.6 Other congenital malformations of lacrimal apparatus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q10.7 Congenital malformation of orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q11 Anophthalmos, microphthalmos and macrophthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q11.0 Cystic eyeball 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q11.1 Other anophthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q11.2 Microphthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q11.3 Macrophthalmos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12 Congenital lens malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.0 Congenital cataract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.1 Congenital displaced lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.2 Coloboma of lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.3 Congenital aphakia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.4 Spherophakia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.8 Other congenital lens malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q12.9 Congenital lens malformation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13 Congenital malformations of anterior segment of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.0 Coloboma of iris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.1 Absence of iris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.2 Other congenital malformations of iris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.3 Congenital corneal opacity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.4 Other congenital corneal malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.5 Blue sclera 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.8 Other congenital malformations of anterior segment of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q13.9 Congenital malformation of anterior segment of eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14 Congenital malformations of posterior segment of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.0 Congenital malformation of vitreous humour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.1 Congenital malformation of retina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.2 Congenital malformation of optic disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.3 Congenital malformation of choroid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.8 Other congenital malformations of posterior segment of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q14.9 Congenital malformation of posterior segment of eye, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q15 Other congenital malformations of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q15.0 Congenital glaucoma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q15.8 Other specified congenital malformations of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q15.9 Congenital malformation of eye, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 365 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16 Congenital malformations of ear causing impairment of hearing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.0 Congenital absence of (ear) auricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.1 Congenital absence, atresia and stricture of auditory canal (external) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.2 Absence of eustachian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.3 Congenital malformation of ear ossicles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.4 Other congenital malformations of middle ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.5 Congenital malformation of inner ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q16.9 Congenital malformation of ear causing impairment of hearing, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17 Other congenital malformations of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.0 Accessory auricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.1 Macrotia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.2 Microtia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.3 Other misshapen ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.4 Misplaced ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.5 Prominent ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.8 Other specified congenital malformations of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q17.9 Congenital malformation of ear, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18 Other congenital malformations of face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.0 Sinus, fistula and cyst of branchial cleft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.1 Preauricular sinus and cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.2 Other branchial cleft malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.3 Webbing of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.4 Macrostomia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.5 Microstomia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.6 Macrocheilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.7 Microcheilia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.8 Other specified congenital malformations of face and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q18.9 Congenital malformation of face and neck, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20 Congenital malformations of cardiac chambers and connections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20-Q28 Congenital malformations of the circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.0 Common arterial trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.1 Double outlet right ventricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.2 Double outlet left ventricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.3 Discordant ventriculoarterial connection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.4 Double inlet ventricle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.5 Discordant atrioventricular connection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.6 Isomerism of atrial appendages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.8 Other congenital malformations of cardiac chambers and connections 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q20.9 Congenital malformation of cardiac chambers and connections, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21 Congenital malformations of cardiac septa

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 366 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.0 Ventricular septal defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.1 Atrial septal defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.2 Atrioventricular septal defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.3 Tetralogy of Fallot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.4 Aortopulmonary septal defect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.8 Other congenital malformations of cardiac septa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q21.9 Congenital malformation of cardiac septum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22 Congenital malformations of pulmonary and tricuspid valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.0 Pulmonary valve atresia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.1 Congenital pulmonary valve stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.2 Congenital pulmonary valve insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.3 Other congenital malformations of pulmonary valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.4 Congenital tricuspid stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.5 Ebstein anomaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.6 Hypoplastic right heart syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.8 Other congenital malformations of tricuspid valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q22.9 Congenital malformation of tricuspid valve, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23 Congenital malformations of aortic and mitral valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.0 Congenital stenosis of aortic valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.1 Congenital insufficiency of aortic valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.2 Congenital mitral stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.3 Congenital mitral insufficiency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.4 Hypoplastic left heart syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.8 Other congenital malformations of aortic and mitral valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q23.9 Congenital malformation of aortic and mitral valves, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24 Other congenital malformations of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.0 Dextrocardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.1 Laevocardia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.2 Cor triatriatum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.3 Pulmonary infundibular stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.4 Congenital subaortic stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.5 Malformation of coronary vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.6 Congenital heart block 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.8 Other specified congenital malformations of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q24.9 Congenital malformation of heart, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25 Congenital malformations of great arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.0 Patent ductus arteriosus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.1 Coarctation of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.2 Atresia of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.3 Stenosis of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.4 Other congenital malformations of aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.5 Atresia of pulmonary artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.6 Stenosis of pulmonary artery © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 367 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.7 Other congenital malformations of pulmonary artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.8 Other congenital malformations of great arteries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q25.9 Congenital malformation of great arteries, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26 Congenital malformations of great veins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.0 Congenital stenosis of vena cava 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.1 Persistent left superior vena cava 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.2 Total anomalous pulmonary venous connection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.3 Partial anomalous pulmonary venous connection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.4 Anomalous pulmonary venous connection, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.5 Anomalous portal venous connection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.6 Portal vein-hepatic artery fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.8 Other congenital malformations of great veins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q26.9 Congenital malformation of great vein, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27 Other congenital malformations of peripheral vascular system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.0 Congenital absence and hypoplasia of umbilical artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.1 Congenital renal artery stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.2 Other congenital malformations of renal artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.3 Peripheral arteriovenous malformation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.4 Congenital phlebectasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.8 Other specified congenital malformations of peripheral vascular system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q27.9 Congenital malformation of peripheral vascular system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28 Other congenital malformations of circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.0 Arteriovenous malformation of precerebral vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.1 Other malformations of precerebral vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.2 Arteriovenous malformation of cerebral vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.3 Other malformations of cerebral vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.8 Other specified congenital malformations of circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q28.9 Congenital malformation of circulatory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30 Congenital malformations of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30-Q34 Congenital malformations of the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.0 Choanal atresia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.1 Agenesis and underdevelopment of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.2 Fissured, notched and cleft nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.3 Congenital perforated nasal septum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.8 Other congenital malformations of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q30.9 Congenital malformation of nose, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31 Congenital malformations of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.0 Web of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.1 Congenital subglottic stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.2 Laryngeal hypoplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.3 Laryngocele 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.5 Congenital laryngomalacia © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 368 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.8 Other congenital malformations of larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q31.9 Congenital malformation of larynx, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32 Congenital malformations of trachea and bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32.0 Congenital tracheomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32.1 Other congenital malformations of trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32.2 Congenital bronchomalacia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32.3 Congenital stenosis of bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q32.4 Other congenital malformations of bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33 Congenital malformations of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.0 Congenital cystic lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.1 Accessory lobe of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.2 Sequestration of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.3 Agenesis of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.4 Congenital bronchiectasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.5 Ectopic tissue in lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.6 Hypoplasia and dysplasia of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.8 Other congenital malformations of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q33.9 Congenital malformation of lung, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q34 Other congenital malformations of respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q34.0 Anomaly of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q34.1 Congenital cyst of mediastinum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q34.8 Other specified congenital malformations of respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q34.9 Congenital malformation of respiratory system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35 Cleft palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35-Q37 Cleft lip and cleft palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35.1 Cleft hard palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35.3 Cleft soft palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35.5 Cleft hard palate with cleft soft palate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35.7 Cleft uvula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q35.9 Cleft palate, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q36 Cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q36.0 Cleft lip, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q36.1 Cleft lip, median 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q36.9 Cleft lip, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37 Cleft palate with cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.0 Cleft hard palate with bilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.1 Cleft hard palate with unilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.2 Cleft soft palate with bilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.3 Cleft soft palate with unilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.4 Cleft hard and soft palate with bilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.5 Cleft hard and soft palate with unilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.8 Unspecified cleft palate with bilateral cleft lip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q37.9 Unspecified cleft palate with unilateral cleft lip © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 369 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38 Other congenital malformations of tongue, mouth and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38-Q45 Other congenital malformations of the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.0 Congenital malformations of lips, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.1 Ankyloglossia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.2 Macroglossia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.3 Other congenital malformations of tongue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.4 Congenital malformations of salivary glands and ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.5 Congenital malformations of palate, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.6 Other congenital malformations of mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.7 Pharyngeal pouch 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q38.8 Other congenital malformations of pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39 Congenital malformations of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.0 Atresia of oesophagus without fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.1 Atresia of oesophagus with tracheo-oesophageal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.2 Congenital tracheo-oesophageal fistula without atresia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.3 Congenital stenosis and stricture of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.4 Oesophageal web 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.5 Congenital dilatation of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.6 Diverticulum of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.8 Other congenital malformations of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q39.9 Congenital malformation of oesophagus, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40 Other congenital malformations of upper alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.0 Congenital hypertrophic pyloric stenosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.1 Congenital hiatus hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.2 Other specified congenital malformations of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.3 Congenital malformation of stomach, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.8 Other specified congenital malformations of upper alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q40.9 Congenital malformation of upper alimentary tract, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41 Congenital absence, atresia and stenosis of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41.0 Congenital absence, atresia and stenosis of duodenum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41.1 Congenital absence, atresia and stenosis of jejunum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41.2 Congenital absence, atresia and stenosis of ileum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41.8 Congenital absence, atresia and stenosis of other specified parts of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q41.9 Congenital absence, atresia and stenosis of small intestine, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42 Congenital absence, atresia and stenosis of large intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.0 Congenital absence, atresia and stenosis of rectum with fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.1 Congenital absence, atresia and stenosis of rectum without fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.2 Congenital absence, atresia and stenosis of anus with fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.3 Congenital absence, atresia and stenosis of anus without fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.8 Congenital absence, atresia and stenosis of other parts of large intestine © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 370 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q42.9 Congenital absence, atresia and stenosis of large intestine, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43 Other congenital malformations of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.0 Meckel diverticulum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.1 Hirschsprung disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.2 Other congenital functional disorders of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.3 Congenital malformations of intestinal fixation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.4 Duplication of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.5 Ectopic anus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.6 Congenital fistula of rectum and anus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.7 Persistent cloaca 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.8 Other specified congenital malformations of intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q43.9 Congenital malformation of intestine, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44 Congenital malformations of gallbladder, bile ducts and liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.0 Agenesis, aplasia and hypoplasia of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.1 Other congenital malformations of gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.2 Atresia of bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.3 Congenital stenosis and stricture of bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.4 Choledochal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.5 Other congenital malformations of bile ducts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.6 Cystic disease of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q44.7 Other congenital malformations of liver 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45 Other congenital malformations of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.0 Agenesis, aplasia and hypoplasia of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.1 Annular pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.2 Congenital pancreatic cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.3 Other congenital malformations of pancreas and pancreatic duct 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.8 Other specified congenital malformations of digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q45.9 Congenital malformation of digestive system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50 Congenital malformations of ovaries, fallopian tubes and broad ligaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50-Q56 Congenital malformations of genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.0 Congenital absence of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.1 Developmental ovarian cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.2 Congenital torsion of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.3 Other congenital malformations of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.4 Embryonic cyst of fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.5 Embryonic cyst of broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q50.6 Other congenital malformations of fallopian tube and broad ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51 Congenital malformations of uterus and cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.0 Agenesis and aplasia of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.1 Doubling of uterus with doubling of cervix and vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.2 Other doubling of uterus

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 371 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.3 Bicornate uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.4 Unicornate uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.5 Agenesis and aplasia of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.6 Embryonic cyst of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.7 Congenital fistulae between uterus and digestive and urinary tracts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.8 Other congenital malformations of uterus and cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q51.9 Congenital malformation of uterus and cervix, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52 Other congenital malformations of female genitalia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.0 Congenital absence of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.1 Doubling of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.2 Congenital rectovaginal fistula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.3 Imperforate hymen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.4 Other congenital malformations of vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.5 Fusion of labia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.6 Congenital malformation of clitoris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.7 Other congenital malformations of vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.8 Other specified congenital malformations of female genitalia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q52.9 Congenital malformation of female genitalia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q53 Undescended testicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q53.0 Ectopic testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q53.1 Undescended testicle, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q53.2 Undescended testicle, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q53.9 Undescended testicle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54 Hypospadias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.0 Hypospadias, balanic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.1 Hypospadias, penile 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.2 Hypospadias, penoscrotal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.3 Hypospadias, perineal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.4 Congenital chordee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.8 Other hypospadias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q54.9 Hypospadias, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55 Other congenital malformations of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.0 Absence and aplasia of testis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.1 Hypoplasia of testis and scrotum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.2 Other congenital malformations of testis and scrotum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.3 Atresia of vas deferens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.4 Other congenital malformations of vas deferens, epididymis, seminal vesicles and prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.5 Congenital absence and aplasia of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.6 Other congenital malformations of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.8 Other specified congenital malformations of male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q55.9 Congenital malformation of male genital organ, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56 Indeterminate sex and pseudohermaphroditism © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 372 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56.0 Hermaphroditism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56.1 Male pseudohermaphroditism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56.2 Female pseudohermaphroditism, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56.3 Pseudohermaphroditism, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q56.4 Indeterminate sex, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60 Renal agenesis and other reduction defects of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60-Q64 Congenital malformations of the urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.0 Renal agenesis, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.1 Renal agenesis, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.2 Renal agenesis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.3 Renal hypoplasia, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.4 Renal hypoplasia, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.5 Renal hypoplasia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q60.6 Potter syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61 Cystic kidney disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.0 Congenital single renal cyst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.1 Polycystic kidney, autosomal recessive 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.2 Polycystic kidney, autosomal dominant 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.3 Polycystic kidney, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.4 Renal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.5 Medullary cystic kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.8 Other cystic kidney diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q61.9 Cystic kidney disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.0 Congenital hydronephrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.1 Atresia and stenosis of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.2 Congenital megaloureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.3 Other obstructive defects of renal pelvis and ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.4 Agenesis of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.5 Duplication of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.6 Malposition of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.7 Congenital vesico-uretero-renal reflux 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q62.8 Other congenital malformations of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63 Other congenital malformations of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.0 Accessory kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.1 Lobulated, fused and horseshoe kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.2 Ectopic kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.3 Hyperplastic and giant kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.8 Other specified congenital malformations of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q63.9 Congenital malformation of kidney, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64 Other congenital malformations of urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.0 Epispadias

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 373 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.1 Exstrophy of urinary bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.2 Congenital posterior urethral valves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.3 Other atresia and stenosis of urethra and bladder neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.4 Malformation of urachus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.5 Congenital absence of bladder and urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.6 Congenital diverticulum of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.7 Other congenital malformations of bladder and urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.8 Other specified congenital malformations of urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q64.9 Congenital malformation of urinary system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65 Congenital deformities of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65-Q79 Congenital malformations and deformations of the musculoskeletal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.0 Congenital dislocation of hip, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.1 Congenital dislocation of hip, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.2 Congenital dislocation of hip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.3 Congenital subluxation of hip, unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.4 Congenital subluxation of hip, bilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.5 Congenital subluxation of hip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.6 Unstable hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.8 Other congenital deformities of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q65.9 Congenital deformity of hip, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66 Congenital deformities of feet 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.0 Talipes equinovarus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.1 Talipes calcaneovarus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.2 Metatarsus varus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.3 Other congenital varus deformities of feet 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.4 Talipes calcaneovalgus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.5 Congenital pes planus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.6 Other congenital valgus deformities of feet 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.7 Pes cavus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.8 Other congenital deformities of feet 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q66.9 Congenital deformity of feet, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67 Congenital musculoskeletal deformities of head, face, spine and chest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.0 Facial asymmetry 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.1 Compression facies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.2 Dolichocephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.3 Plagiocephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.4 Other congenital deformities of skull, face and jaw 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.5 Congenital deformity of spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.6 Pectus excavatum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.7 Pectus carinatum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q67.8 Other congenital deformities of chest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68 Other congenital musculoskeletal deformities © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 374 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.0 Congenital deformity of sternocleidomastoid muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.1 Congenital deformity of hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.2 Congenital deformity of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.3 Congenital bowing of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.4 Congenital bowing of tibia and fibula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.5 Congenital bowing of long bones of leg, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q68.8 Other specified congenital musculoskeletal deformities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q69 Polydactyly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q69.0 Accessory finger(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q69.1 Accessory thumb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q69.2 Accessory toe(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q69.9 Polydactyly, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70 Syndactyly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.0 Fused fingers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.1 Webbed fingers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.2 Fused toes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.3 Webbed toes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.4 Polysyndactyly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q70.9 Syndactyly, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71 Reduction defects of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.0 Congenital complete absence of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.1 Congenital absence of upper arm and forearm with hand present 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.2 Congenital absence of both forearm and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.3 Congenital absence of hand and finger(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.4 Longitudinal reduction defect of radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.5 Longitudinal reduction defect of ulna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.6 Lobster-claw hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.8 Other reduction defects of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q71.9 Reduction defect of upper limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72 Reduction defects of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.0 Congenital complete absence of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.1 Congenital absence of thigh and lower leg with foot present 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.2 Congenital absence of both lower leg and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.3 Congenital absence of foot and toe(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.4 Longitudinal reduction defect of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.5 Longitudinal reduction defect of tibia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.6 Longitudinal reduction defect of fibula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.7 Split foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.8 Other reduction defects of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q72.9 Reduction defect of lower limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q73 Reduction defects of unspecified limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q73.0 Congenital absence of unspecified limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q73.1 Phocomelia, unspecified limb(s) © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 375 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q73.8 Other reduction defects of unspecified limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74 Other congenital malformations of limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.0 Other congenital malformations of upper limb(s), including shoulder girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.1 Congenital malformation of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.2 Other congenital malformations of lower limb(s), including pelvic girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.3 Arthrogryposis multiplex congenita 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.8 Other specified congenital malformations of limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q74.9 Unspecified congenital malformation of limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75 Other congenital malformations of skull and face bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.0 Craniosynostosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.1 Craniofacial dysostosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.2 Hypertelorism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.3 Macrocephaly 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.4 Mandibulofacial dysostosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.5 Oculomandibular dysostosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.8 Other specified congenital malformations of skull and face bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q75.9 Congenital malformation of skull and face bones, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76 Congenital malformations of spine and bony thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.0 Spina bifida occulta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.1 Klippel-Feil syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.2 Congenital spondylolisthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.3 Congenital scoliosis due to congenital bony malformation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.4 Other congenital malformations of spine, not associated with scoliosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.5 Cervical rib 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.6 Other congenital malformations of ribs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.7 Congenital malformation of sternum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.8 Other congenital malformations of bony thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q76.9 Congenital malformation of bony thorax, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77 Osteochondrodysplasia with defects of growth of tubular bones and spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.0 Achondrogenesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.1 Thanatophoric short stature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.2 Short rib syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.3 Chondrodysplasia punctata 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.4 Achondroplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.5 Dystrophic dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.6 Chondroectodermal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.7 Spondyloepiphyseal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.8 Other osteochondrodysplasia with defects of growth of tubular bones and spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q77.9 Osteochondrodysplasia with defects of growth of tubular bones and spine, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 376 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78 Other osteochondrodysplasias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.0 Osteogenesis imperfecta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.1 Polyostotic fibrous dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.2 Osteopetrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.3 Progressive diaphyseal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.4 Enchondromatosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.5 Metaphyseal dysplasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.6 Multiple congenital exostoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.8 Other specified osteochondrodysplasias 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q78.9 Osteochondrodysplasia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79 Congenital malformations of the musculoskeletal system, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.0 Congenital diaphragmatic hernia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.1 Other congenital malformations of diaphragm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.2 Exomphalos 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.3 Gastroschisis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.4 Prune belly syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.5 Other congenital malformations of abdominal wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.6 Ehlers-Danlos syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.8 Other congenital malformations of musculoskeletal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q79.9 Congenital malformation of musculoskeletal system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80 Congenital ichthyosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80-Q89 Other congenital malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.0 Ichthyosis vulgaris 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.1 X-linked ichthyosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.2 Lamellar ichthyosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.3 Congenital bullous ichthyosiform erythroderma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.4 Harlequin fetus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.8 Other congenital ichthyosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q80.9 Congenital ichthyosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81 Epidermolysis bullosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81.0 Epidermolysis bullosa simplex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81.1 Epidermolysis bullosa letalis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81.2 Epidermolysis bullosa dystrophica 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81.8 Other epidermolysis bullosa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q81.9 Epidermolysis bullosa, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82 Other congenital malformations of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.0 Hereditary lymphoedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.2 Mastocytosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.3 Incontinentia pigmenti 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.4 Ectodermal dysplasia (anhidrotic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.5 Congenital non-neoplastic naevus

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 377 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.8 Other specified congenital malformations of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q82.9 Congenital malformation of skin, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83 Congenital malformations of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.0 Congenital absence of breast with absent nipple 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.1 Accessory breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.2 Absent nipple 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.3 Accessory nipple 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.8 Other congenital malformations of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q83.9 Congenital malformation of breast, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84 Other congenital malformations of integument 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.0 Congenital alopecia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.1 Congenital morphological disturbances of hair, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.2 Other congenital malformations of hair 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.3 Anonychia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.4 Congenital leukonychia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.5 Enlarged and hypertrophic nails 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.6 Other congenital malformations of nails 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.8 Other specified congenital malformations of integument 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q84.9 Congenital malformation of integument, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q85 Phakomatoses, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q85.0 Neurofibromatosis (nonmalignant) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q85.1 Tuberous sclerosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q85.8 Other phakomatoses, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q85.9 Phakomatosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q86.0 Fetal alcohol syndrome (dysmorphic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q86.1 Fetal hydantoin syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q86.2 Dysmorphism due to warfarin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q86.8 Other congenital malformation syndromes due to known exogenous causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87 Other specified congenital malformation syndromes affecting multiple systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.0 Congenital malformation syndromes predominantly affecting facial appearance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.1 Congenital malformation syndromes predominantly associated with short stature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.2 Congenital malformation syndromes predominantly involving limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.3 Congenital malformation syndromes involving early overgrowth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.4 Marfan syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.5 Other congenital malformation syndromes with other skeletal changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q87.8 Other specified congenital malformation syndromes, not elsewhere classified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 378 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89 Other congenital malformations, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.0 Congenital malformations of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.1 Congenital malformations of adrenal gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.2 Congenital malformations of other endocrine glands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.3 Situs inversus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.4 Conjoined twins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.7 Multiple congenital malformations, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.8 Other specified congenital malformations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q89.9 Congenital malformation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90 Down syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90-Q99 Chromosomal abnormalities, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90.0 Trisomy 21, meiotic nondisjunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90.1 Trisomy 21, mosaicism (mitotic nondisjunction) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90.2 Trisomy 21, translocation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q90.9 Down syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91 Edwards syndrome and Patau syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.0 Trisomy 18, meiotic nondisjunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.1 Trisomy 18, mosaicism (mitotic nondisjunction) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.2 Trisomy 18, translocation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.3 Edwards syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.4 Trisomy 13, meiotic nondisjunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.5 Trisomy 13, mosaicism (mitotic nondisjunction) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.6 Trisomy 13, translocation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q91.7 Patau syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92 Other trisomies and partial trisomies of the autosomes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.0 Whole chromosome trisomy, meiotic nondisjunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.1 Whole chromosome trisomy, mosaicism (mitotic nondisjunction) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.2 Major partial trisomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.3 Minor partial trisomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.4 Duplications seen only at prometaphase 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.5 Duplications with other complex rearrangements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.6 Extra marker chromosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.7 Triploidy and polyploidy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.8 Other specified trisomies and partial trisomies of autosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q92.9 Trisomy and partial trisomy of autosomes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93 Monosomies and deletions from the autosomes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.0 Whole chromosome monosomy, meiotic nondisjunction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.1 Whole chromosome monosomy, mosaicism (mitotic nondisjunction) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.2 Chromosome replaced with ring or dicentric 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.3 Deletion of short arm of chromosome 4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.4 Deletion of short arm of chromosome 5

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 379 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.5 Other deletions of part of a chromosome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.6 Deletions seen only at prometaphase 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.7 Deletions with other complex rearrangements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.8 Other deletions from the autosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q93.9 Deletion from autosomes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95 Balanced rearrangements and structural markers, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.0 Balanced translocation and insertion in normal individual 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.1 Chromosome inversion in normal individual 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.2 Balanced autosomal rearrangement in abnormal individual 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.3 Balanced sex/autosomal rearrangement in abnormal individual 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.4 Individuals with marker heterochromatin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.5 Individuals with autosomal fragile site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.8 Other balanced rearrangements and structural markers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q95.9 Balanced rearrangement and structural marker, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96 Turner syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.0 Karyotype 45,X 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.1 Karyotype 46,X iso (Xq) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.2 Karyotype 46,X with abnormal sex chromosome, except iso (Xq) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.3 Mosaicism, 45,X/46,XX or XY 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.4 Mosaicism, 45,X/other cell line(s) with abnormal sex chromosome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.8 Other variants of Turner syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q96.9 Turner syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97 Other sex chromosome abnormalities, female phenotype, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.0 Karyotype 47,XXX 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.1 Female with more than three X chromosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.2 Mosaicism, lines with various numbers of X chromosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.3 Female with 46,XY karyotype 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.8 Other specified sex chromosome abnormalities, female phenotype 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q97.9 Sex chromosome abnormality, female phenotype, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98 Other sex chromosome abnormalities, male phenotype, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.0 Klinefelter syndrome karyotype 47,XXY 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.1 Klinefelter syndrome, male with more than two X chromosomes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.2 Klinefelter syndrome, male with 46,XX karyotype 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.3 Other male with 46,XX karyotype 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.4 Klinefelter syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.5 Karyotype 47,XYY 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.6 Male with structurally abnormal sex chromosome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.7 Male with sex chromosome mosaicism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.8 Other specified sex chromosome abnormalities, male phenotype 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q98.9 Sex chromosome abnormality, male phenotype, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 380 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99 Other chromosome abnormalities, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99.0 Chimera 46,XX/46,XY 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99.1 46,XX true hermaphrodite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99.2 Fragile X chromosome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99.8 Other specified chromosome abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Q99.9 Chromosomal abnormality, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00 Abnormalities of heart beat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00-R09 Symptoms and signs involving the circulatory and respiratory systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00.0 Tachycardia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00.1 Bradycardia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00.2 Palpitations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R00.8 Other and unspecified abnormalities of heart beat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R01 Cardiac murmurs and other cardiac sounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R01.0 Benign and innocent cardiac murmurs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R01.1 Cardiac murmur, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R01.2 Other cardiac sounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R02 Gangrene, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R03 Abnormal blood-pressure reading, without diagnosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R03.0 Elevated blood-pressure reading, without diagnosis of hypertension 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R03.1 Nonspecific low blood-pressure reading 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04 Haemorrhage from respiratory passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04.0 Epistaxis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04.1 Haemorrhage from throat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04.2 Haemoptysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04.8 Haemorrhage from other sites in respiratory passages 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R04.9 Haemorrhage from respiratory passages, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R05 Cough 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06 Abnormalities of breathing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.0 Dyspnoea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.1 Stridor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.2 Wheezing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.3 Periodic breathing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.4 Hyperventilation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.5 Mouth breathing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.6 Hiccough 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.7 Sneezing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R06.8 Other and unspecified abnormalities of breathing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07 Pain in throat and chest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07.0 Pain in throat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07.1 Chest pain on breathing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07.2 Precordial pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07.3 Other chest pain © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 381 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R07.4 Chest pain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09 Other symptoms and signs involving the circulatory and respiratory systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09.0 Asphyxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09.1 Pleurisy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09.2 Respiratory arrest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09.3 Abnormal sputum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10 Abdominal and pelvic pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10-R19 Symptoms and signs involving the digestive system and abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10.0 Acute abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10.1 Pain localized to upper abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10.2 Pelvic and perineal pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10.3 Pain localized to other parts of lower abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R10.4 Other and unspecified abdominal pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R11 Nausea and vomiting 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R12 Heartburn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Dysphagia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R14 Flatulence and related conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R15 Faecal incontinence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R16 Hepatomegaly and splenomegaly, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R16.0 Hepatomegaly, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R16.1 Splenomegaly, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R16.2 Hepatomegaly with splenomegaly, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R17 Unspecified jaundice 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R18 Ascites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19 Other symptoms and signs involving the digestive system and abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.0 Intra-abdominal and pelvic swelling, mass and lump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.1 Abnormal bowel sounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.2 Visible peristalsis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.3 Abdominal rigidity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.4 Change in bowel habit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.5 Other faecal abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.6 Halitosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R19.8 Other specified symptoms and signs involving the digestive system and abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20 Disturbances of skin sensation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20-R23 Symptoms and signs involving the skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20.0 Anaesthesia of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20.1 Hypoaesthesia of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20.2 Paraesthesia of skin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20.3 Hyperaesthesia © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 382 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R20.8 Other and unspecified disturbances of skin sensation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R21 Rash and other nonspecific skin eruption 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22 Localized swelling, mass and lump of skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.0 Localized swelling, mass and lump, head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.1 Localized swelling, mass and lump, neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.2 Localized swelling, mass and lump, trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.3 Localized swelling, mass and lump, upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.4 Localized swelling, mass and lump, lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.7 Localized swelling, mass and lump, multiple sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R22.9 Localized swelling, mass and lump, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23 Other skin changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.0 Cyanosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.1 Pallor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.2 Flushing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.3 Spontaneous ecchymoses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.4 Changes in skin texture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R23.8 Other and unspecified skin changes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25 Abnormal involuntary movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25.0 Abnormal head movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25.1 Tremor, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25.2 Cramp and spasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25.3 Fasciculation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R25.8 Other and unspecified abnormal involuntary movements 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26 Abnormalities of gait and mobility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26.0 Ataxic gait 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26.1 Paralytic gait 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26.2 Difficulty in walking, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26.3 Immobility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R26.8 Other and unspecified abnormalities of gait and mobility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R27 Other lack of coordination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R27.0 Ataxia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R27.8 Other and unspecified lack of coordination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29 Other symptoms and signs involving the nervous and musculoskeletal systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.0 Tetany 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.1 Meningismus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.2 Abnormal reflex 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.3 Abnormal posture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.4 Clicking hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.6 Tendency to fall, not elsewhere classified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 383 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R30 Pain associated with micturition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R30-R39 Symptoms and signs involving the urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R30.0 Dysuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R30.1 Vesical tenesmus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R30.9 Painful micturition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R31 Unspecified haematuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R32 Unspecified urinary incontinence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R33 Retention of urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R34 Anuria and oliguria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R35 Polyuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R36 Urethral discharge 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R39 Other symptoms and signs involving the urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R39.0 Extravasation of urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R39.1 Other difficulties with micturition 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R39.2 Extrarenal uraemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R39.8 Other and unspecified symptoms and signs involving the urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R40 Somnolence, stupor and coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R40-R46 Symptoms and signs involving cognition, perception, emotional state and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R40.0 Somnolence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R40.1 Stupor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R40.2 Coma, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41 Other symptoms and signs involving cognitive functions and awareness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41.0 Disorientation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41.1 Anterograde amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41.2 Retrograde amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41.3 Other amnesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R42 Dizziness and giddiness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R43 Disturbances of smell and taste 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R43.0 Anosmia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R43.1 Parosmia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R43.2 Parageusia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R43.8 Other and unspecified disturbances of smell and taste 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44 Other symptoms and signs involving general sensations and perceptions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44.0 Auditory hallucinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44.1 Visual hallucinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44.2 Other hallucinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44.3 Hallucinations, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 384 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45 Symptoms and signs involving emotional state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.0 Nervousness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.1 Restlessness and agitation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.2 Unhappiness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.3 Demoralization and apathy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.4 Irritability and anger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.5 Hostility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.6 Physical violence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.7 State of emotional shock and stress, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R45.8 Other symptoms and signs involving emotional state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46 Symptoms and signs involving appearance and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.0 Very low level of personal hygiene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.1 Bizarre personal appearance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.2 Strange and inexplicable behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.3 Overactivity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.4 Slowness and poor responsiveness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.5 Suspiciousness and marked evasiveness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.6 Undue concern and preoccupation with stressful events 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.7 Verbosity and circumstantial detail obscuring reason for contact 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R46.8 Other symptoms and signs involving appearance and behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R47 Speech disturbances, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R47-R49 Symptoms and signs involving speech and voice 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R47.0 Dysphasia and aphasia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R47.1 Dysarthria and anarthria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R47.8 Other and unspecified speech disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R48.0 Dyslexia and alexia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R48.1 Agnosia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R48.2 Apraxia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R48.8 Other and unspecified symbolic dysfunctions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R49 Voice disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R49.0 Dysphonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R49.1 Aphonia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R49.2 Hypernasality and hyponasality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R49.8 Other and unspecified voice disturbances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R50 Fever of other and unknown origin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R50-R69 General symptoms and signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R50.2 Drug-induced fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R50.8 Other specified fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R50.9 Fever, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R51 Headache © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 385 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R52 Pain, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R52.0 Acute pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R52.1 Chronic intractable pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R52.2 Other chronic pain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R52.9 Pain, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R53 Malaise and fatigue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R54 Senility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R55 Syncope and collapse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R56 Convulsions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R56.0 Febrile convulsions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R56.8 Other and unspecified convulsions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57 Shock, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57.0 Cardiogenic shock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57.1 Hypovolaemic shock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57.2 Septic shock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57.8 Other shock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R57.9 Shock, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R58 Haemorrhage, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R59 Enlarged lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R59.0 Localized enlarged lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R59.1 Generalized enlarged lymph nodes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R59.9 Enlarged lymph nodes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R60 Oedema, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R60.0 Localized oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R60.1 Generalized oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R60.9 Oedema, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R61 Hyperhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R61.0 Localized hyperhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R61.1 Generalized hyperhidrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R61.9 Hyperhidrosis, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R62 Lack of expected normal physiological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R62.0 Delayed milestone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R62.8 Other lack of expected normal physiological development 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R62.9 Lack of expected normal physiological development, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63 Symptoms and signs concerning food and fluid intake 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.0 Anorexia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.1 Polydipsia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.2 Polyphagia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.3 Feeding difficulties and mismanagement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.4 Abnormal weight loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.5 Abnormal weight gain 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.6 Insufficient intake of food and due to self neglect 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R63.8 Other symptoms and signs concerning food and fluid intake © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 386 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R64 Cachexia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65 Systemic Inflammatory Response Syndrome [SIRS] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65.0 Systemic Inflammatory Response Syndrome of infectious origin without organ failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65.1 Systemic Inflammatory Response Syndrome of infectious origin with organ failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65.2 Systemic Inflammatory Response Syndrome of non-infectious origin without organ failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65.3 Systemic Inflammatory Response Syndrome of non-infectious origin with organ failure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R65.9 Systemic Inflammatory Response Syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68 Other general symptoms and signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68.0 Hypothermia, not associated with low environmental temperature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68.1 Nonspecific symptoms peculiar to infancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68.2 Dry mouth, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68.3 Clubbing of fingers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R68.8 Other specified general symptoms and signs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R69 Unknown and unspecified causes of morbidity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R70-R79 Abnormal findings on examination of blood, without diagnosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R70.0 Elevated erythrocyte sedimentation rate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R70.1 Abnormal plasma viscosity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R71 Abnormality of red blood cells 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R72 Abnormality of white blood cells, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R73 Elevated blood glucose level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R73.0 Abnormal glucose tolerance test 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R73.9 Hyperglycaemia, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R74 Abnormal serum enzyme levels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R74.0 Elevation of levels of transaminase and lactic acid dehydrogenase [LDH] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R74.8 Abnormal levels of other serum enzymes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R74.9 Abnormal level of unspecified serum enzyme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R75 Laboratory evidence of human immunodeficiency virus [HIV] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76 Other abnormal immunological findings in serum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76.0 Raised antibody titre 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76.1 Abnormal reaction to tuberculin test 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76.2 False-positive serological test for syphilis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76.8 Other specified abnormal immunological findings in serum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R76.9 Abnormal immunological finding in serum, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77 Other abnormalities of plasma proteins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77.0 Abnormality of albumin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77.1 Abnormality of globulin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77.2 Abnormality of alphafetoprotein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77.8 Other specified abnormalities of plasma proteins

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 387 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R77.9 Abnormality of plasma protein, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78 Findings of drugs and other substances, not normally found in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.0 Finding of alcohol in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.1 Finding of drug in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.2 Finding of cocaine in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.3 Finding of hallucinogen in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.4 Finding of other drugs of addictive potential in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.5 Finding of psychotropic drug in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.6 Finding of steroid agent in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.7 Finding of abnormal level of heavy metals in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.8 Finding of other specified substances, not normally found in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R78.9 Finding of unspecified substance, not normally found in blood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R79 Other abnormal findings of blood chemistry 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R79.0 Abnormal level of blood mineral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R79.8 Other specified abnormal findings of blood chemistry 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R79.9 Abnormal finding of blood chemistry, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R80 Isolated proteinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R80-R82 Abnormal findings on examination of urine, without diagnosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R81 Glycosuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82 Other abnormal findings in urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.0 Chyluria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.1 Myoglobinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.2 Biliuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.3 Haemoglobinuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.4 Acetonuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.5 Elevated urine levels of drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.7 Abnormal findings on microbiological examination of urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.8 Abnormal findings on cytological and histological examination of urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R82.9 Other and unspecified abnormal findings in urine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83 Abnormal findings in cerebrospinal fluid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R84 Abnormal findings in specimens from respiratory organs and thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R85 Abnormal findings in specimens from digestive organs and abdominal cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R86 Abnormal findings in specimens from male genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R87 Abnormal findings in specimens from female genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R89 Abnormal findings in specimens from other organs, systems and tissues

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 388 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R90 Abnormal findings on diagnostic imaging of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R90-R94 Abnormal findings on diagnostic imaging and in function studies, without diagnosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R90.0 Intracranial space-occupying lesion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R90.8 Other abnormal findings on diagnostic imaging of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R91 Abnormal findings on diagnostic imaging of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R92 Abnormal findings on diagnostic imaging of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93 Abnormal findings on diagnostic imaging of other body structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.4 Abnormal findings on diagnostic imaging of urinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.6 Abnormal findings on diagnostic imaging of limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R93.8 Abnormal findings on diagnostic imaging of other specified body structures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94 Abnormal results of function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.0 Abnormal results of function studies of central nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.1 Abnormal results of function studies of peripheral nervous system and special senses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.2 Abnormal results of pulmonary function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.3 Abnormal results of cardiovascular function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.4 Abnormal results of kidney function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.5 Abnormal results of liver function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.6 Abnormal results of thyroid function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.7 Abnormal results of other endocrine function studies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R94.8 Abnormal results of function studies of other organs and systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R95 Sudden infant death syndrome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R95-R99 Ill-defined and unknown causes of mortality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R95.0 Sudden infant death syndrome with mention of autopsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R95.9 Sudden infant death syndrome without mention of autopsy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R96 Other sudden death, cause unknown 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R96.0 Instantaneous death 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R96.1 Death occurring less than 24 hours from onset of symptoms, not otherwise explained 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R98 Unattended death 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 R99 Other ill-defined and unspecified causes of mortality 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00 Superficial injury of head © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 389 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00-S09 Injuries to the head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.0 Superficial injury of scalp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.1 Contusion of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.2 Other superficial injuries of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.3 Superficial injury of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.4 Superficial injury of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.5 Superficial injury of lip and oral cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.7 Multiple superficial injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.8 Superficial injury of other parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S00.9 Superficial injury of head, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01 Open wound of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.0 Open wound of scalp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.1 Open wound of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.2 Open wound of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.3 Open wound of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.4 Open wound of cheek and temporomandibular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.5 Open wound of lip and oral cavity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.7 Multiple open wounds of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.8 Open wound of other parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S01.9 Open wound of head, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02 Fracture of skull and facial bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.0 Fracture of vault of skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.1 Fracture of base of skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.2 Fracture of nasal bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.3 Fracture of orbital floor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.4 Fracture of malar and maxillary bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.5 Fracture of tooth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.6 Fracture of mandible 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.7 Multiple fractures involving skull and facial bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.8 Fractures of other skull and facial bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S02.9 Fracture of skull and facial bones, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03 Dislocation, sprain and strain of joints and ligaments of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.0 Dislocation of jaw 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.1 Dislocation of septal cartilage of nose 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.2 Dislocation of tooth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.3 Dislocation of other and unspecified parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.4 Sprain and strain of jaw 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S03.5 Sprain and strain of joints and ligaments of other and unspecified parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04 Injury of cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.0 Injury of optic nerve and pathways 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.1 Injury of oculomotor nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.2 Injury of trochlear nerve

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 390 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.3 Injury of trigeminal nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.4 Injury of abducent nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.5 Injury of facial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.6 Injury of acoustic nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.7 Injury of accessory nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.8 Injury of other cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S04.9 Injury of unspecified cranial nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05 Injury of eye and orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.1 Contusion of eyeball and orbital tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.3 Ocular laceration without prolapse or loss of intraocular tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.4 Penetrating wound of orbit with or without foreign body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.5 Penetrating wound of eyeball with foreign body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.6 Penetrating wound of eyeball without foreign body 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.7 Avulsion of eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.8 Other injuries of eye and orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S05.9 Injury of eye and orbit, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06 Intracranial injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.0 Concussion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.1 Traumatic cerebral oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.2 Diffuse brain injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.3 Focal brain injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.4 Epidural haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.5 Traumatic subdural haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.6 Traumatic subarachnoid haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.7 Intracranial injury with prolonged coma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.8 Other intracranial injuries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S06.9 Intracranial injury, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S07 Crushing injury of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S07.0 Crushing injury of face 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S07.1 Crushing injury of skull 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S07.8 Crushing injury of other parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S07.9 Crushing injury of head, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S08 Traumatic amputation of part of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S08.0 Avulsion of scalp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S08.1 Traumatic amputation of ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S08.8 Traumatic amputation of other parts of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S08.9 Traumatic amputation of unspecified part of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09 Other and unspecified injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.0 Injury of blood vessels of head, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.1 Injury of muscle and tendon of head © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 391 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.2 Traumatic rupture of ear drum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.7 Multiple injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.8 Other specified injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S09.9 Unspecified injury of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10 Superficial injury of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10-S19 Injuries to the neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10.0 Contusion of throat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10.1 Other and unspecified superficial injuries of throat 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10.7 Multiple superficial injuries of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10.8 Superficial injury of other parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S10.9 Superficial injury of neck, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11 Open wound of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.0 Open wound involving larynx and trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.1 Open wound involving thyroid gland 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.2 Open wound involving pharynx and cervical oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.7 Multiple open wounds of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.8 Open wound of other parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S11.9 Open wound of neck, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12 Fracture of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.0 Fracture of first cervical vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.1 Fracture of second cervical vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.2 Fracture of other specified cervical vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.7 Multiple fractures of cervical spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.8 Fracture of other parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S12.9 Fracture of neck, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13 Dislocation, sprain and strain of joints and ligaments at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.0 Traumatic rupture of cervical intervertebral disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.1 Dislocation of cervical vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.2 Dislocation of other and unspecified parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.3 Multiple dislocations of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.4 Sprain and strain of cervical spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.5 Sprain and strain of thyroid region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S13.6 Sprain and strain of joints and ligaments of other and unspecified parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14 Injury of nerves and spinal cord at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.0 Concussion and oedema of cervical spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.1 Other and unspecified injuries of cervical spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.2 Injury of nerve root of cervical spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.3 Injury of brachial plexus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.4 Injury of peripheral nerves of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.5 Injury of cervical sympathetic nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S14.6 Injury of other and unspecified nerves of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15 Injury of blood vessels at neck level © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 392 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.0 Injury of carotid artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.1 Injury of vertebral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.2 Injury of external jugular vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.3 Injury of internal jugular vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.7 Injury of multiple blood vessels at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.8 Injury of other blood vessels at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S15.9 Injury of unspecified blood vessel at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S16 Injury of muscle and tendon at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S17 Crushing injury of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S17.0 Crushing injury of larynx and trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S17.8 Crushing injury of other parts of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S17.9 Crushing injury of neck, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S18 Traumatic amputation at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S19 Other and unspecified injuries of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S19.7 Multiple injuries of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S19.8 Other specified injuries of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S19.9 Unspecified injury of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20 Superficial injury of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20-S29 Injuries to the thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.0 Contusion of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.1 Other and unspecified superficial injuries of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.2 Contusion of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.3 Other superficial injuries of front wall of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.4 Other superficial injuries of back wall of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.7 Multiple superficial injuries of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S20.8 Superficial injury of other and unspecified parts of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21 Open wound of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.0 Open wound of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.1 Open wound of front wall of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.2 Open wound of back wall of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.7 Multiple open wounds of thoracic wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.8 Open wound of other parts of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S21.9 Open wound of thorax, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22 Fracture of rib(s), sternum and thoracic spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.0 Fracture of thoracic vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.1 Multiple fractures of thoracic spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.2 Fracture of sternum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.3 Fracture of rib 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.4 Multiple fractures of ribs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.5 Flail chest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.8 Fracture of other parts of bony thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S22.9 Fracture of bony thorax, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23 Dislocation, sprain and strain of joints and ligaments of thorax © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 393 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.0 Traumatic rupture of thoracic intervertebral disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.1 Dislocation of thoracic vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.2 Dislocation of other and unspecified parts of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.3 Sprain and strain of thoracic spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.4 Sprain and strain of ribs and sternum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S23.5 Sprain and strain of other and unspecified parts of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24 Injury of nerves and spinal cord at thorax level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.0 Concussion and oedema of thoracic spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.1 Other and unspecified injuries of thoracic spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.2 Injury of nerve root of thoracic spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.3 Injury of peripheral nerves of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.4 Injury of thoracic sympathetic nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.5 Injury of other nerves of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S24.6 Injury of unspecified nerve of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25 Injury of blood vessels of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.0 Injury of thoracic aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.1 Injury of innominate or subclavian artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.2 Injury of superior vena cava 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.3 Injury of innominate or subclavian vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.4 Injury of pulmonary blood vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.5 Injury of intercostal blood vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.7 Injury of multiple blood vessels of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.8 Injury of other blood vessels of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S25.9 Injury of unspecified blood vessel of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S26 Injury of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S26.0 Injury of heart with haemopericardium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S26.8 Other injuries of heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S26.9 Injury of heart, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27 Injury of other and unspecified intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.0 Traumatic pneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.1 Traumatic haemothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.2 Traumatic haemopneumothorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.3 Other injuries of lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.4 Injury of bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.5 Injury of thoracic trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.6 Injury of pleura 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.7 Multiple injuries of intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.8 Injury of other specified intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S27.9 Injury of unspecified intrathoracic organ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S28 Crushing injury of thorax and traumatic amputation of part of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S28.0 Crushed chest 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S28.1 Traumatic amputation of part of thorax

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 394 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S29 Other and unspecified injuries of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S29.0 Injury of muscle and tendon at thorax level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S29.7 Multiple injuries of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S29.8 Other specified injuries of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S29.9 Unspecified injury of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30 Superficial injury of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.0 Contusion of lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.1 Contusion of abdominal wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.2 Contusion of external genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.7 Multiple superficial injuries of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.8 Other superficial injuries of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31 Open wound of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.0 Open wound of lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.1 Open wound of abdominal wall 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.2 Open wound of penis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.3 Open wound of scrotum and testes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.4 Open wound of vagina and vulva 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.5 Open wound of other and unspecified external genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.7 Multiple open wounds of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S31.8 Open wound of other and unspecified parts of abdomen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32 Fracture of lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.0 Fracture of lumbar vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.1 Fracture of sacrum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.2 Fracture of coccyx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.3 Fracture of ilium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.4 Fracture of acetabulum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.5 Fracture of pubis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.7 Multiple fractures of lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.0 Traumatic rupture of lumbar intervertebral disc 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.1 Dislocation of lumbar vertebra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.2 Dislocation of sacroiliac and sacrococcygeal joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.3 Dislocation of other and unspecified parts of lumbar spine and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.4 Traumatic rupture of symphysis pubis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.5 Sprain and strain of lumbar spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.6 Sprain and strain of sacroiliac joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S33.7 Sprain and strain of other and unspecified parts of lumbar spine and pelvis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 395 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.0 Concussion and oedema of lumbar spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.1 Other injury of lumbar spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.2 Injury of nerve root of lumbar and sacral spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.3 Injury of cauda equina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.4 Injury of lumbosacral plexus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.5 Injury of lumbar, sacral and pelvic sympathetic nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.6 Injury of peripheral nerve(s) of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S34.8 Injury of other and unspecified nerves at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35 Injury of blood vessels at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.0 Injury of abdominal aorta 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.1 Injury of inferior vena cava 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.2 Injury of coeliac or mesenteric artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.3 Injury of portal or splenic vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.4 Injury of renal blood vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.5 Injury of iliac blood vessels 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.7 Injury of multiple blood vessels at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.8 Injury of other blood vessels at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S35.9 Injury of unspecified blood vessel at abdomen, lower back and pelvis level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36 Injury of intra-abdominal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.0 Injury of spleen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.1 Injury of liver or gallbladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.2 Injury of pancreas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.3 Injury of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.4 Injury of small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.5 Injury of colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.6 Injury of rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.7 Injury of multiple intra-abdominal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.8 Injury of other intra-abdominal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S36.9 Injury of unspecified intra-abdominal organ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37 Injury of urinary and pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.0 Injury of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.1 Injury of ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.2 Injury of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.3 Injury of urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.4 Injury of ovary 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.5 Injury of fallopian tube 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.6 Injury of uterus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.7 Injury of multiple pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.8 Injury of other pelvic organs © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 396 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S37.9 Injury of unspecified pelvic organ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S38.0 Crushing injury of external genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S38.1 Crushing injury of other and unspecified parts of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S38.2 Traumatic amputation of external genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S38.3 Traumatic amputation of other and unspecified parts of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39 Other and unspecified injuries of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39.0 Injury of muscle and tendon of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39.6 Injury of intra-abdominal organ(s) with pelvic organ(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39.7 Other multiple injuries of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39.8 Other specified injuries of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S39.9 Unspecified injury of abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40 Superficial injury of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40-S49 Injuries to the shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40.0 Contusion of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40.7 Multiple superficial injuries of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40.8 Other superficial injuries of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S40.9 Superficial injury of shoulder and upper arm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S41 Open wound of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S41.0 Open wound of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S41.1 Open wound of upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S41.7 Multiple open wounds of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S41.8 Open wound of other and unspecified parts of shoulder girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42 Fracture of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.0 Fracture of clavicle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.1 Fracture of scapula 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.2 Fracture of upper end of humerus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.3 Fracture of shaft of humerus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.4 Fracture of lower end of humerus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.7 Multiple fractures of clavicle, scapula and humerus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.8 Fracture of other parts of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S42.9 Fracture of shoulder girdle, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.0 Dislocation of shoulder joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.1 Dislocation of acromioclavicular joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.2 Dislocation of sternoclavicular joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.3 Dislocation of other and unspecified parts of shoulder girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.4 Sprain and strain of shoulder joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.5 Sprain and strain of acromioclavicular joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.6 Sprain and strain of sternoclavicular joint © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 397 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S43.7 Sprain and strain of other and unspecified parts of shoulder girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44 Injury of nerves at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.0 Injury of ulnar nerve at upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.1 Injury of median nerve at upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.2 Injury of radial nerve at upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.3 Injury of axillary nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.4 Injury of musculocutaneous nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.5 Injury of cutaneous sensory nerve at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.7 Injury of multiple nerves at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.8 Injury of other nerves at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S44.9 Injury of unspecified nerve at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45 Injury of blood vessels at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.0 Injury of axillary artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.1 Injury of brachial artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.2 Injury of axillary or brachial vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.3 Injury of superficial vein at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.7 Injury of multiple blood vessels at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.8 Injury of other blood vessels at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S45.9 Injury of unspecified blood vessel at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46 Injury of muscle and tendon at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.0 Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.1 Injury of muscle and tendon of long head of biceps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.2 Injury of muscle and tendon of other parts of biceps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.3 Injury of muscle and tendon of triceps 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.7 Injury of multiple muscles and tendons at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.8 Injury of other muscles and tendons at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S46.9 Injury of unspecified muscle and tendon at shoulder and upper arm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S47 Crushing injury of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S48 Traumatic amputation of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S48.0 Traumatic amputation at shoulder joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S48.1 Traumatic amputation at level between shoulder and elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S48.9 Traumatic amputation of shoulder and upper arm, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S49 Other and unspecified injuries of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S49.7 Multiple injuries of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S49.8 Other specified injuries of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S49.9 Unspecified injury of shoulder and upper arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50 Superficial injury of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50-S59 Injuries to the elbow and forearm

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 398 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50.0 Contusion of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50.1 Contusion of other and unspecified parts of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50.7 Multiple superficial injuries of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50.8 Other superficial injuries of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S50.9 Superficial injury of forearm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S51 Open wound of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S51.0 Open wound of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S51.7 Multiple open wounds of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S51.8 Open wound of other parts of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S51.9 Open wound of forearm, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52 Fracture of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.0 Fracture of upper end of ulna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.1 Fracture of upper end of radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.2 Fracture of shaft of ulna 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.3 Fracture of shaft of radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.4 Fracture of shafts of both ulna and radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.5 Fracture of lower end of radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.6 Fracture of lower end of both ulna and radius 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.7 Multiple fractures of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.8 Fracture of other parts of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S52.9 Fracture of forearm, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53 Dislocation, sprain and strain of joints and ligaments of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53.0 Dislocation of radial head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53.1 Dislocation of elbow, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53.2 Traumatic rupture of radial collateral ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53.3 Traumatic rupture of ulnar collateral ligament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S53.4 Sprain and strain of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54 Injury of nerves at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.0 Injury of ulnar nerve at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.1 Injury of median nerve at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.2 Injury of radial nerve at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.3 Injury of cutaneous sensory nerve at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.7 Injury of multiple nerves at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.8 Injury of other nerves at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S54.9 Injury of unspecified nerve at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55 Injury of blood vessels at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.0 Injury of ulnar artery at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.1 Injury of radial artery at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.2 Injury of vein at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.7 Injury of multiple blood vessels at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.8 Injury of other blood vessels at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S55.9 Injury of unspecified blood vessel at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56 Injury of muscle and tendon at forearm level © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 399 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.0 Injury of flexor muscle and tendon of thumb at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.1 Injury of long flexor muscle and tendon of other finger(s) at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.2 Injury of other flexor muscle and tendon at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.3 Injury of extensor or abductor muscles and tendons of thumb at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.4 Injury of extensor muscle and tendon of other finger(s) at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.5 Injury of other extensor muscle and tendon at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.7 Injury of multiple muscles and tendons at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S56.8 Injury of other and unspecified muscles and tendons at forearm level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S57 Crushing injury of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S57.0 Crushing injury of elbow 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S57.8 Crushing injury of other parts of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S57.9 Crushing injury of forearm, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S58 Traumatic amputation of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S58.0 Traumatic amputation at elbow level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S58.1 Traumatic amputation at level between elbow and wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S58.9 Traumatic amputation of forearm, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S59 Other and unspecified injuries of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S59.7 Multiple injuries of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S59.8 Other specified injuries of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S59.9 Unspecified injury of forearm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60 Superficial injury of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60-S69 Injuries to the wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.0 Contusion of finger(s) without damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.1 Contusion of finger(s) with damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.2 Contusion of other parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.7 Multiple superficial injuries of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.8 Other superficial injuries of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S60.9 Superficial injury of wrist and hand, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61 Open wound of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61.0 Open wound of finger(s) without damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61.1 Open wound of finger(s) with damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61.7 Multiple open wounds of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61.8 Open wound of other parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S61.9 Open wound of wrist and hand, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62 Fracture at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.0 Fracture of navicular [scaphoid] bone of hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.1 Fracture of other carpal bone(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.2 Fracture of first metacarpal bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.3 Fracture of other metacarpal bone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.4 Multiple fractures of metacarpal bones

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 400 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.5 Fracture of thumb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.6 Fracture of other finger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.7 Multiple fractures of fingers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S62.8 Fracture of other and unspecified parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.0 Dislocation of wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.1 Dislocation of finger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.2 Multiple dislocations of fingers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.3 Traumatic rupture of ligament of wrist and carpus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.5 Sprain and strain of wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.6 Sprain and strain of finger(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S63.7 Sprain and strain of other and unspecified parts of hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64 Injury of nerves at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.0 Injury of ulnar nerve at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.1 Injury of median nerve at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.2 Injury of radial nerve at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.3 Injury of digital nerve of thumb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.4 Injury of digital nerve of other finger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.7 Injury of multiple nerves at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.8 Injury of other nerves at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S64.9 Injury of unspecified nerve at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65 Injury of blood vessels at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.0 Injury of ulnar artery at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.1 Injury of radial artery at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.2 Injury of superficial palmar arch 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.3 Injury of deep palmar arch 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.4 Injury of blood vessel(s) of thumb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.5 Injury of blood vessel(s) of other finger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.7 Injury of multiple blood vessels at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.8 Injury of other blood vessels at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S65.9 Injury of unspecified blood vessel at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66 Injury of muscle and tendon at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.4 Injury of intrinsic muscle and tendon of thumb at wrist and hand level

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 401 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.5 Injury of intrinsic muscle and tendon of other finger at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.6 Injury of multiple flexor muscles and tendons at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.8 Injury of other muscles and tendons at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S66.9 Injury of unspecified muscle and tendon at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S67 Crushing injury of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S67.0 Crushing injury of thumb and other finger(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S67.8 Crushing injury of other and unspecified parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68 Traumatic amputation of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.0 Traumatic amputation of thumb (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.1 Traumatic amputation of other single finger (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.2 Traumatic amputation of two or more fingers alone (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.3 Combined traumatic amputation of (part of) finger(s) with other parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.4 Traumatic amputation of hand at wrist level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.8 Traumatic amputation of other parts of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S68.9 Traumatic amputation of wrist and hand, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S69 Other and unspecified injuries of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S69.7 Multiple injuries of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S69.8 Other specified injuries of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S69.9 Unspecified injury of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70 Superficial injury of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70-S79 Injuries to the hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70.0 Contusion of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70.1 Contusion of thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70.7 Multiple superficial injuries of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70.8 Other superficial injuries of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S70.9 Superficial injury of hip and thigh, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S71 Open wound of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S71.0 Open wound of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S71.1 Open wound of thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S71.7 Multiple open wounds of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S71.8 Open wound of other and unspecified parts of pelvic girdle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72 Fracture of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.0 Fracture of neck of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.1 Pertrochanteric fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.2 Subtrochanteric fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.3 Fracture of shaft of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.4 Fracture of lower end of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.7 Multiple fractures of femur 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.8 Fractures of other parts of femur © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 402 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S72.9 Fracture of femur, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S73 Dislocation, sprain and strain of joint and ligaments of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S73.0 Dislocation of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S73.1 Sprain and strain of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74 Injury of nerves at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.0 Injury of sciatic nerve at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.1 Injury of femoral nerve at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.2 Injury of cutaneous sensory nerve at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.7 Injury of multiple nerves at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.8 Injury of other nerves at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S74.9 Injury of unspecified nerve at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75 Injury of blood vessels at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.0 Injury of femoral artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.1 Injury of femoral vein at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.2 Injury of greater saphenous vein at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.7 Injury of multiple blood vessels at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.8 Injury of other blood vessels at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S75.9 Injury of unspecified blood vessel at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76 Injury of muscle and tendon at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.0 Injury of muscle and tendon of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.1 Injury of quadriceps muscle and tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.2 Injury of adductor muscle and tendon of thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.3 Injury of muscle and tendon of the posterior muscle group at thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.4 Injury of other and unspecified muscles and tendons at thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S76.7 Injury of multiple muscles and tendons at hip and thigh level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S77 Crushing injury of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S77.0 Crushing injury of hip 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S77.1 Crushing injury of thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S77.2 Crushing injury of hip with thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S78 Traumatic amputation of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S78.0 Traumatic amputation at hip joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S78.1 Traumatic amputation at level between hip and knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S78.9 Traumatic amputation of hip and thigh, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S79 Other and unspecified injuries of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S79.7 Multiple injuries of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S79.8 Other specified injuries of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S79.9 Unspecified injury of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80 Superficial injury of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80-S89 Injuries to the knee and lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80.0 Contusion of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80.1 Contusion of other and unspecified parts of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80.7 Multiple superficial injuries of lower leg © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 403 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80.8 Other superficial injuries of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S80.9 Superficial injury of lower leg, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S81 Open wound of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S81.0 Open wound of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S81.7 Multiple open wounds of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S81.8 Open wound of other parts of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S81.9 Open wound of lower leg, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82 Fracture of lower leg, including ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.0 Fracture of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.1 Fracture of upper end of tibia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.2 Fracture of shaft of tibia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.3 Fracture of lower end of tibia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.4 Fracture of fibula alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.5 Fracture of medial malleolus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.6 Fracture of lateral malleolus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.7 Multiple fractures of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.8 Fractures of other parts of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S82.9 Fracture of lower leg, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83 Dislocation, sprain and strain of joints and ligaments of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.0 Dislocation of patella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.1 Dislocation of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.2 Tear of meniscus, current 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.3 Tear of articular cartilage of knee, current 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.4 Sprain and strain involving (fibular)(tibial) collateral ligament of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.5 Sprain and strain involving (anterior)(posterior) cruciate ligament of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.6 Sprain and strain of other and unspecified parts of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S83.7 Injury to multiple structures of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84 Injury of nerves at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.0 Injury of tibial nerve at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.1 Injury of peroneal nerve at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.2 Injury of cutaneous sensory nerve at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.7 Injury of multiple nerves at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.8 Injury of other nerves at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S84.9 Injury of unspecified nerve at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85 Injury of blood vessels at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.0 Injury of popliteal artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.1 Injury of (anterior)(posterior) tibial artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.2 Injury of peroneal artery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.3 Injury of greater saphenous vein at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.4 Injury of lesser saphenous vein at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.5 Injury of popliteal vein 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.7 Injury of multiple blood vessels at lower leg level © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 404 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.8 Injury of other blood vessels at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S85.9 Injury of unspecified blood vessel at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86 Injury of muscle and tendon at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.0 Injury of Achilles tendon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.1 Injury of other muscle(s) and tendon(s) of posterior muscle group at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.2 Injury of muscle(s) and tendon(s) of anterior muscle group at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.3 Injury of muscle(s) and tendon(s) of peroneal muscle group at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.7 Injury of multiple muscles and tendons at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.8 Injury of other muscles and tendons at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S86.9 Injury of unspecified muscle and tendon at lower leg level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S87 Crushing injury of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S87.0 Crushing injury of knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S87.8 Crushing injury of other and unspecified parts of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S88 Traumatic amputation of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S88.0 Traumatic amputation at knee level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S88.1 Traumatic amputation at level between knee and ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S88.9 Traumatic amputation of lower leg, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S89 Other and unspecified injuries of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S89.7 Multiple injuries of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S89.8 Other specified injuries of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S89.9 Unspecified injury of lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90 Superficial injury of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90-S99 Injuries to the ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.0 Contusion of ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.1 Contusion of toe(s) without damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.2 Contusion of toe(s) with damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.3 Contusion of other and unspecified parts of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.7 Multiple superficial injuries of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.8 Other superficial injuries of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S90.9 Superficial injury of ankle and foot, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91 Open wound of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91.0 Open wound of ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91.1 Open wound of toe(s) without damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91.2 Open wound of toe(s) with damage to nail 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91.3 Open wound of other parts of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S91.7 Multiple open wounds of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92 Fracture of foot, except ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.0 Fracture of calcaneus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.1 Fracture of talus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.2 Fracture of other tarsal bone(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.3 Fracture of metatarsal bone

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 405 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.4 Fracture of great toe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.5 Fracture of other toe 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.7 Multiple fractures of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S92.9 Fracture of foot, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.0 Dislocation of ankle joint 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.1 Dislocation of toe(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.2 Rupture of ligaments at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.3 Dislocation of other and unspecified parts of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.4 Sprain and strain of ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.5 Sprain and strain of toe(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S93.6 Sprain and strain of other and unspecified parts of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94 Injury of nerves at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.0 Injury of lateral plantar nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.1 Injury of medial plantar nerve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.2 Injury of deep peroneal nerve at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.3 Injury of cutaneous sensory nerve at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.7 Injury of multiple nerves at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.8 Injury of other nerves at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S94.9 Injury of unspecified nerve at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95 Injury of blood vessels at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.0 Injury of dorsal artery of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.1 Injury of plantar artery of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.2 Injury of dorsal vein of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.7 Injury of multiple blood vessels at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.8 Injury of other blood vessels at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S95.9 Injury of unspecified blood vessel at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96 Injury of muscle and tendon at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.0 Injury of muscle and tendon of long flexor muscle of toe at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.1 Injury of muscle and tendon of long extensor muscle of toe at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.2 Injury of intrinsic muscle and tendon at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.7 Injury of multiple muscles and tendons at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.8 Injury of other muscles and tendons at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S96.9 Injury of unspecified muscle and tendon at ankle and foot level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S97 Crushing injury of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S97.0 Crushing injury of ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S97.1 Crushing injury of toe(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S97.8 Crushing injury of other parts of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98 Traumatic amputation of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98.0 Traumatic amputation of foot at ankle level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98.1 Traumatic amputation of one toe

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 406 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98.2 Traumatic amputation of two or more toes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98.3 Traumatic amputation of other parts of foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S98.4 Traumatic amputation of foot, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S99 Other and unspecified injuries of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S99.7 Multiple injuries of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S99.8 Other specified injuries of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 S99.9 Unspecified injury of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00 Superficial injuries involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00-T07 Injuries involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.0 Superficial injuries involving head with neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.1 Superficial injuries involving thorax with abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.2 Superficial injuries involving multiple regions of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.3 Superficial injuries involving multiple regions of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.6 Superficial injuries involving multiple regions of upper limb(s) with lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.8 Superficial injuries involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T00.9 Multiple superficial injuries, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01 Open wounds involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.0 Open wounds involving head with neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.1 Open wounds involving thorax with abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.2 Open wounds involving multiple regions of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.3 Open wounds involving multiple regions of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.6 Open wounds involving multiple regions of upper limb(s) with lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.8 Open wounds involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T01.9 Multiple open wounds, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02 Fractures involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.0 Fractures involving head with neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.1 Fractures involving thorax with lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.2 Fractures involving multiple regions of one upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.3 Fractures involving multiple regions of one lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.4 Fractures involving multiple regions of both upper limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.5 Fractures involving multiple regions of both lower limbs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.6 Fractures involving multiple regions of upper limb(s) with lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.7 Fractures involving thorax with lower back and pelvis with limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.8 Fractures involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T02.9 Multiple fractures, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03 Dislocations, sprains and strains involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.0 Dislocations, sprains and strains involving head with neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.1 Dislocations, sprains and strains involving thorax with lower back and pelvis

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 407 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.2 Dislocations, sprains and strains involving multiple regions of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.3 Dislocations, sprains and strains involving multiple regions of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.4 Dislocations, sprains and strains involving multiple regions of upper limb(s) with lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.8 Dislocations, sprains and strains involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T03.9 Multiple dislocations, sprains and strains, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04 Crushing injuries involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.0 Crushing injuries involving head with neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.1 Crushing injuries involving thorax with abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.2 Crushing injuries involving multiple regions of upper limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.3 Crushing injuries involving multiple regions of lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.4 Crushing injuries involving multiple regions of upper limb(s) with lower limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.7 Crushing injuries of thorax with abdomen, lower back and pelvis with limb(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.8 Crushing injuries involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T04.9 Multiple crushing injuries, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05 Traumatic amputations involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.0 Traumatic amputation of both hands 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.1 Traumatic amputation of one hand and other arm [any level, except hand] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.2 Traumatic amputation of both arms [any level] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.3 Traumatic amputation of both feet 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.4 Traumatic amputation of one foot and other leg [any level, except foot] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.5 Traumatic amputation of both legs [any level] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.6 Traumatic amputation of upper and lower limbs, any combination [any level] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.8 Traumatic amputations involving other combinations of body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T05.9 Multiple traumatic amputations, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06 Other injuries involving multiple body regions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.0 Injuries of brain and cranial nerves with injuries of nerves and spinal cord at neck level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.1 Injuries of nerves and spinal cord involving other multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.2 Injuries of nerves involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.3 Injuries of blood vessels involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.4 Injuries of muscles and tendons involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.5 Injuries of intrathoracic organs with intra-abdominal and pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T06.8 Other specified injuries involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T07 Unspecified multiple injuries

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 408 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T08 Fracture of spine, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T08-T14 Injuries to unspecified part of trunk, limb or body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09 Other injuries of spine and trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.0 Superficial injury of trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.1 Open wound of trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.2 Dislocation, sprain and strain of unspecified joint and ligament of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.3 Injury of spinal cord, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.4 Injury of unspecified nerve, spinal nerve root and plexus of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.5 Injury of unspecified muscle and tendon of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.6 Traumatic amputation of trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.8 Other specified injuries of trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T09.9 Unspecified injury of trunk, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T10 Fracture of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11 Other injuries of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.0 Superficial injury of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.1 Open wound of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.2 Dislocation, sprain and strain of unspecified joint and ligament of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.3 Injury of unspecified nerve of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.4 Injury of unspecified blood vessel of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.5 Injury of unspecified muscle and tendon of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.6 Traumatic amputation of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.8 Other specified injuries of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T11.9 Unspecified injury of upper limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T12 Fracture of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13 Other injuries of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.0 Superficial injury of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.1 Open wound of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.2 Dislocation, sprain and strain of unspecified joint and ligament of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.3 Injury of unspecified nerve of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.4 Injury of unspecified blood vessel of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.5 Injury of unspecified muscle and tendon of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.6 Traumatic amputation of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.8 Other specified injuries of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T13.9 Unspecified injury of lower limb, level unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14 Injury of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.0 Superficial injury of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.1 Open wound of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.2 Fracture of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.3 Dislocation, sprain and strain of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.4 Injury of nerve(s) of unspecified body region © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 409 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.5 Injury of blood vessel(s) of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.6 Injury of muscles and tendons of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.7 Crushing injury and traumatic amputation of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.8 Other injuries of unspecified body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T14.9 Injury, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15 Foreign body on external eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15-T19 Effects of foreign body entering through natural orifice 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15.0 Foreign body in cornea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15.1 Foreign body in conjunctival sac 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15.8 Foreign body in other and multiple parts of external eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T15.9 Foreign body on external eye, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T16 Foreign body in ear 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17 Foreign body in respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.0 Foreign body in nasal sinus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.1 Foreign body in nostril 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.2 Foreign body in pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.3 Foreign body in larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.4 Foreign body in trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.5 Foreign body in bronchus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.8 Foreign body in other and multiple parts of respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T17.9 Foreign body in respiratory tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18 Foreign body in alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.0 Foreign body in mouth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.1 Foreign body in oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.2 Foreign body in stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.3 Foreign body in small intestine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.4 Foreign body in colon 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.5 Foreign body in anus and rectum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.8 Foreign body in other and multiple parts of alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T18.9 Foreign body in alimentary tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19 Foreign body in genitourinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.0 Foreign body in urethra 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.1 Foreign body in bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.2 Foreign body in vulva and vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.3 Foreign body in uterus [any part] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.8 Foreign body in other and multiple parts of genitourinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T19.9 Foreign body in genitourinary tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20 Burn and corrosion of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20-T25 Burns and corrosions of external body surface, specified by site 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20-T32 Burns and corrosions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.0 Burn of unspecified degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.1 Burn of first degree of head and neck

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 410 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.2 Burn of second degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.3 Burn of third degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.4 Corrosion of unspecified degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.5 Corrosion of first degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.6 Corrosion of second degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T20.7 Corrosion of third degree of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21 Burn and corrosion of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.0 Burn of unspecified degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.1 Burn of first degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.2 Burn of second degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.3 Burn of third degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.4 Corrosion of unspecified degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.5 Corrosion of first degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.6 Corrosion of second degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T21.7 Corrosion of third degree of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22 Burn and corrosion of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23 Burn and corrosion of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.0 Burn of unspecified degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.1 Burn of first degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.2 Burn of second degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.3 Burn of third degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.4 Corrosion of unspecified degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.5 Corrosion of first degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.6 Corrosion of second degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T23.7 Corrosion of third degree of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24 Burn and corrosion of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.1 Burn of first degree of hip and lower limb, except ankle and foot

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 411 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.2 Burn of second degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.3 Burn of third degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25 Burn and corrosion of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.0 Burn of unspecified degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.1 Burn of first degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.2 Burn of second degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.3 Burn of third degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.4 Corrosion of unspecified degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.5 Corrosion of first degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.6 Corrosion of second degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T25.7 Corrosion of third degree of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26 Burn and corrosion confined to eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26-T28 Burns and corrosions confined to eye and internal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.0 Burn of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.1 Burn of cornea and conjunctival sac 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.2 Burn with resulting rupture and destruction of eyeball 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.3 Burn of other parts of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.4 Burn of eye and adnexa, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.5 Corrosion of eyelid and periocular area 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.6 Corrosion of cornea and conjunctival sac 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.7 Corrosion with resulting rupture and destruction of eyeball 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.8 Corrosion of other parts of eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T26.9 Corrosion of eye and adnexa, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27 Burn and corrosion of respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.0 Burn of larynx and trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.1 Burn involving larynx and trachea with lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.2 Burn of other parts of respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.3 Burn of respiratory tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.4 Corrosion of larynx and trachea 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.5 Corrosion involving larynx and trachea with lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.6 Corrosion of other parts of respiratory tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T27.7 Corrosion of respiratory tract, part unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28 Burn and corrosion of other internal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.0 Burn of mouth and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.1 Burn of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.2 Burn of other parts of alimentary tract © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 412 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.3 Burn of internal genitourinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.4 Burn of other and unspecified internal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.5 Corrosion of mouth and pharynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.6 Corrosion of oesophagus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.7 Corrosion of other parts of alimentary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.8 Corrosion of internal genitourinary organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T28.9 Corrosion of other and unspecified internal organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29 Burns and corrosions of multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29-T32 Burns and corrosions of multiple and unspecified body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.0 Burns of multiple regions, unspecified degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.1 Burns of multiple regions, no more than first-degree burns mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.2 Burns of multiple regions, no more than second-degree burns mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.3 Burns of multiple regions, at least one burn of third degree mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.4 Corrosions of multiple regions, unspecified degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.5 Corrosions of multiple regions, no more than first-degree corrosions mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.6 Corrosions of multiple regions, no more than second-degree corrosions mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T29.7 Corrosions of multiple regions, at least one corrosion of third degree mentioned 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30 Burn and corrosion, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.0 Burn of unspecified body region, unspecified degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.1 Burn of first degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.2 Burn of second degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.3 Burn of third degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.4 Corrosion of unspecified body region, unspecified degree 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.5 Corrosion of first degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.6 Corrosion of second degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T30.7 Corrosion of third degree, body region unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31 Burns classified according to extent of body surface involved 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.0 Burns involving less than 10% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.1 Burns involving 10-19% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.2 Burns involving 20-29% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.3 Burns involving 30-39% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.4 Burns involving 40-49% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.5 Burns involving 50-59% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.6 Burns involving 60-69% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.7 Burns involving 70-79% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.8 Burns involving 80-89% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T31.9 Burns involving 90% or more of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32 Corrosions classified according to extent of body surface involved

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 413 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.0 Corrosions involving less than 10% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.1 Corrosions involving 10-19% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.2 Corrosions involving 20-29% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.3 Corrosions involving 30-39% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.4 Corrosions involving 40-49% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.5 Corrosions involving 50-59% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.6 Corrosions involving 60-69% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.7 Corrosions involving 70-79% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.8 Corrosions involving 80-89% of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T32.9 Corrosions involving 90% or more of body surface 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33 Superficial frostbite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33-T35 Frostbite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.0 Superficial frostbite of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.1 Superficial frostbite of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.2 Superficial frostbite of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.3 Superficial frostbite of abdominal wall, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.4 Superficial frostbite of arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.5 Superficial frostbite of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.6 Superficial frostbite of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.7 Superficial frostbite of knee and lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.8 Superficial frostbite of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T33.9 Superficial frostbite of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34 Frostbite with tissue necrosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.0 Frostbite with tissue necrosis of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.1 Frostbite with tissue necrosis of neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.2 Frostbite with tissue necrosis of thorax 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.3 Frostbite with tissue necrosis of abdominal wall, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.4 Frostbite with tissue necrosis of arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.5 Frostbite with tissue necrosis of wrist and hand 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.6 Frostbite with tissue necrosis of hip and thigh 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.7 Frostbite with tissue necrosis of knee and lower leg 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.8 Frostbite with tissue necrosis of ankle and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T34.9 Frostbite with tissue necrosis of other and unspecified sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35 Frostbite involving multiple body regions and unspecified frostbite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.0 Superficial frostbite involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.1 Frostbite with tissue necrosis involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.2 Unspecified frostbite of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.3 Unspecified frostbite of thorax, abdomen, lower back and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.4 Unspecified frostbite of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.5 Unspecified frostbite of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.6 Unspecified frostbite involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T35.7 Unspecified frostbite of unspecified site © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 414 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36 Poisoning by systemic antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36-T50 Poisoning by drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.0 Poisoning: Penicillins 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.1 Poisoning: Cefalosporins and other beta-lactam antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.2 Poisoning: Chloramphenicol group 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.3 Poisoning: Macrolides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.4 Poisoning: Tetracyclines 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.5 Poisoning: Aminoglycosides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.6 Poisoning: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.7 Poisoning: antibiotics, systemically used 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.8 Poisoning: Other systemic antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T36.9 Poisoning: Systemic , unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37 Poisoning by other systemic anti-infectives and 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.0 Poisoning: Sulfonamides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.1 Poisoning: drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.2 Poisoning: Antimalarials and drugs acting on other blood protozoa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.3 Poisoning: Other drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.4 Poisoning: Anthelminthics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.5 Poisoning: Antiviral drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.8 Poisoning: Other specified systemic anti-infectives and antiparasitics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T37.9 Poisoning: Systemic anti-infective and antiparasitic, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.0 Poisoning: Glucocorticoids and synthetic analogues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.1 Poisoning: Thyroid hormones and substitutes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.2 Poisoning: Antithyroid drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.3 Poisoning: Insulin and oral hypoglycaemic [antidiabetic] drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.4 Poisoning: Oral contraceptives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.5 Poisoning: Other estrogens and progestogens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.6 Poisoning: Antigonadotrophins, , antiandrogens, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.7 Poisoning: Androgens and anabolic congeners 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.8 Poisoning: Other and unspecified hormones and their synthetic substitutes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T38.9 Poisoning: Other and unspecified hormone antagonists 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.0 Poisoning: Salicylates 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.1 Poisoning: 4-Aminophenol derivatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.2 Poisoning: Pyrazolone derivatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.3 Poisoning: Other anti-inflammatory drugs [NSAID] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.4 Poisoning: Antirheumatics, not elsewhere classified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 415 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.8 Poisoning: Other nonopioid analgesics and antipyretics, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T39.9 Poisoning: Nonopioid analgesic, and antirheumatic, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40 Poisoning by and psychodysleptics [hallucinogens] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.0 Poisoning: Opium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.1 Poisoning: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.2 Poisoning: Other opioids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.3 Poisoning: Methadone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.4 Poisoning: Other synthetic narcotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.5 Poisoning: Cocaine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.6 Poisoning: Other and unspecified narcotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.7 Poisoning: (derivatives) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.8 Poisoning: Lysergide [LSD] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T40.9 Poisoning: Other and unspecified psychodysleptics [hallucinogens] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41 Poisoning by anaesthetics and therapeutic gases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.0 Poisoning: Inhaled anaesthetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.1 Poisoning: Intravenous anaesthetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.2 Poisoning: Other and unspecified general anaesthetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.3 Poisoning: Local anaesthetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.4 Poisoning: Anaesthetic, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T41.5 Poisoning: Therapeutic gases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42 Poisoning by antiepileptic, - and antiparkinsonism drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.0 Poisoning: Hydantoin derivatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.1 Poisoning: Iminostilbenes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.2 Poisoning: and 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.3 Poisoning: Barbiturates 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.4 Poisoning: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.5 Poisoning: Mixed antiepileptics, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.6 Poisoning: Other antiepileptic and sedative-hypnotic drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.7 Poisoning: Antiepileptic and sedative-hypnotic drugs, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T42.8 Poisoning: Antiparkinsonism drugs and other central muscle- tone depressants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43 Poisoning by psychotropic drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.0 Poisoning: and tetracyclic antidepressants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.1 Poisoning: Monoamine-oxidase-inhibitor antidepressants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.2 Poisoning: Other and unspecified antidepressants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.3 Poisoning: Phenothiazine antipsychotics and neuroleptics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.4 Poisoning: Butyrophenone and thioxanthene neuroleptics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.5 Poisoning: Other and unspecified antipsychotics and neuroleptics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.6 Poisoning: Psychostimulants with abuse potential 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.8 Poisoning: Other psychotropic drugs, not elsewhere classified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 416 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T43.9 Poisoning: Psychotropic drug, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44 Poisoning by drugs primarily affecting the autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.0 Poisoning: Anticholinesterase agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.1 Poisoning: Other parasympathomimetics [] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.2 Poisoning: Ganglionic blocking drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.3 Poisoning: Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.4 Poisoning: Predominantly alpha-adrenoreceptor agonists, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.5 Poisoning: Predominantly beta-adrenoreceptor agonists, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.6 Poisoning: Alpha-adrenoreceptor antagonists, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.7 Poisoning: Beta-adrenoreceptor antagonists, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.8 Poisoning: Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T44.9 Poisoning: Other and unspecified drugs primarily affecting the autonomic nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.0 Poisoning: Antiallergic and drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.1 Poisoning: Antineoplastic and immunosuppressive drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.2 Poisoning: Vitamins, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.3 Poisoning: Enzymes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.4 Poisoning: Iron and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.5 Poisoning: Anticoagulants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.6 Poisoning: -affecting drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.7 Poisoning: Anticoagulant antagonists, vitamin K and other coagulants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.8 Poisoning: Other primarily systemic and haematological agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T45.9 Poisoning: Primarily systemic and haematological agent, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46 Poisoning by agents primarily affecting the cardiovascular system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.0 Poisoning: Cardiac- glycosides and drugs of similar action 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.1 Poisoning: Calcium-channel blockers 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.2 Poisoning: Other antidysrhythmic drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.3 Poisoning: Coronary vasodilators, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.4 Poisoning: Angiotensin-converting-enzyme inhibitors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.5 Poisoning: Other antihypertensive drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.6 Poisoning: Antihyperlipidaemic and antiarteriosclerotic drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.7 Poisoning: Peripheral vasodilators 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.8 Poisoning: Antivaricose drugs, including sclerosing agents

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 417 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T46.9 Poisoning: Other and unspecified agents primarily affecting the cardiovascular system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47 Poisoning by agents primarily affecting the gastrointestinal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.0 Poisoning: Histamine H2-receptor antagonists 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.1 Poisoning: Other antacids and anti-gastric-secretion drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.2 Poisoning: Stimulant laxatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.3 Poisoning: and osmotic laxatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.4 Poisoning: Other laxatives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.5 Poisoning: Digestants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.6 Poisoning: drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.7 Poisoning: Emetics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.8 Poisoning: Other agents primarily affecting the gastrointestinal system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T47.9 Poisoning: Agent primarily affecting the gastrointestinal system, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.0 Poisoning: Oxytocic drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.1 Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.2 Poisoning: Other and unspecified agents primarily acting on muscles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.3 Poisoning: Antitussives 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.4 Poisoning: Expectorants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.5 Poisoning: Anti-common-cold drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.6 Poisoning: Antiasthmatics, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T48.7 Poisoning: Other and unspecified agents primarily acting on the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.0 Poisoning: Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.1 Poisoning: Antipruritics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.2 Poisoning: Local astringents and local detergents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.3 Poisoning: Emollients, demulcents and protectants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.4 Poisoning: , keratoplastics and other hair treatment drugs and preparations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.5 Poisoning: Ophthalmological drugs and preparations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.6 Poisoning: Otorhinolaryngological drugs and preparations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.7 Poisoning: Dental drugs, topically applied 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.8 Poisoning: Other topical agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T49.9 Poisoning: Topical agent, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.0 Poisoning: Mineralocorticoids and their antagonists 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.1 Poisoning: Loop [high-ceiling] diuretics © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 418 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.2 Poisoning: Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.3 Poisoning: Electrolytic, caloric and water-balance agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.4 Poisoning: Drugs affecting uric acid metabolism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.5 Poisoning: Appetite depressants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.6 Poisoning: Antidotes and chelating agents, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.7 Poisoning: and antagonists 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.8 Poisoning: Diagnostic agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T50.9 Poisoning: Other and unspecified drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51 Toxic effect of alcohol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51-T65 Toxic effects of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.0 Toxic effect: Ethanol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.1 Toxic effect: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.2 Toxic effect: 2-Propanol 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.3 Toxic effect: Fusel oil 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.8 Toxic effect: Other alcohols 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T51.9 Toxic effect: Alcohol, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52 Toxic effect of organic solvents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.0 Toxic effect: Petroleum products 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.1 Toxic effect: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.2 Toxic effect: Homologues of benzene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.3 Toxic effect: Glycols 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.4 Toxic effect: Ketones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.8 Toxic effect: Other organic solvents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T52.9 Toxic effect: Organic solvent, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.0 Toxic effect: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.1 Toxic effect: Chloroform 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.2 Toxic effect: Trichloroethylene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.3 Toxic effect: Tetrachloroethylene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.4 Toxic effect: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.5 Toxic effect: Chlorofluorocarbons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.6 Toxic effect: Other halogen derivatives of aliphatic hydrocarbons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.7 Toxic effect: Other halogen derivatives of aromatic hydrocarbons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T53.9 Toxic effect: Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54 Toxic effect of corrosive substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54.0 Toxic effect: Phenol and phenol homologues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54.1 Toxic effect: Other corrosive organic compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54.2 Toxic effect: Corrosive acids and acid-like substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54.3 Toxic effect: Corrosive alkalis and alkali-like substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T54.9 Toxic effect: Corrosive substance, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 419 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T55 Toxic effect of and detergents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56 Toxic effect of metals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.0 Toxic effect: Lead and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.1 Toxic effect: Mercury and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.2 Toxic effect: Chromium and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.3 Toxic effect: Cadmium and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.4 Toxic effect: Copper and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.5 Toxic effect: Zinc and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.6 Toxic effect: Tin and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.7 Toxic effect: Beryllium and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.8 Toxic effect: Other metals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T56.9 Toxic effect: Metal, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57 Toxic effect of other inorganic substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.0 Toxic effect: Arsenic and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.1 Toxic effect: Phosphorus and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.2 Toxic effect: Manganese and its compounds 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.3 Toxic effect: Hydrogen cyanide 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.8 Toxic effect: Other specified inorganic substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T57.9 Toxic effect: Inorganic substance, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T58 Toxic effect of carbon monoxide 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59 Toxic effect of other gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.0 Toxic effect: Nitrogen oxides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.1 Toxic effect: 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.2 Toxic effect: Formaldehyde 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.3 Toxic effect: Lacrimogenic gas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.4 Toxic effect: Chlorine gas 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.5 Toxic effect: Fluorine gas and hydrogen fluoride 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.6 Toxic effect: Hydrogen sulfide 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.7 Toxic effect: Carbon dioxide 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.8 Toxic effect: Other specified gases, fumes and vapours 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T59.9 Toxic effect: Gases, fumes and vapours, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60 Toxic effect of pesticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.0 Toxic effect: Organophosphate and insecticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.1 Toxic effect: Halogenated insecticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.2 Toxic effect: Other insecticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.3 Toxic effect: Herbicides and fungicides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.4 Toxic effect: Rodenticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.8 Toxic effect: Other pesticides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T60.9 Toxic effect: Pesticide, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61 Toxic effect of noxious substances eaten as seafood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61.0 Toxic effect: Ciguatera fish poisoning 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61.1 Toxic effect: Scombroid fish poisoning 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61.2 Toxic effect: Other fish and shellfish poisoning © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 420 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61.8 Toxic effect: Toxic effect of other seafoods 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T61.9 Toxic effect: Toxic effect of unspecified seafood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62 Toxic effect of other noxious substances eaten as food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62.0 Toxic effect: Ingested mushrooms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62.1 Toxic effect: Ingested berries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62.2 Toxic effect: Other ingested (parts of) plant(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62.8 Toxic effect: Other specified noxious substances eaten as food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T62.9 Toxic effect: Noxious substance eaten as food, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63 Toxic effect of contact with venomous animals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.0 Toxic effect: Snake venom 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.1 Toxic effect: Venom of other reptiles 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.2 Toxic effect: Venom of scorpion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.3 Toxic effect: Venom of spider 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.4 Toxic effect: Venom of other arthropods 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.5 Toxic effect: Toxic effect of contact with fish 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.6 Toxic effect: Toxic effect of contact with other marine animals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.8 Toxic effect: Toxic effect of contact with other venomous animals 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T63.9 Toxic effect: Toxic effect of contact with unspecified venomous animal 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T64 Toxic effect of aflatoxin and other mycotoxin food contaminants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65 Toxic effect of other and unspecified substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.0 Toxic effect: Cyanides 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.1 Toxic effect: and its salts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.2 Toxic effect: Tobacco and nicotine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.3 Toxic effect: Nitroderivatives and aminoderivatives of benzene and its homologues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.4 Toxic effect: Carbon disulfide 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.5 Toxic effect: and other nitric acids and esters 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.6 Toxic effect: Paints and dyes, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.8 Toxic effect: Toxic effect of other specified substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T65.9 Toxic effect: Toxic effect of unspecified substance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T66 Unspecified effects of radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T66-T78 Other and unspecified effects of external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67 Effects of heat and light 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.0 Heatstroke and sunstroke 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.1 Heat syncope 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.2 Heat cramp 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.3 Heat exhaustion, anhydrotic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.4 Heat exhaustion due to salt depletion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.5 Heat exhaustion, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.6 Heat fatigue, transient 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.7 Heat oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.8 Other effects of heat and light 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T67.9 Effect of heat and light, unspecified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 421 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T68 Hypothermia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T69 Other effects of reduced temperature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T69.0 Immersion hand and foot 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T69.1 Chilblains 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T69.8 Other specified effects of reduced temperature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T69.9 Effect of reduced temperature, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70 Effects of air pressure and water pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.0 Otitic barotrauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.1 Sinus barotrauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.2 Other and unspecified effects of high altitude 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.3 Caisson disease [decompression sickness] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.4 Effects of high-pressure fluids 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.8 Other effects of air pressure and water pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T70.9 Effect of air pressure and water pressure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T71 Asphyxiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73 Effects of other deprivation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.0 Effects of hunger 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.1 Effects of thirst 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.2 Exhaustion due to exposure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.3 Exhaustion due to excessive exertion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.8 Other effects of deprivation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T73.9 Effect of deprivation, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74 Maltreatment syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.0 Neglect or abandonment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.1 Physical abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.2 Sexual abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.3 Psychological abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.8 Other maltreatment syndromes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T74.9 Maltreatment syndrome, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75 Effects of other external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.0 Effects of lightning 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.1 Drowning and nonfatal submersion 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.2 Effects of vibration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.3 Motion sickness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.4 Effects of electric current 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T75.8 Other specified effects of external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78 Adverse effects, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.0 Anaphylactic shock due to adverse food reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.1 Other adverse food reactions, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.2 Anaphylactic shock, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.3 Angioneurotic oedema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.4 Allergy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.8 Other adverse effects, not elsewhere classified © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 422 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T78.9 Adverse effect, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79 Certain early complications of trauma, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79-T79 Certain early complications of trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.0 Air embolism (traumatic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.1 Fat embolism (traumatic) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.2 Traumatic secondary and recurrent haemorrhage 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.3 Post-traumatic wound infection, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.4 Traumatic shock 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.5 Traumatic anuria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.6 Traumatic ischaemia of muscle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.7 Traumatic subcutaneous emphysema 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.8 Other early complications of trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T79.9 Unspecified early complication of trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80 Complications following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80-T88 Complications of surgical and medical care, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.0 Air embolism following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.1 Vascular complications following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.2 Infections following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.3 ABO incompatibility reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.4 Rh incompatibility reaction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.5 Anaphylactic shock due to serum 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.6 Other serum reactions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.8 Other complications following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T80.9 Unspecified complication following infusion, transfusion and therapeutic injection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81 Complications of procedures, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.0 Haemorrhage and haematoma complicating a procedure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.1 Shock during or resulting from a procedure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.2 Accidental puncture and laceration during a procedure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.3 Disruption of operation wound, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.4 Infection following a procedure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.5 Foreign body accidentally left in body cavity or operation wound following a procedure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.6 Acute reaction to foreign substance accidentally left during a procedure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.7 Vascular complications following a procedure, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.8 Other complications of procedures, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T81.9 Unspecified complication of procedure

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 423 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82 Complications of cardiac and vascular prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.0 Mechanical complication of heart valve prosthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.1 Mechanical complication of cardiac electronic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.2 Mechanical complication of coronary artery bypass and valve grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.3 Mechanical complication of other vascular grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.4 Mechanical complication of vascular dialysis catheter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.5 Mechanical complication of other cardiac and vascular devices and implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.8 Other specified complications of cardiac and vascular prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T82.9 Unspecified complication of cardiac and vascular prosthetic device, implant and graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83 Complications of genitourinary prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.0 Mechanical complication of urinary (indwelling) catheter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.1 Mechanical complication of other urinary devices and implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.2 Mechanical complication of graft of urinary organ 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.3 Mechanical complication of intrauterine contraceptive device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.8 Other complications of genitourinary prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T83.9 Unspecified complication of genitourinary prosthetic device, implant and graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84 Complications of internal orthopaedic prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.0 Mechanical complication of internal joint prosthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.1 Mechanical complication of internal fixation device of bones of limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.2 Mechanical complication of internal fixation device of other bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.3 Mechanical complication of other bone devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.4 Mechanical complication of other internal orthopaedic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.5 Infection and inflammatory reaction due to internal joint prosthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.6 Infection and inflammatory reaction due to internal fixation device [any site]

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 424 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.7 Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.8 Other complications of internal orthopaedic prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T84.9 Unspecified complication of internal orthopaedic prosthetic device, implant and graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85 Complications of other internal prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.0 Mechanical complication of ventricular intracranial (communicating) shunt 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.1 Mechanical complication of implanted electronic stimulator of nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.2 Mechanical complication of intraocular lens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.3 Mechanical complication of other ocular prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.4 Mechanical complication of breast prosthesis and implant 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.5 Mechanical complication of gastrointestinal prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.8 Other complications of internal prosthetic devices, implants and grafts, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T85.9 Unspecified complication of internal prosthetic device, implant and graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86 Failure and rejection of transplanted organs and tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.0 Bone-marrow transplant rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.1 Kidney transplant failure and rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.2 Heart transplant failure and rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.3 Heart-lung transplant failure and rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.4 Liver transplant failure and rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.8 Failure and rejection of other transplanted organs and tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T86.9 Failure and rejection of unspecified transplanted organ and tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87 Complications peculiar to reattachment and amputation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.0 Complications of reattached (part of) upper extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.1 Complications of reattached (part of) lower extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.2 Complications of other reattached body part 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.3 Neuroma of amputation stump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.4 Infection of amputation stump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.5 Necrosis of amputation stump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T87.6 Other and unspecified complications of amputation stump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88 Other complications of surgical and medical care, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.0 Infection following immunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.1 Other complications following immunization, not elsewhere classified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 425 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.2 Shock due to anaesthesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.3 Malignant hyperthermia due to anaesthesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.4 Failed or difficult intubation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.5 Other complications of anaesthesia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.6 Anaphylactic shock due to adverse effect of correct drug or medicament properly administered 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.7 Unspecified adverse effect of drug or medicament 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.8 Other specified complications of surgical and medical care, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T88.9 Complication of surgical and medical care, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90 Sequelae of injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.0 Sequelae of superficial injury of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.1 Sequelae of open wound of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.2 Sequelae of fracture of skull and facial bones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.3 Sequelae of injury of cranial nerves 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.4 Sequelae of injury of eye and orbit 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.5 Sequelae of intracranial injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.8 Sequelae of other specified injuries of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T90.9 Sequelae of unspecified injury of head 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91 Sequelae of injuries of neck and trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.0 Sequelae of superficial injury and open wound of neck and trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.1 Sequelae of fracture of spine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.2 Sequelae of other fracture of thorax and pelvis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.3 Sequelae of injury of spinal cord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.4 Sequelae of injury of intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.5 Sequelae of injury of intra-abdominal and pelvic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.8 Sequelae of other specified injuries of neck and trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T91.9 Sequelae of unspecified injury of neck and trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92 Sequelae of injuries of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.0 Sequelae of open wound of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.1 Sequelae of fracture of arm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.2 Sequelae of fracture at wrist and hand level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.3 Sequelae of dislocation, sprain and strain of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.4 Sequelae of injury of nerve of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.5 Sequelae of injury of muscle and tendon of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.6 Sequelae of crushing injury and traumatic amputation of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.8 Sequelae of other specified injuries of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T92.9 Sequelae of unspecified injury of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93 Sequelae of injuries of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.0 Sequelae of open wound of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.1 Sequelae of fracture of femur

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 426 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.2 Sequelae of other fractures of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.3 Sequelae of dislocation, sprain and strain of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.4 Sequelae of injury of nerve of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.5 Sequelae of injury of muscle and tendon of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.6 Sequelae of crushing injury and traumatic amputation of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.8 Sequelae of other specified injuries of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T93.9 Sequelae of unspecified injury of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T94 Sequelae of injuries involving multiple and unspecified body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T94.0 Sequelae of injuries involving multiple body regions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T94.1 Sequelae of injuries, not specified by body region 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95 Sequelae of burns, corrosions and frostbite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.0 Sequelae of burn, corrosion and frostbite of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.1 Sequelae of burn, corrosion and frostbite of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.2 Sequelae of burn, corrosion and frostbite of upper limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.3 Sequelae of burn, corrosion and frostbite of lower limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.4 Sequelae of burn and corrosion classifiable only according to extent of body surface involved 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.8 Sequelae of other specified burn, corrosion and frostbite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T95.9 Sequelae of unspecified burn, corrosion and frostbite 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T96 Sequelae of poisoning by drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T98 Sequelae of other and unspecified effects of external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T98.0 Sequelae of effects of foreign body entering through natural orifice 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T98.1 Sequelae of other and unspecified effects of external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T98.2 Sequelae of certain early complications of trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 T98.3 Sequelae of complications of surgical and medical care, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U04 Severe acute respiratory syndrome [SARS] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U04.9 Severe acute respiratory syndrome [SARS], unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06 Emergency use of U06 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.0 Emergency use of U06.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.1 Emergency use of U06.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.2 Emergency use of U06.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.3 Emergency use of U06.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.4 Emergency use of U06.4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.5 Emergency use of U06.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.6 Emergency use of U06.6 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.7 Emergency use of U06.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.8 Emergency use of U06.8 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 427 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U06.9 Emergency use of U06.9 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07 Emergency use of U07 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.0 Emergency use of U07.0 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.1 Emergency use of U07.1 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.2 Emergency use of U07.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.3 Emergency use of U07.3 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.4 Emergency use of U07.4 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.5 Emergency use of U07.5 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.6 Emergency use of U07.6 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.7 Emergency use of U07.7 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.8 Emergency use of U07.8 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U07.9 Emergency use of U07.9 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82 Resistance to betalactam antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82-U85 Resistance to and antineoplastic drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82.0 Resistance to 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82.1 Resistance to methicillin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82.2 Extended spectrum betalactamase (ESBL) resistance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82.8 Resistance to other betalactam antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U82.9 Resistance to betalactam antibiotics, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83 Resistance to other antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.0 Resistance to vancomycin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.1 Resistance to other vancomycin related antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.2 Resistance to quinolones 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.7 Resistance to multiple antibiotics 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.8 Resistance to other single specified antibiotic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U83.9 Resistance to unspecified antibiotic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84 Resistance to other antimicrobial drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.0 Resistance to antiparasitic drug(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.1 Resistance to antifungal drug(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.2 Resistance to (s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.3 Resistance to tuberculostatic drug(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.7 Resistance to multiple antimicrobial drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.8 Resistance to other specified antimicrobial drug 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U84.9 Resistance to unspecified antimicrobial drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 U85 Resistance to antineoplastic drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 V Mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 VI Diseases of the nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 VII Diseases of the eye and adnexa 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 VIII Diseases of the ear and mastoid process 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 X Diseases of the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XI Diseases of the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XII Diseases of the skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XIII Diseases of the musculoskeletal system and connective tissue © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 428 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XIV Diseases of the genitourinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XIX Injury, poisoning and certain other consequences of external causes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XV Pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XVI Certain conditions originating in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XVII Congenital malformations, deformations and chromosomal abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XXI Factors influencing health status and contact with health services 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 XXII Codes for special purposes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00 General examination and investigation of persons without complaint and reported diagnosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00-Z13 Persons encountering health services for examination and investigation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.0 General medical examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.1 Routine child health examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.2 Examination for period of rapid growth in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.3 Examination for adolescent development state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.4 General psychiatric examination, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.5 Examination of potential donor of organ and tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.6 Examination for normal comparison and control in clinical research programme 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z00.8 Other general examinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01 Other special examinations and investigations of persons without complaint or reported diagnosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.0 Examination of eyes and vision 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.1 Examination of ears and hearing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.2 Dental examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.3 Examination of blood pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.4 Gynaecological examination (general)(routine) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.5 Diagnostic skin and sensitization tests 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.6 Radiological examination, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.7 Laboratory examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.8 Other specified special examinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z01.9 Special examination, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02 Examination and encounter for administrative purposes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.0 Examination for admission to educational institution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.1 Pre-employment examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.2 Examination for admission to residential institutions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.3 Examination for recruitment to armed forces 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.4 Examination for driving licence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.5 Examination for participation in sport 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.6 Examination for insurance purposes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.7 Issue of medical certificate © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 429 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.8 Other examinations for administrative purposes 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z02.9 Examination for administrative purposes, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03 Medical observation and evaluation for suspected diseases and conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.0 Observation for suspected tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.1 Observation for suspected malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.2 Observation for suspected mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.3 Observation for suspected nervous system disorder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.4 Observation for suspected myocardial infarction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.5 Observation for other suspected cardiovascular diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.6 Observation for suspected toxic effect from ingested substance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.8 Observation for other suspected diseases and conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z03.9 Observation for suspected disease or condition, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04 Examination and observation for other reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.0 Blood-alcohol and blood-drug test 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.1 Examination and observation following transport accident 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.2 Examination and observation following work accident 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.3 Examination and observation following other accident 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.4 Examination and observation following alleged rape and seduction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.5 Examination and observation following other inflicted injury 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.6 General psychiatric examination, requested by authority 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.8 Examination and observation for other specified reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z04.9 Examination and observation for unspecified reason 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08 Follow-up examination after treatment for malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.0 Follow-up examination after surgery for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.1 Follow-up examination after radiotherapy for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.2 Follow-up examination after for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.7 Follow-up examination after combined treatment for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.8 Follow-up examination after other treatment for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09 Follow-up examination after treatment for conditions other than malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.0 Follow-up examination after surgery for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.1 Follow-up examination after radiotherapy for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.2 Follow-up examination after chemotherapy for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.3 Follow-up examination after psychotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.4 Follow-up examination after treatment of fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.7 Follow-up examination after combined treatment for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.8 Follow-up examination after other treatment for other conditions

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 430 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z09.9 Follow-up examination after unspecified treatment for other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10 Routine general health check-up of defined subpopulation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10.0 Occupational health examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10.1 Routine general health check-up of inhabitants of institutions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10.2 Routine general health check-up of armed forces 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10.3 Routine general health check-up of sports teams 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z10.8 Routine general health check-up of other defined subpopulations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11 Special screening examination for infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.0 Special screening examination for intestinal infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.1 Special screening examination for respiratory tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.2 Special screening examination for other bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.4 Special screening examination for human immunodeficiency virus [HIV] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.5 Special screening examination for other viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.6 Special screening examination for other protozoal diseases and helminthiases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.8 Special screening examination for other infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z11.9 Special screening examination for infectious and parasitic diseases, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12 Special screening examination for neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.0 Special screening examination for neoplasm of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.1 Special screening examination for neoplasm of intestinal tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.2 Special screening examination for neoplasm of respiratory organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.3 Special screening examination for neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.4 Special screening examination for neoplasm of cervix 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.5 Special screening examination for neoplasm of prostate 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.6 Special screening examination for neoplasm of bladder 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.8 Special screening examination for neoplasms of other sites 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z12.9 Special screening examination for neoplasm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13 Special screening examination for other diseases and disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.1 Special screening examination for diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.2 Special screening examination for nutritional disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.3 Special screening examination for mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.4 Special screening examination for certain developmental disorders in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.5 Special screening examination for eye and ear disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.6 Special screening examination for cardiovascular disorders

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 431 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.7 Special screening examination for congenital malformations, deformations and chromosomal abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.8 Special screening examination for other specified diseases and disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z13.9 Special screening examination, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20 Contact with and exposure to communicable diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20-Z29 Persons with potential health hazards related to communicable diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.0 Contact with and exposure to intestinal infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.1 Contact with and exposure to tuberculosis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.3 Contact with and exposure to rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.4 Contact with and exposure to rubella 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.5 Contact with and exposure to viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.6 Contact with and exposure to human immunodeficiency virus [HIV] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.8 Contact with and exposure to other communicable diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z20.9 Contact with and exposure to unspecified communicable disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z21 Asymptomatic human immunodeficiency virus [HIV] infection status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22 Carrier of infectious disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.0 Carrier of typhoid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.1 Carrier of other intestinal infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.2 Carrier of diphtheria 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.3 Carrier of other specified bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.4 Carrier of infections with a predominantly sexual mode of transmission 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.6 Carrier of human T-lymphotropic virus type- 1 [HTLV-1] infection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.8 Carrier of other infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z22.9 Carrier of infectious disease, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23 Need for immunization against single bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.0 Need for immunization against cholera alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.1 Need for immunization against typhoid-paratyphoid alone [TAB] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.2 Need for immunization against tuberculosis [BCG] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.3 Need for immunization against plague 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.4 Need for immunization against tularaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.5 Need for immunization against tetanus alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.6 Need for immunization against diphtheria alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.7 Need for immunization against pertussis alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z23.8 Need for immunization against other single bacterial diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24 Need for immunization against certain single viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.0 Need for immunization against poliomyelitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.1 Need for immunization against arthropod-borne viral encephalitis © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 432 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.2 Need for immunization against rabies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.3 Need for immunization against yellow fever 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.4 Need for immunization against measles alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.5 Need for immunization against rubella alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z24.6 Need for immunization against viral hepatitis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z25 Need for immunization against other single viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z25.0 Need for immunization against mumps alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z25.1 Need for immunization against influenza 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z25.8 Need for immunization against other specified single viral diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z26 Need for immunization against other single infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z26.0 Need for immunization against leishmaniasis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z26.8 Need for immunization against other specified single infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z26.9 Need for immunization against unspecified infectious disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27 Need for immunization against combinations of infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.0 Need for immunization against cholera with typhoid-paratyphoid [cholera + TAB] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.1 Need for immunization against diphtheria-tetanus-pertussis, combined [DTP] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.2 Need for immunization against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.3 Need for immunization against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.4 Need for immunization against measles-mumps-rubella [MMR] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.8 Need for immunization against other combinations of infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z27.9 Need for immunization against unspecified combinations of infectious diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28 Immunization not carried out 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28.0 Immunization not carried out because of contraindication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28.1 Immunization not carried out because of patient's decision for reasons of belief or group pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28.2 Immunization not carried out because of patient's decision for other and unspecified reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28.8 Immunization not carried out for other reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z28.9 Immunization not carried out for unspecified reason 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29 Need for other prophylactic measures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29.0 Isolation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29.1 Prophylactic 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29.2 Other prophylactic chemotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29.8 Other specified prophylactic measures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z29.9 Prophylactic measure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30 Contraceptive management 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30-Z39 Persons encountering health services in circumstances related to reproduction

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 433 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.0 General counselling and advice on contraception 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.1 Insertion of (intrauterine) contraceptive device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.2 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.3 Menstrual extraction 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.4 Surveillance of contraceptive drugs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.5 Surveillance of (intrauterine) contraceptive device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.8 Other contraceptive management 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z30.9 Contraceptive management, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31 Procreative management 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.0 Tuboplasty or vasoplasty after previous sterilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.1 Artificial insemination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.2 In vitrofertilization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.3 Other assisted fertilization methods 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.4 Procreative investigation and testing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.5 Genetic counselling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.6 General counselling and advice on procreation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.8 Other procreative management 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z31.9 Procreative management, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z32 Pregnancy examination and test 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z32.0 Pregnancy, not (yet) confirmed 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z32.1 Pregnancy confirmed 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z33 Pregnant state, incidental 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z34 Supervision of normal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z34.0 Supervision of normal first pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z34.8 Supervision of other normal pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z34.9 Supervision of normal pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35 Supervision of high-risk pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.0 Supervision of pregnancy with history of infertility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.1 Supervision of pregnancy with history of abortive outcome 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.3 Supervision of pregnancy with history of insufficient antenatal care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.4 Supervision of pregnancy with grand multiparity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.5 Supervision of elderly primigravida 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.6 Supervision of very young primigravida 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.7 Supervision of high-risk pregnancy due to social problems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.8 Supervision of other high-risk pregnancies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z35.9 Supervision of high-risk pregnancy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36 Antenatal screening 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.0 Antenatal screening for chromosomal anomalies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.1 Antenatal screening for raised alphafetoprotein level 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.2 Other antenatal screening based on amniocentesis

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 434 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.3 Antenatal screening for malformations using ultrasound and other physical methods 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.4 Antenatal screening for fetal growth retardation using ultrasound and other physical methods 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.5 Antenatal screening for isoimmunization 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.8 Other antenatal screening 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z36.9 Antenatal screening, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37 Outcome of delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.0 Single live birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.1 Single stillbirth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.2 Twins, both liveborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.3 Twins, one liveborn and one stillborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.4 Twins, both stillborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.5 Other multiple births, all liveborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.6 Other multiple births, some liveborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.7 Other multiple births, all stillborn 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z37.9 Outcome of delivery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38 Liveborn infants according to place of birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.0 Singleton, born in hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.1 Singleton, born outside hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.2 Singleton, unspecified as to place of birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.3 Twin, born in hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.4 Twin, born outside hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.5 Twin, unspecified as to place of birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.6 Other multiple, born in hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.7 Other multiple, born outside hospital 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z38.8 Other multiple, unspecified as to place of birth 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z39 Postpartum care and examination 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z39.0 Care and examination immediately after delivery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z39.1 Care and examination of lactating mother 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z39.2 Routine postpartum follow-up 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z40 Prophylactic surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z40-Z54 Persons encountering health services for specific procedures and health care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z40.8 Other prophylactic surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z40.9 Prophylactic surgery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41 Procedures for purposes other than remedying health state 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.0 Hair transplant 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.1 Other plastic surgery for unacceptable cosmetic appearance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.2 Routine and ritual circumcision 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.3 Ear piercing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.8 Other procedures for purposes other than remedying health state © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 435 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z41.9 Procedure for purposes other than remedying health state, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42 Follow-up care involving plastic surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.0 Follow-up care involving plastic surgery of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.1 Follow-up care involving plastic surgery of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.2 Follow-up care involving plastic surgery of other parts of trunk 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.3 Follow-up care involving plastic surgery of upper extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.4 Follow-up care involving plastic surgery of lower extremity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.8 Follow-up care involving plastic surgery of other body part 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z42.9 Follow-up care involving plastic surgery, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43 Attention to artificial openings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.0 Attention to tracheostomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.1 Attention to gastrostomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.2 Attention to ileostomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.3 Attention to colostomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.4 Attention to other artificial openings of digestive tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.5 Attention to cystostomy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.6 Attention to other artificial openings of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.7 Attention to artificial vagina 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.8 Attention to other artificial openings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z43.9 Attention to unspecified artificial opening 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44 Fitting and adjustment of external prosthetic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.0 Fitting and adjustment of artificial arm (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.1 Fitting and adjustment of artificial leg (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.2 Fitting and adjustment of artificial eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.3 Fitting and adjustment of external breast prosthesis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.8 Fitting and adjustment of other external prosthetic devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z44.9 Fitting and adjustment of unspecified external prosthetic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45 Adjustment and management of implanted device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.0 Adjustment and management of cardiac devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.1 Adjustment and management of infusion pump 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.2 Adjustment and management of vascular access device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.3 Adjustment and management of implanted hearing device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.8 Adjustment and management of other implanted devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z45.9 Adjustment and management of unspecified implanted device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46 Fitting and adjustment of other devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.0 Fitting and adjustment of spectacles and contact lenses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.1 Fitting and adjustment of hearing aid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.2 Fitting and adjustment of other devices related to nervous system and special senses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.3 Fitting and adjustment of dental prosthetic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.4 Fitting and adjustment of orthodontic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.5 Fitting and adjustment of ileostomy and other intestinal appliances

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 436 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.6 Fitting and adjustment of urinary device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.7 Fitting and adjustment of orthopaedic device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.8 Fitting and adjustment of other specified devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z46.9 Fitting and adjustment of unspecified device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z47 Other orthopaedic follow-up care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z47.0 Follow-up care involving removal of fracture plate and other internal fixation device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z47.8 Other specified orthopaedic follow-up care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z47.9 Orthopaedic follow-up care, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z48 Other surgical follow-up care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z48.0 Attention to surgical dressings and sutures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z48.8 Other specified surgical follow-up care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z48.9 Surgical follow-up care, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z49 Care involving dialysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z49.0 Preparatory care for dialysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z49.1 Extracorporeal dialysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z49.2 Other dialysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50 Care involving use of rehabilitation procedures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.0 Cardiac rehabilitation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.1 Other physical therapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.2 Alcohol rehabilitation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.3 Drug rehabilitation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.4 Psychotherapy, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.5 Speech therapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.6 Orthoptic training 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.8 Care involving use of other rehabilitation procedures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z50.9 Care involving use of rehabilitation procedure, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51 Other medical care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.0 Radiotherapy session 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.1 Chemotherapy session for neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.2 Other chemotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.3 Blood transfusion (without reported diagnosis) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.4 Preparatory care for subsequent treatment, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.5 Palliative care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.6 Desensitization to allergens 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.8 Other specified medical care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z51.9 Medical care, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52 Donors of organs and tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.0 Blood donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.1 Skin donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.2 Bone donor

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 437 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.3 Bone marrow donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.4 Kidney donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.5 Cornea donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.6 Liver donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.7 Heart donor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.8 Donor of other organs and tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z52.9 Donor of unspecified organ or tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53 Persons encountering health services for specific procedures, not carried out 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53.0 Procedure not carried out because of contraindication 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53.1 Procedure not carried out because of patient's decision for reasons of belief and group pressure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53.2 Procedure not carried out because of patient's decision for other and unspecified reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53.8 Procedure not carried out for other reasons 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z53.9 Procedure not carried out, unspecified reason 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54 Convalescence 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.0 Convalescence following surgery 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.1 Convalescence following radiotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.2 Convalescence following chemotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.3 Convalescence following psychotherapy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.4 Convalescence following treatment of fracture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.7 Convalescence following combined treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.8 Convalescence following other treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z54.9 Convalescence following unspecified treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55 Problems related to education and literacy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.0 Illiteracy and low-level literacy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.1 Schooling unavailable and unattainable 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.2 Failed examinations 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.3 Underachievement in school 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.4 Educational maladjustment and discord with teachers and classmates 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.8 Other problems related to education and literacy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z55.9 Problem related to education and literacy, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56 Problems related to employment and unemployment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.0 Unemployment, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.1 Change of job 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.2 Threat of job loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.3 Stressful work schedule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.4 Discord with boss and workmates 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.5 Uncongenial work 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.6 Other physical and mental strain related to work 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z56.7 Other and unspecified problems related to employment © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 438 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57 Occupational exposure to risk-factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.0 Occupational exposure to noise 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.1 Occupational exposure to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.2 Occupational exposure to dust 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.3 Occupational exposure to other air contaminants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.4 Occupational exposure to toxic agents in agriculture 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.5 Occupational exposure to toxic agents in other industries 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.6 Occupational exposure to extreme temperature 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.7 Occupational exposure to vibration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.8 Occupational exposure to other risk-factors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z57.9 Occupational exposure to unspecified risk-factor 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58 Problems related to physical environment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.0 Exposure to noise 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.1 Exposure to air pollution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.2 Exposure to water pollution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.3 Exposure to soil pollution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.4 Exposure to radiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.5 Exposure to other pollution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.6 Inadequate drinking-water supply 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.7 Exposure to tobacco smoke 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.8 Other problems related to physical environment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z58.9 Problem related to physical environment, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59 Problems related to housing and economic circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.0 Homelessness 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.1 Inadequate housing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.2 Discord with neighbours, lodgers and landlord 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.3 Problems related to living in residential institution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.4 Lack of adequate food 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.5 Extreme poverty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.6 Low income 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.7 Insufficient social insurance and welfare support 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.8 Other problems related to housing and economic circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z59.9 Problem related to housing and economic circumstances, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60 Problems related to social environment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.0 Problems of adjustment to life-cycle transitions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.1 Atypical parenting situation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.2 Living alone 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.3 Acculturation difficulty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.4 Social exclusion and rejection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.5 Target of perceived adverse discrimination and persecution 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.8 Other problems related to social environment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z60.9 Problem related to social environment, unspecified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 439 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61 Problems related to negative life events in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.0 Loss of love relationship in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.1 Removal from home in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.2 Altered pattern of family relationships in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.3 Events resulting in loss of self-esteem in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.4 Problems related to alleged sexual abuse of child by person within primary support group 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.6 Problems related to alleged physical abuse of child 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.7 Personal frightening experience in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.8 Other negative life events in childhood 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z61.9 Negative life event in childhood, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62 Other problems related to upbringing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.0 Inadequate parental supervision and control 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.1 Parental overprotection 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.2 Institutional upbringing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.3 Hostility towards and scapegoating of child 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.4 Emotional neglect of child 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.5 Other problems related to neglect in upbringing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.6 Inappropriate parental pressure and other abnormal qualities of upbringing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.8 Other specified problems related to upbringing 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z62.9 Problem related to upbringing, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63 Other problems related to primary support group, including family circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.0 Problems in relationship with spouse or partner 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.1 Problems in relationship with parents and in-laws 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.2 Inadequate family support 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.3 Absence of family member 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.4 Disappearance and death of family member 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.5 Disruption of family by separation and divorce 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.6 Dependent relative needing care at home 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.7 Other stressful life events affecting family and household 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.8 Other specified problems related to primary support group 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z63.9 Problem related to primary support group, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64 Problems related to certain psychosocial circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64.0 Problems related to unwanted pregnancy 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64.1 Problems related to multiparity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z64.4 Discord with counsellors 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65 Problems related to other psychosocial circumstances

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 440 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.0 Conviction in civil and criminal proceedings without imprisonment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.1 Imprisonment and other incarceration 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.2 Problems related to release from prison 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.3 Problems related to other legal circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.4 Victim of crime and terrorism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.5 Exposure to disaster, war and other hostilities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.8 Other specified problems related to psychosocial circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z65.9 Problem related to unspecified psychosocial circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70 Counselling related to sexual attitude, behaviour and orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70-Z76 Persons encountering health services in other circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.0 Counselling related to sexual attitude 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.1 Counselling related to patient's sexual behaviour and orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.2 Counselling related to sexual behaviour and orientation of third party 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.3 Counselling related to combined concerns regarding sexual attitude, behaviour and orientation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.8 Other sex counselling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z70.9 Sex counselling, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.0 Person consulting on behalf of another person 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.1 Person with feared complaint in whom no diagnosis is made 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.2 Person consulting for explanation of investigation findings 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.3 Dietary counselling and surveillance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.4 Alcohol abuse counselling and surveillance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.5 Drug abuse counselling and surveillance 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.6 Tobacco abuse counselling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.7 Human immunodeficiency virus [HIV] counselling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.8 Other specified counselling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z71.9 Counselling, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72 Problems related to lifestyle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.0 Tobacco use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.1 Alcohol use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.2 Drug use 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.3 Lack of physical exercise 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.4 Inappropriate diet and eating habits 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.5 High-risk sexual behaviour 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.6 Gambling and betting 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.8 Other problems related to lifestyle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z72.9 Problem related to lifestyle, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73 Problems related to life-management difficulty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.0 Burn-out 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.1 Accentuation of personality traits

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 441 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.2 Lack of relaxation and leisure 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.3 Stress, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.4 Inadequate social skills, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.5 Social role conflict, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.6 Limitation of activities due to disability 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.8 Other problems related to life-management difficulty 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z73.9 Problem related to life-management difficulty, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74 Problems related to care-provider dependency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.0 Need for assistance due to reduced mobility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.1 Need for assistance with personal care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.2 Need for assistance at home and no other household member able to render care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.3 Need for continuous supervision 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.8 Other problems related to care-provider dependency 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z74.9 Problem related to care-provider dependency, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75 Problems related to medical facilities and other health care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.0 Medical services not available in home 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.1 Person awaiting admission to adequate facility elsewhere 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.2 Other waiting period for investigation and treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.3 Unavailability and inaccessibility of health-care facilities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.4 Unavailability and inaccessibility of other helping agencies 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.5 Holiday relief care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.8 Other problems related to medical facilities and other health care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z75.9 Unspecified problem related to medical facilities and other health care 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76 Persons encountering health services in other circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.0 Issue of repeat prescription 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.1 Health supervision and care of foundling 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.2 Health supervision and care of other healthy infant and child 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.3 Healthy person accompanying sick person 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.4 Other boarder in health-care facility 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.5 Malingerer [conscious simulation] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.8 Persons encountering health services in other specified circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z76.9 Person encountering health services in unspecified circumstances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80 Family history of malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.0 Family history of malignant neoplasm of digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.3 Family history of malignant neoplasm of breast

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 442 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.4 Family history of malignant neoplasm of genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.5 Family history of malignant neoplasm of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.6 Family history of leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.7 Family history of other malignant neoplasms of lymphoid, haematopoietic and related tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.8 Family history of malignant neoplasm of other organs or systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z80.9 Family history of malignant neoplasm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81 Family history of mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.0 Family history of mental retardation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.1 Family history of alcohol abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.2 Family history of tobacco abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.3 Family history of other psychoactive substance abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.4 Family history of other substance abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z81.8 Family history of other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82 Family history of certain disabilities and chronic diseases leading to disablement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.0 Family history of epilepsy and other diseases of the nervous system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.1 Family history of blindness and visual loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.2 Family history of deafness and hearing loss 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.3 Family history of stroke 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.4 Family history of ischaemic heart disease and other diseases of the circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.5 Family history of asthma and other chronic lower respiratory diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.6 Family history of arthritis and other diseases of the musculoskeletal system and connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.7 Family history of congenital malformations, deformations and chromosomal abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z82.8 Family history of other disabilities and chronic diseases leading to disablement, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83 Family history of other specific disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.0 Family history of human immunodeficiency virus [HIV] disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.1 Family history of other infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.2 Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.3 Family history of diabetes mellitus 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.4 Family history of other endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.5 Family history of eye and ear disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.6 Family history of diseases of the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z83.7 Family history of diseases of the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84 Family history of other conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84.0 Family history of diseases of the skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84.1 Family history of disorders of kidney and ureter 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84.2 Family history of other diseases of the genitourinary system

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 443 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84.3 Family history of consanguinity 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z84.8 Family history of other specified conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85 Personal history of malignant neoplasm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.0 Personal history of malignant neoplasm of digestive organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.3 Personal history of malignant neoplasm of breast 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.4 Personal history of malignant neoplasm of genital organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.5 Personal history of malignant neoplasm of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.6 Personal history of leukaemia 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.8 Personal history of malignant neoplasms of other organs and systems 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z85.9 Personal history of malignant neoplasm, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86 Personal history of certain other diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.0 Personal history of other neoplasms 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.1 Personal history of infectious and parasitic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.2 Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.3 Personal history of endocrine, nutritional and metabolic diseases 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.4 Personal history of psychoactive substance abuse 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.5 Personal history of other mental and behavioural disorders 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.6 Personal history of diseases of the nervous system and sense organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z86.7 Personal history of diseases of the circulatory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87 Personal history of other diseases and conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.0 Personal history of diseases of the respiratory system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.1 Personal history of diseases of the digestive system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.2 Personal history of diseases of the skin and subcutaneous tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.3 Personal history of diseases of the musculoskeletal system and connective tissue 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.4 Personal history of diseases of the genitourinary system 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.5 Personal history of complications of pregnancy, childbirth and the puerperium 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.6 Personal history of certain conditions arising in the perinatal period 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z87.8 Personal history of other specified conditions 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88 Personal history of allergy to drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.0 Personal history of allergy to penicillin 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.1 Personal history of allergy to other antibiotic agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.2 Personal history of allergy to sulfonamides © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 444 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.3 Personal history of allergy to other anti-infective agents 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.4 Personal history of allergy to anaesthetic agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.5 Personal history of allergy to agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.6 Personal history of allergy to analgesic agent 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.7 Personal history of allergy to serum and vaccine 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.8 Personal history of allergy to other drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89 Acquired absence of limb 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.0 Acquired absence of finger(s) [including thumb], unilateral 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.1 Acquired absence of hand and wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.2 Acquired absence of upper limb above wrist 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.3 Acquired absence of both upper limbs [any level] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.4 Acquired absence of foot and ankle 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.5 Acquired absence of leg at or below knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.6 Acquired absence of leg above knee 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.7 Acquired absence of both lower limbs [any level, except toes alone] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.8 Acquired absence of upper and lower limbs [any level] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z89.9 Acquired absence of limb, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90 Acquired absence of organs, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.0 Acquired absence of part of head and neck 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.1 Acquired absence of breast(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.2 Acquired absence of lung [part of] 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.3 Acquired absence of part of stomach 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.4 Acquired absence of other parts of digestive tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.5 Acquired absence of kidney 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.6 Acquired absence of other organs of urinary tract 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.7 Acquired absence of genital organ(s) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z90.8 Acquired absence of other organs 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91 Personal history of risk-factors, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.0 Personal history of allergy, other than to drugs and biological substances 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.1 Personal history of noncompliance with medical treatment and regimen 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.2 Personal history of poor personal hygiene 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.3 Personal history of unhealthy sleep-wake schedule 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.4 Personal history of psychological trauma, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.5 Personal history of self-harm 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.6 Personal history of other physical trauma 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.7 Personal history of female genital mutilation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z91.8 Personal history of other specified risk-factors, not elsewhere classified

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 445 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92 Personal history of medical treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.0 Personal history of contraception 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.1 Personal history of long-term (current) use of anticoagulants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.2 Personal history of long-term (current) use of other medicaments 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.3 Personal history of irradiation 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.4 Personal history of major surgery, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.5 Personal history of rehabilitation measures 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.6 Personal history of chemotherapy for neoplastic disease 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.8 Personal history of other medical treatment 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z92.9 Personal history of medical treatment, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93 Artificial opening status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.0 Tracheostomy status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.1 Gastrostomy status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.2 Ileostomy status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.3 Colostomy status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.4 Other artificial openings of status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.5 Cystostomy status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.6 Other artificial openings of urinary tract status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.8 Other artificial opening status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z93.9 Artificial opening status, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94 Transplanted organ and tissue status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.0 Kidney transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.1 Heart transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.2 Lung transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.3 Heart and lungs transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.4 Liver transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.5 Skin transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.6 Bone transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.7 Corneal transplant status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.8 Other transplanted organ and tissue status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z94.9 Transplanted organ and tissue status, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95 Presence of cardiac and vascular implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.0 Presence of electronic cardiac devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.1 Presence of aortocoronary bypass graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.2 Presence of prosthetic heart valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.3 Presence of xenogenic heart valve 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.4 Presence of other heart-valve replacement 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.5 Presence of coronary angioplasty implant and graft 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.8 Presence of other cardiac and vascular implants and grafts 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z95.9 Presence of cardiac and vascular implant and graft, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96 Presence of other functional implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.0 Presence of urogenital implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.1 Presence of intraocular lens © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 446 of 490 MTC epSOSIllnessesandDisorders

1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.2 Presence of otological and audiological implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.3 Presence of artificial larynx 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.4 Presence of endocrine implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.5 Presence of tooth-root and mandibular implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.6 Presence of orthopaedic joint implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.7 Presence of other bone and tendon implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.8 Presence of other specified functional implants 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z96.9 Presence of functional implant, unspecified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97 Presence of other devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.0 Presence of artificial eye 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.1 Presence of artificial limb (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.2 Presence of dental prosthetic device (complete)(partial) 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.3 Presence of spectacles and contact lenses 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.4 Presence of external hearing-aid 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.5 Presence of (intrauterine) contraceptive device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z97.8 Presence of other specified devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z98 Other postsurgical states 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z98.0 Intestinal bypass and anastomosis status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z98.1 Arthrodesis status 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z98.2 Presence of cerebrospinal fluid drainage device 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z98.8 Other specified postsurgical states 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99 Dependence on enabling machines and devices, not elsewhere classified 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.0 Dependence on aspirator 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.1 Dependence on respirator 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.2 Dependence on renal dialysis 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.3 Dependence on wheelchair 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.4 Dependence on artificial heart 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.8 Dependence on other enabling machines and devices 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 2016 Z99.9 Dependence on unspecified enabling machine and device

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 447 of 490 MTC epSOSLanguage

epSOSLanguage

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.6

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 af-NA Afrikaans-NAMIBIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 af-ZA Afrikaans-SOUTH AFRICA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ak-GH Akan-GHANA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 am-ET Amharic-ETHIOPIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-AE Arabic-UNITED ARAB EMIRATES 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-BH Arabic-BAHRAIN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-DJ Arabic-DJIBOUTI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-DZ Arabic-ALGERIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-EG Arabic-EGYPT 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-EH Arabic-WESTERN SAHARA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-ER Arabic-ERITREA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-IL Arabic-ISRAEL 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-IQ Arabic-IRAQ 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-JO Arabic-JORDAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-KM Arabic-COMOROS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-KW Arabic-KUWAIT 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-LB Arabic-LEBANON 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-LY Arabic-LIBYA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-MA Arabic-MOROCCO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-MR Arabic-MAURITANIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-OM Arabic-OMAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-PS Arabic-PALESTINE, STATE OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-QA Arabic-QATAR 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-SA Arabic-SAUDI ARABIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-SD Arabic-SUDAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-SO Arabic-SOMALIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-SS Arabic-SOUTH SUDAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-SY Arabic-SYRIAN ARAB REPUBLIC 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-TD Arabic-CHAD 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-TN Arabic-TUNISIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ar-YE Arabic-YEMEN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 as-IN Assamese-INDIA

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 448 of 490 MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 az-AZ Azerbaijani-AZERBAIJAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 be-BY Belarusian-BELARUS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 bg-BG Bulgarian-BULGARIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 bm-ML Bambara-MALI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 bn-BD Bengali-BANGLADESH 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 bn-IN Bengali-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 bo-CN Tibetan-CHINA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 bo-IN Tibetan-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 br-FR Breton-FRANCE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 bs-BA Bosnian-BOSNIA AND HERZEGOVINA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ca-AD Catalan; Valencian-ANDORRA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ca-ES Catalan; Valencian-SPAIN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ca-FR Catalan; Valencian-FRANCE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ca-IT Catalan; Valencian-ITALY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 cs-CZ Czech-CZECH REPUBLIC 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 cy-GB Welsh-UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 da-DK Danish-DENMARK 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 da-GL Danish-GREENLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 de-AT German-AUSTRIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 de-BE German-BELGIUM 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 de-CH German-SWITZERLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 de-DE German-GERMANY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 de-LI German-LIECHTENSTEIN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 de-LU German-LUXEMBOURG 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 dz-BT Dzongkha-BHUTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ee-GH Ewe-GHANA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ee-TG Ewe-TOGO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 el-CY Greek, Modern (1453-)-CYPRUS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 el-GR Greek, Modern (1453-)-GREECE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-AG English-ANTIGUA AND BARBUDA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-AI English-ANGUILLA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-AS English-AMERICAN SAMOA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-AU English-AUSTRALIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-BB English-BARBADOS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-BE English-BELGIUM 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-BM English-BERMUDA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-BS English-BAHAMAS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-BW English-BOTSWANA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-BZ English-BELIZE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-CA English-CANADA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-CC English-COCOS (KEELING) ISLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-CK English-COOK ISLANDS

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 449 of 490 MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-CM English-CAMEROON 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-CX English-CHRISTMAS ISLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-DM English-DOMINICA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-ER English-ERITREA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-FJ English-FIJI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-FK English-FALKLAND ISLANDS (MALVINAS) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-FM English-MICRONESIA (FEDERATED STATES OF) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-GB English-UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-GD English-GRENADA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-GG English-GUERNSEY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-GH English-GHANA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-GI English-GIBRALTAR 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-GM English-GAMBIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-GU English-GUAM 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-GY English-GUYANA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-HK English-HONG KONG 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-IE English-IRELAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-IM English-ISLE OF MAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-IN English-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-IO English-BRITISH INDIAN OCEAN TERRITORY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-JE English-JERSEY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-JM English-JAMAICA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-KE English-KENYA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-KI English-KIRIBATI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-KN English-SAINT KITTS AND NEVIS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-KY English-CAYMAN ISLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-LC English-SAINT LUCIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-LR English-LIBERIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-LS English-LESOTHO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-MG English-MADAGASCAR 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-MH English-MARSHALL ISLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-MO English-MACAO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-MP English-NORTHERN MARIANA ISLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-MS English-MONTSERRAT 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-MT English-MALTA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-MU English-MAURITIUS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-MW English-MALAWI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-MY English-MALAYSIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-NA English-NAMIBIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-NF English-NORFOLK ISLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-NG English-NIGERIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-NR English-NAURU

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 450 of 490 MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-NU English-NIUE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-NZ English-NEW ZEALAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-PG English-PAPUA NEW GUINEA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-PH English-PHILIPPINES 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-PK English-PAKISTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-PN English-PITCAIRN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-PR English-PUERTO RICO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-PW English-PALAU 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-RW English-RWANDA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-SB English-SOLOMON ISLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-SC English-SEYCHELLES 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-SD English-SUDAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-SG English-SINGAPORE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-SH English-SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-SL English-SIERRA LEONE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-SS English-SOUTH SUDAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-SX English-SINT MAARTEN (DUTCH PART) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-SZ English-SWAZILAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-TC English-TURKS AND CAICOS ISLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-TK English-TOKELAU 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-TO English-TONGA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-TT English-TRINIDAD AND TOBAGO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-TV English-TUVALU 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-TZ English-TANZANIA, UNITED REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-UG English-UGANDA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-UM English-UNITED STATES MINOR OUTLYING ISLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-US English-UNITED STATES OF AMERICA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-VC English-SAINT VINCENT AND THE GRENADINES 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-VG English-VIRGIN ISLANDS, BRITISH 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-VI English-VIRGIN ISLANDS, U.S. 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-VU English-VANUATU 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-WS English-SAMOA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-ZA English-SOUTH AFRICA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-ZM English-ZAMBIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 en-ZW English-ZIMBABWE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-AR Spanish; Castilian-ARGENTINA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-BO Spanish; Castilian-BOLIVIA (PLURINATIONAL STATE OF) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-CL Spanish; Castilian-CHILE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-CO Spanish; Castilian-COLOMBIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-CR Spanish; Castilian-COSTA RICA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-CU Spanish; Castilian-CUBA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-DO Spanish; Castilian-DOMINICAN REPUBLIC

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 451 of 490 MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-EC Spanish; Castilian-ECUADOR 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-ES Spanish; Castilian-SPAIN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-GQ Spanish; Castilian-EQUATORIAL GUINEA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-GT Spanish; Castilian-GUATEMALA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-HN Spanish; Castilian-HONDURAS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-MX Spanish; Castilian-MEXICO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-NI Spanish; Castilian-NICARAGUA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-PA Spanish; Castilian-PANAMA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-PE Spanish; Castilian-PERU 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-PH Spanish; Castilian-PHILIPPINES 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-PR Spanish; Castilian-PUERTO RICO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-PY Spanish; Castilian-PARAGUAY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-SV Spanish; Castilian-EL SALVADOR 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-US Spanish; Castilian-UNITED STATES OF AMERICA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-UY Spanish; Castilian-URUGUAY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 es-VE Spanish; Castilian-VENEZUELA (BOLIVARIAN REPUBLIC OF) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 et-EE Estonian-ESTONIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 eu-ES Basque; Basque County-SPAIN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fa-AF Persian-AFGHANISTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fa-IR Persian-IRAN (ISLAMIC REPUBLIC OF) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ff-CM Fulah-CAMEROON 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ff-GN Fulah-GUINEA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ff-MR Fulah-MAURITANIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ff-SN Fulah-SENEGAL 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fi-FI Finnish-FINLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fo-FO Faroese-FAROE ISLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-BE French-BELGIUM 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-BF French-BURKINA FASO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-BI French-BURUNDI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-BJ French-BENIN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-BL French-SAINT BARTHÉLEMY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-CA French-CANADA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-CD French-CONGO, DEMOCRATIC REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-CF French-CENTRAL AFRICAN REPUBLIC 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-CG French-CONGO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-CH French-SWITZERLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-CI French-COTE D'IVOIRE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-CM French-CAMEROON 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-DJ French-DJIBOUTI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-DZ French-ALGERIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-FR French-FRANCE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-GA French-GABON 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-GF French-FRENCH GUIANA © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 452 of 490 MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-GN French-GUINEA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-GP French-GUADELOUPE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-GQ French-EQUATORIAL GUINEA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-HT French-HAITI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-KM French-COMOROS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-LU French-LUXEMBOURG 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-MA French-MOROCCO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-MC French-MONACO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-MF French-SAINT MARTIN (FRENCH PART) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-MG French-MADAGASCAR 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-ML French-MALI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-MQ French-MARTINIQUE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-MR French-MAURITANIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-MU French-MAURITIUS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-NC French-NEW CALEDONIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-NE French-NIGER 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-PF French-FRENCH POLYNESIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-PM French-SAINT PIERRE AND MIQUELON 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-RE French-REUNION 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-RW French-RWANDA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-SC French-SEYCHELLES 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-SN French-SENEGAL 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-SY French-SYRIAN ARAB REPUBLIC 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-TD French-CHAD 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-TG French-TOGO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-TN French-TUNISIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-VU French-VANUATU 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-WF French-WALLIS AND FUTUNA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fr-YT French-MAYOTTE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 fy-NL Western Frisian-NETHERLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ga-IE Irish-IRELAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 gd-GB Gaelic; Scottish Gaelic-UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 gl-ES Galician; Galicia-SPAIN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 gu-IN Gujarati-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 gv-IM Manx-ISLE OF MAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ha-GH Hausa-GHANA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ha-NE Hausa-NIGER 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ha-NG Hausa-NIGERIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 he-IL Hebrew-ISRAEL 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 hi-IN Hindi-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 hr-BA Croatian-BOSNIA AND HERZEGOVINA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 hr-HR Croatian-CROATIA

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 453 of 490 MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 hu-HU Hungarian-HUNGARY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 hy-AM Armenian-ARMENIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 id-ID Indonesian-INDONESIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ig-NG Igbo-NIGERIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ii-CN Sichuan Yi; Nuosu-CHINA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 is-IS Icelandic-ICELAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 it-CH Italian-SWITZERLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 it-IT Italian-ITALY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 it-SM Italian-SAN MARINO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ja-JP Japanese-JAPAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ka-GE Georgian-GEORGIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ki-KE Kikuyu; Gikuyu-KENYA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 kk-KZ Kazakh-KAZAKHSTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 kl-GL Kalaallisut; Greenlandic-GREENLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 km-KH Central Khmer-CAMBODIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 kn-IN Kannada-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ko-KP Korean-KOREA (DEMOCRATIC PEOPLE'S REPUBLIC OF) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ko-KR Korean-KOREA, REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ks-IN Kashmiri-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 kw-GB Cornish-UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ky-KG Kirghiz; Kyrgyz-KYRGYZSTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 lb-LU Luxembourgish; Letzeburgesch-LUXEMBOURG 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 lg-UG Ganda-UGANDA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ln-AO Lingala-ANGOLA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ln-CD Lingala-CONGO, DEMOCRATIC REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ln-CF Lingala-CENTRAL AFRICAN REPUBLIC 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ln-CG Lingala-CONGO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 lo-LA Lao-LAO PEOPLE'S DEMOCRATIC REPUBLIC 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 lt-LT Lithuanian-LITHUANIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 lu-CD Luba-Katanga-CONGO, DEMOCRATIC REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 lv-LV Latvian-LATVIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 mg-MG Malagasy-MADAGASCAR 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 mk-MK Macedonian-MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ml-IN Malayalam-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 mn-MN Mongolian-MONGOLIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 mr-IN Marathi-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ms-BN Malay-BRUNEI DARUSSALAM 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ms-MY Malay-MALAYSIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ms-SG Malay-SINGAPORE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 mt-MT Maltese-MALTA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 my-MM Burmese-MYANMAR 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nb-NO Bokmål, Norwegian; Norwegian Bokmål-NORWAY © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 454 of 490 MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nb-SJ Bokmål, Norwegian; Norwegian Bokmål-SVALBARD AND JAN MAYEN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nd-ZW Ndebele, North; North Ndebele-ZIMBABWE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ne-IN Nepali-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ne-NP Nepali-NEPAL 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nl-AW Dutch; Flemish-ARUBA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nl-BE Dutch; Flemish-BELGIUM 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nl-BQ Dutch; Flemish-BONAIRE, SINT EUSTATIUS AND SABA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nl-CW Dutch; Flemish-CURAÇAO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nl-NL Dutch; Flemish-NETHERLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nl-SR Dutch; Flemish-SURINAME 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nl-SX Dutch; Flemish-SINT MAARTEN (DUTCH PART) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 nn-NO Norwegian Nynorsk; Nynorsk, Norwegian-NORWAY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 om-ET Oromo-ETHIOPIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 om-KE Oromo-KENYA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 or-IN Oriya-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 os-GE Ossetian; Ossetic-GEORGIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 os-RU Ossetian; Ossetic-RUSSIAN FEDERATION 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pa-IN Panjabi; Punjabi-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pa-PK Panjabi; Punjabi-PAKISTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pl-PL Polish-POLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ps-AF Pushto; Pashto-AFGHANISTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pt-AO Portuguese-ANGOLA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pt-BR Portuguese-BRAZIL 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pt-CV Portuguese-CAPE VERDE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pt-GW Portuguese-GUINEA-BISSAU 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pt-MO Portuguese-MACAO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pt-MZ Portuguese-MOZAMBIQUE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pt-PT Portuguese-PORTUGAL 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pt-ST Portuguese-SAO TOME AND PRINCIPE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 pt-TL Portuguese-TIMOR-LESTE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 qu-BO Quechua-BOLIVIA (PLURINATIONAL STATE OF) 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 qu-EC Quechua-ECUADOR 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 qu-PE Quechua-PERU 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 rm-CH Romansh-SWITZERLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 rn-BI Rundi-BURUNDI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ro-MD Romanian; Moldavian; Moldovan-MOLDOVA, REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ro-RO Romanian; Moldavian; Moldovan-ROMANIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ru-BY Russian-BELARUS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ru-KG Russian-KYRGYZSTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ru-KZ Russian-KAZAKHSTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ru-MD Russian-MOLDOVA, REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ru-RU Russian-RUSSIAN FEDERATION

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 455 of 490 MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ru-UA Russian-UKRAINE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 rw-RW Kinyarwanda-RWANDA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 se-FI Northern Sami-FINLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 se-NO Northern Sami-NORWAY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 se-SE Northern Sami-SWEDEN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sg-CF Sango-CENTRAL AFRICAN REPUBLIC 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 si-LK Sinhala; Sinhalese-SRI LANKA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sk-SK Slovak-SLOVAKIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sl-SI Slovenian-SLOVENIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sn-ZW Shona-ZIMBABWE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 so-DJ Somali-DJIBOUTI 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 so-ET Somali-ETHIOPIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 so-KE Somali-KENYA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 so-SO Somali-SOMALIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sq-AL Albanian-ALBANIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sq-MK Albanian-MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sr-BA Serbian-BOSNIA AND HERZEGOVINA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sr-ME Serbian-MONTENEGRO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sr-RS Serbian-SERBIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sv-AX Swedish-ÅLAND ISLANDS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sv-FI Swedish-FINLAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sv-SE Swedish-SWEDEN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sw-CD Swahili-CONGO, DEMOCRATIC REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sw-KE Swahili-KENYA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sw-TZ Swahili-TANZANIA, UNITED REPUBLIC OF 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 sw-UG Swahili-UGANDA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ta-IN Tamil-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ta-LK Tamil-SRI LANKA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ta-MY Tamil-MALAYSIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ta-SG Tamil-SINGAPORE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 te-IN Telugu-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 th-TH Thai-THAILAND 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ti-ER Tigrinya-ERITREA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ti-ET Tigrinya-ETHIOPIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 to-TO Tonga (Tonga Islands)-TONGA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 tr-CY Turkish-CYPRUS 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 tr-TR Turkish-TURKEY 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ug-CN Uighur; Uyghur-CHINA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 uk-UA Ukrainian-UKRAINE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ur-IN Urdu-INDIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 ur-PK Urdu-PAKISTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 uz-AF Uzbek-AFGHANISTAN

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 456 of 490 MTC epSOSLanguage

1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 uz-UZ Uzbek-UZBEKISTAN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 vi-VN Vietnamese-VIET NAM 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 yo-BJ Yoruba-BENIN 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 yo-NG Yoruba-NIGERIA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 zh-CN Chinese-CHINA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 zh-HK Chinese-HONG KONG 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 zh-MO Chinese-MACAO 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 zh-SG Chinese-SINGAPORE 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 zh-TW Chinese-TAIWAN, PROVINCE OF CHINA 1dd183a6-6d2b-4a9d-8f5d-be09d6bb5a6e 2017-03 zu-ZA Zulu-SOUTH AFRICA

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 457 of 490 MTC epSOSMedicalDevices

epSOSMedicalDevices

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.8

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 102303004 Vascular prosthesis 2.16.840.1.113883.6.96 2016-07 102314001 Embolisation coil 2.16.840.1.113883.6.96 2016-07 118374007 Silicone implant 2.16.840.1.113883.6.96 2016-07 118382007 Neuropacemaker device 2.16.840.1.113883.6.96 2016-07 118425005 Ventricular reservoir 2.16.840.1.113883.6.96 2016-07 17107009 Mitral valve prosthesis 2.16.840.1.113883.6.96 2016-07 2282003 Breast prosthesis 2.16.840.1.113883.6.96 2016-07 24073000 Artificial cardiac valve prosthesis 2.16.840.1.113883.6.96 2016-07 257275005 Spinal cage 2.16.840.1.113883.6.96 2016-07 257282009 Non-valved conduit 2.16.840.1.113883.6.96 2016-07 257283004 Valved cardiac conduit 2.16.840.1.113883.6.96 2016-07 257343005 Xenograft cardiac valve 2.16.840.1.113883.6.96 2016-07 257366006 JJ-stent 2.16.840.1.113883.6.96 2016-07 258593008 Ventricular shunt 2.16.840.1.113883.6.96 2016-07 264824009 Cardiac conduit 2.16.840.1.113883.6.96 2016-07 268460000 Intrauterine contraceptive device 2.16.840.1.113883.6.96 2016-07 271003 Bone plate 2.16.840.1.113883.6.96 2016-07 272245008 Maxillofacial prosthesis/appliance 2.16.840.1.113883.6.96 2016-07 286558002 Ureteric stent 2.16.840.1.113883.6.96 2016-07 286576009 Urethral stent 2.16.840.1.113883.6.96 2016-07 303277008 Fallopian tube prosthesis 2.16.840.1.113883.6.96 2016-07 303490004 Cardiovascular implant 2.16.840.1.113883.6.96 2016-07 303497001 Urogenital implant 2.16.840.1.113883.6.96 2016-07 303499003 Gastrointestinal implant 2.16.840.1.113883.6.96 2016-07 303500007 Auditory implant 2.16.840.1.113883.6.96 2016-07 303503009 Musculoskeletal implant 2.16.840.1.113883.6.96 2016-07 303515008 Orbital implant 2.16.840.1.113883.6.96 2016-07 303533002 Hip joint implant 2.16.840.1.113883.6.96 2016-07 303608005 Ophthalmological implant 2.16.840.1.113883.6.96 2016-07 303617005 Vascular implant 2.16.840.1.113883.6.96 2016-07 303618000 Nervous system implant 2.16.840.1.113883.6.96 2016-07 303619008 Cardiac implant

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 458 of 490 MTC epSOSMedicalDevices

2.16.840.1.113883.6.96 2016-07 303726000 Shoulder joint prosthesis 2.16.840.1.113883.6.96 2016-07 303947005 Rod fixation system 2.16.840.1.113883.6.96 2016-07 304070008 Body wall implant 2.16.840.1.113883.6.96 2016-07 304120007 Total hip replacement prosthesis 2.16.840.1.113883.6.96 2016-07 304121006 Femoral head prosthesis 2.16.840.1.113883.6.96 2016-07 304124003 Shoulder joint implant 2.16.840.1.113883.6.96 2016-07 304184000 Ankle joint implant 2.16.840.1.113883.6.96 2016-07 304185004 Foot joint implant 2.16.840.1.113883.6.96 2016-07 304186003 Hand joint implant 2.16.840.1.113883.6.96 2016-07 31031000 Orthopaedic internal fixation system 2.16.840.1.113883.6.96 2016-07 314523008 Joint implant 2.16.840.1.113883.6.96 2016-07 360041000 Implanted drug delivery system 2.16.840.1.113883.6.96 2016-07 360046005 Arterial stent 2.16.840.1.113883.6.96 2016-07 360058005 Intraventricular pump 2.16.840.1.113883.6.96 2016-07 360070009 Laryngeal implant 2.16.840.1.113883.6.96 2016-07 360100007 Tracheal stent 2.16.840.1.113883.6.96 2016-07 360117000 Gastric bubble 2.16.840.1.113883.6.96 2016-07 360123005 Biliary stent 2.16.840.1.113883.6.96 2016-07 360145006 Bone prosthesis 2.16.840.1.113883.6.96 2016-07 360329004 Dacron graft 2.16.840.1.113883.6.96 2016-07 413766009 Carotid stent 2.16.840.1.113883.6.96 2016-07 414580007 Laryngeal keel 2.16.840.1.113883.6.96 2016-07 421168009 Eye sphere implant 2.16.840.1.113883.6.96 2016-07 423449009 Pulmonary valve prosthesis, device 2.16.840.1.113883.6.96 2016-07 424921004 Permanent cardiac pacemaker, device 2.16.840.1.113883.6.96 2016-07 429798007 Artificial vertebral disc 2.16.840.1.113883.6.96 2016-07 43252007 Cochlear prosthesis 2.16.840.1.113883.6.96 2016-07 45633005 Peritoneal dialyser 2.16.840.1.113883.6.96 2016-07 63112008 Bone wire 2.16.840.1.113883.6.96 2016-07 63289001 Surgical metal nail, device 2.16.840.1.113883.6.96 2016-07 67270000 Hip prosthesis 2.16.840.1.113883.6.96 2016-07 68183006 Bone screw 2.16.840.1.113883.6.96 2016-07 72506001 Implantable defibrillator 2.16.840.1.113883.6.96 2016-07 74444006 Limb prosthesis 2.16.840.1.113883.6.96 2016-07 77444004 Bone pin 2.16.840.1.113883.6.96 2016-07 77777004 Bone staple 2.16.840.1.113883.6.96 2016-07 84683006 Aortic valve prosthesis 2.16.840.1.113883.6.96 2016-07 90134004 Metal periosteal implant

TRANSCODINGS

MVC NATIONAL CODE SYSTEM © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 459 of 490 MTC epSOSMedicalDevices

Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 460 of 490 MTC epSOSNullFavor

epSOSNullFavor

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.37

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.5.1008 913-20091020 ASKU asked but unknown 2.16.840.1.113883.5.1008 913-20091020 MSK masked 2.16.840.1.113883.5.1008 913-20091020 NA not applicable 2.16.840.1.113883.5.1008 913-20091020 NASK not asked 2.16.840.1.113883.5.1008 913-20091020 NAV temporarily unavailable 2.16.840.1.113883.5.1008 913-20091020 NI NoInformation 2.16.840.1.113883.5.1008 913-20091020 NINF negative infinity 2.16.840.1.113883.5.1008 913-20091020 OTH other 2.16.840.1.113883.5.1008 913-20091020 PINF positive infinity 2.16.840.1.113883.5.1008 913-20091020 TRC trace 2.16.840.1.113883.5.1008 913-20091020 UNK unknown

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 461 of 490 MTC epSOSPackage

epSOSPackage

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.3

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 0.4.0.127.0.16.1.1.2.1 2017-04-14 13059000 Unit-dose blister 0.4.0.127.0.16.1.1.2.1 2017-04-14 30000500 Administration system 0.4.0.127.0.16.1.1.2.1 2017-04-14 30001000 Ampoule 0.4.0.127.0.16.1.1.2.1 2017-04-14 30002000 Applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30004000 Bag 0.4.0.127.0.16.1.1.2.1 2017-04-14 30006000 Barrel 0.4.0.127.0.16.1.1.2.1 2017-04-14 30007000 Blister 0.4.0.127.0.16.1.1.2.1 2017-04-14 30008000 Bottle 0.4.0.127.0.16.1.1.2.1 2017-04-14 30009000 Box 0.4.0.127.0.16.1.1.2.1 2017-04-14 30010000 Brush 0.4.0.127.0.16.1.1.2.1 2017-04-14 30011000 Brush applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30012000 Cannula 0.4.0.127.0.16.1.1.2.1 2017-04-14 30013000 Cap 0.4.0.127.0.16.1.1.2.1 2017-04-14 30014000 Cartridge 0.4.0.127.0.16.1.1.2.1 2017-04-14 30015000 Child-resistant closure 0.4.0.127.0.16.1.1.2.1 2017-04-14 30015500 Container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30016000 Cup 0.4.0.127.0.16.1.1.2.1 2017-04-14 30017000 Dabbing applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30018200 Dose dispenser 0.4.0.127.0.16.1.1.2.1 2017-04-14 30018300 Dose-dispenser cartridge 0.4.0.127.0.16.1.1.2.1 2017-04-14 30019000 Dredging applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30020000 Dredging container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30022000 Dropper applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30023000 Dropper container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30023005 Fixed cryogenic vessel 0.4.0.127.0.16.1.1.2.1 2017-04-14 30024000 Gas cylinder 0.4.0.127.0.16.1.1.2.1 2017-04-14 30026500 Inhaler 0.4.0.127.0.16.1.1.2.1 2017-04-14 30028000 Injection needle 0.4.0.127.0.16.1.1.2.1 2017-04-14 30029000 Injection syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 30032000 Jar 0.4.0.127.0.16.1.1.2.1 2017-04-14 30033000 Measuring device 0.4.0.127.0.16.1.1.2.1 2017-04-14 30034000 Measuring spoon

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 462 of 490 MTC epSOSPackage

0.4.0.127.0.16.1.1.2.1 2017-04-14 30035000 Metering pump 0.4.0.127.0.16.1.1.2.1 2017-04-14 30036000 Metering valve 0.4.0.127.0.16.1.1.2.1 2017-04-14 30036005 Mobile cryogenic vessel 0.4.0.127.0.16.1.1.2.1 2017-04-14 30037000 Mouthpiece 0.4.0.127.0.16.1.1.2.1 2017-04-14 30038000 Multidose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30039000 Multidose container with airless pump 0.4.0.127.0.16.1.1.2.1 2017-04-14 30039400 Multidose container with metering pump 0.4.0.127.0.16.1.1.2.1 2017-04-14 30039500 Multidose container with pump 0.4.0.127.0.16.1.1.2.1 2017-04-14 30040000 Multipuncturer 0.4.0.127.0.16.1.1.2.1 2017-04-14 30041000 Nasal applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30042000 Nebuliser 0.4.0.127.0.16.1.1.2.1 2017-04-14 30043000 Needle applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30043500 Needle-free injector 0.4.0.127.0.16.1.1.2.1 2017-04-14 30044000 Nozzle 0.4.0.127.0.16.1.1.2.1 2017-04-14 30045000 Oral syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 30046000 Pipette 0.4.0.127.0.16.1.1.2.1 2017-04-14 30047000 Pipette applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30049000 Pre-filled gastroenteral tube 0.4.0.127.0.16.1.1.2.1 2017-04-14 30050000 Pre-filled pen 0.4.0.127.0.16.1.1.2.1 2017-04-14 30051000 Pre-filled syringe 0.4.0.127.0.16.1.1.2.1 2017-04-14 30052000 Pressurised container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30053000 Prick test applicator 0.4.0.127.0.16.1.1.2.1 2017-04-14 30053500 Roll-on container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30054000 Sachet 0.4.0.127.0.16.1.1.2.1 2017-04-14 30056000 Screw cap 0.4.0.127.0.16.1.1.2.1 2017-04-14 30057000 Single-dose container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30058000 Spatula 0.4.0.127.0.16.1.1.2.1 2017-04-14 30060000 Spray container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30061000 Spray pump 0.4.0.127.0.16.1.1.2.1 2017-04-14 30062000 Spray valve 0.4.0.127.0.16.1.1.2.1 2017-04-14 30064000 Stopper 0.4.0.127.0.16.1.1.2.1 2017-04-14 30064500 Straw 0.4.0.127.0.16.1.1.2.1 2017-04-14 30065000 Strip 0.4.0.127.0.16.1.1.2.1 2017-04-14 30066000 Tablet container 0.4.0.127.0.16.1.1.2.1 2017-04-14 30067000 Tube 0.4.0.127.0.16.1.1.2.1 2017-04-14 30069000 Vial

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 463 of 490 MTC epSOSPersonalRelationship

epSOSPersonalRelationship

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.38

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.5.111 913-20091020 AUNT aunt 2.16.840.1.113883.5.111 913-20091020 CHILD Child 2.16.840.1.113883.5.111 913-20091020 CHLDADOPT adopted child 2.16.840.1.113883.5.111 913-20091020 CHLDFOST foster child 2.16.840.1.113883.5.111 913-20091020 CHLDINLAW child in-law 2.16.840.1.113883.5.111 913-20091020 COUSN cousin 2.16.840.1.113883.5.111 913-20091020 DAU natural daughter 2.16.840.1.113883.5.111 913-20091020 DAUADOPT adopted daughter 2.16.840.1.113883.5.111 913-20091020 DAUC Daughter 2.16.840.1.113883.5.111 913-20091020 DAUFOST foster daughter 2.16.840.1.113883.5.111 913-20091020 DAUINLAW daughter in-law 2.16.840.1.113883.5.111 913-20091020 DOMPART domestic partner 2.16.840.1.113883.5.111 913-20091020 FAMMEMB Family Member 2.16.840.1.113883.5.111 913-20091020 FRND unrelated friend 2.16.840.1.113883.5.111 913-20091020 FTH Father 2.16.840.1.113883.5.111 913-20091020 FTHINLAW father-in-law 2.16.840.1.113883.5.111 913-20091020 GGRPRN great grandparent 2.16.840.1.113883.5.111 913-20091020 GRNDCHILD grandchild 2.16.840.1.113883.5.111 913-20091020 GRPRN Grandparent 2.16.840.1.113883.5.111 913-20091020 MTH Mother 2.16.840.1.113883.5.111 913-20091020 MTHINLAW mother-in-law 2.16.840.1.113883.5.111 913-20091020 NBOR neighbor 2.16.840.1.113883.5.111 913-20091020 NCHILD natural child 2.16.840.1.113883.5.111 913-20091020 NIENEPH niece/nephew 2.16.840.1.113883.5.111 913-20091020 PRN Parent 2.16.840.1.113883.5.111 913-20091020 PRNINLAW parent in-law 2.16.840.1.113883.5.111 913-20091020 ROOM Roommate 2.16.840.1.113883.5.111 913-20091020 SIB Sibling 2.16.840.1.113883.5.111 913-20091020 SIGOTHR significant other 2.16.840.1.113883.5.111 913-20091020 SON natural son 2.16.840.1.113883.5.111 913-20091020 SONADOPT adopted son 2.16.840.1.113883.5.111 913-20091020 SONC son

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 464 of 490 MTC epSOSPersonalRelationship

2.16.840.1.113883.5.111 913-20091020 SONFOST foster son 2.16.840.1.113883.5.111 913-20091020 SONINLAW son in-law 2.16.840.1.113883.5.111 913-20091020 SPS spouse 2.16.840.1.113883.5.111 913-20091020 STPCHLD step child 2.16.840.1.113883.5.111 913-20091020 STPDAU stepdaughter 2.16.840.1.113883.5.111 913-20091020 STPSON stepson 2.16.840.1.113883.5.111 913-20091020 UNCLE uncle

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 465 of 490 MTC epSOSPregnancyInformation

epSOSPregnancyInformation

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.9

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.1 2.59 11778-8 Delivery date Estimated 2.16.840.1.113883.6.1 2.59 11779-6 Delivery date Estimated from last menstrual period 2.16.840.1.113883.6.1 2.59 11780-4 Delivery date Estimated from ovulation date

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 466 of 490 MTC epSOSProcedures

epSOSProcedures

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.10

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 10458001 Evacuation of intracerebral haematoma 2.16.840.1.113883.6.96 2016-07 107907001 Operative procedure on digestive system 2.16.840.1.113883.6.96 2016-07 108021004 Operative procedure on male genitourinary system 2.16.840.1.113883.6.96 2016-07 10847001 Bronchoscopy 2.16.840.1.113883.6.96 2016-07 112698002 Operation on joint 2.16.840.1.113883.6.96 2016-07 112727005 Revision of hip replacement 2.16.840.1.113883.6.96 2016-07 112802009 Cardiovascular surgical procedure 2.16.840.1.113883.6.96 2016-07 112828007 Femoral-popliteal artery bypass graft 2.16.840.1.113883.6.96 2016-07 11466000 Caesarean section 2.16.840.1.113883.6.96 2016-07 118675001 Procedure on female genital system 2.16.840.1.113883.6.96 2016-07 118683007 Procedure on ear and related structures 2.16.840.1.113883.6.96 2016-07 118716003 Procedure on foot 2.16.840.1.113883.6.96 2016-07 118795000 Procedure on pleura 2.16.840.1.113883.6.96 2016-07 118804001 Procedure on blood vessel 2.16.840.1.113883.6.96 2016-07 118831003 Procedure on intestine 2.16.840.1.113883.6.96 2016-07 118949002 Procedure on extremity 2.16.840.1.113883.6.96 2016-07 118950002 Procedure on head AND/OR neck 2.16.840.1.113883.6.96 2016-07 118955007 Implantation to cardiovascular system 2.16.840.1.113883.6.96 2016-07 119922005 Biliary tract endoscopy 2.16.840.1.113883.6.96 2016-07 122470005 Reduction of closed fracture 2.16.840.1.113883.6.96 2016-07 122471009 Reduction of open fracture 2.16.840.1.113883.6.96 2016-07 12658000 Operation on female genital organs 2.16.840.1.113883.6.96 2016-07 133864008 Lithotripsy 2.16.840.1.113883.6.96 2016-07 13619001 Thyroidectomy 2.16.840.1.113883.6.96 2016-07 15018006 Laparoscopic repair of inguinal hernia 2.16.840.1.113883.6.96 2016-07 16545005 Operation on nervous system 2.16.840.1.113883.6.96 2016-07 173171007 Lobectomy of lung 2.16.840.1.113883.6.96 2016-07 173422009 Tonsillectomy 2.16.840.1.113883.6.96 2016-07 19063003 Arthroplasty of knee 2.16.840.1.113883.6.96 2016-07 21371007 Operation on abdominal region 2.16.840.1.113883.6.96 2016-07 232632009 Wedge excision of lung 2.16.840.1.113883.6.96 2016-07 232717009 Coronary artery bypass graft

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 467 of 490 MTC epSOSProcedures

2.16.840.1.113883.6.96 2016-07 234336002 Haemopoietic stem cell transplant 2.16.840.1.113883.6.96 2016-07 236886002 Hysterectomy 2.16.840.1.113883.6.96 2016-07 236887006 Laparoscopic hysterectomy 2.16.840.1.113883.6.96 2016-07 23968004 Colectomy 2.16.840.1.113883.6.96 2016-07 250980009 Cardioversion 2.16.840.1.113883.6.96 2016-07 257822003 Extracapsular extraction 2.16.840.1.113883.6.96 2016-07 26476002 Operation on bronchus 2.16.840.1.113883.6.96 2016-07 265703000 Jaw and temporomandibular joint operations 2.16.840.1.113883.6.96 2016-07 287310004 Lung tumour excision 2.16.840.1.113883.6.96 2016-07 302343007 Insertion of prosthesis for breast 2.16.840.1.113883.6.96 2016-07 30904006 Vascular surgery procedure 2.16.840.1.113883.6.96 2016-07 312775003 Debridement of ulcer 2.16.840.1.113883.6.96 2016-07 3418002 Chondrectomy of spine 2.16.840.1.113883.6.96 2016-07 34969007 Operation on retroperitoneum 2.16.840.1.113883.6.96 2016-07 359612003 Implantation of cochlear prosthetic device 2.16.840.1.113883.6.96 2016-07 359623004 Total lobectomy of lung 2.16.840.1.113883.6.96 2016-07 36228007 Ophthalmic examination and evaluation 2.16.840.1.113883.6.96 2016-07 363187007 Limb operation 2.16.840.1.113883.6.96 2016-07 370611004 Excision of malignant neoplasm 2.16.840.1.113883.6.96 2016-07 373353005 Surgical procedure on eye proper 2.16.840.1.113883.6.96 2016-07 37508003 Operation on neck 2.16.840.1.113883.6.96 2016-07 38102005 Cholecystectomy 2.16.840.1.113883.6.96 2016-07 384723003 Radical mastectomy 2.16.840.1.113883.6.96 2016-07 385487005 Surgical procedure on thorax 2.16.840.1.113883.6.96 2016-07 385488000 Surgical procedure on chest wall 2.16.840.1.113883.6.96 2016-07 386638009 Obstetric operation 2.16.840.1.113883.6.96 2016-07 386765006 Operation on mediastinum 2.16.840.1.113883.6.96 2016-07 387714009 Operation on lung 2.16.840.1.113883.6.96 2016-07 392011001 Operation on skin 2.16.840.1.113883.6.96 2016-07 392048005 Operation on urinary system 2.16.840.1.113883.6.96 2016-07 392090004 Operation on breast 2.16.840.1.113883.6.96 2016-07 392236004 Operative procedure on spinal structure 2.16.840.1.113883.6.96 2016-07 397956004 Prosthetic arthroplasty of the hip 2.16.840.1.113883.6.96 2016-07 405525004 Repair of aneurysm of abdominal aorta 2.16.840.1.113883.6.96 2016-07 423827005 Endoscopy 2.16.840.1.113883.6.96 2016-07 426153007 Insertion of artificial airway 2.16.840.1.113883.6.96 2016-07 429639007 Percutaneous transluminal balloon angioplasty with insertion of stent into coronary artery 2.16.840.1.113883.6.96 2016-07 441612006 Repair of infrarenal abdominal aortic aneurysm with insertion of endovascular stent 2.16.840.1.113883.6.96 2016-07 44558001 Repair of inguinal hernia 2.16.840.1.113883.6.96 2016-07 45595009 Laparoscopic cholecystectomy 2.16.840.1.113883.6.96 2016-07 46116005 Excision of malignant tumour of breast 2.16.840.1.113883.6.96 2016-07 47534009 Decompression of median nerve © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 468 of 490 MTC epSOSProcedures

2.16.840.1.113883.6.96 2016-07 4770005 Colporrhaphy for repair of urethrocele 2.16.840.1.113883.6.96 2016-07 49509003 Operation on lymphatic structure 2.16.840.1.113883.6.96 2016-07 53266006 Operation on diaphragm 2.16.840.1.113883.6.96 2016-07 54885007 Extraction of cataract 2.16.840.1.113883.6.96 2016-07 56361007 Excision of soft tissue 2.16.840.1.113883.6.96 2016-07 57168000 Operation on bone 2.16.840.1.113883.6.96 2016-07 59300005 Operation on spleen 2.16.840.1.113883.6.96 2016-07 59712006 Evacuation of subdural haematoma 2.16.840.1.113883.6.96 2016-07 6025007 Laparoscopic appendicectomy 2.16.840.1.113883.6.96 2016-07 63016009 Complete cystectomy 2.16.840.1.113883.6.96 2016-07 64253000 Implantation of heart assist system 2.16.840.1.113883.6.96 2016-07 64368001 Partial mastectomy 2.16.840.1.113883.6.96 2016-07 66951008 Carotid endarterectomy 2.16.840.1.113883.6.96 2016-07 70183006 Subcutaneous mastectomy 2.16.840.1.113883.6.96 2016-07 70536003 Transplant of kidney 2.16.840.1.113883.6.96 2016-07 73761001 Colonoscopy 2.16.840.1.113883.6.96 2016-07 76810006 Diagnostic dilation and curettage of uterus 2.16.840.1.113883.6.96 2016-07 78418002 Operation on heart and pericardium 2.16.840.1.113883.6.96 2016-07 80146002 Appendicectomy 2.16.840.1.113883.6.96 2016-07 84877006 Arthroscopy of knee with meniscus repair 2.16.840.1.113883.6.96 2016-07 85548006 Episiotomy 2.16.840.1.113883.6.96 2016-07 85921004 Puncture procedure 2.16.840.1.113883.6.96 2016-07 86273004 Biopsy 2.16.840.1.113883.6.96 2016-07 86749008 Stripping and ligation 2.16.840.1.113883.6.96 2016-07 86800006 Operation on trachea 2.16.840.1.113883.6.96 2016-07 90199006 Transurethral prostatectomy 2.16.840.1.113883.6.96 2016-07 90470006 Prostatectomy 2.16.840.1.113883.6.96 2016-07 9888007 Excision of intracranial lesion

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 469 of 490 MTC epSOSReactionAllergy

epSOSReactionAllergy

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.11

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 126485001 Urticaria 2.16.840.1.113883.6.96 2016-07 162290004 Dry eyes 2.16.840.1.113883.6.96 2016-07 195967001 Asthma 2.16.840.1.113883.6.96 2016-07 1985008 Vomitus 2.16.840.1.113883.6.96 2016-07 23924001 Tight chest 2.16.840.1.113883.6.96 2016-07 24079001 Atopic dermatitis 2.16.840.1.113883.6.96 2016-07 247472004 Weal 2.16.840.1.113883.6.96 2016-07 267036007 Dyspnoea 2.16.840.1.113883.6.96 2016-07 271757001 Papular eruption 2.16.840.1.113883.6.96 2016-07 271759003 Bullous eruption 2.16.840.1.113883.6.96 2016-07 31996006 Vasculitis 2.16.840.1.113883.6.96 2016-07 359610006 Ocular hyperaemia 2.16.840.1.113883.6.96 2016-07 39579001 Anaphylaxis 2.16.840.1.113883.6.96 2016-07 410430005 Cardiorespiratory arrest 2.16.840.1.113883.6.96 2016-07 41291007 Angio-oedema 2.16.840.1.113883.6.96 2016-07 418363000 Itching of skin 2.16.840.1.113883.6.96 2016-07 422587007 Nausea 2.16.840.1.113883.6.96 2016-07 43116000 Eczema 2.16.840.1.113883.6.96 2016-07 4386001 Bronchospasm 2.16.840.1.113883.6.96 2016-07 49727002 Cough 2.16.840.1.113883.6.96 2016-07 51599000 Oedema of larynx 2.16.840.1.113883.6.96 2016-07 62315008 Diarrhoea 2.16.840.1.113883.6.96 2016-07 698247007 Cardiac arrhythmia 2.16.840.1.113883.6.96 2016-07 70076002 Rhinitis 2.16.840.1.113883.6.96 2016-07 702809001 Drug reaction with eosinophilia and systemic symptoms 2.16.840.1.113883.6.96 2016-07 73442001 Stevens-Johnson syndrome 2.16.840.1.113883.6.96 2016-07 76067001 Sneezing 2.16.840.1.113883.6.96 2016-07 91175000 2.16.840.1.113883.6.96 2016-07 9826008 Conjunctivitis

TRANSCODINGS

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 470 of 490 MTC epSOSReactionAllergy

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 471 of 490 MTC epSOSResolutionOutcome

epSOSResolutionOutcome

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.30

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 161045001 Disability - severe 2.16.840.1.113883.6.96 2016-07 161901003 Chronic sick 2.16.840.1.113883.6.96 2016-07 162467007 Free of symptoms 2.16.840.1.113883.6.96 2016-07 21134002 Disability 2.16.840.1.113883.6.96 2016-07 271593001 Moribund 2.16.840.1.113883.6.96 2016-07 313386006 Patient in remission 2.16.840.1.113883.6.96 2016-07 419099009 Dead 2.16.840.1.113883.6.96 2016-07 81323004 Normal general body function

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 472 of 490 MTC epSOSRoleClass

epSOSRoleClass

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.39

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.5.110 913-20091020 ECON emergency contact 2.16.840.1.113883.5.110 913-20091020 NOK next of kin

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 473 of 490 MTC epSOSRouteofAdministration

epSOSRouteofAdministration

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.12

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 0.4.0.127.0.16.1.1.2.1 2017-04-14 20001000 Auricular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20002500 Buccal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20003000 Cutaneous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20004000 Dental use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20006000 Endocervical use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20007000 Endosinusial use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20008000 Endotracheopulmonary use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20009000 Epidural use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20010000 Epilesional use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20011000 Extraamniotic use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20011500 Extracorporeal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20013000 Gastroenteral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20013500 Gastric use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20014000 Gingival use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20015000 Haemodialysis 0.4.0.127.0.16.1.1.2.1 2017-04-14 20015500 Implantation 0.4.0.127.0.16.1.1.2.1 2017-04-14 20019500 Infiltration 0.4.0.127.0.16.1.1.2.1 2017-04-14 20020000 Inhalation use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20021000 Intestinal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20022000 Intraamniotic use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20023000 Intraarterial use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20024000 Intraarticular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20025000 Intrabursal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20025500 Intracameral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20026000 Intracardiac use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20026500 Intracartilaginous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20027000 Intracavernous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20027010 Intracerebral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20028000 Intracervical use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20028300 Intracholangiopancreatic use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20028500 Intracisternal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20029000 Intracoronary use

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 474 of 490 MTC epSOSRouteofAdministration

0.4.0.127.0.16.1.1.2.1 2017-04-14 20030000 Intradermal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20031000 Intradiscal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20031500 Intraepidermal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20031700 Intraglandular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20032000 Intralesional use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20033000 Intralymphatic use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20035000 Intramuscular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20036000 Intraocular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20036500 Intraosseous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20037000 Intrapericardial use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20038000 Intraperitoneal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20039000 Intrapleural use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20039200 Intraportal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20039500 Intraprostatic use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20041000 Intrasternal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20042000 Intrathecal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20043000 Intratumoral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20044000 Intrauterine use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20045000 Intravenous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20046000 Intravesical use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20047000 Intravitreal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20047500 Iontophoresis 0.4.0.127.0.16.1.1.2.1 2017-04-14 20048000 Laryngopharyngeal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20049000 Nasal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20051000 Ocular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20053000 Oral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20054000 Oromucosal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20055000 Oropharyngeal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20057000 Periarticular use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20058000 Perineural use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20059000 Periodontal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20059300 Periosseous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20059400 Peritumoral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20059500 Posterior juxtascleral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20061000 Rectal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20061500 Retrobulbar use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20062000 Route of administration not applicable 0.4.0.127.0.16.1.1.2.1 2017-04-14 20063000 Skin scarification 0.4.0.127.0.16.1.1.2.1 2017-04-14 20065000 Subconjunctival use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20066000 Subcutaneous use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20067000 Sublingual use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20067500 Submucosal use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20070000 Transdermal use © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 475 of 490 MTC epSOSRouteofAdministration

0.4.0.127.0.16.1.1.2.1 2017-04-14 20071000 Urethral use 0.4.0.127.0.16.1.1.2.1 2017-04-14 20072000 Vaginal use

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 476 of 490 MTC epSOSSections

epSOSSections

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.26

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.1 2.59 10160-0 History of Medication use Narrative 2.16.840.1.113883.6.1 2.59 10162-6 History of pregnancies Narrative 2.16.840.1.113883.6.1 2.59 10164-2 History of Present illness Narrative 2.16.840.1.113883.6.1 2.59 11348-0 History of Past illness Narrative 2.16.840.1.113883.6.1 2.59 11369-6 History of Immunization Narrative 2.16.840.1.113883.6.1 2.59 11450-4 Problem list - Reported 2.16.840.1.113883.6.1 2.59 18776-5 Plan of care note 2.16.840.1.113883.6.1 2.59 29554-3 Procedure Narrative 2.16.840.1.113883.6.1 2.59 29762-2 Social history Narrative 2.16.840.1.113883.6.1 2.59 30954-2 Relevant diagnostic tests/laboratory data Narrative 2.16.840.1.113883.6.1 2.59 46264-8 History of medical device use 2.16.840.1.113883.6.1 2.59 47420-5 Functional status assessment note 2.16.840.1.113883.6.1 2.59 47519-4 History of Procedures Document 2.16.840.1.113883.6.1 2.59 48765-2 Allergies and adverse reactions Document 2.16.840.1.113883.6.1 2.59 57828-6 Prescription list 2.16.840.1.113883.6.1 2.59 60590-7 Medication dispensed.brief Document 2.16.840.1.113883.6.1 2.59 8716-3 Vital signs

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 477 of 490 MTC epSOSSeverity

epSOSSeverity

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.13

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 24484000 Severe 2.16.840.1.113883.6.96 2016-07 255604002 Mild 2.16.840.1.113883.6.96 2016-07 371923003 Mild to moderate 2.16.840.1.113883.6.96 2016-07 371924009 Moderate to severe 2.16.840.1.113883.6.96 2016-07 442452003 Life threatening severity 2.16.840.1.113883.6.96 2016-07 6736007 Moderate

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 478 of 490 MTC epSOSSocialHistory

epSOSSocialHistory

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.14

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 160573003 Alcohol intake 2.16.840.1.113883.6.96 2016-07 228272008 Health-related behaviour 2.16.840.1.113883.6.96 2016-07 229819007 Tobacco use and exposure 2.16.840.1.113883.6.96 2016-07 256235009 Exercise 2.16.840.1.113883.6.96 2016-07 363908000 Details of drug misuse behaviour 2.16.840.1.113883.6.96 2016-07 364393001 Nutritional observable 2.16.840.1.113883.6.96 2016-07 364703007 Employment detail 2.16.840.1.113883.6.96 2016-07 425400000 Toxic exposure status

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 479 of 490 MTC epSOSStatusCode

epSOSStatusCode

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.15

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 255227004 Recurrent 2.16.840.1.113883.6.96 2016-07 410516002 Known absent 2.16.840.1.113883.6.96 2016-07 413322009 Problem resolved 2.16.840.1.113883.6.96 2016-07 415684004 Suspected 2.16.840.1.113883.6.96 2016-07 55561003 Active 2.16.840.1.113883.6.96 2016-07 7087005 Intermittent 2.16.840.1.113883.6.96 2016-07 73425007 Inactive 2.16.840.1.113883.6.96 2016-07 90734009 Chronic

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 480 of 490 MTC epSOSSubstitutionCode

epSOSSubstitutionCode

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.7

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.5.1070 913-20091020 G generic 2.16.840.1.113883.5.1070 913-20091020 N none 2.16.840.1.113883.5.1070 913-20091020 TE therapeutic

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 481 of 490 MTC epSOSTelecomAddress

epSOSTelecomAddress

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.40

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.5.1119 913-20091020 AS answering service 2.16.840.1.113883.5.1119 913-20091020 EC emergency contact 2.16.840.1.113883.5.1119 913-20091020 H home address 2.16.840.1.113883.5.1119 913-20091020 HP primary home 2.16.840.1.113883.5.1119 913-20091020 HV vacation home 2.16.840.1.113883.5.1119 913-20091020 MC mobile contact 2.16.840.1.113883.5.1119 913-20091020 PG pager 2.16.840.1.113883.5.1119 913-20091020 WP work place

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 482 of 490 MTC epSOSTimingEvent

epSOSTimingEvent

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.41

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.5.139 913-20091020 AC before meal (from lat. ante cibus) 2.16.840.1.113883.5.139 913-20091020 ACD before lunch (from lat. ante cibus diurnus) 2.16.840.1.113883.5.139 913-20091020 ACM before breakfast (from lat. ante cibus matutinus) 2.16.840.1.113883.5.139 913-20091020 ACV before dinner (from lat. ante cibus vespertinus) 2.16.840.1.113883.5.139 913-20091020 HS Prior to beginning a regular period of extended sleep (this would exclude naps). Note that this might occur at different times of day depending on a person's regular sleep schedule. 2.16.840.1.113883.5.139 913-20091020 IC between meals (from lat. inter cibus) 2.16.840.1.113883.5.139 913-20091020 ICD between lunch and dinner 2.16.840.1.113883.5.139 913-20091020 ICM between breakfast and lunch 2.16.840.1.113883.5.139 913-20091020 ICV between dinner and the hour of sleep 2.16.840.1.113883.5.139 913-20091020 PC after meal (from lat. post cibus) 2.16.840.1.113883.5.139 913-20091020 PCD after lunch (from lat. post cibus diurnus) 2.16.840.1.113883.5.139 913-20091020 PCM after breakfast (from lat. post cibus matutinus) 2.16.840.1.113883.5.139 913-20091020 PCV after dinner (from lat. post cibus vespertinus)

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 483 of 490 MTC epSOSUnits

epSOSUnits

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.16

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.8 2017-03 % percent 2.16.840.1.113883.6.8 2017-03 /d per day 2.16.840.1.113883.6.8 2017-03 /g per gram 2.16.840.1.113883.6.8 2017-03 /h per hour 2.16.840.1.113883.6.8 2017-03 /kg per kilogram 2.16.840.1.113883.6.8 2017-03 /kg{body'wt} per kilogram body weight 2.16.840.1.113883.6.8 2017-03 /min per minute 2.16.840.1.113883.6.8 2017-03 /s per second 2.16.840.1.113883.6.8 2017-03 1 unit 2.16.840.1.113883.6.8 2017-03 Cal calorie 2.16.840.1.113883.6.8 2017-03 Cel degree Celsius 2.16.840.1.113883.6.8 2017-03 J joule 2.16.840.1.113883.6.8 2017-03 L liter 2.16.840.1.113883.6.8 2017-03 L/s liter per second 2.16.840.1.113883.6.8 2017-03 [iU] international unit 2.16.840.1.113883.6.8 2017-03 [iU]/g international unit per gram 2.16.840.1.113883.6.8 2017-03 [iU]/mL international unit per milliliter 2.16.840.1.113883.6.8 2017-03 a year 2.16.840.1.113883.6.8 2017-03 bar bar 2.16.840.1.113883.6.8 2017-03 cal/d calorie per day 2.16.840.1.113883.6.8 2017-03 cal/g calorie per gram 2.16.840.1.113883.6.8 2017-03 cal/h calorie per hour 2.16.840.1.113883.6.8 2017-03 cal/mL calorie per milliliter 2.16.840.1.113883.6.8 2017-03 cm centimeter 2.16.840.1.113883.6.8 2017-03 cm2 square centimeter 2.16.840.1.113883.6.8 2017-03 cm3 cubic centimeter 2.16.840.1.113883.6.8 2017-03 d day 2.16.840.1.113883.6.8 2017-03 g gram 2.16.840.1.113883.6.8 2017-03 g/L gram per liter 2.16.840.1.113883.6.8 2017-03 g/kg gram per kilogram 2.16.840.1.113883.6.8 2017-03 g/mL gram per milliliter 2.16.840.1.113883.6.8 2017-03 h hour

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 484 of 490 MTC epSOSUnits

2.16.840.1.113883.6.8 2017-03 kJ kilojoule 2.16.840.1.113883.6.8 2017-03 kPa kilopascal 2.16.840.1.113883.6.8 2017-03 k[iU] kilointernational unit 2.16.840.1.113883.6.8 2017-03 k[iU]/L kilointernational unit per liter 2.16.840.1.113883.6.8 2017-03 kat katal 2.16.840.1.113883.6.8 2017-03 kcal kilocalorie 2.16.840.1.113883.6.8 2017-03 kcal/d kilocalorie per day 2.16.840.1.113883.6.8 2017-03 kcal/g kilocalorie per gram 2.16.840.1.113883.6.8 2017-03 kcal/h kilocalorie per hour 2.16.840.1.113883.6.8 2017-03 kcal/mL kilocalorie per milliliter 2.16.840.1.113883.6.8 2017-03 kg kilogram 2.16.840.1.113883.6.8 2017-03 kg/m2 kilogram per square meter 2.16.840.1.113883.6.8 2017-03 kg/m3 kilogram per cubic meter 2.16.840.1.113883.6.8 2017-03 m meter 2.16.840.1.113883.6.8 2017-03 m2 square meter 2.16.840.1.113883.6.8 2017-03 mL milliliter 2.16.840.1.113883.6.8 2017-03 mL/s milliliter per second 2.16.840.1.113883.6.8 2017-03 m[iU] milli-international unit 2.16.840.1.113883.6.8 2017-03 m[iU]/L milli-international unit per liter 2.16.840.1.113883.6.8 2017-03 mbar millibar 2.16.840.1.113883.6.8 2017-03 mg milligram 2.16.840.1.113883.6.8 2017-03 mg/L milligram per liter 2.16.840.1.113883.6.8 2017-03 min minute 2.16.840.1.113883.6.8 2017-03 mm millimeter 2.16.840.1.113883.6.8 2017-03 mm2 square millimeter 2.16.840.1.113883.6.8 2017-03 mm[Hg] millimeter of mercury 2.16.840.1.113883.6.8 2017-03 mmol millimole 2.16.840.1.113883.6.8 2017-03 mmol/L millimole per liter 2.16.840.1.113883.6.8 2017-03 mo month 2.16.840.1.113883.6.8 2017-03 mol/L mole per liter 2.16.840.1.113883.6.8 2017-03 ng nanogram 2.16.840.1.113883.6.8 2017-03 ng/L nanogram per liter 2.16.840.1.113883.6.8 2017-03 nmol/L nanomole per liter 2.16.840.1.113883.6.8 2017-03 pH pH 2.16.840.1.113883.6.8 2017-03 s second 2.16.840.1.113883.6.8 2017-03 wk week 2.16.840.1.113883.6.8 2017-03 µL microliter 2.16.840.1.113883.6.8 2017-03 µg microgram 2.16.840.1.113883.6.8 2017-03 µg/(kg.min) microgram per kilogram and minute 2.16.840.1.113883.6.8 2017-03 µg/L microgram per liter 2.16.840.1.113883.6.8 2017-03 µkat microkatal 2.16.840.1.113883.6.8 2017-03 µkat/L microkatal per liter 2.16.840.1.113883.6.8 2017-03 µkat/mL microkatal per milliliter © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 485 of 490 MTC epSOSUnits

2.16.840.1.113883.6.8 2017-03 µmol micromole 2.16.840.1.113883.6.8 2017-03 µmol/L micromole per liter

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 486 of 490 MTC epSOSUnknownInformation

epSOSUnknownInformation

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.17

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 160245001 No current problems or disability 2.16.840.1.113883.6.96 2016-07 396782006 Medical history unknown 2.16.840.1.113883.6.96 2016-07 407559004 Family history unknown 2.16.840.1.113883.6.96 2016-07 409137002 No known drug allergies 2.16.840.1.113883.6.96 2016-07 64970000 Substance type unknown 2.16.840.1.113883.6.96 2016-07 716186003 No known allergy

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 487 of 490 MTC epSOSVaccine

epSOSVaccine

Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.28

TRANSLATIONS

Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.96 2016-07 108729007 Varicella vaccine 2.16.840.1.113883.6.96 2016-07 111164008 Poliovirus vaccine 2.16.840.1.113883.6.96 2016-07 116077000 Rotavirus vaccine 2.16.840.1.113883.6.96 2016-07 14745005 Hepatitis A virus vaccine 2.16.840.1.113883.6.96 2016-07 33234009 Smallpox vaccine 2.16.840.1.113883.6.96 2016-07 333598008 Pneumococcal vaccine 2.16.840.1.113883.6.96 2016-07 333606008 2.16.840.1.113883.6.96 2016-07 333621002 Tetanus vaccine 2.16.840.1.113883.6.96 2016-07 333680004 Haemophilus influenzae Type b vaccine 2.16.840.1.113883.6.96 2016-07 333697005 Japanese B encephalitis vaccine 2.16.840.1.113883.6.96 2016-07 333699008 Tick-borne encephalitis vaccine 2.16.840.1.113883.6.96 2016-07 333702001 Hepatitis A+B vaccine 2.16.840.1.113883.6.96 2016-07 34689006 vaccine 2.16.840.1.113883.6.96 2016-07 350327004 Diphtheria + tetanus vaccine 2.16.840.1.113883.6.96 2016-07 35736007 Cholera vaccine 2.16.840.1.113883.6.96 2016-07 386012008 Measles vaccine 2.16.840.1.113883.6.96 2016-07 386013003 Rubella vaccine 2.16.840.1.113883.6.96 2016-07 414004005 Diphtheria + tetanus + pertussis + poliomyelitis + haemophilus influenzae b vaccine 2.16.840.1.113883.6.96 2016-07 414005006 Diphtheria + tetanus + pertussis + poliomyelitis vaccine 2.16.840.1.113883.6.96 2016-07 420538001 Tuberculosis vaccine 2.16.840.1.113883.6.96 2016-07 421245007 Diphtheria + pertussis + tetanus vaccine 2.16.840.1.113883.6.96 2016-07 423531006 Meningococcus vaccine 2.16.840.1.113883.6.96 2016-07 424519000 Human papillomavirus vaccine 2.16.840.1.113883.6.96 2016-07 427036009 Influenza virus H5N1 vaccine 2.16.840.1.113883.6.96 2016-07 428214002 Diphtheria vaccine 2.16.840.1.113883.6.96 2016-07 46233009 Influenza virus vaccine (product) 2.16.840.1.113883.6.96 2016-07 56844000 Yellow fever vaccine 2.16.840.1.113883.6.96 2016-07 61153008 Measles + Mumps + Rubella vaccine 2.16.840.1.113883.6.96 2016-07 61602008 Pertussis vaccine 2.16.840.1.113883.6.96 2016-07 89428009 Typhoid vaccine 2.16.840.1.113883.6.96 2016-07 90043005 Mumps live virus vaccine

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 488 of 490 MTC epSOSVaccine

TRANSCODINGS

MVC NATIONAL CODE SYSTEM Code System ID Code System Version Concept Code Description (FSN) National Code System ID National Code System National Concept Code National Description Version

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 489 of 490 MTC

End Of Document

© eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 490 of 490